Citrus Sinensis ID: 038351
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 348 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.540 | 0.186 | 0.375 | 4e-33 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.566 | 0.192 | 0.365 | 9e-30 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.554 | 0.187 | 0.367 | 9e-29 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.545 | 0.279 | 0.317 | 3e-26 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.531 | 0.188 | 0.321 | 3e-26 | |
| O65530 | 731 | Proline-rich receptor-lik | no | no | 0.540 | 0.257 | 0.342 | 5e-26 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.545 | 0.249 | 0.327 | 3e-25 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.551 | 0.160 | 0.324 | 1e-24 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.551 | 0.159 | 0.315 | 1e-24 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.551 | 0.159 | 0.315 | 2e-24 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 142 bits (358), Expect = 4e-33, Method: Compositional matrix adjust.
Identities = 87/232 (37%), Positives = 128/232 (55%), Gaps = 44/232 (18%)
Query: 150 ELCRVTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKS 208
+L TNGFS N++ G FG+++KA + ++ +VK ++Q GA KSF EC+ +K
Sbjct: 694 DLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKD 753
Query: 209 TCYRNLIKIISSRSNEDF-----KVLVLEYMPRGSLEKCLYSSNY--------------- 248
+RNL+K++++ S+ DF + L+ E+MP GSL+ L+
Sbjct: 754 IRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLER 813
Query: 249 ------VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR--EDHFM 300
V L+YLH I H DLKPSNVL DD++ H+SDFG+A+LL++ E+ F
Sbjct: 814 LNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFF 873
Query: 301 IQTQTL---ATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337
Q + TIGY A VYSFGI+LLE+FT K+PTN++F
Sbjct: 874 NQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELF 925
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 131 bits (329), Expect = 9e-30, Method: Compositional matrix adjust.
Identities = 88/241 (36%), Positives = 124/241 (51%), Gaps = 44/241 (18%)
Query: 141 SYSKWFSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRME-FSVKGFHLQCSGAFKSF 199
S+ + S EL + T GFS NLI G FG++ K + + + ++K +L GA KSF
Sbjct: 702 SFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSF 761
Query: 200 DFECDVMKSTCYRNLIKII-----SSRSNEDFKVLVLEYMPRGSLEKCLYSSNY------ 248
EC+ + +RNL+K++ S DF+ LV E+MP G+L+ L+
Sbjct: 762 IAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNP 821
Query: 249 ---------------VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293
V AL YLH I H D+KPSN+L D ++ H+SDFG+A+LL
Sbjct: 822 SRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLL 881
Query: 294 IR--EDHFMIQTQTL---ATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336
++ D F IQ + TIGY A VYSFGI+LLE+FT K+PTNK+
Sbjct: 882 LKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKL 941
Query: 337 F 337
F
Sbjct: 942 F 942
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 127 bits (320), Expect = 9e-29, Method: Compositional matrix adjust.
Identities = 87/237 (36%), Positives = 120/237 (50%), Gaps = 44/237 (18%)
Query: 150 ELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEF-SVKGFHLQCSGAFKSFDFECDVMKS 208
EL T+ FS NLI G FG++ K + + +VK +L GA KSF EC+ K
Sbjct: 704 ELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKG 763
Query: 209 TCYRNLIKIIS-----SRSNEDFKVLVLEYMPRGSLEKCLYSSNY--------------- 248
+RNL+K+I+ DF+ LV E+MP+GSL+ L +
Sbjct: 764 IRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEK 823
Query: 249 ------VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH--FM 300
V ALEYLH + H D+KPSN+L DD++ H+SDFG+A+LL + D F+
Sbjct: 824 LNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFL 883
Query: 301 IQTQTL---ATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIFFSQRN 342
Q + TIGY A VYSFGI+LLE+F+ KKPT++ F N
Sbjct: 884 NQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYN 940
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 119 bits (299), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 69/217 (31%), Positives = 114/217 (52%), Gaps = 27/217 (12%)
Query: 145 WFSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECD 204
WFS EL +VT+GFSE NL+ GGFG ++K + D E +VK + S + F E +
Sbjct: 326 WFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVE 385
Query: 205 VMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY--------------VG 250
++ +R+L+ ++ +E ++LV +Y+P +L L++
Sbjct: 386 IISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAA 445
Query: 251 FALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED-HFMIQTQTLATI 309
+ YLH D IIH D+K SN+L D++ ++DFG+AK+ D + + T+ + T
Sbjct: 446 RGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTF 505
Query: 310 GYMA------------SYVYSFGIMLLEVFTRKKPTN 334
GYMA + VYS+G++LLE+ T +KP +
Sbjct: 506 GYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVD 542
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 119 bits (299), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 72/224 (32%), Positives = 116/224 (51%), Gaps = 39/224 (17%)
Query: 150 ELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFK-SFDFECDVMKS 208
+L T GF+ +LI G FG ++K +++ + +VK + + F SF EC ++K
Sbjct: 653 QLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKR 712
Query: 209 TCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY----------------VGFA 252
T +RNLI+II++ S F LVL MP GSLE+ LY Y V
Sbjct: 713 TRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEG 772
Query: 253 LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA----- 307
+ YLH V ++H DLKPSN+L DD + ++DFGI++L+ + + +++
Sbjct: 773 IAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTD 832
Query: 308 -----TIGYMASY------------VYSFGIMLLEVFTRKKPTN 334
++GY+A VYSFG++LLE+ + ++PT+
Sbjct: 833 GLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTD 876
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65530|PEK14_ARATH Proline-rich receptor-like protein kinase PERK14 OS=Arabidopsis thaliana GN=PERK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 119 bits (297), Expect = 5e-26, Method: Compositional matrix adjust.
Identities = 74/216 (34%), Positives = 111/216 (51%), Gaps = 28/216 (12%)
Query: 143 SKWFSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFE 202
S FS EL + T GFSE+NL+ GGFG +HK +++ E +VK + + F E
Sbjct: 374 SGMFSYEELSKATGGFSEENLLGEGGFGYVHKGVLKNGTEVAVKQLKIGSYQGEREFQAE 433
Query: 203 CDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN------------YVG 250
D + +++L+ ++ N D ++LV E++P+ +LE L+ + VG
Sbjct: 434 VDTISRVHHKHLVSLVGYCVNGDKRLLVYEFVPKDTLEFHLHENRGSVLEWEMRLRIAVG 493
Query: 251 FA--LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM--IQTQTL 306
A L YLH D S IIH D+K +N+L D +SDFG+AK + I T+ +
Sbjct: 494 AAKGLAYLHEDCSPTIIHRDIKAANILLDSKFEAKVSDFGLAKFFSDTNSSFTHISTRVV 553
Query: 307 ATIGYMA------------SYVYSFGIMLLEVFTRK 330
T GYMA S VYSFG++LLE+ T +
Sbjct: 554 GTFGYMAPEYASSGKVTDKSDVYSFGVVLLELITGR 589
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 116 bits (290), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 71/217 (32%), Positives = 114/217 (52%), Gaps = 27/217 (12%)
Query: 144 KWFSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFEC 203
+ FS EL TNGFS++NL+ GGFG ++K + D +VK + + F E
Sbjct: 416 ELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREFKAEV 475
Query: 204 DVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF------------ 251
D + +RNL+ ++ +E+ ++L+ +Y+P +L L+++ G
Sbjct: 476 DTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPGLDWATRVKIAAGA 535
Query: 252 --ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATI 309
L YLH D IIH D+K SN+L ++N +SDFG+AKL + + + I T+ + T
Sbjct: 536 ARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLAL-DCNTHITTRVMGTF 594
Query: 310 GYMA------------SYVYSFGIMLLEVFTRKKPTN 334
GYMA S V+SFG++LLE+ T +KP +
Sbjct: 595 GYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVD 631
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 114 bits (285), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 72/222 (32%), Positives = 111/222 (50%), Gaps = 30/222 (13%)
Query: 150 ELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGF-HLQCSGAFKSFDFECDVMKS 208
+L + TNGF D+LI GGFG ++KA ++D ++K H+ G + F E + +
Sbjct: 875 DLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQGD-REFMAEMETIGK 933
Query: 209 TCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF----------------A 252
+RNL+ ++ D ++LV E+M GSLE L+ G
Sbjct: 934 IKHRNLVPLLGYCKVGDERLLVYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAIGSARG 993
Query: 253 LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM 312
L +LH + S IIH D+K SNVL D+N+ +SDFG+A+L+ D + + T GY+
Sbjct: 994 LAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV 1053
Query: 313 ------------ASYVYSFGIMLLEVFTRKKPTNKIFFSQRN 342
VYS+G++LLE+ T K+PT+ F N
Sbjct: 1054 PPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSPDFGDNN 1095
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 114 bits (284), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 70/222 (31%), Positives = 111/222 (50%), Gaps = 30/222 (13%)
Query: 150 ELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGF-HLQCSGAFKSFDFECDVMKS 208
+L TNGF D+L+ GGFG ++KA+++D ++K H+ G + F E + +
Sbjct: 880 DLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGD-REFTAEMETIGK 938
Query: 209 TCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF----------------A 252
+RNL+ ++ + ++LV EYM GSLE L+ +G
Sbjct: 939 IKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKIGIKLNWPARRKIAIGAARG 998
Query: 253 LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM 312
L +LH + IIH D+K SNVL D+N+ +SDFG+A+L+ D + + T GY+
Sbjct: 999 LAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV 1058
Query: 313 ------------ASYVYSFGIMLLEVFTRKKPTNKIFFSQRN 342
VYS+G++LLE+ T K+PT+ F N
Sbjct: 1059 PPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNN 1100
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 113 bits (282), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 70/222 (31%), Positives = 110/222 (49%), Gaps = 30/222 (13%)
Query: 150 ELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGF-HLQCSGAFKSFDFECDVMKS 208
+L TNGF D+L+ GGFG ++KA+++D ++K H+ G + F E + +
Sbjct: 880 DLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGD-REFTAEMETIGK 938
Query: 209 TCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF----------------A 252
+RNL+ ++ + ++LV EYM GSLE L+ G
Sbjct: 939 IKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKTGIKLNWPARRKIAIGAARG 998
Query: 253 LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM 312
L +LH + IIH D+K SNVL D+N+ +SDFG+A+L+ D + + T GY+
Sbjct: 999 LAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYV 1058
Query: 313 ------------ASYVYSFGIMLLEVFTRKKPTNKIFFSQRN 342
VYS+G++LLE+ T K+PT+ F N
Sbjct: 1059 PPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNN 1100
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 348 | ||||||
| 302143445 | 2843 | unnamed protein product [Vitis vinifera] | 0.816 | 0.099 | 0.450 | 4e-61 | |
| 296085726 | 932 | unnamed protein product [Vitis vinifera] | 0.821 | 0.306 | 0.412 | 1e-60 | |
| 302143439 | 830 | unnamed protein product [Vitis vinifera] | 0.778 | 0.326 | 0.428 | 3e-57 | |
| 297740823 | 791 | unnamed protein product [Vitis vinifera] | 0.818 | 0.360 | 0.402 | 7e-56 | |
| 255585401 | 843 | serine-threonine protein kinase, plant-t | 0.810 | 0.334 | 0.416 | 1e-55 | |
| 62732903 | 1030 | Leucine Rich Repeat, putative [Oryza sat | 0.833 | 0.281 | 0.371 | 3e-55 | |
| 298204751 | 1979 | unnamed protein product [Vitis vinifera] | 0.804 | 0.141 | 0.405 | 1e-54 | |
| 359485453 | 1202 | PREDICTED: probable LRR receptor-like se | 0.818 | 0.237 | 0.414 | 9e-54 | |
| 242092142 | 1054 | hypothetical protein SORBIDRAFT_10g00476 | 0.816 | 0.269 | 0.382 | 2e-53 | |
| 297740829 | 1892 | unnamed protein product [Vitis vinifera] | 0.767 | 0.141 | 0.438 | 3e-53 |
| >gi|302143445|emb|CBI22006.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 241 bits (615), Expect = 4e-61, Method: Compositional matrix adjust.
Identities = 151/335 (45%), Positives = 206/335 (61%), Gaps = 51/335 (15%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ ++L SN L S IPS+ W L+ +L+LNLS N L G +PLE+ N+K L ++ S N F+G
Sbjct: 1581 QAINLHSNGLASEIPSSLWILRYLLFLNLSSNFLNGELPLEVGNMKSLEELDLSKNQFSG 1640
Query: 115 VIPNAIGCLNILQHLFLGYNRLQG---------SISYSKW----FSCLELCRVTNG---- 157
IP+ I L L L+L +N+LQG ++ Y K+ F+ L+ + NG
Sbjct: 1641 NIPSTISLLQNLLQLYLSHNKLQGHIPPNFDDLALKYLKYLNVSFNKLQ-GEIPNGGPFA 1699
Query: 158 -FSEDNLISRGGF------GSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC 210
F+ ++ IS G+++K + D + +VK F+L+ GAFKSF+ EC+VM++
Sbjct: 1700 NFTAESFISNLALCGAPRLGTVYKGVLSDGLIVAVKVFNLELQGAFKSFEVECEVMQNIR 1759
Query: 211 YRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------------VGFALEYLH 257
+RNL KIISS SN DFK LVLEYMP GSLEK LYS NY V LEYLH
Sbjct: 1760 HRNLAKIISSCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDFVQRLKIMIDVASGLEYLH 1819
Query: 258 FDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMASY-- 315
DYS ++H DLKP+NVL DD++V H+SDFGIAKLL+ + FM +T+TL TIGYMA
Sbjct: 1820 HDYSSPVVHCDLKPNNVLLDDDMVAHISDFGIAKLLMGSE-FMKRTKTLGTIGYMAPEYG 1878
Query: 316 ----------VYSFGIMLLEVFTRKKPTNKIFFSQ 340
+YSFGIML+E F RKKPT+++F +
Sbjct: 1879 SEGIVSTKCDIYSFGIMLMETFVRKKPTDEMFMEE 1913
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296085726|emb|CBI29526.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 239 bits (611), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 144/349 (41%), Positives = 196/349 (56%), Gaps = 63/349 (18%)
Query: 51 PPQQEN------LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVK 104
PP+ N L L+ N + IPS L+ ++ L+LS N L GPIP+E +L L
Sbjct: 468 PPEVGNMKSITTLDLSKNLVSGYIPSKMGKLQSLITLSLSQNRLQGPIPIEFGDLVSLES 527
Query: 105 IYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSIS----------------------- 141
+ S NN +G IP ++ L L++L + N+LQG I
Sbjct: 528 LDLSQNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFIRDNMEIPTP 587
Query: 142 YSKWF-------SCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSG 194
W S +L TN F EDNLI +G G ++K + + + ++K F+L+ G
Sbjct: 588 IDSWLPGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQG 647
Query: 195 AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY------ 248
A +SFD EC+VM+ +RNL++II+ SN DFK LVLEYMP GSLEK LYS NY
Sbjct: 648 ALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQ 707
Query: 249 -------VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301
V ALEYLH D S L++H DLKP+NVL DD++V H++DFGI KLL + + M
Sbjct: 708 RLNIMIDVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLTKTES-MQ 766
Query: 302 QTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKIF 337
QT+TL TIGYMA S VYS+GI+L+EVF+RKKP +++F
Sbjct: 767 QTKTLGTIGYMAPAEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMF 815
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143439|emb|CBI22000.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 228 bits (581), Expect = 3e-57, Method: Compositional matrix adjust.
Identities = 140/327 (42%), Positives = 187/327 (57%), Gaps = 56/327 (17%)
Query: 66 SVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNI 125
S IPS+ L++++ L+LS N+L GPIPL+ ++ L + S NN +G IP ++ L
Sbjct: 472 SYIPSSVGQLQNLVELSLSKNNLQGPIPLKFGDVVSLESLDLSWNNLSGTIPQSLEALIY 531
Query: 126 LQHLFLGYNRLQGSISYSKWF-------------------------------SCLELCRV 154
L+HL + +N+ QG I F S EL
Sbjct: 532 LKHLNVSFNKRQGEIRNGGPFVNFTAKSFISNEALYIPIQVDSSLPTTYRKISHQELLHA 591
Query: 155 TNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNL 214
TN FSE NLI +G G+++K + D + ++K F+L+ G+FK F+ EC+VM++ +RNL
Sbjct: 592 TNYFSEGNLIGKGSMGTVYKGVLFDGLTAAIKVFNLEFLGSFKGFEAECEVMRNIRHRNL 651
Query: 215 IKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------------VGFALEYLHFDYS 261
IKIISS SN FK LVLE+MP SLE+ LYS NY V ALEYLH DYS
Sbjct: 652 IKIISSCSNLGFKALVLEFMPNRSLERWLYSHNYCLDLIQRLNIMIDVASALEYLHHDYS 711
Query: 262 VLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA-------- 313
++H DLKP+NVL D++ V H+ DFGIAKLL + QT+TL IGYMA
Sbjct: 712 NPVVHCDLKPNNVLLDEDRVAHVGDFGIAKLLPGSESRQ-QTKTLGPIGYMAPEYGSEGI 770
Query: 314 ---SYVYSFGIMLLEVFTRKKPTNKIF 337
S VYS GIMLLEVF RKKPT+++F
Sbjct: 771 VSTSDVYSNGIMLLEVFARKKPTDEMF 797
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740823|emb|CBI31005.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 223 bits (569), Expect = 7e-56, Method: Compositional matrix adjust.
Identities = 146/363 (40%), Positives = 189/363 (52%), Gaps = 78/363 (21%)
Query: 52 PQQENLSLASNELISVIPSTFW----NLKDILYLNLSLNSLTGPIPLEIENLKVLVKIY- 106
P E L + NE IP F N K + L + N L G +P + NL V ++ +
Sbjct: 268 PDLEGLFIGGNEFSGTIPVGFLTSLTNCKFLRTLWIDYNPLKGTLPNSLGNLSVALESFT 327
Query: 107 FSMNNFAGVIPNAIGCLNILQHLFLGYNRLQG-SISYSKWF------------------- 146
S +F G IP IG L L L LG N L G SY+K F
Sbjct: 328 ASACHFRGTIPTGIGNLTNLIWLDLGANDLTGFQHSYTKSFILKYILLPVGSIVTLVAFI 387
Query: 147 ---------------------------SCLELCRVTNGFSEDNLISRGGFGSIHKARIQD 179
S +L TN F EDNLI +G G ++K + +
Sbjct: 388 VLWIRRQDNTEIPAPIDSWLPGAHEKISQQQLLYATNDFGEDNLIGKGSLGMVYKGVLSN 447
Query: 180 RMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL 239
+ ++K F+L+ GA +SFD EC+VM+ C+RNLI+II+ SN DFK LVLEYMP+GSL
Sbjct: 448 GLTVAIKVFNLEFQGALRSFDSECEVMQGICHRNLIRIITCCSNLDFKALVLEYMPKGSL 507
Query: 240 EKCLYSSNY-------------VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSD 286
+K LYS NY V ALEYLH D S L++H DLKPSNVL D+N+V H++D
Sbjct: 508 DKWLYSHNYFLDLFQRLNIMIDVALALEYLHHDCSSLVVHCDLKPSNVLLDNNMVAHVAD 567
Query: 287 FGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTN 334
FGIA+LL E M QT+TL TIGYMA VYS+GI+L+EVF RKKP +
Sbjct: 568 FGIARLL-TETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVYSYGILLMEVFARKKPMD 626
Query: 335 KIF 337
++F
Sbjct: 627 EMF 629
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585401|ref|XP_002533396.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526770|gb|EEF28996.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 223 bits (568), Expect = 1e-55, Method: Compositional matrix adjust.
Identities = 143/343 (41%), Positives = 191/343 (55%), Gaps = 61/343 (17%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLE-----------IENLKV-- 101
E+L L+SN L IP + LK + YLN+S N+L G +P + + NL +
Sbjct: 417 ESLDLSSNNLSGKIPKSLEQLKYLKYLNVSFNNLDGEVPNKGAFANFSASSFLGNLALCG 476
Query: 102 --LVKIYFSMNNFAG------------VIPNAIGCLNIL------QHLFLGYNRLQGSIS 141
L+ + NN G V+P +I + + Q + L + I+
Sbjct: 477 SRLLPLMPCKNNTHGGSKTSTKLLLIYVLPASILTIAFILVFLRCQKVKLELENVMDIIT 536
Query: 142 YSKW--FSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSF 199
W S EL + T+GF NL+ GG+GS++K R++D ++K F+L GAFK F
Sbjct: 537 VGTWRRISFQELEQATDGFCASNLLGAGGYGSVYKGRLEDGTNVAIKVFNLGVEGAFKIF 596
Query: 200 DFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY----------- 248
D EC+VM S +RNL+KIIS SN+DFK +VLEYMP GSLEK LYS NY
Sbjct: 597 DTECEVMSSIRHRNLVKIISCCSNQDFKAIVLEYMPNGSLEKWLYSHNYCLNIQQRLEVM 656
Query: 249 --VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTL 306
V ALEYLH +S I+H DLKPSNVL D ++V H++DFG+AKLL E + QT+TL
Sbjct: 657 IDVASALEYLHHGFSAPIVHCDLKPSNVLLDQDMVGHVADFGMAKLL-GEGDLITQTKTL 715
Query: 307 ATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337
ATIGYMA VYSFGI+L+E FTR KPT+ +F
Sbjct: 716 ATIGYMAPEYGSKGIVSISGDVYSFGILLMETFTRMKPTDDMF 758
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|62732903|gb|AAX95022.1| Leucine Rich Repeat, putative [Oryza sativa Japonica Group] gi|77552642|gb|ABA95439.1| Leucine Rich Repeat family protein, expressed [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 221 bits (564), Expect = 3e-55, Method: Compositional matrix adjust.
Identities = 129/347 (37%), Positives = 180/347 (51%), Gaps = 57/347 (16%)
Query: 53 QQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNF 112
Q + L+SN ++P + L+ I YLNLS+NS IP L L + S NN
Sbjct: 595 QMNIMDLSSNHFTGILPDSIAQLQMIAYLNLSVNSFQNSIPDSFRVLTSLETLDLSHNNI 654
Query: 113 AGVIPNAIGCLNILQHLFLGYNRLQGSI--SYSKWFSCL--------------------- 149
+G IP + +L L L +N L G I + CL
Sbjct: 655 SGTIPEYLANFTVLSSLNLSFNNLHGQIPETVGAVACCLHVILKKKVKHQKMSVGMVDMA 714
Query: 150 --------ELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDF 201
EL R TN FS+DN++ G FG + K ++ + ++K H A +SFD
Sbjct: 715 SHQLLSYHELARATNDFSDDNMLGSGSFGEVFKGQLSSGLVVAIKVIHQHMEHAIRSFDT 774
Query: 202 ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY------------- 248
EC V+++ +RNLIKI+++ SN DF+ LVLEYMP GSLE L+S
Sbjct: 775 ECQVLRTARHRNLIKILNTCSNLDFRALVLEYMPNGSLEALLHSDQRIQLSFLERLDIML 834
Query: 249 -VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA 307
V A+EYLH ++ +++H DLKPSNVLFDD++ H+SDFGIA+LL+ +D MI
Sbjct: 835 DVSMAMEYLHHEHCEVVLHCDLKPSNVLFDDDMTAHVSDFGIARLLLGDDSSMISASMPG 894
Query: 308 TIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIFFSQRN 342
T+ YMA S V+S+GIMLLEVFT K+PT+ +F + N
Sbjct: 895 TVRYMAPEYGALGKASRKSDVFSYGIMLLEVFTAKRPTDAMFVGELN 941
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|298204751|emb|CBI25249.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 219 bits (559), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 140/345 (40%), Positives = 185/345 (53%), Gaps = 65/345 (18%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVI 116
+ L+ N+L IPS L+D+ L+L+ N GPI NLK L + S N G I
Sbjct: 1070 IDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEI 1129
Query: 117 PNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLE---------LCR-------------- 153
P ++ L L++L + +N L G I F+ LCR
Sbjct: 1130 PKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCRKRNAVLPTQSESLL 1189
Query: 154 --------------VTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSF 199
TNGFS NL+ RG GS+++ + D ++K F+LQ AFKSF
Sbjct: 1190 TATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSF 1249
Query: 200 DFECDVMKSTCYRNLIKIISSRSNE--DFKVLVLEYMPRGSLEKCLYSSNY--------- 248
D EC+VM +RNLIKI+SS SN DFK LVLEY+P GSLE+ LYS NY
Sbjct: 1250 DAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLN 1309
Query: 249 ----VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304
V A+EYLH S ++H DLKPSN+L D++ H+ DFGIAKLL RE+ + +TQ
Sbjct: 1310 IMIDVALAMEYLHHGCSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLL-REEESIRETQ 1368
Query: 305 TLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337
TLATIGYMA VYS+GI+L+E FTR++PT++IF
Sbjct: 1369 TLATIGYMAPKYVSNGIVTTSGDVYSYGIVLMETFTRRRPTDEIF 1413
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 216 bits (551), Expect = 9e-54, Method: Compositional matrix adjust.
Identities = 144/347 (41%), Positives = 191/347 (55%), Gaps = 62/347 (17%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLE-----------IENLKVLV 103
E+L L+ N L IP + +LK + YLN+S N L G IP I NL +
Sbjct: 779 ESLDLSGNNLSGTIPKSLEHLKYLEYLNVSFNKLQGEIPNGGPFANFTAESFISNLALCG 838
Query: 104 KIYF--------SMNNFAGVIPNAIGCLN------ILQHLFLGYNR--------LQGSIS 141
F S N ++ I L+ IL LF+ + R +Q +S
Sbjct: 839 APRFQVMACEKDSRKNTKSLLLKCIVPLSVSLSTIILVVLFVQWKRRQTKSETPIQVDLS 898
Query: 142 YSKWFSCL---ELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKS 198
+ + EL TN F EDNLI +G G ++K + D + +VK F+L+ GAFKS
Sbjct: 899 LPRMHRMIPHQELLYATNYFGEDNLIGKGSLGMVYKGVLSDGLIVAVKVFNLELQGAFKS 958
Query: 199 FDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY---------- 248
F+ EC+VM++ +RNL KIISS SN DFK LVLEYMP GSLEK LYS NY
Sbjct: 959 FEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDFVQRLKI 1018
Query: 249 ---VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT 305
V LEYLH YS ++H DLKPSNVL DD++V H+SDFGIAKLL+ + FM +T+T
Sbjct: 1019 MIDVASGLEYLHHYYSNPVVHCDLKPSNVLLDDDMVAHISDFGIAKLLMGSE-FMKRTKT 1077
Query: 306 LATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIFFSQ 340
L T+GYMA +YS+GI+L+E F RKKPT+++F +
Sbjct: 1078 LGTVGYMAPEYGSEGIVSTKGDIYSYGILLMETFVRKKPTDEMFVEE 1124
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|242092142|ref|XP_002436561.1| hypothetical protein SORBIDRAFT_10g004760 [Sorghum bicolor] gi|241914784|gb|EER87928.1| hypothetical protein SORBIDRAFT_10g004760 [Sorghum bicolor] | Back alignment and taxonomy information |
|---|
Score = 216 bits (549), Expect = 2e-53, Method: Compositional matrix adjust.
Identities = 132/345 (38%), Positives = 186/345 (53%), Gaps = 61/345 (17%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVI 116
+ L+SN+L +P +F L+ + YLNLS NS IP L L + S NN +G I
Sbjct: 617 IDLSSNQLFGDLPESFGQLQMLTYLNLSHNSFQDSIPNSFGKLASLEILDLSYNNLSGNI 676
Query: 117 PNAIGCLNILQHLFLGYNRLQGSI---SYSKWFSCL------------------------ 149
P + L L +L L +N+LQG I ++ CL
Sbjct: 677 PMYLANLTYLTNLNLSFNKLQGRIPEGAFGAIVICLYVTIRRKNKNPGALTGSNNITDAV 736
Query: 150 --------ELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDF 201
E+ TN FSE+NL+ G FG + K ++ + + ++K ++Q A KSFD
Sbjct: 737 RHRLISYHEIVHATNNFSEENLLGVGCFGKVFKGQLNNGLVVAIKVLNVQLEAATKSFDA 796
Query: 202 ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN-------------- 247
EC V++ +RNLI+II++ SN DFK L+LEYMP GSL+ L++ +
Sbjct: 797 ECRVLRMVRHRNLIRIINTCSNLDFKALLLEYMPNGSLDAHLHNEDKPPLRFLKRLDIMI 856
Query: 248 YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA 307
V A+EYLH Y +I+H DLKPSNVLFDD++ H++DFGIAKLL+ +++ +I
Sbjct: 857 EVSMAVEYLHHQYHEVILHCDLKPSNVLFDDDMTVHVADFGIAKLLLGDNNSVISASMPG 916
Query: 308 TIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIFFSQ 340
TIGYMA S V+SFGIMLLEVFT KKPT+ +F +
Sbjct: 917 TIGYMAPEYGSMGKASRKSDVFSFGIMLLEVFTGKKPTDTMFVGE 961
|
Source: Sorghum bicolor Species: Sorghum bicolor Genus: Sorghum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740829|emb|CBI31011.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 214 bits (546), Expect = 3e-53, Method: Compositional matrix adjust.
Identities = 136/310 (43%), Positives = 184/310 (59%), Gaps = 43/310 (13%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVI 116
LSL SN L IP +FW+L+D+L LNLS N LT E +L L + S NN +G I
Sbjct: 1520 LSLDSNVLAFNIPMSFWSLRDLLVLNLSSNFLT-----EFGDLVSLESLDLSQNNLSGTI 1574
Query: 117 PNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLELCRVTNGFSEDNLISRGGFGSIH--- 173
P + L L++L + +N+LQG I F + T +E + + G+ H
Sbjct: 1575 PKTLEALIYLKYLNVSFNKLQGEIPNGGPF-----VKFT---AESFMFNEALCGAPHFQV 1626
Query: 174 -KARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232
+ + + ++K F+L+ GA +SF+ EC+VM+ +RNL++II+ SN DFK LVL+
Sbjct: 1627 MAWVLSNGLTVAIKVFNLEFQGALRSFNSECEVMQGIRHRNLVRIITCCSNLDFKALVLK 1686
Query: 233 YMPRGSLEKCLYSSNY-------------VGFALEYLHFDYSVLIIHYDLKPSNVLFDDN 279
YMP GSLEK LYS Y V ALEYLH D S L++H DLKPSNVL DD+
Sbjct: 1687 YMPNGSLEKLLYSHYYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDD 1746
Query: 280 IVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVF 327
+V H++DFGIAKLL E M QT+TL+TIGYMA S VYS+GI+L+EVF
Sbjct: 1747 MVAHVADFGIAKLL-TETESMQQTKTLSTIGYMAPEHGSAGIVSTKSDVYSYGILLMEVF 1805
Query: 328 TRKKPTNKIF 337
RKKP +++F
Sbjct: 1806 ARKKPMDEMF 1815
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 348 | ||||||
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.272 | 0.094 | 0.376 | 1.4e-37 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.272 | 0.094 | 0.376 | 4.2e-37 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.272 | 0.093 | 0.366 | 1.6e-35 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.439 | 0.156 | 0.361 | 8.6e-34 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.293 | 0.099 | 0.376 | 3.2e-33 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.477 | 0.158 | 0.366 | 9.9e-33 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.270 | 0.091 | 0.42 | 1.1e-32 | |
| TAIR|locus:2206179 | 592 | FEI1 "FEI 1" [Arabidopsis thal | 0.557 | 0.327 | 0.321 | 6.9e-32 | |
| TAIR|locus:2170668 | 604 | AT5G62710 [Arabidopsis thalian | 0.548 | 0.316 | 0.322 | 5.1e-31 | |
| TAIR|locus:2058759 | 589 | FEI2 "FEI 2" [Arabidopsis thal | 0.557 | 0.329 | 0.318 | 4.2e-30 |
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 182 (69.1 bits), Expect = 1.4e-37, Sum P(4) = 1.4e-37
Identities = 38/101 (37%), Positives = 64/101 (63%)
Query: 150 ELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEF-SVKGFHLQCSGAFKSFDFECDVMKS 208
+L T+GFS N++ G FG++ KA +Q + +VK ++Q GA KSF EC+ +K
Sbjct: 693 DLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKD 752
Query: 209 TCYRNLIKIISSRSNEDF-----KVLVLEYMPRGSLEKCLY 244
+RNL+K++++ ++ DF + L+ E+MP GSL+K L+
Sbjct: 753 IRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLH 793
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 183 (69.5 bits), Expect = 4.2e-37, Sum P(4) = 4.2e-37
Identities = 38/101 (37%), Positives = 64/101 (63%)
Query: 150 ELCRVTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKS 208
+L TNGFS N++ G FG+++KA + ++ +VK ++Q GA KSF EC+ +K
Sbjct: 694 DLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKD 753
Query: 209 TCYRNLIKIISSRSNEDF-----KVLVLEYMPRGSLEKCLY 244
+RNL+K++++ S+ DF + L+ E+MP GSL+ L+
Sbjct: 754 IRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLH 794
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 182 (69.1 bits), Expect = 1.6e-35, Sum P(4) = 1.6e-35
Identities = 37/101 (36%), Positives = 63/101 (62%)
Query: 150 ELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEF-SVKGFHLQCSGAFKSFDFECDVMKS 208
+L TNGFS N++ G FG++ KA + + +VK ++Q GA KSF EC+ +K
Sbjct: 695 DLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKD 754
Query: 209 TCYRNLIKIISSRSNEDF-----KVLVLEYMPRGSLEKCLY 244
T +RNL+K++++ ++ DF + L+ EY+P GS++ L+
Sbjct: 755 TRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLH 795
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 248 (92.4 bits), Expect = 8.6e-34, Sum P(3) = 8.6e-34
Identities = 64/177 (36%), Positives = 94/177 (53%)
Query: 137 QGSISYSKWFSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFH----LQC 192
Q Y + S +L T GF+ +LI G FG ++K +++ + +VK L+
Sbjct: 641 QNDPKYPR-ISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEF 699
Query: 193 SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY---- 248
SG+FK EC ++K T +RNLI+II++ S F LVL MP GSLE+ LY Y
Sbjct: 700 SGSFKR---ECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKN 756
Query: 249 ------------VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293
V + YLH V ++H DLKPSN+L DD + ++DFGI++L+
Sbjct: 757 LDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLV 813
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 164 (62.8 bits), Expect = 3.2e-33, Sum P(4) = 3.2e-33
Identities = 41/109 (37%), Positives = 63/109 (57%)
Query: 142 YSKWFSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRME-FSVKGFHLQCSGAFKSFD 200
Y K S EL + T GFS NLI G FG++ K + + + ++K +L GA KSF
Sbjct: 704 YEK-ISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFI 762
Query: 201 FECDVMKSTCYRNLIKIIS--SRSN---EDFKVLVLEYMPRGSLEKCLY 244
EC+ + +RNL+K+++ S S+ DF+ LV E+MP G+L+ L+
Sbjct: 763 AECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLH 811
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 258 (95.9 bits), Expect = 9.9e-33, Sum P(2) = 9.9e-33
Identities = 67/183 (36%), Positives = 97/183 (53%)
Query: 146 FSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDV 205
F+ EL T F N + GGFG+++K + D E +VK + F E
Sbjct: 698 FTYSELKNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQLSIGSRQGKGQFVAEIIA 757
Query: 206 MKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLY---------SSNY---VGFA- 252
+ S +RNL+K+ D ++LV EY+P GSL++ L+ S+ Y +G A
Sbjct: 758 ISSVLHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFGDKSLHLDWSTRYEICLGVAR 817
Query: 253 -LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI-REDHFMIQTQTLATIG 310
L YLH + SV IIH D+K SN+L D +V +SDFG+AKL ++ H I T+ TIG
Sbjct: 818 GLVYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYDDKKTH--ISTRVAGTIG 875
Query: 311 YMA 313
Y+A
Sbjct: 876 YLA 878
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 164 (62.8 bits), Expect = 1.1e-32, Sum P(4) = 1.1e-32
Identities = 42/100 (42%), Positives = 58/100 (58%)
Query: 150 ELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEF-SVKGFHLQCSGAFKSFDFECDVMKS 208
EL T+ FS NLI G FG++ K + + +VK +L GA KSF EC+ K
Sbjct: 704 ELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKG 763
Query: 209 TCYRNLIKII---SSRSNE--DFKVLVLEYMPRGSLEKCL 243
+RNL+K+I SS +E DF+ LV E+MP+GSL+ L
Sbjct: 764 IRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWL 803
|
|
| TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 264 (98.0 bits), Expect = 6.9e-32, Sum P(2) = 6.9e-32
Identities = 71/221 (32%), Positives = 117/221 (52%)
Query: 146 FSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDV 205
+S ++ + +E+++I GGFG+++K + D F++K G + F+ E ++
Sbjct: 294 YSSKDIIKKLEMLNEEHIIGCGGFGTVYKLAMDDGKVFALKRILKLNEGFDRFFERELEI 353
Query: 206 MKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN------------YVGFA- 252
+ S +R L+ + ++ K+L+ +Y+P GSL++ L+ +G A
Sbjct: 354 LGSIKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHVERGEQLDWDSRVNIIIGAAK 413
Query: 253 -LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
L YLH D S IIH D+K SN+L D N+ +SDFG+AKLL E+ I T T GY
Sbjct: 414 GLSYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGY 472
Query: 312 MA-SY-----------VYSFGIMLLEVFTRKKPTNKIFFSQ 340
+A Y VYSFG+++LEV + K+PT+ F +
Sbjct: 473 LAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEK 513
|
|
| TAIR|locus:2170668 AT5G62710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 267 (99.0 bits), Expect = 5.1e-31, Sum P(2) = 5.1e-31
Identities = 71/220 (32%), Positives = 115/220 (52%)
Query: 146 FSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDV 205
+S EL E++++ GGFG++++ + D F+VK G+ + F+ E ++
Sbjct: 300 YSSTELIEKLESLDEEDIVGSGGFGTVYRMVMNDLGTFAVKKIDRSRQGSDRVFEREVEI 359
Query: 206 MKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSS-------NY-------VGF 251
+ S + NL+ + ++L+ +Y+ GSL+ L+ N+ +G
Sbjct: 360 LGSVKHINLVNLRGYCRLPSSRLLIYDYLTLGSLDDLLHERAQEDGLLNWNARLKIALGS 419
Query: 252 A--LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATI 309
A L YLH D S I+H D+K SN+L +D + +SDFG+AKLL+ ED + T T
Sbjct: 420 ARGLAYLHHDCSPKIVHRDIKSSNILLNDKLEPRVSDFGLAKLLVDEDAH-VTTVVAGTF 478
Query: 310 GYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337
GY+A S VYSFG++LLE+ T K+PT+ IF
Sbjct: 479 GYLAPEYLQNGRATEKSDVYSFGVLLLELVTGKRPTDPIF 518
|
|
| TAIR|locus:2058759 FEI2 "FEI 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 261 (96.9 bits), Expect = 4.2e-30, Sum P(2) = 4.2e-30
Identities = 70/220 (31%), Positives = 116/220 (52%)
Query: 146 FSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDV 205
++ ++ + +E+++I GGFG+++K + D F++K G + F+ E ++
Sbjct: 292 YASKDIIKKLESLNEEHIIGCGGFGTVYKLSMDDGNVFALKRIVKLNEGFDRFFERELEI 351
Query: 206 MKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN-----------YVGFA-- 252
+ S +R L+ + ++ K+L+ +Y+P GSL++ L+ +G A
Sbjct: 352 LGSIKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHKRGEQLDWDSRVNIIIGAAKG 411
Query: 253 LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM 312
L YLH D S IIH D+K SN+L D N+ +SDFG+AKLL E+ I T T GY+
Sbjct: 412 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYL 470
Query: 313 A-SY-----------VYSFGIMLLEVFTRKKPTNKIFFSQ 340
A Y VYSFG+++LEV + K PT+ F +
Sbjct: 471 APEYMQSGRATEKTDVYSFGVLVLEVLSGKLPTDASFIEK 510
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 348 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-22 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-21 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-20 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-15 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-14 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-13 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-12 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-12 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-12 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-11 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-11 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-11 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-10 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-10 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-09 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-09 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-09 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-08 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-08 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-08 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-08 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-08 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-07 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-06 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-06 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-06 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-06 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-06 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-06 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-06 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-05 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-05 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-05 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-05 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-05 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-05 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-05 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-04 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-04 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-04 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-04 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-04 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 0.001 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.001 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 0.002 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 0.002 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 0.002 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 0.002 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.002 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 0.002 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 0.002 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 0.002 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 0.002 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 0.002 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.002 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 0.002 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 0.002 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.002 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 0.003 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 0.003 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 0.003 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 0.003 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 0.003 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.003 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 0.003 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 0.004 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.004 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 0.004 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.004 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-22
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 33/197 (16%)
Query: 164 ISRGGFGSIHKAR-IQDRMEFSVKGFHLQ--CSGAFKSFDFECDVMKSTCYRNLIKIISS 220
+ G FG+++KA+ +VK + S ++ E +++ + N++++I +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 221 RSNEDFKVLVLEYMPRGSL-----EKCLYSSNYVGF-------ALEYLHFDYSVLIIHYD 268
++D LV+EY G L S + LEYLH S IIH D
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH---SNGIIHRD 123
Query: 269 LKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA-------------SY 315
LKP N+L D+N V ++DFG+AK L++ + T + T YMA
Sbjct: 124 LKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAPEVLLGGNGYGPKVD 181
Query: 316 VYSFGIMLLEVFTRKKP 332
V+S G++L E+ T K P
Sbjct: 182 VWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 2e-21
Identities = 54/192 (28%), Positives = 86/192 (44%), Gaps = 36/192 (18%)
Query: 164 ISRGGFGSIHKARIQDRME-FSVKGFHLQ-CSGAFKSFDFECDVMKSTCYRNLIKIISSR 221
+ GGFG+++ AR + + ++K + S + E +++K + N++K+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 222 SNEDFKVLVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHFDYSVLIIHY 267
+E+ LV+EY GSL+ L N LEYLH S IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLH---SNGIIHR 116
Query: 268 DLKPSNVLFDDNIVT-HLSDFGIAKLLIREDHFMIQTQTLATIGYMA--------SY--- 315
DLKP N+L D + L+DFG++KLL + + T YMA Y
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 316 --VYSFGIMLLE 325
++S G++L E
Sbjct: 175 SDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 5e-20
Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 37/212 (17%)
Query: 162 NLISRGGFGSIHKAR-IQDRMEFSVKGFHLQ-CSGAFKSFDFECDVMKSTCYRNLIKIIS 219
+ G FG ++ AR + ++K + + E ++K + N++++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 220 SRSNEDFKVLVLEYMPRGSLEKCLYSSNY-----VGF-------ALEYLHFDYSVLIIHY 267
+ED LV+EY G L L F ALEYLH S I+H
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH---SKGIVHR 121
Query: 268 DLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA-------SY----- 315
DLKP N+L D++ L+DFG+A+ L + T + T YMA Y
Sbjct: 122 DLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFVGTPEYMAPEVLLGKGYGKAVD 178
Query: 316 VYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
++S G++L E+ T K P F + + L
Sbjct: 179 IWSLGVILYELLTGKPP-----FPGDDQLLEL 205
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 36/202 (17%)
Query: 162 NLISRGGFGSIHKARIQDRME-FSVKGFHLQCSGA--FKSFDFECDVMKSTCYRNLIKII 218
L+ RG FGS++ A +D E +VK L ++ + E ++ S + N+++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 219 SSRSNEDFKVL--VLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHFDYSV 262
S +E+ L LEY+ GSL L + L YLH S
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQILEGLAYLH---SN 120
Query: 263 LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA--------- 313
I+H D+K +N+L D + V L+DFG AK L + T +MA
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 314 ---SYVYSFGIMLLEVFTRKKP 332
+ ++S G ++E+ T K P
Sbjct: 181 GRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 2e-14
Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 34/196 (17%)
Query: 164 ISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRS 222
I +GGFG ++KAR + E ++K L+ + E ++K + N++K S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 223 NEDFKVLVLEYMPRGSLEKCLYSSN------YVGF-------ALEYLHFDYSVLIIHYDL 269
+D +V+E+ GSL+ L S+N + + LEYLH S IIH D+
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124
Query: 270 KPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMA------------SYV 316
K +N+L + L DFG++ L T+ T +MA + +
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDT----KARNTMVGTPYWMAPEVINGKPYDYKADI 180
Query: 317 YSFGIMLLEVFTRKKP 332
+S GI +E+ K P
Sbjct: 181 WSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 2e-13
Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 49/210 (23%)
Query: 162 NLISRGGFGSIHKARIQDRMEFSV-------KGFHLQCSGAFKSFDFECDVMKSTCYRNL 214
+ G FG ++K +++ + + K K F E VMK + N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNV 58
Query: 215 IKII--SSRSNEDFKVLVLEYMPRGSL---------------EKCLYSSNYVGFA----- 252
++++ + + LVLEYM G L + L + + FA
Sbjct: 59 VRLLGVCTEEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 253 -LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
+EYL S +H DL N L +++V +SDFG+++ + +D++ +T I +
Sbjct: 117 GMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173
Query: 312 MA------------SYVYSFGIMLLEVFTR 329
MA S V+SFG++L E+FT
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTL 203
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 2e-13
Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 35/197 (17%)
Query: 164 ISRGGFGSIHKARIQDRMEFS-----VKGFHLQCSG-AFKSFDFECDVMKSTCYRNLIKI 217
+ G FG ++K +++ + VK S + F E +M+ + N++K+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 218 ISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------VGFAL------EYLHFDYSVLI 264
+ + E+ +V+EYM G L L + + FAL EYL S
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNF 123
Query: 265 IHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA----------- 313
IH DL N L +N+V +SDFG+++ + +D + + I +MA
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWMAPESLKEGKFTS 182
Query: 314 -SYVYSFGIMLLEVFTR 329
S V+SFG++L E+FT
Sbjct: 183 KSDVWSFGVLLWEIFTL 199
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 38/87 (43%), Positives = 47/87 (54%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVI 116
L L N L+ IP++ NL + +L L+ N L G IP E+ +K L IY NN +G I
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228
Query: 117 PNAIGCLNILQHLFLGYNRLQGSISYS 143
P IG L L HL L YN L G I S
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSS 255
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 31/91 (34%), Positives = 48/91 (52%)
Query: 50 RPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSM 109
+ ENL L+ N+ +P +L +++ L LS N L+G IP E+ + K LV + S
Sbjct: 473 GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSH 532
Query: 110 NNFAGVIPNAIGCLNILQHLFLGYNRLQGSI 140
N +G IP + + +L L L N+L G I
Sbjct: 533 NQLSGQIPASFSEMPVLSQLDLSQNQLSGEI 563
|
Length = 968 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (159), Expect = 4e-12
Identities = 50/158 (31%), Positives = 72/158 (45%), Gaps = 35/158 (22%)
Query: 202 ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY------------V 249
E +++ + ++K+ + E+ LVLEY P G L L +
Sbjct: 43 ERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEI 102
Query: 250 GFALEYLHFDYSVLIIHYDLKPSNVLFDD--NIVTHLSDFGIAKLLIREDHFMIQTQTLA 307
ALEYLH S+ II+ DLKP N+L D +I L+DFG+AK L E +T T
Sbjct: 103 VLALEYLH---SLGIIYRDLKPENILLDADGHIK--LTDFGLAKELSSEGS---RTNTFC 154
Query: 308 -TIGYMASYV------------YSFGIMLLEVFTRKKP 332
T Y+A V +S G++L E+ T K P
Sbjct: 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 7e-12
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 36/198 (18%)
Query: 164 ISRGGFGSIHKARIQD-----RMEFSVKGFHLQCSG-AFKSFDFECDVMKSTCYRNLIKI 217
+ G FG ++K ++ +E +VK S + F E +M+ + N++K+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 218 ISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY--------VGFAL------EYLHFDYSVL 263
+ + E+ ++V+EYMP G L L + + FAL EYL S
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123
Query: 264 IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA---------- 313
IH DL N L +N+V +SDFG+++ + +D + I +MA
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAPESLKEGKFT 182
Query: 314 --SYVYSFGIMLLEVFTR 329
S V+SFG++L E+FT
Sbjct: 183 SKSDVWSFGVLLWEIFTL 200
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 41/135 (30%), Positives = 56/135 (41%), Gaps = 42/135 (31%)
Query: 229 LVLEYMPRGSLEKCLYSSNYVG------------FALEYLHFDYSVLIIHYDLKPSNVLF 276
+VLEYM GSL L + L+YLH IIH D+KPSN+L
Sbjct: 76 IVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLI 133
Query: 277 DDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-------TIGYM------------ASYVY 317
+ ++DFGI+K+L TL T+ YM A+ ++
Sbjct: 134 NSKGEVKIADFGISKVL---------ENTLDQCNTFVGTVTYMSPERIQGESYSYAADIW 184
Query: 318 SFGIMLLEVFTRKKP 332
S G+ LLE K P
Sbjct: 185 SLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 40/202 (19%)
Query: 162 NLISRGGFGSIHKARIQDRMEFS-VKGFHLQ--CSGAFKSFDFECDVMKSTCYRNLIKII 218
+LI RG FG ++K + +F +K L+ A KS E D++K+ + N++K I
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 219 SSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHFDYSVLI 264
S D ++LEY GSL + + + F L YLH +
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVYQVLQGLAYLH---EQGV 120
Query: 265 IHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH----------FM----IQTQTLATIG 310
IH D+K +N+L + V L+DFG+A L +M I+ +T
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST-- 178
Query: 311 YMASYVYSFGIMLLEVFTRKKP 332
AS ++S G ++E+ T P
Sbjct: 179 --ASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (152), Expect = 4e-11
Identities = 50/198 (25%), Positives = 85/198 (42%), Gaps = 40/198 (20%)
Query: 166 RGGFGSIHKARIQDRMEFS-----VK----GFHLQCSGAFKSFDFECDVMKSTCYRNLIK 216
G FG ++K ++ E + VK G + F E +MK + N+++
Sbjct: 9 EGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLE---EASIMKKLSHPNIVR 65
Query: 217 IISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------VGFA------LEYLHFDYSVL 263
++ + + +V EYMP G L L + A +EYL S
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKN 122
Query: 264 IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA---------- 313
+H DL N L +N+V +SDFG+++ + +D++ + I +MA
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182
Query: 314 --SYVYSFGIMLLEVFTR 329
S V+SFG++L E+FT
Sbjct: 183 SKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 37/89 (41%), Positives = 52/89 (58%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
E L+LASN+L+ IP +K + ++ L N+L+G IP EI L L + NN G
Sbjct: 191 EFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTG 250
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYS 143
IP+++G L LQ+LFL N+L G I S
Sbjct: 251 PIPSSLGNLKNLQYLFLYQNKLSGPIPPS 279
|
Length = 968 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 5e-11
Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 32/177 (18%)
Query: 184 SVKGFHLQCSGAFKS-FDFECDVMKSTCYRNLIKI--ISSRSNEDFKVLVLEYMPRGSLE 240
+VK +C S + E +++K+ + N++K S L++EY+P GSL
Sbjct: 37 AVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLR 96
Query: 241 KCLYSSNYVGFA------------LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFG 288
L + + A + YLH S IH DL NVL D++ + + DFG
Sbjct: 97 DYL-PKHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFG 152
Query: 289 IAKLL--------IREDH----FMIQTQTLATIG-YMASYVYSFGIMLLEVFTRKKP 332
+AK + +RED F + L AS V+SFG+ L E+ T
Sbjct: 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDS 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 9e-11
Identities = 50/216 (23%), Positives = 85/216 (39%), Gaps = 54/216 (25%)
Query: 164 ISRGGFGSIHKARI------QDRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIK 216
+ G FG + D+ +VK S A K F+ E +++ + + N++K
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 217 IISSRSNEDFKVLVLEYMPRGSLEKCLYS--------------------------SNYVG 250
+ D ++V EYM G L K L S + +
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 251 FALEYL---HFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA 307
+ YL HF +H DL N L ++V + DFG+++ + D++ + T+
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 308 TIGYMA------------SYVYSFGIMLLEVFTRKK 331
I +M S V+SFG++L E+FT K
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 9e-11
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 36/220 (16%)
Query: 157 GFSEDNLISRGGFGSIHKARIQDR-----MEFSVKGFHLQCSGAFKSFDFECDVMKSTCY 211
F +I +G FG + + +D M++ K ++ G+ ++ E +++ +
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE-KGSVRNVLNERRILQELNH 59
Query: 212 RNLIKIISSRSNEDFKVLVLEYMPRGSL-----EKCLYSSNYVGF-------ALEYLHFD 259
L+ + S +E+ LV++ + G L +K +S V F ALEYLH
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH-- 117
Query: 260 YSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA-----S 314
S IIH D+KP N+L D+ H++DF IA + + + T T T GYMA
Sbjct: 118 -SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCR 173
Query: 315 YVYSF-------GIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
YS G+ E K+P + R+ I+A
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK 213
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 9e-11
Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 42/215 (19%)
Query: 158 FSEDNL-----ISRGGFGSIHKARI-----QDRMEFSVKGFHLQCSGAFKS-FDFECDVM 206
F + +L + G FG + R + +VK + +S F+ E +++
Sbjct: 1 FEKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEIL 60
Query: 207 KSTCYRNLIKI--ISSRSNEDFKVLVLEYMPRGSLEKCLY-------SSNYVGFAL---- 253
++ + N++K + + L++EY+P GSL L + F+
Sbjct: 61 RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICK 120
Query: 254 --EYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL--------IREDH----F 299
+YL S IH DL N+L + + +SDFG+AK+L ++E F
Sbjct: 121 GMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 300 MIQTQTLAT-IGYMASYVYSFGIMLLEVFTRKKPT 333
+ L T AS V+SFG+ L E+FT P+
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (147), Expect = 2e-10
Identities = 53/208 (25%), Positives = 84/208 (40%), Gaps = 48/208 (23%)
Query: 162 NLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSG------AFKSFDFECDVMKSTCYRNL 214
I +G FG ++ R D + +K L A E ++K + N+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61
Query: 215 IKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVG----------------FALEYLHF 258
IK S + +V+EY G L + + G AL+YLH
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120
Query: 259 DYSVLIIHYDLKPSNV-LFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMA--- 313
S I+H D+KP N+ L + +V L DFGI+K+L + +T+ T Y++
Sbjct: 121 --SRKILHRDIKPQNIFLTSNGLVK-LGDFGISKVL---SSTVDLAKTVVGTPYYLSPEL 174
Query: 314 ---------SYVYSFGIMLLEVFTRKKP 332
S ++S G +L E+ T K P
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 51/199 (25%), Positives = 81/199 (40%), Gaps = 37/199 (18%)
Query: 164 ISRGGFGSIHKAR-IQDRMEFSVKGF---HLQCSGAFKSFDFECDVMKSTCYRNLIKIIS 219
IS+G +G + A+ +++K + E D++ ++K+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 220 SRSNEDFKVLVLEYMPRGSLEKCLYSSNY------------VGFALEYLHFDYSVLIIHY 267
S + LV+EY+P G L L + + ALEYLH S IIH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLH---SNGIIHR 117
Query: 268 DLKPSNVLFDDNIVTHLSDFGIAKL-LIREDHFMIQT-----QTLATIGYMASYV----- 316
DLKP N+L D N L+DFG++K+ L+R + + + T Y+A V
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177
Query: 317 -------YSFGIMLLEVFT 328
+S G +L E
Sbjct: 178 HSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 46/197 (23%)
Query: 163 LISRGGFGSIHKARIQDRMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSR 221
I +G FG + + + + +VK L+ S A ++F E VM + + NL++++
Sbjct: 13 TIGKGEFGDVMLGDYRGQ-KVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 222 SNEDFKVLVLEYMPRGSLEKCLYS--------SNYVGFAL------EYLHFDYSVLIIHY 267
+ +V EYM +GSL L S + +GFAL EYL +H
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHR 126
Query: 268 DLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLAT----IGYMA---------- 313
DL NVL +++V +SDFG+AK +Q + + + A
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK---------EASQGQDSGKLPVKWTAPEALREKKFS 177
Query: 314 --SYVYSFGIMLLEVFT 328
S V+SFGI+L E+++
Sbjct: 178 TKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 34/85 (40%), Positives = 47/85 (55%)
Query: 56 NLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGV 115
+L L N L IPS+ NLK++ YL L N L+GPIP I +L+ L+ + S N+ +G
Sbjct: 240 HLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE 299
Query: 116 IPNAIGCLNILQHLFLGYNRLQGSI 140
IP + L L+ L L N G I
Sbjct: 300 IPELVIQLQNLEILHLFSNNFTGKI 324
|
Length = 968 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 46/153 (30%), Positives = 70/153 (45%), Gaps = 30/153 (19%)
Query: 202 ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYS--------SNYVGFA- 252
E +MK + L+++ + S E+ +V EYM +GSL L S V A
Sbjct: 51 EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA 110
Query: 253 -----LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA 307
+ YL S IH DL N+L +N+V ++DFG+A+ LI +D + +
Sbjct: 111 QIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLAR-LIEDDEYTAREGAKF 166
Query: 308 TIGYMA------------SYVYSFGIMLLEVFT 328
I + A S V+SFGI+L E+ T
Sbjct: 167 PIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 50/196 (25%), Positives = 80/196 (40%), Gaps = 33/196 (16%)
Query: 164 ISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGA-FKSFDFECDVMKSTCYRNLIKIISSR 221
+ G G + K + +VK L+ + A K E D++ ++ +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 222 SNEDFKVLVLEYMPRGSLEKCLYS-------------SNYVGFALEYLHFDYSVLIIHYD 268
N + +EYM GSL+K L + V L YLH + IIH D
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126
Query: 269 LKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYV 316
+KPSN+L + L DFG++ L+ + +T T YMA S +
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFV-GTSSYMAPERIQGNDYSVKSDI 182
Query: 317 YSFGIMLLEVFTRKKP 332
+S G+ L+E+ T + P
Sbjct: 183 WSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 6e-10
Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 163 LISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFK-SFDFECDVMKSTCYRNLIKIISSR 221
I +G FG ++K ++ E +VK K F E +++K + N++K+I
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 222 SNEDFKVLVLEYMPRGSL-------EKCLYSSNYVGFAL------EYLHFDYSVLIIHYD 268
+ +V+E +P GSL + L + +L EYL S IH D
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118
Query: 269 LKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT---------------QTLATIGY-M 312
L N L +N V +SDFG++ RE+ I T + L Y
Sbjct: 119 LAARNCLVGENNVLKISDFGMS----REEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 313 ASYVYSFGIMLLEVFT 328
S V+S+GI+L E F+
Sbjct: 175 ESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-10
Identities = 43/197 (21%), Positives = 85/197 (43%), Gaps = 32/197 (16%)
Query: 167 GGFGSIHKARIQDRMEFSV-KGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNED 225
G FG ++KA+ ++ F+ K ++ + F E D++ + N++ + + E+
Sbjct: 16 GAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN 75
Query: 226 FKVLVLEYMPRGS-------LEKCL------YSSNYVGFALEYLHFDYSVLIIHYDLKPS 272
+++E+ G+ LE+ L Y + AL +LH S +IH DLK
Sbjct: 76 KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAG 132
Query: 273 NVLFDDNIVTHLSDFGIAKLLIRED----------HFM----IQTQTLATIGY-MASYVY 317
N+L + L+DFG++ ++M + +T Y + ++
Sbjct: 133 NILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIW 192
Query: 318 SFGIMLLEVFTRKKPTN 334
S GI L+E+ + P +
Sbjct: 193 SLGITLIELAQMEPPHH 209
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 9e-10
Identities = 45/188 (23%), Positives = 85/188 (45%), Gaps = 29/188 (15%)
Query: 167 GGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDF 226
G FG + + ++R+ ++K + F E +K +++LI + + S +
Sbjct: 17 GYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP 76
Query: 227 KVLVLEYMPRGSL--------EKCLYSSNYVGFA------LEYLHFDYSVLIIHYDLKPS 272
++ E M +GSL + L ++ + A + YL IH DL
Sbjct: 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAAR 133
Query: 273 NVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-------TIGY----MASYVYSFGI 321
N+L +++V ++DFG+A+ LI+ED ++ + + + S V+SFGI
Sbjct: 134 NILVGEDLVCKVADFGLAR-LIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGI 192
Query: 322 MLLEVFTR 329
+L E+FT
Sbjct: 193 LLYEMFTY 200
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 58.6 bits (140), Expect = 1e-09
Identities = 63/209 (30%), Positives = 87/209 (41%), Gaps = 44/209 (21%)
Query: 163 LISRGGFGSIHKARIQDRMEFSVKGFHLQ---CSGAFKSFDFECDVMKS-TCYRNLIKII 218
+ G FG ++ AR DR ++K + S + F E ++ S N++K+
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 219 SSRSNEDFKVLVLEYMPRGSLEK---------------CLYSSNYVGFALEYLHFDYSVL 263
+E LV+EY+ GSLE L+ + ALEYLH S
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121
Query: 264 IIHYDLKPSNVLFD-DNIVTHLSDFGIAKLLIREDHFMIQTQTLA----TIGYMA----- 313
IIH D+KP N+L D D V L DFG+AKLL + T GYMA
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 314 ----------SYVYSFGIMLLEVFTRKKP 332
S ++S GI L E+ T P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 36/213 (16%)
Query: 163 LISRGGFGSIHKARIQDRMEF-SVKGFHL-----QCSGAFKSFDFECDVMKSTCYRNLIK 216
L+ G FGS+++ D +F +VK L A K + E ++ + N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 217 IISSRSNEDFKVLVLEYMPRGSLEKCL--YSS-------NY---VGFALEYLHFDYSVLI 264
+ + ED + LE +P GSL K L Y S Y + LEYLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH---DRNT 123
Query: 265 IHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED---------HFMIQTQTLATIGY-MAS 314
+H D+K +N+L D N V L+DFG+AK ++ ++M GY +A+
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183
Query: 315 YVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
++S G +LE+ T K P +SQ + A+
Sbjct: 184 DIWSLGCTVLEMATGKPP-----WSQLEGVAAV 211
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 35/165 (21%)
Query: 197 KSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCL------------Y 244
K+ E + +K + N+++ + + E++ + LEY+P GS+ CL +
Sbjct: 53 KALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF 112
Query: 245 SSNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304
+ V L YLH S I+H DLK N+L D + + +SDFGI+K + D Q
Sbjct: 113 FTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK---KSDDIYDNDQ 166
Query: 305 TLA---TIGYMA---------SY-----VYSFGIMLLEVFTRKKP 332
++ ++ +MA Y ++S G ++LE+F ++P
Sbjct: 167 NMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 56/205 (27%), Positives = 83/205 (40%), Gaps = 39/205 (19%)
Query: 162 NLISRGGFGSIHKA-RIQDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKII 218
N I G FG ++ A + +VK +Q + K E V++ + NL+K
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 219 SSRSNEDFKVLV-LEYMPRGSLEK-CLYSSN--------YVGF---ALEYLHFDYSVLII 265
+ + KV + +EY G+LE+ + Y L YLH S I+
Sbjct: 66 GVEVHRE-KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH---SHGIV 121
Query: 266 HYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED---HFMIQTQTLATIGYMASYVY----- 317
H D+KP+N+ D N V L DFG A L +Q+ T YMA V
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS-LAGTPAYMAPEVITGGKG 180
Query: 318 ----------SFGIMLLEVFTRKKP 332
S G ++LE+ T K+P
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 48/188 (25%), Positives = 90/188 (47%), Gaps = 25/188 (13%)
Query: 167 GGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDF 226
G FG + + + +VK + + ++F E ++MK+ + L+++ + + E+
Sbjct: 17 GQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP 75
Query: 227 KVLVLEYMPRGSLEKCLYSSNYVGFALEYLHFDYSVLI------------IHYDLKPSNV 274
++ EYM +GSL L S L L D+S I IH DL+ +NV
Sbjct: 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKL-IDFSAQIAEGMAYIERKNYIHRDLRAANV 134
Query: 275 LFDDNIVTHLSDFGIAKLLIREDH-------FMIQTQTLATIGY----MASYVYSFGIML 323
L ++++ ++DFG+A+++ ++ F I+ I + + S V+SFGI+L
Sbjct: 135 LVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 194
Query: 324 LEVFTRKK 331
E+ T K
Sbjct: 195 YEIVTYGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 6e-09
Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 40/201 (19%)
Query: 163 LISRGGFGSIHKAR---IQDRMEFSVKGFHLQCSGA--FKSFDFECDVMKSTCYRNLIK- 216
+ +G FGS+ R +QD V LQ S A + F+ E +++KS + N++K
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 217 --IISSRSNEDFKVLVLEYMPRGSL--------EKC------LYSSNYVGFALEYLHFDY 260
+ S + + LV+EY+P GSL E+ LY+S + +EYL
Sbjct: 71 KGVCYSAGRRNLR-LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ-ICKGMEYLG--- 125
Query: 261 SVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE-DHFMIQTQTLATIGYMA------ 313
S +H DL N+L + + DFG+ K+L ++ +++ ++ + I + A
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185
Query: 314 ------SYVYSFGIMLLEVFT 328
S V+SFG++L E+FT
Sbjct: 186 SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 9e-09
Identities = 86/367 (23%), Positives = 145/367 (39%), Gaps = 96/367 (26%)
Query: 56 NLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGV 115
+L L+ N+L IP++F + + L+LS N L+G IP + N++ LV++ S N+ G
Sbjct: 527 SLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGS 586
Query: 116 IPNAIGCLNILQHLFLGYNRLQGSISYS-------------KWF--SC------------ 148
+P+ L I G L G + S WF +C
Sbjct: 587 LPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVA 646
Query: 149 -----------LELCRVTN-------------------------GFSEDNLISRGGFGSI 172
LEL RV N E+N+ISRG G+
Sbjct: 647 FGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGAS 706
Query: 173 HKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231
+K + I++ M+F VK + + S + M + N++K+I +E L+
Sbjct: 707 YKGKSIKNGMQFVVK--EINDVNSIPSSEIA--DMGKLQHPNIVKLIGLCRSEKGAYLIH 762
Query: 232 EYMPRGSLEKCLYSSNY---------VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVT 282
EY+ +L + L + ++ + AL +LH S ++ +L P ++ D
Sbjct: 763 EYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEP 822
Query: 283 HLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRK 330
HL + LL + I + Y+A S +Y FG++L+E+ T K
Sbjct: 823 HLR-LSLPGLLCTDTKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGK 875
Query: 331 KPTNKIF 337
P + F
Sbjct: 876 SPADAEF 882
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 6/96 (6%)
Query: 51 PPQQENLS------LASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVK 104
P NL L N+L IP + ++L+ ++ L+LS NSL+G IP + L+ L
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEI 312
Query: 105 IYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSI 140
++ NNF G IP A+ L LQ L L N+ G I
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEI 348
|
Length = 968 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 47/161 (29%), Positives = 67/161 (41%), Gaps = 40/161 (24%)
Query: 191 QCSGAFKSFDFE---CDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN 247
+C G F D + C + STC L+K I +P L K +
Sbjct: 78 KCYGYF-ITDSDVFICMELMSTCLDKLLKRIQ------------GPIPEDILGKMTVA-- 122
Query: 248 YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA 307
+ AL YL + V IH D+KPSN+L D + L DFGI+ L+ +T++
Sbjct: 123 -IVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLVDS---KAKTRSAG 176
Query: 308 TIGYMA-----------SY-----VYSFGIMLLEVFTRKKP 332
YMA Y V+S GI L+E+ T + P
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 48/212 (22%), Positives = 86/212 (40%), Gaps = 45/212 (21%)
Query: 164 ISRGGFGSIHKAR------IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKI 217
+ G FG + A +D+M +VK A K F E +++ + + +++K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 218 ISSRSNEDFKVLVLEYMPRGSLEKCL----------------YSSNYVGFALEYLHFDYS 261
+ D ++V EYM G L K L + +G + + LH
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS-QMLHIASQ 131
Query: 262 VL----------IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
+ +H DL N L N++ + DFG+++ + D++ + T+ I +
Sbjct: 132 IASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 191
Query: 312 MA------------SYVYSFGIMLLEVFTRKK 331
M S V+SFG++L E+FT K
Sbjct: 192 MPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 41/163 (25%), Positives = 72/163 (44%), Gaps = 36/163 (22%)
Query: 195 AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL----EKC-------- 242
+ F E VMK + NL++++ + E ++ E+M G+L +C
Sbjct: 45 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV 104
Query: 243 --LYSSNYVGFALEYL---HFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297
LY + + A+EYL +F IH DL N L +N + ++DFG+++L+ D
Sbjct: 105 VLLYMATQISSAMEYLEKKNF------IHRDLAARNCLVGENHLVKVADFGLSRLM-TGD 157
Query: 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
+ I + A S V++FG++L E+ T
Sbjct: 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 49/212 (23%)
Query: 163 LISRGGFGSIHKARIQDRMEF-SVKGFHLQCSGA---------FKSFDFECDVMKSTCYR 212
LI G FGS++ E +VK L A + E ++K +
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 213 NLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHF 258
N+++ + S + D + LEY+P GS+ L +NY F L YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQILKGLNYLH- 123
Query: 259 DYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA------TIGYM 312
+ IIH D+K +N+L D+ +SDFGI+K L E + + A ++ +M
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISKKL--EANSLSTKTNGARPSLQGSVFWM 179
Query: 313 A-------SY-----VYSFGIMLLEVFTRKKP 332
A SY ++S G +++E+ T K P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 39/209 (18%)
Query: 158 FSEDN---LISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRN 213
+ E+ ++ +G +G ++ AR + ++ ++K + S + E + +RN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 214 LIKIISSRSNEDFKVLVLEYMPRGSLEKCLYS--------SNYVGF-------ALEYLHF 258
+++ + S S F + +E +P GSL L S + F L+YLH
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH- 125
Query: 259 DYSVLIIHYDLKPSNVLFDD-NIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMASYV- 316
I+H D+K NVL + + V +SDFG +K L + +T T T+ YMA V
Sbjct: 126 --DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFT-GTLQYMAPEVI 181
Query: 317 -------------YSFGIMLLEVFTRKKP 332
+S G ++E+ T K P
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 45/213 (21%), Positives = 86/213 (40%), Gaps = 48/213 (22%)
Query: 164 ISRGGFGSIHKARI------QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKI 217
+ G FG + A QD+M +VK A + F E +++ ++++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 218 ISSRSNEDFKVLVLEYMPRGSLEKCLYS---------------------------SNYVG 250
+ ++V EYM G L + L S ++ +
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 251 FALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIG 310
+ YL S+ +H DL N L +V + DFG+++ + D++ + +T+ I
Sbjct: 133 SGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 311 YMA------------SYVYSFGIMLLEVFTRKK 331
+M S ++SFG++L E+FT K
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 48/214 (22%), Positives = 85/214 (39%), Gaps = 52/214 (24%)
Query: 164 ISRGGFGSIHKARI------QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKI 217
+ G FG + A QD++ +VK A K F E +++ + + +++K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 218 ISSRSNEDFKVLVLEYMPRGSLEK-------------------------CLYSSNYVGFA 252
D ++V EYM G L K L+ + +
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 253 LEYL---HFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATI 309
+ YL HF +H DL N L +N++ + DFG+++ + D++ + T+ I
Sbjct: 133 MVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 310 GYMA------------SYVYSFGIMLLEVFTRKK 331
+M S V+S G++L E+FT K
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 29/84 (34%), Positives = 44/84 (52%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVI 116
L L + L IP+ L+ + +NLS NS+ G IP + ++ L + S N+F G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 117 PNAIGCLNILQHLFLGYNRLQGSI 140
P ++G L L+ L L N L G +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 36/96 (37%), Positives = 45/96 (46%), Gaps = 20/96 (20%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
AL YL + IIH D+KPSN+L D N L DFGI+ L+ + +T+ Y
Sbjct: 119 ALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS---IAKTRDAGCRPY 173
Query: 312 MA---------------SYVYSFGIMLLEVFTRKKP 332
MA S V+S GI L EV T K P
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 48/210 (22%), Positives = 92/210 (43%), Gaps = 45/210 (21%)
Query: 161 DNLISRGGFGSIHKARIQ---DRMEFSVKGFHLQCS-GAFKSFDFECDVM-KSTCYRNLI 215
+++I G FG + +A I+ +M ++K S + F E +V+ K + N+I
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 216 KIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYV----GFALEY---------------- 255
++ + N + + +EY P G+L L S + FA E+
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 256 -----LHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIG 310
+ + IH DL NVL +N+ + ++DFG+++ E+ ++ +T +
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLPVR 183
Query: 311 YMA------------SYVYSFGIMLLEVFT 328
+MA S V+SFG++L E+ +
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 46/143 (32%), Positives = 61/143 (42%), Gaps = 42/143 (29%)
Query: 229 LVLEYMPRGSL----EK---------CLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVL 275
L+LEY+ G L E+ C Y S ALE+LH II+ DLKP N+L
Sbjct: 77 LILEYLSGGELFMHLEREGIFMEDTACFYLSEIS-LALEHLH---QQGIIYRDLKPENIL 132
Query: 276 FDDNIVTHLSDFGIAKLLIREDHFMIQTQTL-ATIGYMASYV------------YSFGIM 322
D L+DFG+ K I E T T TI YMA + +S G +
Sbjct: 133 LDAQGHVKLTDFGLCKESIHEG---TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGAL 189
Query: 323 LLEVFT---------RKKPTNKI 336
+ ++ T RKK +KI
Sbjct: 190 MYDMLTGAPPFTAENRKKTIDKI 212
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 163 LISRGGFGSIHKAR-IQDRMEFSVKGF---HLQCSGAFKSFDFECDVM-KSTCYRNLIKI 217
+I G F ++ A+ + E+++K L K E +V+ + + +IK+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 218 ISSRSNEDFKVLVLEYMPRGSL-----------EKC--LYSSNYVGFALEYLHFDYSVLI 264
+ +E+ VLEY P G L EKC Y++ + ALEYLH S I
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEIL-LALEYLH---SKGI 123
Query: 265 IHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293
IH DLKP N+L D ++ ++DFG AK+L
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVL 152
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 25/158 (15%)
Query: 197 KSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL--------EKCLYSSNY 248
++F E VMK + L+++ + S E + V EYM +GSL K L
Sbjct: 46 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL 104
Query: 249 VGFALEY---LHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT 305
V A + + + + +H DL+ +N+L +N+V ++DFG+A+ LI ++ + +
Sbjct: 105 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGA 163
Query: 306 LATIGYMA------------SYVYSFGIMLLEVFTRKK 331
I + A S V+SFGI+L E+ T+ +
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 51/203 (25%), Positives = 77/203 (37%), Gaps = 46/203 (22%)
Query: 163 LISRGGFGSIHKARIQDRMEFSVKGFHL-----------QCSGAFKSFDFECDVMKSTCY 211
+ G FG + + E+S G + + S F E +M S +
Sbjct: 2 KLGDGSFGVVRRG------EWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDH 55
Query: 212 RNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGFALEYLHFDYSVLI------- 264
NLI++ +V E P GSL L F + L DY+V I
Sbjct: 56 ENLIRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLC-DYAVQIANGMRYL 113
Query: 265 -----IHYDLKPSNVL-FDDNIVTHLSDFGIAK-LLIREDHFMIQTQTLATIGYM----- 312
IH DL N+L D+ V + DFG+ + L EDH++++ +
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVK-IGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172
Query: 313 -------ASYVYSFGIMLLEVFT 328
AS V+ FG+ L E+FT
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 36/97 (37%), Positives = 47/97 (48%), Gaps = 21/97 (21%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
ALEYLH SV IH D+KPSNVL + N L DFGI+ L+ + +T Y
Sbjct: 115 ALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---VAKTIDAGCKPY 169
Query: 312 MA----------------SYVYSFGIMLLEVFTRKKP 332
MA S V+S GI ++E+ T + P
Sbjct: 170 MAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-08
Identities = 48/194 (24%), Positives = 86/194 (44%), Gaps = 26/194 (13%)
Query: 164 ISRGGFGSIHKARIQDRME-FSVKGF---HLQCSGAFKSFDFECDVMKSTCYR-NLIKII 218
IS+G FGS++ A+ + + F++K + + E +M + K+
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 219 SSRSNEDFKVLVLEYMPRG---SLEKCL------YSSNYVG---FALEYLHFDYSVLIIH 266
S ++D+ LV+EY+ G SL K L ++ Y+ +E LH IIH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIH 120
Query: 267 YDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM-----IQTQTLATIGYM-ASYVYSFG 320
D+KP N+L D L+DFG+++ + F+ + +T+ +G S +S G
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLG 180
Query: 321 IMLLEVFTRKKPTN 334
++ E P +
Sbjct: 181 CVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 51/208 (24%), Positives = 80/208 (38%), Gaps = 39/208 (18%)
Query: 164 ISRGGFGSIHKARIQDR-MEFSVKGFHL-QCSGAFKSFDFECDVMKSTCYRNLIKIISSR 221
I G ++ A + ++K L +C + E M + N++K +S
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 222 SNEDFKVLVLEYMPRGSLEKCLYSSNYVGF---------------ALEYLHFDYSVLIIH 266
D LV+ Y+ GSL + SS G LEYLH S IH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIH 125
Query: 267 YDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLAT-IG---YMASYV------ 316
D+K N+L ++ ++DFG++ L D + T +G +MA V
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASL--ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 317 -------YSFGIMLLEVFTRKKPTNKIF 337
+SFGI +E+ T P +K
Sbjct: 184 YDFKADIWSFGITAIELATGAAPYSKYP 211
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 7e-08
Identities = 50/191 (26%), Positives = 75/191 (39%), Gaps = 38/191 (19%)
Query: 164 ISRGGFGSIHKA-RIQDRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIIS 219
I G G ++KA E ++K L+ E +MK + N++
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN----EILIMKDCKHPNIVDYYD 82
Query: 220 SRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------------VGFALEYLHFDYSVLIIH 266
S D +V+EYM GSL + + V LEYLH S +IH
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIH 139
Query: 267 YDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA-------SY---- 315
D+K N+L + L+DFG A L +E + + T +MA Y
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTKE-KSKRNSV-VGTPYWMAPEVIKRKDYGPKV 197
Query: 316 -VYSFGIMLLE 325
++S GIM +E
Sbjct: 198 DIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 32/91 (35%), Positives = 46/91 (50%)
Query: 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNN 111
P E L L++N L IP+ + + L+L N L G IP + NL L + + N
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199
Query: 112 FAGVIPNAIGCLNILQHLFLGYNRLQGSISY 142
G IP +G + L+ ++LGYN L G I Y
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIPY 230
|
Length = 968 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 45/209 (21%)
Query: 162 NLISRGGFGSIHKARIQD---RMEFSVKGFHLQCS-GAFKSFDFECDVM-KSTCYRNLIK 216
++I G FG + KARI+ RM+ ++K S + F E +V+ K + N+I
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 217 IISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYV----GFAL-----------EYLHFDYS 261
++ + + + L +EY P G+L L S + FA+ + LHF
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 262 VL----------IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
V IH DL N+L +N V ++DFG+++ ++ ++ +T + +
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRW 189
Query: 312 MA------------SYVYSFGIMLLEVFT 328
MA S V+S+G++L E+ +
Sbjct: 190 MAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 29/94 (30%), Positives = 44/94 (46%), Gaps = 21/94 (22%)
Query: 213 NLIKIISSRSNEDFKVLVLEYMPRGSLE---------------KCLYSSNYVGFALEYLH 257
N+I ++ ++ LV E+M LE K G LEYLH
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRG--LEYLH 119
Query: 258 FDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291
++ I+H DLKP+N+L + V L+DFG+A+
Sbjct: 120 SNW---ILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 52/193 (26%), Positives = 91/193 (47%), Gaps = 30/193 (15%)
Query: 161 DNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISS 220
+ + G FG + A + +VK S + ++F E +VMK+ + L+K+ +
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 221 RSNEDFKVLVLEYMPRGSLEKCLYSSNYVGFALEYLHFDYSVLI------------IHYD 268
+ E ++ E+M +GSL L S L L D+S I IH D
Sbjct: 70 VTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGMAFIEQRNYIHRD 127
Query: 269 LKPSNVLFDDNIVTHLSDFGIAKLLIREDH---------FMIQTQTLATIGY----MASY 315
L+ +N+L ++V ++DFG+A+++ ED+ F I+ I + + S
Sbjct: 128 LRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185
Query: 316 VYSFGIMLLEVFT 328
V+SFGI+L+E+ T
Sbjct: 186 VWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 52/194 (26%), Positives = 85/194 (43%), Gaps = 34/194 (17%)
Query: 163 LISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFK-SFDFECDVMKSTCYRNLIKIISSR 221
L+ +G FG + K ++D+ +VK K F E ++K + N++K+I
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 222 SNEDFKVLVLEYMPRGSL-------EKCLYSSNYVGFALE------YLHFDYSVLIIHYD 268
+ +V+E +P G + L + V FAL+ YL S IH D
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118
Query: 269 LKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATI------------GYMASY- 315
L N L +N V +SDFG+++ +ED + + L I G +S
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 316 -VYSFGIMLLEVFT 328
V+S+GI+L E F+
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 48/192 (25%), Positives = 81/192 (42%), Gaps = 28/192 (14%)
Query: 164 ISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKIISSR 221
I G FG + ++ + ++K GA DF E VM + L+++
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR---EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 222 SNEDFKVLVLEYMPRGSLEKCLYSSN-------YVGFAL---EYLHFDYSVLIIHYDLKP 271
+ LV E+M G L L + +G L E + + S +IH DL
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAA 128
Query: 272 SNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSF 319
N L +N V +SDFG+ + ++ +D + T T + + + S V+SF
Sbjct: 129 RNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSF 187
Query: 320 GIMLLEVFTRKK 331
G+++ EVF+ K
Sbjct: 188 GVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 29/95 (30%), Positives = 48/95 (50%)
Query: 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNN 111
+ L L+ N+L IP + K ++ L+LS N L+G IP + VL ++ S N
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558
Query: 112 FAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWF 146
+G IP +G + L + + +N L GS+ + F
Sbjct: 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAF 593
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 39/96 (40%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 50 RPPQQENLSLASNELISVIP-STFWNLKDILYLNLSLNSLTGPIPL-EIENLKVLVKIYF 107
R P + ++L++N+L IP F + YLNLS N+ TG IP I NL+ L
Sbjct: 91 RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETL---DL 147
Query: 108 SMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYS 143
S N +G IPN IG + L+ L LG N L G I S
Sbjct: 148 SNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183
|
Length = 968 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 40/207 (19%)
Query: 156 NGFSEDNLISRGGFGSIHKA--RIQDRMEFSVKGFHLQCSGAFKS-FDF--ECDVMKSTC 210
+ ++ +I G FG + + ++ R E +V L+ K DF E +M
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 211 YRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCL------YSS-------NYVGFALEYL- 256
+ N+I++ + +++ EYM G+L+K L +SS + ++YL
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124
Query: 257 HFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED-----------HFMIQTQT 305
+Y +H DL N+L + N+ +SDFG++++L ED I+
Sbjct: 125 DMNY----VHRDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTSGGKIPIRWTA 178
Query: 306 LATIGYM----ASYVYSFGIMLLEVFT 328
I Y AS V+SFGI++ EV +
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 25/158 (15%)
Query: 197 KSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL--------EKCLYSSNY 248
+SF E +MK + L+++ + S E + V EYM +GSL + L N
Sbjct: 46 ESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKDGEGRALKLPNL 104
Query: 249 VGFALEY---LHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT 305
V A + + + + IH DL+ +N+L D +V ++DFG+A+ LI ++ + +
Sbjct: 105 VDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR-LIEDNEYTARQGA 163
Query: 306 LATIGYMA------------SYVYSFGIMLLEVFTRKK 331
I + A S V+SFGI+L E+ T+ +
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 34/167 (20%), Positives = 73/167 (43%), Gaps = 37/167 (22%)
Query: 199 FDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSS---NYVGFA--- 252
F E ++M + N++ ++ + E ++ EY+ G L + L + + VG
Sbjct: 55 FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114
Query: 253 ---------LEYLHFDYSVL----------IIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293
++LH + +H DL N L + + +SDFG+++ +
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174
Query: 294 IREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
D++ +Q+++L + +M S ++SFG++L E+F+
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 50/211 (23%)
Query: 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKS------------FDFECDVMKST 209
+I +G FG ++ + D G + C A KS F E +MK
Sbjct: 1 RVIGKGHFGCVYHGTLIDS-----DGQKIHC--AVKSLNRITDLEEVEQFLKEGIIMKDF 53
Query: 210 CYRNLIKIIS-SRSNEDFKVLVLEYMPRGSLEKCLYS-------SNYVGFAL------EY 255
+ N++ ++ +E ++VL YM G L + S + +GF L EY
Sbjct: 54 SHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 256 LHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLAT--IGYMA 313
L S +H DL N + D++ ++DFG+A+ + ++++ + T A + +MA
Sbjct: 114 LA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 314 ------------SYVYSFGIMLLEVFTRKKP 332
S V+SFG++L E+ TR P
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 51/195 (26%), Positives = 85/195 (43%), Gaps = 34/195 (17%)
Query: 164 ISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKIISSR 221
+ G FG +H + + +++ ++K GA DF E VM + NL+++
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 222 SNEDFKVLVLEYMPRGSL-------------EKCLYSSNYVGFALEYLHFDYSVLIIHYD 268
+ + +V EYM G L E L + V A+EYL S IH D
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125
Query: 269 LKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYV 316
L N L ++ V +SDFG+A+ ++ +D + T + + S V
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 317 YSFGIMLLEVFTRKK 331
+SFG+++ EVF+ K
Sbjct: 185 WSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 24/63 (38%), Positives = 37/63 (58%), Gaps = 5/63 (7%)
Query: 253 LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR--EDHFMIQTQTLATIG 310
L+Y+H S +IH DLKPSN+L +++ + DFG+A+ L +H T+ +AT
Sbjct: 120 LKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 311 YMA 313
Y A
Sbjct: 177 YRA 179
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 40/172 (23%), Positives = 72/172 (41%), Gaps = 39/172 (22%)
Query: 193 SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRG--------------- 237
A F E +M N+I+++ ++D ++ EYM G
Sbjct: 58 KTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTF 117
Query: 238 ---------SLEKCLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFG 288
S+ LY + + ++YL S+ +H DL N L ++ ++DFG
Sbjct: 118 THANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFG 174
Query: 289 IAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
+++ L D++ IQ + + I +MA S V++FG+ L E+FT
Sbjct: 175 MSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 6e-07
Identities = 42/150 (28%), Positives = 69/150 (46%), Gaps = 36/150 (24%)
Query: 202 ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL-------------EKCLYSSNY 248
E +++S + L+ + S ++ LV+EY+P G L Y++
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ- 109
Query: 249 VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTL-A 307
V ALEYLH S+ I++ DLKP N+L D + ++DFG AK + + T TL
Sbjct: 110 VVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV--KGR----TYTLCG 160
Query: 308 TIGYMASYV------------YSFGIMLLE 325
T Y+A + ++ GI++ E
Sbjct: 161 TPEYLAPEIILSKGYGKAVDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 6e-07
Identities = 40/149 (26%), Positives = 69/149 (46%), Gaps = 21/149 (14%)
Query: 163 LISRGGFGSIHKA-RIQDRMEFSVKGF--HLQCSGAFKSFDFECDVMKSTCYRNLIKIIS 219
++ RG FG +H R D+ +K + EC V+K + N+I+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 220 SRSNEDFKVLVLEYMPRGSLEK--------------CLYSSNYVGFALEYLHFDYSVLII 265
+ + ++V+EY P G+L + L+ + AL ++H + LI+
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLIL 123
Query: 266 HYDLKPSNVLFDDN-IVTHLSDFGIAKLL 293
H DLK N+L D + +V + DFGI+K+L
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKIL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 6e-07
Identities = 52/199 (26%), Positives = 88/199 (44%), Gaps = 38/199 (19%)
Query: 164 ISRGGFGSIH--KARIQDRMEFSVKGF---HLQCSGAFKSFDFECDVMKSTCYRNLIKII 218
+ GGFG + K + ++R F++K H+ +G + E ++++ + ++K+
Sbjct: 1 LGVGGFGRVELVKVKSKNRT-FALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 219 SSRSNEDFKVLVLEYMPRGSLEKCLYSSN---------YVGF---ALEYLHFDYSVLIIH 266
+ ++ + +++EY G L L Y+ A EYLH + II+
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLH---NRGIIY 116
Query: 267 YDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTL-ATIGYMASYV--------- 316
DLKP N+L D N L DFG AK L +T T T Y+A +
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWTFCGTPEYVAPEIILNKGYDFS 172
Query: 317 ---YSFGIMLLEVFTRKKP 332
+S GI+L E+ T + P
Sbjct: 173 VDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 6e-07
Identities = 40/154 (25%), Positives = 72/154 (46%), Gaps = 25/154 (16%)
Query: 198 SFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGFALEYLH 257
+F E ++MK + L+++ + + E ++ EYM GSL L + + + L
Sbjct: 47 AFLAEANLMKQLQHPRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPEGIKLTINKL- 104
Query: 258 FDYSVLI------------IHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH------- 298
D + I IH DL+ +N+L + + ++DFG+A+L+ ++
Sbjct: 105 IDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAK 164
Query: 299 FMIQTQTLATIGY----MASYVYSFGIMLLEVFT 328
F I+ I Y + S V+SFGI+L E+ T
Sbjct: 165 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 7e-07
Identities = 55/235 (23%), Positives = 94/235 (40%), Gaps = 63/235 (26%)
Query: 164 ISRGGFGSIHKARIQDRMEFSVKGFHLQCSG------AFKSF----------DF--ECDV 205
+ G FG +H + +F K F L SG A K DF E +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 206 MKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCL---------------------- 243
M N+I++++ D ++ EYM G L + L
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 244 -YSSNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302
+ + + ++YL S+ +H DL N L N ++DFG+++ L D++ IQ
Sbjct: 133 IFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 303 TQTLATIGYM------------ASYVYSFGIMLLEVFT--RKKPTNKIFFSQRND 343
+ + I +M AS V++FG+ L E+ T +++P +SQ +D
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP-----YSQLSD 239
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 9e-07
Identities = 40/135 (29%), Positives = 58/135 (42%), Gaps = 32/135 (23%)
Query: 223 NEDFKVLVLEYMPRGSL------------EKCLYSSNYVGFALEYLHFDYSVL-IIHYDL 269
NE+ + +E+M GSL E + V L YL Y+V I+H D+
Sbjct: 74 NENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYL---YNVHRIMHRDI 130
Query: 270 KPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVY 317
KPSN+L + L DFG++ LI I + T YM+ S V+
Sbjct: 131 KPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVW 186
Query: 318 SFGIMLLEVFTRKKP 332
S GI ++E+ K P
Sbjct: 187 SLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 9e-07
Identities = 50/188 (26%), Positives = 79/188 (42%), Gaps = 31/188 (16%)
Query: 167 GGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKIISSRSNE 224
G FG + + + +VK G DF E +MK + LI++ + + E
Sbjct: 17 GQFGEVWEGLWNNTTPVAVKTLK---PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 225 DFKVLVLEYMPRGSLEKCLYSSNYVGFALEYLHFDYSVLI------------IHYDLKPS 272
+ +V E M GSL + L L L D + + IH DL
Sbjct: 74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQL-IDMAAQVASGMAYLEAQNYIHRDLAAR 132
Query: 273 NVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFG 320
NVL +N + ++DFG+A+ +I+ED + + I + A S V+SFG
Sbjct: 133 NVLVGENNICKVADFGLAR-VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFG 191
Query: 321 IMLLEVFT 328
I+L E+ T
Sbjct: 192 ILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 9e-07
Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 27/159 (16%)
Query: 197 KSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGFALEYL 256
++F E +MK + L+ + + S E + V E+M +GSL L + L L
Sbjct: 46 EAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQL 104
Query: 257 HFDYSVLI------------IHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304
D + I IH DL+ +N+L DN+V ++DFG+A+ LI ++ + +
Sbjct: 105 -VDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR-LIEDNEYTARQG 162
Query: 305 TLATIGYMA------------SYVYSFGIMLLEVFTRKK 331
I + A S V+SFGI+L E+ T+ +
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 9e-07
Identities = 48/209 (22%), Positives = 87/209 (41%), Gaps = 45/209 (21%)
Query: 163 LISRGGFGSIHKARI-QDRMEF---SVKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIK 216
++ G FGS+ + ++ QD +VK L + +F E MK + N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 217 II------SSRSNEDFKVLVLEYMPRGSLEKCLYSSNY------------------VGFA 252
+I SS +++L +M G L L S +
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 253 LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM-----------I 301
+EYL + IH DL N + +++ ++DFG++K + D++ I
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 302 QTQTLATIGYMA-SYVYSFGIMLLEVFTR 329
++LA Y + S V++FG+ + E+ TR
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATR 211
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 44/198 (22%), Positives = 89/198 (44%), Gaps = 30/198 (15%)
Query: 167 GGFGSIHKARIQDRMEFSV-KGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNED 225
G FG ++KA+ ++ + K + + + E +++ + + ++K++ + +
Sbjct: 23 GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82
Query: 226 FKVLVLEYMPRGSLEKCLYSSNYVGFA-----------LEYLHFDYSVLIIHYDLKPSNV 274
+++E+ P G+++ + + G LE L + +S+ IIH DLK NV
Sbjct: 83 KLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNV 141
Query: 275 LFDDNIVTHLSDFGIA----KLLIREDHF------------MIQTQTLATIGYMASYVYS 318
L + L+DFG++ K L R D F M +T Y A ++S
Sbjct: 142 LLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKAD-IWS 200
Query: 319 FGIMLLEVFTRKKPTNKI 336
GI L+E+ + P +++
Sbjct: 201 LGITLIEMAQIEPPHHEL 218
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 44/200 (22%), Positives = 86/200 (43%), Gaps = 30/200 (15%)
Query: 163 LISRGGFGSIHKARIQDR-MEFSVKGFHL-----QCSGAFKSFDFECDVMKSTCYRNLIK 216
L+ +G FG ++ D E +VK + S + + E ++K+ + +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 217 IISSRSNEDFKVL--VLEYMPRGSLEKCLYS---------SNYVGFALEYLHFDYSVLII 265
+ + L +E+MP GS++ L S Y LE + + +S +I+
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIV 128
Query: 266 HYDLKPSNVLFDDNIVTHLSDFGIAKLL------------IREDHFMIQTQTLATIGY-M 312
H D+K +N+L D L DFG +K L + + + + ++ GY
Sbjct: 129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGR 188
Query: 313 ASYVYSFGIMLLEVFTRKKP 332
+ ++S G ++E+ T K P
Sbjct: 189 KADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 17/93 (18%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
AL++LH S+ II+ DLKP N+L D+ L+DFG++K I DH T+ Y
Sbjct: 110 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVEY 164
Query: 312 MASYV------------YSFGIMLLEVFTRKKP 332
MA V +SFG+++ E+ T P
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 45/209 (21%)
Query: 162 NLISRGGFGSIHKARIQD---RMEFSVKGFHLQCS-GAFKSFDFECDVM-KSTCYRNLIK 216
++I G FG + KARI+ RM+ ++K S + F E +V+ K + N+I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 217 IISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYV----GFALEY----------------- 255
++ + + + L +EY P G+L L S + FA+
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 256 ----LHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
+ + IH DL N+L +N V ++DFG+++ ++ ++ +T + +
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRW 177
Query: 312 MA------------SYVYSFGIMLLEVFT 328
MA S V+S+G++L E+ +
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 44/168 (26%), Positives = 74/168 (44%), Gaps = 44/168 (26%)
Query: 202 ECDVMKSTC-YRNLIKIISSRSNEDFKVLVLEYMPRGSL--------------------- 239
E ++MK ++N+I ++ + E +V+EY G+L
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 240 -EKCLYSSNYVGFA------LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292
E+ L + V FA +E+L S IH DL NVL ++ V ++DFG+A+
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARD 181
Query: 293 LIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
+ D++ T + +MA S V+SFG++L E+FT
Sbjct: 182 IHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 32/131 (24%), Positives = 59/131 (45%), Gaps = 34/131 (25%)
Query: 229 LVLEYMPRGSLE-----KCLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTH 283
++LE+M GSLE + ++ L + + + I+H D+KPSN+L +
Sbjct: 149 VLLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVK 208
Query: 284 LSDFGIAKLLIREDHFMIQT-----QTLATIGYM-----------------ASYVYSFGI 321
++DFG++++L QT ++ TI YM A ++S G+
Sbjct: 209 IADFGVSRIL-------AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGV 261
Query: 322 MLLEVFTRKKP 332
+LE + + P
Sbjct: 262 SILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 34/208 (16%)
Query: 164 ISRGGFGSIHKA-RIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRS 222
I +G G+++ A + E ++K +LQ + E VM+ + N++ + S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 223 NEDFKVLVLEYMPRGSL-----EKCLYSSNYVGF------ALEYLHFDYSVLIIHYDLKP 271
D +V+EY+ GSL E C+ ALE+LH S +IH D+K
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKS 143
Query: 272 SNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMASYV------------YSF 319
N+L + L+DFG + E ++ + T +MA V +S
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201
Query: 320 GIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
GIM +E+ + P + N ++AL
Sbjct: 202 GIMAIEMVEGEPP-----YLNENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 34/118 (28%), Positives = 48/118 (40%), Gaps = 27/118 (22%)
Query: 213 NLIKIISSRSNEDFKVL--VLEYMPRGSLEKCLYSSNYVGF------------ALEYLHF 258
L+ I+ S EDF + V E M L K + S + L+YLH
Sbjct: 63 GLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH- 120
Query: 259 DYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMASYV 316
S +IH DLKPSN+L + N + DFG+A+ G++ YV
Sbjct: 121 --SANVIHRDLKPSNILVNSNCDLKICDFGLAR---------GVDPDEDEKGFLTEYV 167
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 67/227 (29%)
Query: 158 FSEDNLISRGGFGSI-----------------HKARIQDRMEFSVKGFHLQCSGAFKSFD 200
F + ++ +GGFG + K RI+ R KG + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-----KGESMALN------- 49
Query: 201 FECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF--------- 251
E +++ R ++ + + +D LVL M G L+ +Y GF
Sbjct: 50 -EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYA 108
Query: 252 -----ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTL 306
LE LH + I++ DLKP N+L DD+ +SD G+A + + E + +
Sbjct: 109 AEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTI--KGRV 162
Query: 307 ATIGYMASYV-----YSF-------GIMLLEVFTRKKPTNKIFFSQR 341
T+GYMA V Y+F G +L E+ + P F QR
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP-----FQQR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 54/203 (26%), Positives = 80/203 (39%), Gaps = 39/203 (19%)
Query: 156 NGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDF-ECDVMKSTCYRN 213
E + + G GS+ K R+ M F++K + + E ++ KS
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 214 LIKIISSRSNEDFKVL--VLEYMPRGSLE----KCLYSSNYVG------------FALEY 255
++K + +E + +EY GSL+ K +G L Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 256 LHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA-- 313
LH S IIH D+KPSN+L L DFG++ L+ + T T T YMA
Sbjct: 121 LH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS---LAGTFT-GTSFYMAPE 173
Query: 314 ----------SYVYSFGIMLLEV 326
S V+S G+ LLEV
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 36/106 (33%), Positives = 53/106 (50%), Gaps = 17/106 (16%)
Query: 202 ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCL-------------YSSNY 248
E V+K + +I++ + ++ F +++EY+P G L L Y+S
Sbjct: 51 EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI 110
Query: 249 VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294
V ALEYLH S I++ DLKP N+L D L+DFG AK L
Sbjct: 111 VC-ALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 49/223 (21%), Positives = 91/223 (40%), Gaps = 58/223 (26%)
Query: 161 DNLISRGGFGSIHKA---RIQDRMEFSVKGFHLQCSGA----FKSFDFECDVMKSTCYRN 213
+ G FG + KA R++ R ++ + A + E +++K + +
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 214 LIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVG----------------------- 250
+IK+ + S + +L++EY GSL L S VG
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 251 -------FA------LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297
FA ++YL + ++H DL NVL + +SDFG+++ + ED
Sbjct: 125 TMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
++ +++ + +MA S V+SFG++L E+ T
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 5e-06
Identities = 42/156 (26%), Positives = 70/156 (44%), Gaps = 42/156 (26%)
Query: 164 ISRGGFGSIHKARIQD----------RMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRN 213
I G +G ++KAR + RME +GF + A + E +++ + N
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPIT---AIR----EIKLLQKLRHPN 59
Query: 214 LIKII----SSRSNEDFKVLVLEYMP---RGSLE-----------KCLYSSNYVGFALEY 255
++++ S + +V EYM G L+ KC G L+Y
Sbjct: 60 IVRLKEIVTSKGKGSIY--MVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEG--LQY 115
Query: 256 LHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291
LH S I+H D+K SN+L +++ V L+DFG+A+
Sbjct: 116 LH---SNGILHRDIKGSNILINNDGVLKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 32/82 (39%), Positives = 41/82 (50%)
Query: 59 LASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPN 118
L N L IP L + +L+L N+LTGPIP + NLK L ++ N +G IP
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278
Query: 119 AIGCLNILQHLFLGYNRLQGSI 140
+I L L L L N L G I
Sbjct: 279 SIFSLQKLISLDLSDNSLSGEI 300
|
Length = 968 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 38/174 (21%), Positives = 70/174 (40%), Gaps = 34/174 (19%)
Query: 193 SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYV--G 250
A + F E ++ N+ +++ + + +++EYM G L + L G
Sbjct: 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG 119
Query: 251 FALEYLHFDYSVLI------------------IHYDLKPSNVLFDDNIVTHLSDFGIAKL 292
A +S L+ +H DL N L N ++DFG+++
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRN 179
Query: 293 LIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT--RKKP 332
L D++ +Q + I +MA S V++FG+ L E+ T R++P
Sbjct: 180 LYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 45/202 (22%), Positives = 85/202 (42%), Gaps = 36/202 (17%)
Query: 163 LISRGGFGSIHKARIQDR-MEFSVKGFHL-----QCSGAFKSFDFECDVMKSTCYRNLIK 216
L+ +G FG ++ D E +VK + + + E ++K+ + +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 217 IISSRSNEDFKVLVLEYMPRGSLEK------CLYSS---NYVGFALEYLHFDYSVLIIHY 267
+++ + +EYMP GS++ L + Y LE + + +S +I+H
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128
Query: 268 DLKPSNVLFDDNIVTHLSDFGIAKLL--IREDHFMIQTQTLATIG---YMA--------- 313
D+K +N+L D L DFG +K L I T + G +M+
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQTIC----SSGTGMKSVTGTPYWMSPEVISGEGY 184
Query: 314 ---SYVYSFGIMLLEVFTRKKP 332
+ V+S G ++E+ T K P
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-06
Identities = 45/200 (22%), Positives = 85/200 (42%), Gaps = 30/200 (15%)
Query: 163 LISRGGFGSIHKARIQDR-MEFSVKGFHL-----QCSGAFKSFDFECDVMKSTCYRNLIK 216
L+ +G FG ++ D E + K + S + + E ++K+ + +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 217 IISSRSNEDFKVLV--LEYMPRGSLEKCL---------YSSNYVGFALEYLHFDYSVLII 265
+ K L +EYMP GS++ L + Y LE + + +S +I+
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIV 128
Query: 266 HYDLKPSNVLFDDNIVTHLSDFGIAKLL------------IREDHFMIQTQTLATIGY-M 312
H D+K +N+L D L DFG +K L + + + + ++ GY
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGR 188
Query: 313 ASYVYSFGIMLLEVFTRKKP 332
+ V+S G ++E+ T K P
Sbjct: 189 KADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 32/112 (28%), Positives = 57/112 (50%), Gaps = 21/112 (18%)
Query: 249 VGFALEY---LHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT 305
VGF+ + + F S +H DL NVL + + + DFG+A+ ++R+ +++ + T
Sbjct: 242 VGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGST 301
Query: 306 LATIGYMA------------SYVYSFGIMLLEVFT------RKKPTNKIFFS 339
+ +MA S V+SFGI+L E+FT + P N+ F++
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 42/206 (20%)
Query: 149 LELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKS 208
L L ++T G +I G FG++ + + + +VK +++C ++F E VM
Sbjct: 3 LNLQKLTLG----EIIGEGEFGAVLQGEYTGQ-KVAVK--NIKCDVTAQAFLEETAVMTK 55
Query: 209 TCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYS--------------SNYVGFALE 254
++NL++++ + + V+E M +G+L L + S V +E
Sbjct: 56 LHHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114
Query: 255 YLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA- 313
YL S ++H DL N+L ++ V +SDFG+A++ M + + + A
Sbjct: 115 YLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARV-----GSMGVDNSKLPVKWTAP 166
Query: 314 -----------SYVYSFGIMLLEVFT 328
S V+S+G++L EVF+
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 8e-06
Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNN 111
P + LSLA N+ +P +F + K + L+LS N +G +P ++ +L L+++ S N
Sbjct: 452 PSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENK 510
Query: 112 FAGVIPNAIGCLNILQHLFLGYNRLQGSISYS 143
+G IP+ + L L L +N+L G I S
Sbjct: 511 LSGEIPDELSSCKKLVSLDLSHNQLSGQIPAS 542
|
Length = 968 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 53/214 (24%), Positives = 84/214 (39%), Gaps = 48/214 (22%)
Query: 157 GFSEDNLISRGGFGSIHKA-RIQDRMEFSVKGFHLQCSGAFKSFDF--ECDVMKSTCYRN 213
F + +G +GS++K R+ D +++K L + D E ++ S + N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 214 LIKIISSRSNEDF-----KVLVLEYMPRGSLEKCLYSSNYVG----------------FA 252
+I E F +V+EY P G L K +
Sbjct: 61 II-----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 253 LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM 312
L+ LH I+H DLK +N+L N + + D GI+K+L + M +TQ T YM
Sbjct: 116 LQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQI-GTPHYM 168
Query: 313 A------------SYVYSFGIMLLEVFTRKKPTN 334
A S ++S G +L E+ T P
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 41/142 (28%), Positives = 54/142 (38%), Gaps = 43/142 (30%)
Query: 229 LVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHFDYSVLIIHYDLKPSNV 274
LV+ M G L+ +Y+ GF LE+LH I++ DLKP NV
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENV 126
Query: 275 LFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA---TIGYMA-----SYVYSF------- 319
L DD+ +SD G+A + T GYMA VY F
Sbjct: 127 LLDDHGNVRISDLGLAV------ELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFAL 180
Query: 320 GIMLLEVFTRKKPTNKIFFSQR 341
G L E+ + P F QR
Sbjct: 181 GCTLYEMIAGRSP-----FRQR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 8e-06
Identities = 47/165 (28%), Positives = 72/165 (43%), Gaps = 40/165 (24%)
Query: 202 ECDVMKSTCYRNLIKII-SSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF--------- 251
E +M + ++I+++ ++ + F + V E+M GS+ L S Y F
Sbjct: 53 EIRLMARLNHPHIIRMLGATCEDSHFNLFV-EWMAGGSVSHLL--SKYGAFKEAVIINYT 109
Query: 252 -----ALEYLHFDYSVLIIHYDLKPSNVLFDDN-IVTHLSDFGIAKLL----IREDHFMI 301
L YLH + IIH D+K +N+L D ++DFG A L F
Sbjct: 110 EQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF-- 164
Query: 302 QTQTLATIGYMA-------SY-----VYSFGIMLLEVFTRKKPTN 334
Q Q L TI +MA Y V+S G +++E+ T K P N
Sbjct: 165 QGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 9e-06
Identities = 44/164 (26%), Positives = 68/164 (41%), Gaps = 26/164 (15%)
Query: 164 ISRGGFGSIHKA-RIQDRMEFSVKGFHL-QCSGAFKS-FDFECDVMKSTCYRNLIKI--- 217
I +G FG++ K R D K + K E ++++ + N+++
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 218 ISSRSNEDFKVLVLEYMPRGSL----EKCLYSSNYVG------------FALEYLHF--D 259
I RSN+ +V+EY G L +KC Y+ AL H D
Sbjct: 68 IIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 260 YSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303
++H DLKP+N+ D N L DFG+AK+L D +T
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 18/109 (16%)
Query: 232 EYMPRGSLEKCLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291
E M L C Y V +EYL S IH DL NVL +N V ++DFG+A+
Sbjct: 132 EQMTFKDLVSCTYQ---VARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
Query: 292 LLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
+ D++ T + +MA S V+SFG+++ E+FT
Sbjct: 186 DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 12/79 (15%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL--IREDHFM-IQTQTLAT 308
AL+Y+H S +IH DLKPSN+L + + L+DFG+A+ L + E+ + T +AT
Sbjct: 119 ALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 309 IGY------MASYVYSFGI 321
Y + S Y+ G+
Sbjct: 176 RWYRAPEILLGSTRYTKGV 194
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (110), Expect = 1e-05
Identities = 40/160 (25%), Positives = 63/160 (39%), Gaps = 40/160 (25%)
Query: 158 FSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYR---- 212
+ + + G +G ++KAR + ++K L D E + + ST R
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL---------DNEEEGIPSTALREISL 51
Query: 213 -------NLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF-------------- 251
N++K++ E LV EY L+K L
Sbjct: 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIKSIMYQLLR 109
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291
L Y H S I+H DLKP N+L + + V L+DFG+A+
Sbjct: 110 GLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 18/102 (17%)
Query: 239 LEKCLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298
L C Y V +EYL S IH DL NVL ++ V ++DFG+A+ + D+
Sbjct: 136 LVSCAYQ---VARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDY 189
Query: 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
+ T + +MA S V+SFG++L E+FT
Sbjct: 190 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 36/130 (27%), Positives = 56/130 (43%), Gaps = 30/130 (23%)
Query: 229 LVLEYMPRGSLEKCLYSSN---------YVG---FALEYLHFDYSVLIIHYDLKPSNVLF 276
L+L+Y+ G L LY Y+ AL++LH + II+ D+K N+L
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILL 138
Query: 277 DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMASYV--------------YSFGIM 322
D L+DFG++K + E+ + TI YMA V +S G++
Sbjct: 139 DSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVL 197
Query: 323 LLEVFTRKKP 332
E+ T P
Sbjct: 198 TFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 45/194 (23%), Positives = 81/194 (41%), Gaps = 32/194 (16%)
Query: 164 ISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKIISSR 221
+ G FG +H + + +++ ++K + GA DF E VM + L+++
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 222 SNEDFKVLVLEYMPRGSL-------------EKCLYSSNYVGFALEYLHFDYSVLIIHYD 268
+ + +V E+M G L + L V +EYL + IH D
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRD 125
Query: 269 LKPSNVLFDDNIVTHLSDFGIAKLLIREDH-------FMIQTQTLATIGY----MASYVY 317
L N L V +SDFG+ + ++ +++ F ++ + S V+
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185
Query: 318 SFGIMLLEVFTRKK 331
SFG+++ EVFT K
Sbjct: 186 SFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 34/109 (31%), Positives = 51/109 (46%), Gaps = 18/109 (16%)
Query: 232 EYMPRGSLEKCLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291
E + L C Y V +EYL S IH DL NVL ++ V ++DFG+A+
Sbjct: 135 EQLSFKDLVSCAYQ---VARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
Query: 292 LLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
+ D++ T + +MA S V+SFG++L E+FT
Sbjct: 189 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 47/197 (23%), Positives = 90/197 (45%), Gaps = 28/197 (14%)
Query: 167 GGFGSIHKARIQD-RMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNED 225
G FG ++KA+ ++ + + K + + + E D++ S + N++K++ + E+
Sbjct: 16 GAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 75
Query: 226 FKVLVLEYMPRGS-------LEKCLYSSN---YVGFALEYLHFDYSVLIIHYDLKPSNVL 275
+++E+ G+ LE+ L LE L++ + IIH DLK N+L
Sbjct: 76 NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNIL 135
Query: 276 FDDNIVTHLSDFGIA----KLLIREDHF------------MIQTQTLATIGYMASYVYSF 319
F + L+DFG++ + + R D F M +T Y A V+S
Sbjct: 136 FTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKAD-VWSL 194
Query: 320 GIMLLEVFTRKKPTNKI 336
GI L+E+ + P +++
Sbjct: 195 GITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 25/94 (26%), Positives = 48/94 (51%), Gaps = 19/94 (20%)
Query: 249 VGFALEYL--HFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTL 306
+ +EYL HF +H DL N+L + + +SD G+++ + D++ +Q ++L
Sbjct: 133 IAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 307 ATIGYMA------------SYVYSFGIMLLEVFT 328
I +M S ++SFG++L E+F+
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 25/63 (39%), Positives = 32/63 (50%)
Query: 81 LNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSI 140
L L L G IP +I L+ L I S N+ G IP ++G + L+ L L YN GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 141 SYS 143
S
Sbjct: 483 PES 485
|
Length = 623 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 2e-05
Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 34/208 (16%)
Query: 164 ISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRS 222
I +G G+++ A + E +++ +LQ + E VM+ N++ + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 223 NEDFKVLVLEYMPRGSL-----EKCLYSSNYVGF------ALEYLHFDYSVLIIHYDLKP 271
D +V+EY+ GSL E C+ ALE+LH S +IH D+K
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKS 144
Query: 272 SNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMASYV------------YSF 319
N+L + L+DFG + E ++ + T +MA V +S
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202
Query: 320 GIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
GIM +E+ + P + N ++AL
Sbjct: 203 GIMAIEMIEGEPP-----YLNENPLRAL 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 15/85 (17%)
Query: 229 LVLEYMPRGSLEKCLYSSNY------------VGFALEYLHFDYSVLIIHYDLKPSNVLF 276
LV+EY+ G ++ L+ Y V AL+YLH IIH DLKP N+L
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLI 137
Query: 277 DDNIVTHLSDFGIAKLLIREDHFMI 301
+ L+DFG++K+ + + M+
Sbjct: 138 SNEGHIKLTDFGLSKVTLNRELNMM 162
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 34/148 (22%)
Query: 213 NLIKI---ISSRSNEDFK--VLVLEYMPRGSLEKCLYSSN-------YVGF----ALEYL 256
N+I I I S E F +V E M L K + + + Y + L+Y+
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYI 122
Query: 257 HFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE-DHFMIQTQTLATIGYMA-- 313
H S ++H DLKPSN+L + N + DFG+A++ E DH T+ +AT Y A
Sbjct: 123 H---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179
Query: 314 ------SY-----VYSFGIMLLEVFTRK 330
Y ++S G +L E+ + +
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 47/208 (22%), Positives = 77/208 (37%), Gaps = 47/208 (22%)
Query: 158 FSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQC-----SGAFKSFDFECDVMKSTCYR 212
F + G +GS++KA ++ G + + E ++K
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKE------TGQVVAIKVVPVEEDLQEIIKEISILKQCDSP 58
Query: 213 NLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFD 259
++K S +V+EY GS+ + +N LEYLH
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH-- 116
Query: 260 YSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIG---YMASYV 316
S IH D+K N+L ++ L+DFG++ L M + T+ IG +MA V
Sbjct: 117 -SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT---DTMAKRNTV--IGTPFWMAPEV 170
Query: 317 ------------YSFGIMLLEVFTRKKP 332
+S GI +E+ K P
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 37/132 (28%), Positives = 61/132 (46%), Gaps = 35/132 (26%)
Query: 229 LVLEYMPRGSLEKCLYSSN---------YVG---FALEYLHFDYSVLIIHYDLKPSNVLF 276
L+L+Y+ G + LY + Y G ALE+LH + I++ D+K N+L
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILL 138
Query: 277 DDNIVTHLSDFGIAKLLIREDHFMIQTQTLA---TIGYMASYV-------------YSFG 320
D L+DFG++K + E+ + +T + TI YMA + +S G
Sbjct: 139 DSEGHVVLTDFGLSKEFLSEE----KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLG 194
Query: 321 IMLLEVFTRKKP 332
I++ E+ T P
Sbjct: 195 ILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 2e-05
Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 28/205 (13%)
Query: 164 ISRGGFGSIHKA-RIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRS 222
I +G G+++ A I E ++K +LQ + E VM+ N++ + S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 223 NEDFKVLVLEYMPRGSL-----EKCLYSSNYVGFA---LEYLHFDYSVLIIHYDLKPSNV 274
D +V+EY+ GSL E C+ L+ L F +S +IH D+K N+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNI 146
Query: 275 LFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMASYV------------YSFGIM 322
L + L+DFG + E ++ + T +MA V +S GIM
Sbjct: 147 LLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 204
Query: 323 LLEVFTRKKPTNKIFFSQRNDIKAL 347
+E+ + P + N ++AL
Sbjct: 205 AIEMVEGEPP-----YLNENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 7/102 (6%)
Query: 213 NLIKIISSRSNEDFKVLVLEYMPRG-SLEKCLYSSNYVGFALEYLHFDYSVLIIHYDLKP 271
+L ++S + D K + RG +E+ ++ S + + +LH S+ I++ D+KP
Sbjct: 67 HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKP 123
Query: 272 SNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
NVL DD LSD G+A + TQ T GYMA
Sbjct: 124 ENVLLDDQGNCRLSDLGLA---VELKDGKTITQRAGTNGYMA 162
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 51/207 (24%), Positives = 80/207 (38%), Gaps = 40/207 (19%)
Query: 158 FSEDNLISRGGFGSIHKA-RIQDRMEFSVKGFHLQCSGAFKSFDF--ECDVMKSTCYRNL 214
F N I +G FG + K R D+ +++K L + + E V+ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 215 IKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVG----------------FALEYLHF 258
I+ S ++ +V+EY G L K L G L +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKM--QRGRPLPEDQVWRFFIQILLGLAHLH- 118
Query: 259 DYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT-LATIGYMA---- 313
S I+H D+K N+ D + D G+AKLL +F T + T Y++
Sbjct: 119 --SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF---ANTIVGTPYYLSPELC 173
Query: 314 --------SYVYSFGIMLLEVFTRKKP 332
S V++ G++L E T K P
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 33/208 (15%)
Query: 155 TNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKG---FHLQCSGAFKSFDFECDVMKSTC 210
F + I +G F ++KA + D ++K F + + A + E D++K
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 211 YRNLIKIISSRSNEDFKVLVLEYMPRGSL---------------EKCLYSSNY-VGFALE 254
+ N+IK ++S + +VLE G L E+ ++ + ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 255 YLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL---IREDHFMIQT------QT 305
++H S I+H D+KP+NV V L D G+ + H ++ T +
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 306 LATIGY-MASYVYSFGIMLLEVFTRKKP 332
+ GY S ++S G +L E+ + P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 30/152 (19%)
Query: 158 FSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKS--------FDFECDVMKST 209
F +I RG FG + R + S + + ++ F+ F E D+M
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKS----SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 210 CYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------------VGFALEYL 256
++++ + ++ + +V+EYMP G L + SNY V AL+ +
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWARFYTAEVVLALDAI 158
Query: 257 HFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFG 288
H S+ IH D+KP N+L D + L+DFG
Sbjct: 159 H---SMGFIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 43/203 (21%)
Query: 161 DNLISRGGFGSIHKARIQ----DRMEFSVKGFHLQCSGAFKSFDF--ECDVMKSTCYRNL 214
+ +I G FG + + R++ ++ ++K S + DF E +M + N+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-DFLTEASIMGQFDHPNI 67
Query: 215 IKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------------VGFALEYLHFDYS 261
I++ + +++ EYM GSL+K L ++ + ++YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---E 124
Query: 262 VLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA------------TI 309
+ +H DL N+L + N+V +SDFG L R T T I
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFG----LSRRLEDSEATYTTKGGKIPIRWTAPEAI 180
Query: 310 GY----MASYVYSFGIMLLEVFT 328
Y AS V+SFGI++ EV +
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 44/165 (26%), Positives = 69/165 (41%), Gaps = 47/165 (28%)
Query: 197 KSFDFECDVMKSTCYRNLIKIISSRSNEDFKV-LVLEYMPRGSL--------------EK 241
++F E VM + NL++++ E + +V EYM +GSL +
Sbjct: 44 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 103
Query: 242 CLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL-------- 293
L S V A+EYL + +H DL NVL ++ V +SDFG+ K
Sbjct: 104 LLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 160
Query: 294 ----------IREDHFMIQTQTLATIGYMASYVYSFGIMLLEVFT 328
+RE F + S V+SFGI+L E+++
Sbjct: 161 LPVKWTAPEALREKKFSTK-----------SDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 50/211 (23%)
Query: 162 NLISRGGFGSIHKARIQD----------RMEFSVKGFHLQCSGAFKSFDFECDVMKSTCY 211
I G +G ++KAR +D R++ +GF + A + E +++ +
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPIT---AIR----EIKILRQLNH 65
Query: 212 RNLIK---IISSRSNE-DFK------VLVLEYMPR---GSLEKCLYSSNYVGFA------ 252
RN++ I++ + + DFK LV EYM G LE L +
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125
Query: 253 LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM 312
LE L++ + +H D+K SN+L ++ L+DFG+A+L E+ T + T+ Y
Sbjct: 126 LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYR 184
Query: 313 -------------ASYVYSFGIMLLEVFTRK 330
A V+S G +L E+FT+K
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 48/205 (23%)
Query: 162 NLISRGGFGSIHKARIQD-RMEFSVKGFHLQCSGAFKSFDF------ECDVMKSTCYRNL 214
+ + G +G + A + ++K S F+S E ++K + N+
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKL----SRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 215 IKIIS----SRSNEDFK--VLVLEYMPR--GSLEKC-LYSSNYVGF-------ALEYLHF 258
I ++ + S EDF+ LV M ++ KC S +++ F L+Y+H
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH- 135
Query: 259 DYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA----- 313
S IIH DLKPSN+ +++ + DFG+A+ D M T +AT Y A
Sbjct: 136 --SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEM--TGYVATRWYRAPEIML 188
Query: 314 ---SY-----VYSFGIMLLEVFTRK 330
Y ++S G ++ E+ T K
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 49/195 (25%), Positives = 87/195 (44%), Gaps = 25/195 (12%)
Query: 164 ISRGGFGSIHKARIQDRMEFS-VKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRS 222
I G +G ++KAR + E + +K L+ F E +MK + N++ S
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 223 NEDFKVLVLEYMPRGSLEKCLY-----SSNYVGF----ALEYLHFDYSVLIIHYDLKPSN 273
D + +E+ GSL+ + S + + + L+ L++ +S +H D+K +N
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGAN 136
Query: 274 VLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMASYVYSFGIMLLEVFTRKKPT 333
+L DN L+DFG++ Q ATI S++ + M EV ++
Sbjct: 137 ILLTDNGHVKLADFGVS------------AQITATIAKRKSFIGTPYWMAPEVAAVER-- 182
Query: 334 NKIFFSQRNDIKALG 348
K ++Q DI A+G
Sbjct: 183 -KGGYNQLCDIWAVG 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 41/145 (28%), Positives = 68/145 (46%), Gaps = 26/145 (17%)
Query: 163 LISRGGFGSI----HKARIQDRMEFSVKGFHL--QCSGAFKSFDFECDVMKSTCYRNLIK 216
+I RG FG + HK+ + + F + + AF F E D+M +++
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQ 107
Query: 217 IISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------------VGFALEYLHFDYSVL 263
+ + ++ + +V+EYMP G L + SNY V AL+ +H S+
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIH---SMG 162
Query: 264 IIHYDLKPSNVLFDDNIVTHLSDFG 288
+IH D+KP N+L D + L+DFG
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 32/123 (26%), Positives = 53/123 (43%), Gaps = 23/123 (18%)
Query: 229 LVLEYMPRGSLEKCLYSSNYVGFALE-YLHFDYSVL----------IIHYDLKPSNVLFD 277
++ EY G L L LE L F Y V IH DL NVL
Sbjct: 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT 175
Query: 278 DNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLE 325
+ + DFG+A+ ++ + +++++ + +MA S V+S+GI+L E
Sbjct: 176 HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWE 235
Query: 326 VFT 328
+F+
Sbjct: 236 IFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 39/147 (26%), Positives = 66/147 (44%), Gaps = 30/147 (20%)
Query: 163 LISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKS--------FDFECDVMKSTCYRNL 214
+I RG FG + R + + K + ++ F+ F E D+M +
Sbjct: 50 VIGRGAFGEVQLVR----HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 105
Query: 215 IKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------------VGFALEYLHFDYS 261
+++ + ++ + +V+EYMP G L + SNY V AL+ +H S
Sbjct: 106 VQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDAIH---S 160
Query: 262 VLIIHYDLKPSNVLFDDNIVTHLSDFG 288
+ IH D+KP N+L D + L+DFG
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 34/208 (16%)
Query: 164 ISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRS 222
I +G G++ A + E ++K +LQ + E VMK N++ + S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 223 NEDFKVLVLEYMPRGSL-----EKCLYSSNYVGF------ALEYLHFDYSVLIIHYDLKP 271
D +V+EY+ GSL E C+ + ALE+LH + +IH D+K
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKS 143
Query: 272 SNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMASYV------------YSF 319
NVL + L+DFG + E ++ + T +MA V +S
Sbjct: 144 DNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201
Query: 320 GIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
GIM +E+ + P + N ++AL
Sbjct: 202 GIMAIEMVEGEPP-----YLNENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 32/102 (31%), Positives = 49/102 (48%), Gaps = 18/102 (17%)
Query: 239 LEKCLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298
L C Y V +EYL S IH DL NVL ++ V ++DFG+A+ + D+
Sbjct: 136 LVSCAYQ---VARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY 189
Query: 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
+ + + +MA S V+SFGI++ E+FT
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 38/144 (26%), Positives = 60/144 (41%), Gaps = 17/144 (11%)
Query: 164 ISRGGFGSIHKARIQDRMEFS-VKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRS 222
I G +G ++KAR E +K L+ F+ E ++K + N++ S
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 223 NEDFKVLVLEYMPRGSL------------EKCL-YSSNYVGFALEYLHFDYSVLIIHYDL 269
D +V+EY GSL E + Y L YLH IH D+
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDI 127
Query: 270 KPSNVLFDDNIVTHLSDFGIAKLL 293
K +N+L ++ L+DFG++ L
Sbjct: 128 KGANILLTEDGDVKLADFGVSAQL 151
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 45/214 (21%)
Query: 158 FSEDNLISRGGFGSIHKARIQDR----MEFSVKGFH--LQCSGAFKSFDFECDVMKSTCY 211
F+ ++ +G FGS+ +A+++ + +VK + S + F E MK +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 212 RNLIKIIS----SRSNEDFKV--LVLEYMPRGSLEKCLYSSNY----------------- 248
N+IK+I SR+ + ++L +M G L L S
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 249 -VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM------- 300
+ +EYL S IH DL N + ++N+ ++DFG++K + D++
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 301 ----IQTQTLATIGYMA-SYVYSFGIMLLEVFTR 329
+ ++LA Y S V++FG+ + E+ TR
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 28/89 (31%), Positives = 45/89 (50%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVI 116
L L++N L IP + ++ L L NSL G IP + + L ++ N+F+G +
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420
Query: 117 PNAIGCLNILQHLFLGYNRLQGSISYSKW 145
P+ L ++ L + N LQG I+ KW
Sbjct: 421 PSEFTKLPLVYFLDISNNNLQGRINSRKW 449
|
Length = 968 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 44/141 (31%), Positives = 62/141 (43%), Gaps = 37/141 (26%)
Query: 229 LVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHFDYSVLIIHYDLKPSNV 274
LVL M G L+ +Y+ GF LE LH I++ DLKP N+
Sbjct: 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENI 133
Query: 275 LFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMASYV-----YSF-------GIM 322
L DD +SD G+A + I E I+ + + T+GYMA V Y+F G +
Sbjct: 134 LLDDYGHIRISDLGLA-VEIPEGE-TIRGR-VGTVGYMAPEVVKNERYTFSPDWWGLGCL 190
Query: 323 LLEVFTRKKPTNKIFFSQRND 343
+ E+ K P F QR +
Sbjct: 191 IYEMIEGKSP-----FRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 37/148 (25%), Positives = 66/148 (44%), Gaps = 30/148 (20%)
Query: 202 ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL-----------EKCLYSSNYVG 250
E +M+ + N++++ SS D +V+E++ G+L E+ V
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVL 125
Query: 251 FALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIG 310
AL +LH + +IH D+K ++L + LSDFG + +E + + ++L
Sbjct: 126 KALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE---VPRRKSLVGTP 179
Query: 311 Y-MASYV------------YSFGIMLLE 325
Y MA V +S GIM++E
Sbjct: 180 YWMAPEVISRLPYGTEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 46/202 (22%), Positives = 81/202 (40%), Gaps = 34/202 (16%)
Query: 161 DNLISRGGFGSIHKA----RIQDRMEFSVKGFHLQCSGAFKS-FDFECDVMKSTCYRNLI 215
I G FG +++ +++ +VK S + + F E +M+ + +++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 216 KIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------------VGFALEYLHFDYSV 262
K+I + E+ +V+E P G L L + Y + AL YL S
Sbjct: 71 KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126
Query: 263 LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-------TIGY---- 311
+H D+ NVL L DFG+++ L E ++ L +I +
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186
Query: 312 MASYVYSFGIMLLEVFTR-KKP 332
AS V+ FG+ + E+ KP
Sbjct: 187 SASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 18/91 (19%)
Query: 253 LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM 312
L+Y+H S ++H DLKPSN+L + N + DFG+A+ + FM T+ + T Y
Sbjct: 121 LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTRWYR 175
Query: 313 A--------SY-----VYSFGIMLLEVFTRK 330
A Y V+S G + E+ RK
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 6e-05
Identities = 42/191 (21%), Positives = 78/191 (40%), Gaps = 32/191 (16%)
Query: 167 GGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKIISSRSNE 224
G FG + + + + + ++K G+ +F E VM + L+++ + +
Sbjct: 15 GQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71
Query: 225 DFKVLVLEYMPRGSLEKCLYSSNY-------------VGFALEYLHFDYSVLIIHYDLKP 271
+V EYM G L L V + YL S IH DL
Sbjct: 72 RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAA 128
Query: 272 SNVLFDDNIVTHLSDFGIAKLLIREDH-------FMIQTQTLATIGYM----ASYVYSFG 320
N L DD +SDFG+++ ++ +++ F ++ + Y S V++FG
Sbjct: 129 RNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFG 188
Query: 321 IMLLEVFTRKK 331
+++ EV++ K
Sbjct: 189 VLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 6e-05
Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 44/207 (21%)
Query: 164 ISRGGFGSIHKARI-QDR--MEFSVKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKII 218
+ G FGS+ + ++ QD ++ +VK + + DF E MK + N++++I
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 219 ----SSRSNEDFK--VLVLEYMPRGSLEKCLYSSNY------------------VGFALE 254
+ +E + V++L +M G L L S + +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 255 YLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM-----------IQT 303
YL S IH DL N + ++N+ ++DFG++K + D++ I
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 304 QTLATIGYMA-SYVYSFGIMLLEVFTR 329
++LA Y S V+SFG+ + E+ TR
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATR 210
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 7e-05
Identities = 47/217 (21%), Positives = 84/217 (38%), Gaps = 59/217 (27%)
Query: 162 NLISRGGFGSIHKARIQDRMEFSV-----------KGFHLQCSGAFKSFDFECDVMKSTC 210
N + G FG +++ D + KG Q K F E +M +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ---EKKEFLKEAHLMSNFN 57
Query: 211 YRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGFA------------------ 252
+ N++K++ + + +++E M G L L + F
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 253 ----LEYLHFDYSVLIIHYDLKPSNVL-----FDDNIVTHLSDFGIAKLLIREDHFMIQT 303
LE +HF IH DL N L +D + V + DFG+A+ + + D++ +
Sbjct: 118 GCVYLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG 171
Query: 304 QTLATIGYMA------------SYVYSFGIMLLEVFT 328
+ L + +MA S V+SFG+++ E+ T
Sbjct: 172 EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 8e-05
Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 19/100 (19%)
Query: 253 LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM 312
L YL +S+ I+H D+KPSN+L + L DFG++ L+ I + T YM
Sbjct: 108 LTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYM 160
Query: 313 A------------SYVYSFGIMLLEVFTRKKPTNKIFFSQ 340
A S V+S GI +E+ + P +I +Q
Sbjct: 161 APERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQ 200
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 8e-05
Identities = 48/196 (24%), Positives = 87/196 (44%), Gaps = 34/196 (17%)
Query: 164 ISRGGFGSIHKARIQDRMEF-SVKGFHL--QCSGAFKSFDFECDVMKSTCYRNLIKIISS 220
I G +G ++KAR + E ++K L + G + E ++K + N++K++
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 221 RSNEDFKVLVLEYMPRGSLEKCLYSSNYVGFAL----EYLH-------FDYSVLIIHYDL 269
E+ LV E++ + L+K + +S G L YL F +S ++H DL
Sbjct: 68 IHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126
Query: 270 KPSNVLFDDNIVTHLSDFGIAK---------------LLIREDHFMIQTQTLATIGYMAS 314
KP N+L + L+DFG+A+ L R ++ + +T A
Sbjct: 127 KPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST----AV 182
Query: 315 YVYSFGIMLLEVFTRK 330
++S G + E+ TR+
Sbjct: 183 DIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 9e-05
Identities = 51/199 (25%), Positives = 83/199 (41%), Gaps = 34/199 (17%)
Query: 161 DNLISRGGFGSIHKARI--QDRMEFSVKGFHLQCSGAFKS---FDFECDVMKSTCYRNLI 215
+ +I G FG + R+ + E V L+ K F E +M + N+I
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 216 KIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN-------YVGF------ALEYLHFDYSV 262
+ + ++V EYM GSL+ L + VG ++YL D
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS-DMGY 127
Query: 263 LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL---------IREDHFMIQTQTLATIGYM- 312
+H DL N+L + N+V +SDFG++++L R I+ I Y
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 313 ---ASYVYSFGIMLLEVFT 328
AS V+S+GI++ EV +
Sbjct: 186 FTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 9e-05
Identities = 38/162 (23%), Positives = 69/162 (42%), Gaps = 42/162 (25%)
Query: 213 NLIKIISSRSNEDFKVLVLEYMPRGSL----------EKCLYSSNYVGFALEYLHFDYSV 262
N+I+++ +ED ++ EYM G L +K ++ V A YS
Sbjct: 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSS 139
Query: 263 LI------------------IHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304
L+ +H DL N L +N+ ++DFG+++ L D++ IQ +
Sbjct: 140 LLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGR 199
Query: 305 TLATIGYM------------ASYVYSFGIMLLEVFT--RKKP 332
+ I +M AS V++FG+ L E+ +++P
Sbjct: 200 AVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 29/103 (28%), Positives = 51/103 (49%), Gaps = 15/103 (14%)
Query: 238 SLEKCLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297
+LE + S V +E+L S IH DL N+L +N V + DFG+A+ + ++
Sbjct: 177 TLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP 233
Query: 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
++ + + +MA S V+SFG++L E+F+
Sbjct: 234 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 29/103 (28%), Positives = 51/103 (49%), Gaps = 15/103 (14%)
Query: 238 SLEKCLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297
+LE + S V +E+L S IH DL N+L +N V + DFG+A+ + ++
Sbjct: 171 TLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP 227
Query: 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
++ + + +MA S V+SFG++L E+F+
Sbjct: 228 DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 41/167 (24%), Positives = 66/167 (39%), Gaps = 36/167 (21%)
Query: 195 AFKSFDFECDVMKSTCYRNLIKII----SSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVG 250
A K E VM S + ++++++ SS+ L+ + MP G L Y N+
Sbjct: 52 ANKEILDEAYVMASVDHPHVVRLLGICLSSQV-----QLITQLMPLGCLLD--YVRNHKD 104
Query: 251 FALEYLHFDYSVLI------------IHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298
++ V I +H DL NVL ++DFG+AKLL ++
Sbjct: 105 NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164
Query: 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKP 332
I +MA S V+S+G+ + E+ T KP
Sbjct: 165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 27/94 (28%), Positives = 43/94 (45%), Gaps = 22/94 (23%)
Query: 219 SSRSNEDFKVL--------VLEYMP---RGSLEKCLYSSNYVGF-------ALEYLHFDY 260
S ED L V EYM LE+ S + L+Y+H
Sbjct: 75 GSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIH--- 131
Query: 261 SVLIIHYDLKPSNVLFD-DNIVTHLSDFGIAKLL 293
S ++H DLKP+NV + +++V + DFG+A+++
Sbjct: 132 SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 50/190 (26%)
Query: 158 FSEDNLISRGGFGSI-----------------HKARIQDRMEFSVKGFHLQCSGAFKSFD 200
F + ++ +GGFG + K RI+ R KG + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKR-----KGESMALN------- 49
Query: 201 FECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF--------- 251
E +++ + ++ + + +D LVL M G L+ +Y+ GF
Sbjct: 50 -EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYA 108
Query: 252 -----ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTL 306
LE LH + ++ DLKP N+L DD +SD G+A + + I+ + +
Sbjct: 109 AEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIRGR-V 162
Query: 307 ATIGYMASYV 316
T+GYMA V
Sbjct: 163 GTVGYMAPEV 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 1e-04
Identities = 18/58 (31%), Positives = 28/58 (48%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNF 112
++L L++N L + F L ++ L+LS N+LT P L L + S NN
Sbjct: 3 KSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 16/98 (16%)
Query: 228 VLVLEYMPRG------SLEKCLYSSNYVGF------ALEYLHFDYSVLIIHYDLKPSNVL 275
VLV+EYMP E+ L + + + Y+H + I+H DLKP+N+L
Sbjct: 75 VLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLL 131
Query: 276 FDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
+ V ++DFG+A+L E+ + Q +AT Y A
Sbjct: 132 ISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRA 168
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 19/48 (39%), Positives = 31/48 (64%), Gaps = 6/48 (12%)
Query: 253 LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300
L+Y+H S ++H DLKPSN+L ++N + DFG+A++ +D M
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQM 162
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 39/156 (25%), Positives = 65/156 (41%), Gaps = 38/156 (24%)
Query: 163 LISRGGFGSIHKARIQDRMEF-SVKGFHLQCSGAFKSFDFECDVMKSTC----------Y 211
++ G +G + K R + E ++K F K + + DV K+ +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF--------KESEDDEDVKKTALREVKVLRQLRH 59
Query: 212 RNLIKIISSRSNEDFKV-----LVLEYMPRGSLEKCLYSSNYVGFA---------LEYLH 257
N++ + E F+ LV EY+ R LE S + L+ +
Sbjct: 60 ENIVNLK-----EAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIA 114
Query: 258 FDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293
+ +S IIH D+KP N+L ++ V L DFG A+ L
Sbjct: 115 YCHSHNIIHRDIKPENILVSESGVLKLCDFGFARAL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 23/62 (37%), Positives = 33/62 (53%), Gaps = 5/62 (8%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
L+YLH ++ IIH DLK SN+L D ++DFG+A+ M T + T+ Y
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWY 174
Query: 312 MA 313
A
Sbjct: 175 RA 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 48/194 (24%), Positives = 86/194 (44%), Gaps = 44/194 (22%)
Query: 164 ISRGGFGSIHKARIQD--------RMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLI 215
+ +GG+G + A+ +D RM+ S+ L + E D++ +T L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSL----LFKLNEVRHVLTERDILTTTKSEWLV 64
Query: 216 KIISSRSNEDFKVLVLEYMPRGSLEKCL-----YSSNYVGF-------ALEYLHFDYSVL 263
K++ + ++++ L +EY+P G L S ++ F A++ LH +
Sbjct: 65 KLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH---ELG 121
Query: 264 IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMASYV------- 316
IH DLKP N L D + L+DFG++K ++ + ++ + YMA V
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPD-----YMAPEVLRGKGYD 176
Query: 317 -----YSFGIMLLE 325
+S G ML E
Sbjct: 177 FTVDYWSLGCMLYE 190
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 30/200 (15%)
Query: 163 LISRGGFGSIHKARIQDR-MEFSVKG--FHLQCSGAFKSFD-FECDV--MKSTCYRNLIK 216
L+ RG FG ++ D E +VK F K + EC++ +K+ + +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 217 IISS-RSNEDFKV-LVLEYMPRGSLEKCL---------YSSNYVGFALEYLHFDYSVLII 265
R E+ K+ + +EYMP GS++ L + Y L+ + + +S +I+
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIV 128
Query: 266 HYDLKPSNVLFDDNIVTHLSDFGIAKLL------------IREDHFMIQTQTLATIGY-M 312
H D+K +N+L D L DFG +K + + + + + ++ GY
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGR 188
Query: 313 ASYVYSFGIMLLEVFTRKKP 332
+ V+S ++E+ T K P
Sbjct: 189 KADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 20/108 (18%)
Query: 253 LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM 312
L L F +S ++H DLKP N+L + L+DFG+A++ + M T + T+ Y
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYR 176
Query: 313 A-------SY-----VYSFGIMLLEVFTRKKPTNKIFFSQRNDIKALG 348
A SY ++S G + E+F R+KP F +D+ LG
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMF-RRKP----LFRGSSDVDQLG 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 35/126 (27%), Positives = 57/126 (45%), Gaps = 30/126 (23%)
Query: 231 LEYMPRGSLEKCLYSS-----NYVG-------FALEYLHFDYSVLIIHYDLKPSNVLFDD 278
+E+M GSL++ L + N +G L YL + I+H D+KPSN+L +
Sbjct: 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNS 135
Query: 279 NIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEV 326
L DFG++ LI M + + T YM+ S ++S G+ L+E+
Sbjct: 136 RGEIKLCDFGVSGQLIDS---MANS-FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
Query: 327 FTRKKP 332
+ P
Sbjct: 192 AIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 31/155 (20%)
Query: 202 ECDVMKSTCYRNLIK---IISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGFALEYLHF 258
E +++++ + N++K I + K L++E++P GSL++ L N L+
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIK-LIMEFLPSGSLKEYL-PRNKNKINLKQQL- 112
Query: 259 DYSVLI------------IHYDLKPSNVLFDDNIVTHLSDFGIAKLL--------IREDH 298
Y+V I +H DL NVL + + DFG+ K + +++D
Sbjct: 113 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 299 ----FMIQTQTLATIG-YMASYVYSFGIMLLEVFT 328
F + L Y+AS V+SFG+ L E+ T
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 37/130 (28%), Positives = 57/130 (43%), Gaps = 30/130 (23%)
Query: 229 LVLEYMPRGSL-----EKCLYSSN----YVG---FALEYLHFDYSVLIIHYDLKPSNVLF 276
L+L+Y+ G L ++ + Y G ALE+LH + II+ D+K N+L
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILL 138
Query: 277 DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMASYV--------------YSFGIM 322
D N L+DFG++K ED TI YMA + +S G++
Sbjct: 139 DSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVL 197
Query: 323 LLEVFTRKKP 332
+ E+ T P
Sbjct: 198 MYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 30/85 (35%), Positives = 43/85 (50%)
Query: 56 NLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGV 115
+L L+ N L IP L+++ L+L N+ TG IP+ + +L L + N F+G
Sbjct: 288 SLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGE 347
Query: 116 IPNAIGCLNILQHLFLGYNRLQGSI 140
IP +G N L L L N L G I
Sbjct: 348 IPKNLGKHNNLTVLDLSTNNLTGEI 372
|
Length = 968 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 19/67 (28%), Positives = 37/67 (55%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
++++L+ N + IP + ++ + L+LS NS G IP + L L + + N+ +G
Sbjct: 445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG 504
Query: 115 VIPNAIG 121
+P A+G
Sbjct: 505 RVPAALG 511
|
Length = 623 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 18/91 (19%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
+++LH S I+H DLKP N+L + ++DFG+A++ E M T + T+ Y
Sbjct: 119 GVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MALTSVVVTLWY 172
Query: 312 MA-------SY-----VYSFGIMLLEVFTRK 330
A SY ++S G + E+F R+
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 46/205 (22%)
Query: 164 ISRGGFGSIHKARIQDRMEF-SVKGFHLQCS--GAFKSFDFECDVMK---STCYRNLIKI 217
I G +G+++KAR F ++K +Q + G S E ++K + + N++++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 218 I----SSRSNEDFKV-LVLEYMP---RGSLEKC------------LYSSNYVGFALEYLH 257
+ +SR++ + KV LV E++ R L+K L G L++LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG--LDFLH 125
Query: 258 FDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMASYV- 316
+ I+H DLKP N+L L+DFG+A++ M T + T+ Y A V
Sbjct: 126 AN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEVL 179
Query: 317 -----------YSFGIMLLEVFTRK 330
+S G + E+F RK
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 28/118 (23%), Positives = 50/118 (42%), Gaps = 23/118 (19%)
Query: 234 MPRGSLEKCLYSSNYVGFA-LEYLHFDYSVL----------IIHYDLKPSNVLFDDNIVT 282
++ L G L+ L F Y V +H DL NVL +
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIV 276
Query: 283 HLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
+ DFG+A+ ++ + +++ + T + +MA S V+S+GI+L E+F+
Sbjct: 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 22/76 (28%), Positives = 40/76 (52%), Gaps = 12/76 (15%)
Query: 265 IHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA----------- 313
IH DL N+L +N V + DFG+A+ + ++ ++ + + +MA
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 314 -SYVYSFGIMLLEVFT 328
S V+SFG++L E+F+
Sbjct: 256 QSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 4e-04
Identities = 48/194 (24%), Positives = 78/194 (40%), Gaps = 34/194 (17%)
Query: 164 ISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKS-FDFECDVMKSTCYRNLIKIISSR 221
I RG FG + R++ D +VK K+ F E ++K + N++++I
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 222 SNE-------------DFKVLVLEYMPRGSLEKCLYSSNYVGFALEYLHFDYSVLIIHYD 268
+ + DF + PR +++ + +EYL S IH D
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119
Query: 269 LKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATI------------GYMASY- 315
L N L + V +SDFG+++ ED T + I G +S
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177
Query: 316 -VYSFGIMLLEVFT 328
V+SFGI+L E F+
Sbjct: 178 DVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 31/95 (32%), Positives = 44/95 (46%), Gaps = 19/95 (20%)
Query: 224 EDFKVLVLEYMPRGSL--------EKCLYSSNYVGF-------ALEYLHFDYSVLIIHYD 268
E + LV++Y P G L KCL S F ALEYLH + I++ D
Sbjct: 73 ETYLCLVMDYCPGGELFRLLQRQPGKCL-SEEVARFYAAEVLLALEYLH---LLGIVYRD 128
Query: 269 LKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303
LKP N+L ++ LSDF ++K E + +
Sbjct: 129 LKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 33/108 (30%), Positives = 51/108 (47%), Gaps = 22/108 (20%)
Query: 253 LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM 312
L+YLH S I+H D+KP N+L + N V + DFG+A++ D TQ + T Y
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVE-EPDESKHMTQEVVTQYYR 171
Query: 313 AS--------Y-----VYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
A Y ++S G + E+ R +I F ++ I+ L
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGR-----RILFQAQSPIQQL 214
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 32/115 (27%), Positives = 53/115 (46%), Gaps = 27/115 (23%)
Query: 232 EYMPRGSLEKCLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291
+YM ++ LY L+ + F +S ++H DLKP N+L D+ V L+DFG+A+
Sbjct: 96 QYMDAELVKSYLYQ------ILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
Query: 292 LL---IREDHFMIQTQTLATIGYMASYV-------------YSFGIMLLEVFTRK 330
+R + T + T+ Y A V +S G + E+ T+K
Sbjct: 150 AFGIPVR-----VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 39/155 (25%), Positives = 63/155 (40%), Gaps = 27/155 (17%)
Query: 163 LISRGGFGSIHKAR-IQDRMEFSVK-----GFHLQCSGAFKSFDFECDVMKSTCYRNLIK 216
+I RG FG + R +++K + A E D++ ++K
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH--VRAERDILADADSPWIVK 65
Query: 217 IISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHFDYSV 262
+ S +E+ LV+EYMP G L L F AL+ +H +
Sbjct: 66 LYYSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEETARFYIAELVLALDSVH---KL 120
Query: 263 LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297
IH D+KP N+L D + L+DFG+ K + +
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 22/76 (28%), Positives = 41/76 (53%), Gaps = 12/76 (15%)
Query: 265 IHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA----------- 313
IH D+ NVL D V + DFG+A+ ++ + +++++ + +MA
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293
Query: 314 -SYVYSFGIMLLEVFT 328
S V+S+GI+L E+F+
Sbjct: 294 QSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 27/90 (30%), Positives = 43/90 (47%)
Query: 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNN 111
P+ + L L SN+ IP ++ L+LS N+LTG IP + + L K+ N+
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNS 391
Query: 112 FAGVIPNAIGCLNILQHLFLGYNRLQGSIS 141
G IP ++G L+ + L N G +
Sbjct: 392 LEGEIPKSLGACRSLRRVRLQDNSFSGELP 421
|
Length = 968 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 32/151 (21%), Positives = 69/151 (45%), Gaps = 23/151 (15%)
Query: 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGA------FKSFDFECDVMKSTCYRNLI 215
++ +G +G+++ +VK L S ++ E D++KS + N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 216 KIISSRSNEDFKVLVLEYMPRGSLEK-------------CLYSSNYVGFALEYLHFDYSV 262
+ + + +++ + +E++P GS+ C Y+ + + YLH +
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-GVAYLHNN--- 121
Query: 263 LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293
++H D+K +NV+ N + L DFG A+ L
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 17/103 (16%)
Query: 202 ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCL-------------YSSNY 248
E ++ + ++ ++ S +E+ +LE++ G L L Y +
Sbjct: 68 EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAEL 127
Query: 249 VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291
V A EYLH S II+ DLKP N+L D+ ++DFG AK
Sbjct: 128 V-LAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 45/203 (22%), Positives = 84/203 (41%), Gaps = 39/203 (19%)
Query: 164 ISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAF--KSFDFECDVMKSTCYRNLIKIISS 220
+ +G +G + R D ++ +K +L+ + K+ + E ++ + N++ S
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 221 RSNEDFKV-LVLEYMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLII 265
ED + +V+ + G L L + AL+YLH + I+
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---IL 124
Query: 266 HYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMASYVYSFGIMLLE 325
H DLK NV + + D GIA++L E+ + + + T YM+ ++S
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPELFS------- 175
Query: 326 VFTRKKPTNKIFFSQRNDIKALG 348
KP N ++D+ ALG
Sbjct: 176 ----NKPYN-----YKSDVWALG 189
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 29/96 (30%), Positives = 40/96 (41%), Gaps = 24/96 (25%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
L YLH S IH D+K N+L + L+DFG A L+ + F + T +
Sbjct: 127 GLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF------VGTPYW 177
Query: 312 MASYV---------------YSFGIMLLEVFTRKKP 332
MA V +S GI +E+ RK P
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 6e-04
Identities = 31/106 (29%), Positives = 49/106 (46%), Gaps = 24/106 (22%)
Query: 242 CLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301
C Y++ + LE+LH II+ DLKP NVL D++ +SD G+A L
Sbjct: 100 CFYTAQIIS-GLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG----- 150
Query: 302 QTQT---LATIGYMASYV------------YSFGIMLLEVFTRKKP 332
Q++T T G+MA + ++ G+ L E+ + P
Sbjct: 151 QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 17/42 (40%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293
L + H S I+H DLKP N+L + V L+DFG+A+
Sbjct: 110 GLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSF 148
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 27/107 (25%), Positives = 49/107 (45%), Gaps = 12/107 (11%)
Query: 215 IKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN---------YVGFALEYLHFDYSVLII 265
+K+ S +E++ L++EY+P G + L + Y+ + + + + I
Sbjct: 64 VKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYI 123
Query: 266 HYDLKPSNVLFDDNIVTHLSDFGIAKLL---IREDHFMIQTQTLATI 309
H D+KP N+L D LSDFG+ L R + + I + L +
Sbjct: 124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 30/74 (40%), Positives = 37/74 (50%), Gaps = 3/74 (4%)
Query: 68 IPSTFWNLKDILYLNLSLNSLTGPIPLEIENL-KVLVKIYFSMNNFAGVIPNAIGCLNIL 126
I S + L I +NLS N L+GPIP +I L + S NNF G IP G + L
Sbjct: 85 ISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNL 142
Query: 127 QHLFLGYNRLQGSI 140
+ L L N L G I
Sbjct: 143 ETLDLSNNMLSGEI 156
|
Length = 968 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 29/95 (30%), Positives = 43/95 (45%), Gaps = 20/95 (21%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
AL+Y+H V +IH D+K +N+L + L DFG+A LL + + T Y
Sbjct: 113 ALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS---KRSTFVGTPY 166
Query: 312 -MA--------SY-----VYSFGIMLLEVFTRKKP 332
MA Y ++S GI + E+ T P
Sbjct: 167 WMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 43/176 (24%), Positives = 70/176 (39%), Gaps = 23/176 (13%)
Query: 156 NGFSEDNLISRGGFGSIHKARIQ--------DRMEFSVKGFHLQCSGAFKSFDFECDVMK 207
F +L+ RG FG + R + M+ SV S F+ E D++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVS----FFEEERDILS 56
Query: 208 STCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCL------YSSNYVGFAL----EYLH 257
+ + ++ + ++D LV+EY P G L L + + F L +H
Sbjct: 57 ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIH 116
Query: 258 FDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
+ + +H D+KP NVL D L+DFG A L + + T Y+A
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGTPDYIA 171
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 39/172 (22%), Positives = 67/172 (38%), Gaps = 44/172 (25%)
Query: 152 CRVTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVK---------GFHLQCSGAFKSFDF 201
C + + G FG ++KAR I+ ++K GF + A +
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPIT---ALR---- 56
Query: 202 ECDVMKSTCYRNLIKII------SSRSNEDFKV--LVLEYM----------PRGSLE--- 240
E ++K + N++ +I +S +V YM P L
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ 116
Query: 241 -KCLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291
KC G + YLH I+H D+K +N+L D+ + ++DFG+A+
Sbjct: 117 IKCYMLQLLEG--INYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 39/221 (17%)
Query: 158 FSEDNLISRGGFGSIHKAR-IQDRMEFSVKG---FHLQCSGAFKSFDFECDVMKSTCYRN 213
F + I RG F +++A + D + ++K F L + A E D++K + N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 214 LIKIISSRSNEDFKVLVLEYMPRGSL---------------EKCLYSSNYVGF--ALEYL 256
+IK +S ++ +VLE G L EK ++ +V ALE++
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY-FVQLCSALEHM 122
Query: 257 HFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED---HFMIQT------QTLA 307
H S ++H D+KP+NV V L D G+ + + H ++ T + +
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 308 TIGY-MASYVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
GY S ++S G +L E+ + P F+ + ++ +L
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 41/160 (25%), Positives = 67/160 (41%), Gaps = 32/160 (20%)
Query: 202 ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF---------- 251
E +++ R ++ + + +D LVL M G L+ +Y+ GF
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109
Query: 252 ----ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA 307
LE L + I++ DLKP N+L DD +SD G+A + I E + +
Sbjct: 110 ELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETV--RGRVG 163
Query: 308 TIGYMA-------SYVYS-----FGIMLLEVFTRKKPTNK 335
T+GYMA Y +S G ++ E+ + P K
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 20/40 (50%), Positives = 25/40 (62%), Gaps = 3/40 (7%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291
AL YLH S+ II+ DLKP N+L D L+DFG+ K
Sbjct: 108 ALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 20/95 (21%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ---TQTLAT 308
L+Y+H S ++H DLKP N+L + + + DFG+A+ E+ T+ +AT
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVAT 172
Query: 309 IGY-----MASY--------VYSFGIMLLEVFTRK 330
Y M S+ V+S G +L E+ RK
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.002
Identities = 41/189 (21%), Positives = 78/189 (41%), Gaps = 55/189 (29%)
Query: 175 ARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKS-TCYRNLIKIISSRSNEDFKVLVLEY 233
A +++R+EF L E VMK C+ ++++++ S ++V+E
Sbjct: 48 ASMRERIEF------LN----------EASVMKEFNCH-HVVRLLGVVSTGQPTLVVMEL 90
Query: 234 MPRGSLEKCLYS----------------SNYVGFALE------YLHFDYSVLIIHYDLKP 271
M +G L+ L S ++ A E YL + +H DL
Sbjct: 91 MAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAA 147
Query: 272 SNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSF 319
N + +++ + DFG+ + + D++ + L + +MA S V+SF
Sbjct: 148 RNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSF 207
Query: 320 GIMLLEVFT 328
G++L E+ T
Sbjct: 208 GVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 25/103 (24%), Positives = 43/103 (41%), Gaps = 18/103 (17%)
Query: 202 ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRG-------------SLEKCLYSSNY 248
E +M + N++ ++ DF LV++ M S KC+
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQIL 129
Query: 249 VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291
G L LH Y +H DL P+N+ + + ++DFG+A+
Sbjct: 130 NG--LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 21/149 (14%)
Query: 164 ISRGGFGSIHKARIQDR-MEFSVKGFHLQCSGA-FKSFDFECDVMKSTCYRNLIKIISSR 221
+ +G +GS++K + + ++K L+ + F E D++ ++ +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 222 SNEDFKVLVLEYMPRGSLEKCLYS----------------SNYVGFALEYLHFDYSVLII 265
E + +EYM GSL+K LY+ + V L++L +++ II
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 266 HYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294
H D+KP+NVL + N L DFG++ L+
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.002
Identities = 22/72 (30%), Positives = 34/72 (47%), Gaps = 14/72 (19%)
Query: 230 VLEYMPRGS----LEKCLYSSNYVGF-------ALEYLHFDYSVLIIHYDLKPSNVLFDD 278
++EY GS L+ Y+ F LEYLH + IH D+K +N+L +
Sbjct: 77 IMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGK---IHRDIKAANILLSE 133
Query: 279 NIVTHLSDFGIA 290
L+DFG++
Sbjct: 134 EGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 14/40 (35%), Positives = 25/40 (62%), Gaps = 3/40 (7%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291
L Y+H + I+H D+K +N+L + + L+DFG+A+
Sbjct: 131 GLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 38/145 (26%), Positives = 70/145 (48%), Gaps = 22/145 (15%)
Query: 164 ISRGGFGSIHKARIQDRMEF-SVKGFHLQC------SGAFKSFDFECDVMKSTCYRNLIK 216
I G +G++ KA+ ++ E ++K L S A + E ++K ++N+++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 63
Query: 217 IISSRSNEDFKVLVLEYMPRGSLEKCLYSSN----------YVGFALEYLHFDYSVLIIH 266
+ ++ LV EY + L+K S N ++ L+ L F +S ++H
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLH 122
Query: 267 YDLKPSNVLFDDNIVTHLSDFGIAK 291
DLKP N+L + N L+DFG+A+
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 21/76 (27%), Positives = 40/76 (52%), Gaps = 12/76 (15%)
Query: 265 IHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA----------- 313
IH DL N+L +T + DFG+A+ + + +++++ + +MA
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF 295
Query: 314 -SYVYSFGIMLLEVFT 328
S V+S+GI+L E+F+
Sbjct: 296 ESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 23/64 (35%), Positives = 36/64 (56%), Gaps = 2/64 (3%)
Query: 230 VLEYMPRGSLEKCLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGI 289
+LE MP G + + S Y+ ++ +H+ + I+H D+KP N+L N V L DFG
Sbjct: 89 LLEEMPNGVPPEKVRS--YIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGF 146
Query: 290 AKLL 293
A+ L
Sbjct: 147 ARNL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 50/220 (22%), Positives = 95/220 (43%), Gaps = 37/220 (16%)
Query: 158 FSEDNLISRGGFGSIHKAR-IQDRMEFSVKG---FHLQCSGAFKSFDFECDVMKSTCYRN 213
F + I RG F +++A + DR ++K F + + A + E D++K + N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 214 LIKIISSRSNEDFKVLVLEYMPRGSLEKCLYS--------------SNYVGF--ALEYLH 257
+IK + S ++ +VLE G L + + +V A+E++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 258 FDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED---HFMIQT------QTLAT 308
S ++H D+KP+NV V L D G+ + + H ++ T + +
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 309 IGY-MASYVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
GY S ++S G +L E+ + P F+ + ++ +L
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLFSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 27/109 (24%), Positives = 50/109 (45%), Gaps = 22/109 (20%)
Query: 251 FALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIA-KLLIREDHFMIQTQTLATI 309
LE++H + +++ DLKP+N+L D++ +SD G+A ++ H ++ T
Sbjct: 108 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-----ASVGTH 159
Query: 310 GYMASYV-------------YSFGIMLLEVFTRKKPTNKIFFSQRNDIK 345
GYMA V +S G ML ++ P + +++I
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 19/41 (46%), Positives = 26/41 (63%), Gaps = 3/41 (7%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292
ALEYLH + I+H DLKP N+L L+DFG++K+
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.003
Identities = 16/40 (40%), Positives = 23/40 (57%), Gaps = 3/40 (7%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291
+ Y H S ++H DLKP N+L D L+DFG+A+
Sbjct: 111 GIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.003
Identities = 18/42 (42%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293
+E+ H S IIH D+KP N+L + V L DFG A+ L
Sbjct: 112 GIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 21/60 (35%), Positives = 32/60 (53%), Gaps = 5/60 (8%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
AL YLH + I+H DL P+N++ ++ ++DFG+AK E T + TI Y
Sbjct: 125 ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTILY 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 36/140 (25%), Positives = 60/140 (42%), Gaps = 16/140 (11%)
Query: 164 ISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRS 222
+ G +G ++KAR + +VK L+ F E ++K + N++ S
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 223 NEDFKVLVLEYMPRGSLE------------KCLYSSNYVGFALEYLHFDYSVLIIHYDLK 270
+ + + +EY GSL+ + Y L YLH S +H D+K
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIK 133
Query: 271 PSNVLFDDNIVTHLSDFGIA 290
+N+L DN L+DFG+A
Sbjct: 134 GANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 48/204 (23%), Positives = 88/204 (43%), Gaps = 42/204 (20%)
Query: 161 DNLISRGGFGSIHKARIQ--DRMEFSVKGFHLQ---CSGAFKSFDFECDVMKSTCYRNLI 215
+ +I G FG + + R++ + E V L+ + F E +M + N+I
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 216 KIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN-------YVGF------ALEYL-HFDYS 261
+ + +++ E+M G+L+ L ++ VG ++YL +Y
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY- 127
Query: 262 VLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM--------- 312
+H DL N+L + N+V +SDFG+++ L ED T T + G +
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 313 --------ASYVYSFGIMLLEVFT 328
AS V+S+GI++ EV +
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 40/206 (19%), Positives = 85/206 (41%), Gaps = 44/206 (21%)
Query: 164 ISRGGFGSIH----KARIQDRMEFSVKGFHLQCSGAFKS---FDFECDVMKSTCYRNLIK 216
+ +G FG ++ K ++D E V + + + + F E VMK ++++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 217 IISSRSNEDFKVLVLEYMPRG----------------------SLEKCLYSSNYVGFALE 254
++ S ++++E M RG SL+K + + + +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 255 YLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA- 313
YL+ + +H DL N + ++ + DFG+ + + D++ + L + +M+
Sbjct: 134 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 314 -----------SYVYSFGIMLLEVFT 328
S V+SFG++L E+ T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.003
Identities = 51/197 (25%), Positives = 80/197 (40%), Gaps = 35/197 (17%)
Query: 167 GGFGSIHKARIQDR----MEFSVKGFHLQCSGAFKS-FDFECDVMKSTCYRNLIKIISSR 221
G FGS+ K + +E +VK + A K F E VM + ++++I
Sbjct: 6 GNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC 65
Query: 222 SNEDFKVLVLEYMPRGSLEKCLYS------------SNYVGFALEYLHFDYSVLIIHYDL 269
E +LV+E P G L K L ++ V + YL S +H DL
Sbjct: 66 KGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLE---SKHFVHRDL 121
Query: 270 KPSNVLFDDNIVTHLSDFGIAKLL-IREDHFMIQTQTLATIGYMA------------SYV 316
NVL + +SDFG+++ L D++ T + + A S V
Sbjct: 122 AARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDV 181
Query: 317 YSFGIMLLEVFTR-KKP 332
+S+G+ L E F+ KP
Sbjct: 182 WSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 27/75 (36%), Positives = 38/75 (50%), Gaps = 15/75 (20%)
Query: 229 LVLEYMPRGSL------EKCL------YSSNYVGFALEYLHFDYSVLIIHYDLKPSNVLF 276
VL+Y+ G L E+C + + V A+ YLH S+ II+ DLKP N+L
Sbjct: 73 FVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILL 129
Query: 277 DDNIVTHLSDFGIAK 291
D L+DFG+ K
Sbjct: 130 DSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 43/149 (28%), Positives = 68/149 (45%), Gaps = 26/149 (17%)
Query: 163 LISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVM-------KSTCYRNL 214
+I +G FG + AR + + ++VK LQ K + E +M K+ + L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVK--VLQKKAILKKKE-EKHIMSERNVLLKNVKHPFL 58
Query: 215 IKIISSRSNEDFKVLVLEYMPRGSL------EKCL------YSSNYVGFALEYLHFDYSV 262
+ + S D VL+Y+ G L E+C + + + AL YLH S+
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH---SL 115
Query: 263 LIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291
I++ DLKP N+L D L+DFG+ K
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 28/98 (28%), Positives = 49/98 (50%), Gaps = 11/98 (11%)
Query: 242 CLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM- 300
C Y++ V EYL S+ I++ DLKP N+L D + ++DFG AK++ + +
Sbjct: 134 CFYAAQIV-LIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC 189
Query: 301 -----IQTQTLATIGY-MASYVYSFGIMLLEVFTRKKP 332
I + L +G+ A+ ++ GI + E+ P
Sbjct: 190 GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 19/77 (24%), Positives = 38/77 (49%), Gaps = 12/77 (15%)
Query: 264 IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA---------- 313
++H +L N+L + + ++DFG+A LL +D ++ I +MA
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189
Query: 314 --SYVYSFGIMLLEVFT 328
S V+S+G+ + E+ +
Sbjct: 190 HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.004
Identities = 22/80 (27%), Positives = 37/80 (46%), Gaps = 8/80 (10%)
Query: 234 MPRGSLEKCLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293
+P ++K ++ + L+ ++F + IH D+KP N+L L DFG A++L
Sbjct: 97 VPEHLIKKIIWQT------LQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL 150
Query: 294 IREDHFMIQTQTLATIGYMA 313
T +AT Y A
Sbjct: 151 TGPGDDY--TDYVATRWYRA 168
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 348 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.98 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.98 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.98 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.98 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.98 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.98 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.98 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.98 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.98 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.98 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.98 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.98 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.98 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.96 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.96 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.96 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.96 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.95 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.95 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.95 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.95 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.95 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.95 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.95 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.95 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.95 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.95 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.95 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.94 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.94 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.94 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.94 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.94 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.94 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.94 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.94 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.94 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.94 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.94 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.94 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.94 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.94 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.94 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.94 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.94 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.94 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.93 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.93 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.93 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.91 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.9 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.88 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.87 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.86 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.86 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.86 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.86 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.78 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.75 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.67 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.58 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.54 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.53 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.52 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.5 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.48 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.48 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.3 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.29 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.18 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.04 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.02 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.01 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.99 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.97 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.95 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.91 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.81 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.8 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.8 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.78 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.77 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.73 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.7 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.61 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.58 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.5 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.5 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.43 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.43 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.4 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.4 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.4 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.39 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.33 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.32 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.31 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.3 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.29 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.27 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.26 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.25 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.25 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.21 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.19 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.15 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.11 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.1 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.09 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.08 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.06 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.06 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.05 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.04 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 97.99 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.93 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 97.93 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.92 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 97.91 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.91 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.9 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.84 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.81 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.76 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.75 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.73 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.71 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 97.66 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=393.35 Aligned_cols=278 Identities=28% Similarity=0.433 Sum_probs=233.6
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|+++|.+|.++++|++|++|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..+..++.|+.
T Consensus 496 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 575 (968)
T PLN00113 496 GSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQ 575 (968)
T ss_pred hhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCE
Confidence 77899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeeecccccccccccccc-------------chh-----------h----------------------------------
Q 038351 129 LFLGYNRLQGSISYSKWF-------------SCL-----------E---------------------------------- 150 (348)
Q Consensus 129 L~ls~N~lsG~ip~~~~~-------------~~~-----------~---------------------------------- 150 (348)
+++++|+++|.+|..+.| .|. .
T Consensus 576 l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (968)
T PLN00113 576 VNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGR 655 (968)
T ss_pred EeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhh
Confidence 999999999988854321 110 0
Q ss_pred -----------------------------HHhhhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCccchhhH
Q 038351 151 -----------------------------LCRVTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFD 200 (348)
Q Consensus 151 -----------------------------~~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~ 200 (348)
.......|+..++||+|+||.||+|+. .++..||||++.... ....
T Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~ 731 (968)
T PLN00113 656 NNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN----SIPS 731 (968)
T ss_pred hcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc----cccH
Confidence 000112345567899999999999997 578899999886332 2234
Q ss_pred HHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCHHHHHhch---------hHHHHHHHHHHhcCCCceEecCCCc
Q 038351 201 FECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSS---------NYVGFALEYLHFDYSVLIIHYDLKP 271 (348)
Q Consensus 201 ~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~---------~~i~~~L~yLH~~~~~~iiHrDik~ 271 (348)
.|++.+++++|||||+++++|..++..++|||||++|+|.++++.- .++++|++|||+.++++|+|||+||
T Consensus 732 ~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp 811 (968)
T PLN00113 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811 (968)
T ss_pred HHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCH
Confidence 5788999999999999999999999999999999999999988641 2488999999988889999999999
Q ss_pred CceEEcCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 272 SNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 272 ~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
+||+++.++.+++. ||.+...... ....+|+.|+| +|||||||++|||+||+.||+..+
T Consensus 812 ~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~ 882 (968)
T PLN00113 812 EKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882 (968)
T ss_pred HhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc
Confidence 99999999998876 7766543221 12245666665 899999999999999999997654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=338.19 Aligned_cols=194 Identities=38% Similarity=0.557 Sum_probs=168.3
Q ss_pred ccccchhhHHhhhCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEe
Q 038351 143 SKWFSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRS 222 (348)
Q Consensus 143 ~~~~~~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 222 (348)
...|+..++..+|++|+..++||+|+||.||+|.+.++..||||++.....+..++|.+|++++.+++|||+|+++|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 34578899999999999999999999999999999999999999886544321466999999999999999999999999
Q ss_pred cCC-eEEEEEeccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeec
Q 038351 223 NED-FKVLVLEYMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDF 287 (348)
Q Consensus 223 ~~~-~~~lV~Ey~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~Df 287 (348)
+.+ +.+||||||++|+|.++|+... .+|+||+|||+.+.++|||||||++|||||+++++||+||
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence 998 5999999999999999987643 2889999999999999999999999999999999999999
Q ss_pred CCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 288 GIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 288 Gla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
|+|+..... .....+...||.+|+| +|||||||+|+|++||+.|.+...
T Consensus 222 GLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~ 282 (361)
T KOG1187|consen 222 GLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR 282 (361)
T ss_pred cCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC
Confidence 999766431 1111111178999987 999999999999999999988654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=310.96 Aligned_cols=179 Identities=27% Similarity=0.432 Sum_probs=157.5
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeec--cCccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ--CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
....+|...+.||+|+|++||+|+++ ++.+||||.+... .....+.+..|+.+|+.++|||||++++++..++.+||
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 34567888888999999999999976 6789999999655 33445668899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCC------CcEEEeecCCcc
Q 038351 230 VLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN------IVTHLSDFGIAK 291 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~------~~~kl~DfGla~ 291 (348)
|||||.+|||.++++... ++|.||++|| +.+||||||||.||||+.. -.+||+|||+|+
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999999998752 4899999999 8999999999999999764 568999999999
Q ss_pred ccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 292 LLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
.+.+.. ...+.+|++.||| +|+||.|+|+|||++|+.||+..-
T Consensus 164 ~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 164 FLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 987533 2367899999999 899999999999999999999543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=291.99 Aligned_cols=177 Identities=29% Similarity=0.404 Sum_probs=155.2
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
.+.|+..++||+|+||+||.++.+ +++.+|+|.+++.. ....+....|..+|.+++||.||+++-.|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467899999999999999999865 67889999986542 23456788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 231 LEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
+||+.||.|..+|.... .++.||+||| +.+|||||+||+|||||++|.++|+|||+++.....+.
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 99999999999998533 1778999999 99999999999999999999999999999997544322
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.+..++||+.||| +|.||+||++|||++|.+||...
T Consensus 181 --~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~ 228 (357)
T KOG0598|consen 181 --ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE 228 (357)
T ss_pred --ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence 3456899999998 89999999999999999999764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=305.96 Aligned_cols=176 Identities=24% Similarity=0.346 Sum_probs=158.6
Q ss_pred CCCccccccccCCcceEEEeEe-cCCceEEEEeeeec---cCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQ---CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
..|...++||+|+|+.||+++. ..|.+||+|.+... .....+...+|+++.++++|||||+++++|++.+.+|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5689999999999999999997 88999999999653 3345577899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|+|++++|.++++.+. +|+.||.||| +.+|||||||..|++|++++++||+|||||..+..+++.
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 9999999999988432 4889999999 889999999999999999999999999999998755332
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..+.+|||.|+| +||||+|||||-|++|++||+..
T Consensus 175 --k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 175 --KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred --cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 357899999998 89999999999999999999875
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=291.04 Aligned_cols=181 Identities=23% Similarity=0.355 Sum_probs=154.6
Q ss_pred hhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCc-------cchhhHHHhhhcccccccceeeEEEEEecCC
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSG-------AFKSFDFECDVMKSTCYRNLIKIISSRSNED 225 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 225 (348)
..+.|-..+.+|+|+||.|-+|.- ++++.||||.++..... ......+|+++|++++|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 445677788999999999999975 58999999999654221 1123468999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCC---CcEEEeecCCc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN---IVTHLSDFGIA 290 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~---~~~kl~DfGla 290 (348)
..|||||||++|+|.+.+-... ++..|+.||| +.+|+||||||+|||+..+ ..+||+|||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 9999999999999998875432 4788999999 9999999999999999765 77899999999
Q ss_pred cccccCCceeeecccccccCccc---------------cccHHHHHHHHHHHcCCCCCccccccc
Q 038351 291 KLLIREDHFMIQTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTNKIFFSQ 340 (348)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~~~~~~~ 340 (348)
+..... ....+++||+.|.| .|+||+|||+|-+++|.+||.+...+.
T Consensus 327 K~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~ 388 (475)
T KOG0615|consen 327 KVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP 388 (475)
T ss_pred hccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence 987532 23468899999998 699999999999999999998877654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=286.11 Aligned_cols=174 Identities=26% Similarity=0.372 Sum_probs=152.8
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCC-eEEEEEec
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNED-FKVLVLEY 233 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~Ey 233 (348)
+.+..+.||+|..|+|||++++ +++.+|+|.+..... ...+++.+|++++++.+||+||+++|.|..+. .+.++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3445688999999999999987 678899999965543 34578999999999999999999999999988 59999999
Q ss_pred cCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 234 MPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 234 ~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
|.+|+|+++++.. .+|.+||.|||+ +.+||||||||+|||++..|++||||||.++.+.+. .
T Consensus 160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~ 233 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----I 233 (364)
T ss_pred cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----h
Confidence 9999999998842 237889999995 378999999999999999999999999999988653 3
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..++.||..||| +||||||+.++|+++|+.||-..
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 467889999998 99999999999999999998764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=291.49 Aligned_cols=174 Identities=29% Similarity=0.404 Sum_probs=150.3
Q ss_pred cccccccCCcceEEEeEecCCceEEEEeeeeccCcc--chhhHHHhhhcccccccceeeEEEEEecCC-eEEEEEeccCC
Q 038351 160 EDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGA--FKSFDFECDVMKSTCYRNLIKIISSRSNED-FKVLVLEYMPR 236 (348)
Q Consensus 160 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~Ey~~~ 236 (348)
..+.+|+|+||+||+|.++....||||++....... .+.|.+|+.+|.+++|||||+++|+|..+. ..++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 445699999999999999988779999997554332 458999999999999999999999999988 79999999999
Q ss_pred CCHHHHHhch-h-------------HHHHHHHHHHhcCCCc-eEecCCCcCceEEcCCC-cEEEeecCCccccccCCcee
Q 038351 237 GSLEKCLYSS-N-------------YVGFALEYLHFDYSVL-IIHYDLKPSNVLFDDNI-VTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 237 gsL~~~l~~~-~-------------~i~~~L~yLH~~~~~~-iiHrDik~~NILld~~~-~~kl~DfGla~~~~~~~~~~ 300 (348)
|+|.++++.. . .||+|++||| +.. |||||||++|||++.++ .+||+|||+++...... .
T Consensus 125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~ 199 (362)
T KOG0192|consen 125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T 199 (362)
T ss_pred CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence 9999999762 1 2899999999 666 99999999999999997 99999999998765422 2
Q ss_pred eecccccccCccc--------------cccHHHHHHHHHHHcCCCCCccccc
Q 038351 301 IQTQTLATIGYMA--------------SYVYSFGIMLLEVFTRKKPTNKIFF 338 (348)
Q Consensus 301 ~~~~~~gt~~y~a--------------sDV~S~Gvvl~elltG~~P~~~~~~ 338 (348)
..+...||..||| +|||||||++|||+||+.||.....
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 2344778999998 8999999999999999999987654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=287.56 Aligned_cols=182 Identities=26% Similarity=0.395 Sum_probs=155.8
Q ss_pred HhhhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeec---cCccchhhHHHhhhcccc-cccceeeEEEEEecCCe
Q 038351 152 CRVTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQ---CSGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDF 226 (348)
Q Consensus 152 ~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 226 (348)
.+-.++|...+.||+|+|++|++|+. ..++++|||++.+. .....+....|-++|.+| .||.|++|+..|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 55667899999999999999999985 47899999998543 223345677788899999 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 227 KVLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
.|.|+||+++|+|.++|+..+ +|..||+||| +.+||||||||+|||+|++|+++|+|||.|+.+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999999998643 2777999999 9999999999999999999999999999999985
Q ss_pred cCCce---------e--eecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHF---------M--IQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~---------~--~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+.... . ....++||..|.+ +|+|+|||++|+|++|++||.+.
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~ 290 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA 290 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc
Confidence 43211 1 1246889999986 99999999999999999999763
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=283.53 Aligned_cols=184 Identities=27% Similarity=0.374 Sum_probs=150.9
Q ss_pred hhCCCccccccccCCcceEEEeE-ecCCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecC--CeEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNE--DFKV 228 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 228 (348)
..+.|+..++||+|.||.||||+ ..+++.||+|++.... .+......+||.+|+++.||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 34568888999999999999998 4689999999997654 34556678999999999999999999988876 6899
Q ss_pred EEEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 229 LVLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
||+|||++ ||.-++... .++..||+|+| ..+|+|||||.+|||||.+|.+||+|||||+++..
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99999977 887776653 24778888888 99999999999999999999999999999998865
Q ss_pred CCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccccccchhhhhhh
Q 038351 296 EDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~~~~~~~~~~~~ 347 (348)
.... ..+..+-|..|.| .|+||.||||.||++|++.|. |..+++|+
T Consensus 271 ~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~-----G~tEveQl 329 (560)
T KOG0600|consen 271 SGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ-----GRTEVEQL 329 (560)
T ss_pred CCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC-----CccHHHHH
Confidence 4321 1233344555544 999999999999999999765 45566654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=266.06 Aligned_cols=174 Identities=28% Similarity=0.394 Sum_probs=154.1
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
.++|+..+.||.|+||.|..++.+ ++..+|+|.+..+.. ...+....|..+|+.+.||.++++++.|.+.+..+||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 457888899999999999999976 577899999975532 2345677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 231 LEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
|||+++|.|..+++..+ +|+.||+||| +..|++||+||+|||+|.+|.+||+|||+|+.+...
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 99999999999998732 3788999999 889999999999999999999999999999987542
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+.+.|||+.|+| +|.|||||++|||+.|.+||-+.
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 357899999998 89999999999999999999653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=273.28 Aligned_cols=182 Identities=26% Similarity=0.304 Sum_probs=147.6
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-c-cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-G-AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
+.|+...++|+|+||.|||++.+ +|+.||||++..... . -.+-..+|+++|++++|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35777788999999999999976 689999999965433 2 23457899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 233 YMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 233 y~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
||+..-|.+.-+... +++.|+.|+| +.++|||||||+|||+..++.+|+||||+|+.+...+.
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd-- 156 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD-- 156 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc--
Confidence 998755544433221 3666777777 89999999999999999999999999999999874322
Q ss_pred eecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccccccchhhhhhh
Q 038351 301 IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347 (348)
Q Consensus 301 ~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~~~~~~~~~~~~ 347 (348)
.-+...+|.+|.| .||||.||++.||+||.+-| .|.++++|+
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~-----PG~SDiDQL 211 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW-----PGRSDIDQL 211 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC-----CCcchHHHH
Confidence 2255666777766 89999999999999999854 566777664
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=283.88 Aligned_cols=174 Identities=29% Similarity=0.444 Sum_probs=148.0
Q ss_pred cccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCH
Q 038351 160 EDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL 239 (348)
Q Consensus 160 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 239 (348)
..+.||+|-||.||.|.++....||+|.++... -..++|.+|+++|++++|+|||+++++|..++.++||||||++|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 346899999999999999999999999997653 3347899999999999999999999999999999999999999999
Q ss_pred HHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeeccc
Q 038351 240 EKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT 305 (348)
Q Consensus 240 ~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~ 305 (348)
.++|+... +||+|++||+ ++++|||||-++|||++++..+||+|||+||... ++.+......
T Consensus 289 l~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d~~Y~~~~~~ 364 (468)
T KOG0197|consen 289 LDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIG-DDEYTASEGG 364 (468)
T ss_pred HHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccC-CCceeecCCC
Confidence 99998722 3999999999 8999999999999999999999999999999544 3344333322
Q ss_pred ccccCccc------------cccHHHHHHHHHHHc-CCCCCccccc
Q 038351 306 LATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIFF 338 (348)
Q Consensus 306 ~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~~ 338 (348)
.-.+.|.| ||||||||+|+||+| |+.|+..+..
T Consensus 365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn 410 (468)
T KOG0197|consen 365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN 410 (468)
T ss_pred CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH
Confidence 22334444 999999999999998 8889877654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=273.47 Aligned_cols=178 Identities=23% Similarity=0.323 Sum_probs=149.9
Q ss_pred CCCccccccccCCcceEEEeE-ecCCceEEEEeeeec--cCccchhhHHHhhhcccccccceeeEEE-EEecCCe-EEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQ--CSGAFKSFDFECDVMKSTCYRNLIKIIS-SRSNEDF-KVLV 230 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~-~~~~~~~-~~lV 230 (348)
.+|.+.++||+|.||+|||+. ..++..+|.|.++-. .....+....|+.+|++++|||||++++ .+..+.+ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 357788999999999999997 568999999998633 2234566889999999999999999998 4555555 8999
Q ss_pred EeccCCCCHHHHHhchh----------------HHHHHHHHHHhcCCCc--eEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 231 LEYMPRGSLEKCLYSSN----------------YVGFALEYLHFDYSVL--IIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~----------------~i~~~L~yLH~~~~~~--iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
||||..|+|...++..+ +++.||..+|+.. ++ |+||||||.||+++.+|.+|++|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999887532 2677899899532 44 99999999999999999999999999999
Q ss_pred cccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 293 LIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+..+.. ...+..|||.||+ |||||+||++|||..-++||...
T Consensus 178 l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 178 LSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred hcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 865433 3467889999997 99999999999999999999754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=256.31 Aligned_cols=181 Identities=27% Similarity=0.422 Sum_probs=151.7
Q ss_pred CCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 156 NGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.+|...+.+|+|.||.||+|+. .+++.||||+++.... +-.....+|+..|+.++|+||+++++.|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677889999999999999985 5899999999976543 234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhchhH-------------HHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 233 YMPRGSLEKCLYSSNY-------------VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 233 y~~~gsL~~~l~~~~~-------------i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+. +|+..+++... +.+|++|+| ...|+|||+||.|+|++.+|..||+|||+|+.+......
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9976 99999887542 677899999 889999999999999999999999999999998654332
Q ss_pred eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccccccchhhhhhh
Q 038351 300 MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347 (348)
Q Consensus 300 ~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~~~~~~~~~~~~ 347 (348)
. +...-|..|.| .||||.|||+.||+-|.+ +..|.+|++|+
T Consensus 158 ~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P-----~fpG~sDidQL 211 (318)
T KOG0659|consen 158 Q--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVP-----FFPGDSDIDQL 211 (318)
T ss_pred c--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCC-----CCCCCchHHHH
Confidence 2 22234455554 899999999999999987 45677888876
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=282.32 Aligned_cols=175 Identities=26% Similarity=0.369 Sum_probs=152.9
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
++|-..+.||+|+||.||||+.+ +.+.||+|.+.+... ...+.+.+|+++++.++|||||.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777889999999999999865 677899999865432 345668999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 233 YMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 233 y~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
|+.+ +|.++|.... .+..||.||| +.+|+|||+||.|||++..+.+|++|||+|+.+... ..
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--TS 155 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccC--ce
Confidence 9977 9999987543 2567889999 999999999999999999999999999999988643 34
Q ss_pred eecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 301 IQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..+...||+.||| +|.||+||++|||++|++||-..
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~ 203 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR 203 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH
Confidence 5677889999998 89999999999999999999553
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=275.30 Aligned_cols=176 Identities=23% Similarity=0.354 Sum_probs=153.2
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc----C-ccchhhHHHhhhccccc-ccceeeEEEEEecCCe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC----S-GAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDF 226 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 226 (348)
...+|...+.||+|+||+|+.|... ++..||+|.+.... . ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4568889999999999999999754 67999999665431 1 23455678999999999 9999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCC-CcEEEeecCCcccc
Q 038351 227 KVLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN-IVTHLSDFGIAKLL 293 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DfGla~~~ 293 (348)
.++||||+.+|+|.+++... .+++.|++|+| +.+|+||||||+|||+|.+ +++||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999998763 24888999999 8999999999999999999 99999999999987
Q ss_pred c-cCCceeeecccccccCccc--------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 294 I-REDHFMIQTQTLATIGYMA--------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 294 ~-~~~~~~~~~~~~gt~~y~a--------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
. ... .....+||+.|+| +||||+||+||.|++|+.||++
T Consensus 172 ~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d 225 (370)
T KOG0583|consen 172 PGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD 225 (370)
T ss_pred CCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 3 222 3467889999988 8999999999999999999987
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=274.26 Aligned_cols=180 Identities=25% Similarity=0.427 Sum_probs=150.5
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
..++|+..+.||+|+||.||.|+-+ +|..+|+|++++.. ....+....|-.+|....+|+||+|+-.|++.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 3568999999999999999999865 68899999997552 3455778889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhchh---------HHH---HHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC-
Q 038351 230 VLEYMPRGSLEKCLYSSN---------YVG---FALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE- 296 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~---------~i~---~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~- 296 (348)
||||+|||++.++|...+ +++ .|++.+| +.++|||||||+|+|||..|++||+||||++-+...
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 999999999999987643 244 4677777 999999999999999999999999999998654210
Q ss_pred --------------------Ccee------------------------eecccccccCccc------------cccHHHH
Q 038351 297 --------------------DHFM------------------------IQTQTLATIGYMA------------SYVYSFG 320 (348)
Q Consensus 297 --------------------~~~~------------------------~~~~~~gt~~y~a------------sDV~S~G 320 (348)
.... ....+.|||.||| +|.||+|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0000 0013569999999 8999999
Q ss_pred HHHHHHHcCCCCCccc
Q 038351 321 IMLLEVFTRKKPTNKI 336 (348)
Q Consensus 321 vvl~elltG~~P~~~~ 336 (348)
||||||+.|-+||...
T Consensus 376 ~ImyEmLvGyPPF~s~ 391 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSE 391 (550)
T ss_pred HHHHHHHhCCCCCCCC
Confidence 9999999999999764
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=261.42 Aligned_cols=187 Identities=23% Similarity=0.316 Sum_probs=150.5
Q ss_pred hHHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEec--C
Q 038351 150 ELCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSN--E 224 (348)
Q Consensus 150 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~ 224 (348)
.-|+..++|+..+.|++|.||.||+|+.+ ++..||+|+++.... +..-.-.+||.+|.+++|||||.+..+... -
T Consensus 70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM 149 (419)
T ss_pred cCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence 34566678999999999999999999965 678899999976532 233456899999999999999999888764 4
Q ss_pred CeEEEEEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcc
Q 038351 225 DFKVLVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291 (348)
Q Consensus 225 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~ 291 (348)
+.+|+|||||+. +|...+.... ++..|++||| ..-|+|||+|++|+|+.+.|..||+|||+|+
T Consensus 150 d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 150 DKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAR 225 (419)
T ss_pred ceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhh
Confidence 679999999987 8888887543 3778999999 7889999999999999999999999999999
Q ss_pred ccccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccccccchhhhhhh
Q 038351 292 LLIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347 (348)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~~~~~~~~~~~~ 347 (348)
.+..... ..+...-|..|.| .|+||+|||+.||+++++-|. |..+++|+
T Consensus 226 ~ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~-----G~sE~dQl 287 (419)
T KOG0663|consen 226 EYGSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP-----GKSEIDQL 287 (419)
T ss_pred hhcCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC-----CCchHHHH
Confidence 9865422 2233444555554 899999999999999998664 44445443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=268.83 Aligned_cols=178 Identities=31% Similarity=0.441 Sum_probs=151.0
Q ss_pred CCCccccccccCCcceEEEeEecC-CceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCC--eEEEEEe
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQD-RMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNED--FKVLVLE 232 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~E 232 (348)
.++...+.||+|+||.||++...+ +...|||..........+.+.+|+.+|++++|||||+.+|.....+ ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 457788999999999999998764 8899999997664333577899999999999999999999865555 6899999
Q ss_pred ccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcC-CCcEEEeecCCccccccC-C
Q 038351 233 YMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDD-NIVTHLSDFGIAKLLIRE-D 297 (348)
Q Consensus 233 y~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DfGla~~~~~~-~ 297 (348)
|+++|+|.+++.... ++.+||+||| +++||||||||+|||++. ++.+||+|||+++..... .
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999887542 3888999999 999999999999999999 799999999999877531 1
Q ss_pred ceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.........||+.||| +||||+||++.||+||++||...
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 1223345778888887 89999999999999999999863
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=274.43 Aligned_cols=174 Identities=26% Similarity=0.373 Sum_probs=156.1
Q ss_pred CCCccccccccCCcceEEEeE-ecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 156 NGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
..|..-..||+|+.|.||.|+ ..+++.||||++........+-+.+|+.+|+..+|+|||++++.|...++.|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 357777899999999999997 5578899999999887777778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch----h-------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeec
Q 038351 235 PRGSLEKCLYSS----N-------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303 (348)
Q Consensus 235 ~~gsL~~~l~~~----~-------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 303 (348)
++|+|.+.+... . .+.+||+||| ..+|+|||||.+|||++.++.+||+|||++..+..... ...
T Consensus 353 ~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~ 427 (550)
T KOG0578|consen 353 EGGSLTDVVTKTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRS 427 (550)
T ss_pred CCCchhhhhhcccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccc
Confidence 999999887653 1 2667999999 89999999999999999999999999999998876543 346
Q ss_pred ccccccCccc------------cccHHHHHHHHHHHcCCCCCc
Q 038351 304 QTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 304 ~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~ 334 (348)
+..||+.||| .||||+|++++||+-|++||=
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYl 470 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYL 470 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCcc
Confidence 7889999999 899999999999999999984
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=269.13 Aligned_cols=178 Identities=22% Similarity=0.361 Sum_probs=148.6
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||+||+|+.. +++.+|+|.+.... ......+..|++++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999865 67899999986432 223356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|||++|+|.+++.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999999999886432 3778999999 889999999999999999999999999999765321100
Q ss_pred ---------------------------------eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCc
Q 038351 300 ---------------------------------MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 300 ---------------------------------~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~ 334 (348)
......+||+.|+| +|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00123568999987 899999999999999999997
Q ss_pred cc
Q 038351 335 KI 336 (348)
Q Consensus 335 ~~ 336 (348)
..
T Consensus 238 ~~ 239 (363)
T cd05628 238 SE 239 (363)
T ss_pred CC
Confidence 53
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=275.66 Aligned_cols=178 Identities=21% Similarity=0.326 Sum_probs=151.5
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhccccc-ccceeeEEEEEecCCeEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 228 (348)
..++|...++||+|.||+|+++..+ ++..+|||.+++.. ..+.+....|.+++.... ||.++.++..|++++++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4568889999999999999999976 56788999997653 234567788888887775 999999999999999999
Q ss_pred EEEeccCCCCHHHHHhchh-----------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 229 LVLEYMPRGSLEKCLYSSN-----------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~~-----------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
.||||+.||++..+.+... .|+.||+||| +.+||+||||.+|||||.+|.+||+|||+++.....+
T Consensus 446 fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 9999999999654444221 1778999999 8999999999999999999999999999999765322
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. .+.+++||+.||| .|.|||||+||||++|+.||...
T Consensus 523 ~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd 571 (694)
T KOG0694|consen 523 D--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD 571 (694)
T ss_pred C--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 2 4578999999998 89999999999999999999743
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=264.70 Aligned_cols=179 Identities=22% Similarity=0.405 Sum_probs=144.1
Q ss_pred hCCCccccccccCCcceEEEeEe------cCCceEEEEeeeeccC-ccchhhHHHhhhcccc-cccceeeEEEEEecC-C
Q 038351 155 TNGFSEDNLISRGGFGSIHKARI------QDRMEFSVKGFHLQCS-GAFKSFDFECDVMKST-CYRNLIKIISSRSNE-D 225 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~ 225 (348)
.++|...+.||+|+||.||+|.. .++..||+|.+..... ...+.+..|++++.++ +||||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 35788889999999999999974 2346799999864322 2345688999999999 899999999988764 4
Q ss_pred eEEEEEeccCCCCHHHHHhch-----------------------------------------------------------
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS----------------------------------------------------------- 246 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~----------------------------------------------------------- 246 (348)
..++||||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 689999999999999887632
Q ss_pred ---------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecccccccCc
Q 038351 247 ---------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311 (348)
Q Consensus 247 ---------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 311 (348)
.+++.||+||| +.+|+||||||+||++++++.+||+|||+++.+.............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 15888999999 789999999999999999999999999999876433222222233345566
Q ss_pred cc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 312 MA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 312 ~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
+| +|||||||++|||+| |+.||...
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~ 280 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence 65 899999999999997 99999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=245.36 Aligned_cols=177 Identities=22% Similarity=0.317 Sum_probs=155.3
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeec---cCccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ---CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
..++|+..+.||+|.||.||.|+.+ ++..||+|.+.+. ..+...++.+|+++-+.++||||++++++|.++...||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4568899999999999999999965 6778999998544 23445778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 230 VLEYMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
++||.++|++...|.... ++|.|+.|+| .++||||||||+|+|++..+..|++|||-+..-..
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999998321 3888999999 99999999999999999999999999999876432
Q ss_pred CCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 296 EDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
....+.+||..|.+ .|+|++||+.||++.|.+||+...
T Consensus 177 ----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 177 ----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred ----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 23467889999987 899999999999999999998765
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=272.63 Aligned_cols=172 Identities=26% Similarity=0.424 Sum_probs=146.7
Q ss_pred CCccccccccCCcceEEEeEecCCceEEEEeeeeccCc--cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 157 GFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSG--AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
.+...+.||+|+||+||+|++.+ .||||.+...... ..+.|..|+.++++-+|.||+-+.|+|..+.. .||+.+|
T Consensus 393 ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwC 469 (678)
T KOG0193|consen 393 EVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWC 469 (678)
T ss_pred Hhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhc
Confidence 44567889999999999999865 6999999766433 45789999999999999999999999999888 9999999
Q ss_pred CCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 235 PRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 235 ~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
++-+|+.+++.. ++|++|+.||| .++|||||+|..||++.+++++||+|||++..-..-.....
T Consensus 470 eGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q 546 (678)
T KOG0193|consen 470 EGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQ 546 (678)
T ss_pred cCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccc
Confidence 999999998864 34899999999 99999999999999999999999999999965432211112
Q ss_pred ecccccccCccc---------------cccHHHHHHHHHHHcCCCCCc
Q 038351 302 QTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 302 ~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~ 334 (348)
.....|...||| +||||||||+|||+||..||.
T Consensus 547 ~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 547 LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 233456778888 999999999999999999997
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=268.78 Aligned_cols=177 Identities=22% Similarity=0.341 Sum_probs=146.8
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.|...+.||+|+||+||+|+.. ++..+|+|.+.... ....+.+..|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999864 67889999996542 2234568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc--
Q 038351 233 YMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH-- 298 (348)
Q Consensus 233 y~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~-- 298 (348)
|+++|+|.+++.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999999998875421 3778999999 78999999999999999999999999999864321000
Q ss_pred -------------------------------------------eeeecccccccCccc------------cccHHHHHHH
Q 038351 299 -------------------------------------------FMIQTQTLATIGYMA------------SYVYSFGIML 323 (348)
Q Consensus 299 -------------------------------------------~~~~~~~~gt~~y~a------------sDV~S~Gvvl 323 (348)
........||+.|+| +|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 000123468899987 8999999999
Q ss_pred HHHHcCCCCCccc
Q 038351 324 LEVFTRKKPTNKI 336 (348)
Q Consensus 324 ~elltG~~P~~~~ 336 (348)
|||+||+.||...
T Consensus 239 ~elltG~~Pf~~~ 251 (381)
T cd05626 239 FEMLVGQPPFLAP 251 (381)
T ss_pred HHHHhCCCCCcCC
Confidence 9999999999653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=268.61 Aligned_cols=178 Identities=22% Similarity=0.373 Sum_probs=147.2
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|...+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888899999999999999864 78899999886432 223456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc-
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH- 298 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~- 298 (348)
||+++|+|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999999887542 23788999999 88999999999999999999999999999964321000
Q ss_pred -----------e---------------------------------eeecccccccCccc------------cccHHHHHH
Q 038351 299 -----------F---------------------------------MIQTQTLATIGYMA------------SYVYSFGIM 322 (348)
Q Consensus 299 -----------~---------------------------------~~~~~~~gt~~y~a------------sDV~S~Gvv 322 (348)
. .......||+.|+| +|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0 00012468888987 899999999
Q ss_pred HHHHHcCCCCCccc
Q 038351 323 LLEVFTRKKPTNKI 336 (348)
Q Consensus 323 l~elltG~~P~~~~ 336 (348)
+|||+||+.||...
T Consensus 238 l~elltG~~Pf~~~ 251 (377)
T cd05629 238 MFECLIGWPPFCSE 251 (377)
T ss_pred hhhhhcCCCCCCCC
Confidence 99999999999653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=266.98 Aligned_cols=178 Identities=24% Similarity=0.399 Sum_probs=148.7
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||.||+|+.. +++.||||.+.... ......+.+|++++..++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47888999999999999999975 68899999996432 223456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+++|+|.+++.... +++.||+||| +.+|+||||||+|||++.++.++|+|||+++.+......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999999886432 3788999999 889999999999999999999999999999765321100
Q ss_pred e------------------------------------eecccccccCccc------------cccHHHHHHHHHHHcCCC
Q 038351 300 M------------------------------------IQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKK 331 (348)
Q Consensus 300 ~------------------------------------~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~ 331 (348)
. ......||+.|+| +|||||||++|||++|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0 0012458888987 899999999999999999
Q ss_pred CCccc
Q 038351 332 PTNKI 336 (348)
Q Consensus 332 P~~~~ 336 (348)
||...
T Consensus 238 Pf~~~ 242 (364)
T cd05599 238 PFCSD 242 (364)
T ss_pred CCCCC
Confidence 99653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=254.45 Aligned_cols=174 Identities=24% Similarity=0.367 Sum_probs=146.0
Q ss_pred CCccccccccCCcceEEEeEe-cCCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 157 GFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++|++|+++++++...+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999986 478899999886432 1223457889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 233 YMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 233 y~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
|+++|+|...+... .+++.||+||| +.+|+||||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999998776431 13788999999 88999999999999999999999999999987543221
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....||..|+| +|||||||++|||++|+.||...
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 204 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204 (285)
T ss_pred ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence 134467888876 89999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=262.56 Aligned_cols=173 Identities=24% Similarity=0.347 Sum_probs=148.8
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|...+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888899999999999999976 67889999986432 223456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+++|+|.+.+.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-- 172 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence 9999999998886432 3788999999 8899999999999999999999999999998764321
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....||+.|+| +|||||||++|||+||+.||...
T Consensus 173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 23467888876 89999999999999999999653
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=263.73 Aligned_cols=174 Identities=23% Similarity=0.332 Sum_probs=148.0
Q ss_pred hCCCccccccccCCcceEEEeEecC--CceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQD--RMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
.++|...+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+++++.++||||+++++++..++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4578888999999999999998643 3689999886432 2234568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 230 VLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
||||+++|+|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 99999999999988643 23788999999 889999999999999999999999999999876432
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....||+.|+| +|||||||++|||+||+.||...
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 124567888886 89999999999999999999653
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=266.51 Aligned_cols=180 Identities=23% Similarity=0.362 Sum_probs=150.9
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEE
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 228 (348)
...++|+..+.||+|+||.||+++.. +++.+|+|.+.... ....+.+..|+.+++.++||||+++++.+..++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999976 57889999886422 123345788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 229 LVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
+||||+++|+|.+++... .+++.||+||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 120 lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 999999999999988642 23788999999 8899999999999999999999999999998764322
Q ss_pred ceeeecccccccCccc----------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA----------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a----------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. .......||+.|+| +||||+||++|||+||+.||...
T Consensus 197 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 197 M-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred c-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 2 12234567777776 89999999999999999999653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=267.89 Aligned_cols=177 Identities=22% Similarity=0.352 Sum_probs=146.4
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.|+..+.||+|+||.||+|+.. ++..+|+|.+.... ......+.+|++++++++||||+++++.+..++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999864 67889999986432 2234568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc--
Q 038351 233 YMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH-- 298 (348)
Q Consensus 233 y~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~-- 298 (348)
||++|+|.+++.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999999999886431 3778999999 78999999999999999999999999999754311000
Q ss_pred -------------------------------------------eeeecccccccCccc------------cccHHHHHHH
Q 038351 299 -------------------------------------------FMIQTQTLATIGYMA------------SYVYSFGIML 323 (348)
Q Consensus 299 -------------------------------------------~~~~~~~~gt~~y~a------------sDV~S~Gvvl 323 (348)
........||+.|+| +||||+||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 000123468889987 8999999999
Q ss_pred HHHHcCCCCCccc
Q 038351 324 LEVFTRKKPTNKI 336 (348)
Q Consensus 324 ~elltG~~P~~~~ 336 (348)
|||+||+.||...
T Consensus 239 ~elltG~~Pf~~~ 251 (382)
T cd05625 239 YEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=258.33 Aligned_cols=173 Identities=27% Similarity=0.397 Sum_probs=147.8
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999976 688999999864321 23456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+++|+|.+++.... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-- 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-- 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence 9999999999876432 3788999999 8899999999999999999999999999998764321
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....||+.|+| +|||||||++|||+||+.||...
T Consensus 156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 23457777776 89999999999999999999754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=261.88 Aligned_cols=173 Identities=25% Similarity=0.387 Sum_probs=148.5
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||.||+|+.. ++..||+|.+.... ....+.+..|++++.+++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888899999999999999976 57899999986542 223456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 999999999998642 13788999999 88999999999999999999999999999986543
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......||+.|+| +|||||||++|||++|+.||...
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 201 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC
Confidence 1234567777776 89999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=268.63 Aligned_cols=164 Identities=25% Similarity=0.404 Sum_probs=145.5
Q ss_pred ccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCC
Q 038351 159 SEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGS 238 (348)
Q Consensus 159 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 238 (348)
++.+.||+|+-|.||+|++++. .||||+++.. -+.+|+-|++|+||||+.+.|+|....-++||||||+.|-
T Consensus 127 sELeWlGSGaQGAVF~Grl~ne-tVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLHNE-TVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeeccCc-eehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 4567899999999999998754 8999988532 2457888999999999999999999999999999999999
Q ss_pred HHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecccc
Q 038351 239 LEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTL 306 (348)
Q Consensus 239 L~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 306 (348)
|.++|+..+ +||.|+.||| ...|||||+|.-|||+..+..+||+|||.++...+. .....++
T Consensus 199 L~~VLka~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFa 272 (904)
T KOG4721|consen 199 LYEVLKAGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFA 272 (904)
T ss_pred HHHHHhccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhh
Confidence 999998754 3899999999 788999999999999999999999999999887543 2335789
Q ss_pred cccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 307 ATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 307 gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
||..||| +||||||||||||+||..||.+.
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence 9999999 89999999999999999999764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=260.25 Aligned_cols=170 Identities=24% Similarity=0.301 Sum_probs=143.3
Q ss_pred cccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCC
Q 038351 162 NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRG 237 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 237 (348)
+.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999865 68899999987532 223356778999999999999999999999999999999999999
Q ss_pred CHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeeccc
Q 038351 238 SLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT 305 (348)
Q Consensus 238 sL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~ 305 (348)
+|.+.+... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~ 155 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTF 155 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccce
Confidence 998887642 24788999999 88999999999999999999999999999976432221 12345
Q ss_pred ccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 306 LATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 306 ~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.||+.|+| +||||+||++|||+||+.||...
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 68888887 89999999999999999999653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=255.17 Aligned_cols=180 Identities=24% Similarity=0.299 Sum_probs=155.8
Q ss_pred hCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCc-cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSG-AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
...|+....||.|..++||+|+. ..+..||||++..+... ..+.+.+|+..|+.++||||++++..|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 34688889999999999999984 46789999999866443 45889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 233 YMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 233 y~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
||.+|++.+.++... .+..||.||| ..+-||||||+.|||++.+|.+||+|||.+..+...+.
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 999999999887532 2677999999 88999999999999999999999999999877654332
Q ss_pred -eeee-cccccccCccc--------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 299 -FMIQ-TQTLATIGYMA--------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 299 -~~~~-~~~~gt~~y~a--------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
.... ..+.||+.||| +||||||+...||++|..||.+..
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 1122 56689999998 899999999999999999998754
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=266.45 Aligned_cols=178 Identities=22% Similarity=0.337 Sum_probs=147.4
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|+||+++++.+..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999865 67899999986432 223456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC--
Q 038351 232 EYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED-- 297 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~-- 297 (348)
||+++|+|.+++.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999999999886432 3778999999 8899999999999999999999999999985331000
Q ss_pred ---------------------------------------ceeeecccccccCccc------------cccHHHHHHHHHH
Q 038351 298 ---------------------------------------HFMIQTQTLATIGYMA------------SYVYSFGIMLLEV 326 (348)
Q Consensus 298 ---------------------------------------~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~el 326 (348)
.........||+.|+| +|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0000123468999987 7999999999999
Q ss_pred HcCCCCCccc
Q 038351 327 FTRKKPTNKI 336 (348)
Q Consensus 327 ltG~~P~~~~ 336 (348)
+||+.||...
T Consensus 238 l~G~~Pf~~~ 247 (376)
T cd05598 238 LVGQPPFLAD 247 (376)
T ss_pred hhCCCCCCCC
Confidence 9999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=263.49 Aligned_cols=179 Identities=24% Similarity=0.364 Sum_probs=149.8
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
..++|+..+.||+|+||.||+++.. ++..+|+|.+.... ....+.+..|+.+++.++||||+++++++..++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3567888999999999999999875 67889999986432 2233457789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 230 VLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
||||+++|+|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 121 v~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999999999987652 13788999999 78999999999999999999999999999987643221
Q ss_pred eeeecccccccCccc----------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA----------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a----------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.......||+.|+| +|||||||++|||+||+.||...
T Consensus 198 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 198 -VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred -ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 11234567777776 79999999999999999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=263.30 Aligned_cols=181 Identities=25% Similarity=0.375 Sum_probs=151.2
Q ss_pred HHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCe
Q 038351 151 LCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDF 226 (348)
Q Consensus 151 ~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 226 (348)
.....++|+..+.||+|+||.||+++.. +++.+|+|.+.... ....+.+..|+.+++.++||||+++++.+..++.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3345678999999999999999999976 67789999886422 1223457789999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 227 KVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
.++||||+++|+|.++++.. .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 99999999999999888653 13788999999 88999999999999999999999999999987643
Q ss_pred CCceeeecccccccCccc----------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 296 EDHFMIQTQTLATIGYMA----------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a----------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
... .......||+.|+| +|||||||++|||++|+.||..
T Consensus 195 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 195 EGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred CCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 221 12234567877776 7999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=257.53 Aligned_cols=170 Identities=23% Similarity=0.303 Sum_probs=142.4
Q ss_pred cccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCC
Q 038351 162 NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRG 237 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 237 (348)
+.||+|+||.||+++.. ++..||+|.+.... ......+..|++++++++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999864 68899999986542 223456778999999999999999999999999999999999999
Q ss_pred CHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeeccc
Q 038351 238 SLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT 305 (348)
Q Consensus 238 sL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~ 305 (348)
+|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~ 155 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTF 155 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccccc
Confidence 998877543 23788999999 78999999999999999999999999999876432211 12335
Q ss_pred ccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 306 LATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 306 ~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.||+.|+| +|||||||++|||+||+.||...
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 198 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence 67888876 89999999999999999999653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=255.74 Aligned_cols=168 Identities=26% Similarity=0.347 Sum_probs=142.1
Q ss_pred cccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCH
Q 038351 164 ISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL 239 (348)
Q Consensus 164 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 239 (348)
||+|+||.||+|+.. ++..||+|.+.... ......+..|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999875 57789999986432 23345678899999999999999999999999999999999999999
Q ss_pred HHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeeccccc
Q 038351 240 EKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA 307 (348)
Q Consensus 240 ~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~g 307 (348)
.+++.... +++.||+||| +.+|+||||||+||+++.++.++|+|||+++....... ......|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g 155 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCG 155 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccccccC
Confidence 98885431 3788999999 88999999999999999999999999999986432221 2234568
Q ss_pred ccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 308 TIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 308 t~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
|+.|+| +|||||||++|||+||+.||...
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 888887 89999999999999999999653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-33 Score=256.56 Aligned_cols=183 Identities=21% Similarity=0.323 Sum_probs=157.7
Q ss_pred hhhHHhhhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEec
Q 038351 148 CLELCRVTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSN 223 (348)
Q Consensus 148 ~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 223 (348)
|........+|+..+.||+|.||+|-+|+- ..+++||||.++... .++.-.+.+|+++|+.++||||+.++.+|..
T Consensus 45 hhhkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN 124 (668)
T KOG0611|consen 45 HHHKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN 124 (668)
T ss_pred cCcccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC
Confidence 333445566788899999999999999985 689999999996543 3445567899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcc
Q 038351 224 EDFKVLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291 (348)
Q Consensus 224 ~~~~~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~ 291 (348)
.+.+.|||||..+|.|++++.... +|..|+.|+| ..+++|||+|.+|||+|.++++||+|||++.
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSN 201 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSN 201 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhh
Confidence 999999999999999999998653 3667777777 9999999999999999999999999999999
Q ss_pred ccccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 292 LLIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.+..... ..+++|++-|.. .|-||+||+||-|+.|.+|||..
T Consensus 202 ly~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~ 256 (668)
T KOG0611|consen 202 LYADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR 256 (668)
T ss_pred hhccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc
Confidence 8865432 357888888875 78999999999999999999864
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-34 Score=264.52 Aligned_cols=182 Identities=21% Similarity=0.303 Sum_probs=153.2
Q ss_pred hhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCccch-hhHHHhhhccccc-ccceeeEEEEEecCC-eEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFK-SFDFECDVMKSTC-YRNLIKIISSRSNED-FKVL 229 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~l 229 (348)
..++|...+.||.|.||.||+|+- .++..||||+++..-....+ .-.+|+..|+++. |||||++.+++.+.+ ..++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 456788889999999999999984 57889999999765443322 2367999999999 999999999999988 9999
Q ss_pred EEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 230 VLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
|||||+. +|+++++.++ +|.+||+|+| ..++.|||+||+|||+.....+||+|||+||.+...
T Consensus 88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC
Confidence 9999954 8999988753 3888999999 899999999999999999999999999999988654
Q ss_pred CceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccccccchhhhhhh
Q 038351 297 DHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~~~~~~~~~~~~ 347 (348)
..+ +....|.+|.| .||||+|||++|+.+-++-| .|.+|++|+
T Consensus 164 pPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF-----PG~sE~Dqi 219 (538)
T KOG0661|consen 164 PPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF-----PGASEIDQI 219 (538)
T ss_pred CCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC-----CCCcHHHHH
Confidence 433 56777888887 89999999999999998854 456666664
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=269.15 Aligned_cols=177 Identities=21% Similarity=0.272 Sum_probs=147.7
Q ss_pred CCccccccccCCcceEEEeEec-C-CceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-D-RMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
.|...+.||+|+||.||+|... + +..||+|.+..........+..|+++++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3778899999999999999754 3 5678888765444444456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 235 PRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 235 ~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
++|+|.++++.. .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999998876531 13778899999 88999999999999999999999999999987654322
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
........||++|+| +|||||||++|||+||+.||...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 222345668889987 89999999999999999999653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=266.12 Aligned_cols=175 Identities=25% Similarity=0.362 Sum_probs=152.5
Q ss_pred CCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
.-|+.++.||.|+.|.|-.|++ .+|+.+|||.+..... .....+++|+.+|+.+.|||++++++++....+.|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3577889999999999999985 5899999999965522 23456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+++|.|++++...+ +|..|+.|+| ..+|+|||+||+|+|||.++.+||+|||+|.+-.++.
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-- 166 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-- 166 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCc--
Confidence 9999999999886543 4888999999 7789999999999999999999999999998754433
Q ss_pred eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...+.||++.|.| +||||+|||||.|+||+.|||+.
T Consensus 167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd 215 (786)
T KOG0588|consen 167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD 215 (786)
T ss_pred -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc
Confidence 2356789999987 99999999999999999999853
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=257.02 Aligned_cols=170 Identities=25% Similarity=0.318 Sum_probs=142.9
Q ss_pred cccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCC
Q 038351 162 NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRG 237 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 237 (348)
+.||+|+||.||+++.. ++..||+|.+.... ......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999865 68899999986442 223456788999999999999999999999999999999999999
Q ss_pred CHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeeccc
Q 038351 238 SLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT 305 (348)
Q Consensus 238 sL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~ 305 (348)
+|...+... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~ 155 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKTF 155 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--ccccc
Confidence 998877542 23788999999 88999999999999999999999999999976432211 12345
Q ss_pred ccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 306 LATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 306 ~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.||+.|+| +|||||||++|||+||+.||...
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~ 198 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence 68888887 89999999999999999999653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=262.53 Aligned_cols=178 Identities=22% Similarity=0.368 Sum_probs=148.4
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||.||+++.. ++..||+|.+.... ......+..|++++.+++|++|+++++.+...+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999875 68899999986432 223456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+++|+|.+++.... +++.||+||| +.+|+||||||+||+++.++.++|+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999999999886432 3778999999 889999999999999999999999999998755321100
Q ss_pred ---------------------------------eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCc
Q 038351 300 ---------------------------------MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 300 ---------------------------------~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~ 334 (348)
.......||+.|+| +|||||||++|||+||+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00123468999987 899999999999999999996
Q ss_pred cc
Q 038351 335 KI 336 (348)
Q Consensus 335 ~~ 336 (348)
..
T Consensus 238 ~~ 239 (360)
T cd05627 238 SE 239 (360)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-33 Score=278.33 Aligned_cols=179 Identities=28% Similarity=0.480 Sum_probs=154.0
Q ss_pred CccccccccCCcceEEEeEe------cCCceEEEEeeeeccCc-cchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 158 FSEDNLISRGGFGSIHKARI------QDRMEFSVKGFHLQCSG-AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
....+.||+|+||+||+|+. ++.+.||||.++..... ..++|++|+++++.++|||||+++|.|..++..++|
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 34557899999999999984 34567999999766554 678899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhch--------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEE
Q 038351 231 LEYMPRGSLEKCLYSS--------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHL 284 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~--------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl 284 (348)
+|||..|||.++|+.. .+||.|++||- +..+|||||-++|+|+.++..+||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEEe
Confidence 9999999999998752 13899999999 778999999999999999999999
Q ss_pred eecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccccc
Q 038351 285 SDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIFFS 339 (348)
Q Consensus 285 ~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~~~ 339 (348)
+|||++|.+...+.+.......-.+.||+ ||||||||+|||++| |+.||.....+
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~ 712 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ 712 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence 99999998876666654444455677886 999999999999998 89999775543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=256.76 Aligned_cols=185 Identities=25% Similarity=0.359 Sum_probs=148.1
Q ss_pred hHHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc--------------cchhhHHHhhhcccccccce
Q 038351 150 ELCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG--------------AFKSFDFECDVMKSTCYRNL 214 (348)
Q Consensus 150 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~H~ni 214 (348)
+-+...|.|...+.||+|.||.|-+|+.. +++.||||.+.+.... ..+...+|+.+|++++||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 34556789999999999999999999964 7889999999543110 12467889999999999999
Q ss_pred eeEEEEEecC--CeEEEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC
Q 038351 215 IKIISSRSNE--DFKVLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI 280 (348)
Q Consensus 215 v~l~~~~~~~--~~~~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~ 280 (348)
|+|+++..+. +.+|||+|||..|.+...=... ..+..||+||| ..+||||||||+|+|++++|
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCC
Confidence 9999998764 6799999999998775432111 12788999999 78899999999999999999
Q ss_pred cEEEeecCCccccccC---CceeeecccccccCccc----------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 281 VTHLSDFGIAKLLIRE---DHFMIQTQTLATIGYMA----------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 281 ~~kl~DfGla~~~~~~---~~~~~~~~~~gt~~y~a----------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
++||+|||.+...... +.........||+.|+| .||||+||.||-|+.|+.||-+.+
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 9999999999765221 11111234679999998 699999999999999999996643
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=250.87 Aligned_cols=174 Identities=25% Similarity=0.373 Sum_probs=137.9
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCC-----eEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNED-----FKV 228 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 228 (348)
+-.|...+++|+|+||.||+|.+. +...||||+..... +.-.+|+++|++++|||||++.-+|.... ...
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 345777899999999999999976 46899999986432 23457999999999999999998886532 345
Q ss_pred EEEeccCCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCC-CcEEEeecCCcc
Q 038351 229 LVLEYMPRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN-IVTHLSDFGIAK 291 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DfGla~ 291 (348)
+||||||. +|.+.++.. -|+.+||.||| +.+|+||||||.|+|+|.+ |..||||||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999987 899888741 14889999999 7899999999999999975 999999999999
Q ss_pred ccccCCce---------eeecccccccCccc-cccHHHHHHHHHHHcCCCCCccc
Q 038351 292 LLIREDHF---------MIQTQTLATIGYMA-SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 292 ~~~~~~~~---------~~~~~~~gt~~y~a-sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.+...+.. ++++-..|...|.. .||||.|||+.||+-|++-|...
T Consensus 175 ~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~ 229 (364)
T KOG0658|consen 175 VLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD 229 (364)
T ss_pred eeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence 98654321 22222334444432 89999999999999999987653
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=255.37 Aligned_cols=170 Identities=26% Similarity=0.396 Sum_probs=141.8
Q ss_pred cccccCCcceEEEeEe----cCCceEEEEeeeecc----CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 162 NLISRGGFGSIHKARI----QDRMEFSVKGFHLQC----SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+.||+|+||.||+++. .+++.||+|.+.... ......+..|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 357889999986432 12234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 234 MPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 234 ~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+++|+|.+.+... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 156 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--V 156 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--c
Confidence 9999999887542 13788999999 78999999999999999999999999999875432221 1
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....||+.|+| +|||||||++|||++|+.||...
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~ 203 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC
Confidence 234567888876 89999999999999999999653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-33 Score=243.32 Aligned_cols=178 Identities=25% Similarity=0.396 Sum_probs=153.0
Q ss_pred HhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCcc--------chhhHHHhhhccccc-ccceeeEEEEE
Q 038351 152 CRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGA--------FKSFDFECDVMKSTC-YRNLIKIISSR 221 (348)
Q Consensus 152 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~-H~niv~l~~~~ 221 (348)
...-+.|...+.+|.|..++|-++..+ ++.++|+|++....... .+.-..|+.+|+++. ||+|+++.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 344567888899999999999998765 78899999996442211 234567999999986 99999999999
Q ss_pred ecCCeEEEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCC
Q 038351 222 SNEDFKVLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGI 289 (348)
Q Consensus 222 ~~~~~~~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGl 289 (348)
+++.+.++|+|.|+.|.|.++|... .++..|++||| ...|||||+||+|||+|++++++|+|||+
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccce
Confidence 9999999999999999999999753 23677999999 89999999999999999999999999999
Q ss_pred ccccccCCceeeecccccccCccc------------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 290 AKLLIREDHFMIQTQTLATIGYMA------------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 290 a~~~~~~~~~~~~~~~~gt~~y~a------------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
|..+.+.+. ....+||++|.| .|+||.||+||.|+.|.+||-.
T Consensus 170 a~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH 230 (411)
T KOG0599|consen 170 ACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH 230 (411)
T ss_pred eeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH
Confidence 999876543 357899999998 7999999999999999999843
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=245.16 Aligned_cols=175 Identities=26% Similarity=0.363 Sum_probs=143.1
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccc-eeeEEEEEecCC------
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRN-LIKIISSRSNED------ 225 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~------ 225 (348)
..|...+.||+|.||+||+|+.. +++.||+|++..... +......+|+.++++++|+| |+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34666788999999999999854 788999999976644 34566789999999999999 999999999877
Q ss_pred eEEEEEeccCCCCHHHHHhchh----------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCC
Q 038351 226 FKVLVLEYMPRGSLEKCLYSSN----------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGI 289 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~~----------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGl 289 (348)
..++|+||+.. +|.+++.... |+..|++||| +.+|+||||||.|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence 78999999954 7877765422 4788999999 89999999999999999999999999999
Q ss_pred ccccccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 290 AKLLIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 290 a~~~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
|+...-... .-+...+|..|.| .||||+|||+.||++++.-|...
T Consensus 167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~ 224 (323)
T KOG0594|consen 167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGD 224 (323)
T ss_pred HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCC
Confidence 997652221 1233445555554 89999999999999998876543
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=256.28 Aligned_cols=176 Identities=22% Similarity=0.347 Sum_probs=146.7
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|...+.||+|+||.||+++.. +++.+|+|.+.... ......+..|..++..++|++|+++++++..++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999976 67789999886421 122345788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 232 EYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999988652 13677889999 88999999999999999999999999999987644322
Q ss_pred eeeecccccccCccc-----------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 299 FMIQTQTLATIGYMA-----------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a-----------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
. ......||+.|+| +|||||||++|||+||+.||..
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 158 V-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred e-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 1 1223457777765 6999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=254.70 Aligned_cols=177 Identities=23% Similarity=0.345 Sum_probs=147.1
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|...+.||+|+||.||+++.. +++.||+|.+.... ....+.+..|..++..++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888899999999999999965 58899999986421 223455788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 232 EYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
||+++|+|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999988642 13788999999 88999999999999999999999999999976543222
Q ss_pred eeeecccccccCccc-----------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA-----------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a-----------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. ......||+.|+| +|||||||++|||++|+.||...
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 158 V-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred c-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 1 1122357777765 69999999999999999999653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=250.04 Aligned_cols=176 Identities=20% Similarity=0.310 Sum_probs=144.2
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.++|...+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467899999999999999999976 688999999864432 223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 233 YMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 233 y~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|++ ++|.+.+... .+++.||+||| +.+|+||||||+||++++++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH- 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-
Confidence 995 5777766532 13788999999 88999999999999999999999999999975432211
Q ss_pred eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......+|+.|+| +||||+||++|||+||+.||...
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 159 -TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred -cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1122345566655 79999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=259.47 Aligned_cols=178 Identities=26% Similarity=0.403 Sum_probs=150.9
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|...+.||+|+||.||+|+.. +++.||+|.+.... ......+..|++++..++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999976 68899999986442 233456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC--
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED-- 297 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~-- 297 (348)
||+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 999999999988653 13788999999 7899999999999999999999999999998764332
Q ss_pred -------------------------ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 -------------------------HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 -------------------------~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.........||+.|+| +|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 0011234568888887 89999999999999999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=248.61 Aligned_cols=175 Identities=22% Similarity=0.311 Sum_probs=143.0
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
++|...+.||+|+||.||+|+.+ ++..||+|.+..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999865 678999998864432 2345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 234 MPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 234 ~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
+++ +|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence 974 888877532 13788999999 88999999999999999999999999999976432211
Q ss_pred eecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 301 IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......+++.|+| +||||+||++|||+||+.||...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1112234555544 89999999999999999999653
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=259.27 Aligned_cols=179 Identities=23% Similarity=0.382 Sum_probs=144.7
Q ss_pred hCCCccccccccCCcceEEEeEe------cCCceEEEEeeeecc-CccchhhHHHhhhcccc-cccceeeEEEEEecCCe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARI------QDRMEFSVKGFHLQC-SGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDF 226 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 226 (348)
.++|+..+.||+|+||.||+|+. .++..||||.++... ....+.+.+|+++++.+ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688889999999999999963 245689999986432 22345688999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhch------------------------------------------------------------
Q 038351 227 KVLVLEYMPRGSLEKCLYSS------------------------------------------------------------ 246 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~------------------------------------------------------------ 246 (348)
.++|||||++|+|.++++..
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999999887531
Q ss_pred ---------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 247 ---------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 247 ---------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
.+++.||+||| +.+|+||||||+||++++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 14788999999 789999999999999999999999999999876433221
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.......++..|+| +|||||||++|||+| |..||...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 11112223445654 899999999999998 89998764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=255.09 Aligned_cols=175 Identities=25% Similarity=0.366 Sum_probs=145.1
Q ss_pred CCccccccccCCcceEEEeEe----cCCceEEEEeeeecc----CccchhhHHHhhhccccc-ccceeeEEEEEecCCeE
Q 038351 157 GFSEDNLISRGGFGSIHKARI----QDRMEFSVKGFHLQC----SGAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFK 227 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 227 (348)
+|+..+.||+|+||.||+++. .++..+|+|.+.... ....+.+..|++++.+++ |++|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999875 357889999986432 122356788999999995 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 228 VLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
++||||+++|+|.+++.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 99999999999998875432 4888999999 78999999999999999999999999999986543
Q ss_pred CCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 296 EDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.... ......||+.|+| +|||||||++|||+||+.||..
T Consensus 158 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 158 EEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred cCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 2211 1223467777776 8999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=254.23 Aligned_cols=177 Identities=23% Similarity=0.341 Sum_probs=146.4
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||.||+++.+ +++.+|+|.+.... ......+..|+.++..++|++|+++++.+...+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888899999999999999976 46779999885321 122345788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 232 EYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
||+++|+|.++++.. .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999998652 13778999999 78999999999999999999999999999976543222
Q ss_pred eeeecccccccCccc-----------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA-----------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a-----------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.......||+.|+| +|||||||++|||++|+.||...
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 11223457777765 79999999999999999999653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=249.16 Aligned_cols=178 Identities=26% Similarity=0.463 Sum_probs=143.6
Q ss_pred CCCccccccccCCcceEEEeEecC-----------------CceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQD-----------------RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKI 217 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l 217 (348)
++|...+.||+|+||.||+|..++ +..||+|.+..... .....+.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467888999999999999997542 33689998865422 234568899999999999999999
Q ss_pred EEEEecCCeEEEEEeccCCCCHHHHHhch-------------------------------hHHHHHHHHHHhcCCCceEe
Q 038351 218 ISSRSNEDFKVLVLEYMPRGSLEKCLYSS-------------------------------NYVGFALEYLHFDYSVLIIH 266 (348)
Q Consensus 218 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~-------------------------------~~i~~~L~yLH~~~~~~iiH 266 (348)
++++...+..++||||+++|+|.+++... .+++.||+||| +.+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 99999999999999999999999887431 23788999999 788999
Q ss_pred cCCCcCceEEcCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc--CCCC
Q 038351 267 YDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT--RKKP 332 (348)
Q Consensus 267 rDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt--G~~P 332 (348)
|||||+||++++++.+||+|||+++...............++..|+| +|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999987643332222223334556665 899999999999986 5677
Q ss_pred Cccc
Q 038351 333 TNKI 336 (348)
Q Consensus 333 ~~~~ 336 (348)
|...
T Consensus 242 ~~~~ 245 (304)
T cd05096 242 YGEL 245 (304)
T ss_pred CCcC
Confidence 7653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=252.83 Aligned_cols=175 Identities=24% Similarity=0.328 Sum_probs=147.6
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.++|+..+.||+|+||.||+++.. ++..+|+|.+..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367889999999999999999976 677889998865432 234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 233 YMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 233 y~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
|+++|+|.+++.... +++.||.|||. ..+|+||||||+||+++.++.++|+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---
Confidence 999999999886432 37889999993 2369999999999999999999999999998654321
Q ss_pred eecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 301 IQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 301 ~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.....||..|+| +|||||||++|||+||+.||..
T Consensus 159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 133457777776 8999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=251.57 Aligned_cols=175 Identities=23% Similarity=0.299 Sum_probs=144.1
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhccccccc-ceeeEEEEEecCCeEEEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYR-NLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lV~ 231 (348)
+|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|.+++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999876 56789999986432 23345678899999999765 6888999999999999999
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+++|+|.+.+... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK- 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC-
Confidence 999999998887542 23788999999 78999999999999999999999999999875322111
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......||+.|+| +||||+||++|||+||+.||+..
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred -ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 1234567888876 79999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=256.18 Aligned_cols=177 Identities=24% Similarity=0.354 Sum_probs=148.1
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|...+.||+|+||.||+++.. +++.+|+|.+..... ...+.+..|+.+++.++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999865 688999999875422 23456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 232 EYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999988653 13778999999 88999999999999999999999999999987654322
Q ss_pred eeeecccccccCccc------------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA------------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. ......||+.|+| +|||||||++|||+||+.||...
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 212 (330)
T cd05601 158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212 (330)
T ss_pred e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence 1 2223356666654 79999999999999999999653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=258.17 Aligned_cols=179 Identities=23% Similarity=0.428 Sum_probs=145.2
Q ss_pred CCCccccccccCCcceEEEeEec------CCceEEEEeeeeccC-ccchhhHHHhhhcccc-cccceeeEEEEEecCCeE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQCS-GAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFK 227 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 227 (348)
++|+..+.||+|+||.||+|+.. ++..||+|.+..... ...+.+.+|+++++++ +|+||++++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 46888899999999999998742 345799999864432 2345688899999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhch-------------------------------------------------------------
Q 038351 228 VLVLEYMPRGSLEKCLYSS------------------------------------------------------------- 246 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~------------------------------------------------------------- 246 (348)
++|||||++|+|.++++..
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999999999887431
Q ss_pred ---------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeeccc
Q 038351 247 ---------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT 305 (348)
Q Consensus 247 ---------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~ 305 (348)
.+++.||+||| +.+|+||||||+||++++++.+||+|||+++.+............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 23788999999 789999999999999999999999999999876433222222222
Q ss_pred ccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 306 LATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 306 ~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
.++..|+| +|||||||++|||++ |+.||....
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 34456765 899999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=254.83 Aligned_cols=170 Identities=22% Similarity=0.302 Sum_probs=142.1
Q ss_pred cccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCC
Q 038351 162 NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRG 237 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 237 (348)
+.||+|+||.||+++.. ++..||+|.+.... ......+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999864 78899999986542 223456778999999999999999999999999999999999999
Q ss_pred CHHHHHhch------------hHHHHHHHHHHhcCC-CceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecc
Q 038351 238 SLEKCLYSS------------NYVGFALEYLHFDYS-VLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304 (348)
Q Consensus 238 sL~~~l~~~------------~~i~~~L~yLH~~~~-~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 304 (348)
+|.+++... .+++.||+||| + .+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~ 155 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKT 155 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--cccc
Confidence 998877543 24888999999 5 6899999999999999999999999999976432221 1234
Q ss_pred cccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 305 TLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 305 ~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..||+.|+| +|||||||++|||+||+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 568888887 89999999999999999999653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=256.70 Aligned_cols=175 Identities=23% Similarity=0.361 Sum_probs=143.5
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
.+|+..+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34566789999999999999865 688999999864432 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhc--------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeeccc
Q 038351 234 MPRGSLEKCLYS--------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT 305 (348)
Q Consensus 234 ~~~gsL~~~l~~--------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~ 305 (348)
+++|+|...... ..+++.||+||| +.+|+||||||+|||+++++.+||+|||+++.+..... .....
T Consensus 154 ~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~ 228 (353)
T PLN00034 154 MDGGSLEGTHIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSS 228 (353)
T ss_pred CCCCcccccccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--ccccc
Confidence 999998654322 234888999999 78999999999999999999999999999987643211 11233
Q ss_pred ccccCccc-----------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 306 LATIGYMA-----------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 306 ~gt~~y~a-----------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.||..|+| +|||||||++|||++|+.||..
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 45665554 7999999999999999999973
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=266.74 Aligned_cols=174 Identities=28% Similarity=0.414 Sum_probs=146.9
Q ss_pred CccccccccCCcceEEEeEe-cCCceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecC------CeEEE
Q 038351 158 FSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNE------DFKVL 229 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~l 229 (348)
+...+.||+|+||.||+++. .+|..||||.+.... ....+...+|+++|++++|+|||++++.-... ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44567899999999999995 589999999996543 34557788999999999999999999976654 35789
Q ss_pred EEeccCCCCHHHHHhchhH---------------HHHHHHHHHhcCCCceEecCCCcCceEEc--CCCc--EEEeecCCc
Q 038351 230 VLEYMPRGSLEKCLYSSNY---------------VGFALEYLHFDYSVLIIHYDLKPSNVLFD--DNIV--THLSDFGIA 290 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~~---------------i~~~L~yLH~~~~~~iiHrDik~~NILld--~~~~--~kl~DfGla 290 (348)
|||||.+|||...|..... ++.||.||| +.+|+||||||.||++- .+|+ -||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999987532 778999999 88999999999999984 3343 599999999
Q ss_pred cccccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 291 KLLIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
|.+.++. ..+++.||..|.+ +|.|||||++||.+||..||...-
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 9987654 4578899999887 799999999999999999997643
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=251.61 Aligned_cols=175 Identities=23% Similarity=0.295 Sum_probs=144.0
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 231 (348)
+|...+.||+|+||.||+|+.. ++..+|+|.+..... ...+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4777899999999999999876 567899999865421 2234566777887776 4899999999999999999999
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+++|+|.+.+... .+++.||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~- 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV- 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-
Confidence 999999998887542 23788999999 78999999999999999999999999999976432211
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......||+.|+| +|||||||++|||+||+.||+..
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~ 204 (323)
T cd05616 157 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204 (323)
T ss_pred -ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC
Confidence 2234568888887 89999999999999999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=250.90 Aligned_cols=170 Identities=24% Similarity=0.352 Sum_probs=139.4
Q ss_pred cccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhccc-ccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKS-TCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
+.||+|+||.||+|+.. ++..||+|.++... ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 57789999986532 2233445667766654 4799999999999999999999999999
Q ss_pred CCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecc
Q 038351 237 GSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304 (348)
Q Consensus 237 gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 304 (348)
|+|..++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAST 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccccc
Confidence 9999887542 23888999999 7899999999999999999999999999998653322 12234
Q ss_pred cccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 305 TLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 305 ~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..||+.|+| +|||||||++|||++|+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 568888887 89999999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=251.82 Aligned_cols=170 Identities=23% Similarity=0.312 Sum_probs=141.0
Q ss_pred cccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
+.||+|+||.||+|+.. ++..||+|.+.... ....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 57889999986532 22335567788888765 799999999999999999999999999
Q ss_pred CCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecc
Q 038351 237 GSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304 (348)
Q Consensus 237 gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 304 (348)
|+|...+... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~ 155 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTT 155 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--cccc
Confidence 9998877542 23788999999 78999999999999999999999999999976432221 1234
Q ss_pred cccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 305 TLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 305 ~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..||+.|+| +|||||||++|||+||+.||+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence 567888886 89999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=247.60 Aligned_cols=177 Identities=25% Similarity=0.299 Sum_probs=147.3
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeee--eccCccchhhHHHhhhcccccccceeeEEEEEec-----CC
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFH--LQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSN-----ED 225 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~ 225 (348)
+...|...+.||+|+||.|+.|... ++..||||++. .+.....+...+|+.+|+.++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3445666788999999999999864 78999999996 3344456788999999999999999999999876 24
Q ss_pred eEEEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
.+|+|+|+| .-+|...++... ++.+||.|+| +.+|+|||+||+|++++.+...||+|||+|+..
T Consensus 100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeec
Confidence 689999999 458999888764 3788999999 899999999999999999999999999999988
Q ss_pred ccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCc
Q 038351 294 IREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~ 334 (348)
.........+....|..|.| .||||.|||+.||++|++-|.
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp 229 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP 229 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC
Confidence 54322222356667777776 899999999999999998653
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=251.29 Aligned_cols=174 Identities=22% Similarity=0.332 Sum_probs=142.3
Q ss_pred CccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhh---cccccccceeeEEEEEecCCeEEEE
Q 038351 158 FSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDV---MKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~---l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|+++ +++++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 556789999999999999865 68899999986442 1223455666554 4677899999999999999999999
Q ss_pred EeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 231 LEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|||+++|+|...++.. .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 156 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD- 156 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC-
Confidence 9999999998877642 23788999999 88999999999999999999999999999875432211
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......|++.|+| +|||||||++|||++|+.||...
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~ 204 (324)
T cd05589 157 -RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204 (324)
T ss_pred -cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence 1234568888887 89999999999999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=251.06 Aligned_cols=170 Identities=24% Similarity=0.322 Sum_probs=141.4
Q ss_pred cccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999975 57889999986432 22345667788888776 699999999999999999999999999
Q ss_pred CCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecc
Q 038351 237 GSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304 (348)
Q Consensus 237 gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 304 (348)
|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~~ 155 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTST 155 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--cccc
Confidence 9999887543 23788999999 88999999999999999999999999999876432221 2234
Q ss_pred cccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 305 TLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 305 ~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..||+.|+| +|||||||++|||+||+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 568888887 89999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=252.49 Aligned_cols=169 Identities=24% Similarity=0.357 Sum_probs=140.2
Q ss_pred cccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
+.||+|+||.||+|+.. +++.+|+|.+..... ...+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 578899999875422 2334577888888766 799999999999999999999999999
Q ss_pred CCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecc
Q 038351 237 GSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304 (348)
Q Consensus 237 gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 304 (348)
|+|..++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTST 155 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--cccc
Confidence 9998877542 13888999999 78999999999999999999999999999976432221 1234
Q ss_pred cccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 305 TLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 305 ~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
..||+.|+| +|||||||++|||+||+.||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 567888876 8999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=246.42 Aligned_cols=177 Identities=23% Similarity=0.273 Sum_probs=145.7
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
++|+..+.||+|+||.||+|+.+ ++..+|+|++..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999986 578899999864422 234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 233 YMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 233 y~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
|++++.+..+.... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-A 156 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-c
Confidence 99988776554321 23788999999 88999999999999999999999999999987643221 1
Q ss_pred eecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 301 IQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......|++.|+| +|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 1123456777766 89999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=251.99 Aligned_cols=169 Identities=23% Similarity=0.354 Sum_probs=141.0
Q ss_pred cccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
++||+|+||.||+|+.. +++.||+|.++.... ...+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999875 678899999975422 2335578899999888 699999999999999999999999999
Q ss_pred CCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecc
Q 038351 237 GSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304 (348)
Q Consensus 237 gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 304 (348)
|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTST 155 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--cccc
Confidence 9998877532 13788999999 88999999999999999999999999999975322111 1234
Q ss_pred cccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 305 TLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 305 ~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
..||+.|+| +|||||||++|||+||+.||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 567888876 8999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=250.59 Aligned_cols=176 Identities=24% Similarity=0.317 Sum_probs=147.1
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.++|+..+.||+|+||.||++... ++..+|+|.+..... ...+.+.+|++++++++||||++++++|..+++.++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367889999999999999999976 677888988765432 234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 233 YMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 233 y~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
|+++|+|.+++.... +++.|++|||. ..+|+||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--- 158 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc---
Confidence 999999999886432 37889999993 2469999999999999999999999999997653221
Q ss_pred eecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 301 IQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....|+..|+| +|||||||++|||++|+.||...
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred -cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 123456666765 89999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=244.44 Aligned_cols=168 Identities=23% Similarity=0.263 Sum_probs=137.7
Q ss_pred ccccccCCcceEEEeEecCCceEEEEeeeeccCcc---chhhHHHhhhcccccccceeeEEEEEec----CCeEEEEEec
Q 038351 161 DNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGA---FKSFDFECDVMKSTCYRNLIKIISSRSN----EDFKVLVLEY 233 (348)
Q Consensus 161 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~Ey 233 (348)
...|++|+++.||+|+. +++.||||.+....... .+.+.+|++++++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 57799999986543322 3667899999999999999999999876 3578999999
Q ss_pred cCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 234 MPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 234 ~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+++|+|.++++... +++.|++|||.. .+++||||||+||++++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---- 177 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---- 177 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence 99999999987532 378899999931 367899999999999999999999999998654321
Q ss_pred ecccccccCccc--------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 302 QTQTLATIGYMA--------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~a--------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....++..|+| +|||||||++|||+||+.||+..
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 12234444443 89999999999999999999864
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=250.62 Aligned_cols=170 Identities=26% Similarity=0.339 Sum_probs=138.8
Q ss_pred cccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhh-hcccccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECD-VMKSTCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
++||+|+||.||+|+.. ++..+|+|.+.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 67889999986432 122334555554 57889999999999999999999999999999
Q ss_pred CCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecc
Q 038351 237 GSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304 (348)
Q Consensus 237 gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 304 (348)
|+|...+... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 155 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTST 155 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--cccc
Confidence 9998877542 24888999999 78999999999999999999999999999876422211 1234
Q ss_pred cccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 305 TLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 305 ~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..||+.|+| +|||||||++|||++|+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 567888876 89999999999999999999653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=248.26 Aligned_cols=178 Identities=25% Similarity=0.343 Sum_probs=143.2
Q ss_pred CCCccccccccCCcceEEEeEec-CCc----eEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRM----EFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
.+|+..+.||+|+||.||+|++. ++. .||+|.+..... ...+.+..|+.+++.++||||++++++|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46889999999999999999864 333 389998864322 3346788999999999999999999998865 5679
Q ss_pred EEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 230 VLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
|+||+++|+|.++++.. .+++.||+||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999999988653 14888999999 889999999999999999999999999999876543
Q ss_pred CceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 297 DHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
...........+..|+| +|||||||++|||+| |+.||+...
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 22211122223455665 799999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=248.33 Aligned_cols=170 Identities=24% Similarity=0.344 Sum_probs=140.2
Q ss_pred cccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhccc-ccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKS-TCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
+.||+|+||.||+|+.. ++..||+|.++... ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 67889999987542 2233556778877765 4899999999999999999999999999
Q ss_pred CCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecc
Q 038351 237 GSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304 (348)
Q Consensus 237 gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 304 (348)
|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.++|+|||+++....... ....
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 155 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RAST 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--ceec
Confidence 9998887543 14888999999 78999999999999999999999999999875322111 2234
Q ss_pred cccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 305 TLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 305 ~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..||+.|+| +||||+||++|||++|+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 568888876 89999999999999999999654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=255.11 Aligned_cols=180 Identities=23% Similarity=0.411 Sum_probs=145.5
Q ss_pred hCCCccccccccCCcceEEEeEec------CCceEEEEeeeeccC-ccchhhHHHhhhccccc-ccceeeEEEEEecCCe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDF 226 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 226 (348)
.++|...+.||+|+||.||+|+.. ....||||++..... ...+.+.+|+++++++. ||||++++++|...+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 456778899999999999999853 234699999864332 23457889999999996 9999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhch------------------------------------------------------------
Q 038351 227 KVLVLEYMPRGSLEKCLYSS------------------------------------------------------------ 246 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~------------------------------------------------------------ 246 (348)
.++|||||++|+|.+++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999998877532
Q ss_pred ------------------------------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC
Q 038351 247 ------------------------------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD 278 (348)
Q Consensus 247 ------------------------------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~ 278 (348)
.+++.||+||| +.+|+||||||+||++++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence 13788999999 789999999999999999
Q ss_pred CCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 279 NIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 279 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
++.+||+|||+++...............++..|+| +|||||||++|||++ |..||....
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 99999999999987643322222223334555654 899999999999997 999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=247.34 Aligned_cols=170 Identities=24% Similarity=0.347 Sum_probs=139.9
Q ss_pred cccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhccc-ccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKS-TCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
+.||+|+||.||+|+.. ++..||+|.++... ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999976 57789999987542 2233456678888775 4899999999999999999999999999
Q ss_pred CCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecc
Q 038351 237 GSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304 (348)
Q Consensus 237 gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 304 (348)
|+|.+.+... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 155 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCT 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ceee
Confidence 9999888642 23788999999 88999999999999999999999999999875422111 1234
Q ss_pred cccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 305 TLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 305 ~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..||+.|+| +|||||||++|||++|+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence 567888877 89999999999999999999653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=249.96 Aligned_cols=170 Identities=28% Similarity=0.350 Sum_probs=138.9
Q ss_pred cccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhh-hcccccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECD-VMKSTCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
+.||+|+||+||+|+.. +++.||+|.+..... .....+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999975 688999999864321 22234555554 56789999999999999999999999999999
Q ss_pred CCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecc
Q 038351 237 GSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304 (348)
Q Consensus 237 gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 304 (348)
|+|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 155 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTST 155 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--cccc
Confidence 9998887543 23888999999 78999999999999999999999999999976432211 1234
Q ss_pred cccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 305 TLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 305 ~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..||+.|+| +|||||||++|||++|+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 567888876 89999999999999999999653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=248.99 Aligned_cols=175 Identities=21% Similarity=0.297 Sum_probs=140.8
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecC-----CeEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNE-----DFKV 228 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~ 228 (348)
+|+..+.||+|+||.||+|+.. ++..||+|++.... ......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4777899999999999999865 68899999886432 22335688999999999999999999988643 2479
Q ss_pred EEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 229 LVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
+|||||+ ++|.+.+... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999995 6898877543 24888999999 789999999999999999999999999999865322
Q ss_pred Cc-eeeecccccccCccc--------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 297 DH-FMIQTQTLATIGYMA--------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 297 ~~-~~~~~~~~gt~~y~a--------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.. ........||+.|+| +|||||||++|||+||+.||..
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 11 111123456666665 8999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=252.16 Aligned_cols=177 Identities=27% Similarity=0.356 Sum_probs=156.4
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
...|+..+.||+|+||.||||... .++.||+|.+..... ...++.++|+.++.+++++||.++++.+..+...+++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 345777899999999999999864 788999999987644 346788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 233 YMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 233 y~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
||.+|++.+.++... .+..|+.||| ..+.+|||||+.|||+..+|.+|++|||++..+.....
T Consensus 92 y~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~-- 166 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK-- 166 (467)
T ss_pred HhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence 999999999887543 2778999999 88999999999999999999999999999998865433
Q ss_pred eecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 301 IQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...++.||+.||| +||||+|++.+||++|.+|+.+.
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~ 214 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKL 214 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCccc
Confidence 2367899999999 89999999999999999998764
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=248.09 Aligned_cols=175 Identities=22% Similarity=0.289 Sum_probs=144.0
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhccccc-ccceeeEEEEEecCCeEEEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 231 (348)
+|+..+.||+|+||.||+|+.. ++..||+|.+.... ....+.+..|.+++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999865 68899999986432 223355778888888876 577888999999999999999
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~- 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV- 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-
Confidence 999999999887542 13788999999 78999999999999999999999999999976432211
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......||+.|+| +|||||||++|||+||+.||...
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred -cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 1234557888877 89999999999999999999764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=250.08 Aligned_cols=170 Identities=27% Similarity=0.337 Sum_probs=138.7
Q ss_pred cccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhh-hcccccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECD-VMKSTCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
+.||+|+||.||+|+.. ++..+|+|.+..... .....+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999865 688999999864421 22344555554 46789999999999999999999999999999
Q ss_pred CCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecc
Q 038351 237 GSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304 (348)
Q Consensus 237 gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 304 (348)
|+|...+... .+++.||+||| +.+|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~ 155 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTT 155 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Cccc
Confidence 9998877542 13788999999 88999999999999999999999999999875432111 1234
Q ss_pred cccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 305 TLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 305 ~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..||+.|+| +|||||||++|||++|+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 567888876 89999999999999999999653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=251.14 Aligned_cols=170 Identities=26% Similarity=0.391 Sum_probs=142.5
Q ss_pred cccccCCcceEEEeEe----cCCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 162 NLISRGGFGSIHKARI----QDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
+.||+|+||.||+++. .++..+|+|.+..... .....+..|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 3678999999875432 223456789999999999999999999999999999999999
Q ss_pred CCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeec
Q 038351 236 RGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303 (348)
Q Consensus 236 ~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 303 (348)
+|+|.+.+... .+++.||+||| +.+|+||||||+||++++++.+||+|||+++....... ...
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~ 156 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAY 156 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--cee
Confidence 99999887542 23888999999 78999999999999999999999999999986543211 123
Q ss_pred ccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 304 QTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 304 ~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...||+.|+| +|||||||++|||+||+.||+..
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence 4567777776 99999999999999999999753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=241.60 Aligned_cols=167 Identities=24% Similarity=0.373 Sum_probs=139.3
Q ss_pred cccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCH
Q 038351 164 ISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL 239 (348)
Q Consensus 164 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 239 (348)
||+|+||+||++... +++.+|+|.+..... ...+.+..|++++++++|+||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 678999999864322 2235677899999999999999999999999999999999999999
Q ss_pred HHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeec
Q 038351 240 EKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303 (348)
Q Consensus 240 ~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 303 (348)
...+... .+++.||+||| +.+|+||||||+||++++++.++|+|||+++.+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 8776321 13788999999 78999999999999999999999999999976643221 122
Q ss_pred ccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 304 QTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 304 ~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
...||+.|+| +|||||||++|||+||+.||..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 3457777776 8999999999999999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=248.51 Aligned_cols=170 Identities=28% Similarity=0.354 Sum_probs=138.4
Q ss_pred cccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhh-hcccccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECD-VMKSTCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
+.||+|+||.||+|+.. ++..+|+|.+.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 56789999986432 122234444443 56788999999999999999999999999999
Q ss_pred CCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecc
Q 038351 237 GSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304 (348)
Q Consensus 237 gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 304 (348)
|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~~ 155 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTST 155 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Cccc
Confidence 9999887642 23788999999 88999999999999999999999999999976432221 2234
Q ss_pred cccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 305 TLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 305 ~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..||+.|+| +||||+||++|||++|+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence 568888887 89999999999999999999653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=247.51 Aligned_cols=169 Identities=22% Similarity=0.341 Sum_probs=140.7
Q ss_pred cccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
+.||+|+||.||+|+.. +++.+|+|.+..... ...+.+..|+.++.++ +||+|+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 578899999975422 2345577899998888 599999999999999999999999999
Q ss_pred CCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecc
Q 038351 237 GSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304 (348)
Q Consensus 237 gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 304 (348)
|+|...+... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTST 155 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ceec
Confidence 9998877542 23788999999 78999999999999999999999999999975322111 1234
Q ss_pred cccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 305 TLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 305 ~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
..||+.|+| +|||||||++|||+||+.||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 568888876 8999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=261.73 Aligned_cols=184 Identities=23% Similarity=0.318 Sum_probs=149.6
Q ss_pred hHHhhhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCC-
Q 038351 150 ELCRVTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNED- 225 (348)
Q Consensus 150 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~- 225 (348)
+.....++|...+.||+|+||+||+|+. .+++.||||.+..... .....+.+|+.++..++|+|+++++..+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3344567999999999999999999985 4788999999865432 23456788999999999999999988765432
Q ss_pred -------eEEEEEeccCCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcE
Q 038351 226 -------FKVLVLEYMPRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVT 282 (348)
Q Consensus 226 -------~~~lV~Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ 282 (348)
..++||||+++|+|.++++.. .+++.||.||| +.+|+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCE
Confidence 368999999999999988642 13677888888 8899999999999999999999
Q ss_pred EEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 283 HLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 283 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
||+|||+++.+.............||+.|+| +|||||||++|||++|+.||...
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~ 248 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999987643222222345568888887 89999999999999999999753
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=273.57 Aligned_cols=178 Identities=25% Similarity=0.427 Sum_probs=149.9
Q ss_pred CCccccccccCCcceEEEeEecC--C----ceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQD--R----MEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~~--~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
+....+.||+|.||.||+|...+ + ..||||.+.... .+...+|.+|..+|++++|||||+++|.|.+....+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 34456789999999999998653 3 348999986543 4566889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhchh-------------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCc
Q 038351 230 VLEYMPRGSLEKCLYSSN-------------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIA 290 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~-------------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla 290 (348)
++|||++|+|..+|++.+ +||+|+.||+ ++++|||||.++|+||+....+||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999998762 2899999999 888999999999999999999999999999
Q ss_pred cccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 291 KLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
+.+...+.+.......-...||| +|||||||++||++| |..||-+..
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~ 909 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS 909 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc
Confidence 97665555544333233456877 999999999999998 788986643
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=254.84 Aligned_cols=178 Identities=26% Similarity=0.385 Sum_probs=155.5
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCe-EEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDF-KVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lV~ 231 (348)
++|...+++|+|+||.++.++.+ +.+.+++|.+..... ...+...+|+.++++++|||||.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888899999999999999865 677899999976543 334568899999999999999999999999888 99999
Q ss_pred eccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 232 EYMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
+||+||++.+.+...+ ++..|+.||| +..|+|||||++||++..+..+||+|||+|+.+..+.
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999987655 2777999999 8899999999999999999999999999999987654
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIFF 338 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~~ 338 (348)
. ...+..||+.||. +||||+||++|||++-+++|+....
T Consensus 161 ~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m 211 (426)
T KOG0589|consen 161 S--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM 211 (426)
T ss_pred h--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch
Confidence 2 2356789999996 9999999999999999999987543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=244.12 Aligned_cols=178 Identities=24% Similarity=0.312 Sum_probs=147.4
Q ss_pred CCCccccccccCCcceEEEeEecC-CceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQD-RMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
+.|+..+.||+|.-|+||.+++++ +..+|+|.+.+... ....+.+.|-+||+.++||.++.||..+..++..++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 356677899999999999999875 48899999975532 23456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchhH--------------HHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc--
Q 038351 232 EYMPRGSLEKCLYSSNY--------------VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR-- 295 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~~--------------i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~-- 295 (348)
|||+||+|....+.+.. |..||+||| -.+||+||+||+|||+.++|.+.|+||-|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 99999999988775431 667999999 88999999999999999999999999998744310
Q ss_pred -------------------------------C-Cc--------------------eeeecccccccCccc----------
Q 038351 296 -------------------------------E-DH--------------------FMIQTQTLATIGYMA---------- 313 (348)
Q Consensus 296 -------------------------------~-~~--------------------~~~~~~~~gt~~y~a---------- 313 (348)
. .. ......++||..|+|
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 00 001124568899987
Q ss_pred --cccHHHHHHHHHHHcCCCCCccc
Q 038351 314 --SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 314 --sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+|+|+|||++|||+.|+.||...
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~ 338 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGS 338 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCC
Confidence 89999999999999999999764
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=240.41 Aligned_cols=177 Identities=23% Similarity=0.425 Sum_probs=143.4
Q ss_pred CCCccccccccCCcceEEEeEe-----cCCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARI-----QDRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
.+|+..+.||+|+||.||+|.. .++..+|+|.+..... .....+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3567778999999999999974 3567899999864322 233568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch-----------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC
Q 038351 230 VLEYMPRGSLEKCLYSS-----------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI 280 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~-----------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~ 280 (348)
||||+++++|.+++... .+++.||+||| +.+|+||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 99999999999987411 23788999999 78899999999999999999
Q ss_pred cEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcc
Q 038351 281 VTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNK 335 (348)
Q Consensus 281 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~ 335 (348)
.+|++|||+++...............++..|+| +|||||||++|||+| |..||..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 999999999987643322222222333444543 899999999999999 9999854
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=241.58 Aligned_cols=173 Identities=24% Similarity=0.384 Sum_probs=144.6
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
+|+..+.||+|+||.||++... ++..||+|.+..... .....+.+|++++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777899999999999999865 688999999864322 223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 233 YMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 233 y~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
|+++|+|.+.+... .+++.|++||| +.+|+||||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999998876432 13788999999 78999999999999999999999999999987543221
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.....|++.|+| +||||+||++|||++|+.||..
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~ 203 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203 (285)
T ss_pred ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCC
Confidence 123456777766 8999999999999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=238.70 Aligned_cols=166 Identities=25% Similarity=0.381 Sum_probs=138.4
Q ss_pred cccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCH
Q 038351 164 ISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL 239 (348)
Q Consensus 164 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 239 (348)
||+|+||.||+++.+ +++.+|+|.+..... .....+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 688999999864321 2234566799999999999999999999999999999999999999
Q ss_pred HHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeeccc
Q 038351 240 EKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT 305 (348)
Q Consensus 240 ~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~ 305 (348)
.+.+... .+++.||+||| +.+|+||||||+||++++++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eecc
Confidence 8876432 24788999999 88999999999999999999999999999987643221 1234
Q ss_pred ccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 306 LATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 306 ~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.|+..|+| +||||+||++|||++|+.||..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 56777766 8999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=236.60 Aligned_cols=176 Identities=24% Similarity=0.381 Sum_probs=144.5
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
++|+..+.||+|+||.||++..+++..+|+|.+.... ...+.+..|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3577788999999999999999888899999876332 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeee
Q 038351 236 RGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302 (348)
Q Consensus 236 ~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 302 (348)
+|+|.++++... +++.||+||| +.+|+||||||+||++++++.+|++|||+++....... ...
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ecc
Confidence 999999886421 3788999999 78899999999999999999999999999986533211 111
Q ss_pred cccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 303 TQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 303 ~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
....++..|+| +||||||+++|||+| |+.||...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~ 205 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK 205 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 11222334443 899999999999999 99998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=241.15 Aligned_cols=178 Identities=27% Similarity=0.474 Sum_probs=146.1
Q ss_pred CCCccccccccCCcceEEEeEe------cCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARI------QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
++|...+.||+|+||.||++.. .++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4678889999999999999974 2345688998865544445678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch-------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEE
Q 038351 230 VLEYMPRGSLEKCLYSS-------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHL 284 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~-------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl 284 (348)
||||+++++|.++++.. .+++.||+||| +.+++||||||+||++++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 99999999999888532 13788999999 789999999999999999999999
Q ss_pred eecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 285 SDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 285 ~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
+|||+++...............++..|+| +|||||||+++||+| |+.||...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999986643322222222334455655 999999999999998 99998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=258.24 Aligned_cols=174 Identities=26% Similarity=0.427 Sum_probs=141.9
Q ss_pred CccccccccCCcceEEEeEecCC----ce-EEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 158 FSEDNLISRGGFGSIHKARIQDR----ME-FSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~~~----~~-vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
....++||+|+||.||+|++..+ .. ||||..+... .....+|.+|+++|++++|||||+++|++..+...++
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i 238 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML 238 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence 34458999999999999987532 23 8999887522 3456789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 230 VLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
|||+|+||+|.++|+... +.|.||+||| +..+|||||-++|+|++.++.+||+|||+++.-..
T Consensus 239 vmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~- 314 (474)
T KOG0194|consen 239 VMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ- 314 (474)
T ss_pred EEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCcc-
Confidence 999999999999998753 2788999999 89999999999999999999999999999976531
Q ss_pred Cceeeec-ccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 297 DHFMIQT-QTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 297 ~~~~~~~-~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
+.... ...-...|+| +|||||||++||+++ |..||...-
T Consensus 315 --~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~ 367 (474)
T KOG0194|consen 315 --YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK 367 (474)
T ss_pred --eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC
Confidence 11111 1112233443 999999999999999 888987654
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=267.47 Aligned_cols=177 Identities=24% Similarity=0.328 Sum_probs=148.5
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc---cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG---AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||.||+|+.. +++.||+|++...... ..+.+.+|++++++++||||+++++++...+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999865 5889999998643221 2356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch-----------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecC
Q 038351 232 EYMPRGSLEKCLYSS-----------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFG 288 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~-----------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfG 288 (348)
||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999887531 14788999999 7899999999999999999999999999
Q ss_pred CccccccCCc----------------eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 289 IAKLLIREDH----------------FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 289 la~~~~~~~~----------------~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
+++....... ........||+.|+| +|||||||+++||+||+.||..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9987621110 001123468999987 7999999999999999999965
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=260.46 Aligned_cols=169 Identities=27% Similarity=0.415 Sum_probs=150.6
Q ss_pred ccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCHHH
Q 038351 163 LISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEK 241 (348)
Q Consensus 163 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 241 (348)
++|+|.||+||-|+.. +...+|||.+........+.+..|+.+.++++|+|||+++|.+..+++.-|.||.+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999965 566789999987777777889999999999999999999999999999999999999999999
Q ss_pred HHhch---------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC-CCcEEEeecCCccccccCCceeeeccc
Q 038351 242 CLYSS---------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD-NIVTHLSDFGIAKLLIREDHFMIQTQT 305 (348)
Q Consensus 242 ~l~~~---------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DfGla~~~~~~~~~~~~~~~ 305 (348)
.|+.. ++|.+||.||| +..|||||||-+|||++. .|.+||+|||.++.+..- ...++++
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccC--Ccccccc
Confidence 98752 35899999999 888999999999999975 899999999999887532 2234677
Q ss_pred ccccCccc--------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 306 LATIGYMA--------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 306 ~gt~~y~a--------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.||..||| +|||||||.+.||.||++||-+.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El 781 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL 781 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec
Confidence 89999998 89999999999999999999764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=253.92 Aligned_cols=179 Identities=26% Similarity=0.469 Sum_probs=158.1
Q ss_pred CccccccccCCcceEEEeEecCCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 158 FSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
....+.||+|.||.|..+....+..||||+++.... ....+|.+|+++|.+++||||++++|+|..++..++|+|||++
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEn 619 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMEN 619 (807)
T ss_pred eehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhc
Confidence 345678999999999999999999999999986644 3458899999999999999999999999999999999999999
Q ss_pred CCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeee
Q 038351 237 GSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302 (348)
Q Consensus 237 gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 302 (348)
|+|..++... .+|+.|++||. +.++||||+.+.|+|+|.++++||+|||+++-+...+.+...
T Consensus 620 GDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq 696 (807)
T KOG1094|consen 620 GDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ 696 (807)
T ss_pred CcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence 9999998764 24899999999 889999999999999999999999999999987766777776
Q ss_pred cccccccCccc------------cccHHHHHHHHHHH--cCCCCCcccccc
Q 038351 303 TQTLATIGYMA------------SYVYSFGIMLLEVF--TRKKPTNKIFFS 339 (348)
Q Consensus 303 ~~~~gt~~y~a------------sDV~S~Gvvl~ell--tG~~P~~~~~~~ 339 (348)
....-.+.||| +|||+|||.+||++ ....||.+.-.+
T Consensus 697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e 747 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE 747 (807)
T ss_pred cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH
Confidence 66667788887 99999999999975 477898776544
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=244.93 Aligned_cols=170 Identities=24% Similarity=0.321 Sum_probs=140.7
Q ss_pred cccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
+.||+|+||.||+|+.. ++..+|+|.+.... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 57789999987542 22345567888888877 699999999999999999999999999
Q ss_pred CCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecc
Q 038351 237 GSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304 (348)
Q Consensus 237 gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 304 (348)
|+|...+... .+++.||+||| +.+|+||||||+||++++++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 155 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTST 155 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cccc
Confidence 9998877543 13788999999 88999999999999999999999999999975322211 1233
Q ss_pred cccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 305 TLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 305 ~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..||+.|+| +|||||||++|||+||+.||...
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 457778876 89999999999999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=247.23 Aligned_cols=178 Identities=23% Similarity=0.321 Sum_probs=153.8
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc---cchhhHHHhhhccccc-ccceeeEEEEEecCCeEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG---AFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 228 (348)
....|+..+.||+|.||.||+++.+ ++..+|+|.+.+.... ..+...+|+++|+++. |||||++.+.|.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4456788899999999999999976 4999999999755433 3357899999999999 999999999999999999
Q ss_pred EEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCC----CcEEEeecCCcccc
Q 038351 229 LVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN----IVTHLSDFGIAKLL 293 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~----~~~kl~DfGla~~~ 293 (348)
+|||+|.+|.|.+.+... .+++.|++||| +.+|+|||+||+|+|+... +.+|++|||++...
T Consensus 113 lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 999999999999988664 13788999999 8999999999999999643 57999999999988
Q ss_pred ccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 294 IREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
.... .....+||+.|+| +||||.||++|.|++|.+||....
T Consensus 190 ~~~~---~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 190 KPGE---RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred cCCc---eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 6522 2356789999998 899999999999999999997654
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=238.54 Aligned_cols=177 Identities=20% Similarity=0.362 Sum_probs=142.3
Q ss_pred CCCccccccccCCcceEEEeEec----CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ----DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
++|+..+.||+|+||.||+|.+. .+..||+|.++.... .....+.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788899999999999999753 356899998875432 2335688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 231 LEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
|||+++|+|.+++.... +++.||+||| +.+++||||||+||+++.++.++++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 99999999999886521 2788999999 8899999999999999999999999999876543211
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.. ......++..|+| +|||||||++||+++ |+.||...
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 162 IY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred hh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 11 1111223344554 899999999999775 99999754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=242.54 Aligned_cols=175 Identities=19% Similarity=0.303 Sum_probs=142.0
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
++|...+.||+|+||.||+|+.. ++..||+|.+..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999875 677899999865432 2334678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 234 MPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 234 ~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
+++ +|.+.+... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 160 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT- 160 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc-
Confidence 975 787776432 24788999999 789999999999999999999999999999764322111
Q ss_pred eecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 301 IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....+|+.|+| +|||||||++|||+||+.||...
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 161 -YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred -cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 112233444443 89999999999999999999653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=239.07 Aligned_cols=174 Identities=26% Similarity=0.318 Sum_probs=138.6
Q ss_pred CCCccccccccCCcceEEEeEec--CCceEEEEeeeeccC--ccchhhHHHhhhcccc---cccceeeEEEEEec-----
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ--DRMEFSVKGFHLQCS--GAFKSFDFECDVMKST---CYRNLIKIISSRSN----- 223 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~----- 223 (348)
++|...+.||+|+||.||+|+.. ++..||+|.+..... .....+.+|+++++++ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 467899998864432 2234566777776655 69999999998853
Q ss_pred CCeEEEEEeccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCC
Q 038351 224 EDFKVLVLEYMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGI 289 (348)
Q Consensus 224 ~~~~~lV~Ey~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGl 289 (348)
....++||||++ ++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 5888877531 23788999999 78999999999999999999999999999
Q ss_pred ccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 290 AKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 290 a~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
++...... ......||+.|+| +|||||||++|||++|++||...
T Consensus 157 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 212 (290)
T cd07862 157 ARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 212 (290)
T ss_pred eEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC
Confidence 98754321 2234457777876 89999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=250.98 Aligned_cols=169 Identities=22% Similarity=0.223 Sum_probs=141.2
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
.++|+..+.||+|+||.||+|+.. +++.||+|... ...+.+|++++++++||||+++++++..+...++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 457999999999999999999864 67889999643 24568899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 234 MPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 234 ~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+. ++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+|+....... ..
T Consensus 165 ~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~ 239 (391)
T PHA03212 165 YK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NK 239 (391)
T ss_pred CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-cc
Confidence 95 6887776542 24888999999 78999999999999999999999999999975432111 11
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHcCCCCCc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~ 334 (348)
.....||+.|+| +|||||||++|||+||+.||-
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 234567888876 899999999999999998863
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=237.81 Aligned_cols=180 Identities=22% Similarity=0.394 Sum_probs=145.2
Q ss_pred hhCCCccccccccCCcceEEEeEec------CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDF 226 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 226 (348)
.+++|+..+.||+|+||.||+|... .+..||+|.+..... ....++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567899999999999999998753 346799998754322 233568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhch----------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEE
Q 038351 227 KVLVLEYMPRGSLEKCLYSS----------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHL 284 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~----------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl 284 (348)
.++||||+++|+|.++++.. .+++.||+||| +.+++||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999887531 13788999999 789999999999999999999999
Q ss_pred eecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 285 SDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 285 ~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
+|||+++...............++..|+| +|||||||++|||++ |+.||...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~ 225 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999976543322221122233555665 899999999999999 78898654
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=237.72 Aligned_cols=178 Identities=28% Similarity=0.457 Sum_probs=145.6
Q ss_pred CCCccccccccCCcceEEEeEecC------CceEEEEeeeeccCc-cchhhHHHhhhcccccccceeeEEEEEecCCeEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQD------RMEFSVKGFHLQCSG-AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 228 (348)
.+|...+.||+|+||.||+|...+ +..||+|.+...... ..+.+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457788999999999999998643 478999998654333 3467899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhch--------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcE
Q 038351 229 LVLEYMPRGSLEKCLYSS--------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVT 282 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~--------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ 282 (348)
+||||+++++|.++++.. .+++.|++||| +.+++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence 999999999999988632 13778999999 7899999999999999999999
Q ss_pred EEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 283 HLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 283 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
+|+|||+++...............+++.|+| +|||||||++|||++ |+.||...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~ 228 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999976533222111222233445554 899999999999999 99998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=235.18 Aligned_cols=176 Identities=25% Similarity=0.416 Sum_probs=146.2
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
++|+..+.||+|+||.||+|...++..||+|.+.... ...+.+..|+.++++++|+||+++++.+...+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 4678889999999999999998888899999876432 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 236 RGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 236 ~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+++|.++++.. .+++.||+||| +.+++||||||+||+++.++.++++|||+++....... ..
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 160 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TA 160 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-ec
Confidence 99999988542 13788999999 78899999999999999999999999999987643221 11
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.....++..|+| +|||||||++|||+| |+.||...
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 122223445554 899999999999999 99998653
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=234.61 Aligned_cols=176 Identities=23% Similarity=0.289 Sum_probs=145.3
Q ss_pred CCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 156 NGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
.+|+..+.||+|+||.||+|+. .++..+|+|.+..........+.+|+.++++++||||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688899999999999999996 467889999987554444566888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeee
Q 038351 235 PRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302 (348)
Q Consensus 235 ~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 302 (348)
++++|.++++.. .+++.|++||| +.+|+|||+||+||++++++.++|+|||+++....... ..
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~ 163 (267)
T cd06646 89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KR 163 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--cc
Confidence 999999887532 24788999999 78999999999999999999999999999986532111 01
Q ss_pred cccccccCcc---------------ccccHHHHHHHHHHHcCCCCCccc
Q 038351 303 TQTLATIGYM---------------ASYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 303 ~~~~gt~~y~---------------asDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....++..|+ ++|||||||+++||++|+.||...
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 1223344443 389999999999999999998543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=236.22 Aligned_cols=173 Identities=24% Similarity=0.386 Sum_probs=144.5
Q ss_pred CccccccccCCcceEEEeEec-CCceEEEEeeeeccCc---cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 158 FSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG---AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
|+..+.||+|+||.||++... +++.+|+|.+...... ..+.+..|+.++++++|++++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999865 6889999988643221 224567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 234 MPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 234 ~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
+++++|.+.+... .+++.||+||| +.+|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 9999998887432 13788999999 88999999999999999999999999999976532221
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....|+..|+| +|||||||++|||++|+.||...
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 123457777776 89999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=234.00 Aligned_cols=172 Identities=24% Similarity=0.393 Sum_probs=136.4
Q ss_pred cccccCCcceEEEeEecC---CceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCC
Q 038351 162 NLISRGGFGSIHKARIQD---RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRG 237 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 237 (348)
+.||+|+||.||+|...+ ...+|+|.+..... .....+.+|+.++++++||||+++++++......++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998653 35689998865432 23346888999999999999999999999999999999999999
Q ss_pred CHHHHHhch-----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 238 SLEKCLYSS-----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 238 sL~~~l~~~-----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
+|.++++.. .+++.|++||| +.+++||||||+||+++.++.++++|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999887531 13788999999 7899999999999999999999999999997643322211
Q ss_pred eecccccccCcc-------------------ccccHHHHHHHHHHHc-CCCCCccc
Q 038351 301 IQTQTLATIGYM-------------------ASYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~-------------------asDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
......++..|+ ++|||||||+++||++ |+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 111222333332 3799999999999996 99999653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=252.76 Aligned_cols=171 Identities=27% Similarity=0.353 Sum_probs=135.8
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecC--------C
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNE--------D 225 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------~ 225 (348)
..+|...+.||+|+||.||+|+.. ++..||||++... .....+|+.++++++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457889999999999999999875 6789999988532 23346799999999999999999887432 2
Q ss_pred eEEEEEeccCCCCHHHHHhc----------------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC-cEEEeecC
Q 038351 226 FKVLVLEYMPRGSLEKCLYS----------------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI-VTHLSDFG 288 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~----------------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DfG 288 (348)
..++||||+++ ++.+++.. ..+++.||+||| +.+|+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46799999975 67665532 124888999999 78999999999999999654 79999999
Q ss_pred CccccccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 289 IAKLLIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 289 la~~~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+|+.+..... .....||+.|+| +|||||||++|||+||++||...
T Consensus 217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9987643221 123445666665 89999999999999999999653
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=249.13 Aligned_cols=178 Identities=25% Similarity=0.425 Sum_probs=144.9
Q ss_pred CCCccccccccCCcceEEEeEec------CCceEEEEeeeeccC-ccchhhHHHhhhccccc-ccceeeEEEEEecCCeE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFK 227 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 227 (348)
++|...+.||+|+||.||+|++. .+..||+|++..... ...+.+..|++++.++. ||||++++++|..++..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 35677899999999999999864 346799999965432 22346889999999997 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHhch-------------------------------------------------------------
Q 038351 228 VLVLEYMPRGSLEKCLYSS------------------------------------------------------------- 246 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~------------------------------------------------------------- 246 (348)
++||||+++|+|.++++..
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 9999999999999988532
Q ss_pred -------------------------------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEc
Q 038351 247 -------------------------------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFD 277 (348)
Q Consensus 247 -------------------------------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld 277 (348)
.+++.||+||| +.+|+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEe
Confidence 14778999999 88999999999999999
Q ss_pred CCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 278 DNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 278 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
+++.+|++|||+++...............++..|+| +|||||||+++||++ |+.||...
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999987543222111223345566665 799999999999998 89998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=235.06 Aligned_cols=171 Identities=23% Similarity=0.356 Sum_probs=133.6
Q ss_pred ccccCCcceEEEeEecC---CceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCC
Q 038351 163 LISRGGFGSIHKARIQD---RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGS 238 (348)
Q Consensus 163 ~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 238 (348)
.||+|+||.||+|...+ ...+++|.+..... .....+.+|+++++.++|+||+++++.+...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 34577887653322 223567889999999999999999999999999999999999999
Q ss_pred HHHHHhch-----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 239 LEKCLYSS-----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 239 L~~~l~~~-----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
|.+++... .+++.|++||| +.+|+||||||+||++++++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99987542 13788999999 78999999999999999999999999999875432221111
Q ss_pred ecccccccCcc-------------------ccccHHHHHHHHHHHc-CCCCCccc
Q 038351 302 QTQTLATIGYM-------------------ASYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~-------------------asDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.....+++.|+ ++|||||||++|||++ |+.||...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 11122233333 3899999999999999 78888654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=235.08 Aligned_cols=174 Identities=27% Similarity=0.323 Sum_probs=144.3
Q ss_pred CCccccccccCCcceEEEeEe-cCCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 157 GFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
+|+..+.||+|+||.||+|+. .++..+|+|.+..... ...+.+..|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 567788999999999999986 4778899998864422 23356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhc--------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecccc
Q 038351 235 PRGSLEKCLYS--------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTL 306 (348)
Q Consensus 235 ~~gsL~~~l~~--------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 306 (348)
++++|..+... ..+++.|++||| +.+|+|+||||+||+++.++.++|+|||++....... .....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~ 154 (279)
T cd06619 82 DGGSLDVYRKIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYV 154 (279)
T ss_pred CCCChHHhhcCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCC
Confidence 99998755432 234888999999 8899999999999999999999999999997654321 12345
Q ss_pred cccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 307 ATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 307 gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
++..|+| +|||||||++|||+||+.||....
T Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 197 (279)
T cd06619 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQ 197 (279)
T ss_pred CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhc
Confidence 6666655 899999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=238.11 Aligned_cols=178 Identities=28% Similarity=0.472 Sum_probs=145.4
Q ss_pred CCCccccccccCCcceEEEeEec------CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
.+|...+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777889999999999999743 355688888865544445678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch----------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCc
Q 038351 230 VLEYMPRGSLEKCLYSS----------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIV 281 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~----------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~ 281 (348)
||||+++++|.+++... .+++.|++||| +.+|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 99999999999988532 13788999999 889999999999999999999
Q ss_pred EEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 282 THLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 282 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
++|+|||+++...............++..|+| +|||||||++|||+| |+.||...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999976543322222223334555654 999999999999999 99998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=248.75 Aligned_cols=175 Identities=25% Similarity=0.289 Sum_probs=141.0
Q ss_pred CCccccccccCCcceEEEeEe-cCCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCC-----eEE
Q 038351 157 GFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNED-----FKV 228 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 228 (348)
+|+..+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999986 478899999885432 123456889999999999999999999998876 789
Q ss_pred EEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 229 LVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
+|+||+. ++|.+.+... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999996 5787766432 24888999999 789999999999999999999999999999865322
Q ss_pred CceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 297 DHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
... ......++..|+| +|||||||+++||++|+.||+..
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 208 (372)
T cd07853 157 ESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208 (372)
T ss_pred ccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence 111 1122334555544 79999999999999999999754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=233.61 Aligned_cols=178 Identities=25% Similarity=0.426 Sum_probs=144.3
Q ss_pred CCCccccccccCCcceEEEeEecC----CceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQD----RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
++|+..+.||+|+||.||+|++.. ...||+|.+..... .....|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999998753 45789998864432 2345688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 231 LEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
|||+++++|.+++... .+++.|++||| +.+|+||||||+||++++++.++++|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999988542 13778999999 7899999999999999999999999999998875222
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.........+++.|+| +||||||+++|||++ |+.||...
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~ 212 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC
Confidence 1111112223344544 899999999999998 99998654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=232.83 Aligned_cols=177 Identities=27% Similarity=0.347 Sum_probs=145.3
Q ss_pred hCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
.++|+..+.||+|++|.||+|...++..||+|.++... ...+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35688889999999999999998888899999986443 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 235 PRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 235 ~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
++++|.+++.... +++.|+.||| +.+|+||||||+||++++++.++|+|||+++........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE- 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-
Confidence 9999999986432 2778999999 788999999999999999999999999999876432111
Q ss_pred eecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 301 IQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.......+..|+| +|||||||+++||+| |+.||...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 208 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 1111111223443 899999999999999 99998654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=236.34 Aligned_cols=178 Identities=22% Similarity=0.450 Sum_probs=144.8
Q ss_pred CCCccccccccCCcceEEEeEecCC------ceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDR------MEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 228 (348)
++|+..+.||+|+||.||+|..... ..||+|.+..... .....+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 3677889999999999999986432 5789998864332 22356889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhch----------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC
Q 038351 229 LVLEYMPRGSLEKCLYSS----------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI 280 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~----------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~ 280 (348)
++|||+++|+|.+++... .+++.||+||| +.+++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence 999999999999888542 23788999999 78899999999999999999
Q ss_pred cEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 281 VTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 281 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.++|+|||+++...............+++.|+| +|||||||++|||+| |..||...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999986543322222233344566665 899999999999998 99998754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=234.73 Aligned_cols=174 Identities=32% Similarity=0.478 Sum_probs=139.8
Q ss_pred cccccccCCcceEEEeEec-----CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 160 EDNLISRGGFGSIHKARIQ-----DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 160 ~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
..+.||.|.||.||+|.+. .+..|+||.+..... ...+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3478999999999999977 356799999954322 2357899999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhch--h------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 234 MPRGSLEKCLYSS--N------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 234 ~~~gsL~~~l~~~--~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
+++|+|.++|... . +++.||+||| +.+++|+||+++||++++++.+||+|||+++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 9999999998875 1 2889999999 678999999999999999999999999999877332222
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
...........|+| +||||||+++|||+| |+.||...
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 22233334555665 999999999999999 78998765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=235.28 Aligned_cols=178 Identities=21% Similarity=0.354 Sum_probs=139.7
Q ss_pred CCCccccccccCCcceEEEeEec-CCc----eEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRM----EFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
.+|...+.||+|+||.||+|++. ++. .+++|.+..... ....++..|+..++++.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46778899999999999999864 343 467777643322 223567778889999999999999998764 45788
Q ss_pred EEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 230 VLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
++||+++|+|.+++... .+++.||+||| +.+++||||||+||++++++.+||+|||+++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999988642 13788999999 788999999999999999999999999999876433
Q ss_pred CceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 297 DHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
..........++..|++ +|||||||++|||+| |+.||....
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 22222223344555654 799999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=237.09 Aligned_cols=177 Identities=25% Similarity=0.331 Sum_probs=148.7
Q ss_pred hCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 155 TNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
..+|+..+.||+|+||.||+|+. .++..+|+|.+........+.+.+|+.+++.++|+|++++++.+...+..++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 45788889999999999999985 46889999998765555557788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhchh-----------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeee
Q 038351 234 MPRGSLEKCLYSSN-----------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302 (348)
Q Consensus 234 ~~~gsL~~~l~~~~-----------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 302 (348)
+++++|.+++.... +++.||+||| +.+|+||||||+||+++.++.++|+|||+++........ .
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~ 173 (296)
T cd06654 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--R 173 (296)
T ss_pred cCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc--c
Confidence 99999999876421 3788999999 789999999999999999999999999998765432211 1
Q ss_pred cccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 303 TQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 303 ~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....+++.|+| +|||||||++|||++|+.||...
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~ 219 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 22345555654 89999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=260.41 Aligned_cols=181 Identities=24% Similarity=0.317 Sum_probs=148.6
Q ss_pred hCCCccccccccCCcceEEEeEecCC-ceEEEEeeeeccCccchhhHHHhhhccccc-ccceeeEEEE-Eec------CC
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQDR-MEFSVKGFHLQCSGAFKSFDFECDVMKSTC-YRNLIKIISS-RSN------ED 225 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~-~~~------~~ 225 (348)
..++++.+.|.+|||+.||.|....+ .++|+|++........+...+|+++|++|+ |+|||.+++. ... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34566789999999999999998766 999999997777777788999999999998 9999999993 221 13
Q ss_pred eEEEEEeccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~ 291 (348)
+++|.||||++|.|-+++..+. .+++|+++||+. .++|||||||-+||||+.++..||||||.|.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 6889999999999999987543 288999999965 7899999999999999999999999999986
Q ss_pred ccccCCceee-------ecccccccCccc---------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 292 LLIREDHFMI-------QTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 292 ~~~~~~~~~~-------~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.......... .-....|+-|.| +||||+||+||-|+....||++.
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 5422111000 012235778877 99999999999999999999874
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=234.23 Aligned_cols=178 Identities=26% Similarity=0.396 Sum_probs=148.6
Q ss_pred hhCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
...+|+..+.||+|+||.||+|...++..+|+|.+..........+..|+++++.++|+||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 44578888999999999999999988999999998765554557789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 234 MPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 234 ~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
+++++|.++++.. .+++.|++||| +.+|+||||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999998642 13778999999 788999999999999999999999999999776432111
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.....++..|++ +|||||||+++||++ |+.||...
T Consensus 161 --~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~ 208 (261)
T cd05148 161 --SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208 (261)
T ss_pred --ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence 111222333433 899999999999998 89999654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=232.22 Aligned_cols=175 Identities=23% Similarity=0.374 Sum_probs=143.7
Q ss_pred CCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 157 GFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
+|...+.||+|+||.||+++..++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 567778999999999999998887789999886432 2346789999999999999999999999999999999999999
Q ss_pred CCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeec
Q 038351 237 GSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303 (348)
Q Consensus 237 gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 303 (348)
|+|.+++... .+++.||+||| +.+++|+||||+||++++++.+||+|||.++....... ....
T Consensus 84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~ 159 (256)
T cd05113 84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSV 159 (256)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eecC
Confidence 9999988642 13788999999 88999999999999999999999999999986543221 1111
Q ss_pred ccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 304 QTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 304 ~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
...++..|++ +|||||||++|||+| |+.||...
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 1223334443 999999999999999 99998653
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=232.92 Aligned_cols=176 Identities=23% Similarity=0.438 Sum_probs=138.6
Q ss_pred CccccccccCCcceEEEeEecC----CceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCe-----
Q 038351 158 FSEDNLISRGGFGSIHKARIQD----RMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDF----- 226 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 226 (348)
|...+.||+|+||.||+|.... +..||+|.++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 36799999864422 234578899999999999999999998876554
Q ss_pred -EEEEEeccCCCCHHHHHhch------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeec
Q 038351 227 -KVLVLEYMPRGSLEKCLYSS------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDF 287 (348)
Q Consensus 227 -~~lV~Ey~~~gsL~~~l~~~------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~Df 287 (348)
.++|+||+++|+|.+++... .+++.||+||| +.+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 79999999999998887432 13778999999 789999999999999999999999999
Q ss_pred CCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 288 GIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 288 Gla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
|+++...............++..|+| +|||||||++|||++ |..||...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~ 219 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV 219 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 99987643322111111122333433 999999999999999 99998654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=232.31 Aligned_cols=177 Identities=22% Similarity=0.386 Sum_probs=149.2
Q ss_pred hhhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeec--cCccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQ--CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
..+++|+..+.||+|.|+.||++.. .+|+.+|+|.+... .....+.+.+|+.+-+.++||||+++.+.+.+....|+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 3566788889999999999999975 47889999888543 33456889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC---CCcEEEeecCCccccc
Q 038351 230 VLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD---NIVTHLSDFGIAKLLI 294 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~DfGla~~~~ 294 (348)
|+|+|.+++|..-+-.+ +++..||.|.| ..+|||||+||+|+++.. ..-+|++|||+|..+.
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99999999996544322 24677888888 999999999999999964 3457999999999886
Q ss_pred cCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 295 REDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.. .......|||+||| +|||+.|||||-|+.|.+||.+
T Consensus 165 ~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 165 DG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred Cc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 32 23457789999998 8999999999999999999865
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=235.06 Aligned_cols=173 Identities=23% Similarity=0.359 Sum_probs=143.4
Q ss_pred CccccccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 158 FSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
|+..+.||+|+||+||++... +++.+|+|.+..... .....+.+|++++++++|++++++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999865 688999999864322 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 234 MPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 234 ~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
+++++|.+.+... .+++.||+||| +.+|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 9999998877532 13788999999 88999999999999999999999999999976532211
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....|+..|+| +|||||||++|||+||+.||...
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 123456667765 89999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=241.86 Aligned_cols=172 Identities=24% Similarity=0.387 Sum_probs=151.6
Q ss_pred CccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 158 FSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
|+....||+|+||.||||.++ .|..+|+|.+... .+.+++..|+.+|.+.+.|++|++||.|......|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 566789999999999999876 7899999998654 4568899999999999999999999999999999999999999
Q ss_pred CCHHHHHhchhH-------------HHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeec
Q 038351 237 GSLEKCLYSSNY-------------VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303 (348)
Q Consensus 237 gsL~~~l~~~~~-------------i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 303 (348)
|++.+.++.++. ...||+||| ..+-||||||+-|||++.+|.+|++|||.|..+.+. .....
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRN 187 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRN 187 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhhC
Confidence 999999886542 556999999 566799999999999999999999999999988542 23446
Q ss_pred ccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 304 QTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 304 ~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+..||+.||| +||||+|+...||..|++||.++
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI 232 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI 232 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc
Confidence 7889999999 89999999999999999999765
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=230.98 Aligned_cols=175 Identities=27% Similarity=0.409 Sum_probs=142.5
Q ss_pred CCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 157 GFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
+|+..+.||+|+||.||++..+++..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 577889999999999999998887889999875432 2335688899999999999999999999999999999999999
Q ss_pred CCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeec
Q 038351 237 GSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303 (348)
Q Consensus 237 gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 303 (348)
++|.++++.. .+++.|++||| +.+|+||||||+||++++++.+|++|||+++....... ....
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~~ 159 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSSQ 159 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccc-cccC
Confidence 9999988642 13778999999 78899999999999999999999999999986543211 1111
Q ss_pred ccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 304 QTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 304 ~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
...++..|+| +|||||||++|||+| |+.||+..
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 1112223443 999999999999999 89998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=237.92 Aligned_cols=174 Identities=24% Similarity=0.317 Sum_probs=143.9
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc-cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG-AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
++|+..+.||+|+||.||++... ++..+|+|.+...... ....+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46888999999999999999865 5778888887644222 235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 234 MPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 234 ~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+++++|.++++... +++.||.|||. ..+++||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---- 154 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 154 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc----
Confidence 99999999986432 37889999993 2589999999999999999999999999987653221
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.....++..|+| +|||||||+++||+||+.||..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 123345555554 8999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=235.79 Aligned_cols=177 Identities=27% Similarity=0.427 Sum_probs=141.9
Q ss_pred CCccccccccCCcceEEEeEec------CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
+|...+.||+|+||.||+|+.. ....+++|.+..... ...+.+.+|+++++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999853 235688887754332 234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch------------------------------------hHHHHHHHHHHhcCCCceEecCCCcCc
Q 038351 230 VLEYMPRGSLEKCLYSS------------------------------------NYVGFALEYLHFDYSVLIIHYDLKPSN 273 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~------------------------------------~~i~~~L~yLH~~~~~~iiHrDik~~N 273 (348)
|+||+++|+|.+++... .+++.||+||| +.+|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 99999999999887531 13788999999 7899999999999
Q ss_pred eEEcCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 274 VLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 274 ILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
|++++++.+||+|||+++...............++..|+| +||||||++++||+| |+.||...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999986543322211122233445554 899999999999999 99998654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=234.54 Aligned_cols=178 Identities=25% Similarity=0.469 Sum_probs=144.2
Q ss_pred CCCccccccccCCcceEEEeEec------CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
.+++..+.||+|+||.||++... ++..+|+|.+........+.+.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677889999999999999642 456788998765544455679999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch---------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcE
Q 038351 230 VLEYMPRGSLEKCLYSS---------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVT 282 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~---------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ 282 (348)
||||+++++|.++++.. .+++.|++||| +.+++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence 99999999999887542 13778999999 8899999999999999999999
Q ss_pred EEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 283 HLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 283 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
+|+|||+++...............+++.|+| +|||||||++|||++ |+.||...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 228 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence 9999999976543222111122223444544 899999999999998 99998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=245.56 Aligned_cols=168 Identities=25% Similarity=0.313 Sum_probs=135.9
Q ss_pred cccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccc---cccceeeEEEEEecCCeEEEEEeccCC
Q 038351 164 ISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKST---CYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 164 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
||+|+||.||+|+.. ++..||+|.+..... .....+..|..++.+. .||||+++++.+...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 688999999864321 1223445566666555 699999999999999999999999999
Q ss_pred CCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecc
Q 038351 237 GSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304 (348)
Q Consensus 237 gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 304 (348)
|+|.+.+... .+++.||+||| +.+|+||||||+|||++.++.++|+|||+++....... ....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~ 155 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNT 155 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--CccC
Confidence 9998877542 23888999999 78999999999999999999999999999976432221 1234
Q ss_pred cccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 305 TLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 305 ~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..||+.|+| +|||||||++|||+||+.||...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence 557777776 89999999999999999998653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=229.66 Aligned_cols=178 Identities=24% Similarity=0.363 Sum_probs=145.6
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-----ccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-----GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
++|...+.||+|++|.||+|... ++..+|+|.+..... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999864 688999998864321 123468889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 230 VLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
|+||+++++|.+.+... .+++.|+.||| +.+|+||||||+||++++++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 99999999999887642 23788999999 8899999999999999999999999999997653221
Q ss_pred ceee-ecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMI-QTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~-~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.... .....++..|+| +||||+||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 1100 022334555554 89999999999999999998653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=242.42 Aligned_cols=177 Identities=23% Similarity=0.236 Sum_probs=142.6
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCC----
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNED---- 225 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 225 (348)
...++|+..+.||+|+||.||+++.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 35678999999999999999999864 68899999986432 233456788999999999999999999986543
Q ss_pred --eEEEEEeccCCCCHHHHHhc----------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 226 --FKVLVLEYMPRGSLEKCLYS----------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 226 --~~~lV~Ey~~~gsL~~~l~~----------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
..++||||+++ ++.+.+.. ..+++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 47999999975 55554432 124888999999 889999999999999999999999999999765
Q ss_pred ccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 294 IREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.... ......+|+.|+| +|||||||++|||+||+.||...
T Consensus 174 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 174 CTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 3221 1223456777766 89999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=231.39 Aligned_cols=182 Identities=27% Similarity=0.368 Sum_probs=148.4
Q ss_pred hHHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEE
Q 038351 150 ELCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 150 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 228 (348)
++..+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++|+||+++++++..++..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34556777778889999999999999865 67789999887655455577899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhch---------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC-CCcEEEeecCCccc
Q 038351 229 LVLEYMPRGSLEKCLYSS---------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD-NIVTHLSDFGIAKL 292 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~---------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DfGla~~ 292 (348)
+|+||+++++|.+++... .+++.|++||| +.+|+||||||+||+++. .+.++|+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999988642 13788999999 789999999999999986 67999999999876
Q ss_pred cccCCceeeecccccccCccc--------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 293 LIREDHFMIQTQTLATIGYMA--------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~a--------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...... ......++..|+| +|||||||+++||++|+.||...
T Consensus 159 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 159 LAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred cccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 532211 1111223444433 89999999999999999998653
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=242.18 Aligned_cols=177 Identities=24% Similarity=0.419 Sum_probs=141.6
Q ss_pred CCCccccccccCCcceEEEeEec------CCceEEEEeeeeccC-ccchhhHHHhhhcccc-cccceeeEEEEEecC-Ce
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQCS-GAFKSFDFECDVMKST-CYRNLIKIISSRSNE-DF 226 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~ 226 (348)
++|...+.||+|+||.||+|+.. +++.||+|++..... ...+.+..|++++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888999999999999999642 346899998864322 2235677899999999 799999999988754 56
Q ss_pred EEEEEeccCCCCHHHHHhch------------------------------------------------------------
Q 038351 227 KVLVLEYMPRGSLEKCLYSS------------------------------------------------------------ 246 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~------------------------------------------------------------ 246 (348)
.++||||+++++|.+++...
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 88999999999999887531
Q ss_pred -------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecccccccCccc
Q 038351 247 -------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313 (348)
Q Consensus 247 -------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 313 (348)
.+++.||+||| +.+|+||||||+||++++++.++|+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 24888999999 78999999999999999999999999999987643322222223334455655
Q ss_pred ------------cccHHHHHHHHHHHc-CCCCCcc
Q 038351 314 ------------SYVYSFGIMLLEVFT-RKKPTNK 335 (348)
Q Consensus 314 ------------sDV~S~Gvvl~ellt-G~~P~~~ 335 (348)
+|||||||++|||++ |+.||..
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 899999999999998 9999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-30 Score=235.26 Aligned_cols=179 Identities=22% Similarity=0.383 Sum_probs=142.8
Q ss_pred hCCCccccccccCCcceEEEeEec------CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFK 227 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 227 (348)
.++|+..+.||+|+||.||+|..+ .+..||+|.+..... .....+.+|+.++++++||||+++++++...+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 567888999999999999999754 245789998753322 2234578899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhch----------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEe
Q 038351 228 VLVLEYMPRGSLEKCLYSS----------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLS 285 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~----------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~ 285 (348)
++||||+++|+|.++++.. .+++.||+||| +.+|+||||||+||++++++.++++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEEC
Confidence 9999999999999998631 13778999999 8899999999999999999999999
Q ss_pred ecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 286 DFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 286 DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
|||+++...............++..|+| +|||||||++|||++ |+.||...
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~ 225 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999986543222111112223344544 899999999999998 78898654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-30 Score=234.04 Aligned_cols=177 Identities=21% Similarity=0.361 Sum_probs=143.3
Q ss_pred CCccccccccCCcceEEEeEec------CCceEEEEeeeeccCc-cchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQCSG-AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
.|...+.||+|+||.||+|... ++..||+|.+...... ..+.+..|+.++.+++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3566788999999999999864 3578999998744332 23568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch----------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCc
Q 038351 230 VLEYMPRGSLEKCLYSS----------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIV 281 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~----------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~ 281 (348)
++||+++++|.+++... .+++.||+|+| +.+|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence 99999999999887421 24888999999 789999999999999999999
Q ss_pred EEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 282 THLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 282 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
+||+|||+++...............+++.|+| +|||||||++|||+| |..||...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999887643322222222334556665 899999999999998 88888654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=229.15 Aligned_cols=175 Identities=27% Similarity=0.369 Sum_probs=146.4
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+|+..+.||+|++|.||+|... ++..+++|.+.... ....+.+..|++++++++|||++++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999875 68889999886432 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 234 MPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 234 ~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
+++++|.+++... .+++.||+||| +.+++|+||||+||+++.++.++|+|||+++.+......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999988653 13788999999 789999999999999999999999999999876433221
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....++..|+| +|||||||+++||+||+.||...
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 204 (256)
T cd08529 158 --ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN 204 (256)
T ss_pred --hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 122345555554 99999999999999999999654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=246.75 Aligned_cols=173 Identities=22% Similarity=0.214 Sum_probs=143.2
Q ss_pred hCCCccccccccCCcceEEEeEec---CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ---DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
..+|...+.||+|+||.||++... .+..||+|.+... +...+|++++++++||||+++++++...+..++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457889999999999999999753 3567888877532 34578999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|++. ++|.+++... .+++.||+||| +.+|+||||||+|||++.++.++|+|||+++........
T Consensus 166 e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 166 PKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred hhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 9995 6888777432 23788999999 789999999999999999999999999999876543322
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.......||+.|+| +|||||||++|||++|+.||...
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 22234567888876 89999999999999999998543
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=231.62 Aligned_cols=175 Identities=25% Similarity=0.418 Sum_probs=136.0
Q ss_pred ccccccccCCcceEEEeEecCCc---eEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecC------CeE
Q 038351 159 SEDNLISRGGFGSIHKARIQDRM---EFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNE------DFK 227 (348)
Q Consensus 159 ~~~~~lG~G~fg~Vy~~~~~~~~---~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~ 227 (348)
...+.||+|+||.||+|...+.. .+|+|.+.... ....+.+..|++++++++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45688999999999999876432 58999876432 23346788899999999999999999987532 246
Q ss_pred EEEEeccCCCCHHHHHhch------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCC
Q 038351 228 VLVLEYMPRGSLEKCLYSS------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGI 289 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGl 289 (348)
++||||+++|+|.+++... .+++.||+||| +.+|+||||||+||++++++.++|+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999998876311 13788999999 78999999999999999999999999999
Q ss_pred ccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 290 AKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 290 a~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
++...............+++.|++ +|||||||++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 218 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 987643322111112223344443 999999999999999 89998653
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=229.70 Aligned_cols=173 Identities=25% Similarity=0.372 Sum_probs=137.2
Q ss_pred cccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCH
Q 038351 162 NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL 239 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 239 (348)
+.||+|+||.||+|+.. +++.+|+|....... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999875 788899998754322 2345688999999999999999999999999999999999999999
Q ss_pred HHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecccc
Q 038351 240 EKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTL 306 (348)
Q Consensus 240 ~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 306 (348)
.+++.... +++.||+||| +.+|+||||||+||+++.++.+|++|||+++...............
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 99885421 3778999999 8899999999999999999999999999987643211100000001
Q ss_pred cccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 307 ATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 307 gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
.+..|+| +|||||||++|||++ |..||+...
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~ 201 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS 201 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 1223433 899999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-31 Score=258.22 Aligned_cols=176 Identities=24% Similarity=0.430 Sum_probs=146.5
Q ss_pred ccccccccCCcceEEEeEec----CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 159 SEDNLISRGGFGSIHKARIQ----DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 159 ~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
.+.++||.|.||.||+|+++ ....||||.++.... ....+|..|..||.+++||||++|-|+......++||.||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 45689999999999999976 235689999986543 3567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 234 MPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 234 ~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
|+||+|+.+|+..+ +||.|+.||- +.+.|||||-++|||++.+..+||+|||+++.+.++...
T Consensus 712 MENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~- 787 (996)
T KOG0196|consen 712 MENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA- 787 (996)
T ss_pred hhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCCc-
Confidence 99999999999764 2889999999 899999999999999999999999999999988654421
Q ss_pred eeccccc--ccCccc------------cccHHHHHHHHHHHc-CCCCCccccc
Q 038351 301 IQTQTLA--TIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIFF 338 (348)
Q Consensus 301 ~~~~~~g--t~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~~ 338 (348)
..+..-| .+.|.| ||||||||||||.++ |++||-++..
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN 840 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 840 (996)
T ss_pred cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence 1111111 123333 999999999999765 9999877654
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=232.05 Aligned_cols=176 Identities=24% Similarity=0.293 Sum_probs=145.3
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
.++|...+.||+|+||.||+|+.. +++.+|+|.++.........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 347888899999999999999864 6888999988765444455678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 234 MPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 234 ~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+++++|.+++... .+++.|++||| +.+++|+||||+||+++.++.++|+|||++....... ..
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~ 162 (267)
T cd06645 88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AK 162 (267)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cc
Confidence 9999999887542 23788999999 7799999999999999999999999999987653211 11
Q ss_pred ecccccccCccc---------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 302 QTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 302 ~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.....|+..|+| +|||||||++|||++|+.||..
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~ 211 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence 122334544443 8999999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=236.55 Aligned_cols=169 Identities=21% Similarity=0.292 Sum_probs=133.9
Q ss_pred ccccccCCcceEEEeEec---CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEec--CCeEEEEEeccC
Q 038351 161 DNLISRGGFGSIHKARIQ---DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSN--EDFKVLVLEYMP 235 (348)
Q Consensus 161 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey~~ 235 (348)
.+.||+|+||.||+|+.. +++.+|+|.+... .....+.+|++++++++||||+++++.+.. +...++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999865 4578999988543 223567889999999999999999998854 456899999996
Q ss_pred CCCHHHHHhc---------------------hhHHHHHHHHHHhcCCCceEecCCCcCceEE----cCCCcEEEeecCCc
Q 038351 236 RGSLEKCLYS---------------------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLF----DDNIVTHLSDFGIA 290 (348)
Q Consensus 236 ~gsL~~~l~~---------------------~~~i~~~L~yLH~~~~~~iiHrDik~~NILl----d~~~~~kl~DfGla 290 (348)
+ +|.+++.. ..+++.||+||| +.+|+||||||+|||+ +..+.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 77766532 124788999999 8899999999999999 45688999999999
Q ss_pred cccccCCc-eeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 291 KLLIREDH-FMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 291 ~~~~~~~~-~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
+....... ........+|+.|+| +||||+||+++||+||++||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 87643211 111233456777766 8999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=234.77 Aligned_cols=177 Identities=25% Similarity=0.333 Sum_probs=149.0
Q ss_pred hhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
...+|+..+.||+|+||.||+++. .++..||+|.+........+.+..|+.+++.++|+||+++++++...+..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 346788899999999999999986 4788999999876555555678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 233 YMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 233 y~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
|+++++|.+++... .+++.||.||| +.+|+||||||+||+++.++.++|+|||++.........
T Consensus 97 ~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-- 171 (297)
T cd06656 97 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 171 (297)
T ss_pred ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC--
Confidence 99999999987542 13788999999 789999999999999999999999999999765432211
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.....+++.|+| +|||||||++|||+||+.||..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~ 217 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 122345555554 8999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=233.32 Aligned_cols=177 Identities=21% Similarity=0.331 Sum_probs=146.8
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
.++|+..+.||+|+||.||++... ++..+|+|.+........+.+..|++++++++||||+++++.+..++..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888899999999999999875 6788999998765544556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 234 MPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 234 ~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
+++++|.+++... .+++.|+.||| +.+|+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 9999999887642 13788999999 78999999999999999999999999999876532211
Q ss_pred eecccccccCcc-----------------ccccHHHHHHHHHHHcCCCCCccc
Q 038351 301 IQTQTLATIGYM-----------------ASYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~-----------------asDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......+++.|+ ++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 111223344333 389999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=232.19 Aligned_cols=178 Identities=22% Similarity=0.393 Sum_probs=144.9
Q ss_pred CCCccccccccCCcceEEEeEecC------CceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQD------RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 228 (348)
++|...+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+++++.++||||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 467788999999999999998643 36799999854322 23356888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhch----------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEee
Q 038351 229 LVLEYMPRGSLEKCLYSS----------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSD 286 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~----------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~D 286 (348)
+||||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECC
Confidence 999999999999887531 13778999999 88999999999999999999999999
Q ss_pred cCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 287 FGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 287 fGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
||+++.+.............++..|+| +|||||||++|||+| |+.||...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 225 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL 225 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC
Confidence 999987654332222223334555655 899999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-31 Score=265.99 Aligned_cols=180 Identities=25% Similarity=0.387 Sum_probs=153.4
Q ss_pred HhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeec---cCccchhhHHHhhhcccccccceeeEEEEEecCCeE
Q 038351 152 CRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ---CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFK 227 (348)
Q Consensus 152 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 227 (348)
.-...+|.+.++||+|+||.|..++++ +++.+|.|++.+. .......|..|-++|..-..+.|++++-.|.++.+.
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 334578999999999999999999976 6778899998652 223446688899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhchh---------H---HHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 228 VLVLEYMPRGSLEKCLYSSN---------Y---VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~~---------~---i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
|+|||||+||+|-.++.... + |..||.-+| +.+.|||||||+|||||..|++|++|||.+-.+..
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 99999999999999887644 2 444566666 99999999999999999999999999999988765
Q ss_pred CCceeeecccccccCccc-----------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 296 EDHFMIQTQTLATIGYMA-----------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a-----------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
++. ..+...+|||.|++ +|.||+||++|||+.|..||-.
T Consensus 228 dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 228 DGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred CCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 544 34567789999997 8999999999999999999954
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=235.28 Aligned_cols=178 Identities=26% Similarity=0.455 Sum_probs=141.6
Q ss_pred CCCccccccccCCcceEEEeEecC---------------CceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQD---------------RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIIS 219 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~ 219 (348)
++|...+.||+|+||.||+++... ...||+|.+..... .....+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 478888999999999999987543 23488998864422 23356889999999999999999999
Q ss_pred EEecCCeEEEEEeccCCCCHHHHHhch------------------------hHHHHHHHHHHhcCCCceEecCCCcCceE
Q 038351 220 SRSNEDFKVLVLEYMPRGSLEKCLYSS------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVL 275 (348)
Q Consensus 220 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NIL 275 (348)
++...+..++||||+++++|.+++... .+++.|++||| +.+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 999999999999999999999887532 23788999999 789999999999999
Q ss_pred EcCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc--CCCCCccc
Q 038351 276 FDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT--RKKPTNKI 336 (348)
Q Consensus 276 ld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt--G~~P~~~~ 336 (348)
+++++.+||+|||+++...............++..|+| +|||||||+++||++ |..||+..
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 99999999999999976543222111122223444543 999999999999988 66787653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=234.86 Aligned_cols=175 Identities=21% Similarity=0.289 Sum_probs=141.9
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+.|...+.||+|+||.||+|+.. ++..||+|.+..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999875 678899999864432 2334677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 234 MPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 234 ~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
++ ++|.+.+... .+++.||+||| +.+|+||||||+||+++.++.++|+|||+++........
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~- 160 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT- 160 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc-
Confidence 97 5888776542 24888999999 889999999999999999999999999999764321110
Q ss_pred eecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 301 IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....+++.|+| +|||||||++|||+||+.||...
T Consensus 161 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 161 -YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred -ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 111223444443 89999999999999999999653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=249.24 Aligned_cols=181 Identities=22% Similarity=0.295 Sum_probs=149.7
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhccccc-c-----cceeeEEEEEecCCeEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-Y-----RNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~~~~~~~~~~~l 229 (348)
+|.+.++||+|.||.|-||... +++.||||+++... ....+...|+.+|..++ | -|+|+++++|..+++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 6788999999999999999854 68999999997543 33456677999999997 4 389999999999999999
Q ss_pred EEeccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcC--CCcEEEeecCCcccc
Q 038351 230 VLEYMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDD--NIVTHLSDFGIAKLL 293 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~--~~~~kl~DfGla~~~ 293 (348)
|+|.++. +|+++|+... +|..||.+|| +.+|||+||||+||||.+ ...+||+|||.|...
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999954 9999998643 4888999999 889999999999999975 347899999999875
Q ss_pred cc-------CCceeeecccccccCccccccHHHHHHHHHHHcCCCCCccccccchhhhhhh
Q 038351 294 IR-------EDHFMIQTQTLATIGYMASYVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347 (348)
Q Consensus 294 ~~-------~~~~~~~~~~~gt~~y~asDV~S~Gvvl~elltG~~P~~~~~~~~~~~~~~~ 347 (348)
.. ...+.+++..+|.+.-.|.||||||||+.||+||.+-| .|.++.+|+
T Consensus 342 ~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf-----pG~ne~DQl 397 (586)
T KOG0667|consen 342 SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF-----PGDNEYDQL 397 (586)
T ss_pred CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc-----CCCCHHHHH
Confidence 43 23355667777887778899999999999999997644 455666554
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=228.73 Aligned_cols=176 Identities=26% Similarity=0.339 Sum_probs=144.8
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||.||+|+.. ++..||+|.+..... .....+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999865 788999998754322 22346788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 232 EYMPRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
||+++|+|.+++... .+++.||+||| +.+++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999998877421 13788999999 88999999999999999999999999999887643
Q ss_pred CCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 296 EDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
... ......+++.|+| +||||||++++||+||+.||...
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 221 1122345555655 89999999999999999998543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=234.13 Aligned_cols=178 Identities=25% Similarity=0.454 Sum_probs=141.4
Q ss_pred CCCccccccccCCcceEEEeEec-----------------CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-----------------DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKI 217 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l 217 (348)
++|+..+.||+|+||.||+++.. +...+|+|.+..... .....+.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888999999999999998533 244688998864422 234678899999999999999999
Q ss_pred EEEEecCCeEEEEEeccCCCCHHHHHhch-----------------------hHHHHHHHHHHhcCCCceEecCCCcCce
Q 038351 218 ISSRSNEDFKVLVLEYMPRGSLEKCLYSS-----------------------NYVGFALEYLHFDYSVLIIHYDLKPSNV 274 (348)
Q Consensus 218 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~-----------------------~~i~~~L~yLH~~~~~~iiHrDik~~NI 274 (348)
++++...+..++||||+++|+|.+++... .+++.|++||| +.+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence 99999999999999999999999887642 23788999999 78899999999999
Q ss_pred EEcCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc--CCCCCccc
Q 038351 275 LFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT--RKKPTNKI 336 (348)
Q Consensus 275 Lld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt--G~~P~~~~ 336 (348)
++++++.++|+|||+++.+.............++..|++ +|||||||++|||+| |..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999999999999999986543221111111222333433 899999999999998 77888643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=246.84 Aligned_cols=181 Identities=25% Similarity=0.329 Sum_probs=157.8
Q ss_pred HHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc--cchhhHHHhhhcccccccceeeEEEEEecCCeE
Q 038351 151 LCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG--AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFK 227 (348)
Q Consensus 151 ~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 227 (348)
....+..|...+.||+|.|+.|..|+.. ++.+||+|.+++.... ....+.+|+++|+.+.|||||+++.+...+...
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 3445668889999999999999999865 7899999999765432 235588999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 228 VLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
|+||||+.+|.+++++.... ++..|++|+| +..|||||||++||||+.++++||+|||++..+..
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999999987532 3778999999 89999999999999999999999999999998863
Q ss_pred CCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 296 EDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
.. ...+.+|++.|.| +|+||+||++|-|+.|..|||...
T Consensus 208 ~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 208 GL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred cc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence 22 3457889999988 899999999999999999999643
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=236.70 Aligned_cols=176 Identities=27% Similarity=0.445 Sum_probs=138.7
Q ss_pred hCCCccccccccCCcceEEEeEec-CCc--eEEEEeeeecc-CccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRM--EFSVKGFHLQC-SGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 229 (348)
.++|+..+.||+|+||.||+|+.+ ++. .+|+|.+.... ......+.+|++++.++ +||||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888899999999999999875 343 45777665322 22345688899999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhch----------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCc
Q 038351 230 VLEYMPRGSLEKCLYSS----------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIV 281 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~----------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~ 281 (348)
||||+++++|.++++.. .+++.|++||| +.+|+||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence 99999999999988632 13788999999 889999999999999999999
Q ss_pred EEEeecCCccccccCCceeeecccccccCcc------------ccccHHHHHHHHHHHc-CCCCCccc
Q 038351 282 THLSDFGIAKLLIREDHFMIQTQTLATIGYM------------ASYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 282 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~------------asDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
+||+|||+++...... .......+..|+ ++|||||||+++||+| |..||...
T Consensus 163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 227 (303)
T cd05088 163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227 (303)
T ss_pred EEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence 9999999986432110 001111122333 3899999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-31 Score=273.55 Aligned_cols=183 Identities=29% Similarity=0.403 Sum_probs=156.5
Q ss_pred HHhhhCCCccccccccCCcceEEEeE-ecCCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCCeE
Q 038351 151 LCRVTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFK 227 (348)
Q Consensus 151 ~~~~~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 227 (348)
+..++-++.....||.|.||.||.|. ..+|...|+|-+..+. ....+.+.+|+.++..++|||+|+++|+-..++..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 44567788889999999999999998 5578788999886443 34457788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 228 VLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
+|.||||++|+|.+.+.... +++.|+.||| +.+||||||||+||+|+.+|.+|.+|||.|..+..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999999886542 3778999999 88999999999999999999999999999988765
Q ss_pred CCcee--eecccccccCccc---------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 296 EDHFM--IQTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 296 ~~~~~--~~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..+.. .-....||+.||| .||||+|||++||+||++||...
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL 1444 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc
Confidence 42211 1235679999998 89999999999999999999653
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=229.84 Aligned_cols=176 Identities=24% Similarity=0.387 Sum_probs=143.5
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
.+|+..+.||+|+||.||+|... .+..+|+|.+... ....+.+.+|++++++++|+||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35777889999999999999865 5778999987643 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 235 PRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 235 ~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
++++|.+++... .+++.||+||| +.+++||||||+||++++++.+||+|||+++....... .
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~ 160 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T 160 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-e
Confidence 999999987542 13788999999 78999999999999999999999999999987643221 1
Q ss_pred eecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 301 IQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
......++..|+| +|||||||++|||+| |..||...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 209 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 209 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 1111122334544 899999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=228.69 Aligned_cols=176 Identities=23% Similarity=0.376 Sum_probs=144.4
Q ss_pred CCccccccccCCcceEEEeEecCCceEEEEeeeeccCc------cchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSG------AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
+|...+.||+|+||.||+|...++..+|+|.+...... ....+.+|++++++++|+||+++++++...+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 46778899999999999999888899999988643221 124578899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 231 LEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
+||+++++|.+++... .+++.|++||| +.+|+|+||||+||++++++.++|+|||+++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 9999999999988642 13778999999 78899999999999999999999999999876532110
Q ss_pred ----eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 299 ----FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 299 ----~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
........++..|+| +|||||||+++||+||+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 011122345555554 9999999999999999999965
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=226.65 Aligned_cols=171 Identities=26% Similarity=0.372 Sum_probs=138.6
Q ss_pred cccccCCcceEEEeEecCCceEEEEeeeeccCc-cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCHH
Q 038351 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQCSG-AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLE 240 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 240 (348)
++||+|+||.||+|...++..+|+|.+...... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888899999988644322 2346888999999999999999999999999999999999999999
Q ss_pred HHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeeccccc
Q 038351 241 KCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA 307 (348)
Q Consensus 241 ~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~g 307 (348)
+++.... +++.||.|+| +.+++||||||+||++++++.++++|||++........ .......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence 8875421 2778999999 88999999999999999999999999999975432111 11111122
Q ss_pred ccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 308 TIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 308 t~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
++.|+| +|||||||++|||++ |..||...
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 334544 899999999999999 99998654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=247.85 Aligned_cols=169 Identities=21% Similarity=0.239 Sum_probs=141.4
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
..+|...+.||+|+||.||+|+.. .++.||||... ...+.+|++++++++|+||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457889999999999999999976 57789999532 24567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 234 MPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 234 ~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
+. ++|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 95 6888776532 23788999999 7899999999999999999999999999998764332222
Q ss_pred eecccccccCccc------------cccHHHHHHHHHHHcCCCCC
Q 038351 301 IQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPT 333 (348)
Q Consensus 301 ~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~ 333 (348)
......||+.|+| +|||||||++|||++|..|+
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 2234568999987 89999999999999988664
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=235.46 Aligned_cols=179 Identities=27% Similarity=0.425 Sum_probs=142.8
Q ss_pred hCCCccccccccCCcceEEEeEec--------CCceEEEEeeeecc-CccchhhHHHhhhcccc-cccceeeEEEEEecC
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ--------DRMEFSVKGFHLQC-SGAFKSFDFECDVMKST-CYRNLIKIISSRSNE 224 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 224 (348)
..+|...+.||+|+||.||+|+.. ++..+|+|...... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 346778899999999999999742 34578999886432 23346788999999999 799999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhch----------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEE
Q 038351 225 DFKVLVLEYMPRGSLEKCLYSS----------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLF 276 (348)
Q Consensus 225 ~~~~lV~Ey~~~gsL~~~l~~~----------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILl 276 (348)
...++||||+++|+|.+++... .+++.||+||| +.+|+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence 9999999999999999988642 24889999999 7899999999999999
Q ss_pred cCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 277 DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 277 d~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
++++.+||+|||+++...............++..|+| +|||||||++|||+| |..||...
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999987643222111111223334444 999999999999998 88888654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=232.86 Aligned_cols=173 Identities=27% Similarity=0.361 Sum_probs=146.6
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888899999999999999875 67899999886432 223466888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+++++|.+++.... +++.||+||| +.+|+||||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 9999999998875432 3788999999 789999999999999999999999999999876433
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....+++.|+| +||||||++++||++|+.||...
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 201 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 123345555654 89999999999999999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=228.34 Aligned_cols=175 Identities=22% Similarity=0.390 Sum_probs=142.8
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
+.|...+.||+|+||.||+|...+++.+|+|.+.... ...+.+.+|++++++++|+||+++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 4677889999999999999999899999999986443 23467899999999999999999999874 567899999999
Q ss_pred CCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 236 RGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 236 ~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+++|.+++... .+++.||+||| +.+++||||||+||++++++.++++|||+++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-cc
Confidence 99999987542 13778999999 88999999999999999999999999999977642211 11
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.....++..|+| +|||||||++|||++ |+.||...
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 207 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 112223344543 899999999999999 99999754
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=235.76 Aligned_cols=178 Identities=24% Similarity=0.405 Sum_probs=144.3
Q ss_pred CCCccccccccCCcceEEEeEe------cCCceEEEEeeeeccC-ccchhhHHHhhhcccc-cccceeeEEEEEecCCeE
Q 038351 156 NGFSEDNLISRGGFGSIHKARI------QDRMEFSVKGFHLQCS-GAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFK 227 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 227 (348)
++|...+.||+|+||.||++.. ..+..+|+|.+..... ...+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4688889999999999999974 2345789998864422 2335688999999999 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 228 VLVLEYMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
++||||+++|+|.++++.. .+++.||+||| +.+|+|+||||+||++++++.++++|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 9999999999999988642 13788999999 789999999999999999999999999999876
Q ss_pred ccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 294 IREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.............++..|+| +|||||||++|||+| |+.||...
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 44322211222234455655 799999999999998 99998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=240.38 Aligned_cols=178 Identities=23% Similarity=0.409 Sum_probs=141.2
Q ss_pred CCCccccccccCCcceEEEeEe------cCCceEEEEeeeeccC-ccchhhHHHhhhcccc-cccceeeEEEEEecC-Ce
Q 038351 156 NGFSEDNLISRGGFGSIHKARI------QDRMEFSVKGFHLQCS-GAFKSFDFECDVMKST-CYRNLIKIISSRSNE-DF 226 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~ 226 (348)
++|+..+.||+|+||.||+|.. .+++.||||.++.... .....+.+|++++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4688899999999999999973 3567899999865432 2345688899999999 589999999988654 56
Q ss_pred EEEEEeccCCCCHHHHHhch------------------------------------------------------------
Q 038351 227 KVLVLEYMPRGSLEKCLYSS------------------------------------------------------------ 246 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~------------------------------------------------------------ 246 (348)
.++||||+++|+|.++++..
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 78999999999999887531
Q ss_pred -------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeeccccc
Q 038351 247 -------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA 307 (348)
Q Consensus 247 -------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~g 307 (348)
.+++.||+||| +.+|+||||||+||++++++.+||+|||+++...............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 14788999999 88999999999999999999999999999987533222111112223
Q ss_pred ccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 308 TIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 308 t~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
+..|+| +|||||||+++||++ |..||...
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 344554 799999999999997 99998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=231.78 Aligned_cols=174 Identities=25% Similarity=0.369 Sum_probs=142.3
Q ss_pred CccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 158 FSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
|+..+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++|||++++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999976 4677888888654444456788899999999999999999999999999999999999
Q ss_pred CCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeec
Q 038351 237 GSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303 (348)
Q Consensus 237 gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 303 (348)
++|..++... .+++.||+||| +.+|+||||||+||+++.++.++++|||++........ ...
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~ 161 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRD 161 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc--ccc
Confidence 9998876531 13788999999 78999999999999999999999999999876532111 112
Q ss_pred ccccccCccc-----------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 304 QTLATIGYMA-----------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 304 ~~~gt~~y~a-----------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...++..|+| +|||||||++|||++|++||...
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence 2234444433 89999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=240.92 Aligned_cols=176 Identities=22% Similarity=0.222 Sum_probs=142.8
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecC-----
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNE----- 224 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 224 (348)
...++|...+.||+|+||.||+++.. .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 34578999999999999999999865 67889999986432 22345678899999999999999999987643
Q ss_pred -CeEEEEEeccCCCCHHHHHhc----------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 225 -DFKVLVLEYMPRGSLEKCLYS----------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 225 -~~~~lV~Ey~~~gsL~~~l~~----------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
...++||||+++ ++.+.+.. ..+++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHhcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 357999999975 66665532 124788999999 889999999999999999999999999999865
Q ss_pred ccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 294 IREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.... ......+|..|+| +|||||||++|||+||+.||..
T Consensus 177 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 177 GTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred CCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 3321 1233457777876 8999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=229.42 Aligned_cols=176 Identities=26% Similarity=0.417 Sum_probs=142.7
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
++|...+.||+|+||.||+|+..+...||+|.+..... ..+.+.+|++++++++||||+++++++. .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 46888899999999999999988777899999864332 3467899999999999999999999875 456799999999
Q ss_pred CCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 236 RGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 236 ~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+|+|.+++... .+++.||+||| +.+|+||||||+||++++++.++|+|||.++.+..... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~ 159 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA 159 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-cc
Confidence 99999988642 13788999999 88999999999999999999999999999986643221 11
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
.....++..|++ +|||||||++|||+| |+.||....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~ 208 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 208 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 112233444544 899999999999999 888987543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=227.65 Aligned_cols=171 Identities=25% Similarity=0.403 Sum_probs=140.2
Q ss_pred cccccCCcceEEEeEecC----CceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQD----RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
+.||+|++|.||+|.+.+ ...||+|.+..... ...+.+..|++++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998653 23689999876544 445678999999999999999999999988 889999999999
Q ss_pred CCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc-eee
Q 038351 237 GSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH-FMI 301 (348)
Q Consensus 237 gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~-~~~ 301 (348)
++|.+.+.... +++.||+||| +.+++||||||+||+++.++.+||+|||+++.+..... +..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999886532 3788999999 88999999999999999999999999999987644221 111
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.....++..|++ +|||||||+++||+| |+.||+..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 204 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL 204 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 122334555654 899999999999999 99999653
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=228.99 Aligned_cols=178 Identities=23% Similarity=0.323 Sum_probs=143.2
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-----ccchhhHHHhhhcccccccceeeEEEEEecC--CeE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-----GAFKSFDFECDVMKSTCYRNLIKIISSRSNE--DFK 227 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 227 (348)
++|+..+.||+|+||.||+++.. ++..||+|.+..... ...+.+.+|++++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999865 588999998853321 1234678899999999999999999988763 467
Q ss_pred EEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 228 VLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
++||||+++++|.+++... .+++.||+||| +.+|+|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 8999999999999887542 13788999999 78899999999999999999999999999976532
Q ss_pred CCce-eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 296 EDHF-MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 296 ~~~~-~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.... .......++..|+| +|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 1110 01123346666665 89999999999999999998653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=226.80 Aligned_cols=175 Identities=26% Similarity=0.336 Sum_probs=145.3
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||.||+|... +++.+|+|.++... ....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999976 78899999886432 223467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 232 EYMPRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
||+++++|.+++... .+++.|++||| +.+|+||||||+||+++.++.++++|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999887531 12788999999 88999999999999999999999999999876543
Q ss_pred CCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 296 EDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
... ......+++.|+| +|||||||+++||++|+.||..
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 208 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence 211 1122334555544 8999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=231.13 Aligned_cols=178 Identities=25% Similarity=0.343 Sum_probs=140.8
Q ss_pred hCCCccccccccCCcceEEEeEec-CCc----eEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRM----EFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 228 (348)
.++|...+.||+|+||.||+|++. ++. .||+|.+..... ...+.+..|+.+++.++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 356788899999999999999853 443 478998864332 2345688899999999999999999998754 568
Q ss_pred EEEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 229 LVLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
+++||+++|+|.++++.. .+++.||+||| +.+|+||||||+||++++++.+||+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999988652 23888999999 88999999999999999999999999999987643
Q ss_pred CCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 296 EDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
...........++..|++ +|||||||++|||+| |..||+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 222111111223344554 799999999999998 99998754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=227.96 Aligned_cols=177 Identities=28% Similarity=0.405 Sum_probs=143.8
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccCcc---------chhhHHHhhhcccccccceeeEEEEEecCCe
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGA---------FKSFDFECDVMKSTCYRNLIKIISSRSNEDF 226 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 226 (348)
+|...+.||+|+||.||+|... +++.+|+|.+....... .+.+.+|++++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999864 67889999886432221 2457889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 227 KVLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
.++||||+++++|.+++... .+++.|++||| +.+++||||||+||++++++.++|+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 99999999999999888642 13778999999 7889999999999999999999999999998765
Q ss_pred cCCcee----eecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHFM----IQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~~----~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...... ......++..|+| +|||||||++|||+||+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 221110 1112335555654 89999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=231.65 Aligned_cols=175 Identities=22% Similarity=0.346 Sum_probs=143.0
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
+.|+..+.||+|+||.||+|+.. ++..+++|.+........+.+..|++++++++|+|++++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 46788899999999999999976 57889999987655445577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 235 PRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 235 ~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
++++|..++... .+++.+++||| +.+++||||||+||+++.++.++|+|||++........ .
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~--~ 166 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ--R 166 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccccc--c
Confidence 999998776432 13778999999 88999999999999999999999999999875432111 0
Q ss_pred ecccccccCcc-----------------ccccHHHHHHHHHHHcCCCCCcc
Q 038351 302 QTQTLATIGYM-----------------ASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 302 ~~~~~gt~~y~-----------------asDV~S~Gvvl~elltG~~P~~~ 335 (348)
.....++..|+ ++|||||||++|||+||+.||..
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 11112232332 38999999999999999999865
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=235.02 Aligned_cols=178 Identities=26% Similarity=0.415 Sum_probs=141.0
Q ss_pred CCCccccccccCCcceEEEeEec--------CCceEEEEeeeecc-CccchhhHHHhhhcccc-cccceeeEEEEEecCC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ--------DRMEFSVKGFHLQC-SGAFKSFDFECDVMKST-CYRNLIKIISSRSNED 225 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 225 (348)
++|...+.||+|+||.||+++.. +...+|+|.+.... ......+..|+++++++ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56888899999999999999753 23468999886432 22345688899999999 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhch----------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS----------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFD 277 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~----------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld 277 (348)
..++||||+++|+|.+++... .+++.||+||| +.+++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence 999999999999999988642 13778999999 78999999999999999
Q ss_pred CCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 278 DNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 278 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
+++.++|+|||+++...............+++.|+| +|||||||++|||++ |+.||...
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 999999999999976532211111111112234544 899999999999998 88898643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=233.89 Aligned_cols=169 Identities=21% Similarity=0.283 Sum_probs=132.7
Q ss_pred ccccccCCcceEEEeEec---CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEec--CCeEEEEEeccC
Q 038351 161 DNLISRGGFGSIHKARIQ---DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSN--EDFKVLVLEYMP 235 (348)
Q Consensus 161 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey~~ 235 (348)
...||+|+||.||+|+.. ++..+|+|.+... .....+.+|++++++++||||+++++++.. +...++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 367999999999999865 4568999987543 223567889999999999999999998854 567899999997
Q ss_pred CCCHHHHHhc---------------------hhHHHHHHHHHHhcCCCceEecCCCcCceEE----cCCCcEEEeecCCc
Q 038351 236 RGSLEKCLYS---------------------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLF----DDNIVTHLSDFGIA 290 (348)
Q Consensus 236 ~gsL~~~l~~---------------------~~~i~~~L~yLH~~~~~~iiHrDik~~NILl----d~~~~~kl~DfGla 290 (348)
+ +|.+.+.. ..+++.||+||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 67665531 124788999999 7899999999999999 56779999999999
Q ss_pred cccccCCce-eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 291 KLLIREDHF-MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 291 ~~~~~~~~~-~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
+........ .......+|+.|+| +|||||||++|||+||++||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 876432211 11123445666665 8999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=230.94 Aligned_cols=180 Identities=23% Similarity=0.390 Sum_probs=141.5
Q ss_pred hhCCCccccccccCCcceEEEeEecC------CceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQD------RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDF 226 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 226 (348)
.+++|...+.||+|+||.||+|...+ ...||+|....... .....+..|+.++++++|+||+++++++...+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678889999999999999998753 56788887754332 233568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhch-------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC---cEEE
Q 038351 227 KVLVLEYMPRGSLEKCLYSS-------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI---VTHL 284 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~-------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~---~~kl 284 (348)
.++||||+++++|.+++... .+++.|++||| +.+++||||||+||+++.++ .+|+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence 99999999999999987542 13788999999 77899999999999998754 5899
Q ss_pred eecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 285 SDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 285 ~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
+|||+++................+..|+| +|||||||++|||+| |+.||+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~ 225 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999987632221111111112233443 999999999999997 99999754
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=233.06 Aligned_cols=175 Identities=26% Similarity=0.434 Sum_probs=138.1
Q ss_pred CCCccccccccCCcceEEEeEecC-C--ceEEEEeeeecc-CccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQD-R--MEFSVKGFHLQC-SGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~-~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 230 (348)
++|+..+.||+|+||.||+|+.++ + ..+++|.++... ....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578888999999999999998753 3 246788775322 22345688999999999 699999999999999999999
Q ss_pred EeccCCCCHHHHHhch----------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcE
Q 038351 231 LEYMPRGSLEKCLYSS----------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVT 282 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~----------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ 282 (348)
+||+++++|.++++.. .+++.|++||| +.+|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 9999999999988532 12778999999 7899999999999999999999
Q ss_pred EEeecCCccccccCCceeeecccccccCcc------------ccccHHHHHHHHHHHc-CCCCCccc
Q 038351 283 HLSDFGIAKLLIREDHFMIQTQTLATIGYM------------ASYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 283 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~------------asDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
||+|||++........ ......+..|+ ++|||||||++|||+| |+.||...
T Consensus 159 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~ 222 (297)
T cd05089 159 KIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM 222 (297)
T ss_pred EECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999864321100 00011122233 3999999999999997 99999664
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=232.73 Aligned_cols=176 Identities=27% Similarity=0.338 Sum_probs=148.5
Q ss_pred CCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 156 NGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
.+|+..+.||.|++|.||+|+. .+++.|++|.+........+.+.+|+++++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688889999999999999985 578899999987655555577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhchh-----------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeec
Q 038351 235 PRGSLEKCLYSSN-----------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303 (348)
Q Consensus 235 ~~gsL~~~l~~~~-----------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 303 (348)
++++|.+++.... +++.|++||| +.+++||||||+||+++.++.++|+|||++......... ..
T Consensus 99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~ 173 (296)
T cd06655 99 AGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RS 173 (296)
T ss_pred CCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc--CC
Confidence 9999998876531 3778999999 889999999999999999999999999998865432211 12
Q ss_pred ccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 304 QTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 304 ~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...++..|+| +|||||||++|||+||+.||...
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~ 218 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2345556654 89999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=241.06 Aligned_cols=176 Identities=23% Similarity=0.233 Sum_probs=142.5
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecC-----
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNE----- 224 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 224 (348)
...++|...+.||+|+||.||++... .++.+|+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45678999999999999999999864 67889999886432 22345677899999999999999999988653
Q ss_pred -CeEEEEEeccCCCCHHHHHhc----------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 225 -DFKVLVLEYMPRGSLEKCLYS----------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 225 -~~~~lV~Ey~~~gsL~~~l~~----------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
...++||||+++ ++.+.+.. ..+++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhhcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357999999965 56555432 124888999999 889999999999999999999999999999865
Q ss_pred ccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 294 IREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.... ......+|..|+| +|||||||++|||++|+.||..
T Consensus 170 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 170 GTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred CCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3221 1233457777776 8999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=232.43 Aligned_cols=180 Identities=28% Similarity=0.414 Sum_probs=144.3
Q ss_pred hhCCCccccccccCCcceEEEeEecC------CceEEEEeeeecc-CccchhhHHHhhhcccc-cccceeeEEEEEecCC
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQD------RMEFSVKGFHLQC-SGAFKSFDFECDVMKST-CYRNLIKIISSRSNED 225 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 225 (348)
..++|+..+.||+|+||.||++.... ...+|+|.+.... ......+.+|++++.++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34578888999999999999998642 3578999886432 22335688899999999 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhch----------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS----------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFD 277 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~----------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld 277 (348)
..++||||+++|+|.++++.. .+++.||+||| +.+|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEc
Confidence 999999999999999988531 23788999999 78999999999999999
Q ss_pred CCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 278 DNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 278 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
+++.+|++|||+++.+.............++..|+| +|||||||++|||++ |..||...
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 999999999999987654322211122223344554 899999999999998 99998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=230.41 Aligned_cols=177 Identities=18% Similarity=0.258 Sum_probs=141.5
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc-cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG-AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++++|...+.||+|+||.||+|... ++..+|+|.+...... ....+.+|+++++.++|+||+++++++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4678999999999999999999864 6889999998654322 2345778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 232 EYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
||+. +++.+.+... .+++.||+||| +.+|+||||||+||+++.++.++|+|||+++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9996 6776655321 23788999999 77899999999999999999999999999876432211
Q ss_pred eeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. .....+++.|+| +|||||||+++||+||+.||+..
T Consensus 159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 159 T--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred C--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 1 111223334433 79999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=227.00 Aligned_cols=175 Identities=27% Similarity=0.420 Sum_probs=142.4
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
++|+..+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46778899999999999999988888999999865432 3467899999999999999999999875 456799999999
Q ss_pred CCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 236 RGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 236 ~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+++|.++++.. .+++.||+||| +.+|+||||||+||++++++.++++|||+++.+...... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-c
Confidence 99999988642 13788999999 778999999999999999999999999999875432211 1
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.....++..|+| +|||||||++|||++ |+.||...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 207 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 111223344544 899999999999999 89998654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=225.53 Aligned_cols=174 Identities=30% Similarity=0.440 Sum_probs=144.6
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-----ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-----GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
+|+..+.||+|+||.||+|... ++..|++|.+..... ...+.+.+|++++++++|+||+++++++...+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999976 788999998865432 2345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 231 LEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
+||+++++|.+++.... +++.|++||| +.+|+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 99999999998875432 3788999999 7899999999999999999999999999988754322
Q ss_pred eeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......++..|++ +|+|||||+++||++|+.||+..
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 1122334444433 89999999999999999999664
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=228.70 Aligned_cols=170 Identities=21% Similarity=0.319 Sum_probs=130.0
Q ss_pred ccccCCcceEEEeEecCCc---eEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCC
Q 038351 163 LISRGGFGSIHKARIQDRM---EFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGS 238 (348)
Q Consensus 163 ~lG~G~fg~Vy~~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 238 (348)
.||+|+||.||+++..++. .+++|.+..... ...+.+.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5899999999999765433 355665543322 234678999999999999999999999999999999999999999
Q ss_pred HHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeee
Q 038351 239 LEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302 (348)
Q Consensus 239 L~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 302 (348)
|.++++.. .+++.||+||| +.+++||||||+||+++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99988642 13788999999 788999999999999999999999999998643211110000
Q ss_pred cccccccCc-------------------cccccHHHHHHHHHHHc-CCCCCcc
Q 038351 303 TQTLATIGY-------------------MASYVYSFGIMLLEVFT-RKKPTNK 335 (348)
Q Consensus 303 ~~~~gt~~y-------------------~asDV~S~Gvvl~ellt-G~~P~~~ 335 (348)
....++..| .++|||||||++|||++ |..||+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 111222222 24899999999999997 5678754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=229.51 Aligned_cols=179 Identities=23% Similarity=0.350 Sum_probs=144.8
Q ss_pred hCCCccccccccCCcceEEEeEecC-----CceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEec-CCeE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQD-----RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSN-EDFK 227 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~ 227 (348)
.++|...+.||+|+||.||+|...+ +..|++|.+..... ...+.+.+|+.++++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578888999999999999999765 67889998764322 234668889999999999999999998776 5778
Q ss_pred EEEEeccCCCCHHHHHhch--------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeec
Q 038351 228 VLVLEYMPRGSLEKCLYSS--------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDF 287 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~--------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~Df 287 (348)
++++||+++++|.+++... .+++.||+||| +.+++||||||+||++++++.+|++||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999987542 13788999999 789999999999999999999999999
Q ss_pred CCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 288 GIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 288 Gla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
|+++.+.............++..|+| +|||||||+++|+++ |+.||+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 223 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI 223 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence 99987643322221222234445554 899999999999999 99999753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=230.39 Aligned_cols=179 Identities=25% Similarity=0.435 Sum_probs=144.9
Q ss_pred hCCCccccccccCCcceEEEeEecC-----------------CceEEEEeeeeccC-ccchhhHHHhhhcccccccceee
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQD-----------------RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIK 216 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~ 216 (348)
..+|+..+.||+|+||.||+|...+ ...||+|.+..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578888999999999999987543 24578998864432 23467889999999999999999
Q ss_pred EEEEEecCCeEEEEEeccCCCCHHHHHhchh-----------------------HHHHHHHHHHhcCCCceEecCCCcCc
Q 038351 217 IISSRSNEDFKVLVLEYMPRGSLEKCLYSSN-----------------------YVGFALEYLHFDYSVLIIHYDLKPSN 273 (348)
Q Consensus 217 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------------------~i~~~L~yLH~~~~~~iiHrDik~~N 273 (348)
+++++..++..++||||+++++|.+++.... +++.||+||| +.+|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 9999999999999999999999998875432 3788999999 7889999999999
Q ss_pred eEEcCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc--CCCCCccc
Q 038351 274 VLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT--RKKPTNKI 336 (348)
Q Consensus 274 ILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt--G~~P~~~~ 336 (348)
|+++.++.++++|||+++...............+++.|+| +|||||||++|||++ |..||...
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999999986543332222223334555665 999999999999998 77887653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=225.55 Aligned_cols=170 Identities=25% Similarity=0.417 Sum_probs=135.8
Q ss_pred ccccCCcceEEEeEec---CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCC
Q 038351 163 LISRGGFGSIHKARIQ---DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRG 237 (348)
Q Consensus 163 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 237 (348)
.||+|+||.||+|.++ ++..+|+|.+..... ...+.+..|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 577899998864432 23467889999999999999999999886 45678999999999
Q ss_pred CHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee-eecc
Q 038351 238 SLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM-IQTQ 304 (348)
Q Consensus 238 sL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~-~~~~ 304 (348)
+|.+++.... +++.|++||| +.+|+||||||+||++++++.+||+|||+++.+....... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9998885421 3788999999 7899999999999999999999999999998764332211 1111
Q ss_pred cccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 305 TLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 305 ~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
..++..|+| +|||||||++|||+| |+.||...
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 222345554 899999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=229.11 Aligned_cols=178 Identities=25% Similarity=0.340 Sum_probs=141.9
Q ss_pred CCCccccccccCCcceEEEeEecC-C----ceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQD-R----MEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~-~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
.+|...+.||+|+||.||+|...+ + ..+|+|....... .....+.+|++++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467788999999999999998643 2 2578887754432 234678899999999999999999999987 78899
Q ss_pred EEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 230 VLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
||||+++|+|.+++... .+++.|++||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999988653 23888999999 789999999999999999999999999999876533
Q ss_pred CceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 297 DHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
..........++..|+| +|||||||+++|++| |+.||+...
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 22111111112334443 899999999999999 999997653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=226.30 Aligned_cols=177 Identities=27% Similarity=0.421 Sum_probs=145.0
Q ss_pred hCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
.++|...+.||+|+||.||+|..+++..+|+|.+.... ...+.+.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 35788889999999999999998888899999886433 23467899999999999999999999999989999999999
Q ss_pred CCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 235 PRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 235 ~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
++++|.+++.... +++.|++||| +.+++|+||||+||++++++.++++|||+++....... .
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-T 159 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh-h
Confidence 9999999886532 2778999999 77899999999999999999999999999987643111 0
Q ss_pred eecccccccCcc------------ccccHHHHHHHHHHHc-CCCCCccc
Q 038351 301 IQTQTLATIGYM------------ASYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~------------asDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.......+..|+ ++|||||||+++||+| |+.||...
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 208 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 011111223343 3899999999999999 99998653
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=224.44 Aligned_cols=172 Identities=32% Similarity=0.507 Sum_probs=144.2
Q ss_pred cccccCCcceEEEeEecC----CceEEEEeeeeccCcc-chhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQD----RMEFSVKGFHLQCSGA-FKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
+.||+|+||.||+|.... +..+++|.+....... .+.+..|++++..++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999998764 7889999987554332 57788999999999999999999999999999999999999
Q ss_pred CCHHHHHhch---------h------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 237 GSLEKCLYSS---------N------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 237 gsL~~~l~~~---------~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
++|.+++... . +++.|++||| +.+++||||||+||+++.++.++++|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999998764 1 2778999999 88999999999999999999999999999987754
Q ss_pred CCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 296 EDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
...........++..|+| +||||+||++|||++ |+.||+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 332222233445556665 899999999999999 69999765
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=227.63 Aligned_cols=176 Identities=23% Similarity=0.244 Sum_probs=142.7
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
++|+..+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|++++++++|+|++++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999976 588999998864422 223567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 233 YMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 233 y~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
|++++++..++... .+++.||+||| +.+++||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~- 156 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD- 156 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCccc-
Confidence 99998888776432 13788999999 789999999999999999999999999999876433210
Q ss_pred eecccccccCcc-------------ccccHHHHHHHHHHHcCCCCCccc
Q 038351 301 IQTQTLATIGYM-------------ASYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~-------------asDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....++..|+ ++|||||||+++||+||+.||...
T Consensus 157 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 157 -YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred -ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 01112222232 389999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=229.34 Aligned_cols=175 Identities=26% Similarity=0.426 Sum_probs=138.0
Q ss_pred CccccccccCCcceEEEeEe-----cCCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecC--CeEEE
Q 038351 158 FSEDNLISRGGFGSIHKARI-----QDRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNE--DFKVL 229 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 229 (348)
|...+.||+|+||+||++.. .++..||+|.+..... ...+.+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988652 3677899999865432 2346788999999999999999999988753 46899
Q ss_pred EEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 230 VLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
||||+++++|.+++... .+++.||+||| +.+|+||||||+||++++++.++|+|||+++.......
T Consensus 86 v~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 86 IMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 99999999999887642 23788999999 78999999999999999999999999999987643221
Q ss_pred ee-eecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 299 FM-IQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 299 ~~-~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.. ......++..|++ +|||||||+++||+||+.|+..
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 10 0111112223333 8999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=231.60 Aligned_cols=177 Identities=23% Similarity=0.281 Sum_probs=152.7
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
.++|+..++||+|.||+|-.++-+ +++.+|+|++++... .....-..|-++|+..+||.+..+.-.|+..++.+.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 367889999999999999999854 788999999975532 2334567799999999999999999899999999999
Q ss_pred EeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 231 LEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
|||..+|.|.-+|.... .|..||.||| +.+||.||+|.+|.|+|.+|.+||+|||+++.-.....
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 99999999988776532 2889999999 89999999999999999999999999999987544332
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....++||+.|.| .|.|.+|||||||+.|+.||-..
T Consensus 324 --t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 324 --TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred --eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 3467899999998 78999999999999999999553
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=228.36 Aligned_cols=173 Identities=25% Similarity=0.344 Sum_probs=139.8
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+|+..+.||+|++|.||+|+.. ++..||+|.+..... ...+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999875 688999998864322 2345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch---------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 234 MPRGSLEKCLYSS---------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 234 ~~~gsL~~~l~~~---------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
++ ++|.+++... .+++.||+||| +.+|+||||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 6887776431 23888999999 78999999999999999999999999999875432111
Q ss_pred eeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 299 FMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
......+++.|+| +|||||||+++||+||+.||..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~ 204 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1111223333433 8999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=223.85 Aligned_cols=175 Identities=22% Similarity=0.308 Sum_probs=146.3
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+|+..+.||+|+||.||.++.. ++..+++|.+.... ....+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778899999999999998854 68889999886542 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 234 MPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 234 ~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
+++++|.+++... .+++.+++||| +.+++|+||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999988653 13778999999 78899999999999999999999999999987643321
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......+++.|+| +||||||++++||++|+.||+..
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence 1123345666654 89999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=224.61 Aligned_cols=174 Identities=25% Similarity=0.337 Sum_probs=147.3
Q ss_pred CCCccccccccCCcceEEEeEecC-CceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQD-RMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
++|+..+.||+|+||.||+|+..+ +..+++|.+..... .+.+.+|++++++++|+||+++++.+..+...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999999875 78899999865432 578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 235 PRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 235 ~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
++++|.+++.... +++.|+.||| +.+++||||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence 9999999885421 2778999999 77899999999999999999999999999987643221 1
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....++..|+| +|||||||+++||+||+.||...
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 122335555654 89999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=225.16 Aligned_cols=176 Identities=23% Similarity=0.301 Sum_probs=145.7
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
++|...+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++||||+++++++...+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888899999999999999875 57789999987655555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 235 PRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 235 ~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
++++|.+++... .+++.|++||| +.+|+|+||||+||++++++.++|+|||++........ .
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~ 157 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--K 157 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--c
Confidence 999999887653 12788999999 78999999999999999999999999999876543211 0
Q ss_pred ecccccccCc---------------cccccHHHHHHHHHHHcCCCCCccc
Q 038351 302 QTQTLATIGY---------------MASYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y---------------~asDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....++..| .++|||||||+++||+||+.||...
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 0111222222 3489999999999999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=226.33 Aligned_cols=178 Identities=24% Similarity=0.337 Sum_probs=143.5
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-----ccchhhHHHhhhcccccccceeeEEEEEec--CCeE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-----GAFKSFDFECDVMKSTCYRNLIKIISSRSN--EDFK 227 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~ 227 (348)
.+|...+.||+|+||.||+|... ++..+|+|.+..... ...+.+.+|++++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999864 688999998864321 123457889999999999999999998875 3678
Q ss_pred EEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 228 VLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
++++||+++++|.+.+... .+++.||+||| +.+|+||||||+||+++.++.++|+|||+++.+..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 8999999999999887642 23888999999 78899999999999999999999999999976532
Q ss_pred CCc-eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 296 EDH-FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 296 ~~~-~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
... ........++..|+| +|||||||++|||+||+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 111 011122345666654 89999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=225.92 Aligned_cols=175 Identities=26% Similarity=0.413 Sum_probs=141.7
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
++|.....||+|++|.||+|...++..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 3577788999999999999998887789999876432 23467889999999999999999998875 456789999999
Q ss_pred CCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 236 RGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 236 ~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+++|.++++.. .+++.||+||| +.+++||||||+||++++++.++|+|||+++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence 99999988642 13778999999 78899999999999999999999999999987643221 11
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.....++..|+| +|||||||++|||+| |+.||...
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 207 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 112233445554 899999999999999 99998754
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=229.28 Aligned_cols=176 Identities=27% Similarity=0.422 Sum_probs=139.7
Q ss_pred CCCccccccccCCcceEEEeEec-----CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEec--CCeEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-----DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSN--EDFKV 228 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~ 228 (348)
..|+..+.||+|+||.||++... ++..||+|.+........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46778899999999999999743 577899999875544455678999999999999999999998754 35689
Q ss_pred EEEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 229 LVLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
+|+||+++++|.+++... .+++.||+||| +.+|+||||||+||++++++.++|+|||+++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999988542 13788999999 78999999999999999999999999999987643
Q ss_pred CCceee-ecccccccCcc------------ccccHHHHHHHHHHHcCCCCCc
Q 038351 296 EDHFMI-QTQTLATIGYM------------ASYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 296 ~~~~~~-~~~~~gt~~y~------------asDV~S~Gvvl~elltG~~P~~ 334 (348)
...... .....++..|+ ++|||||||+++||++|..|+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 222111 01111122233 3899999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=228.41 Aligned_cols=177 Identities=24% Similarity=0.418 Sum_probs=140.6
Q ss_pred CCccccccccCCcceEEEeEecC-C---ceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQD-R---MEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
.|+..+.||+|+||.||+|+... + ..||+|.+.... ....+.|..|++++++++||||+++++++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778999999999999998653 2 359999886432 223467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 232 EYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
||+++++|.+++... .+++.|++||| +.+++||||||+||+++.++.++++|||+++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999999988642 13778999999 78999999999999999999999999999976543221
Q ss_pred eeeecccc-c--ccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 299 FMIQTQTL-A--TIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~-g--t~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
........ + +..|+| +|||||||++|||++ |+.||...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~ 215 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence 11101111 1 123443 899999999999886 99998654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=227.18 Aligned_cols=179 Identities=23% Similarity=0.416 Sum_probs=142.1
Q ss_pred hCCCccccccccCCcceEEEeEecC-C---ceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQD-R---MEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
.++|+..+.||+|+||.||+|+... + ..+|+|.+.... ....+.+..|++++++++|+|++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4578888999999999999998752 3 368999886442 2234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 230 VLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
||||+++++|.+++.... +++.|++||| +.+++||||||+||++++++.++++|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 999999999999886421 2778999999 788999999999999999999999999999866432
Q ss_pred Cceeee-cccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 297 DHFMIQ-TQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 297 ~~~~~~-~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
...... .....+..|+| +|||||||++|||+| |+.||...
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~ 214 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 211100 01111223443 899999999999998 99998654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=228.01 Aligned_cols=178 Identities=24% Similarity=0.310 Sum_probs=143.2
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccc-cccceeeEEEEEecC------
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKST-CYRNLIKIISSRSNE------ 224 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~------ 224 (348)
.+++.|+..+.||+|+||.||+|+.. ++..+|+|.+.... .....+..|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45677888899999999999999865 57789999886443 3345688899999998 699999999998753
Q ss_pred CeEEEEEeccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCc
Q 038351 225 DFKVLVLEYMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIA 290 (348)
Q Consensus 225 ~~~~lV~Ey~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla 290 (348)
...++||||+++++|.+++.... +++.|++||| +.+|+|||+||+||++++++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 46899999999999999876421 3788999999 788999999999999999999999999999
Q ss_pred cccccCCceeeecccccccCccc-----------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 291 KLLIREDHFMIQTQTLATIGYMA-----------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~a-----------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+....... ......|+..|+| +|||||||++|||++|+.||+..
T Consensus 159 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 159 AQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219 (272)
T ss_pred eecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 86532211 1122334444433 89999999999999999999653
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=232.87 Aligned_cols=178 Identities=27% Similarity=0.421 Sum_probs=141.3
Q ss_pred CCCccccccccCCcceEEEeEec--------CCceEEEEeeeeccC-ccchhhHHHhhhcccc-cccceeeEEEEEecCC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ--------DRMEFSVKGFHLQCS-GAFKSFDFECDVMKST-CYRNLIKIISSRSNED 225 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 225 (348)
.+|...+.||+|+||.||+|+.. ....+|+|.+..... .....+..|+++++++ +||||+++++++...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46778899999999999999742 345688998764322 2345688899999999 5999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhch----------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS----------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFD 277 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~----------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld 277 (348)
..++||||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence 999999999999999988542 14888999999 78999999999999999
Q ss_pred CCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 278 DNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 278 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
+++.+||+|||+++...............++..|+| +|||||||++|||++ |+.||...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999986643211111111122334544 899999999999999 89998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=224.68 Aligned_cols=170 Identities=25% Similarity=0.432 Sum_probs=134.0
Q ss_pred cccCCcceEEEeEec---CCceEEEEeeeeccCc-cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCH
Q 038351 164 ISRGGFGSIHKARIQ---DRMEFSVKGFHLQCSG-AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL 239 (348)
Q Consensus 164 lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 239 (348)
||+|+||.||+|.+. ++..||+|.+...... ..+.+.+|++++++++||||+++++++. .+..++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999764 3557899988654322 2356889999999999999999999886 4577999999999999
Q ss_pred HHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee-eccc
Q 038351 240 EKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI-QTQT 305 (348)
Q Consensus 240 ~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~-~~~~ 305 (348)
.+++... .+++.|++||| +.+++||||||+||+++.++.+||+|||+++.......... ....
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 9988542 13788999999 78999999999999999999999999999986543222111 1111
Q ss_pred ccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 306 LATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 306 ~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
.++..|+| +|||||||++|||++ |+.||....
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 12334544 899999999999996 999997643
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=226.27 Aligned_cols=176 Identities=28% Similarity=0.423 Sum_probs=141.2
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc----------cchhhHHHhhhcccccccceeeEEEEEecCC
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG----------AFKSFDFECDVMKSTCYRNLIKIISSRSNED 225 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 225 (348)
+|...+.||+|+||.||+|... ++..+|+|.+...... ..+.+..|++++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999864 6889999987532111 1235778999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
..++||||+++++|.++++.. .+++.||.||| +.+++||||||+||+++.++.++++|||+++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 999999999999999887652 23788999999 789999999999999999999999999999765
Q ss_pred ccCCceeeecccccccCccc--------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 294 IREDHFMIQTQTLATIGYMA--------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~a--------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.............++..|+| +||||||++++||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 32211111112233444433 8999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=227.25 Aligned_cols=178 Identities=24% Similarity=0.422 Sum_probs=142.2
Q ss_pred CCCccccccccCCcceEEEeEec----CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ----DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
.+|...+.||+|+||.||+|+.. ....+|+|.+..... ...+.+..|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999864 234689998864322 2345788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 231 LEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
|||+++++|.+++... .+++.|++||| +.+++||||||+||+++.++.++++|||+++.+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999988643 13788999999 8899999999999999999999999999998764332
Q ss_pred ceeee-cccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 298 HFMIQ-TQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 298 ~~~~~-~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
..... ....++..|++ +|||||||++||+++ |+.||...
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~ 213 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence 21111 11112234443 899999999999886 99998654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=225.61 Aligned_cols=175 Identities=22% Similarity=0.335 Sum_probs=146.0
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
+|+..+.||+|+||.||++... ++..+|+|.++... ....+.+..|+.++++++|+||+++++.+..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999865 67889999886432 234467888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 235 PRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 235 ~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
++|+|.+.+... .+++.||+||| +.+|+|+||||+||++++++.++++|||+++........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY- 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc-
Confidence 999998877531 23788999999 889999999999999999999999999999766432211
Q ss_pred eecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 301 IQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....+++.|+| +||||||+++++|++|+.||+..
T Consensus 157 -~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 203 (255)
T cd08219 157 -ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203 (255)
T ss_pred -cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC
Confidence 123446666665 89999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=229.65 Aligned_cols=179 Identities=25% Similarity=0.417 Sum_probs=144.2
Q ss_pred hCCCccccccccCCcceEEEeEec------CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFK 227 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 227 (348)
.++|+..+.||+|+||.||+|+.. ++..+|+|.+..... ...+.+.+|++++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888999999999999999863 467899998864432 2345688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhch----------------------------------hHHHHHHHHHHhcCCCceEecCCCcCc
Q 038351 228 VLVLEYMPRGSLEKCLYSS----------------------------------NYVGFALEYLHFDYSVLIIHYDLKPSN 273 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~----------------------------------~~i~~~L~yLH~~~~~~iiHrDik~~N 273 (348)
++||||+++|+|.+++... .+++.||+||| ..+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 9999999999999988631 23778999999 7899999999999
Q ss_pred eEEcCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 274 VLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 274 ILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
|++++++.++|+|||+++.+..............+..|+| +|||||||++|||++ |..||...
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999976543222111122223344554 899999999999998 88888543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=231.20 Aligned_cols=177 Identities=27% Similarity=0.377 Sum_probs=143.4
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|...+.||+|+||.||+++.. +++.|++|.+..... ...+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888899999999999999875 577899998865432 23456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc-
Q 038351 232 EYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH- 298 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~- 298 (348)
||+++++|.+++.... +++.|++||| +.+++||||||+||+++.++.++++|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 9999999999886422 3678999999 78999999999999999999999999999874211000
Q ss_pred ------------eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 299 ------------FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 299 ------------~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
........++..|+| +|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~ 218 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 000112234555655 8999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=228.61 Aligned_cols=177 Identities=20% Similarity=0.291 Sum_probs=140.6
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
++|+..+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999876 678999999865432 2234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc--
Q 038351 234 MPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH-- 298 (348)
Q Consensus 234 ~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~-- 298 (348)
+++ +|.+++... .+++.||.||| +.+|+||||||+||+++.++.++|+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 975 898877532 14888999999 78999999999999999999999999999875421111
Q ss_pred --------eeeecccccccCcc-ccccHHHHHHHHHHHcCCCCCccc
Q 038351 299 --------FMIQTQTLATIGYM-ASYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 --------~~~~~~~~gt~~y~-asDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+..++...++..|. ++||||+||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 01111111222221 389999999999999999999654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=246.63 Aligned_cols=173 Identities=26% Similarity=0.378 Sum_probs=145.0
Q ss_pred ccccccccCCcceEEEeEec-CCceEEEEeeee----ccCccchhhHHHhhhcccccccceeeEEEEEecCCe--EEEEE
Q 038351 159 SEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHL----QCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDF--KVLVL 231 (348)
Q Consensus 159 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lV~ 231 (348)
....+||+|+|-+||||... +|.+||---++. +.....+.|..|+.+|+.|+||||++++.++.+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34578999999999999875 678887433321 223345789999999999999999999999987655 77899
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC-CCcEEEeecCCccccccCCc
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD-NIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DfGla~~~~~~~~ 298 (348)
|.|..|+|..+.+.. ++|..||.|||. +.++|||||||-+||+++. .|.+||+|+|||..+....
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 999999999998753 358999999996 4789999999999999985 6999999999999875422
Q ss_pred eeeecccccccCccc-----------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA-----------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a-----------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...+.|||.||| .||||||++|+||+|+..||.+-
T Consensus 201 ---aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC 246 (632)
T KOG0584|consen 201 ---AKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSEC 246 (632)
T ss_pred ---cceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhh
Confidence 234789999999 99999999999999999999653
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=222.98 Aligned_cols=172 Identities=28% Similarity=0.384 Sum_probs=138.0
Q ss_pred cccccCCcceEEEeEecCCceEEEEeeeeccCc-cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCHH
Q 038351 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQCSG-AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLE 240 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 240 (348)
++||+|+||.||++...+++.||+|.+...... ..+.+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999999877999999988654333 3467889999999999999999999999999999999999999999
Q ss_pred HHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeeccccc
Q 038351 241 KCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA 307 (348)
Q Consensus 241 ~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~g 307 (348)
+++.... +++.|++||| +.+++||||||+||+++.++.++|+|||+++................
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 9885421 2667899999 88899999999999999999999999999976532111100011111
Q ss_pred ccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 308 TIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 308 t~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
+..|+| +|||||||++|||+| |..||...
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~ 199 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM 199 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC
Confidence 222333 899999999999999 88898654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=230.38 Aligned_cols=175 Identities=25% Similarity=0.378 Sum_probs=142.4
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
++|+..+.||+|+||.||+++.. ++..+|+|.+..... .....+.+|++++++++|+||+++++.+..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778899999999999999976 788999998864322 2245788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch---------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 234 MPRGSLEKCLYSS---------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 234 ~~~gsL~~~l~~~---------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
+++++|.+++... .+++.|++|||. +.+|+||||||+||+++.++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA 158 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence 9999999887652 127789999994 35899999999999999999999999999876532111
Q ss_pred eeeecccccccCcc------------------ccccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYM------------------ASYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~------------------asDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....++..|+ ++|||||||++|||+||+.||...
T Consensus 159 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 159 ----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred ----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 1112233332 379999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=226.87 Aligned_cols=176 Identities=24% Similarity=0.312 Sum_probs=147.1
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
++|+..+.||.|++|.||+|+.. ++..+|+|.+.... ......+.+|++++++++|+|++++++++..+...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778899999999999999865 67899999886543 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhchh-----------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeee
Q 038351 234 MPRGSLEKCLYSSN-----------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302 (348)
Q Consensus 234 ~~~gsL~~~l~~~~-----------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 302 (348)
+++++|.+++.... +++.|++||| +.+++||||+|+||++++++.++++|||+++....... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~ 155 (274)
T cd06609 81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KR 155 (274)
T ss_pred eCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc--cc
Confidence 99999999887531 3778999999 78899999999999999999999999999987653211 11
Q ss_pred cccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 303 TQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 303 ~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....++..|++ +|||||||++|||+||+.||+..
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 23345555554 89999999999999999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=237.69 Aligned_cols=174 Identities=25% Similarity=0.286 Sum_probs=141.9
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecC-----
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNE----- 224 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 224 (348)
...++|...+.||+|+||.||+|... ++..||||.+..... ...+.+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45678999999999999999999864 678899998864321 2335577899999999999999999887543
Q ss_pred -CeEEEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 225 -DFKVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 225 -~~~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
...++++|++ +++|.++++.. .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 4578999998 77888776532 24888999999 78999999999999999999999999999987
Q ss_pred cccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 293 LIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
..... ....||..|+| +|||||||++|||++|+.||..
T Consensus 168 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 168 ADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred cCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 54321 23345666654 8999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=228.26 Aligned_cols=183 Identities=22% Similarity=0.257 Sum_probs=146.1
Q ss_pred hhhHHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccc-cccceeeEEEEEe---
Q 038351 148 CLELCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKST-CYRNLIKIISSRS--- 222 (348)
Q Consensus 148 ~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~--- 222 (348)
+..+..+.++|+..+.||+|+||.||+++.. +++.+|+|.+.... .....+.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3556678899999999999999999999865 57789999875322 2235678899999999 6999999999874
Q ss_pred --cCCeEEEEEeccCCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEE
Q 038351 223 --NEDFKVLVLEYMPRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHL 284 (348)
Q Consensus 223 --~~~~~~lV~Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl 284 (348)
..+..++||||+++++|.++++.. .+++.|+.||| +.+|+||||||+||++++++.+++
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEE
Confidence 345789999999999998876421 13778999999 789999999999999999999999
Q ss_pred eecCCccccccCCceeeecccccccCccc-----------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 285 SDFGIAKLLIREDHFMIQTQTLATIGYMA-----------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 285 ~DfGla~~~~~~~~~~~~~~~~gt~~y~a-----------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+|||+++.+..... ......|++.|+| +||||+||++|||+||+.||...
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999986543211 1112234555543 79999999999999999998653
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=237.20 Aligned_cols=173 Identities=29% Similarity=0.374 Sum_probs=144.6
Q ss_pred CCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhc--ccccccceeeEEEEEecCC----eEEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVM--KSTCYRNLIKIISSRSNED----FKVLV 230 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l--~~l~H~niv~l~~~~~~~~----~~~lV 230 (348)
.....++||+|+||.||||.+.+ +.||||++.... .+.|..|-++. -.++|+||++++++-.... +.+||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhccC-ceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 34456789999999999999877 699999997553 35677777664 4668999999999877655 88999
Q ss_pred EeccCCCCHHHHHhchh-----------HHHHHHHHHHhc------CCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 231 LEYMPRGSLEKCLYSSN-----------YVGFALEYLHFD------YSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~-----------~i~~~L~yLH~~------~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
+||.++|+|.++|+... .+++||+|||.. ++++|+|||||++|||+..++.+.|+|||+|..+
T Consensus 287 t~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred eeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 99999999999998643 388999999974 5678999999999999999999999999999888
Q ss_pred ccCCceeeecccccccCccc------------------cccHHHHHHHHHHHcCCCCC
Q 038351 294 IREDHFMIQTQTLATIGYMA------------------SYVYSFGIMLLEVFTRKKPT 333 (348)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~a------------------sDV~S~Gvvl~elltG~~P~ 333 (348)
.........-..+||..||| .||||+|.|||||+++..-+
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 75544333445789999998 79999999999999976544
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=225.69 Aligned_cols=166 Identities=18% Similarity=0.276 Sum_probs=132.8
Q ss_pred cccccCCcceEEEeEecC-------------CceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEE
Q 038351 162 NLISRGGFGSIHKARIQD-------------RMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 228 (348)
+.||+|+||.||+|+..+ ...|++|.+..........+..|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998542 2357888876544444557888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCc-------EEEeecC
Q 038351 229 LVLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIV-------THLSDFG 288 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~-------~kl~DfG 288 (348)
+||||+++|+|..++... .+++.|++||| +.+|+||||||+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999998877542 23888999999 889999999999999987654 8999999
Q ss_pred CccccccCCceeeecccccccCccc-------------cccHHHHHHHHHHH-cCCCCCccc
Q 038351 289 IAKLLIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVF-TRKKPTNKI 336 (348)
Q Consensus 289 la~~~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~ell-tG~~P~~~~ 336 (348)
++....... ...++..|+| +|||||||++|||+ +|+.|+...
T Consensus 158 ~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 158 IPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred CCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 987653221 1233444443 79999999999997 688888654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=246.10 Aligned_cols=177 Identities=23% Similarity=0.279 Sum_probs=138.0
Q ss_pred hHHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccc------cceeeEEEEEe
Q 038351 150 ELCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCY------RNLIKIISSRS 222 (348)
Q Consensus 150 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~~~~~ 222 (348)
++...+++|...+.||+|+||+||+|+.. ++..||||+++... .....+..|++++..++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445688999999999999999999865 57789999986432 122445667777766655 45889999887
Q ss_pred cC-CeEEEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC---------
Q 038351 223 NE-DFKVLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI--------- 280 (348)
Q Consensus 223 ~~-~~~~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~--------- 280 (348)
.+ .+.++|||++ +++|.+++... .+++.||+|||. +.+||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccccc
Confidence 64 5789999998 67888777542 247889999993 25899999999999998765
Q ss_pred -------cEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 281 -------VTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 281 -------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.+||+|||.+..... ......||+.|+| +|||||||++|||+||+.||+.
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred ccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 499999998864321 1245678888887 7999999999999999999975
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=234.21 Aligned_cols=178 Identities=27% Similarity=0.418 Sum_probs=141.5
Q ss_pred CCCccccccccCCcceEEEeEec--------CCceEEEEeeeecc-CccchhhHHHhhhcccc-cccceeeEEEEEecCC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ--------DRMEFSVKGFHLQC-SGAFKSFDFECDVMKST-CYRNLIKIISSRSNED 225 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 225 (348)
.+|...+.||+|+||.||+|+.. ....+|+|.+.... ....+.+.+|+++++++ +||||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35778899999999999999742 12368999876432 22346788999999999 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhch----------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS----------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFD 277 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~----------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld 277 (348)
..++|+||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence 999999999999999987531 14888999999 78999999999999999
Q ss_pred CCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 278 DNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 278 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
+++.+||+|||+++...............++..|+| +|||||||++|||++ |..||...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 999999999999986543221111111222334544 899999999999998 88998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=228.03 Aligned_cols=172 Identities=26% Similarity=0.346 Sum_probs=136.1
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccc---cccceeeEEEEEec-----CC
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKST---CYRNLIKIISSRSN-----ED 225 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~-----~~ 225 (348)
+|+..+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777889999999999999865 688899998865422 2234566788777665 69999999998864 34
Q ss_pred eEEEEEeccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~ 291 (348)
..++||||+++ +|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57999999974 887776531 23788999999 7899999999999999999999999999998
Q ss_pred ccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 292 LLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
....... .....+|..|+| +||||+||++|||++|++||..
T Consensus 157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~ 209 (288)
T cd07863 157 IYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 209 (288)
T ss_pred cccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence 7643211 123345666665 8999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=228.30 Aligned_cols=165 Identities=21% Similarity=0.309 Sum_probs=130.2
Q ss_pred ccccCCcceEEEeEecC-------------------------CceEEEEeeeeccCccchhhHHHhhhcccccccceeeE
Q 038351 163 LISRGGFGSIHKARIQD-------------------------RMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKI 217 (348)
Q Consensus 163 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 217 (348)
.||+|+||.||+|.+.. ...|++|.+..........+..|++++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 68999999999997421 13478888765433334578889999999999999999
Q ss_pred EEEEecCCeEEEEEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC----
Q 038351 218 ISSRSNEDFKVLVLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI---- 280 (348)
Q Consensus 218 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~---- 280 (348)
+++|......++||||+++|+|..++... .+++.||+||| +.+|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999888642 13888999999 88999999999999997643
Q ss_pred ---cEEEeecCCccccccCCceeeecccccccCcc-------------ccccHHHHHHHHHH-HcCCCCCccc
Q 038351 281 ---VTHLSDFGIAKLLIREDHFMIQTQTLATIGYM-------------ASYVYSFGIMLLEV-FTRKKPTNKI 336 (348)
Q Consensus 281 ---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~-------------asDV~S~Gvvl~el-ltG~~P~~~~ 336 (348)
.++++|||++........ ..++..|+ ++|||||||++||| ++|+.||...
T Consensus 159 ~~~~~kl~d~g~~~~~~~~~~------~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSREE------RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred ccceeeecCCccccccccccc------cccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 479999998865432111 11222232 28999999999998 5799998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=256.72 Aligned_cols=180 Identities=22% Similarity=0.348 Sum_probs=144.1
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEec--CCeE
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSN--EDFK 227 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~ 227 (348)
...++|...+.||+|+||.||+|+.. ++..+|+|.+.... ......+..|+.++++++||||++++++|.. ....
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999999875 56678888886432 2234568899999999999999999998854 4578
Q ss_pred EEEEeccCCCCHHHHHhch----------------hHHHHHHHHHHhcC----CCceEecCCCcCceEEcC---------
Q 038351 228 VLVLEYMPRGSLEKCLYSS----------------NYVGFALEYLHFDY----SVLIIHYDLKPSNVLFDD--------- 278 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~----~~~iiHrDik~~NILld~--------- 278 (348)
++||||+++|+|.++|... .+|+.||+|||... ..+||||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999887541 13788999999543 256999999999999964
Q ss_pred --------CCcEEEeecCCccccccCCceeeecccccccCccc--------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 279 --------NIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA--------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 279 --------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a--------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
...+||+|||+++.+..... .....||+.|+| +|||||||++|||+||+.||..
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 34589999999987643221 234467777776 7999999999999999999964
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=231.21 Aligned_cols=179 Identities=24% Similarity=0.333 Sum_probs=140.0
Q ss_pred hCCCccccccccCCcceEEEeEec-CCc----eEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRM----EFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 228 (348)
.++|+..+.||+|+||.||+|... ++. .+|+|.+..... .....+.+|+.++++++||||++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 346778899999999999999864 343 468887754322 2234678899999999999999999998764 467
Q ss_pred EEEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 229 LVLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
+++||+++|+|.+++... .+++.||+||| +.+|+||||||+||++++++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999887642 13788999999 78999999999999999999999999999987643
Q ss_pred CCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 296 EDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
...........++..|+| +|||||||++|||+| |+.||....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 222111122233455654 899999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=226.53 Aligned_cols=175 Identities=26% Similarity=0.340 Sum_probs=145.3
Q ss_pred CCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||.||+++. .++..+|||.+..... .....+.+|+++++.++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999985 4788999998864322 23357888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 232 EYMPRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
||+++++|.+++... .+++.|++||| +.+++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999887521 13788999999 88999999999999999999999999999877643
Q ss_pred CCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 296 EDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
... ......++..|+| +||||||++++||++|..||..
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 208 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccc
Confidence 221 1122345666655 7999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=225.60 Aligned_cols=169 Identities=27% Similarity=0.463 Sum_probs=133.4
Q ss_pred cccccCCcceEEEeEecC-Cc--eEEEEeeeecc-CccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQD-RM--EFSVKGFHLQC-SGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
+.||+|+||.||+|+..+ +. .+++|.+.... ....+.+..|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999754 33 46788776332 23345788899999999 799999999999999999999999999
Q ss_pred CCHHHHHhch----------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecC
Q 038351 237 GSLEKCLYSS----------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFG 288 (348)
Q Consensus 237 gsL~~~l~~~----------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfG 288 (348)
|+|.++++.. .+++.|++||| +.+++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 9999988632 12778999999 7899999999999999999999999999
Q ss_pred CccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 289 IAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 289 la~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
+++...... .......+..|+| +|||||||+++||+| |+.||...
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 215 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 986432110 0111112233443 899999999999997 99999654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=237.63 Aligned_cols=182 Identities=26% Similarity=0.393 Sum_probs=153.8
Q ss_pred hhHHhhh-CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEec
Q 038351 149 LELCRVT-NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSN 223 (348)
Q Consensus 149 ~~~~~~~-~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 223 (348)
.|....+ +.|+.-++||+|+||.||-+..+ +|+-+|.|++.+.. .....-...|-++|.+++.+.||.+--.|.+
T Consensus 177 lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT 256 (591)
T KOG0986|consen 177 LELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET 256 (591)
T ss_pred HHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence 3444444 56788899999999999999865 68888988885432 2334557789999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCC
Q 038351 224 EDFKVLVLEYMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGI 289 (348)
Q Consensus 224 ~~~~~lV~Ey~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGl 289 (348)
.+..++|+..|.||+|.-+|.+.. .|+.||++|| ..+||+||+||+|||+|+.|+++|+|+|+
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGL 333 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGL 333 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccce
Confidence 999999999999999988776543 2778999999 89999999999999999999999999999
Q ss_pred ccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 290 AKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 290 a~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
|..+...... ....||.|||| .|.||+||++|||+.|+.||..-
T Consensus 334 Avei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 334 AVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred EEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 9988654432 34589999999 89999999999999999999764
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=225.69 Aligned_cols=174 Identities=30% Similarity=0.436 Sum_probs=142.4
Q ss_pred CccccccccCCcceEEEeEec-CCceEEEEeeeeccCccc--hhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 158 FSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAF--KSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
|+..+.||+|+||+||+++.. ++..+|+|.+........ ....+|+.++++++||||+++++++...+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999976 456899999976543221 23355999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeee
Q 038351 235 PRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302 (348)
Q Consensus 235 ~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 302 (348)
++++|.+++... .+++.||++|| +.+|+|+||||+||+++.++.++|+|||.+....... ...
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN--ENF 155 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--SEB
T ss_pred ccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc--ccc
Confidence 999999988721 13888999999 7799999999999999999999999999997641111 122
Q ss_pred cccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 303 TQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 303 ~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....++..|+| +||||+|++++||++|+.||...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 33445555554 99999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=228.48 Aligned_cols=176 Identities=26% Similarity=0.304 Sum_probs=145.3
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
++|+..+.||+|+||+||++... +++.+|+|.+..... ...+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46778899999999999999865 678899998765432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 234 MPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 234 ~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+++++|.+++.... +++.|+.|||. ..+++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---- 158 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---- 158 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc----
Confidence 99999998876531 37789999994 2479999999999999999999999999987543211
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
.....|+..|+| +|||||||+++||+||+.||+...
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 122345556654 899999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=232.73 Aligned_cols=174 Identities=20% Similarity=0.246 Sum_probs=136.3
Q ss_pred cccccccC--CcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 160 EDNLISRG--GFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 160 ~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
..++||+| +|++||+++.+ ++..||+|.+..... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 34789999 68899999864 788999999865432 22356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 235 PRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 235 ~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999887531 13788999999 7889999999999999999999999998654432111000
Q ss_pred -----eecccccccCccc--------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 301 -----IQTQTLATIGYMA--------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 301 -----~~~~~~gt~~y~a--------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......++..|+| +|||||||+++||+||+.||+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0011122233333 89999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=229.37 Aligned_cols=175 Identities=24% Similarity=0.328 Sum_probs=144.3
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
.|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+..|++++++++||||+++++++..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4566788999999999999865 57789999876432 233457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeec
Q 038351 235 PRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303 (348)
Q Consensus 235 ~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 303 (348)
++++|.+++... .+++.|+.||| +.+++|+||+|+||++++++.++++|||+++.+..... ...
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~ 159 (277)
T cd06642 85 GGGSALDLLKPGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRN 159 (277)
T ss_pred CCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch--hhh
Confidence 999999887543 23788999999 78999999999999999999999999999987643221 112
Q ss_pred ccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 304 QTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 304 ~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...++..|+| +|||||||+++||+||+.||...
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc
Confidence 2345555654 89999999999999999998653
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=226.01 Aligned_cols=176 Identities=24% Similarity=0.330 Sum_probs=145.3
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
..|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+++++++.||||+++++.+..++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35677789999999999999875 57889999886443 23346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhchh-----------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeee
Q 038351 234 MPRGSLEKCLYSSN-----------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302 (348)
Q Consensus 234 ~~~gsL~~~l~~~~-----------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 302 (348)
+++++|.+++.... +++.|++||| +.+++|+||+|+||+++.++.++++|||++........ ..
T Consensus 84 ~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 158 (277)
T cd06640 84 LGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KR 158 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--cc
Confidence 99999999876422 3778999999 78999999999999999999999999999977643221 11
Q ss_pred cccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 303 TQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 303 ~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....++..|+| +|||||||++|||+||+.||...
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 12234444444 89999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=231.25 Aligned_cols=173 Identities=24% Similarity=0.302 Sum_probs=144.6
Q ss_pred CccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 158 FSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
|+....||+|+||.||++... ++..||+|.+........+.+.+|+.+++.++|||++++++++..++..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 444567999999999999865 6889999998765544556788999999999999999999999999999999999999
Q ss_pred CCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeeccc
Q 038351 237 GSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT 305 (348)
Q Consensus 237 gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~ 305 (348)
++|.+++... .+++.||+||| +.+++||||||+||+++.++.++|+|||+++....... .....
T Consensus 103 ~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~ 177 (297)
T cd06659 103 GALTDIVSQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSL 177 (297)
T ss_pred CCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccce
Confidence 9998877542 23788999999 78899999999999999999999999999876543211 11234
Q ss_pred ccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 306 LATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 306 ~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.++..|+| +|||||||+++||++|+.||..
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 219 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS 219 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 46666765 8999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=223.16 Aligned_cols=171 Identities=29% Similarity=0.440 Sum_probs=142.6
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
++|...+.||+|+||.||+|... ++.||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46788899999999999999876 67899999875533 45678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 236 RGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 236 ~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+++|.++++... +++.|+.||| +.+++||||||+||+++.++.++|+|||.++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 999999886432 3788999999 88999999999999999999999999999987632211
Q ss_pred ecccccccCcc------------ccccHHHHHHHHHHHc-CCCCCccc
Q 038351 302 QTQTLATIGYM------------ASYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~------------asDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
....+..|+ ++||||||++++||++ |+.||...
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 111122232 2899999999999997 99998654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=222.39 Aligned_cols=178 Identities=26% Similarity=0.343 Sum_probs=148.1
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
++|+..+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+++++.++|+|++++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999864 67789999886432 22456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch---------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 234 MPRGSLEKCLYSS---------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 234 ~~~gsL~~~l~~~---------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
+++++|.+.+... .+++.|++||| +.+|+||||||+||++++++.++++|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999988542 13788999999 88999999999999999999999999999987654322
Q ss_pred ee--eecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FM--IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~--~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.. ......++..|++ +|||||||+++||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 21 1223345666654 79999999999999999999764
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=222.35 Aligned_cols=177 Identities=25% Similarity=0.381 Sum_probs=143.5
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
.+|+..+.||+|+||.||++...++..+|+|.+.... .....+..|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3677789999999999999998778889999886432 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeee
Q 038351 236 RGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302 (348)
Q Consensus 236 ~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 302 (348)
+++|.+++.... +++.|++||| +.+++||||||+||+++.++.++|+|||+++....... ...
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc-ccc
Confidence 999998886421 2677899999 77899999999999999999999999999876533211 111
Q ss_pred cccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 303 TQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 303 ~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
....++.+|+| +|||||||++|||++ |+.||+...
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 206 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 11222334443 899999999999998 999987543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=225.08 Aligned_cols=175 Identities=25% Similarity=0.377 Sum_probs=144.7
Q ss_pred CCccccccccCCcceEEEeEe-cCCceEEEEeeeecc-CccchhhHHHhhhccccc---ccceeeEEEEEecCCeEEEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQC-SGAFKSFDFECDVMKSTC---YRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~ 231 (348)
.|+..+.||+|+||.||+|.. .++..+|+|.+.... ....+.+.+|++++++++ |||++++++++...+..++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999996 478899999886542 233466888999999887 999999999999999999999
Q ss_pred eccCCCCHHHHHhchh-----------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 232 EYMPRGSLEKCLYSSN-----------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~-----------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
||+++++|.+++.... +++.|++||| +.+|+|+||+|+||++++++.++++|||++........
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-- 156 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--
Confidence 9999999998876531 3778999999 88999999999999999999999999999987643321
Q ss_pred eecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 301 IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......|+..|+| +|||||||++|||++|+.||+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence 1122345555543 89999999999999999999654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=222.51 Aligned_cols=188 Identities=21% Similarity=0.291 Sum_probs=153.8
Q ss_pred hhCCCccccccccCCcceEEEeE-ecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecC-----CeE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNE-----DFK 227 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 227 (348)
-.++|...+.+|+|||+.||.++ ..++..+|+|++.-....+.+...+|++..++++|||+++++++...+ .+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34689999999999999999998 567889999999776666778899999999999999999999887543 458
Q ss_pred EEEEeccCCCCHHHHHhchh----------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcc
Q 038351 228 VLVLEYMPRGSLEKCLYSSN----------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~~----------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~ 291 (348)
||+++|...|+|.+.+.... ++.+||++||.. .++..||||||.|||+.+++.+++.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999998876432 388899999944 4469999999999999999999999999987
Q ss_pred ccccCC-------ceeeecccccccCccc---------------cccHHHHHHHHHHHcCCCCCccccccchh
Q 038351 292 LLIRED-------HFMIQTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTNKIFFSQRN 342 (348)
Q Consensus 292 ~~~~~~-------~~~~~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~~~~~~~~~ 342 (348)
...-.- .........-|+.|.| +|||||||++|+|+.|..||+.++..|.+
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS 250 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS 250 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence 652110 0011123345677776 89999999999999999999998876543
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=231.93 Aligned_cols=174 Identities=24% Similarity=0.295 Sum_probs=144.3
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
.|.....||+|+||.||++... ++..||+|.+........+.+.+|+.++++++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444567999999999999864 678999999865544455678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecc
Q 038351 236 RGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304 (348)
Q Consensus 236 ~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 304 (348)
+++|.+++... .+++.|++||| +.+|+||||||+||++++++.++|+|||++........ ....
T Consensus 103 ~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~ 177 (292)
T cd06658 103 GGALTDIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKS 177 (292)
T ss_pred CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCce
Confidence 99999887542 23788999999 77899999999999999999999999999876532221 1123
Q ss_pred cccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 305 TLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 305 ~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
..++..|+| +|||||||++|||++|+.||..
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 220 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 346666665 8999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=227.24 Aligned_cols=175 Identities=22% Similarity=0.385 Sum_probs=140.0
Q ss_pred CCCccccccccCCcceEEEeEe-----cCCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecC--CeE
Q 038351 156 NGFSEDNLISRGGFGSIHKARI-----QDRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNE--DFK 227 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 227 (348)
..|...+.||+|+||.||+++. .++..||+|.+..... ...+.+.+|++++++++|||++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467788999999999999974 3577899999864432 2346788999999999999999999998875 568
Q ss_pred EEEEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 228 VLVLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
++||||+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++.++|+|||+++.+.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999999988542 13788999999 8899999999999999999999999999998764
Q ss_pred cCCce-eeecccccccCccc------------cccHHHHHHHHHHHcCCCCC
Q 038351 295 REDHF-MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPT 333 (348)
Q Consensus 295 ~~~~~-~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~ 333 (348)
..... .......++..|+| +|||||||++|||+|++.|.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 32221 11112233444443 99999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=229.56 Aligned_cols=175 Identities=24% Similarity=0.301 Sum_probs=142.2
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
++|+..+.||+|+||.||+|..+ +++.+|+|.+..... ...+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46788899999999999999976 588999998754322 234568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 233 YMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 233 y~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
|+++++|.++.... .+++.||+||| +.+++|||++|+||++++++.++|+|||++.........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~- 156 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV- 156 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc-
Confidence 99999888776432 24889999999 778999999999999999999999999998865432211
Q ss_pred eecccccccCcc-------------ccccHHHHHHHHHHHcCCCCCcc
Q 038351 301 IQTQTLATIGYM-------------ASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 301 ~~~~~~gt~~y~-------------asDV~S~Gvvl~elltG~~P~~~ 335 (348)
.....++..|+ ++|||||||+++||++|++||..
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 157 -YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred -cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 11122333333 38999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=225.69 Aligned_cols=184 Identities=22% Similarity=0.239 Sum_probs=145.8
Q ss_pred chhhHHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccc-cccceeeEEEEEecC
Q 038351 147 SCLELCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKST-CYRNLIKIISSRSNE 224 (348)
Q Consensus 147 ~~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 224 (348)
.+.++..++++|...+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 34667778899999999999999999999874 67889999885432 2235677899999988 799999999998754
Q ss_pred -----CeEEEEEeccCCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEE
Q 038351 225 -----DFKVLVLEYMPRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTH 283 (348)
Q Consensus 225 -----~~~~lV~Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~k 283 (348)
+..++||||+++++|.++++.. .+++.||+||| +.+|+||||||+||++++++.++
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEE
Confidence 3589999999999999877521 12678999999 78999999999999999999999
Q ss_pred EeecCCccccccCCceeeecccccccCc-----------------cccccHHHHHHHHHHHcCCCCCccc
Q 038351 284 LSDFGIAKLLIREDHFMIQTQTLATIGY-----------------MASYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 284 l~DfGla~~~~~~~~~~~~~~~~gt~~y-----------------~asDV~S~Gvvl~elltG~~P~~~~ 336 (348)
|+|||+++........ .....++..| .++|||||||++|||++|+.||...
T Consensus 169 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 169 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred Eeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 9999998865422110 0111233333 2389999999999999999998654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=223.12 Aligned_cols=171 Identities=27% Similarity=0.454 Sum_probs=132.7
Q ss_pred cccccCCcceEEEeEec----CCceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEe-cCCeEEEEEeccC
Q 038351 162 NLISRGGFGSIHKARIQ----DRMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRS-NEDFKVLVLEYMP 235 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lV~Ey~~ 235 (348)
+.||+|+||.||+|... +...+|+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 34578999875332 233467888999999999999999999876 4556899999999
Q ss_pred CCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee--
Q 038351 236 RGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM-- 300 (348)
Q Consensus 236 ~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~-- 300 (348)
+|+|.+++... .+++.|++||| +.+++||||||+||++++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999987542 14888999999 7899999999999999999999999999998654321110
Q ss_pred eecccccccCccc------------cccHHHHHHHHHHHcC-CCCCcc
Q 038351 301 IQTQTLATIGYMA------------SYVYSFGIMLLEVFTR-KKPTNK 335 (348)
Q Consensus 301 ~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG-~~P~~~ 335 (348)
......++..|+| +|||||||++|||++| .+||..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 205 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 0112223444554 8999999999999995 566653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=245.76 Aligned_cols=169 Identities=27% Similarity=0.315 Sum_probs=143.5
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
-|+..+.||.|+||.||.|+.. +...||||++.-..+ ..+.++..|+..|.+++|||+|.+.|+|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3666788999999999999964 677899999964433 345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 233 YMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 233 y~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||-| +-.+++.... ++.+||+||| +.+.||||||+-|||+.+.|.+|++|||.|....+.
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 9954 5555543321 2567899999 888999999999999999999999999999876543
Q ss_pred eeecccccccCccc---------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 300 MIQTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 300 ~~~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.++.|||.||| +||||+|+...||.-+++|.-.
T Consensus 180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn 227 (948)
T KOG0577|consen 180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 227 (948)
T ss_pred ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC
Confidence 56889999998 8999999999999999999643
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=229.35 Aligned_cols=178 Identities=26% Similarity=0.346 Sum_probs=146.9
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc---cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG---AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||.||+|... ++..+|+|.+...... ..+.+..|++++++++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999876 4889999998654322 3456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 232 EYMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
||+++++|.+++... .+++.||+||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999988642 23788999999 7899999999999999999999999999987653211
Q ss_pred ce---------------------------eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HF---------------------------MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~---------------------------~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.. .......||..|+| +|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 10 00112346667766 79999999999999999999644
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=223.30 Aligned_cols=175 Identities=25% Similarity=0.424 Sum_probs=142.7
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
.+|...+.||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++|+||+++++.+.. ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 4678889999999999999998888889999876432 234678899999999999999999999887 77899999999
Q ss_pred CCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 236 RGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 236 ~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+++|.+++... .+++.||+||| +.+++||||||+||+++.++.++|+|||.+........ ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 159 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TA 159 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-cc
Confidence 99999988642 13788999999 78899999999999999999999999999976543221 11
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.....++..|+| +|||||||++|||+| |+.||...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 111223334543 899999999999999 99998754
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=227.81 Aligned_cols=177 Identities=26% Similarity=0.329 Sum_probs=147.4
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
..+|...+.||+|+||.||++... ++..+|+|.+........+.+..|+.++++++|||++++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 357888899999999999999854 6788999998655444456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeee
Q 038351 234 MPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302 (348)
Q Consensus 234 ~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 302 (348)
+++++|.+++... .+++.|+.||| +.+++|||+||+||+++.++.++|+|||++......... .
T Consensus 98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~--~ 172 (293)
T cd06647 98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--R 172 (293)
T ss_pred CCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc--c
Confidence 9999999887643 13778999999 889999999999999999999999999998765432211 1
Q ss_pred cccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 303 TQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 303 ~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....+++.|++ +|||||||++|||++|+.||...
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~ 218 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22345555554 89999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=223.83 Aligned_cols=167 Identities=23% Similarity=0.350 Sum_probs=132.0
Q ss_pred ccccCCcceEEEeEec-CCceEEEEeeeeccCc---cchhhHHHhhh---cccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 163 LISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG---AFKSFDFECDV---MKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 163 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~---l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
+||+|+||.||+++.. +++.+|+|.+...... ....+..|..+ +...+|||++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 6789999988643221 11233444433 334479999999999999999999999999
Q ss_pred CCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeec
Q 038351 236 RGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303 (348)
Q Consensus 236 ~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 303 (348)
+|+|.+++... .+++.||+||| +.+|+||||||+||++++++.++++|||++....... ..
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~ 153 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PH 153 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----cc
Confidence 99999887643 23788999999 7889999999999999999999999999987543211 12
Q ss_pred ccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 304 QTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 304 ~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...|+..|+| +|||||||+++||+||+.||...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 2345666654 79999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=222.69 Aligned_cols=178 Identities=24% Similarity=0.320 Sum_probs=143.5
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc-----CccchhhHHHhhhcccccccceeeEEEEEecC--CeE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC-----SGAFKSFDFECDVMKSTCYRNLIKIISSRSNE--DFK 227 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 227 (348)
.+|+..+.||+|+||.||+|+.. ++..+|+|.+.... ......+.+|++++++++|+||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999864 68899999875321 12335688899999999999999999998764 468
Q ss_pred EEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 228 VLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
++|+||+++++|.+++... .+++.|++||| +.+++|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 8999999999999887542 24888999999 78899999999999999999999999999986532
Q ss_pred CCc-eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 296 EDH-FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 296 ~~~-~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
... ........++..|+| +|||||||+++||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 110 001122345666655 89999999999999999999653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=221.54 Aligned_cols=170 Identities=29% Similarity=0.420 Sum_probs=138.0
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEe-cCCeEEEEEecc
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRS-NEDFKVLVLEYM 234 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lV~Ey~ 234 (348)
.+|...+.||+|+||.||++... +..+|+|..... ...+.+..|+.++++++|+|++++++++. .++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 36778899999999999999765 667899987533 23467889999999999999999999764 456789999999
Q ss_pred CCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 235 PRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 235 ~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
++++|.++++... +++.||+||| +.+++||||||+||++++++.+|++|||+++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-- 157 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccCC--
Confidence 9999999876421 3788999999 78999999999999999999999999999876532211
Q ss_pred eecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 301 IQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
....+..|+| +|||||||++|||++ |+.||...
T Consensus 158 ---~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~ 203 (256)
T cd05082 158 ---TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred ---CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1122233443 899999999999997 99998653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=221.20 Aligned_cols=171 Identities=28% Similarity=0.410 Sum_probs=135.6
Q ss_pred cccccCCcceEEEeEecC----CceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQD----RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
+.||+|+||.||+|+... ...+|+|.+..... ...+.+..|++++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997532 26899998865433 23467889999999999999999999876 4567999999999
Q ss_pred CCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee-eec
Q 038351 237 GSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM-IQT 303 (348)
Q Consensus 237 gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~-~~~ 303 (348)
|+|.+++.... +++.|++||| ..+++||||||+||+++.++.+||+|||+++......... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 99999886432 3788999999 7789999999999999999999999999998764332211 111
Q ss_pred ccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 304 QTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 304 ~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
...++..|+| +|||||||++|||++ |+.||+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence 1112234544 899999999999998 99999764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=225.26 Aligned_cols=175 Identities=22% Similarity=0.303 Sum_probs=147.7
Q ss_pred ccccccCCcceEEEeE-ecCCceEEEEeeeeccCccchhhHHHhhhccccc-ccceeeEEEEEecCCeEEEEEeccCCCC
Q 038351 161 DNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKVLVLEYMPRGS 238 (348)
Q Consensus 161 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gs 238 (348)
.++||+|+++.|-.++ +.++.++|||++.++.........+|++++.+.+ |+||++++++|+++...|||||-|.+|+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 3689999999999987 7799999999998876667788999999999997 9999999999999999999999999999
Q ss_pred HHHHHhchhH------------HHHHHHHHHhcCCCceEecCCCcCceEEcCCC---cEEEeecCCccccccCCcee---
Q 038351 239 LEKCLYSSNY------------VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI---VTHLSDFGIAKLLIREDHFM--- 300 (348)
Q Consensus 239 L~~~l~~~~~------------i~~~L~yLH~~~~~~iiHrDik~~NILld~~~---~~kl~DfGla~~~~~~~~~~--- 300 (348)
|..+|..+.. |+.||.||| .++|.|||+||+|||-.+.. -+||+||.+...+.-.....
T Consensus 163 lLshI~~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 163 LLSHIQKRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred HHHHHHHhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 9998876542 889999999 99999999999999986543 36999999886543222111
Q ss_pred --eecccccccCccc-----------------cccHHHHHHHHHHHcCCCCCccccc
Q 038351 301 --IQTQTLATIGYMA-----------------SYVYSFGIMLLEVFTRKKPTNKIFF 338 (348)
Q Consensus 301 --~~~~~~gt~~y~a-----------------sDV~S~Gvvl~elltG~~P~~~~~~ 338 (348)
...+.+|+..||| .|.||+|||+|-|++|.+||...-+
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 1123457778998 7899999999999999999977544
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=224.71 Aligned_cols=172 Identities=26% Similarity=0.430 Sum_probs=137.1
Q ss_pred cccccCCcceEEEeEecC-------CceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 162 NLISRGGFGSIHKARIQD-------RMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+.||+|+||.||+|+..+ +..+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999998643 2578899875432 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch-------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC-----cEEEeecCC
Q 038351 234 MPRGSLEKCLYSS-------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI-----VTHLSDFGI 289 (348)
Q Consensus 234 ~~~gsL~~~l~~~-------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~-----~~kl~DfGl 289 (348)
+++++|.+++... .+++.|++||| +.+++|+||||+||+++.+. .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999988631 13778999999 78899999999999999877 899999999
Q ss_pred ccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 290 AKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 290 a~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
++...............++..|+| +|||||||++|||+| |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 976543222111112223445554 899999999999998 99998653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=225.76 Aligned_cols=175 Identities=24% Similarity=0.322 Sum_probs=142.4
Q ss_pred CCccccccccCCcceEEEeEe----cCCceEEEEeeeeccC----ccchhhHHHhhhcccc-cccceeeEEEEEecCCeE
Q 038351 157 GFSEDNLISRGGFGSIHKARI----QDRMEFSVKGFHLQCS----GAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFK 227 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 227 (348)
+|+..+.||+|+||.||+++. .++..||+|.+..... ...+.+..|++++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999985 3688899999864321 2235678899999999 589999999999999999
Q ss_pred EEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 228 VLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
++||||+++++|.+++.... +++.||+||| +.+++||||||+||+++.++.++|+|||+++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 99999999999999875422 3788999999 78999999999999999999999999999987543
Q ss_pred CCceeeecccccccCccc--------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 296 EDHFMIQTQTLATIGYMA--------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a--------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
... .......|+..|+| +||||||+++|||+||+.||..
T Consensus 158 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 158 DEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 211 11112334555543 8999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=221.65 Aligned_cols=177 Identities=28% Similarity=0.365 Sum_probs=148.5
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
++|+..+.||+|++|.||+|... +++.+++|.+..... ...+.+.+|++.+.+++|+|++++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888899999999999999977 588999999865543 3356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch------------hHHHHHHHHHHhcCC-CceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 234 MPRGSLEKCLYSS------------NYVGFALEYLHFDYS-VLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 234 ~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~-~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
+++++|.+++... .+++.|++||| + .+++||||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 9999999998642 13788999999 7 899999999999999999999999999998764322211
Q ss_pred eecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 301 IQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 301 ~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
....++..|+| +||||||+++|||+||+.||....
T Consensus 158 --~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 158 --NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred --cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 12234555544 899999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=237.11 Aligned_cols=176 Identities=23% Similarity=0.359 Sum_probs=154.0
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeec--cCccchhhHHHhhhccccc-ccceeeEEEEEecCCeEEEEEe
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQ--CSGAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E 232 (348)
..|+..+.||+||.+.||++...+...+|+|++... +.+....|..|+..|.+++ |.+||++++|-..++..|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 468888999999999999999998889999887533 3345678999999999997 9999999999999999999999
Q ss_pred ccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 233 YMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 233 y~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|= ..+|..+|+.. .++.+|+.++| ..+|||.|+||.|+|+- +|..||+|||+|+.+..+...
T Consensus 441 ~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred cc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence 75 45888887653 24778888888 88999999999999986 468999999999999887777
Q ss_pred eeecccccccCccc-----------------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA-----------------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a-----------------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......+||+.||+ +||||+|||||+|+.|++||...
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~ 575 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI 575 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence 77778899999997 89999999999999999999764
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=224.85 Aligned_cols=177 Identities=24% Similarity=0.369 Sum_probs=140.1
Q ss_pred CCCccccccccCCcceEEEeEecC----CceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQD----RMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
++|...+.||+|+||.||+|...+ ...||+|...... ....+.+.+|++++++++||||+++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 357778999999999999998643 3468889876543 2334678899999999999999999998875 457899
Q ss_pred EeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 231 LEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
|||+++|+|.+++... .+++.||+||| +.+++||||||+||+++.++.++++|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999988642 13788999999 7899999999999999999999999999998764332
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
... .....++..|+| +|||||||+++||++ |+.||....
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 162 YYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred cee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 111 111122334443 899999999999986 999996653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=226.48 Aligned_cols=173 Identities=25% Similarity=0.329 Sum_probs=140.9
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc-----cchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG-----AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
+|+..+.||+|+||.||+|... +++.||+|.+...... ....+..|++++++++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677889999999999999865 6889999999654322 234567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 231 LEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
|||+ +|+|.+++.... +++.||+||| +.+|+|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 899999886533 3888999999 7899999999999999999999999999998764322
Q ss_pred ceeeecccccccCcc-------------ccccHHHHHHHHHHHcCCCCCcc
Q 038351 298 HFMIQTQTLATIGYM-------------ASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~-------------asDV~S~Gvvl~elltG~~P~~~ 335 (348)
... ....+++.|+ ++|||||||+++||++|.+||..
T Consensus 157 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 157 RKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred ccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence 110 1112222332 39999999999999999888754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=224.43 Aligned_cols=174 Identities=23% Similarity=0.331 Sum_probs=142.9
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+|+..+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999975 68899999987543 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 234 MPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 234 ~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
+ +++|.+++... .+++.||+||| +.+++|+||||+||+++.++.++++|||++........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 9 99999887542 23788999999 78999999999999999999999999999987643321 0
Q ss_pred eecccccccCcc-------------ccccHHHHHHHHHHHcCCCCCcc
Q 038351 301 IQTQTLATIGYM-------------ASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 301 ~~~~~~gt~~y~-------------asDV~S~Gvvl~elltG~~P~~~ 335 (348)
......++..|+ ++||||+||+++||+||++||..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence 111223444443 39999999999999999888754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=224.99 Aligned_cols=178 Identities=26% Similarity=0.411 Sum_probs=142.2
Q ss_pred CCccccccccCCcceEEEeEec-----CCceEEEEeeeeccCc-cchhhHHHhhhcccccccceeeEEEEEec--CCeEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-----DRMEFSVKGFHLQCSG-AFKSFDFECDVMKSTCYRNLIKIISSRSN--EDFKV 228 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~ 228 (348)
.|+..+.||+|+||.||+++.. ++..+|+|.+...... ..+.+..|++++++++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4667789999999999999854 3678999998754432 35679999999999999999999999887 56789
Q ss_pred EEEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 229 LVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
+||||+++++|.+++.... +++.||+||| +.+++||||||+||+++.++.++++|||++.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 9999999999999886432 3788999999 78999999999999999999999999999987653
Q ss_pred CCceee-ecccccccCcc------------ccccHHHHHHHHHHHcCCCCCcccc
Q 038351 296 EDHFMI-QTQTLATIGYM------------ASYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 296 ~~~~~~-~~~~~gt~~y~------------asDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
...... .....++..|+ ++||||||++++||+||+.|+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 221111 11111122232 3899999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=220.78 Aligned_cols=170 Identities=21% Similarity=0.292 Sum_probs=132.5
Q ss_pred cccccCCcceEEEeEecCCc-----------eEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 162 NLISRGGFGSIHKARIQDRM-----------EFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999976433 4677776543322 5778999999999999999999999988 778999
Q ss_pred EeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCC-------cEEEeecCCc
Q 038351 231 LEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI-------VTHLSDFGIA 290 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~-------~~kl~DfGla 290 (348)
|||+++|+|.+++.... +++.||+||| +.+|+||||||+||+++.++ .++++|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999886432 4788999999 88999999999999999887 7999999999
Q ss_pred cccccCCc------eeeecccccc--cCccccccHHHHHHHHHHHc-CCCCCccc
Q 038351 291 KLLIREDH------FMIQTQTLAT--IGYMASYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 291 ~~~~~~~~------~~~~~~~~gt--~~y~asDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
+....... +..++...+. ..-.++|||||||+++||++ |..||...
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 156 ITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred cccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 87543111 1111111111 11123899999999999999 57887665
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=234.39 Aligned_cols=178 Identities=21% Similarity=0.302 Sum_probs=151.7
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc--cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG--AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
..=|+..+.||+|-|..|-.|++- +|..||||.+.+..-. ....+.+|++.|+.++|||||++|++.......|||.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 345778899999999999999865 7899999999755332 3356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEc-CCCcEEEeecCCccccccCC
Q 038351 232 EYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFD-DNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld-~~~~~kl~DfGla~~~~~~~ 297 (348)
|.=.+|+|++++.... +|..|+.|+| +..+||||+||+||.+- .-|-+|+.|||++..+.+..
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 9999999999987542 3778999999 66699999999999875 56889999999998887654
Q ss_pred ceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccccc
Q 038351 298 HFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKIFF 338 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~~~ 338 (348)
. .++.+|+..|-| .||||+|||||.|+.|++||++.-.
T Consensus 174 k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND 224 (864)
T KOG4717|consen 174 K---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND 224 (864)
T ss_pred h---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc
Confidence 3 256788888876 8999999999999999999987544
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=226.98 Aligned_cols=177 Identities=23% Similarity=0.323 Sum_probs=140.9
Q ss_pred CCccccccccCCcceEEEeEec---CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecC--CeEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ---DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNE--DFKV 228 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 228 (348)
.|+..+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|++++++++||||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677789999999999999975 47899999987532 33346678899999999999999999999988 8899
Q ss_pred EEEeccCCCCHHHHHhch-----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC----CCcEEEeec
Q 038351 229 LVLEYMPRGSLEKCLYSS-----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD----NIVTHLSDF 287 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~-----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~----~~~~kl~Df 287 (348)
+||||+++ ++.+.+... .+++.|++||| +.+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 666554311 23788999999 888999999999999999 999999999
Q ss_pred CCccccccCCc-eeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 288 GIAKLLIREDH-FMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 288 Gla~~~~~~~~-~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
|+++....... ........++..|+| +|||||||+++||++|+.||....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99987643221 111122334555544 899999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=223.78 Aligned_cols=175 Identities=29% Similarity=0.406 Sum_probs=146.8
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
+|+..+.||+|+||.||+|+.. ++..+|+|.+..... ...+.+.+|++++++++||||+++++.+...+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999976 588999999864322 335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 233 YMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 233 y~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
|+++++|.+.+... .++++||+||| +.+++|+||||+||++++++.++++|||++........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-- 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-- 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc--
Confidence 99999999888654 13888999999 78899999999999999999999999999987643321
Q ss_pred eecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 301 IQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 301 ~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
.....++..|+| +||||||+++|+|++|+.||+...
T Consensus 156 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 156 -TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred -ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 122334444544 899999999999999999998654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=224.28 Aligned_cols=177 Identities=21% Similarity=0.379 Sum_probs=141.4
Q ss_pred CCCccccccccCCcceEEEeEec------CCceEEEEeeeeccCc-cchhhHHHhhhcccccccceeeEEEEEecCCeEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQCSG-AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 228 (348)
.+|+....||+|+||.||+|+.+ +...+++|.+...... ..+.+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46788899999999999999864 3457889988654333 3467899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhchh---------------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeec
Q 038351 229 LVLEYMPRGSLEKCLYSSN---------------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDF 287 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~~---------------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~Df 287 (348)
+||||+++|+|.+++.... +++.||+||| +.+|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999886422 3788999999 788999999999999999999999999
Q ss_pred CCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 288 GIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 288 Gla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
|+++....... .......+++.|++ +|||||||+++||++ |..||...
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~ 222 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL 222 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 99875432111 11111122333332 899999999999999 88898643
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=222.46 Aligned_cols=176 Identities=26% Similarity=0.457 Sum_probs=136.3
Q ss_pred CccccccccCCcceEEEeEec----CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCC------
Q 038351 158 FSEDNLISRGGFGSIHKARIQ----DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNED------ 225 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 225 (348)
|...+.||+|+||.||+|.+. ++..+|+|.+.... ....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456789999999999999854 36789999886432 223456889999999999999999999886532
Q ss_pred eEEEEEeccCCCCHHHHHhch------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeec
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDF 287 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~Df 287 (348)
..++++||+++|+|.+++... .+++.|++||| +.+|+||||||+||++++++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 347899999999998776321 23788999999 788999999999999999999999999
Q ss_pred CCccccccCCceeeecccccccCcc------------ccccHHHHHHHHHHHc-CCCCCccc
Q 038351 288 GIAKLLIREDHFMIQTQTLATIGYM------------ASYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 288 Gla~~~~~~~~~~~~~~~~gt~~y~------------asDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
|+++...............+++.|+ ++|||||||++|||++ |++||...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~ 219 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence 9998764322111111222233343 2899999999999999 88998654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=233.81 Aligned_cols=167 Identities=19% Similarity=0.235 Sum_probs=136.5
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
...+|...+.||+|+||.||+|+.. ++..||+|.... .....|+.++++++||||+++++++...+..++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999976 567788886432 234679999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 233 YMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 233 y~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|+. ++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 212 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA- 212 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCcc-
Confidence 994 6888777532 24888999999 78999999999999999999999999999975432111
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCC
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPT 333 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~ 333 (348)
.....||..|+| +|||||||++|||+++..|+
T Consensus 213 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 213 --FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 123456777766 89999999999999865554
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=219.20 Aligned_cols=175 Identities=23% Similarity=0.391 Sum_probs=142.7
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEec-CCeEEEEEe
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSN-EDFKVLVLE 232 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~E 232 (348)
+|+..+.||+|++|.||++... +++.+|+|.+..... ...+.+..|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999865 577899999864432 234568889999999999999999998764 446899999
Q ss_pred ccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 233 YMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 233 y~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
|+++++|.++++.. .+++.|++||| +.+++||||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999887542 12778899999 88999999999999999999999999999987643221
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......+++.|+| +|||||||+++||++|+.||+..
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 1223445666655 89999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=225.53 Aligned_cols=165 Identities=24% Similarity=0.329 Sum_probs=132.3
Q ss_pred cccccCCcceEEEeEecC--------CceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 162 NLISRGGFGSIHKARIQD--------RMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+.||+|+||.||+|.... ...+|+|.+........+.+..|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999998642 234788887654444456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCc--------EEEeecCCccc
Q 038351 234 MPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIV--------THLSDFGIAKL 292 (348)
Q Consensus 234 ~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~--------~kl~DfGla~~ 292 (348)
+++|+|.++++.. .+++.||+||| +.+|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999988642 13788999999 889999999999999987765 59999999875
Q ss_pred cccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCC-CCCcc
Q 038351 293 LIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRK-KPTNK 335 (348)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~-~P~~~ 335 (348)
..... ...+++.|+| +|||||||++|||++|. .|+..
T Consensus 158 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 158 VLPKE------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred cCCch------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 53221 2233444443 89999999999999995 56543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=225.07 Aligned_cols=173 Identities=26% Similarity=0.363 Sum_probs=139.2
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+|+..+.||+|++|.||+|+.. ++..||+|.+..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999875 688999998864432 2335688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 234 MPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 234 ~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
++ ++|.+++... .+++.||+||| +.+++||||||+||++++++.+|++|||+++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 96 5888776431 13788999999 788999999999999999999999999998765322110
Q ss_pred eeecccccccCcc-------------ccccHHHHHHHHHHHcCCCCCcc
Q 038351 300 MIQTQTLATIGYM-------------ASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 300 ~~~~~~~gt~~y~-------------asDV~S~Gvvl~elltG~~P~~~ 335 (348)
.....++..|+ ++|||||||++|||+||+.||..
T Consensus 157 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 157 --YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred --cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 01112233333 28999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=219.89 Aligned_cols=177 Identities=30% Similarity=0.398 Sum_probs=146.1
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc--cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG--AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+|+..+.||+|+||.||++... ++..+++|.+...... ..+.+..|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777899999999999999865 6889999998755432 457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 234 MPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 234 ~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+++++|.+++... .+++.|++||| +.+|+|+||||+||++++++.+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 9999999988654 13788999999 78899999999999999999999999999987643222110
Q ss_pred e--cccccccCccc---------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 302 Q--TQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 302 ~--~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. ....++..|++ +||||||++++||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 0 11233444433 79999999999999999999654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=223.25 Aligned_cols=173 Identities=29% Similarity=0.383 Sum_probs=135.7
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhh-cccccccceeeEEEEEecCCeEEEEEe
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDV-MKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
++|+..+.||+|+||.||+++.. ++..||+|.+..... .....+..|+.+ ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999875 688999998865432 223445566664 666789999999999999999999999
Q ss_pred ccCCCCHHHHHhch----------------hHHHHHHHHHHhcCCC-ceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 233 YMPRGSLEKCLYSS----------------NYVGFALEYLHFDYSV-LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 233 y~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~-~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
|++ |+|.+++... .+++.||+||| +. +++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6787766431 13788999999 54 899999999999999999999999999986532
Q ss_pred CCceeeecccccccCcc----------------ccccHHHHHHHHHHHcCCCCCcc
Q 038351 296 EDHFMIQTQTLATIGYM----------------ASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~----------------asDV~S~Gvvl~elltG~~P~~~ 335 (348)
... .+...++..|+ ++|||||||++|||++|+.||+.
T Consensus 157 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 157 SVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 111 11122333333 27999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=225.58 Aligned_cols=172 Identities=24% Similarity=0.320 Sum_probs=138.7
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+|+..+.||+|+||.||+|+.. ++..+|+|.+..... .....+.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677889999999999999975 688999999864422 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 234 MPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 234 ~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
++ ++|.+.+... .++++||+||| +.+|+||||||+||+++.++.++|+|||+++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~- 155 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC- 155 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-
Confidence 97 4777766431 13888999999 789999999999999999999999999999865322111
Q ss_pred eecccccccCccc-------------cccHHHHHHHHHHHcCCCCCc
Q 038351 301 IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 301 ~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~ 334 (348)
.....++..|+| +|||||||++|||+||+.|+.
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 112233444443 899999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=219.41 Aligned_cols=174 Identities=22% Similarity=0.343 Sum_probs=144.1
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+|+..+.||+|+||.||+++.. +++.+|+|.+.... ....+++.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999864 67899999986432 22345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 234 MPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 234 ~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
+++++|.+.+... .+++.|++||| +.+++|+||+|+||+++.++.++++|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 9999999887542 13788999999 789999999999999999999999999999766432211
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.....|++.|+| +|||||||+++||+||+.||..
T Consensus 158 --~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08218 158 --ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203 (256)
T ss_pred --hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence 112334555554 8999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=224.36 Aligned_cols=175 Identities=22% Similarity=0.272 Sum_probs=141.3
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc--cchhhHHHhhhcccccccceeeEEEEEecC--CeEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG--AFKSFDFECDVMKSTCYRNLIKIISSRSNE--DFKVL 229 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 229 (348)
.++|+..+.||+|+||.||+|... +++.+|+|.++..... ....+.+|++++++++||||+++++++... +..++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 457888999999999999999976 5788999998654322 223567899999999999999999999877 88999
Q ss_pred EEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 230 VLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
||||+++ +|.+.+... .+++.||+||| +.+++||||||+||+++.++.++|+|||+++.....
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9999974 888776532 23889999999 778999999999999999999999999999876432
Q ss_pred CceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 297 DHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.. ......+++.|+| +|||||||+++||++|+.||..
T Consensus 160 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~ 209 (293)
T cd07843 160 LK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209 (293)
T ss_pred cc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 11 1111223344433 8999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=216.89 Aligned_cols=173 Identities=29% Similarity=0.498 Sum_probs=142.0
Q ss_pred ccccccccCCcceEEEeEecC-----CceEEEEeeeeccCc-cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 159 SEDNLISRGGFGSIHKARIQD-----RMEFSVKGFHLQCSG-AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 159 ~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
+..+.||+|+||.||+++..+ +..+|+|.+...... ..+.+..|++++..++|+||+++++++...+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456889999999999998764 478999998654332 45688999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 233 YMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 233 y~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
|+++++|.+++.... +++.|++||| +.+++||||||+||++++++.++++|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 999999998886422 2778899999 88999999999999999999999999999987654322
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNK 335 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~ 335 (348)
... ....+++.|+| +||||+|++++||++ |+.||+.
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred ccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 211 11224445544 899999999999998 8888865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=221.75 Aligned_cols=175 Identities=25% Similarity=0.339 Sum_probs=143.4
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
-|+..+.||+|+||.||+|... ++..+|+|...... ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667788999999999999864 67889999875432 223456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeec
Q 038351 235 PRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303 (348)
Q Consensus 235 ~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 303 (348)
++++|.+++... .+++.|++||| +.+++|+||||+||+++.++.++++|||+++.+..... ...
T Consensus 85 ~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~ 159 (277)
T cd06641 85 GGGSALDLLEPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRN 159 (277)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--hhc
Confidence 999999887642 13778899999 88999999999999999999999999999876543211 112
Q ss_pred ccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 304 QTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 304 ~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...++..|++ +|||||||+++||++|+.||...
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 2334555544 89999999999999999998653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=221.00 Aligned_cols=177 Identities=27% Similarity=0.357 Sum_probs=144.1
Q ss_pred CCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCc------cchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSG------AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
+|+..+.||+|++|.||+++. .++..+|+|.+...... ..+.+..|++++++++|+||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999985 57889999988643211 23568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC-cEEEeecCCccccccC
Q 038351 230 VLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI-VTHLSDFGIAKLLIRE 296 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DfGla~~~~~~ 296 (348)
|+||+++++|.+++... .+++.||+||| +.+++|+||||+||+++.++ .++|+|||.+..+...
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999888642 23888999999 78999999999999998775 5899999999776432
Q ss_pred Cce--eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 297 DHF--MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 297 ~~~--~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
... .......++..|+| +||||+|++++||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 211 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 110 01112345556655 89999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-30 Score=225.33 Aligned_cols=172 Identities=31% Similarity=0.362 Sum_probs=139.2
Q ss_pred CccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEEEecc
Q 038351 158 FSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
.+....||.|+||+|+|-.++ .++..|||++..... ...+++..|.+...+- ..||||+++|.+..++-.|+.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 345568999999999998765 789999999976544 3456788888865444 5899999999999999999999999
Q ss_pred CCCCHHHHHhc---hh------H--------HHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 235 PRGSLEKCLYS---SN------Y--------VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 235 ~~gsL~~~l~~---~~------~--------i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
. -++..+-+. -. . +..||.||.. ...|||||+||+|||+|..|.+|+||||++..+.+
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~-- 220 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD-- 220 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH--
Confidence 4 466543321 11 1 4579999986 56799999999999999999999999999988743
Q ss_pred ceeeecccccccCccc--------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 298 HFMIQTQTLATIGYMA--------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a--------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
+.+.+..+|...||| |||||+|+.|||+.||+.|++.
T Consensus 221 -SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 221 -SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred -HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 234456678888887 8999999999999999999875
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=222.22 Aligned_cols=174 Identities=24% Similarity=0.289 Sum_probs=144.8
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
.|...+.||+|++|.||++... ++..+++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4555679999999999999864 788899998865544445668899999999999999999999999999999999999
Q ss_pred CCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecc
Q 038351 236 RGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304 (348)
Q Consensus 236 ~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 304 (348)
+++|.+++... .+++.|++||| +.+|+||||||+||+++.++.++++|||++........ ....
T Consensus 100 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~ 174 (285)
T cd06648 100 GGALTDIVTHTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKS 174 (285)
T ss_pred CCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cccc
Confidence 99999887542 23778999999 78999999999999999999999999998876533211 1122
Q ss_pred cccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 305 TLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 305 ~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
..|+..|+| +|||||||+++||++|+.||..
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 345666665 8999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=221.82 Aligned_cols=174 Identities=30% Similarity=0.355 Sum_probs=141.1
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecC--CeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNE--DFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 231 (348)
++|...+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||++++++|... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36778899999999999999975 678899998864432 2346688999999999999999999998654 4689999
Q ss_pred eccCCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 232 EYMPRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
||+++++|.+++... .+++.||.||| +.+++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998875421 13788999999 78999999999999999999999999999876432
Q ss_pred CCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 296 EDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
... ....++..|+| +||||+||++|||+||+.||+..
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 211 12223344433 89999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=222.94 Aligned_cols=176 Identities=26% Similarity=0.309 Sum_probs=143.2
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
++|+..+.||+|+||.||+|... ++..||+|.++... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999876 57889999886432 2234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 233 YMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 233 y~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
|++++.+..+.... .+++.|++||| +.+++|||+||+||++++++.+||+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~ 156 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-S 156 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-c
Confidence 99987776655432 13888999999 78899999999999999999999999999987654321 0
Q ss_pred eecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 301 IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 301 ~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
......++..|+| +||||||+++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 1122333444443 8999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=221.42 Aligned_cols=174 Identities=28% Similarity=0.351 Sum_probs=145.2
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
++|+..+.||+|+||.||++... +++.+|+|.+..... ...+.+.+|++++++++||||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999976 678899998865432 3346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch-------------hHHHHHHHHHHhcCC-CceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 234 MPRGSLEKCLYSS-------------NYVGFALEYLHFDYS-VLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 234 ~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~-~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
+++++|.+++... .+++.|++||| + .+++|+||||+||++++++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 9999999988643 13778999999 7 8999999999999999999999999999876532211
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....++..|++ +||||||++++||++|+.||...
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 11344445544 89999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=220.94 Aligned_cols=167 Identities=25% Similarity=0.371 Sum_probs=136.5
Q ss_pred cccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCH
Q 038351 164 ISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL 239 (348)
Q Consensus 164 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 239 (348)
||+|+||+||+|... +++.+|+|.+.... ......+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 68899999886432 12234567899999999999999999999999999999999999999
Q ss_pred HHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeeccc
Q 038351 240 EKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT 305 (348)
Q Consensus 240 ~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~ 305 (348)
.+++.... +++.|+.||| +.+++||||||+||++++++.++++|||++........ ....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cccc
Confidence 98875432 3788999999 78999999999999999999999999999876542111 1122
Q ss_pred ccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 306 LATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 306 ~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.++..|++ +|||||||+++||++|+.||...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 33344443 89999999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=213.19 Aligned_cols=174 Identities=30% Similarity=0.406 Sum_probs=147.1
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
.|+..+.||+|++|.||++... ++..+++|++........+.+.+|++++++++|++++++++.+...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677789999999999999976 688899999876544455788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeee
Q 038351 236 RGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302 (348)
Q Consensus 236 ~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 302 (348)
+++|.+++... .+++.|++||| ..+++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999987654 13778999999 78999999999999999999999999999987654321 1
Q ss_pred cccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 303 TQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 303 ~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....++..|++ +||||||++++||++|+.||+..
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 22334445543 89999999999999999998764
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=220.69 Aligned_cols=174 Identities=22% Similarity=0.341 Sum_probs=140.5
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
+|+..+.||+|++|.||+|+.. ++..||+|.+..... ...+.+..|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999975 688899999865433 23456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch---------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 235 PRGSLEKCLYSS---------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 235 ~~gsL~~~l~~~---------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
++ +|.+++... .+++.||+||| +.+++||||||+||++++++.++++|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 887776432 13788999999 78899999999999999999999999999976532111
Q ss_pred eeecccccccCcc-------------ccccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYM-------------ASYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~-------------asDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......++..|+ ++|||||||+++||++|+.||...
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 204 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 001112233333 389999999999999999998754
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=216.57 Aligned_cols=174 Identities=26% Similarity=0.465 Sum_probs=142.5
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+|+..+.||+|+||.||++... ++..+|+|.+.... ....+.+..|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 67889999986442 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCC-CcEEEeecCCccccccCCc
Q 038351 234 MPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN-IVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 234 ~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DfGla~~~~~~~~ 298 (348)
+++++|.+++.... +++.+++||| +.+++|+||||+||+++++ ..++++|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999886421 3778999999 7899999999999999854 5689999999987643221
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....++..|+| +||||||++++||++|+.||+..
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 112334555544 99999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-29 Score=219.07 Aligned_cols=173 Identities=26% Similarity=0.330 Sum_probs=139.5
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeec-cCccchhhHHHhhhccccc-ccceeeEEEEEecCCeEEEEEec
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ-CSGAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+......||.|..|.|++++.+ .+..+|||.+... .....+.+...++++.+-. .|.||+.+|+|..+..+++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 3344567999999999999976 5788999999654 3344567777887766554 79999999999999999999999
Q ss_pred cCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 234 MPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 234 ~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
|.. -++++++.-. .+..||.||.+ ..+|||||+||+|||+|+.|++|+||||++..+.+. .
T Consensus 173 Ms~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---k 246 (391)
T KOG0983|consen 173 MST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---K 246 (391)
T ss_pred HHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecc---c
Confidence 843 3333333211 26678999986 568999999999999999999999999999887543 3
Q ss_pred eecccccccCccc---------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 301 IQTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 301 ~~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
+.+..+|.+.||| +||||||+.++||+||+.||..
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 4466789999998 8999999999999999999976
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=228.67 Aligned_cols=178 Identities=25% Similarity=0.305 Sum_probs=143.1
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeec--cCccchhhHHHhhhcccc-cccceeeEEEEEecC--CeE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ--CSGAFKSFDFECDVMKST-CYRNLIKIISSRSNE--DFK 227 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~--~~~ 227 (348)
..++|+..+.||+|+||.||+|... ++..+|+|++... .......+.+|+++++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4678889999999999999999976 6788999988532 222345677899999999 999999999998654 468
Q ss_pred EEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 228 VLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
++||||++ ++|...+... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 85 YLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEEecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 99999997 5888877542 23788999999 789999999999999999999999999999876433
Q ss_pred Cce---eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 297 DHF---MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 297 ~~~---~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
... .......++..|+| +|||||||++|||+||+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 211 11123345556654 8999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=219.12 Aligned_cols=178 Identities=24% Similarity=0.293 Sum_probs=144.5
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccc-cccceeeEEEEEecCC-----
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKST-CYRNLIKIISSRSNED----- 225 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~----- 225 (348)
..+++|+..+.||+|++|.||+|... ++..+++|.+..... ..+.+.+|+++++++ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45789999999999999999999975 577899998865432 346788999999999 6999999999997644
Q ss_pred -eEEEEEeccCCCCHHHHHhchh----------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecC
Q 038351 226 -FKVLVLEYMPRGSLEKCLYSSN----------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFG 288 (348)
Q Consensus 226 -~~~lV~Ey~~~gsL~~~l~~~~----------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfG 288 (348)
..++||||+++++|.+++.... +++.||+||| +.+++|+||+|+||++++++.++++|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999988775421 3788999999 8899999999999999999999999999
Q ss_pred CccccccCCceeeecccccccCccc-----------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 289 IAKLLIREDHFMIQTQTLATIGYMA-----------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 289 la~~~~~~~~~~~~~~~~gt~~y~a-----------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
++........ ......++..|+| +|||||||+++||+||+.||...
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 159 VSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred cceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 9876532211 1122334444443 79999999999999999999643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=217.57 Aligned_cols=174 Identities=23% Similarity=0.371 Sum_probs=140.0
Q ss_pred CCccccccccCCcceEEEeEecC--CceEEEEeeeeccC----------ccchhhHHHhhhccc-ccccceeeEEEEEec
Q 038351 157 GFSEDNLISRGGFGSIHKARIQD--RMEFSVKGFHLQCS----------GAFKSFDFECDVMKS-TCYRNLIKIISSRSN 223 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~ 223 (348)
+|+..+.||+|+||.||++.... +..+|+|.+..... .....+..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999765 67899998753321 122446778887764 789999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeec
Q 038351 224 EDFKVLVLEYMPRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDF 287 (348)
Q Consensus 224 ~~~~~lV~Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~Df 287 (348)
++..++||||+++++|.+++... .+++.++.|||. ..+++|+||||+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999998876321 137789999992 257999999999999999999999999
Q ss_pred CCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 288 GIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 288 Gla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
|++....... ......++..|++ +||||||+++|||++|+.||..
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~ 215 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence 9998764332 1223445666655 8999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=223.44 Aligned_cols=171 Identities=26% Similarity=0.299 Sum_probs=138.6
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
...|+..+.||+|+||.||+|+.. ++..||+|.+..... ...+.+.+|+++++.++||||++++++|...+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 346888899999999999999865 688999998854322 2235688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 231 LEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
+||++ |++.+.+... .+++.||.||| +.+|+||||+|+||++++++.++|+|||++.......
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~ 169 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN 169 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCCC
Confidence 99997 5666655321 23788999999 7889999999999999999999999999997654221
Q ss_pred ceeeecccccccCc---------------cccccHHHHHHHHHHHcCCCCCcc
Q 038351 298 HFMIQTQTLATIGY---------------MASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 298 ~~~~~~~~~gt~~y---------------~asDV~S~Gvvl~elltG~~P~~~ 335 (348)
. ..++..| .++|||||||++|||+||+.||..
T Consensus 170 ~------~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 170 S------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred C------ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 1 1222222 238999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=218.97 Aligned_cols=167 Identities=23% Similarity=0.346 Sum_probs=131.9
Q ss_pred ccccCCcceEEEeEec-CCceEEEEeeeeccCc---cchhhHHHhh---hcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 163 LISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG---AFKSFDFECD---VMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 163 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
+||+|+||.||+|+.. +++.||+|.+...... ....+..|.. .++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 5789999988654221 1122333433 4445579999999999999999999999999
Q ss_pred CCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeec
Q 038351 236 RGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303 (348)
Q Consensus 236 ~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 303 (348)
+|+|.+++.... +++.|++||| +.+|+||||||+||+++.++.++|+|||+++...... ..
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~ 153 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PH 153 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----Cc
Confidence 999988875431 3788999999 7889999999999999999999999999987653221 12
Q ss_pred ccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 304 QTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 304 ~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...|+..|+| +||||+||++|||++|+.||...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 2345555654 79999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=221.05 Aligned_cols=179 Identities=28% Similarity=0.330 Sum_probs=149.3
Q ss_pred HhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 152 CRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 152 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
...++.|+..+.||+|++|.||++..+ ++..+++|.+..... ..+.+..|++++++++|+|++++++.+...+..++|
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 345677888899999999999999977 688899999875543 456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 231 LEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
+||+++++|.+++.... +++.||+||| +.+|+|+|+||+||+++.++.++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999999987652 2788999999 7899999999999999999999999999987654321
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. ......++..|++ +|||||||++|||++|+.||...
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~ 219 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE 219 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 1 1112234444443 89999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=221.08 Aligned_cols=174 Identities=25% Similarity=0.344 Sum_probs=138.0
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
++|+..+.||+|++|.||+|+.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999875 688999998864322 223568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC-CCcEEEeecCCccccccCC
Q 038351 233 YMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD-NIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 233 y~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DfGla~~~~~~~ 297 (348)
|++ ++|.+.+... .+++.||+||| +.+++||||||+||+++. ++.+||+|||+++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 5777665321 14788999999 789999999999999985 5678999999997653211
Q ss_pred ceeeecccccccCcc-------------ccccHHHHHHHHHHHcCCCCCcc
Q 038351 298 HFMIQTQTLATIGYM-------------ASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~-------------asDV~S~Gvvl~elltG~~P~~~ 335 (348)
.. .....+++.|+ ++||||+||++|||+||+.||..
T Consensus 158 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 158 RT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred cc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 10 01112233333 39999999999999999999864
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=216.91 Aligned_cols=178 Identities=24% Similarity=0.367 Sum_probs=144.1
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEec--CCeEEEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSN--EDFKVLVL 231 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~ 231 (348)
+|+..+.||+|+||.||++... ++..+|+|.+..... ...+.+..|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4677889999999999999864 678899998864322 234567889999999999999999998764 45689999
Q ss_pred eccCCCCHHHHHhch----------------hHHHHHHHHHHhcC--CCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 232 EYMPRGSLEKCLYSS----------------NYVGFALEYLHFDY--SVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~--~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
||+++++|.+++... .+++.||+|||..+ +.+++|+||||+||++++++.+|++|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999888542 13788999999665 788999999999999999999999999999876
Q ss_pred ccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 294 IREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...... .....+++.|++ +||||||+++++|++|+.||+..
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 543221 122345555654 79999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-29 Score=233.52 Aligned_cols=168 Identities=23% Similarity=0.373 Sum_probs=142.4
Q ss_pred ccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCC
Q 038351 161 DNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRG 237 (348)
Q Consensus 161 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 237 (348)
.++||+|-||+||-|+.+ +|+.||||.+.+... ....++.+|+.+|.+++||.||.+-..|+..+.+++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 478999999999999865 799999999965432 23467889999999999999999999999999999999999 56
Q ss_pred CHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcC---CCcEEEeecCCccccccCCcee
Q 038351 238 SLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDD---NIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 238 sL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~DfGla~~~~~~~~~~ 300 (348)
++.+.+-... +|..||+||| ..+|+|+|+||+|||+.. --.+||||||+|+++.+..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--- 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--- 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence 7665554321 3677899999 789999999999999964 3468999999999986432
Q ss_pred eecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 301 IQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 301 ~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
......||+.|.| -|+||.|||+|--++|..||.+
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 3467889999998 6999999999999999999864
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=216.92 Aligned_cols=168 Identities=28% Similarity=0.406 Sum_probs=140.7
Q ss_pred cccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCH
Q 038351 164 ISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL 239 (348)
Q Consensus 164 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 239 (348)
||+|++|.||+++.. ++..+|+|.+..... ...+.+.+|++++++++||||+++++++..++..++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999976 478999999864322 2346688999999999999999999999999999999999999999
Q ss_pred HHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeeccccc
Q 038351 240 EKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA 307 (348)
Q Consensus 240 ~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~g 307 (348)
.+++.... +++.||+||| +.+++|+||||+||+++.++.++++|||+++...... ......+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~ 154 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCG 154 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccC
Confidence 99886532 3788999999 7899999999999999999999999999998765432 1122345
Q ss_pred ccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 308 TIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 308 t~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
+..|++ +|+||||+++|||++|+.||....
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 555654 799999999999999999997543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-29 Score=236.91 Aligned_cols=172 Identities=26% Similarity=0.397 Sum_probs=144.6
Q ss_pred cccccccCCcceEEEeEecC-CceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCC
Q 038351 160 EDNLISRGGFGSIHKARIQD-RMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGS 238 (348)
Q Consensus 160 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 238 (348)
-.++||-|-||.||.|.|+. ...||||.++... ...++|..|..+|+.++|||+|+++|+|..+...|||+|||.+|+
T Consensus 271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN 349 (1157)
T KOG4278|consen 271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN 349 (1157)
T ss_pred eeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence 45789999999999999874 5679999987543 456899999999999999999999999999999999999999999
Q ss_pred HHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecc
Q 038351 239 LEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304 (348)
Q Consensus 239 L~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 304 (348)
|.++|+..+ +|+.|++||. .+.+||||+-++|+|+.++..+||+|||+++++..+.. .+...
T Consensus 350 LLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY-TAHAG 425 (1157)
T KOG4278|consen 350 LLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY-TAHAG 425 (1157)
T ss_pred HHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce-ecccC
Confidence 999998753 4788999999 88999999999999999999999999999999875432 22111
Q ss_pred cccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 305 TLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 305 ~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
..-.+.|.| +|||+|||+|||+.| |..||-.+
T Consensus 426 AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi 470 (1157)
T KOG4278|consen 426 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI 470 (1157)
T ss_pred ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence 111233443 999999999999988 77788654
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=227.99 Aligned_cols=178 Identities=24% Similarity=0.311 Sum_probs=142.2
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecC-----Ce
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNE-----DF 226 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 226 (348)
.+++|+..+.||+|+||.||+|+.. ++..||+|.+.... ......+..|++++++++|+||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 4578999999999999999999864 68899999885322 22345678899999999999999999987654 35
Q ss_pred EEEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 227 KVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
.++|+||+++ ++.+.+... .+++.||+||| +.+|+||||||+||+++.++.++|+|||+++....
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 83 VYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 7999999965 887776542 24788999999 78999999999999999999999999999976543
Q ss_pred CCcee-eecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 296 EDHFM-IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 296 ~~~~~-~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
..... ......|+..|+| +|||||||++|||+||+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 22111 1122345666655 8999999999999999999954
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=222.71 Aligned_cols=179 Identities=26% Similarity=0.322 Sum_probs=141.1
Q ss_pred HhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc--cchhhHHHhhhcccccccceeeEEEEEecC--Ce
Q 038351 152 CRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG--AFKSFDFECDVMKSTCYRNLIKIISSRSNE--DF 226 (348)
Q Consensus 152 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~ 226 (348)
|+..++|+..+.||+|+||.||+|... ++..||+|.+...... ....+.+|++++++++|+||+++++++... +.
T Consensus 3 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 3 CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred cccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 345678999999999999999999975 6889999998654322 223466899999999999999999998765 56
Q ss_pred EEEEEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 227 KVLVLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
.++||||+++ +|.+++... .+++.|++||| +.+++||||||+||++++++.+||+|||+++..
T Consensus 83 ~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 8999999964 777766532 23788999999 788999999999999999999999999999876
Q ss_pred ccCCceeeecccccccCcc-------------ccccHHHHHHHHHHHcCCCCCccc
Q 038351 294 IREDHFMIQTQTLATIGYM-------------ASYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~-------------asDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....... ....++..|+ ++||||+||++|||++|+.||...
T Consensus 159 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 159 GLPAKPM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred CCccCCC--CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4321110 1111233333 389999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=221.45 Aligned_cols=178 Identities=28% Similarity=0.349 Sum_probs=140.3
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCC----
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNED---- 225 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 225 (348)
...++|+..+.||+|+||.||+|... ++..||+|.++.... .....+.+|++++++++|||++++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999976 578899999865432 23356778999999999999999999987655
Q ss_pred ------eEEEEEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEee
Q 038351 226 ------FKVLVLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSD 286 (348)
Q Consensus 226 ------~~~lV~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~D 286 (348)
..++|+||+++ ++...+... .+++.||+||| +.+|+||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999976 666655432 23788999999 78999999999999999999999999
Q ss_pred cCCccccccCCceeeecccccccCcc-------------ccccHHHHHHHHHHHcCCCCCcc
Q 038351 287 FGIAKLLIREDHFMIQTQTLATIGYM-------------ASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 287 fGla~~~~~~~~~~~~~~~~gt~~y~-------------asDV~S~Gvvl~elltG~~P~~~ 335 (348)
||+++........ ......++..|+ ++|||||||+++||++|++||+.
T Consensus 160 fg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 160 FGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred ccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999876432210 001111222232 38999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=218.21 Aligned_cols=170 Identities=29% Similarity=0.398 Sum_probs=139.6
Q ss_pred cccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCH
Q 038351 164 ISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL 239 (348)
Q Consensus 164 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 239 (348)
||+|+||.||+++.. ++..+++|.+..... ...+.+.+|++++++++||||+++++.+..++..++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 488999998864432 3446788899999999999999999999999999999999999999
Q ss_pred HHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc------eee
Q 038351 240 EKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH------FMI 301 (348)
Q Consensus 240 ~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~------~~~ 301 (348)
.+++... .+++.||+||| +.+++||||+|+||++++++.++++|||++........ ...
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 9887642 23888999999 78999999999999999999999999999876533211 001
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....++..|++ +||||||++++||+||+.||+..
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 204 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE 204 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 122334555553 89999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=222.41 Aligned_cols=170 Identities=24% Similarity=0.288 Sum_probs=141.7
Q ss_pred ccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCH
Q 038351 161 DNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL 239 (348)
Q Consensus 161 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 239 (348)
...||+|+||.||++... ++..||+|.+..........+.+|+.++++++|+|++++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 367999999999999874 7889999988654444456688999999999999999999999999999999999999999
Q ss_pred HHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecccccc
Q 038351 240 EKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLAT 308 (348)
Q Consensus 240 ~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt 308 (348)
.+++... .+++.|++||| +.+++||||||+||+++.++.++|+|||++........ ......++
T Consensus 105 ~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~ 179 (292)
T cd06657 105 TDIVTHTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGT 179 (292)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccC
Confidence 9877432 23778999999 78999999999999999999999999999876543221 11233456
Q ss_pred cCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 309 IGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 309 ~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
..|++ +|||||||+++||++|+.||..
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~ 218 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 66655 8999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=219.68 Aligned_cols=174 Identities=20% Similarity=0.290 Sum_probs=137.4
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhccccc-ccceeeEEEEEecCCe-----
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDF----- 226 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~----- 226 (348)
++|+..+.||+|+||.||+|+.. +++.||+|....... .....+.+|++++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999975 688999998764432 23456888999999996 6999999999987665
Q ss_pred EEEEEeccCCCCHHHHHhch-----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC-CCcEEEeecC
Q 038351 227 KVLVLEYMPRGSLEKCLYSS-----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD-NIVTHLSDFG 288 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~-----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DfG 288 (348)
.++||||+++ +|.+++... .+++.||+||| +.+|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 787776421 13788999999 789999999999999998 8999999999
Q ss_pred CccccccCCceeeecccccccCcc-------------ccccHHHHHHHHHHHcCCCCCcc
Q 038351 289 IAKLLIREDHFMIQTQTLATIGYM-------------ASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 289 la~~~~~~~~~~~~~~~~gt~~y~-------------asDV~S~Gvvl~elltG~~P~~~ 335 (348)
+++....... ......+++.|+ ++|||||||++|||+||+.||..
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence 9876532111 001112233333 38999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=215.32 Aligned_cols=174 Identities=25% Similarity=0.298 Sum_probs=136.4
Q ss_pred hHHhhhCCCcccccc--ccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccc-cccceeeEEEEEecCC
Q 038351 150 ELCRVTNGFSEDNLI--SRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKST-CYRNLIKIISSRSNED 225 (348)
Q Consensus 150 ~~~~~~~~f~~~~~l--G~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 225 (348)
+.....++|+..+.+ |+|+||.||+++.+ ++..+|+|.+....... . |+.....+ +|||++++++.+..++
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 444455677776666 99999999999864 67788888876432211 1 22222212 6999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCC-cEEEeecCCccc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI-VTHLSDFGIAKL 292 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DfGla~~ 292 (348)
..++||||+++++|.++++... +++.|++||| +.+++||||||+||+++.++ .++|+|||+++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 9999999999999999886541 3888999999 78899999999999999988 999999999976
Q ss_pred cccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 293 LIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
..... ...++..|+| +|||||||+++||++|+.||....
T Consensus 160 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 160 IGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred cCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 54321 2235555554 799999999999999999997543
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=241.62 Aligned_cols=173 Identities=20% Similarity=0.249 Sum_probs=133.5
Q ss_pred hhCCCccccccccCCcceEEEeEecCC--ceEEEE------------------eeeeccCccchhhHHHhhhcccccccc
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQDR--MEFSVK------------------GFHLQCSGAFKSFDFECDVMKSTCYRN 213 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~--~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~H~n 213 (348)
..++|...+.||+|+||+||++..+.. ...++| .+. ........+.+|++++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 457899999999999999999875421 111222 111 01112345788999999999999
Q ss_pred eeeEEEEEecCCeEEEEEeccCCCCHHHHHhc-----------------hhHHHHHHHHHHhcCCCceEecCCCcCceEE
Q 038351 214 LIKIISSRSNEDFKVLVLEYMPRGSLEKCLYS-----------------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLF 276 (348)
Q Consensus 214 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-----------------~~~i~~~L~yLH~~~~~~iiHrDik~~NILl 276 (348)
|+++++++...+..++|+|++. +++.+++.. ..+++.||+||| +.+|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 9999999999999999999985 466655432 124788999999 7899999999999999
Q ss_pred cCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCC
Q 038351 277 DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKP 332 (348)
Q Consensus 277 d~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P 332 (348)
+.++.+||+|||+++.+...... ......||..|+| +|||||||++|||++|+.+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999999876432221 1223567888876 8999999999999999854
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-29 Score=244.06 Aligned_cols=183 Identities=26% Similarity=0.359 Sum_probs=150.5
Q ss_pred CccccccccCCcceEEEeEe-cC----CceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 158 FSEDNLISRGGFGSIHKARI-QD----RMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~-~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
....++||+|+||+||||.+ .. +.+||+|.+.... .....++..|+-+|.+++|||+++++++|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34567899999999999975 23 3468899885443 344678999999999999999999999998876 78999
Q ss_pred eccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 232 EYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
+|||.|+|.++++..+ +||+|+.||| +.+++||||-++|||+..-..+||.|||+|+.+..+..
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999999988653 4999999999 89999999999999999999999999999999876543
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccccccchhhh
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIFFSQRNDI 344 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~~~~~~~~ 344 (348)
......-.-.+.||| +|||||||.+||++| |..|++.+..++-.++
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl 912 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL 912 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH
Confidence 222222223456776 999999999999988 9999998877654444
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=220.31 Aligned_cols=177 Identities=21% Similarity=0.233 Sum_probs=128.7
Q ss_pred CCCccccccccCCcceEEEeEecCC----ceEEEEeeeeccCccc-----------hhhHHHhhhcccccccceeeEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDR----MEFSVKGFHLQCSGAF-----------KSFDFECDVMKSTCYRNLIKIISS 220 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~~~ 220 (348)
++|...++||+|+||.||+|...+. ..+|+|.......... .....+...+..+.|++++++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5788999999999999999997643 4556664432221110 111223345567789999999987
Q ss_pred EecCC----eEEEEEeccCCCCHHHHHhc------------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEE
Q 038351 221 RSNED----FKVLVLEYMPRGSLEKCLYS------------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHL 284 (348)
Q Consensus 221 ~~~~~----~~~lV~Ey~~~gsL~~~l~~------------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl 284 (348)
+.... ..++++|++.. ++.+.+.. ..+++.||+||| +.+|+||||||+|||++.++.++|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEEE
Confidence 66543 45788887743 44444322 234888999999 789999999999999999999999
Q ss_pred eecCCccccccCCce-----eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 285 SDFGIAKLLIREDHF-----MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 285 ~DfGla~~~~~~~~~-----~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+|||+|+........ .......||+.|+| +|||||||+++||+||+.||...
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999876432211 11123468888887 89999999999999999999765
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=217.82 Aligned_cols=170 Identities=20% Similarity=0.265 Sum_probs=134.7
Q ss_pred CccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhccccc-ccceeeEEEEEecC--CeEEEEEe
Q 038351 158 FSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTC-YRNLIKIISSRSNE--DFKVLVLE 232 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~E 232 (348)
|+..+.||+|+||.||+|... ++..+|+|.+..... ........|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456788999999999999865 688999998864322 22234457888888886 99999999999987 88999999
Q ss_pred ccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 233 YMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 233 y~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|++ |++.+.+... .+++.||+||| +.+++||||||+||+++. +.+||+|||+++........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 997 5777776542 13788999999 789999999999999999 99999999999876432211
Q ss_pred eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 300 MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 300 ~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
....++..|+| +|||||||++|||++|+.||..
T Consensus 156 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~ 201 (282)
T cd07831 156 ---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG 201 (282)
T ss_pred ---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence 11223434433 9999999999999999999964
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-28 Score=217.06 Aligned_cols=169 Identities=27% Similarity=0.445 Sum_probs=136.6
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
++|...+.||+|+||.||++.. .+..+|+|...... ..+.+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3577889999999999999975 56689999885432 336788999999999999999999998765 4799999999
Q ss_pred CCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 236 RGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 236 ~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+++|.+++.... +++.|+.||| +.+++||||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~--- 155 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD--- 155 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccCC---
Confidence 999999886421 3788999999 78999999999999999999999999999876432111
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
....+..|+| +|||||||+++||++ |+.||...
T Consensus 156 --~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 156 --NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred --CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 1111222332 899999999999997 99998654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=219.25 Aligned_cols=181 Identities=24% Similarity=0.314 Sum_probs=144.0
Q ss_pred hHHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccc-cccceeeEEEEEec----
Q 038351 150 ELCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKST-CYRNLIKIISSRSN---- 223 (348)
Q Consensus 150 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~---- 223 (348)
++....+.|+..+.||+|+||.||+|+.. ++..+|+|.+.... .....+..|+.+++++ +|+||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 34456678899999999999999999874 67889999875432 2335678899999888 69999999999853
Q ss_pred --CCeEEEEEeccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeec
Q 038351 224 --EDFKVLVLEYMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDF 287 (348)
Q Consensus 224 --~~~~~lV~Ey~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~Df 287 (348)
.+..++||||+++|+|.+++... .+++.|++||| +.+|+|||+||+||++++++.++|+||
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~df 165 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDF 165 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeC
Confidence 46789999999999999887542 13788999999 789999999999999999999999999
Q ss_pred CCccccccCCceeeecccccccCccc-----------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 288 GIAKLLIREDHFMIQTQTLATIGYMA-----------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 288 Gla~~~~~~~~~~~~~~~~gt~~y~a-----------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
|++........ ......|+..|+| +|||||||++|||+||+.||...
T Consensus 166 g~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 166 GVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred cchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 99876532111 1122334444433 79999999999999999999653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=216.13 Aligned_cols=175 Identities=25% Similarity=0.348 Sum_probs=143.6
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+|+..+.||+|+||.||++... ++..+|+|.+..... ...+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777899999999999999976 578899999865421 2345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC-cEEEeecCCccccccCCc
Q 038351 234 MPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI-VTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 234 ~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DfGla~~~~~~~~ 298 (348)
+++++|.+++... .+++.|++||| +.+++|+||||+||++++++ .++++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999887542 13788999999 78899999999999999875 569999999987643222
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. .....|++.|+| +|||||||+++||++|+.||...
T Consensus 158 ~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 158 L--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred c--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1 122345555654 89999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=217.66 Aligned_cols=174 Identities=25% Similarity=0.338 Sum_probs=140.2
Q ss_pred CccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecC--CeEEEEEe
Q 038351 158 FSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNE--DFKVLVLE 232 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~E 232 (348)
|+..+.||+|+||.||+|+.. ++..+|+|.+.... ......+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456788999999999999876 57899999997653 23345688899999999999999999999988 89999999
Q ss_pred ccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 233 YMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 233 y~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|+++ +|.+++... .+++.||+||| +.+++|+||||+||++++++.++++|||++.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9975 888877543 13788999999 778999999999999999999999999999876443210
Q ss_pred eeecccccccCcc-------------ccccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYM-------------ASYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~-------------asDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......++..|+ ++||||||++++||+||+.||+..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~ 205 (287)
T cd07840 157 -DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS 205 (287)
T ss_pred -cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 011112233333 389999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=212.68 Aligned_cols=178 Identities=29% Similarity=0.368 Sum_probs=147.1
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecC--CeEEEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNE--DFKVLVL 231 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 231 (348)
+|+..+.||+|++|.||+|... ++..+++|.+..... ...+.+.+|++++++++|+||+++++.+... +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999976 788999999865432 3456788999999999999999999999988 8999999
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+++++|.+++... .+++.|++||| +.+++|+|++|+||+++.++.++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 999999999987653 13788999999 789999999999999999999999999999876543221
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
.......++..|++ +||||||++++||++|+.||+...
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 01122334555543 899999999999999999997643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=224.79 Aligned_cols=177 Identities=23% Similarity=0.304 Sum_probs=146.9
Q ss_pred CCCccccccccCCcceEEEeEecC-CceEEEEeeeecc---CccchhhHHHhhhccccc-ccceeeEEEEEecCCeEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQD-RMEFSVKGFHLQC---SGAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV 230 (348)
.+|....+||+|+||+|-.|..+. ...+|||+++... ..+.+.-+.|-++|+... -|.+++++..|+.-++.|.|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 357778899999999999998664 4568999886542 233455667778887664 67899999999999999999
Q ss_pred EeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 231 LEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
|||+.+|+|--.+..-. .||.||-+|| +.+||.||+|.+||++|.+|.+||+|||+++.-.-+.
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~- 504 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG- 504 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccCC-
Confidence 99999999977765422 2788999999 9999999999999999999999999999998643322
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
..+.+++||+.|+| .|.|||||+||||+.|++||+..-
T Consensus 505 -~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD 554 (683)
T KOG0696|consen 505 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 554 (683)
T ss_pred -cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 23467899999998 899999999999999999998653
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=218.05 Aligned_cols=172 Identities=25% Similarity=0.356 Sum_probs=138.4
Q ss_pred CccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 158 FSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
|+..+.||+|++|.||+|... ++..||+|++..... ...+.+.+|++++++++|||++++++++...+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999865 788999998865432 22356888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 235 PRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 235 ~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
+ ++|.+++.... +++.||+||| +.+++||||+|+||+++.++.++|+|||+++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 5 68888775432 3788999999 789999999999999999999999999999765321110
Q ss_pred eecccccccCcc-------------ccccHHHHHHHHHHHcCCCCCcc
Q 038351 301 IQTQTLATIGYM-------------ASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 301 ~~~~~~gt~~y~-------------asDV~S~Gvvl~elltG~~P~~~ 335 (348)
.....++..|+ ++|||||||++|||+||+.||..
T Consensus 156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 202 (283)
T cd07835 156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG 202 (283)
T ss_pred -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 01111222332 29999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=220.49 Aligned_cols=170 Identities=26% Similarity=0.317 Sum_probs=137.8
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.|+..+.||+|+||.||+++.. ++..+|+|.+..... .....+..|++++++++|||++++++++..++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4778889999999999999864 678999998864322 223468889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 233 YMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 233 y~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|++ |++.+.+... .+++.|+.||| +.+|+||||+|+||+++.++.++|+|||++.......
T Consensus 106 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~-- 179 (317)
T cd06635 106 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN-- 179 (317)
T ss_pred CCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCcc--
Confidence 997 4777665421 13788999999 7899999999999999999999999999987653321
Q ss_pred eeecccccccCcc---------------ccccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYM---------------ASYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~---------------asDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...++..|+ ++|||||||+++||++|+.||...
T Consensus 180 ----~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 180 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred ----cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 122333333 389999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=219.59 Aligned_cols=178 Identities=21% Similarity=0.289 Sum_probs=139.0
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc--cchhhHHHhhhcccccccceeeEEEEEecCC-----
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG--AFKSFDFECDVMKSTCYRNLIKIISSRSNED----- 225 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 225 (348)
..++|+..+.||+|+||.||+|+.. ++..||+|.+...... ....+.+|++++++++||||+++++++...+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4457888999999999999999875 6889999988643322 2334578999999999999999999987654
Q ss_pred ---eEEEEEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCC
Q 038351 226 ---FKVLVLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGI 289 (348)
Q Consensus 226 ---~~~lV~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGl 289 (348)
..++||||+++ ++.+.+... .+++.||+||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 45999999964 777766532 23888999999 77999999999999999999999999999
Q ss_pred ccccccCCce--eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 290 AKLLIREDHF--MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 290 a~~~~~~~~~--~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
+......... .......++..|+| +||||||+++|||+||+.||..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~ 226 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG 226 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 9766432211 00112223444443 8999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=225.80 Aligned_cols=179 Identities=23% Similarity=0.274 Sum_probs=142.3
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEec----CCe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSN----EDF 226 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~ 226 (348)
+..+|+..+.||+|+||.||+|... ++..||+|++..... ...+.+..|+.++++++||||+++++++.. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 3478899999999999999999865 688999999864322 234567889999999999999999988753 356
Q ss_pred EEEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 227 KVLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
.++||||++ ++|.+++... .+++.||+||| +.+|+||||||+||++++++.+||+|||+++...
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 899999995 6888877532 23888999999 7889999999999999999999999999997754
Q ss_pred cCCce--eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHF--MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~--~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..... .......++..|+| +|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 32211 01112344544543 89999999999999999999654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=232.51 Aligned_cols=177 Identities=24% Similarity=0.413 Sum_probs=143.8
Q ss_pred CCccccccccCCcceEEEeEe-cCCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 157 GFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
-|...+.||-|+||+|..++- ++...+|.|.+++.+. ........|-+||+..+.+.||+|+-.|.+++..|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 366678899999999999874 4566789998865432 234557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhchh---------H---HHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc------
Q 038351 233 YMPRGSLEKCLYSSN---------Y---VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI------ 294 (348)
Q Consensus 233 y~~~gsL~~~l~~~~---------~---i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~------ 294 (348)
|++||++-.+|-..+ + +..|+++.| ..++|||||||+|||||.+|.+||.||||+.-+.
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 999999988775432 2 456899999 9999999999999999999999999999986542
Q ss_pred ---cCCc-----------e--------------------eeecccccccCccc------------cccHHHHHHHHHHHc
Q 038351 295 ---REDH-----------F--------------------MIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328 (348)
Q Consensus 295 ---~~~~-----------~--------------------~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt 328 (348)
..+. + .......||+.|+| +|.||.|||||||+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 1000 0 00113468999998 899999999999999
Q ss_pred CCCCCccc
Q 038351 329 RKKPTNKI 336 (348)
Q Consensus 329 G~~P~~~~ 336 (348)
|+.||-+.
T Consensus 867 g~~pf~~~ 874 (1034)
T KOG0608|consen 867 GQPPFLAD 874 (1034)
T ss_pred CCCCccCC
Confidence 99999654
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=225.05 Aligned_cols=175 Identities=23% Similarity=0.221 Sum_probs=141.7
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeec--cCccchhhHHHhhhcccccccceeeEEEEEecC------
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ--CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNE------ 224 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 224 (348)
..++|+..+.||+|+||.||+|+.. ++..||+|.+... .......+.+|++++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999865 7889999988532 222335677899999999999999999988644
Q ss_pred CeEEEEEeccCCCCHHHHHhc----------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 225 DFKVLVLEYMPRGSLEKCLYS----------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 225 ~~~~lV~Ey~~~gsL~~~l~~----------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
...++||||+. ++|.+.+.. ..+++.||+||| ..+|+||||||+||+++.++.+||+|||+++...
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhcCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 35799999996 477776543 124888999999 7899999999999999999999999999998754
Q ss_pred cCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 295 REDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.... .....++..|+| +|||||||+++||++|+.||..
T Consensus 170 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 170 TSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred CCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 3211 123345666765 8999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=213.83 Aligned_cols=166 Identities=26% Similarity=0.355 Sum_probs=132.1
Q ss_pred cccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhh-cccccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDV-MKSTCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
+.||+|+||.||+|... +++.||+|.+..... .....+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999875 678999998864321 112334445444 4556899999999999999999999999999
Q ss_pred CCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecc
Q 038351 237 GSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304 (348)
Q Consensus 237 gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 304 (348)
++|.+++... .+++.||+||| +.+++||||+|+||++++++.++|+|||+++..... ..
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------~~ 152 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN------KK 152 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceecccc------cc
Confidence 9999988642 13788999999 789999999999999999999999999998764321 12
Q ss_pred cccccCcc------------ccccHHHHHHHHHHHcCCCCCccc
Q 038351 305 TLATIGYM------------ASYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 305 ~~gt~~y~------------asDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..++..|+ ++||||||+++|||+||+.||...
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 22334443 389999999999999999999654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=211.51 Aligned_cols=174 Identities=30% Similarity=0.402 Sum_probs=144.6
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+|+..+.||+|++|.||+++.. ++..+++|.+..... ...+.+.+|++++++++|+|++++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677899999999999999865 677899999865543 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 234 MPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 234 ~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+++++|.+++... .+++.|+.||| +.+|+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 155 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-- 155 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--
Confidence 9999999887542 13778899999 889999999999999999999999999999876543221
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.....++..|+| +||||+|++++||++|+.||..
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 122334444443 8999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-27 Score=210.91 Aligned_cols=175 Identities=28% Similarity=0.411 Sum_probs=146.9
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+|+..+.||+|+||.||++... ++..+++|.+..... ...+.+..|++++++++|+|++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999976 688999999865433 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhchh----------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 234 MPRGSLEKCLYSSN----------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 234 ~~~gsL~~~l~~~~----------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
+++++|.+.+.... +++.|+.||| +.+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886531 3788999999 7799999999999999999999999999998764432
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. ......+++.|+| +||||+|+++++|++|+.||+..
T Consensus 158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 1 1122345555654 99999999999999999998664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-29 Score=234.89 Aligned_cols=171 Identities=24% Similarity=0.328 Sum_probs=147.8
Q ss_pred ccccccccCCcceEEEeEecCCc-eEEEEeeeec---cCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 159 SEDNLISRGGFGSIHKARIQDRM-EFSVKGFHLQ---CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 159 ~~~~~lG~G~fg~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
.....||-|+||.|-.+...... .+|+|.+++. .....+....|-.+|...+.|.||++|..|.+..++|+.||-|
T Consensus 423 ~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaC 502 (732)
T KOG0614|consen 423 KRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEAC 502 (732)
T ss_pred hhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhh
Confidence 34456899999999998866543 4777777433 3334466788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhchhH------------HHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeee
Q 038351 235 PRGSLEKCLYSSNY------------VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302 (348)
Q Consensus 235 ~~gsL~~~l~~~~~------------i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 302 (348)
-+|.|++.|+++.. +.+|++||| ..+||+||+||+|.++|.+|.+|+.|||+|+.+..... +
T Consensus 503 lGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K---T 576 (732)
T KOG0614|consen 503 LGGELWTILRDRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK---T 576 (732)
T ss_pred cCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCc---e
Confidence 99999999987642 778999999 89999999999999999999999999999999865443 4
Q ss_pred cccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 303 TQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 303 ~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.+++||+.|.| +|.||+|+++|||+||++||..
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~ 621 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG 621 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 68999999998 8999999999999999999975
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-29 Score=238.20 Aligned_cols=174 Identities=22% Similarity=0.316 Sum_probs=147.5
Q ss_pred CccccccccCCcceEEEeEecCCce-EEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 158 FSEDNLISRGGFGSIHKARIQDRME-FSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~~~~~-vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
|.+..-||.|+||.||+|..++... .|.|.+........+++.-|++||+..+||+||++++.|..++..|+..|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4455678899999999999776544 467777777767788999999999999999999999999999999999999999
Q ss_pred CCHHHHHhc-------------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeec
Q 038351 237 GSLEKCLYS-------------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303 (348)
Q Consensus 237 gsL~~~l~~-------------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 303 (348)
|-++.++-. ..++..||.||| +..|||||+|+-|||+.-+|.++++|||.+...... .....
T Consensus 114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qkRD 188 (1187)
T KOG0579|consen 114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQKRD 188 (1187)
T ss_pred chHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhH--Hhhhc
Confidence 988766543 224778999999 899999999999999999999999999998765332 22335
Q ss_pred ccccccCccc-----------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 304 QTLATIGYMA-----------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 304 ~~~gt~~y~a-----------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.+.||+.||| +||||||+.|.||..+.+|..+.
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel 238 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL 238 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc
Confidence 7889999998 89999999999999999997553
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=217.27 Aligned_cols=174 Identities=24% Similarity=0.353 Sum_probs=140.8
Q ss_pred CCccccccccCCcceEEEeEe----cCCceEEEEeeeecc----CccchhhHHHhhhcccc-cccceeeEEEEEecCCeE
Q 038351 157 GFSEDNLISRGGFGSIHKARI----QDRMEFSVKGFHLQC----SGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFK 227 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 227 (348)
+|+..+.||+|++|.||+++. .++..+|||.+.... ....+.+..|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467778999999999999874 356789999886432 12335678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 228 VLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
++||||+++|+|.+.+.... +++.+|+||| +.+++||||||+||+++.++.++++|||+++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 99999999999998875422 4788999999 78999999999999999999999999999877543
Q ss_pred CCceeeecccccccCccc--------------cccHHHHHHHHHHHcCCCCCc
Q 038351 296 EDHFMIQTQTLATIGYMA--------------SYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a--------------sDV~S~Gvvl~elltG~~P~~ 334 (348)
.... ......++..|+| +||||||++++||+||+.||.
T Consensus 158 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 158 EEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred cccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 2211 1112334555543 899999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-27 Score=220.87 Aligned_cols=177 Identities=20% Similarity=0.276 Sum_probs=138.7
Q ss_pred hCCCc-cccccccCCcceEEEeEec-CCceEEEEeeeeccCcc--------------chhhHHHhhhcccccccceeeEE
Q 038351 155 TNGFS-EDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGA--------------FKSFDFECDVMKSTCYRNLIKII 218 (348)
Q Consensus 155 ~~~f~-~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~ 218 (348)
.++|. ..+.||+|+||.||+|+.. +++.||+|.+....... ...+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 44565 4578999999999999865 68899999885432211 12467899999999999999999
Q ss_pred EEEecCCeEEEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEee
Q 038351 219 SSRSNEDFKVLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSD 286 (348)
Q Consensus 219 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~D 286 (348)
+++...+..++||||++ |+|.+++... .+++.||+||| +.+|+||||||+||+++.++.++++|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence 99999999999999996 6888887542 23788999999 78999999999999999999999999
Q ss_pred cCCccccccCCc------------eeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 287 FGIAKLLIREDH------------FMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 287 fGla~~~~~~~~------------~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
||+++....... ........++..|+| +|||||||++|||+||+.||..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999976541100 000011123444443 8999999999999999999864
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=223.20 Aligned_cols=176 Identities=26% Similarity=0.319 Sum_probs=140.6
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeec--cCccchhhHHHhhhcccccccceeeEEEEEecC-----C
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ--CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNE-----D 225 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~ 225 (348)
+.++|...+.||+|+||.||+|+.. ++..||+|.+... .......+.+|+.+++.++|+||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3567889999999999999999864 6889999988643 222345677899999999999999999987654 3
Q ss_pred eEEEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
..++|+||+. ++|.+++... .+++.||+||| +.+++||||||+||+++.++.+||+|||+++..
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 5799999996 6888777542 24788999999 789999999999999999999999999999876
Q ss_pred ccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 294 IREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
...... .....++..|+| +|||||||++|||++|+.||..
T Consensus 159 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 211 (337)
T cd07858 159 SEKGDF--MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211 (337)
T ss_pred CCCccc--ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence 432111 112234444443 9999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-28 Score=233.67 Aligned_cols=173 Identities=23% Similarity=0.381 Sum_probs=142.6
Q ss_pred cccccccCCcceEEEeEecC----CceEEEEeeeeccCc-cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 160 EDNLISRGGFGSIHKARIQD----RMEFSVKGFHLQCSG-AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 160 ~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
..++||+|.||.|++|.|.. ...||||.+...... ...+|.+|+.+|.+|+|||+++|||...+ ....+|+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 34789999999999999762 346899999765544 56889999999999999999999999988 6778999999
Q ss_pred CCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc-e
Q 038351 235 PRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH-F 299 (348)
Q Consensus 235 ~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~-~ 299 (348)
+.|+|.++|+.. .+||.|+.||. .++.||||+-++|+|+...-.+||+||||.+.+...+. +
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 999999999873 24899999999 89999999999999999999999999999998865433 2
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.......-.+.|.| +|||+|||.+|||+| |+.||...
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~ 319 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC 319 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC
Confidence 22222222233333 999999999999998 67888654
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=219.65 Aligned_cols=170 Identities=21% Similarity=0.220 Sum_probs=131.0
Q ss_pred ccccCCcceEEEeEecCCceEEEEeeeec--cCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCHH
Q 038351 163 LISRGGFGSIHKARIQDRMEFSVKGFHLQ--CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLE 240 (348)
Q Consensus 163 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 240 (348)
.+|.|+++.||+++. +++.||+|++... .....+.+..|++++++++|+||+++++++...+..+++|||+++|+|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 344444444444443 6889999998654 2234567899999999999999999999999999999999999999999
Q ss_pred HHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce-----ee
Q 038351 241 KCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF-----MI 301 (348)
Q Consensus 241 ~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~-----~~ 301 (348)
+++... .+++.||+||| +.+|+||||||+||+++.++.++++|||.+..+...... ..
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 988642 13788999999 788999999999999999999999999988755322110 00
Q ss_pred ecccccccCcc--------------ccccHHHHHHHHHHHcCCCCCccc
Q 038351 302 QTQTLATIGYM--------------ASYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~--------------asDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....++..|+ ++|||||||+++||++|+.||...
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 01112223332 389999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=218.88 Aligned_cols=178 Identities=21% Similarity=0.261 Sum_probs=138.8
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc--cchhhHHHhhhcccccccceeeEEEEEecC------
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG--AFKSFDFECDVMKSTCYRNLIKIISSRSNE------ 224 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 224 (348)
..++|+..+.||+|+||.||+|+.. ++..+|+|.+...... ....+.+|++++++++||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 3678999999999999999999865 6788999988654322 234577899999999999999999987543
Q ss_pred --CeEEEEEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCC
Q 038351 225 --DFKVLVLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGI 289 (348)
Q Consensus 225 --~~~~lV~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGl 289 (348)
...++|+||++. ++...+... .++++||+||| +.+|+||||||+||++++++.++++|||+
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 346999999965 666555432 23888999999 78999999999999999999999999999
Q ss_pred ccccccCCcee---------eecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 290 AKLLIREDHFM---------IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 290 a~~~~~~~~~~---------~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
++......... ..+...+++.|+| +|||||||++|||++|++||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~ 229 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence 98654321110 0112233444543 8999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-28 Score=223.67 Aligned_cols=180 Identities=27% Similarity=0.329 Sum_probs=146.9
Q ss_pred CCccccccccCCcceEEEeE-ecCCceEEEEeeeeccC-------ccchhhHHHhhhcccccccceeeEEEEEec-CCeE
Q 038351 157 GFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCS-------GAFKSFDFECDVMKSTCYRNLIKIISSRSN-EDFK 227 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~ 227 (348)
+|-..++||+|+|+.||||. +...+.||||+-..... ...+...+|.++.+.+.||.||++++++.- .+..
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 45556789999999999997 45677889987754321 123567889999999999999999999975 4678
Q ss_pred EEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEc---CCCcEEEeecCCccc
Q 038351 228 VLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFD---DNIVTHLSDFGIAKL 292 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld---~~~~~kl~DfGla~~ 292 (348)
+-|.|||++.+|+-+|+... +|..||.||.+. +++|||-|+||.|||+- ..|.+||.|||+++.
T Consensus 544 CTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred eeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 89999999999998887643 267799999965 78999999999999995 478999999999999
Q ss_pred cccCCce-----eeecccccccCccc----------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 293 LIREDHF-----MIQTQTLATIGYMA----------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 293 ~~~~~~~-----~~~~~~~gt~~y~a----------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
+.++... ..+....||.+|++ .||||.|||+|..+.|+.||....
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 8764432 12345678888875 899999999999999999997643
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-27 Score=219.38 Aligned_cols=177 Identities=24% Similarity=0.287 Sum_probs=142.2
Q ss_pred hHHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEec-CC
Q 038351 150 ELCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSN-ED 225 (348)
Q Consensus 150 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~ 225 (348)
++...+++|+..+.||+|+||.||+|+.. ++..+|+|++.... ....+.+..|++++++++||||+++++++.. .+
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34557889999999999999999999855 78899999885422 2234668889999999999999999998875 56
Q ss_pred eEEEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
..++|+||+ +++|.+.++.. .+++.||+||| +.+|+||||||+||++++++.++++|||+++...
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 789999999 56888877542 23778999999 8899999999999999999999999999997653
Q ss_pred cCCceeeecccccccCcc-------------ccccHHHHHHHHHHHcCCCCCcc
Q 038351 295 REDHFMIQTQTLATIGYM-------------ASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~-------------asDV~S~Gvvl~elltG~~P~~~ 335 (348)
.... ...++..|+ ++|||||||++|||+||+.||..
T Consensus 160 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~ 208 (328)
T cd07856 160 PQMT-----GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208 (328)
T ss_pred CCcC-----CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2211 111222222 38999999999999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-27 Score=214.81 Aligned_cols=173 Identities=31% Similarity=0.368 Sum_probs=134.2
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhccccc-ccceeeEEEEEecCCeEEEEEec
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+|...+.||+|+||.||+++.. ++..+|+|.+..... .....+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4566788999999999999865 678999998864432 23456888999999996 99999999999999999999999
Q ss_pred cCCCCHHHHHh---c--------------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 234 MPRGSLEKCLY---S--------------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 234 ~~~gsL~~~l~---~--------------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
++. ++.++.. . ..+++.||+|||+ ..+|+||||||+||+++.++.++|+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 5443321 1 1237789999993 358999999999999999999999999999765332
Q ss_pred CceeeecccccccCcc---------------ccccHHHHHHHHHHHcCCCCCcc
Q 038351 297 DHFMIQTQTLATIGYM---------------ASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~---------------asDV~S~Gvvl~elltG~~P~~~ 335 (348)
... ....++..|+ ++|||||||+++||++|+.||..
T Consensus 162 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 162 IAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred Ccc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 111 1112333332 38999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=220.90 Aligned_cols=178 Identities=24% Similarity=0.281 Sum_probs=142.4
Q ss_pred hhHHhhhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecC-
Q 038351 149 LELCRVTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNE- 224 (348)
Q Consensus 149 ~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~- 224 (348)
.++..++++|...+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 34566789999999999999999999985 478899999886432 12235677899999999999999999988643
Q ss_pred -----CeEEEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecC
Q 038351 225 -----DFKVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFG 288 (348)
Q Consensus 225 -----~~~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfG 288 (348)
...++++|++ +++|.+.+... .+++.|++||| +.+|+||||||+||++++++.+||+|||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~dfg 165 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 165 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEeccc
Confidence 3468888887 77888766532 24788999999 7899999999999999999999999999
Q ss_pred CccccccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 289 IAKLLIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 289 la~~~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
+++...... ....++..|+| +|||||||+++||++|+.||..
T Consensus 166 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 166 LARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred ccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 997653221 12234444443 8999999999999999999854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=210.65 Aligned_cols=173 Identities=27% Similarity=0.367 Sum_probs=143.5
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+|+..+.||+|+||.||+++.. ++..+|+|.+.... ......+..|++++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777899999999999999755 67889999986532 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 234 MPRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 234 ~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
+++++|.+++... .+++.|++||| +.+++|+||+|+||++++++.+|++|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999887541 13788999999 8899999999999999999999999999998764431
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....++..|++ +|+||+|++++||++|+.||+..
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 204 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR 204 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 112234445543 89999999999999999999754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=215.57 Aligned_cols=178 Identities=28% Similarity=0.437 Sum_probs=146.4
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhccccc-ccceeeEEEEEecCCeEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV 230 (348)
++|...+.||+|+||.||++... ++..+|+|.+.... ....+.+..|.+++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999875 78899999886432 122356788999999999 99999999999999999999
Q ss_pred EeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 231 LEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
|||+++++|.+.+... .+++.||+||| +.+++|+||||+||+++.++.++++|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 9999999999888654 23888999999 78899999999999999999999999999987643221
Q ss_pred e------------------eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 F------------------MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~------------------~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. .......++..|++ +||||||++++|+++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 0 11122334555654 89999999999999999999754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=220.38 Aligned_cols=176 Identities=22% Similarity=0.278 Sum_probs=141.1
Q ss_pred HHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCC--
Q 038351 151 LCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNED-- 225 (348)
Q Consensus 151 ~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-- 225 (348)
+-...++|+..+.||+|+||.||++... ++..||+|.+..... ...+.+..|++++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3345678999999999999999999854 788999998854321 22346788999999999999999999987653
Q ss_pred ----eEEEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCc
Q 038351 226 ----FKVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIA 290 (348)
Q Consensus 226 ----~~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla 290 (348)
..++||||+ +++|.+++... .+++.|++||| +.+|+||||||+||+++.++.++++|||++
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 458999999 67888776542 24888999999 789999999999999999999999999999
Q ss_pred cccccCCceeeecccccccCcc-------------ccccHHHHHHHHHHHcCCCCCcc
Q 038351 291 KLLIREDHFMIQTQTLATIGYM-------------ASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~-------------asDV~S~Gvvl~elltG~~P~~~ 335 (348)
....... ....+++.|+ ++||||+||+++||++|+.||..
T Consensus 166 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 166 RQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred cccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 8654321 1122333343 28999999999999999999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=218.76 Aligned_cols=181 Identities=24% Similarity=0.375 Sum_probs=145.0
Q ss_pred hhCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcc--cccccceeeEEEEEecCC----eE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMK--STCYRNLIKIISSRSNED----FK 227 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~~~~~~~~----~~ 227 (348)
+.......+.||+|+||.||+|+++. ..||||.+... +.+.+.+|.++.. .++|+||..+++.-..++ +.
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wrG-e~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWRG-EDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeeccccC-CceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 44556677899999999999999975 48999999643 3466778877765 568999999998765543 68
Q ss_pred EEEEeccCCCCHHHHHhchh-----------HHHHHHHHHHh-----cCCCceEecCCCcCceEEcCCCcEEEeecCCcc
Q 038351 228 VLVLEYMPRGSLEKCLYSSN-----------YVGFALEYLHF-----DYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~~-----------~i~~~L~yLH~-----~~~~~iiHrDik~~NILld~~~~~kl~DfGla~ 291 (348)
|||+||-|.|+|+++|.... .+|.||++||. ..++.|.|||||+.|||+..++...|+|+|||-
T Consensus 285 wLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred EEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 99999999999999997632 27889999995 346889999999999999999999999999996
Q ss_pred ccccCCc--eeeecccccccCccc------------------cccHHHHHHHHHHHcC----------CCCCccccc
Q 038351 292 LLIREDH--FMIQTQTLATIGYMA------------------SYVYSFGIMLLEVFTR----------KKPTNKIFF 338 (348)
Q Consensus 292 ~~~~~~~--~~~~~~~~gt~~y~a------------------sDV~S~Gvvl~elltG----------~~P~~~~~~ 338 (348)
....+.. .......+||-.||| +||||||.|+||++.+ +.||.+...
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 6543321 223456789999999 8999999999999753 357765543
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=211.88 Aligned_cols=172 Identities=26% Similarity=0.350 Sum_probs=136.0
Q ss_pred CccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccc---cccceeeEEEEEecCCe-----
Q 038351 158 FSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKST---CYRNLIKIISSRSNEDF----- 226 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~----- 226 (348)
|+..+.||+|+||.||+|+.+ ++..+|+|.+..... .....+..|+++++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999987 488999999864322 2234566787776655 59999999999988776
Q ss_pred EEEEEeccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 227 KVLVLEYMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
.+++|||+.+ +|.+++... .+++.||+||| +.+++|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999999974 787766431 13788999999 78899999999999999999999999999987
Q ss_pred cccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 293 LIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....... ....++..|+| +|||||||+++||+||++||+..
T Consensus 157 ~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~ 209 (287)
T cd07838 157 YSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209 (287)
T ss_pred ccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence 6432211 12234445544 89999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=200.68 Aligned_cols=172 Identities=27% Similarity=0.358 Sum_probs=137.1
Q ss_pred cccccccCCcceEEEeEe-cCCceEEEEeeeeccC-ccchhhHHHhhhcc-cccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 160 EDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCS-GAFKSFDFECDVMK-STCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 160 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
....||+|++|.|-+-++ .+|+..|+|++..... +..+...+|+++.. ....|.+|.++|.......+++.||.|..
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t 129 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT 129 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence 346799999999988875 4789999999975533 33466778888754 45689999999999999999999999954
Q ss_pred CCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 237 GSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 237 gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
+|..+-+.. -.+..||.|||. +..|||||+||+|||++.+|++|+||||.+..+.+. .
T Consensus 130 -Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS---i 203 (282)
T KOG0984|consen 130 -SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS---I 203 (282)
T ss_pred -hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhh---h
Confidence 666543321 127789999996 568999999999999999999999999999887532 2
Q ss_pred eecccccccCccc----------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 301 IQTQTLATIGYMA----------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 301 ~~~~~~gt~~y~a----------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
+.+...|...||| +||||+|+.+.||.+++.||+.-+
T Consensus 204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 2233456667776 999999999999999999997643
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-27 Score=220.38 Aligned_cols=172 Identities=23% Similarity=0.284 Sum_probs=136.8
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCC------
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNED------ 225 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 225 (348)
.++|...+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999864 68899999886432 222356788999999999999999999887542
Q ss_pred eEEEEEeccCCCCHHHHHhc----------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 226 FKVLVLEYMPRGSLEKCLYS----------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~----------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
..++|+||+.. ++...... ..+++.||+||| +.+|+||||||+||+++.++.++|+|||+++....
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred eEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 46999999964 67665432 124888999999 78899999999999999999999999999976532
Q ss_pred CCceeeecccccccCcc-------------ccccHHHHHHHHHHHcCCCCCcc
Q 038351 296 EDHFMIQTQTLATIGYM-------------ASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~-------------asDV~S~Gvvl~elltG~~P~~~ 335 (348)
... ...++..|+ ++|||||||+++||++|+.||..
T Consensus 170 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 170 EMT-----GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred CCC-----CceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 211 112233333 38999999999999999999975
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-28 Score=214.66 Aligned_cols=179 Identities=22% Similarity=0.301 Sum_probs=141.2
Q ss_pred hhhCCCccccccccCCcceEEEeEec---C--CceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEec-C
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ---D--RMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSN-E 224 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~ 224 (348)
.....|+....||+|.||.||+|.-. + .+.+|+|+++.+.. +......+|+.+++.++|||++.+..++.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 34457888889999999999999633 2 34789999975533 334678899999999999999999999887 7
Q ss_pred CeEEEEEeccCCCCHHHHHhchh-----------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCC----CcEE
Q 038351 225 DFKVLVLEYMPRGSLEKCLYSSN-----------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN----IVTH 283 (348)
Q Consensus 225 ~~~~lV~Ey~~~gsL~~~l~~~~-----------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~----~~~k 283 (348)
..+++++||.+. +|...++-.. ++..|+.||| +.=|+|||+||+|||+..+ |.+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeE
Confidence 889999999987 8988886432 2666888888 7779999999999999876 9999
Q ss_pred EeecCCccccccCCc-------------eeeecccccccCcc-ccccHHHHHHHHHHHcCCCCCcc
Q 038351 284 LSDFGIAKLLIREDH-------------FMIQTQTLATIGYM-ASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 284 l~DfGla~~~~~~~~-------------~~~~~~~~gt~~y~-asDV~S~Gvvl~elltG~~P~~~ 335 (348)
|+|||+++.+...-. +.+++-..|...|. |.||||.|||+.||+|-++-|..
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 999999998754321 11222333444443 38999999999999999987754
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-27 Score=214.47 Aligned_cols=171 Identities=22% Similarity=0.300 Sum_probs=138.4
Q ss_pred CccccccccCCcceEEEeEec-CCceEEEEeeeeccCc-cchhhHHHhhhccccc-ccceeeEEEEEecCCeEEEEEecc
Q 038351 158 FSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG-AFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
|...+.||+|++|.||+|+.. ++..|++|++...... ......+|+..+++++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 556788999999999999976 5778999988644322 2234567999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 235 PRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 235 ~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
+|+|.+.+.... +++.+|.||| +.+++|+||||+||++++++.++|+|||+++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY- 155 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc-
Confidence 889988776532 3788999999 789999999999999999999999999999876432211
Q ss_pred eecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 301 IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 301 ~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
....++..|+| +||||||++++||++|+.||..
T Consensus 156 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~ 201 (283)
T cd07830 156 --TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG 201 (283)
T ss_pred --CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCC
Confidence 12233333433 8999999999999999999854
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=196.86 Aligned_cols=170 Identities=25% Similarity=0.341 Sum_probs=133.8
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+|+..+.||+|.||+||||+.+ ++..||+|+++... .+......+|+-+++.++|+|||++++...++....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 5667789999999999999965 56788999987653 34456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 234 MPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 234 ~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
|.. +|.++...-+ ++.+||.|.| +..+.|||+||.|.|++.+|+.|++|||+++...-.-..
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrc- 157 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC- 157 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-
Confidence 943 6666554322 2556777777 889999999999999999999999999999876432211
Q ss_pred eecccccccCccc-------------cccHHHHHHHHHHHcCCCC
Q 038351 301 IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKP 332 (348)
Q Consensus 301 ~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P 332 (348)
-....-|..|.+ .|+||.||++.|+...-.|
T Consensus 158 -ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp 201 (292)
T KOG0662|consen 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_pred -eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence 112223444433 7899999999999875555
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=217.63 Aligned_cols=173 Identities=21% Similarity=0.236 Sum_probs=134.5
Q ss_pred cccccC--CcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRG--GFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
..||+| +|++||+++.. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456776 89999999864 789999999864432 2346688899999999999999999999999999999999999
Q ss_pred CCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee--
Q 038351 237 GSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM-- 300 (348)
Q Consensus 237 gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~-- 300 (348)
+++.+++... .+++.||+||| +.+|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999887642 13788999999 7899999999999999999999999997653322111000
Q ss_pred ---eecccccccCcc--------------ccccHHHHHHHHHHHcCCCCCcccc
Q 038351 301 ---IQTQTLATIGYM--------------ASYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 301 ---~~~~~~gt~~y~--------------asDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
......++..|+ ++|||||||+++||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 000011122233 3799999999999999999997653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=215.51 Aligned_cols=170 Identities=27% Similarity=0.332 Sum_probs=137.2
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
+.|+..+.||+|+||.||+|+.. ++..+|+|.+..... ...+.+..|+++++.++|+|++++++++...+..++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34677788999999999999965 577899998864221 22356778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 232 EYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
||+. |++.+.+... .+++.|+.||| +.+++||||||+||+++.++.++++|||++.......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 169 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN- 169 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCcc-
Confidence 9996 5777665321 13678999999 7889999999999999999999999999987654321
Q ss_pred eeeecccccccCcc---------------ccccHHHHHHHHHHHcCCCCCcc
Q 038351 299 FMIQTQTLATIGYM---------------ASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 299 ~~~~~~~~gt~~y~---------------asDV~S~Gvvl~elltG~~P~~~ 335 (348)
...++..|+ ++|||||||+++||++|+.||..
T Consensus 170 -----~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 170 -----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred -----cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 122333333 38999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-27 Score=220.74 Aligned_cols=177 Identities=22% Similarity=0.291 Sum_probs=139.1
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecC---------
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNE--------- 224 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------- 224 (348)
..+|...+.||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367888999999999999999865 6889999998766555567788999999999999999999776543
Q ss_pred -----CeEEEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC-CCcEEEeec
Q 038351 225 -----DFKVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD-NIVTHLSDF 287 (348)
Q Consensus 225 -----~~~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~Df 287 (348)
...++||||++ ++|.+.+... .+++.||+||| +.+|+||||||+||+++. +..++++||
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 35789999997 5888776532 24888999999 788999999999999984 567899999
Q ss_pred CCccccccCCcee-eecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 288 GIAKLLIREDHFM-IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 288 Gla~~~~~~~~~~-~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
|+++.+....... ......++..|+| +|||||||++|||++|+.||..
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 221 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG 221 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9997653211100 0011223434433 8999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=213.74 Aligned_cols=169 Identities=27% Similarity=0.304 Sum_probs=135.9
Q ss_pred CccccccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 158 FSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
|...+.||+|+||.||+|+.. ++..+++|.+..... .....+..|++++++++|||++++++++...+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999864 678899998864322 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 234 MPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 234 ~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
+. |++.+.+... .+++.|++||| +.+++||||||+||++++++.++|+|||++.......
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~--- 175 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN--- 175 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCCC---
Confidence 96 5776665431 23788999999 7789999999999999999999999999986543211
Q ss_pred eecccccccCcc---------------ccccHHHHHHHHHHHcCCCCCccc
Q 038351 301 IQTQTLATIGYM---------------ASYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~---------------asDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...|+..|+ ++|||||||+++||++|+.||...
T Consensus 176 ---~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 176 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred ---CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 122333333 379999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=213.15 Aligned_cols=175 Identities=27% Similarity=0.342 Sum_probs=135.8
Q ss_pred hCCCccccccccCCcceEEEeEecC-CceEEEEeeeeccC-ccchhhHHHhhhccccc-ccceeeEEEEEecCCeEEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQD-RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 231 (348)
.++|+..+.||+|+||.||+|...+ ++.+|||.+..... .....+..|+.++.+.. ||||+++++++......++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3567888999999999999999874 88999999865432 23345667777666665 999999999999999999999
Q ss_pred eccCCCCHHHHHhc-------------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 232 EYMPRGSLEKCLYS-------------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 232 Ey~~~gsL~~~l~~-------------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
||+++ ++.+.+.. ..+++.|++|||. ..+|+||||+|+||++++++.++|+|||++..+.....
T Consensus 94 e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 94 ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 99854 55554432 1237889999993 25899999999999999999999999999976543211
Q ss_pred eeeecccccccCcc----------------ccccHHHHHHHHHHHcCCCCCcc
Q 038351 299 FMIQTQTLATIGYM----------------ASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 299 ~~~~~~~~gt~~y~----------------asDV~S~Gvvl~elltG~~P~~~ 335 (348)
. ....++..|+ ++||||||+++|||++|+.||..
T Consensus 171 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 171 K---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred c---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 1 1112333333 37999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=217.97 Aligned_cols=176 Identities=25% Similarity=0.282 Sum_probs=142.4
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCC-----eEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNED-----FKV 228 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 228 (348)
+|...+.||+|++|.||+|+.. ++..+|+|.+.... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999975 48899999886543 334567889999999999999999999988775 789
Q ss_pred EEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 229 LVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
+||||++ ++|.+.+... .+++.||+||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9999997 4888877653 23788999999 789999999999999999999999999999876543
Q ss_pred Cce-eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 297 DHF-MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 297 ~~~-~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
... .......++..|+| +||||||++++||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~ 210 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence 210 01122234444443 89999999999999999999653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-27 Score=223.57 Aligned_cols=173 Identities=27% Similarity=0.457 Sum_probs=143.3
Q ss_pred ccccccccCCcceEEEeEecC-----CceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 159 SEDNLISRGGFGSIHKARIQD-----RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 159 ~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
...++||.|-||.||+|...+ ...||||.-+..+. ...+.|..|..+|++++|||||+++|.|... ..|+|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence 345789999999999998543 34578888776443 3457799999999999999999999999865 5799999
Q ss_pred ccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 233 YMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 233 y~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
.++-|.|..+|.... ++..||.||| +.+.|||||-++|||+...-.+|++|||+++.+.++..+
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 999999999987643 3788999999 999999999999999999999999999999998766555
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.+. ...-.+.||| ||||-|||.|||++. |..||...
T Consensus 548 kaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv 596 (974)
T KOG4257|consen 548 KAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV 596 (974)
T ss_pred hcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc
Confidence 433 2223445654 999999999999875 99999764
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=216.25 Aligned_cols=175 Identities=23% Similarity=0.261 Sum_probs=137.4
Q ss_pred CCccccccccCCcceEEEeEec-C--CceEEEEeeeeccC--ccchhhHHHhhhccccc-ccceeeEEEEEecC----Ce
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-D--RMEFSVKGFHLQCS--GAFKSFDFECDVMKSTC-YRNLIKIISSRSNE----DF 226 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~----~~ 226 (348)
+|+..+.||+|+||.||+++.. + +..+|+|.+..... ...+.+.+|++++++++ ||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999965 3 67899998864322 22456788999999995 99999999875432 45
Q ss_pred EEEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 227 KVLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
.++++||++ ++|.+.+... .+++.||+||| +.+|+||||||+||++++++.++|+|||+++...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 789999986 6888877542 23888999999 7899999999999999999999999999998654
Q ss_pred cCCcee--eecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 295 REDHFM--IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 295 ~~~~~~--~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
...... ......|+..|+| +||||+||+++||++|++||..
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 321110 1123356666655 7999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=211.05 Aligned_cols=172 Identities=26% Similarity=0.318 Sum_probs=139.0
Q ss_pred CccccccccCCcceEEEeEec-CCceEEEEeeeeccCc--cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 158 FSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG--AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
|+..+.||+|++|.||+|... ++..+++|.+...... ....+..|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456688999999999999875 6888999988644322 3467888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 235 PRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 235 ~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
++ ++.+.+... .+++.||+||| +.+|+|+||||+||++++++.++|+|||.+........ .
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--P 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--c
Confidence 75 887776553 13788999999 78899999999999999999999999999977644320 0
Q ss_pred ecccccccCcc-------------ccccHHHHHHHHHHHcCCCCCcc
Q 038351 302 QTQTLATIGYM-------------ASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 302 ~~~~~gt~~y~-------------asDV~S~Gvvl~elltG~~P~~~ 335 (348)
.....++..|+ ++||||+|++++||+||+.||..
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 201 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG 201 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 11122333333 28999999999999999999854
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=210.18 Aligned_cols=173 Identities=27% Similarity=0.325 Sum_probs=140.2
Q ss_pred CccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 158 FSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
|+..+.||+|++|.||+|+.. ++..+|+|.+.... ....+.+..|++++++++|+|++++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456688999999999999976 58899999987553 233466788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 235 PRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 235 ~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+ ++|.+++... .+++.||+||| +.+|+||||+|+||++++++.++|+|||+++........
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-- 154 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-- 154 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc--
Confidence 7 5899888654 13788999999 778999999999999999999999999999876432211
Q ss_pred ecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 302 QTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....++..|+| +|||||||+++||++|+.||...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 011122233332 89999999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=228.59 Aligned_cols=176 Identities=23% Similarity=0.301 Sum_probs=148.5
Q ss_pred hCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCccchhhHHHhhhccccc-ccceeeEEEEEec-----CCeE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-YRNLIKIISSRSN-----EDFK 227 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~-----~~~~ 227 (348)
++-|...+.||+|.+|.||+++. ++++.+|+|+....... .++.+.|.++++... |||++.+++++.. ++..
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 45677889999999999999985 47888899988755433 367788889988875 9999999999864 5789
Q ss_pred EEEEeccCCCCHHHHHhchhH--------------HHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 228 VLVLEYMPRGSLEKCLYSSNY--------------VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~~~--------------i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
|||||||.+|+..++++.... +..|+.+|| ...++|||||-.|||++.++.+|++|||++..+
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 999999999999998875322 456777777 889999999999999999999999999999887
Q ss_pred ccCCceeeecccccccCccc-----------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 294 IREDHFMIQTQTLATIGYMA-----------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~a-----------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
... .....+..||+.||| +|+||+|++..||.-|.+|+.++
T Consensus 174 dsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 174 DST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred ecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 543 234467889999998 89999999999999999998764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=225.20 Aligned_cols=178 Identities=19% Similarity=0.254 Sum_probs=130.6
Q ss_pred hhCCCccccccccCCcceEEEeEe-----------------cCCceEEEEeeeeccCccc--------------hhhHHH
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARI-----------------QDRMEFSVKGFHLQCSGAF--------------KSFDFE 202 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~--------------~~~~~E 202 (348)
..++|+..++||+|+||.||+|.. ..++.||||++........ +.+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 2356799999864432222 234457
Q ss_pred hhhcccccccce-----eeEEEEEec--------CCeEEEEEeccCCCCHHHHHhch-----------------------
Q 038351 203 CDVMKSTCYRNL-----IKIISSRSN--------EDFKVLVLEYMPRGSLEKCLYSS----------------------- 246 (348)
Q Consensus 203 ~~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~----------------------- 246 (348)
+.++.+++|+++ ++++++|.. .+..+|||||+++++|.++++..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 677777753 35689999999999999887631
Q ss_pred -------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecccccccCccc
Q 038351 247 -------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313 (348)
Q Consensus 247 -------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 313 (348)
.+++.+|+||| +.+|+||||||+||+++.++.+||+|||+++........ ......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 12667899999 788999999999999999999999999999765322111 0011112333332
Q ss_pred ----------------------------------cccHHHHHHHHHHHcCCC-CCcc
Q 038351 314 ----------------------------------SYVYSFGIMLLEVFTRKK-PTNK 335 (348)
Q Consensus 314 ----------------------------------sDV~S~Gvvl~elltG~~-P~~~ 335 (348)
.||||+||+++||++|.. |+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 499999999999999986 6653
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=205.54 Aligned_cols=168 Identities=30% Similarity=0.394 Sum_probs=138.9
Q ss_pred cccCCcceEEEeEec-CCceEEEEeeeeccCc---cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCH
Q 038351 164 ISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG---AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL 239 (348)
Q Consensus 164 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 239 (348)
||+|+||.||++... ++..+|+|.+...... ....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999876 5888999988654322 345788899999999999999999999999999999999999999
Q ss_pred HHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeeccccc
Q 038351 240 EKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA 307 (348)
Q Consensus 240 ~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~g 307 (348)
.+++.... ++++|+.||| +.+++|+||||+||+++.++.++++|||++........ ......+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCG 155 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCcC
Confidence 98886431 3788999999 78999999999999999999999999999977643211 1122334
Q ss_pred ccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 308 TIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 308 t~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+..|++ +|+||||++++||++|+.||+..
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 196 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 444543 89999999999999999999654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=218.95 Aligned_cols=174 Identities=24% Similarity=0.281 Sum_probs=140.7
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCCe---
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDF--- 226 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--- 226 (348)
...++|+..+.||+|++|.||+|+.. ++..||+|.+.... ....+.+.+|+.++++++|+|++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45678999999999999999999975 57889999885432 2233567789999999999999999988876654
Q ss_pred ---EEEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 227 ---KVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 227 ---~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
.++|+||+ +++|.+++... .+++.||+||| +.+|+||||||+||++++++.++|+|||++..
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999999 66998877542 24788999999 78999999999999999999999999999986
Q ss_pred cccCCceeeecccccccCcc-------------ccccHHHHHHHHHHHcCCCCCcc
Q 038351 293 LIREDHFMIQTQTLATIGYM-------------ASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~-------------asDV~S~Gvvl~elltG~~P~~~ 335 (348)
..... ....++..|+ ++|||||||++|||+||+.||..
T Consensus 168 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 168 TDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred ccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 54321 1223344443 38999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=208.39 Aligned_cols=177 Identities=22% Similarity=0.330 Sum_probs=147.8
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 229 (348)
.++|....+||+|+|.+|..+++. +.+.+|+|.+++.. ..+....+.|-.+..+. +||.+|.+...|..+...+.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 357889999999999999999975 56788999886543 23445566777777666 49999999999999999999
Q ss_pred EEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 230 VLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
|.||+++|+|--++.... .|..||.||| +.+||.||+|.+|+|+|..|.+|+.|+|+++.-....
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 999999999854443321 2777888999 9999999999999999999999999999998765443
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. .+.+++||+.|+| .|.|++||+|+||+.|+.|||-.
T Consensus 406 d--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 406 D--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred c--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 3 3467899999998 79999999999999999999753
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-27 Score=237.54 Aligned_cols=174 Identities=28% Similarity=0.431 Sum_probs=138.0
Q ss_pred HhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCC----
Q 038351 152 CRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNED---- 225 (348)
Q Consensus 152 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 225 (348)
-+..++|++.++||+||||.|||++.+ ||+.+|||++.... ........+|+.++++++|||||+++..+....
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 456778999999999999999999977 89999999997553 233456888999999999999999876442100
Q ss_pred --------------------------------------------------------------------------------
Q 038351 226 -------------------------------------------------------------------------------- 225 (348)
Q Consensus 226 -------------------------------------------------------------------------------- 225 (348)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -----------------------------------eEEEEEeccCCCCHHHHHhchh-------------HHHHHHHHHH
Q 038351 226 -----------------------------------FKVLVLEYMPRGSLEKCLYSSN-------------YVGFALEYLH 257 (348)
Q Consensus 226 -----------------------------------~~~lV~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH 257 (348)
..||=||||+.-++.++++... .|..||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0366788888877766665431 2888999999
Q ss_pred hcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc----------------CCceeeecccccccCccc--------
Q 038351 258 FDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR----------------EDHFMIQTQTLATIGYMA-------- 313 (348)
Q Consensus 258 ~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~----------------~~~~~~~~~~~gt~~y~a-------- 313 (348)
+.+||||||||.||++|++..+||+|||+|+.... .......+...||.-|+|
T Consensus 715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 88899999999999999999999999999987310 011113456778988987
Q ss_pred -------cccHHHHHHHHHHHc
Q 038351 314 -------SYVYSFGIMLLEVFT 328 (348)
Q Consensus 314 -------sDV~S~Gvvl~ellt 328 (348)
+|+||+|||++||+.
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc
Confidence 899999999999974
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=206.15 Aligned_cols=173 Identities=24% Similarity=0.330 Sum_probs=139.8
Q ss_pred hhhCCCccc-cccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccc-cccceeeEEEEEec----CC
Q 038351 153 RVTNGFSED-NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKST-CYRNLIKIISSRSN----ED 225 (348)
Q Consensus 153 ~~~~~f~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~ 225 (348)
..+++|+.. ++||-|-.|.|-.+..+ ++..+|+|.+.. .....+|+++.-.. .|||||.++++|.. ..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 356667654 67999999999999865 678899998853 24567788876555 49999999998764 45
Q ss_pred eEEEEEeccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcC---CCcEEEeecC
Q 038351 226 FKVLVLEYMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDD---NIVTHLSDFG 288 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~DfG 288 (348)
...+|||.|+||.|+..+.++. +|+.|+.||| +..|.||||||+|+|... +-..|++|||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccc
Confidence 6789999999999999887643 3888999999 899999999999999964 5678999999
Q ss_pred CccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 289 IAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 289 la~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+|+.-... ....+.+-|+.|.| +|+||+||++|-|+.|-+||-..
T Consensus 210 FAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~ 266 (400)
T KOG0604|consen 210 FAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_pred cccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc
Confidence 99875432 22345567888887 89999999999999999999653
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8e-26 Score=205.10 Aligned_cols=173 Identities=20% Similarity=0.292 Sum_probs=135.2
Q ss_pred CCccccccccCCcceEEEeEecC-CceEEEEeeeecc-----CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQD-RMEFSVKGFHLQC-----SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
+|...+.||+|+||.||+++... +..+++|.++... ......+..|+.++++++||||+++++++...+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46778899999999999998653 3345555443211 12234567799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 231 LEYMPRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
|||+++++|.+++... .+++.|++||| +.+++|+|+||+||++++ +.++++|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999998877531 13788999999 789999999999999986 569999999998764
Q ss_pred cCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 295 REDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.... ......++..|+| +||||||++++||++|+.||+.
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3222 1122345555554 8999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-28 Score=209.52 Aligned_cols=179 Identities=21% Similarity=0.313 Sum_probs=139.1
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeee--ccCccchhhHHHhhhcccccccceeeEEEEEecC-----
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHL--QCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNE----- 224 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 224 (348)
...+.|....+||+|.||.||+|+.+ +++.||+|++-. ...+......+|+++|..++|+|++.+++.|...
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 33445667789999999999999965 577789887743 2334556778999999999999999998887642
Q ss_pred ---CeEEEEEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecC
Q 038351 225 ---DFKVLVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFG 288 (348)
Q Consensus 225 ---~~~~lV~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfG 288 (348)
...|+|+++|+. +|+..|.+.. .+..||.|+| ...|+|||+|++|+|++.++..||+|||
T Consensus 94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccc
Confidence 347999999977 7877776542 3677899999 8899999999999999999999999999
Q ss_pred CccccccCCceee--ecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 289 IAKLLIREDHFMI--QTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 289 la~~~~~~~~~~~--~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
+++.+...+.... .+...-|..|.. .|||+.|||+.||+||.+-++.
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg 231 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG 231 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC
Confidence 9987653322111 112223555543 8999999999999999987654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=226.14 Aligned_cols=174 Identities=24% Similarity=0.339 Sum_probs=123.9
Q ss_pred hhCCCccccccccCCcceEEEeEecC-----CceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEE------Ee
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQD-----RMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISS------RS 222 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------~~ 222 (348)
..++|+..+.||+|+||.||+|+..+ +..||+|++.... ..+.+..| .+....+.++..+... +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--hhHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 46789999999999999999999754 6889999875321 11111111 1111122222222111 24
Q ss_pred cCCeEEEEEeccCCCCHHHHHhch--------------------------------hHHHHHHHHHHhcCCCceEecCCC
Q 038351 223 NEDFKVLVLEYMPRGSLEKCLYSS--------------------------------NYVGFALEYLHFDYSVLIIHYDLK 270 (348)
Q Consensus 223 ~~~~~~lV~Ey~~~gsL~~~l~~~--------------------------------~~i~~~L~yLH~~~~~~iiHrDik 270 (348)
.....++||||+++++|.+++... .+++.||+||| +.+|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 567899999999999998887532 12677899999 7899999999
Q ss_pred cCceEEcC-CCcEEEeecCCccccccCCceeeecccccccCccc----------------------------------cc
Q 038351 271 PSNVLFDD-NIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA----------------------------------SY 315 (348)
Q Consensus 271 ~~NILld~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a----------------------------------sD 315 (348)
|+|||+++ ++.+||+|||+|+.+...... ......+++.|+| +|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 689999999999865432221 2234556677765 29
Q ss_pred cHHHHHHHHHHHcCCCCCcc
Q 038351 316 VYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 316 V~S~Gvvl~elltG~~P~~~ 335 (348)
||||||++|||+++..|++.
T Consensus 362 VwSlGviL~el~~~~~~~~~ 381 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS 381 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch
Confidence 99999999999998887664
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=200.49 Aligned_cols=156 Identities=23% Similarity=0.244 Sum_probs=124.6
Q ss_pred CCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCHHHHHhc
Q 038351 167 GGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYS 245 (348)
Q Consensus 167 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 245 (348)
|.+|.||+++.. +++.+|+|.+.... .+..|...+....||||+++++++...+..++||||+++|+|.+.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999865 67899999986542 234455555666799999999999999999999999999999988754
Q ss_pred h------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecccccccCcc-
Q 038351 246 S------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM- 312 (348)
Q Consensus 246 ~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~- 312 (348)
. .+++.||+||| +.+|+||||||+||+++.++.++++|||.+........ ...++..|+
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~y~a 150 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD-----GEAVENMYCA 150 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccccc-----cCCcCccccC
Confidence 3 13778999999 88999999999999999999999999998765532111 111222233
Q ss_pred -----------ccccHHHHHHHHHHHcCCCCCcc
Q 038351 313 -----------ASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 313 -----------asDV~S~Gvvl~elltG~~P~~~ 335 (348)
++||||+||++|||++|+.|++.
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 28999999999999999988654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=215.36 Aligned_cols=173 Identities=23% Similarity=0.254 Sum_probs=138.1
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 231 (348)
.+..|.....+|.|+|+.|-++... +.+..+||++... ..+...|+.++... +||||+++.+.+.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3567777788999999999998854 6788999998654 23345677665555 5999999999999999999999
Q ss_pred eccCCCCHHHHHhchh-----------HHHHHHHHHHhcCCCceEecCCCcCceEE-cCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSSN-----------YVGFALEYLHFDYSVLIIHYDLKPSNVLF-DDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~-----------~i~~~L~yLH~~~~~~iiHrDik~~NILl-d~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|++.++-+.+.+.... +++.|++||| +.+|||||+||+|||+ ++.+.++|+|||.++.....-
T Consensus 396 e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~-- 470 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC-- 470 (612)
T ss_pred hhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchhh--
Confidence 9999998776665422 2677999999 7899999999999999 589999999999999875431
Q ss_pred eeecccccccCcc------------ccccHHHHHHHHHHHcCCCCCccccc
Q 038351 300 MIQTQTLATIGYM------------ASYVYSFGIMLLEVFTRKKPTNKIFF 338 (348)
Q Consensus 300 ~~~~~~~gt~~y~------------asDV~S~Gvvl~elltG~~P~~~~~~ 338 (348)
...+-|..|. |+|+|||||+||||++|+.||..-..
T Consensus 471 ---~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~ 518 (612)
T KOG0603|consen 471 ---DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA 518 (612)
T ss_pred ---cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc
Confidence 1112233333 39999999999999999999976544
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=191.11 Aligned_cols=174 Identities=28% Similarity=0.383 Sum_probs=141.6
Q ss_pred CccccccccCCcceEEEeEecC-CceEEEEeeeeccCc-cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 158 FSEDNLISRGGFGSIHKARIQD-RMEFSVKGFHLQCSG-AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
|+..+.||+|++|.||++...+ +..+++|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999875 889999999765444 56788899999999999999999999999999999999999
Q ss_pred CCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeee
Q 038351 236 RGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302 (348)
Q Consensus 236 ~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 302 (348)
+++|.+++.... +++.++.||| +.+++|+|++++||+++.++.++++|||.+......... ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence 999998875421 2677888999 779999999999999999999999999999876543200 00
Q ss_pred cccccccCc-------------cccccHHHHHHHHHHHcCCCCCcc
Q 038351 303 TQTLATIGY-------------MASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 303 ~~~~gt~~y-------------~asDV~S~Gvvl~elltG~~P~~~ 335 (348)
....++..| ..+|||+||++++||++|+.||+.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 011111111 149999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-25 Score=221.69 Aligned_cols=173 Identities=28% Similarity=0.437 Sum_probs=143.8
Q ss_pred ccccccccCCcceEEEeEec--------CCceEEEEeeeeccC-ccchhhHHHhhhccccc-ccceeeEEEEEecCCeEE
Q 038351 159 SEDNLISRGGFGSIHKARIQ--------DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 159 ~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 228 (348)
...+.+|+|.||.|++|... ....||||.++.... ...+.+..|+++|+.+. |+||+.++|+|..++..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 34458999999999999743 256789999864433 34577999999999986 999999999999999999
Q ss_pred EEEeccCCCCHHHHHhchh----------------------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCC
Q 038351 229 LVLEYMPRGSLEKCLYSSN----------------------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI 280 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~~----------------------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~ 280 (348)
+|+||++.|+|.++|+... |||.|++||+ +.++||||+-++|||+.++.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCC
Confidence 9999999999999987665 3899999999 88899999999999999999
Q ss_pred cEEEeecCCccccccCCceeeeccccc--ccCccc------------cccHHHHHHHHHHHc-CCCCCcc
Q 038351 281 VTHLSDFGIAKLLIREDHFMIQTQTLA--TIGYMA------------SYVYSFGIMLLEVFT-RKKPTNK 335 (348)
Q Consensus 281 ~~kl~DfGla~~~~~~~~~~~~~~~~g--t~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~ 335 (348)
.+||+|||+|+.......+... ...+ ...||| +|||||||+|||++| |..||..
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred EEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9999999999976554444322 1122 334777 999999999999998 7788865
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-25 Score=211.99 Aligned_cols=176 Identities=20% Similarity=0.293 Sum_probs=146.0
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--------ccchhhHHHhhhccccc---ccceeeEEEE
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--------GAFKSFDFECDVMKSTC---YRNLIKIISS 220 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---H~niv~l~~~ 220 (348)
.....|+..+.+|+|+||.|+.|.++ +..+|+||.+.+... ........|+++|+.++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 33456888899999999999999976 467888998854421 12234667999999998 9999999999
Q ss_pred EecCCeEEEEEecc-CCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeec
Q 038351 221 RSNEDFKVLVLEYM-PRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDF 287 (348)
Q Consensus 221 ~~~~~~~~lV~Ey~-~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~Df 287 (348)
|+++++.||+||-- ++-+|++++... .+|+.|+++|| +.+|||||||-+|+.+|.+|.+|++||
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeec
Confidence 99999999999965 566888887643 25888999999 999999999999999999999999999
Q ss_pred CCccccccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 288 GIAKLLIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 288 Gla~~~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
|.|....... -..+.||.+|.| -|||++|++||.++..+.||-.
T Consensus 715 gsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 715 GSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9997654322 246789999988 7999999999999999999853
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-25 Score=189.88 Aligned_cols=174 Identities=21% Similarity=0.329 Sum_probs=137.2
Q ss_pred hCCCccccccccCCcceEEEeE-ecCCceEEEEeeeeccCccchhhHHHhhhccccc-ccceeeEEEEEecCC--eEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-YRNLIKIISSRSNED--FKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~~lV 230 (348)
.++|+..+.+|+|.++.||.|. ..+...++||.++... .+.+.+|+.+|..++ ||||+++++...++. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4578888999999999999998 4577889999987543 366889999999998 999999999988764 46799
Q ss_pred EeccCCCCHHHHHh---ch------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC-CCcEEEeecCCccccccCCcee
Q 038351 231 LEYMPRGSLEKCLY---SS------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD-NIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~---~~------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DfGla~~~~~~~~~~ 300 (348)
+||+.+.+....-. .. ..+..||.|+| +.+|+|||+||.|+++|. .-+.+++|+|+|.++.+..++.
T Consensus 114 FE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn 190 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190 (338)
T ss_pred hhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCceee
Confidence 99999887654322 11 23778899999 999999999999999996 4568999999999987766554
Q ss_pred eeccc---ccc------cCc-cccccHHHHHHHHHHHcCCCCCc
Q 038351 301 IQTQT---LAT------IGY-MASYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 301 ~~~~~---~gt------~~y-~asDV~S~Gvvl~elltG~~P~~ 334 (348)
..... .|. ..| .+-|+|||||++.+|+..+.||-
T Consensus 191 VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 191 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence 32211 111 011 12799999999999999999974
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=187.02 Aligned_cols=162 Identities=33% Similarity=0.416 Sum_probs=135.5
Q ss_pred CcceEEEeEec-CCceEEEEeeeeccCcc-chhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCHHHHHhc
Q 038351 168 GFGSIHKARIQ-DRMEFSVKGFHLQCSGA-FKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYS 245 (348)
Q Consensus 168 ~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 245 (348)
+||.||+|+.. ++..+|+|.+....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48899999997654433 57899999999999999999999999999999999999999999998754
Q ss_pred hh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecccccccCccc
Q 038351 246 SN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313 (348)
Q Consensus 246 ~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a 313 (348)
.. +++.++.||| +.+++|+||+|+||++++++.++++|||.+....... ......++..|++
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMA 154 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCC
Confidence 32 2778999999 7799999999999999999999999999998765421 1122334444433
Q ss_pred ------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 314 ------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 314 ------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
+||||||++++||++|+.||+.
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-25 Score=192.94 Aligned_cols=185 Identities=22% Similarity=0.304 Sum_probs=140.2
Q ss_pred hHHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhccccc-ccceeeEEEE-EecCCe
Q 038351 150 ELCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-YRNLIKIISS-RSNEDF 226 (348)
Q Consensus 150 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~-~~~~~~ 226 (348)
+.....+.|.+.+.+|+|.||.+-.++++ ..+.+++|.++... ...++|.+|..---.+. |.||+.-++. |+..+.
T Consensus 18 ~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 18 KKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred cccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 34456678999999999999999999987 56778888876432 34578999998665564 8999988774 677888
Q ss_pred EEEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEc--CCCcEEEeecCCcccc
Q 038351 227 KVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFD--DNIVTHLSDFGIAKLL 293 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld--~~~~~kl~DfGla~~~ 293 (348)
.+.++||+|.|+|.+-+... .+++.|++||| +..+||||||.+|||+- +..++|+||||+.+..
T Consensus 97 YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred EEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999999998876543 24788999999 99999999999999984 3458999999998765
Q ss_pred ccCCceeeec------ccccc---cCccc---cccHHHHHHHHHHHcCCCCCccccc
Q 038351 294 IREDHFMIQT------QTLAT---IGYMA---SYVYSFGIMLLEVFTRKKPTNKIFF 338 (348)
Q Consensus 294 ~~~~~~~~~~------~~~gt---~~y~a---sDV~S~Gvvl~elltG~~P~~~~~~ 338 (348)
...-...... ..+.+ -.|.+ +|||.||++++.++||+.||+....
T Consensus 174 g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~ 230 (378)
T KOG1345|consen 174 GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI 230 (378)
T ss_pred CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc
Confidence 3221111000 00001 11222 8999999999999999999986543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=214.60 Aligned_cols=162 Identities=27% Similarity=0.367 Sum_probs=132.6
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|...+.||+|+||.||+|+.. +++.||+|.+..... .....+..|+++++.++||||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999976 688999999864322 12356888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+++++|.+++... .+++.||+||| ..+|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~- 159 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNREL- 159 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCcc-
Confidence 999999999988642 23788999999 77999999999999999999999999999987643221
Q ss_pred eeecccccccCccc-------------cccHHHHHH
Q 038351 300 MIQTQTLATIGYMA-------------SYVYSFGIM 322 (348)
Q Consensus 300 ~~~~~~~gt~~y~a-------------sDV~S~Gvv 322 (348)
......+|+.|++ +++|++|.-
T Consensus 160 -~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~ 194 (669)
T cd05610 160 -NMMDILTTPSMAKPKNDYSRTPGQVLSLISSLGFN 194 (669)
T ss_pred -cccccccCccccCccccccCCCCceeeeeeecCcC
Confidence 1123445555554 778888853
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-24 Score=213.23 Aligned_cols=178 Identities=26% Similarity=0.365 Sum_probs=144.9
Q ss_pred CCccccccccCCcc-eEEEeEecCCceEEEEeeeeccCccchhhHHHhhhccccc-ccceeeEEEEEecCCeEEEEEecc
Q 038351 157 GFSEDNLISRGGFG-SIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 157 ~f~~~~~lG~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
-|...+++|.|+.| .||+|..++ ++||||++-.. ...-.++|++.|..-+ |||||++++.-.++.+.||+.|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~-R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEG-REVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCC-ceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 35666789999887 578998864 49999998543 2345688999998875 999999999999999999999999
Q ss_pred CCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC-----CCcEEEeecCCcccc
Q 038351 235 PRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD-----NIVTHLSDFGIAKLL 293 (348)
Q Consensus 235 ~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~-----~~~~kl~DfGla~~~ 293 (348)
..+|.+++... .+++.||++|| +.+|||||+||.||||+. ...++|+|||+++.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 45899888762 13788999999 789999999999999975 357899999999998
Q ss_pred ccCCce-eeecccccccCccc------------cccHHHHHHHHHHHcC-CCCCccccccchh
Q 038351 294 IREDHF-MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTR-KKPTNKIFFSQRN 342 (348)
Q Consensus 294 ~~~~~~-~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG-~~P~~~~~~~~~~ 342 (348)
..+... .......||-||+| +||+|+|||+|..+|| +.||.+....+.+
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N 724 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN 724 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh
Confidence 765432 22356678999998 7999999999999887 9999877655433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=192.68 Aligned_cols=139 Identities=19% Similarity=0.187 Sum_probs=111.3
Q ss_pred hHHhhhCCCccccccccCCcceEEEeEec--CCceEEEEeeeecc-----CccchhhHHHhhhcccccccceee-EEEEE
Q 038351 150 ELCRVTNGFSEDNLISRGGFGSIHKARIQ--DRMEFSVKGFHLQC-----SGAFKSFDFECDVMKSTCYRNLIK-IISSR 221 (348)
Q Consensus 150 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~-l~~~~ 221 (348)
.+.....+|...+.||+|+||+||+|+.. ++..+|||++.... ....+.+.+|++++++++|+|++. ++++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 34456678999999999999999999865 56778999875321 112456899999999999999985 4442
Q ss_pred ecCCeEEEEEeccCCCCHHHHHhc-----hhHHHHHHHHHHhcCCCceEecCC-CcCceEEcCCCcEEEeecCCcccccc
Q 038351 222 SNEDFKVLVLEYMPRGSLEKCLYS-----SNYVGFALEYLHFDYSVLIIHYDL-KPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 222 ~~~~~~~lV~Ey~~~gsL~~~l~~-----~~~i~~~L~yLH~~~~~~iiHrDi-k~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
+..++||||+++++|...... ..+++++|+||| +.+|+|||| ||+|||++.++.++|+|||+|+.+..
T Consensus 91 ---~~~~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred ---CCcEEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 457999999999999743211 124788999999 889999999 99999999999999999999997754
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8e-25 Score=192.26 Aligned_cols=176 Identities=22% Similarity=0.331 Sum_probs=139.2
Q ss_pred CCccccccccCCcceEEEeEe-cCCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCC-----eEE
Q 038351 157 GFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNED-----FKV 228 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 228 (348)
+.+..+-||-|+||.||.+.. ++++.||.|++..-. -...+.+.+|+.+|...+|.|+...++...... +.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 445678899999999999875 589999999985322 224577899999999999999999988776543 568
Q ss_pred EEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 229 LVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
+|+|.|.. +|.+.+-... +|.+||.||| +.+|.||||||-|.|++.+-..||+|||+|+....+
T Consensus 134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 88898844 7877665432 4889999999 889999999999999999999999999999986543
Q ss_pred Cc-----------eeeecccccccCcc-ccccHHHHHHHHHHHcCCCCCccc
Q 038351 297 DH-----------FMIQTQTLATIGYM-ASYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 297 ~~-----------~~~~~~~~gt~~y~-asDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+. +..++...|...|. |.||||.|||+.|++.++.-|+..
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq 261 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA 261 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence 32 22233344555554 389999999999999998887664
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-23 Score=201.58 Aligned_cols=174 Identities=24% Similarity=0.327 Sum_probs=150.2
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
.++|.....+|.|.+|.||||+.. .+...|+|.++.......+..+.|+-+++..+|||||.+++.+..++..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 457888899999999999999964 6778899999888777778889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 234 MPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 234 ~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
|.+|+|.+.-+.. +...+++.||| +.+-+|||||-.||++.+.+.+|++|||.+..+... ...
T Consensus 94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~K 168 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAK 168 (829)
T ss_pred cCCCcccceeeecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh--hhh
Confidence 9999998754432 22556899999 888899999999999999999999999999877432 223
Q ss_pred ecccccccCccc---------------cccHHHHHHHHHHHcCCCCC
Q 038351 302 QTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPT 333 (348)
Q Consensus 302 ~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~ 333 (348)
...+.||+.||| +|||+.|+...|+---++|.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 457889999998 89999999999998777773
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.5e-23 Score=187.16 Aligned_cols=175 Identities=21% Similarity=0.266 Sum_probs=140.4
Q ss_pred HhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccc--c----ceeeEEEEEecC
Q 038351 152 CRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCY--R----NLIKIISSRSNE 224 (348)
Q Consensus 152 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~----niv~l~~~~~~~ 224 (348)
-..+++|.....+|+|.||.|-++..+ .+..||+|+++.-. ...+...-|++++.++.+ | -+|++.++|...
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 344789999999999999999999865 46789999886432 234667779999999943 2 478889999999
Q ss_pred CeEEEEEeccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcC------------
Q 038351 225 DFKVLVLEYMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDD------------ 278 (348)
Q Consensus 225 ~~~~lV~Ey~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~------------ 278 (348)
++.++|+|.+ +-++.++++... |+.++++||| +.+++|-|+||+|||+-+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999998 668999888743 4778999999 899999999999999931
Q ss_pred --------CCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 279 --------NIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 279 --------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+..+||.|||.|....+.. .....|..|.| +||||+||||.|+.||..-|+.-
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 3457999999998764432 23445666665 99999999999999999987643
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-22 Score=181.27 Aligned_cols=172 Identities=22% Similarity=0.228 Sum_probs=129.0
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeec--cCccchhhHHHhhhcccccccceeeEEEEEecCC------eE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ--CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNED------FK 227 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~ 227 (348)
+|.....+|.|.- .|.-|... .++.||+|+.... .....+...+|..++..+.|+||++++.++.... ..
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4444556666665 45555432 5778999988433 2344577889999999999999999999997653 57
Q ss_pred EEEEeccCCCCHHHHHhchh----------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC-
Q 038351 228 VLVLEYMPRGSLEKCLYSSN----------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE- 296 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~~----------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~- 296 (348)
|+||||| ..+|...+.... ++..|++||| +.+|+|||+||+||++..+...||.|||+|+.-..+
T Consensus 97 y~v~e~m-~~nl~~vi~~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~ 172 (369)
T KOG0665|consen 97 YLVMELM-DANLCQVILMELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF 172 (369)
T ss_pred HHHHHhh-hhHHHHHHHHhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCccc
Confidence 9999999 457877665321 3778999999 899999999999999999999999999999875432
Q ss_pred --------CceeeecccccccCccc-cccHHHHHHHHHHHcCCCCCc
Q 038351 297 --------DHFMIQTQTLATIGYMA-SYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 297 --------~~~~~~~~~~gt~~y~a-sDV~S~Gvvl~elltG~~P~~ 334 (348)
..+++++..+|+. |.+ +||||.||++.||++|+.-|.
T Consensus 173 ~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred ccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEec
Confidence 0122233333443 443 999999999999999998654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.6e-21 Score=164.24 Aligned_cols=160 Identities=33% Similarity=0.474 Sum_probs=127.9
Q ss_pred cccCCcceEEEeEecC-CceEEEEeeeeccCc-cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCHHH
Q 038351 164 ISRGGFGSIHKARIQD-RMEFSVKGFHLQCSG-AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEK 241 (348)
Q Consensus 164 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 241 (348)
||+|.+|.||++.... +..+++|.+...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 889999998754332 34678999999999999999999999999999999999999999999
Q ss_pred HHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC-CCcEEEeecCCccccccCC--c-------
Q 038351 242 CLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD-NIVTHLSDFGIAKLLIRED--H------- 298 (348)
Q Consensus 242 ~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DfGla~~~~~~~--~------- 298 (348)
++... .+++.+++||| +.+++|+||+|.||+++. ++.++++|||.+....... .
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 88653 13788999999 779999999999999999 8999999999998664321 0
Q ss_pred -eeeecccccc-cCccccccHHHHHHHHHH
Q 038351 299 -FMIQTQTLAT-IGYMASYVYSFGIMLLEV 326 (348)
Q Consensus 299 -~~~~~~~~gt-~~y~asDV~S~Gvvl~el 326 (348)
+..+...... ..-.+.|+|++|++++||
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 0001111111 112338999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.3e-22 Score=182.62 Aligned_cols=185 Identities=23% Similarity=0.301 Sum_probs=146.0
Q ss_pred HHhhhCCCccccccccCCcceEEEeEecC------CceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEec
Q 038351 151 LCRVTNGFSEDNLISRGGFGSIHKARIQD------RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSN 223 (348)
Q Consensus 151 ~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 223 (348)
+.-...+++...++-+|.||.||+|.+++ .+.|-+|.++.... -....+..|.-++..+.|||+..+.+++..
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 33334567777889999999999997653 44566777754332 234567889999999999999999999876
Q ss_pred C-CeEEEEEeccCCCCHHHHHhch--------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcE
Q 038351 224 E-DFKVLVLEYMPRGSLEKCLYSS--------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVT 282 (348)
Q Consensus 224 ~-~~~~lV~Ey~~~gsL~~~l~~~--------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ 282 (348)
+ +..+++|.++.-|+|..+|... .+++.|++||| ..+|||.||-++|+++|+..++
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeE
Confidence 4 6778999999999999998821 23788999999 8999999999999999999999
Q ss_pred EEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccccc
Q 038351 283 HLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIFF 338 (348)
Q Consensus 283 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~~ 338 (348)
|++|-.+++.+-+.+.............||+ +|||||||+||||+| |+.|+.++..
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP 504 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP 504 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH
Confidence 9999999998866544333333334556665 999999999999987 8999877643
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.3e-22 Score=183.64 Aligned_cols=182 Identities=26% Similarity=0.318 Sum_probs=145.2
Q ss_pred HHhhhCCCccccccccCCcceEEEeEec----CCceEEEEeeeeccCccchhhHHHhhhccccc-ccceeeEEEEEecCC
Q 038351 151 LCRVTNGFSEDNLISRGGFGSIHKARIQ----DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-YRNLIKIISSRSNED 225 (348)
Q Consensus 151 ~~~~~~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 225 (348)
+....+.|...++||+|.|++||++... ....||+|.+...+. ......|+++|..+. +.||+++.+.+..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445667889999999999999999854 467899999875543 456889999999997 899999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhchh---------HHHHHHHHHHhcCCCceEecCCCcCceEEcC-CCcEEEeecCCcccccc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSSN---------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDD-NIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~~---------~i~~~L~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DfGla~~~~~ 295 (348)
.+.+|+||++.-+..++...-. .+..||+++| ..+||||||||.|+|.+. .+.-.|.|||+|.....
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 9999999999988887766533 2667889999 999999999999999985 46678999999973211
Q ss_pred CC------c----------------------------e--------eeecccccccCccc-------------cccHHHH
Q 038351 296 ED------H----------------------------F--------MIQTQTLATIGYMA-------------SYVYSFG 320 (348)
Q Consensus 296 ~~------~----------------------------~--------~~~~~~~gt~~y~a-------------sDV~S~G 320 (348)
.. . . .......||+||.| +||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 0 0 00112458899887 8999999
Q ss_pred HHHHHHHcCCCCCcccc
Q 038351 321 IMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 321 vvl~elltG~~P~~~~~ 337 (348)
||++-+++++.||-...
T Consensus 266 VI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAK 282 (418)
T ss_pred ceeehhhccccccccCc
Confidence 99999999999985543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.7e-22 Score=174.02 Aligned_cols=166 Identities=11% Similarity=0.065 Sum_probs=126.5
Q ss_pred hhCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchh---------hHHHhhhcccccccceeeEEEEEecC
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKS---------FDFECDVMKSTCYRNLIKIISSRSNE 224 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~H~niv~l~~~~~~~ 224 (348)
..++|...+++|+|+||.||.+.. ++..+|+|.+.......... +.+|++.+.++.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467899999999999999999766 56689999997543332222 67899999999999999998886643
Q ss_pred --------CeEEEEEeccCCCCHHHHHhc----hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 225 --------DFKVLVLEYMPRGSLEKCLYS----SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 225 --------~~~~lV~Ey~~~gsL~~~l~~----~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
...++||||++|.+|.++... ...++.++..+| ..+++|||+||+||+++.++ ++++|||..+.
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~ 183 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRC 183 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEEEECCCccc
Confidence 357899999999999877432 234788888999 88999999999999999988 99999998876
Q ss_pred cccCCceeeecccccccCccccccHHHHHHHHHH
Q 038351 293 LIREDHFMIQTQTLATIGYMASYVYSFGIMLLEV 326 (348)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~asDV~S~Gvvl~el 326 (348)
...+.... .-..-.... +++|+|||||.+.-.
T Consensus 184 ~~e~~a~d-~~vler~y~-~~~di~~lg~~~~~~ 215 (232)
T PRK10359 184 TAQRKAKD-RIDLERHYG-IKNEIKDLGYYLLIY 215 (232)
T ss_pred ccchhhHH-HHHHHhHhc-ccccccceeEeehHH
Confidence 53221110 000001122 569999999987654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-21 Score=183.06 Aligned_cols=178 Identities=20% Similarity=0.249 Sum_probs=139.7
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccc------cceeeEEEEEecCCe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCY------RNLIKIISSRSNEDF 226 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~~~~~~~~~ 226 (348)
....|......|+|-|+.|.+|... .+.+||||++..... ..+.=..|+++|++|.. -|+++++..|...++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 3456777788999999999999865 577999999975432 12444679999999952 488999999999999
Q ss_pred EEEEEeccCCCCHHHHHhchh---------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCC-CcEEEeecCCc
Q 038351 227 KVLVLEYMPRGSLEKCLYSSN---------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN-IVTHLSDFGIA 290 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~~---------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DfGla 290 (348)
.|||+|-+ ..+|.++|+.-+ ++..||..|. ..+|+|.||||.|||+++. ...||||||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccc
Confidence 99999987 558888887532 3666888888 8899999999999999975 55799999999
Q ss_pred cccccCCc--------eeeecccccccCccccccHHHHHHHHHHHcCCCCCccc
Q 038351 291 KLLIREDH--------FMIQTQTLATIGYMASYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 291 ~~~~~~~~--------~~~~~~~~gt~~y~asDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.......- +.++....|-+.-.+.|+||.||.||||.||+.-|-..
T Consensus 585 ~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 585 SFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred cccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 87754321 33444455555555699999999999999999877554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-20 Score=161.86 Aligned_cols=179 Identities=23% Similarity=0.258 Sum_probs=144.1
Q ss_pred hhCCCccccccccCCcceEEEeE-ecCCceEEEEeeeeccCccchhhHHHhhhcccccc-cceeeEEEEEecCCeEEEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCY-RNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~ 231 (348)
....|...+.||+|+||.+|.|. +.+|.+||||.-.... ...++..|..+...+++ ..|..+..|...+.+-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 45678899999999999999997 6789999999764332 23567889999998886 67888888888899999999
Q ss_pred eccCCCCHHHHHhc-------------hhHHHHHHHHHHhcCCCceEecCCCcCceEEc---CCCcEEEeecCCcccccc
Q 038351 232 EYMPRGSLEKCLYS-------------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFD---DNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 232 Ey~~~gsL~~~l~~-------------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld---~~~~~kl~DfGla~~~~~ 295 (348)
|.. +.+|++...- ..++..-++|+| ....|||||||+|+|.. ....+.++|||+|+.+.+
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 998 7788876543 234667799999 78899999999999986 356688999999998754
Q ss_pred CCc-----eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccccc
Q 038351 296 EDH-----FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIFF 338 (348)
Q Consensus 296 ~~~-----~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~~ 338 (348)
..+ +.......||..|.+ .|+-|+|.+|..+-.|+.||+.+-.
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 321 233345668888875 7999999999999999999998754
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.8e-20 Score=158.96 Aligned_cols=128 Identities=17% Similarity=0.083 Sum_probs=94.6
Q ss_pred ccccccCCcceEEEeEecCCceEEEEeeeeccCcc---------chhh-----------------HHHhhhcccccccce
Q 038351 161 DNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGA---------FKSF-----------------DFECDVMKSTCYRNL 214 (348)
Q Consensus 161 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---------~~~~-----------------~~E~~~l~~l~H~ni 214 (348)
...||+|+||.||+|...+|+.||||.++...... ...| ..|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 36799999999999998889999999997542211 1122 349999999988876
Q ss_pred eeEEEEEecCCeEEEEEeccCCCCHHHH-Hhc-----------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcE
Q 038351 215 IKIISSRSNEDFKVLVLEYMPRGSLEKC-LYS-----------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVT 282 (348)
Q Consensus 215 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~-l~~-----------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ 282 (348)
.....+... ..++||||++++++... +.. ..+++.+|+|+|+ ..+|+||||||+||+++ ++.+
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEE-CCcE
Confidence 443333222 23899999998776543 221 1237788999842 67899999999999998 4789
Q ss_pred EEeecCCcccc
Q 038351 283 HLSDFGIAKLL 293 (348)
Q Consensus 283 kl~DfGla~~~ 293 (348)
+++|||+|...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 99999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.7e-19 Score=166.63 Aligned_cols=177 Identities=25% Similarity=0.284 Sum_probs=138.4
Q ss_pred CCccccccccCCcceEEEeEecCC--ceEEEEeeeeccCccchhhHHHhhhcccccc----cceeeEEEEE-ecCCeEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQDR--MEFSVKGFHLQCSGAFKSFDFECDVMKSTCY----RNLIKIISSR-SNEDFKVL 229 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~~l 229 (348)
+|...+.||+|+||.||.+..... ..+|+|............+..|+.++..+.. +++.++++.. ..+.+.++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997654 4788887765433333378889999988873 6899999998 57888999
Q ss_pred EEeccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCC-----CcEEEeecCCc
Q 038351 230 VLEYMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN-----IVTHLSDFGIA 290 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~-----~~~kl~DfGla 290 (348)
||+.+ +.+|.++.+.. .++..+|+++| +.+++||||||+|+++... ..+.+.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 66888765322 23667899999 8999999999999999865 46899999999
Q ss_pred c--ccccCCce--e---e-ecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 291 K--LLIREDHF--M---I-QTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 291 ~--~~~~~~~~--~---~-~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
+ .+...... . . ...+.||..|.+ .|+||++-++.|+..|..||...-
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 8 43222211 1 1 124568999986 899999999999999999996643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.6e-19 Score=154.19 Aligned_cols=128 Identities=21% Similarity=0.153 Sum_probs=97.6
Q ss_pred ccccccCCcceEEEeEecCCceEEEEeeeeccCcc--------------------------chhhHHHhhhcccccccce
Q 038351 161 DNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGA--------------------------FKSFDFECDVMKSTCYRNL 214 (348)
Q Consensus 161 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~H~ni 214 (348)
...||+|+||.||+|+..+|+.||||.+....... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999998889999999987542110 0123578899999999987
Q ss_pred eeEEEEEecCCeEEEEEeccCCCCHHHH-Hhc-----------hhHHHHHHHHHHhcCC-CceEecCCCcCceEEcCCCc
Q 038351 215 IKIISSRSNEDFKVLVLEYMPRGSLEKC-LYS-----------SNYVGFALEYLHFDYS-VLIIHYDLKPSNVLFDDNIV 281 (348)
Q Consensus 215 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~-l~~-----------~~~i~~~L~yLH~~~~-~~iiHrDik~~NILld~~~~ 281 (348)
.....+.... .++||||++++++... +.. ..+++.++.++| . .+|+||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-CCC
Confidence 5544443332 4899999998754322 221 123778999999 5 7999999999999999 789
Q ss_pred EEEeecCCccccc
Q 038351 282 THLSDFGIAKLLI 294 (348)
Q Consensus 282 ~kl~DfGla~~~~ 294 (348)
++|+|||+++...
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.4e-19 Score=153.68 Aligned_cols=168 Identities=15% Similarity=0.118 Sum_probs=123.0
Q ss_pred ccccccccCCcceEEEeEecCCceEEEEeeeeccCc----cchhhHHHhhhccccc-ccceeeEEEEEecCCeEEEEEec
Q 038351 159 SEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSG----AFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 159 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
.....|++|+||+||.+.- .+..++.+.+.....- ....+.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997765 5667777766533221 1124788999999996 5889999886 446999999
Q ss_pred cCCCCHHHHHhch-----hHHHHHHHHHHhcCCCceEecCC-CcCceEEcCCCcEEEeecCCccccccCCce---ee---
Q 038351 234 MPRGSLEKCLYSS-----NYVGFALEYLHFDYSVLIIHYDL-KPSNVLFDDNIVTHLSDFGIAKLLIREDHF---MI--- 301 (348)
Q Consensus 234 ~~~gsL~~~l~~~-----~~i~~~L~yLH~~~~~~iiHrDi-k~~NILld~~~~~kl~DfGla~~~~~~~~~---~~--- 301 (348)
+++.+|...+... .++..+++++| ..+|+|||| ||+|||++.++.++|+|||+|......... ..
T Consensus 80 I~G~~L~~~~~~~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rD 156 (218)
T PRK12274 80 LAGAAMYQRPPRGDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLARED 156 (218)
T ss_pred ecCccHHhhhhhhhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHH
Confidence 9999997654321 23677899999 889999999 799999999999999999999854332210 00
Q ss_pred -----ecccccccCc--------------cccccHHHHHHHHHHHcCCCCCc
Q 038351 302 -----QTQTLATIGY--------------MASYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 302 -----~~~~~gt~~y--------------~asDV~S~Gvvl~elltG~~P~~ 334 (348)
..-...++.| .+.+.++-|.-+|.++||+.|.-
T Consensus 157 l~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 157 LRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0000123333 33778999999999999999853
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.5e-19 Score=159.99 Aligned_cols=179 Identities=19% Similarity=0.257 Sum_probs=145.2
Q ss_pred hhCCCccccccccCCcceEEEeE-ecCCceEEEEeeeeccCccchhhHHHhhhccccc-ccceeeEEEEEecCCeEEEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 231 (348)
+--+|...++||+|+||..+.|+ +-++..||||.-...+ ...++..|.+..+.|. .+.|..++-|.....+-.||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 34479999999999999999997 5688899999765432 3456777888888776 589999988888888889999
Q ss_pred eccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC-----CCcEEEeecCCcccc
Q 038351 232 EYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD-----NIVTHLSDFGIAKLL 293 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~-----~~~~kl~DfGla~~~ 293 (348)
|.+ +.+|+++..-. .++..-++|+| ++.+|.|||||+|+||.. ...+.+.|||+|+.+
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 998 77887765432 23555688999 888999999999999974 345789999999998
Q ss_pred ccCCc-----eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccccc
Q 038351 294 IREDH-----FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIFF 338 (348)
Q Consensus 294 ~~~~~-----~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~~ 338 (348)
.+... +.......||..||+ -|+-|+|-|++..+.|..||+..-.
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 75432 344567789999997 7999999999999999999987643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=152.67 Aligned_cols=130 Identities=15% Similarity=0.172 Sum_probs=99.2
Q ss_pred CccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccc-----cccceeeEEEEEecCC---eE-E
Q 038351 158 FSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKST-----CYRNLIKIISSRSNED---FK-V 228 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~~-~ 228 (348)
.+..+.||+|+||.||. ...+.. .+||++........+.+.+|+++++.+ .||||+++++++.++. .. .
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999996 323443 478888765444557799999999999 5799999999998873 43 4
Q ss_pred EEEec--cCCCCHHHHHhchh---------HHHHHH-HHHHhcCCCceEecCCCcCceEEcC----CCcEEEeecCCccc
Q 038351 229 LVLEY--MPRGSLEKCLYSSN---------YVGFAL-EYLHFDYSVLIIHYDLKPSNVLFDD----NIVTHLSDFGIAKL 292 (348)
Q Consensus 229 lV~Ey--~~~gsL~~~l~~~~---------~i~~~L-~yLH~~~~~~iiHrDik~~NILld~----~~~~kl~DfGla~~ 292 (348)
+|+|| +++|+|.+++.... ++..++ +||| +.+|+||||||+|||++. +..++|+||+.++.
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~ 158 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIGEST 158 (210)
T ss_pred EEecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCcc
Confidence 78999 66899999986421 233344 8889 889999999999999974 34799999544433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.9e-18 Score=156.38 Aligned_cols=175 Identities=33% Similarity=0.441 Sum_probs=138.4
Q ss_pred CccccccccCCcceEEEeEecCCceEEEEeeeeccCc---cchhhHHHhhhccccccc-ceeeEEEEEecCCeEEEEEec
Q 038351 158 FSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSG---AFKSFDFECDVMKSTCYR-NLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lV~Ey 233 (348)
|...+.||.|+|+.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556678999999999999987 77888888654332 356799999999999988 799999999888888999999
Q ss_pred cCCCCHHHHHhchh---------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCC-cEEEeecCCccccccCC
Q 038351 234 MPRGSLEKCLYSSN---------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI-VTHLSDFGIAKLLIRED 297 (348)
Q Consensus 234 ~~~gsL~~~l~~~~---------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DfGla~~~~~~~ 297 (348)
+.++++.+.+.... +++.+++|+| ..+++|||+||+||+++... .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997766431 2667788999 77899999999999999988 79999999998654322
Q ss_pred cee----eecccccccCcc---------------ccccHHHHHHHHHHHcCCCCCcccc
Q 038351 298 HFM----IQTQTLATIGYM---------------ASYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 298 ~~~----~~~~~~gt~~y~---------------asDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
... ......||..|+ ..|+||+|++++++++|..||....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 111 112333444333 2899999999999999999976543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.9e-19 Score=183.82 Aligned_cols=126 Identities=21% Similarity=0.243 Sum_probs=90.6
Q ss_pred cccccc-cceeeEEEEEe-------cCCeEEEEEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCce
Q 038351 206 MKSTCY-RNLIKIISSRS-------NEDFKVLVLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLI 264 (348)
Q Consensus 206 l~~l~H-~niv~l~~~~~-------~~~~~~lV~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~i 264 (348)
.+.++| +||.+++++|. ..+..+.++||+ .++|.++|... .+++.||+||| +.+|
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gI 101 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGI 101 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 345566 68888888872 234567788987 56999999642 14889999999 8899
Q ss_pred EecCCCcCceEEcC-------------------CCcEEEeecCCccccccCCc--------------eeeecccccccCc
Q 038351 265 IHYDLKPSNVLFDD-------------------NIVTHLSDFGIAKLLIREDH--------------FMIQTQTLATIGY 311 (348)
Q Consensus 265 iHrDik~~NILld~-------------------~~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y 311 (348)
+||||||+|||++. ++.+|++|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566677777654211000 0001123567788
Q ss_pred cc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 312 MA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 312 ~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
|| +|||||||+||||++|.+|+..
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 87 8999999999999999999764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=156.65 Aligned_cols=117 Identities=22% Similarity=0.265 Sum_probs=95.5
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhccccc-----c---cceeeEEEEEec---
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-----Y---RNLIKIISSRSN--- 223 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~~--- 223 (348)
.+|-..++||.|-|++||.|... ..+.||+|+.+... ...+....||++|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 57778899999999999999854 67788999886432 33466788999999885 2 379999999975
Q ss_pred -CCeEEEEEeccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEE
Q 038351 224 -EDFKVLVLEYMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLF 276 (348)
Q Consensus 224 -~~~~~lV~Ey~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILl 276 (348)
..+++||+|++ |-+|..+|.... +|..||.|||. +.+|||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 45899999999 668888876543 37889999997 4589999999999999
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=144.56 Aligned_cols=131 Identities=20% Similarity=0.059 Sum_probs=103.0
Q ss_pred CCccccccccCCcceEEEeEecCCceEEEEeeeeccCc----------------------cchhhHHHhhhccccccc--
Q 038351 157 GFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSG----------------------AFKSFDFECDVMKSTCYR-- 212 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~H~-- 212 (348)
.|...+.||+|+||.||++...+++.||||.+...... ....+..|+.++.++.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 47778999999999999999888999999987543210 011256788889998887
Q ss_pred ceeeEEEEEecCCeEEEEEeccCCCCHHHHHh------chhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEee
Q 038351 213 NLIKIISSRSNEDFKVLVLEYMPRGSLEKCLY------SSNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSD 286 (348)
Q Consensus 213 niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~------~~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~D 286 (348)
.+++.++. ...++||||+++++|.+... ...+++.++.++| ..+|+||||||+||++++++.++|+|
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~~~~~liD 168 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDDEKIYIID 168 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCCCcEEEEE
Confidence 44455442 34589999999999877654 1234777888999 78999999999999999999999999
Q ss_pred cCCccccc
Q 038351 287 FGIAKLLI 294 (348)
Q Consensus 287 fGla~~~~ 294 (348)
||.+....
T Consensus 169 fg~~~~~~ 176 (198)
T cd05144 169 WPQMVSTD 176 (198)
T ss_pred CCccccCC
Confidence 99996654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.1e-17 Score=143.27 Aligned_cols=126 Identities=21% Similarity=0.233 Sum_probs=101.9
Q ss_pred ccccCCcceEEEeEecCCceEEEEeeeeccCc--------cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 163 LISRGGFGSIHKARIQDRMEFSVKGFHLQCSG--------AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 163 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
+||+|+||.||+|.. ++..+++|........ ....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 4578888886432211 1245678999999999987665555566667779999999
Q ss_pred CCCCHHHHHhch-----hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 235 PRGSLEKCLYSS-----NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 235 ~~gsL~~~l~~~-----~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
++++|.+.+... .+++.+|.++| +.+++|+|++|.||+++ ++.+++.|||+++..
T Consensus 80 ~g~~l~~~~~~~~~~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGNDELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999887653 34788999999 88999999999999999 789999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.1e-17 Score=144.58 Aligned_cols=127 Identities=23% Similarity=0.214 Sum_probs=104.5
Q ss_pred cccccCCcceEEEeEecCCceEEEEeeeeccCc--------cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQCSG--------AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+.||+|++|.||+|+. ++..+++|........ ....+.+|++++..+.|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 5667888876432211 123577899999999999988777777777888999999
Q ss_pred cCCCCHHHHHhch--------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 234 MPRGSLEKCLYSS--------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 234 ~~~gsL~~~l~~~--------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
+++++|.+.+... .+++.++.++| ..+++|||++|.||+++ ++.++++|||.++..
T Consensus 81 ~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSNGMEELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhccHHHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999887542 24778899999 88999999999999999 788999999998763
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.6e-17 Score=165.06 Aligned_cols=134 Identities=22% Similarity=0.209 Sum_probs=106.3
Q ss_pred CCccccccccCCcceEEEeEecCCceEEEEeeeec-cC------ccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQ-CS------GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~-~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
.|...+.||+|+||.||++.+.+...++.++.... .. ...+.+.+|++++.+++|++++....++...+..++
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 34557889999999999998765543332222211 11 112457889999999999999988888887778899
Q ss_pred EEeccCCCCHHHHHhch----hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 230 VLEYMPRGSLEKCLYSS----NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~----~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
||||+++++|.+++... .+++.++.||| +.+++|||+||+||++ +++.++|+|||+++...
T Consensus 414 v~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 414 VMEYIGGKDLKDVLEGNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEEecCCCcHHHHHHHHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 99999999999987532 34888999999 8899999999999999 57789999999998753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.7e-17 Score=144.24 Aligned_cols=130 Identities=18% Similarity=0.030 Sum_probs=99.0
Q ss_pred CCccccccccCCcceEEEeE--ecCCceEEEEeeeeccCcc------------------------chhhHHHhhhccccc
Q 038351 157 GFSEDNLISRGGFGSIHKAR--IQDRMEFSVKGFHLQCSGA------------------------FKSFDFECDVMKSTC 210 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l~ 210 (348)
-|+..+.||+|+||.||+|+ ..++..||+|.++...... ...+..|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 5689999999986432100 012467999999998
Q ss_pred ccc--eeeEEEEEecCCeEEEEEeccCCCCHHHHHh------------chhHHHHHHHHHHhcCCCc-eEecCCCcCceE
Q 038351 211 YRN--LIKIISSRSNEDFKVLVLEYMPRGSLEKCLY------------SSNYVGFALEYLHFDYSVL-IIHYDLKPSNVL 275 (348)
Q Consensus 211 H~n--iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~------------~~~~i~~~L~yLH~~~~~~-iiHrDik~~NIL 275 (348)
+.. +.+++++ ...++||||+++.++..... -..+++.++++|| ..+ |+||||||+||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhEE
Confidence 633 4444543 23489999999988755431 1124778889999 788 999999999999
Q ss_pred EcCCCcEEEeecCCccccc
Q 038351 276 FDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 276 ld~~~~~kl~DfGla~~~~ 294 (348)
++ +++++++|||.+....
T Consensus 182 i~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EE-CCCEEEEEChhhhccC
Confidence 99 8899999999998653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.7e-17 Score=144.13 Aligned_cols=167 Identities=19% Similarity=0.342 Sum_probs=128.6
Q ss_pred cccccCCcceEEEeEecCCceEEEEeeeec--cCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCH
Q 038351 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQ--CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL 239 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 239 (348)
.+|.+.-.|..|+|+++.+ .+++|.+... .....++|..|.-.|+...||||..+++.|..+....++..|||.|+|
T Consensus 196 tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 4567788899999999866 4555666433 223457899999999999999999999999999999999999999999
Q ss_pred HHHHhchhH--------------HHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeeccc
Q 038351 240 EKCLYSSNY--------------VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT 305 (348)
Q Consensus 240 ~~~l~~~~~--------------i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~ 305 (348)
+..|+.... +++|++|||.. ++-|..--+.+..+++|++.+++|+ .+-+++..+ ....
T Consensus 275 ynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfsfq------e~gr 346 (448)
T KOG0195|consen 275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ------EVGR 346 (448)
T ss_pred HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceeeee------cccc
Confidence 999987532 88999999965 5666677899999999999998875 222221110 0111
Q ss_pred ccccCc---------------cccccHHHHHHHHHHHcCCCCCcccc
Q 038351 306 LATIGY---------------MASYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 306 ~gt~~y---------------~asDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
.-.+.| .|+|+|||.++++|+.|++.||.+..
T Consensus 347 ~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls 393 (448)
T KOG0195|consen 347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS 393 (448)
T ss_pred ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC
Confidence 123334 34999999999999999999998754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=6e-18 Score=164.17 Aligned_cols=164 Identities=23% Similarity=0.297 Sum_probs=132.8
Q ss_pred ccccCCcceEEEeE----ecCCceEEEEeeeeccC--ccchhhHHHhhhccccc-ccceeeEEEEEecCCeEEEEEeccC
Q 038351 163 LISRGGFGSIHKAR----IQDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 163 ~lG~G~fg~Vy~~~----~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
.+|+|.||.|+.++ .+.+.-+|.|....... ........|..++...+ ||.++++.-.++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 36899999999865 33455677776644322 12224556778888887 9999999999999999999999999
Q ss_pred CCCHHHHHhchhH------------HHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeec
Q 038351 236 RGSLEKCLYSSNY------------VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303 (348)
Q Consensus 236 ~gsL~~~l~~~~~------------i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 303 (348)
+|++...+..... .+-+++.+| +.+|+|||+|++||+++.+|.+++.|||+++.....+
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------ 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------ 151 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhh------
Confidence 9999887765431 455677777 8999999999999999999999999999998765432
Q ss_pred ccccccCccc----------cccHHHHHHHHHHHcCCCCCcc
Q 038351 304 QTLATIGYMA----------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 304 ~~~gt~~y~a----------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
..+||..||| +|.||||++++||+||..||..
T Consensus 152 ~~cgt~eymApEI~~gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 IACGTYEYRAPEIINGHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hcccchhhhhhHhhhccCCcccchhhhhhHHHHhhCCCCCch
Confidence 2288999988 7899999999999999999976
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.5e-16 Score=126.64 Aligned_cols=130 Identities=18% Similarity=0.208 Sum_probs=108.3
Q ss_pred cccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccc--cceeeEEEEEecCCeEEEEEeccCCC
Q 038351 160 EDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCY--RNLIKIISSRSNEDFKVLVLEYMPRG 237 (348)
Q Consensus 160 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~Ey~~~g 237 (348)
..+.+|+|.++.||++...+ ..+++|....... ...+..|+.++..++| ..+++++.+....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 34679999999999999866 6889998754332 4578999999999987 48999999988888999999999988
Q ss_pred CHHH-----HHhchhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 238 SLEK-----CLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 238 sL~~-----~l~~~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
++.. .......++.+++++|..+..+++|+|+||+||++++.+.+++.|||.++.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7753 233344588899999976667899999999999999989999999999865
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.5e-17 Score=161.86 Aligned_cols=177 Identities=23% Similarity=0.283 Sum_probs=133.3
Q ss_pred ccccccccCCcceEEEeEec-CCceEEEEeeeec--cCcc----chhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 159 SEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ--CSGA----FKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 159 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
...+++|.|++|.|+.+... .....+.|..... .... ...+..|+.+-..++|+|++..+..+.......-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999977776533 3333444433211 1111 122556888888999999988877777666655669
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|||++ +|...+... +++..|++|+| ..+|.|||+|++|+++...+.+||+|||.+.......+.
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 99999 999888764 24788999999 889999999999999999999999999999776543332
Q ss_pred --eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcccccc
Q 038351 300 --MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKIFFS 339 (348)
Q Consensus 300 --~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~~~~ 339 (348)
......+|+-.|+| .||||.||++..|++|+.||...-.+
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 44456778888887 89999999999999999999765443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.3e-15 Score=129.06 Aligned_cols=126 Identities=20% Similarity=0.117 Sum_probs=89.5
Q ss_pred ccccccCCcceEEEeEecCCceEEEEeeeeccCc--cchh----------------------hHHHhhhcccccccc--e
Q 038351 161 DNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSG--AFKS----------------------FDFECDVMKSTCYRN--L 214 (348)
Q Consensus 161 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--i 214 (348)
.+.||+|+||+||+|+..++..||||.+...... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999988643211 1111 134555555555443 3
Q ss_pred eeEEEEEecCCeEEEEEeccCCC-----CHHHHHhc------hhHHHHHHHHHHhcCC-CceEecCCCcCceEEcCCCcE
Q 038351 215 IKIISSRSNEDFKVLVLEYMPRG-----SLEKCLYS------SNYVGFALEYLHFDYS-VLIIHYDLKPSNVLFDDNIVT 282 (348)
Q Consensus 215 v~l~~~~~~~~~~~lV~Ey~~~g-----sL~~~l~~------~~~i~~~L~yLH~~~~-~~iiHrDik~~NILld~~~~~ 282 (348)
.+.++. ...++||||++++ .|.+.... ..+++.++.++| . .+|+|||+||+||+++ ++.+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-CCcE
Confidence 444443 2358999999984 44443321 123677888888 6 8999999999999999 8999
Q ss_pred EEeecCCccccc
Q 038351 283 HLSDFGIAKLLI 294 (348)
Q Consensus 283 kl~DfGla~~~~ 294 (348)
+++|||.+....
T Consensus 154 ~liDfg~a~~~~ 165 (187)
T cd05119 154 YIIDVPQAVEID 165 (187)
T ss_pred EEEECccccccc
Confidence 999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.1e-15 Score=132.36 Aligned_cols=129 Identities=16% Similarity=0.188 Sum_probs=100.3
Q ss_pred ccccc-cCCcceEEEeEecCCceEEEEeeeecc-------------CccchhhHHHhhhcccccccce--eeEEEEEecC
Q 038351 161 DNLIS-RGGFGSIHKARIQDRMEFSVKGFHLQC-------------SGAFKSFDFECDVMKSTCYRNL--IKIISSRSNE 224 (348)
Q Consensus 161 ~~~lG-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~ 224 (348)
...|| .|+.|+||++... +..+++|.+.... ......+.+|++++.+++|+++ ++.+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45687 8999999999876 5578888774311 0122457889999999999885 6777765432
Q ss_pred C----eEEEEEeccCC-CCHHHHHhch-------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 225 D----FKVLVLEYMPR-GSLEKCLYSS-------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 225 ~----~~~lV~Ey~~~-gsL~~~l~~~-------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
. ..++||||+++ .+|.+++... .+++.++.+|| +.+|+||||||+|||++.++.++|+|||.++.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 2 23599999997 6898877542 24888999999 89999999999999999988999999999876
Q ss_pred c
Q 038351 293 L 293 (348)
Q Consensus 293 ~ 293 (348)
.
T Consensus 192 ~ 192 (239)
T PRK01723 192 R 192 (239)
T ss_pred C
Confidence 4
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.4e-15 Score=152.92 Aligned_cols=91 Identities=32% Similarity=0.454 Sum_probs=86.3
Q ss_pred CCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceeee
Q 038351 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFL 131 (348)
Q Consensus 52 ~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~l 131 (348)
..++.|+|++|.|+|.+|.+|++|++|+.|+|++|+|+|.||.+++.+++|+.|+|++|+|+|.+|.+++.+++|+.|+|
T Consensus 418 ~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~L 497 (623)
T PLN03150 418 WFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497 (623)
T ss_pred eEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEEC
Confidence 35788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecccccccccc
Q 038351 132 GYNRLQGSISY 142 (348)
Q Consensus 132 s~N~lsG~ip~ 142 (348)
++|+++|.+|.
T Consensus 498 s~N~l~g~iP~ 508 (623)
T PLN03150 498 NGNSLSGRVPA 508 (623)
T ss_pred cCCcccccCCh
Confidence 99999999995
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.2e-14 Score=124.17 Aligned_cols=71 Identities=30% Similarity=0.288 Sum_probs=59.3
Q ss_pred HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecccccccCccc------------cc
Q 038351 248 YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SY 315 (348)
Q Consensus 248 ~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sD 315 (348)
+++.||+|||. .+ ||+||+++.++.+++ ||+++..... ...||+.|+| +|
T Consensus 25 qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~g~~~y~aPE~~~~~~~~~~~D 86 (176)
T smart00750 25 QCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSRVDPYFMAPEVIQGQSYTEKAD 86 (176)
T ss_pred HHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc-------cCCCcccccChHHhcCCCCcchhh
Confidence 48899999994 33 999999999999999 9999876432 1256777876 89
Q ss_pred cHHHHHHHHHHHcCCCCCccc
Q 038351 316 VYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 316 V~S~Gvvl~elltG~~P~~~~ 336 (348)
||||||++|||+||+.||...
T Consensus 87 iwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 87 IYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred HHHHHHHHHHHHhCCCCcccc
Confidence 999999999999999999654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.7e-14 Score=154.56 Aligned_cols=135 Identities=25% Similarity=0.332 Sum_probs=88.0
Q ss_pred CCCcccccCcccCCcccCCC----C--CCcEEEEeccccee-eecCCCCCCCCCCCCCccEEEcccCcccccCccccc-C
Q 038351 3 QRSHSVLHGWKINHLVRQKP----T--HKAVTNITFGLLVF-IILCPRYNYPPLRPPQQENLSLASNELISVIPSTFW-N 74 (348)
Q Consensus 3 ~~~~~~~~~w~~~~~~~~~~----~--~~~v~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~L~~N~l~g~ip~~~~-~ 74 (348)
.||.+.+.+|+.++ +||.| | .++|+.|.+..... +.+.+.+ ..+++|+.|+|++|+++|.||..+. +
T Consensus 42 ~~~~~~~~~w~~~~-~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~----~~l~~L~~L~Ls~n~~~~~ip~~~~~~ 116 (968)
T PLN00113 42 NDPLKYLSNWNSSA-DVCLWQGITCNNSSRVVSIDLSGKNISGKISSAI----FRLPYIQTINLSNNQLSGPIPDDIFTT 116 (968)
T ss_pred CCCcccCCCCCCCC-CCCcCcceecCCCCcEEEEEecCCCccccCChHH----hCCCCCCEEECCCCccCCcCChHHhcc
Confidence 36778889997643 57776 2 35688888754332 2233333 4556666666666666666665543 4
Q ss_pred C----------------------ccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceeeee
Q 038351 75 L----------------------KDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLG 132 (348)
Q Consensus 75 l----------------------~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ls 132 (348)
+ ++|++|+|++|+++|.+|.+++++++|++|++++|.++|.+|..++++++|++|+++
T Consensus 117 l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 196 (968)
T PLN00113 117 SSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLA 196 (968)
T ss_pred CCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeecc
Confidence 4 455555555555556666677777777777777777777777777777777788887
Q ss_pred cccccccccc
Q 038351 133 YNRLQGSISY 142 (348)
Q Consensus 133 ~N~lsG~ip~ 142 (348)
+|++.+.+|.
T Consensus 197 ~n~l~~~~p~ 206 (968)
T PLN00113 197 SNQLVGQIPR 206 (968)
T ss_pred CCCCcCcCCh
Confidence 7777777664
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.4e-14 Score=147.88 Aligned_cols=169 Identities=22% Similarity=0.214 Sum_probs=120.3
Q ss_pred hCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhccccc---ccceeeEEEEEecCCeEEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC---YRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~ 231 (348)
...|.+.+.+|+|+||+||+|...+++.||+|.-+....- +|.--.+++.+|+ -+.|..+...+...+..+||+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 3457788899999999999999988999999986544321 1222233444444 234555555566678889999
Q ss_pred eccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEc-------CCCcEEEeecCCccc
Q 038351 232 EYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFD-------DNIVTHLSDFGIAKL 292 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld-------~~~~~kl~DfGla~~ 292 (348)
||.+.|+|.+++.... +++..++.|| ..+|||+||||+|.||. +...++|+|||-+-.
T Consensus 774 ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 774 EYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred eccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 9999999999987543 2667788888 88999999999999994 345689999999855
Q ss_pred cc--cCCceeeecccc------------cccCccccccHHHHHHHHHHHcCCC
Q 038351 293 LI--REDHFMIQTQTL------------ATIGYMASYVYSFGIMLLEVFTRKK 331 (348)
Q Consensus 293 ~~--~~~~~~~~~~~~------------gt~~y~asDV~S~Gvvl~elltG~~ 331 (348)
+. .+... -...+ |-+.-...|.|.+..+++-|+.|+.
T Consensus 851 m~lfp~~~~--F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 851 MKLFPDGTK--FKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeEcCCCcE--EeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 42 11110 01111 2222223899999999999999985
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.3e-14 Score=147.82 Aligned_cols=150 Identities=28% Similarity=0.358 Sum_probs=108.5
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
..+|...++|..|++|.||..+++ ..+.+|.| +..+.. +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee------------------
Confidence 467889999999999999999977 45677874 322210 1110 22222333333
Q ss_pred cCCCCHHHHHhch----hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC------------
Q 038351 234 MPRGSLEKCLYSS----NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED------------ 297 (348)
Q Consensus 234 ~~~gsL~~~l~~~----~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~------------ 297 (348)
|+-.+.++.. ..++.+++|+| +.+|+|||+||+|.++..-|.+|+.|||+.+......
T Consensus 136 ---gDc~tllk~~g~lPvdmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~ 209 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGPLPVDMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKD 209 (1205)
T ss_pred ---chhhhhcccCCCCcchhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHH
Confidence 3444444432 12567999999 9999999999999999999999999999987643210
Q ss_pred -ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 -HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 -~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
........+||+.|+| +|+|++|+|+||.+.|+.||+..
T Consensus 210 t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 210 THEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred HHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 0112345689999998 89999999999999999999776
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.5e-14 Score=144.51 Aligned_cols=111 Identities=19% Similarity=0.256 Sum_probs=93.9
Q ss_pred EEEEeccccee-eecCCCCCCCCCCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCccccee
Q 038351 27 VTNITFGLLVF-IILCPRYNYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKI 105 (348)
Q Consensus 27 v~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l 105 (348)
|+.|.+...++ +.+.+.+ +.+++|+.|+|++|+|+|.||.+++++++|+.|||++|+|+|.+|.++++|++|+.|
T Consensus 420 v~~L~L~~n~L~g~ip~~i----~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L 495 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDI----SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRIL 495 (623)
T ss_pred EEEEECCCCCccccCCHHH----hCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEE
Confidence 44555544332 3344444 889999999999999999999999999999999999999999999999999999999
Q ss_pred ecccCcccCccCCccccc-cccceeeeeccccccccc
Q 038351 106 YFSMNNFAGVIPNAIGCL-NILQHLFLGYNRLQGSIS 141 (348)
Q Consensus 106 ~ls~N~l~G~iP~~l~~l-~~L~~L~ls~N~lsG~ip 141 (348)
+|++|+|+|.+|..++.+ ..+..++++.|...+..|
T Consensus 496 ~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 496 NLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred ECcCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999999999998874 456788888887665555
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.5e-14 Score=136.85 Aligned_cols=130 Identities=29% Similarity=0.409 Sum_probs=102.3
Q ss_pred cccccccceeeEEEEEecCCeEEEEEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCce-EecCCCc
Q 038351 206 MKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLI-IHYDLKP 271 (348)
Q Consensus 206 l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~i-iHrDik~ 271 (348)
|+.+.|.|+.+++|.+..+...++|.+||+.|+|.+.+.... .++.||+|+| ..+| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence 467899999999999999999999999999999999988743 2788999999 4444 9999999
Q ss_pred CceEEcCCCcEEEeecCCccccccCCc------------eeeecccccc-------cCccccccHHHHHHHHHHHcCCCC
Q 038351 272 SNVLFDDNIVTHLSDFGIAKLLIREDH------------FMIQTQTLAT-------IGYMASYVYSFGIMLLEVFTRKKP 332 (348)
Q Consensus 272 ~NILld~~~~~kl~DfGla~~~~~~~~------------~~~~~~~~gt-------~~y~asDV~S~Gvvl~elltG~~P 332 (348)
+|+++|....+|++|||+......... +..+....+. .+-...||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 999999999999999999887632100 0011111110 011238999999999999999999
Q ss_pred Cccccc
Q 038351 333 TNKIFF 338 (348)
Q Consensus 333 ~~~~~~ 338 (348)
|+....
T Consensus 158 ~~~~~~ 163 (484)
T KOG1023|consen 158 FDLRNL 163 (484)
T ss_pred cccccc
Confidence 987543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.3e-13 Score=124.25 Aligned_cols=177 Identities=19% Similarity=0.204 Sum_probs=105.9
Q ss_pred CccccccccCCcceEEEeEec-CCceEEEEeeeeccCc---cchhhHHHhhhccccc----------ccceeeEEEEEe-
Q 038351 158 FSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG---AFKSFDFECDVMKSTC----------YRNLIKIISSRS- 222 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~----------H~niv~l~~~~~- 222 (348)
....+.||.|+++.||.+... +++++|+|.+...... ..+++.+|.-....+. |-.++--++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 445678999999999999976 5889999998654322 3355666654444322 212222222111
Q ss_pred --------cC---C-----eEEEEEeccCCCCHHHHHhc---h----------------hHHHHHHHHHHhcCCCceEec
Q 038351 223 --------NE---D-----FKVLVLEYMPRGSLEKCLYS---S----------------NYVGFALEYLHFDYSVLIIHY 267 (348)
Q Consensus 223 --------~~---~-----~~~lV~Ey~~~gsL~~~l~~---~----------------~~i~~~L~yLH~~~~~~iiHr 267 (348)
.. . ..+++|+-+ .+||.+++.. . .++.+.+++|| ..+++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence 11 1 135677777 5588776542 1 12456788999 8899999
Q ss_pred CCCcCceEEcCCCcEEEeecCCccccccCCceeeecccccc----------------cCccccccHHHHHHHHHHHcCCC
Q 038351 268 DLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLAT----------------IGYMASYVYSFGIMLLEVFTRKK 331 (348)
Q Consensus 268 Dik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt----------------~~y~asDV~S~Gvvl~elltG~~ 331 (348)
||||+|++++.+|.+.|+||+........... .......+ ....+.|.|++|+++|.|++|+.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999999876544221110 00000000 01123799999999999999999
Q ss_pred CCcccccc
Q 038351 332 PTNKIFFS 339 (348)
Q Consensus 332 P~~~~~~~ 339 (348)
||+....+
T Consensus 249 Pf~~~~~~ 256 (288)
T PF14531_consen 249 PFGLSSPE 256 (288)
T ss_dssp STCCCGGG
T ss_pred CCCCCCcc
Confidence 99866443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.1e-13 Score=133.04 Aligned_cols=139 Identities=17% Similarity=0.175 Sum_probs=94.3
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccc---------------------------------------
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAF--------------------------------------- 196 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~--------------------------------------- 196 (348)
..|+ .+.||.|++|.||+|++.+|+.||||..+.......
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3444 367999999999999999999999999854311100
Q ss_pred -hhhHHHhhhccccc----ccceeeEEEEEe-cCCeEEEEEeccCCCCHHHHHhch------hHHHHH-H-HHHHhcCCC
Q 038351 197 -KSFDFECDVMKSTC----YRNLIKIISSRS-NEDFKVLVLEYMPRGSLEKCLYSS------NYVGFA-L-EYLHFDYSV 262 (348)
Q Consensus 197 -~~~~~E~~~l~~l~----H~niv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~~------~~i~~~-L-~yLH~~~~~ 262 (348)
-+|.+|.+.+.+++ |.+-+.+-..+. .....+|||||+++++|.+..... ..++.. + .+++..+..
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhC
Confidence 02444555555443 222233323222 234579999999999998765421 123321 1 234444488
Q ss_pred ceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 263 LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 263 ~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
+++|+|+||.||++++++.+++.|||+++.+.+
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1e-13 Score=141.79 Aligned_cols=173 Identities=20% Similarity=0.211 Sum_probs=122.4
Q ss_pred CCccccccccCCcceEEEeEecCCceEEEEeeeeccC-ccchhhHH---HhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 157 GFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCS-GAFKSFDF---ECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
++...+.+|+++|=+|.+|+.+.|. |+||.+-.+.. -..+.|.+ |++ ...++|||.+.+.-+-..+...|||=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5666788999999999999999986 88998865542 23444544 444 566689999998777667777788888
Q ss_pred ccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc-ccCCc-
Q 038351 233 YMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL-IREDH- 298 (348)
Q Consensus 233 y~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~-~~~~~- 298 (348)
|..+ +|++.+..+. ++..|+.-.| ..+|+|+|||.+|||++.-.=+.|+||.--|-- .+++.
T Consensus 102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 8844 8888876543 2445566566 999999999999999998777889998754431 11110
Q ss_pred ---------------eeeecccccccCcc-----------ccccHHHHHHHHHHHc-CCCCCcc
Q 038351 299 ---------------FMIQTQTLATIGYM-----------ASYVYSFGIMLLEVFT-RKKPTNK 335 (348)
Q Consensus 299 ---------------~~~~~~~~gt~~y~-----------asDV~S~Gvvl~ellt-G~~P~~~ 335 (348)
+.+++.+..+.+++ |-||||+||++.|+++ |++||+-
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 11222222222222 2799999999999987 5888753
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.7e-12 Score=107.33 Aligned_cols=126 Identities=17% Similarity=0.141 Sum_probs=92.4
Q ss_pred cccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhccccccccee-eEEEEEecCCeEEEEEeccCCCCHH
Q 038351 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLI-KIISSRSNEDFKVLVLEYMPRGSLE 240 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~Ey~~~gsL~ 240 (348)
+.++.|.++.||+++.. +..+++|....... ....+..|++++..+.+.+++ +++.+.. ...++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 56788999999999876 66799998754322 234568899999988765544 5555433 3458999999998886
Q ss_pred HHH----hchhHHHHHHHHHHhcC--CCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 241 KCL----YSSNYVGFALEYLHFDY--SVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 241 ~~l----~~~~~i~~~L~yLH~~~--~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
+.- .....++++++.||... ...++|+|++|.||+++ ++.+++.||+.+..
T Consensus 80 ~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TEDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 421 11234888999999432 22369999999999999 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.30 E-value=2e-12 Score=128.14 Aligned_cols=141 Identities=17% Similarity=0.156 Sum_probs=95.9
Q ss_pred hhCCCccccccccCCcceEEEeEecC-CceEEEEeeeeccCc----------------------------------cch-
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQD-RMEFSVKGFHLQCSG----------------------------------AFK- 197 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~- 197 (348)
.-..|+. +.+|+|++|.||+|++++ |++||||..+..... ..+
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3445776 789999999999999987 999999998643110 001
Q ss_pred -----hhHHHhhhccccc----ccceeeEEEEEec-CCeEEEEEeccCCCCHHHH--Hhchh----HHHH--HHHHHHhc
Q 038351 198 -----SFDFECDVMKSTC----YRNLIKIISSRSN-EDFKVLVLEYMPRGSLEKC--LYSSN----YVGF--ALEYLHFD 259 (348)
Q Consensus 198 -----~~~~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~--l~~~~----~i~~--~L~yLH~~ 259 (348)
++.+|+..+.+++ +...+.+-..+.+ ....+|||||++|+++.+. +...+ .++. +-.|++..
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 2334444444443 3333443333332 3457899999999999764 32221 2322 22355555
Q ss_pred CCCceEecCCCcCceEEcCCC----cEEEeecCCcccccc
Q 038351 260 YSVLIIHYDLKPSNVLFDDNI----VTHLSDFGIAKLLIR 295 (348)
Q Consensus 260 ~~~~iiHrDik~~NILld~~~----~~kl~DfGla~~~~~ 295 (348)
...+++|+|+||.||+++.++ .+++.|||++..+.+
T Consensus 277 f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 578999999999999999888 999999999987754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.7e-13 Score=136.71 Aligned_cols=182 Identities=24% Similarity=0.282 Sum_probs=142.7
Q ss_pred CCCccccccccCCcceEEEeEec--CCceEEEEeeeecc--CccchhhHHHhhhccccc-ccceeeEEEEEecCCeEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ--DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV 230 (348)
..|...+.||+|+|+.|-.+... ....+|+|.+.... .........|..+-+.+. |+|++++++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 35666677999999999887653 34455666654332 223344556888877887 99999999999999999999
Q ss_pred EeccCCCCHHHHH-hchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCC-cEEEeecCCcccccc
Q 038351 231 LEYMPRGSLEKCL-YSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI-VTHLSDFGIAKLLIR 295 (348)
Q Consensus 231 ~Ey~~~gsL~~~l-~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DfGla~~~~~ 295 (348)
.||..++++.+.+ .... +...++.|+|. ..++.|||+||+|.+++..+ ..+++|||+|..+..
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999998887 3321 25567888884 56799999999999999999 999999999988876
Q ss_pred -CCceeeeccccc-ccCccc-------------cccHHHHHHHHHHHcCCCCCcccccc
Q 038351 296 -EDHFMIQTQTLA-TIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKIFFS 339 (348)
Q Consensus 296 -~~~~~~~~~~~g-t~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~~~~ 339 (348)
.+........+| ++.|+| .|+||.|+++.-+++|..|++.....
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~ 236 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK 236 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence 444445556677 888887 79999999999999999999876543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.3e-11 Score=111.89 Aligned_cols=123 Identities=23% Similarity=0.339 Sum_probs=84.1
Q ss_pred ccccceeeEEEEEecC---------------------------CeEEEEEeccCCCCHHHHHhchh-----------HHH
Q 038351 209 TCYRNLIKIISSRSNE---------------------------DFKVLVLEYMPRGSLEKCLYSSN-----------YVG 250 (348)
Q Consensus 209 l~H~niv~l~~~~~~~---------------------------~~~~lV~Ey~~~gsL~~~l~~~~-----------~i~ 250 (348)
.+|||||++.++|.+. ...|+||.-.+. +|.+++.... ++.
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHH
Confidence 3699999999987652 136788887744 8888876432 245
Q ss_pred HHHHHHHhcCCCceEecCCCcCceEE--cCCCc--EEEeecCCccccccC----------------Cceeeecc---ccc
Q 038351 251 FALEYLHFDYSVLIIHYDLKPSNVLF--DDNIV--THLSDFGIAKLLIRE----------------DHFMIQTQ---TLA 307 (348)
Q Consensus 251 ~~L~yLH~~~~~~iiHrDik~~NILl--d~~~~--~kl~DfGla~~~~~~----------------~~~~~~~~---~~g 307 (348)
+|+.||| ..+|.|||+|++|||+ |++.. ..|+|||.+-.-... ...++++. ..|
T Consensus 352 Eav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 5667777 8999999999999998 44443 579999986322110 00111111 111
Q ss_pred ---ccCccccccHHHHHHHHHHHcCCCCCcc
Q 038351 308 ---TIGYMASYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 308 ---t~~y~asDV~S~Gvvl~elltG~~P~~~ 335 (348)
...|-.+|.|+.|.+.||+++...||-.
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 1234459999999999999999999965
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.9e-10 Score=95.41 Aligned_cols=127 Identities=21% Similarity=0.215 Sum_probs=94.9
Q ss_pred cccccCCcceEEEeEecCCceEEEEeeeeccCc--c------chhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQCSG--A------FKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
..+++|+-+.+|.+.+.+.. +++|.-..+... . .....+|+.++.+++--.|..-.=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999775443 445533222111 1 23456799999988766665555566677788899999
Q ss_pred cCCCCHHHHHhchh-----HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 234 MPRGSLEKCLYSSN-----YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 234 ~~~gsL~~~l~~~~-----~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
+++-.|.+.+.... .+..-+.-|| ..+|+|+|+.++||++.... +.++|||+++.-
T Consensus 81 I~G~~lkd~l~~~~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEARPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhcchHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 99988888887662 2666778899 89999999999999998775 899999999864
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.1e-11 Score=99.63 Aligned_cols=105 Identities=22% Similarity=0.393 Sum_probs=63.9
Q ss_pred EEEEecccceeeecCCCCCCCCCCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceee
Q 038351 27 VTNITFGLLVFIILCPRYNYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIY 106 (348)
Q Consensus 27 v~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ 106 (348)
+|.++++---+...+|.+ ..+.+|+.|+|++|++.. +|.+|+++++|+.|+++-|+|. ..|..||.++.|++||
T Consensus 35 ITrLtLSHNKl~~vppni----a~l~nlevln~~nnqie~-lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 35 ITRLTLSHNKLTVVPPNI----AELKNLEVLNLSNNQIEE-LPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhcccCceeecCCcH----HHhhhhhhhhcccchhhh-cChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 444444322234455555 666777777777777663 6777777777777777777776 6677777777777777
Q ss_pred cccCcccC-ccCCccccccccceeeeeccccc
Q 038351 107 FSMNNFAG-VIPNAIGCLNILQHLFLGYNRLQ 137 (348)
Q Consensus 107 ls~N~l~G-~iP~~l~~l~~L~~L~ls~N~ls 137 (348)
|..|+|+- .+|..+..+..|..|.|+.|.|.
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe 140 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE 140 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc
Confidence 77776653 34555555555555555555544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.6e-09 Score=95.59 Aligned_cols=131 Identities=17% Similarity=0.124 Sum_probs=97.7
Q ss_pred cccccCCcceEEEeEecCCceEEEEeeeeccC-ccchhhHHHhhhccccccc--ceeeEEEEEecCC---eEEEEEeccC
Q 038351 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYR--NLIKIISSRSNED---FKVLVLEYMP 235 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~~~---~~~lV~Ey~~ 235 (348)
+.++.|.++.||+++..++..+++|....... .....+..|.++++.+++. .+.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56889999999999987777899998754322 2346788999999998764 4577777776543 5689999999
Q ss_pred CCCHHHHHh-----------chhHHHHHHHHHHhc---------------------------------------------
Q 038351 236 RGSLEKCLY-----------SSNYVGFALEYLHFD--------------------------------------------- 259 (348)
Q Consensus 236 ~gsL~~~l~-----------~~~~i~~~L~yLH~~--------------------------------------------- 259 (348)
+.++.+.+. ....++++|..||..
T Consensus 84 G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (223)
T cd05154 84 GRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRW 163 (223)
T ss_pred CEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHH
Confidence 988866542 012356666666631
Q ss_pred --------CCCceEecCCCcCceEEcC--CCcEEEeecCCccc
Q 038351 260 --------YSVLIIHYDLKPSNVLFDD--NIVTHLSDFGIAKL 292 (348)
Q Consensus 260 --------~~~~iiHrDik~~NILld~--~~~~kl~DfGla~~ 292 (348)
....++|+|+++.||+++. ++.+.|.||+.+..
T Consensus 164 ~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 164 LEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1245899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.4e-11 Score=114.73 Aligned_cols=97 Identities=29% Similarity=0.515 Sum_probs=79.0
Q ss_pred eEEEEEeccCCCCHHHHHhchh---------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSSN---------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIA 290 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~~---------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla 290 (348)
+.++.|++|...+|.++|.... +++.|++| ++.+|||+||.||....+...||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 5789999999999999996432 24455555 67899999999999999999999999998
Q ss_pred cccccCC----ceeeecccccccCccc------------cccHHHHHHHHHHHc
Q 038351 291 KLLIRED----HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328 (348)
Q Consensus 291 ~~~~~~~----~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt 328 (348)
....... .....+.-.||..||+ +||||+|++++|+++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7765443 1223356679999997 899999999999998
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.2e-09 Score=92.20 Aligned_cols=124 Identities=18% Similarity=0.146 Sum_probs=86.0
Q ss_pred cccccCCcceEEEeEecC-------CceEEEEeeeeccC----------cc------------chhh----HHHhhhccc
Q 038351 162 NLISRGGFGSIHKARIQD-------RMEFSVKGFHLQCS----------GA------------FKSF----DFECDVMKS 208 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~----------~~------------~~~~----~~E~~~l~~ 208 (348)
..||.|.-+.||.|...+ +..+|||..+.... +. .+.+ .+|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998553 47899997753210 00 1112 378888888
Q ss_pred ccc--cceeeEEEEEecCCeEEEEEeccCCCCH-----HHHHhc-------hhHHHHHHHHH-HhcCCCceEecCCCcCc
Q 038351 209 TCY--RNLIKIISSRSNEDFKVLVLEYMPRGSL-----EKCLYS-------SNYVGFALEYL-HFDYSVLIIHYDLKPSN 273 (348)
Q Consensus 209 l~H--~niv~l~~~~~~~~~~~lV~Ey~~~gsL-----~~~l~~-------~~~i~~~L~yL-H~~~~~~iiHrDik~~N 273 (348)
+.- -++.+.+++ ..-++||||+.+..+ .+.... ..++..++..+ | ..+|||+|+++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHH
Confidence 864 456677764 456899999976422 222111 12366677777 5 7799999999999
Q ss_pred eEEcCCCcEEEeecCCcccc
Q 038351 274 VLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 274 ILld~~~~~kl~DfGla~~~ 293 (348)
|++++ +.+.++|||-+-..
T Consensus 156 IL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred EEEEC-CcEEEEECCCceeC
Confidence 99974 67999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.1e-09 Score=104.98 Aligned_cols=152 Identities=14% Similarity=0.098 Sum_probs=111.2
Q ss_pred EecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCCHHHHHhch---------
Q 038351 176 RIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSS--------- 246 (348)
Q Consensus 176 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~--------- 246 (348)
+..++.+|.|...+...........+-++.|+.++||||+++++.+..++..|||+|-+.- |..+++..
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l~~~~v~~Gl 110 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKELGKEEVCLGL 110 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHhHHHHHHHHH
Confidence 4557788888887655543345567788899999999999999999999999999998743 44444432
Q ss_pred hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecccccc--------cCccccccHH
Q 038351 247 NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLAT--------IGYMASYVYS 318 (348)
Q Consensus 247 ~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt--------~~y~asDV~S 318 (348)
.+|..||.|||+ +..++|++|....|+++..|+-||++|-++.................+ +.-++.|.|-
T Consensus 111 ~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~s~D~~~ 188 (690)
T KOG1243|consen 111 FQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEWSIDSWG 188 (690)
T ss_pred HHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccccchhhhh
Confidence 248899999985 568999999999999999999999999887554322110000000000 0013469999
Q ss_pred HHHHHHHHHcCCC
Q 038351 319 FGIMLLEVFTRKK 331 (348)
Q Consensus 319 ~Gvvl~elltG~~ 331 (348)
|||+++|++.|..
T Consensus 189 Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 189 LGCLIEELFNGSL 201 (690)
T ss_pred HHHHHHHHhCccc
Confidence 9999999999943
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.5e-10 Score=96.33 Aligned_cols=89 Identities=30% Similarity=0.481 Sum_probs=82.7
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
-.+..++.|-||+|.++ .+|+.|+.|.+|+.|++++|++. .+|.++..|+.|+.|+++-|.|. ..|..++.++.|+.
T Consensus 30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence 44677889999999999 59999999999999999999999 99999999999999999999998 78999999999999
Q ss_pred eeeecccccccc
Q 038351 129 LFLGYNRLQGSI 140 (348)
Q Consensus 129 L~ls~N~lsG~i 140 (348)
|||++|+++...
T Consensus 107 ldltynnl~e~~ 118 (264)
T KOG0617|consen 107 LDLTYNNLNENS 118 (264)
T ss_pred hhcccccccccc
Confidence 999999998643
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.91 E-value=9.3e-10 Score=77.22 Aligned_cols=61 Identities=38% Similarity=0.486 Sum_probs=42.1
Q ss_pred CCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcc
Q 038351 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNF 112 (348)
Q Consensus 52 ~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l 112 (348)
|+|+.|+|++|+|+.--+..|.++++|++|+|++|+++.--|..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4677777777777754334667777777777777777755556677777777777777764
|
... |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=3e-08 Score=83.90 Aligned_cols=130 Identities=18% Similarity=0.209 Sum_probs=91.8
Q ss_pred cccccccCCcceEEEeEecCCceEEEEe-eeecc-C------ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 160 EDNLISRGGFGSIHKARIQDRMEFSVKG-FHLQC-S------GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 160 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~-~~~~~-~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
...++-||+-+.|+++.+... ...||. +.+.- . -..+...+|++++.+++--.|.--.=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~Ge-~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGE-AAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccCCc-eeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567889999999999987654 444443 22111 1 11345677999998887655554445566666668999
Q ss_pred eccCC-CCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC---cEEEeecCCcccc
Q 038351 232 EYMPR-GSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI---VTHLSDFGIAKLL 293 (348)
Q Consensus 232 Ey~~~-gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~---~~kl~DfGla~~~ 293 (348)
||+++ .++.+++... ..+.+.+.-|| ...|||+|+.++||++..++ .+.+.|||++..-
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99977 3566666532 12667788899 88999999999999997544 3589999998654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.80 E-value=5.1e-09 Score=102.16 Aligned_cols=177 Identities=22% Similarity=0.215 Sum_probs=129.2
Q ss_pred CCCcccccccc--CCcceEEEeEe---cCCceEEEEeeeeccC--ccchhhHHHhhhccccc-ccceeeEEEEEecCCeE
Q 038351 156 NGFSEDNLISR--GGFGSIHKARI---QDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFK 227 (348)
Q Consensus 156 ~~f~~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 227 (348)
..|.....+|. |.+|.||.++. .+...+|+|+-+.... .....-.+|+...++++ |+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34556678899 99999999986 3677888887432222 22334456777777776 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHhchhH-------------HHH----HHHHHHhcCCCceEecCCCcCceEEcCC-CcEEEeecCC
Q 038351 228 VLVLEYMPRGSLEKCLYSSNY-------------VGF----ALEYLHFDYSVLIIHYDLKPSNVLFDDN-IVTHLSDFGI 289 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~~~-------------i~~----~L~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DfGl 289 (348)
++-+|+|. .++.++.+.... ..+ |+..+| ...++|-|+||+||++..+ ...++.|||+
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence 99999995 566665543211 222 555555 9999999999999999998 8899999999
Q ss_pred ccccccCCcee---eecccccccCccc-----------cccHHHHHHHHHHHcCCCCCccc
Q 038351 290 AKLLIREDHFM---IQTQTLATIGYMA-----------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 290 a~~~~~~~~~~---~~~~~~gt~~y~a-----------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...+....... ......|..-|++ +|+||+|.+++|..++..+...-
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCC
Confidence 98876543211 1112245556765 89999999999999988765444
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.5e-09 Score=74.24 Aligned_cols=61 Identities=34% Similarity=0.355 Sum_probs=55.0
Q ss_pred ccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceeeeecccc
Q 038351 76 KDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLGYNRL 136 (348)
Q Consensus 76 ~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ls~N~l 136 (348)
++|++|+|++|+++.--+..|..+++|++|++++|+++..-|..+..+++|++|++++|++
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4789999999999944446789999999999999999988788999999999999999985
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.2e-08 Score=84.79 Aligned_cols=115 Identities=23% Similarity=0.164 Sum_probs=72.7
Q ss_pred eEEEeEecCCceEEEEeeeeccCcc--------------------------chhhHHHhhhccccccc--ceeeEEEEEe
Q 038351 171 SIHKARIQDRMEFSVKGFHLQCSGA--------------------------FKSFDFECDVMKSTCYR--NLIKIISSRS 222 (348)
Q Consensus 171 ~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~H~--niv~l~~~~~ 222 (348)
.||.|...++..+|+|......... .....+|.+.|.++..- ++.+.+.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899999999999999875321100 12356799999988765 566776553
Q ss_pred cCCeEEEEEeccC--CCCHHHHHhch------h----HHHHHHH-HHHhcCCCceEecCCCcCceEEcCCCcEEEeecCC
Q 038351 223 NEDFKVLVLEYMP--RGSLEKCLYSS------N----YVGFALE-YLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGI 289 (348)
Q Consensus 223 ~~~~~~lV~Ey~~--~gsL~~~l~~~------~----~i~~~L~-yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGl 289 (348)
.-.|||||++ +..+..+.... . .+...+. .+| ..+|+|+|+.+.||+++++ .+.++|||-
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ---CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2379999998 54444333222 1 1333233 345 8899999999999999988 899999998
Q ss_pred cccc
Q 038351 290 AKLL 293 (348)
Q Consensus 290 a~~~ 293 (348)
+...
T Consensus 153 av~~ 156 (188)
T PF01163_consen 153 AVDS 156 (188)
T ss_dssp EEET
T ss_pred ceec
Confidence 8654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.3e-10 Score=102.44 Aligned_cols=87 Identities=26% Similarity=0.384 Sum_probs=77.5
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceeccccccc----------------------CCCCcC-CCCCccccee
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLT----------------------GPIPLE-IENLKVLVKI 105 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~----------------------G~iP~~-~~~l~~L~~l 105 (348)
+.+++|+.|+|++|-|. .||.+++.+-+||.||+|.|+|. |.+|.+ +.+|.+|+.|
T Consensus 432 ~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tL 510 (565)
T KOG0472|consen 432 SQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTL 510 (565)
T ss_pred Hhhhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhccee
Confidence 77899999999988877 59999999999999999999885 455555 7788899999
Q ss_pred ecccCcccCccCCccccccccceeeeeccccc
Q 038351 106 YFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137 (348)
Q Consensus 106 ~ls~N~l~G~iP~~l~~l~~L~~L~ls~N~ls 137 (348)
||.+|.+. +||+.++++++|++|.+++|.|+
T Consensus 511 DL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 511 DLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 99999998 89999999999999999999998
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.9e-09 Score=105.29 Aligned_cols=88 Identities=33% Similarity=0.441 Sum_probs=64.6
Q ss_pred CCCCCccEEEcccCcccc-cCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCcc-cccccc
Q 038351 49 LRPPQQENLSLASNELIS-VIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAI-GCLNIL 126 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g-~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l-~~l~~L 126 (348)
+.||.|+++.+..|+|.- .||.+|.+|..|+.||||+|+|+ ..|..+..-+++-+|+||+|++. +||.++ .+|+.|
T Consensus 75 s~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDL 152 (1255)
T KOG0444|consen 75 SDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDL 152 (1255)
T ss_pred ccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhH
Confidence 777888888888888732 38888888888888888888887 77888877778778888877776 566543 455666
Q ss_pred ceeeeecccccc
Q 038351 127 QHLFLGYNRLQG 138 (348)
Q Consensus 127 ~~L~ls~N~lsG 138 (348)
-+||||+|+|.-
T Consensus 153 LfLDLS~NrLe~ 164 (1255)
T KOG0444|consen 153 LFLDLSNNRLEM 164 (1255)
T ss_pred hhhccccchhhh
Confidence 666666666654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=9.3e-09 Score=93.77 Aligned_cols=128 Identities=23% Similarity=0.300 Sum_probs=90.0
Q ss_pred hhhcccccccceeeEEEEEecC-----CeEEEEEeccCCCCHHHHHhchh----------------HHHHHHHHHHhcCC
Q 038351 203 CDVMKSTCYRNLIKIISSRSNE-----DFKVLVLEYMPRGSLEKCLYSSN----------------YVGFALEYLHFDYS 261 (348)
Q Consensus 203 ~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~----------------~i~~~L~yLH~~~~ 261 (348)
...+-++.|-|||+++.|+.+. .+..++.|||+.|++..+|+... +|..||.||| .|.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccC
Confidence 3456677899999999988654 45788999999999999998643 2788999999 458
Q ss_pred CceEecCCCcCceEEcCCCcEEEeecCCccccc--cCCceeeecccccccCcc------------ccccHHHHHHHHHHH
Q 038351 262 VLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI--REDHFMIQTQTLATIGYM------------ASYVYSFGIMLLEVF 327 (348)
Q Consensus 262 ~~iiHrDik~~NILld~~~~~kl~DfGla~~~~--~~~~~~~~~~~~gt~~y~------------asDV~S~Gvvl~ell 327 (348)
++|+|+++..+-|++..++-+|+.--.-...-. ..........-.+-++|. |+|||+||...+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 999999999999999999988875321110000 000000000111223332 399999999999998
Q ss_pred cCCC
Q 038351 328 TRKK 331 (348)
Q Consensus 328 tG~~ 331 (348)
.+..
T Consensus 277 ilEi 280 (458)
T KOG1266|consen 277 ILEI 280 (458)
T ss_pred Hhee
Confidence 8875
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.5e-09 Score=99.56 Aligned_cols=96 Identities=23% Similarity=0.223 Sum_probs=83.2
Q ss_pred eecCCCCCCCCCCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCC-CCcccceeecccCcccCcc
Q 038351 38 IILCPRYNYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIE-NLKVLVKIYFSMNNFAGVI 116 (348)
Q Consensus 38 ~~~~~~~~~~~~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~-~l~~L~~l~ls~N~l~G~i 116 (348)
+++++.+ +.+.+|.-|||..|.+.- +| +|+.|+.|..|.++.|++. .+|.+.+ ++.+|.+|||..|++. ++
T Consensus 196 ~tlP~~l----g~l~~L~~LyL~~Nki~~-lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~ 267 (565)
T KOG0472|consen 196 ETLPPEL----GGLESLELLYLRRNKIRF-LP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EV 267 (565)
T ss_pred hcCChhh----cchhhhHHHHhhhccccc-CC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cC
Confidence 5677777 888899999999999874 78 8889998988888888888 8888877 8999999999999998 89
Q ss_pred CCccccccccceeeeeccccccccc
Q 038351 117 PNAIGCLNILQHLFLGYNRLQGSIS 141 (348)
Q Consensus 117 P~~l~~l~~L~~L~ls~N~lsG~ip 141 (348)
|..+..+.+|.+||+|+|.+++--+
T Consensus 268 Pde~clLrsL~rLDlSNN~is~Lp~ 292 (565)
T KOG0472|consen 268 PDEICLLRSLERLDLSNNDISSLPY 292 (565)
T ss_pred chHHHHhhhhhhhcccCCccccCCc
Confidence 9999999999999999999987543
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.61 E-value=7.1e-09 Score=101.42 Aligned_cols=93 Identities=30% Similarity=0.379 Sum_probs=70.3
Q ss_pred eecCCCCCCCCCCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCC-CCCcccceeecccCcccCcc
Q 038351 38 IILCPRYNYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFAGVI 116 (348)
Q Consensus 38 ~~~~~~~~~~~~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~-~~l~~L~~l~ls~N~l~G~i 116 (348)
.++++++ -++.-|+.|+||+|+|.- .|..+-+-+++..|+||+|++. +||.++ .+|+.|-+||||+|.|. .+
T Consensus 93 sGiP~di----F~l~dLt~lDLShNqL~E-vP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~L 165 (1255)
T KOG0444|consen 93 SGIPTDI----FRLKDLTILDLSHNQLRE-VPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-ML 165 (1255)
T ss_pred CCCCchh----cccccceeeecchhhhhh-cchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hc
Confidence 3455555 677778888888888774 7778888888888888888877 777664 47777788888888877 77
Q ss_pred CCccccccccceeeeeccccc
Q 038351 117 PNAIGCLNILQHLFLGYNRLQ 137 (348)
Q Consensus 117 P~~l~~l~~L~~L~ls~N~ls 137 (348)
|+++..|..|+.|+||+|.|.
T Consensus 166 PPQ~RRL~~LqtL~Ls~NPL~ 186 (1255)
T KOG0444|consen 166 PPQIRRLSMLQTLKLSNNPLN 186 (1255)
T ss_pred CHHHHHHhhhhhhhcCCChhh
Confidence 778888888888888887664
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.7e-08 Score=104.03 Aligned_cols=180 Identities=24% Similarity=0.212 Sum_probs=119.7
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeee---eccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFH---LQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~---~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.|...+-+-++.++.++.++-. .+...+.|... .-.....+....+-.++-..+||-+++..-.+......+||++
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~ 884 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGH 884 (1205)
T ss_pred cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhH
Confidence 3444555667788888776533 22222222221 1111222333334444444456666665555556778899999
Q ss_pred ccCCCCHHHHHhchhH------------HHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc-----
Q 038351 233 YMPRGSLEKCLYSSNY------------VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR----- 295 (348)
Q Consensus 233 y~~~gsL~~~l~~~~~------------i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~----- 295 (348)
|..+++|...|+.... +.++++||| ...++|||++|.|++...++..+++|||+......
T Consensus 885 ~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 885 YLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred HhccCCchhhhhcCCCcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 9999999999876431 667889999 77799999999999999999999999985433210
Q ss_pred -C-----------------------CceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccccc
Q 038351 296 -E-----------------------DHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIFFS 339 (348)
Q Consensus 296 -~-----------------------~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~~~ 339 (348)
. +.........||+.|.+ +|.|++|++++|.++|.+||+....+
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 0 00011223457777776 89999999999999999999886554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.5e-08 Score=101.78 Aligned_cols=81 Identities=22% Similarity=0.224 Sum_probs=57.0
Q ss_pred CccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceeeee
Q 038351 53 QQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLG 132 (348)
Q Consensus 53 ~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ls 132 (348)
+|+.|+|++|.|++ +|... ++|+.|+|++|+|+ .||.. ..+|+.|++++|+|+ .||..+..++.|+.|+|+
T Consensus 383 ~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 383 GLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 453 (788)
T ss_pred ccceEEecCCcccC-CCCcc---cCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence 45555555555553 44332 35666667777766 36653 245677888888887 789999999999999999
Q ss_pred cccccccccc
Q 038351 133 YNRLQGSISY 142 (348)
Q Consensus 133 ~N~lsG~ip~ 142 (348)
+|+|+|.+|.
T Consensus 454 ~N~Ls~~~~~ 463 (788)
T PRK15387 454 GNPLSERTLQ 463 (788)
T ss_pred CCCCCchHHH
Confidence 9999998774
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.50 E-value=5.3e-08 Score=95.15 Aligned_cols=174 Identities=22% Similarity=0.176 Sum_probs=119.7
Q ss_pred hhhCCCccccccccCCcceEEEeEec--CCceEEEEeeeeccCccchh--hHHHhhhccccc-ccceeeEEEEEecCCeE
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ--DRMEFSVKGFHLQCSGAFKS--FDFECDVMKSTC-YRNLIKIISSRSNEDFK 227 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 227 (348)
..+.+|.....||.+.|+.|++...+ ++..+++|...........+ -..|+.+...+. |.++++....+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34557888889999999999998644 67788888775443332221 234555555553 88889888888887888
Q ss_pred EEEEeccCCCCHHHHHhchh---------HHHHHHHHHHhcCCCceEecCCCcCceEEcCC-CcEEEeecCCccccccCC
Q 038351 228 VLVLEYMPRGSLEKCLYSSN---------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN-IVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~~---------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DfGla~~~~~~~ 297 (348)
++--|||++++....+.... ..++.+..+|..+++.++|+|+||+||++..+ +..+++|||.+..+.-..
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec
Confidence 89999999998765542111 13344444444449999999999999999876 788999999986421100
Q ss_pred ceeeeccccc-ccCc------------c-ccccHHHHHHHHHHHcCCC
Q 038351 298 HFMIQTQTLA-TIGY------------M-ASYVYSFGIMLLEVFTRKK 331 (348)
Q Consensus 298 ~~~~~~~~~g-t~~y------------~-asDV~S~Gvvl~elltG~~ 331 (348)
..... +..| . ..|++|||.-+.|.+++..
T Consensus 422 -----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 422 -----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred -----ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 01111 1112 1 1899999999999998875
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=9.5e-07 Score=80.75 Aligned_cols=126 Identities=12% Similarity=0.021 Sum_probs=85.8
Q ss_pred ccccCCcceEEEeEecCCceEEEEeeeeccC-----------ccchhhHHHhhhccccccccee--eEEEEEec-----C
Q 038351 163 LISRGGFGSIHKARIQDRMEFSVKGFHLQCS-----------GAFKSFDFECDVMKSTCYRNLI--KIISSRSN-----E 224 (348)
Q Consensus 163 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~niv--~l~~~~~~-----~ 224 (348)
.+-+.....|++..+ +|+.+.||....... .....+.+|...+.++...+|. +.+++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333333344666655 455788886632210 0111478899998888654443 44555543 2
Q ss_pred CeEEEEEeccCCC-CHHHHHhc---h-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC-------CCcE
Q 038351 225 DFKVLVLEYMPRG-SLEKCLYS---S-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD-------NIVT 282 (348)
Q Consensus 225 ~~~~lV~Ey~~~g-sL~~~l~~---~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~-------~~~~ 282 (348)
...++|+|++++- +|.+++.. . ..++..+.-|| ..+|+|+|++++|||++. +..+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceE
Confidence 3578999999886 78887642 0 12677788899 899999999999999985 5688
Q ss_pred EEeecCCccc
Q 038351 283 HLSDFGIAKL 292 (348)
Q Consensus 283 kl~DfGla~~ 292 (348)
.++||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.3e-06 Score=84.41 Aligned_cols=153 Identities=18% Similarity=0.204 Sum_probs=112.3
Q ss_pred cceEEEeEe-cCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEec----CCeEEEEEeccCC-CCHHHH
Q 038351 169 FGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSN----EDFKVLVLEYMPR-GSLEKC 242 (348)
Q Consensus 169 fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~Ey~~~-gsL~~~ 242 (348)
..+.||+.. .||..++.|+++.........-..-+++.+++.|+|+|++.+++.. +...++||+|.|+ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 457889875 4899999999965443333333445778999999999999998873 4568999999986 456554
Q ss_pred Hhch---------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 243 LYSS---------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 243 l~~~---------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
-... .++..||.++| +.++.-+-+.+.+|+++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 2210 12677999999 77888899999999999999999998888877765
Q ss_pred CCceeeecccccccCccccccHHHHHHHHHHHcCCC
Q 038351 296 EDHFMIQTQTLATIGYMASYVYSFGIMLLEVFTRKK 331 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~asDV~S~Gvvl~elltG~~ 331 (348)
+...... .-..-|.-.||.+++-|.||.-
T Consensus 446 d~~~~le-------~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPTEPLE-------SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCcchh-------HHhhhhHHHHHHHHHHHhhccc
Confidence 4311000 0011588899999999999953
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=6.4e-07 Score=80.43 Aligned_cols=128 Identities=20% Similarity=0.129 Sum_probs=89.6
Q ss_pred ccccccccCCcceEEEeEecCCceEEEEeeeeccCc----------------------cchhhHHHhhhccccccc--ce
Q 038351 159 SEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSG----------------------AFKSFDFECDVMKSTCYR--NL 214 (348)
Q Consensus 159 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~H~--ni 214 (348)
...+.||-|.-+.||.|....+.++|||.-+..... .....++|.+.|.++.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 456889999999999999999999999954322100 012456788899888644 55
Q ss_pred eeEEEEEecCCeEEEEEeccCCCCHHHHH-hchh--H-HHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCc
Q 038351 215 IKIISSRSNEDFKVLVLEYMPRGSLEKCL-YSSN--Y-VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIA 290 (348)
Q Consensus 215 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l-~~~~--~-i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla 290 (348)
.+.+++ +.-.+||||+++-.|...- .... . .-..|+.+-.....+|||+|+.+-||+++++|.+.++||-=+
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQA 249 (304)
T ss_pred CCcccc----ccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCccc
Confidence 655553 4558999999887665532 1111 1 112233333333688999999999999999999999999544
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=6.8e-08 Score=94.01 Aligned_cols=86 Identities=22% Similarity=0.221 Sum_probs=58.7
Q ss_pred CCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceee
Q 038351 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLF 130 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ 130 (348)
+..++.|+|+.|+++-.--..+.+|++|+.|+||+|++.---++...-.++|+.||||+|+++--=|.++..|.+|+.|+
T Consensus 268 l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~Ln 347 (873)
T KOG4194|consen 268 LEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELN 347 (873)
T ss_pred ecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhc
Confidence 45556666777777666666777777777777777777766677777777777777777777755555666665555555
Q ss_pred eecccc
Q 038351 131 LGYNRL 136 (348)
Q Consensus 131 ls~N~l 136 (348)
|++|++
T Consensus 348 Ls~Nsi 353 (873)
T KOG4194|consen 348 LSHNSI 353 (873)
T ss_pred ccccch
Confidence 555544
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.40 E-value=2e-07 Score=79.53 Aligned_cols=86 Identities=24% Similarity=0.299 Sum_probs=37.7
Q ss_pred CCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCC-CCcccceeecccCcccCc-cCCccccccccc
Q 038351 50 RPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIE-NLKVLVKIYFSMNNFAGV-IPNAIGCLNILQ 127 (348)
Q Consensus 50 ~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~-~l~~L~~l~ls~N~l~G~-iP~~l~~l~~L~ 127 (348)
.+.+|+.|+|++|.++. |+ .+..|+.|+.|+|++|+++ .|+..+. .+++|+.|++++|++..- -=..+..++.|+
T Consensus 40 ~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~ 116 (175)
T PF14580_consen 40 TLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLR 116 (175)
T ss_dssp T-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--
T ss_pred hhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcc
Confidence 46788888888888875 54 5777888888888888888 5655453 578888888888887631 114566777888
Q ss_pred eeeeecccccc
Q 038351 128 HLFLGYNRLQG 138 (348)
Q Consensus 128 ~L~ls~N~lsG 138 (348)
.|++.+|.+..
T Consensus 117 ~L~L~~NPv~~ 127 (175)
T PF14580_consen 117 VLSLEGNPVCE 127 (175)
T ss_dssp EEE-TT-GGGG
T ss_pred eeeccCCcccc
Confidence 88888887763
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.40 E-value=7.9e-07 Score=97.09 Aligned_cols=91 Identities=22% Similarity=0.175 Sum_probs=67.4
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|+..+.|| +++++++|+.|+|++|.....+|.+++++++|+.|++++++.-+.+|..+ ++++|+.
T Consensus 631 ~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~ 708 (1153)
T PLN03210 631 HSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYR 708 (1153)
T ss_pred ccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCE
Confidence 667888888888776667777 47788888888888877777888888888888888888776666777765 5677777
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|++++|...+.+|
T Consensus 709 L~Lsgc~~L~~~p 721 (1153)
T PLN03210 709 LNLSGCSRLKSFP 721 (1153)
T ss_pred EeCCCCCCccccc
Confidence 7777665444443
|
syringae 6; Provisional |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.8e-07 Score=93.63 Aligned_cols=77 Identities=25% Similarity=0.344 Sum_probs=40.5
Q ss_pred CccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceeeee
Q 038351 53 QQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLG 132 (348)
Q Consensus 53 ~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ls 132 (348)
+|+.|+|++|+|+ .||..+. .+|+.|+|++|+++ .||..+. ++|+.|++++|+|+ .+|..+. .+|+.|+++
T Consensus 221 nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls 291 (754)
T PRK15370 221 NIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVY 291 (754)
T ss_pred CCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECC
Confidence 4444444444444 2444332 23455555555554 4554443 35666666666666 4565553 356666777
Q ss_pred cccccc
Q 038351 133 YNRLQG 138 (348)
Q Consensus 133 ~N~lsG 138 (348)
+|+|++
T Consensus 292 ~N~Lt~ 297 (754)
T PRK15370 292 DNSIRT 297 (754)
T ss_pred CCcccc
Confidence 766664
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.33 E-value=4e-07 Score=94.04 Aligned_cols=72 Identities=21% Similarity=0.230 Sum_probs=54.5
Q ss_pred EecCCCcC-ceEEcCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCC
Q 038351 265 IHYDLKPS-NVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKK 331 (348)
Q Consensus 265 iHrDik~~-NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~ 331 (348)
.+++.+|. |++++.....++.|||.++...............||+.|+| +|||||||++|||+||+.
T Consensus 499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~ 578 (669)
T cd05610 499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIP 578 (669)
T ss_pred CCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 34555665 56667777788999999987654333233345678999987 899999999999999999
Q ss_pred CCccc
Q 038351 332 PTNKI 336 (348)
Q Consensus 332 P~~~~ 336 (348)
||...
T Consensus 579 pf~~~ 583 (669)
T cd05610 579 PFNDE 583 (669)
T ss_pred CCCCC
Confidence 99754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.32 E-value=5.8e-07 Score=93.03 Aligned_cols=101 Identities=25% Similarity=0.328 Sum_probs=74.4
Q ss_pred cEEEEecccceeeecCCCCCCCCCCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCccccee
Q 038351 26 AVTNITFGLLVFIILCPRYNYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKI 105 (348)
Q Consensus 26 ~v~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l 105 (348)
..+.+.+...++..++.. ..+.|+.|+|++|+|+ .||..+. ++|+.|+|++|+|+ .||..+. .+|+.|
T Consensus 179 ~~~~L~L~~~~LtsLP~~------Ip~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L 246 (754)
T PRK15370 179 NKTELRLKILGLTTIPAC------IPEQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEM 246 (754)
T ss_pred CceEEEeCCCCcCcCCcc------cccCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEE
Confidence 355566654443333322 3467889999999988 4888765 58899999999998 7887664 478899
Q ss_pred ecccCcccCccCCccccccccceeeeecccccccccc
Q 038351 106 YFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISY 142 (348)
Q Consensus 106 ~ls~N~l~G~iP~~l~~l~~L~~L~ls~N~lsG~ip~ 142 (348)
+|++|+++ .||..+. .+|+.|++++|+++. +|.
T Consensus 247 ~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~ 279 (754)
T PRK15370 247 ELSINRIT-ELPERLP--SALQSLDLFHNKISC-LPE 279 (754)
T ss_pred ECcCCccC-cCChhHh--CCCCEEECcCCccCc-ccc
Confidence 99999988 7888775 478899999998883 553
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=7.8e-08 Score=97.88 Aligned_cols=83 Identities=30% Similarity=0.368 Sum_probs=56.5
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCccc-CccCCccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFA-GVIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~-G~iP~~l~~l~~L~ 127 (348)
.++..|+.|+||+|.|+ .||.++.+|..|++|...+|++. ..| ++.++++|+++|+|.|+|+ +.+|..... +.|+
T Consensus 404 ~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~Lk 479 (1081)
T KOG0618|consen 404 RKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLK 479 (1081)
T ss_pred hchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC-cccc
Confidence 45566666777777776 37777777777777777777777 666 6777777777777777776 445544443 5677
Q ss_pred eeeeeccc
Q 038351 128 HLFLGYNR 135 (348)
Q Consensus 128 ~L~ls~N~ 135 (348)
+|||+.|.
T Consensus 480 yLdlSGN~ 487 (1081)
T KOG0618|consen 480 YLDLSGNT 487 (1081)
T ss_pred eeeccCCc
Confidence 77777765
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.30 E-value=4.4e-07 Score=59.01 Aligned_cols=37 Identities=32% Similarity=0.494 Sum_probs=23.7
Q ss_pred CCccEEEcccCcccccCcccccCCccCcceeccccccc
Q 038351 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLT 89 (348)
Q Consensus 52 ~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~ 89 (348)
++|+.|+|++|+++ .||++|++|++|+.|+|++|+++
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 45667777777776 46666777777777777777666
|
... |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.29 E-value=9.9e-07 Score=91.17 Aligned_cols=15 Identities=40% Similarity=0.625 Sum_probs=9.9
Q ss_pred CCccEEEcccCcccc
Q 038351 52 PQQENLSLASNELIS 66 (348)
Q Consensus 52 ~~l~~l~L~~N~l~g 66 (348)
++|+.|+|++|+|++
T Consensus 302 ~~L~~LdLS~N~L~~ 316 (788)
T PRK15387 302 PGLQELSVSDNQLAS 316 (788)
T ss_pred cccceeECCCCcccc
Confidence 556666666666665
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=7.1e-08 Score=93.86 Aligned_cols=91 Identities=23% Similarity=0.170 Sum_probs=46.7
Q ss_pred CCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCcccccccccee
Q 038351 50 RPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHL 129 (348)
Q Consensus 50 ~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L 129 (348)
+|+.|+.|+||.|.+..-=++...-+++|+.||||+|+++--=|.+|.-|+.|+.|.|+.|.++----..+-.+++|+.|
T Consensus 291 gLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~L 370 (873)
T KOG4194|consen 291 GLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKL 370 (873)
T ss_pred ccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhh
Confidence 34555555555555555545555555555555555555553334445555555555555555443333344444555555
Q ss_pred eeecccccccc
Q 038351 130 FLGYNRLQGSI 140 (348)
Q Consensus 130 ~ls~N~lsG~i 140 (348)
||++|.+++.|
T Consensus 371 dLr~N~ls~~I 381 (873)
T KOG4194|consen 371 DLRSNELSWCI 381 (873)
T ss_pred cCcCCeEEEEE
Confidence 55555554433
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.3e-07 Score=96.33 Aligned_cols=86 Identities=30% Similarity=0.350 Sum_probs=80.3
Q ss_pred CCCCCccEEEcccCcccccCcc-cccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPS-TFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~-~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
.+.+.|+.|+|++|.|.- +|+ .+.++..|+.|+||+|.|+ .||.++.+++.|++|...+|++. ..| ++..++.|+
T Consensus 380 ~~~~hLKVLhLsyNrL~~-fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~ 455 (1081)
T KOG0618|consen 380 VNFKHLKVLHLSYNRLNS-FPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLK 455 (1081)
T ss_pred ccccceeeeeeccccccc-CCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcce
Confidence 778999999999999874 777 6789999999999999999 99999999999999999999998 788 999999999
Q ss_pred eeeeecccccc
Q 038351 128 HLFLGYNRLQG 138 (348)
Q Consensus 128 ~L~ls~N~lsG 138 (348)
++|+|.|+|+-
T Consensus 456 ~lDlS~N~L~~ 466 (1081)
T KOG0618|consen 456 VLDLSCNNLSE 466 (1081)
T ss_pred EEecccchhhh
Confidence 99999999974
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.8e-06 Score=85.47 Aligned_cols=139 Identities=19% Similarity=0.165 Sum_probs=92.2
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccc----------------------------------h----
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAF----------------------------------K---- 197 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------~---- 197 (348)
.+|+. +-|+.++-|.||+|++++|++||||..+..-.... +
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34443 57899999999999999999999998764321110 0
Q ss_pred --hhHHHhhhccccc----ccceeeEEEEEe-cCCeEEEEEeccCCCCHHHHH--hc----hhHHHHHH--HHHHhcCCC
Q 038351 198 --SFDFECDVMKSTC----YRNLIKIISSRS-NEDFKVLVLEYMPRGSLEKCL--YS----SNYVGFAL--EYLHFDYSV 262 (348)
Q Consensus 198 --~~~~E~~~l~~l~----H~niv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l--~~----~~~i~~~L--~yLH~~~~~ 262 (348)
++.+|...+.+++ ..--+++-..|. -.....|+|||++|-.+.+.. +. ...++..+ .|+......
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRD 284 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhc
Confidence 2233444443332 222233333333 245678999999998887763 22 12243322 344433457
Q ss_pred ceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 263 LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 263 ~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
++.|.|..|-||+++.+++..+.|||+...+.+
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999987753
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.25 E-value=3.9e-07 Score=77.75 Aligned_cols=85 Identities=26% Similarity=0.376 Sum_probs=29.8
Q ss_pred CCCCCccEEEcccCcccccCccccc-CCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCcc-cccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFW-NLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAI-GCLNIL 126 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~-~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l-~~l~~L 126 (348)
.++.+++.|+|++|.++- |. .++ .+++|+.||||+|.++ .|+ .+..++.|+.|++++|+++ .|+..+ ..++.|
T Consensus 16 ~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L 90 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNL 90 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT-
T ss_pred cccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcC
Confidence 456678999999999885 54 677 6889999999999999 675 4888999999999999999 455445 368899
Q ss_pred ceeeeecccccc
Q 038351 127 QHLFLGYNRLQG 138 (348)
Q Consensus 127 ~~L~ls~N~lsG 138 (348)
+.|++++|++..
T Consensus 91 ~~L~L~~N~I~~ 102 (175)
T PF14580_consen 91 QELYLSNNKISD 102 (175)
T ss_dssp -EEE-TTS---S
T ss_pred CEEECcCCcCCC
Confidence 999999999974
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.4e-05 Score=71.38 Aligned_cols=125 Identities=12% Similarity=0.076 Sum_probs=84.1
Q ss_pred cccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccc--eeeEEEEEecCCeEEEEEeccCCCC-
Q 038351 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRN--LIKIISSRSNEDFKVLVLEYMPRGS- 238 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lV~Ey~~~gs- 238 (348)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999984 24456777765322 2345788999998887443 4677888888888899999998863
Q ss_pred HHHHHhch--------hHHHH---------------------------------------HHHHHHhc-CCCceEecCCC
Q 038351 239 LEKCLYSS--------NYVGF---------------------------------------ALEYLHFD-YSVLIIHYDLK 270 (348)
Q Consensus 239 L~~~l~~~--------~~i~~---------------------------------------~L~yLH~~-~~~~iiHrDik 270 (348)
+...+... ..+++ ..++|... ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 22221110 00111 12222211 13347899999
Q ss_pred cCceEEcCCCcEEEeecCCccc
Q 038351 271 PSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 271 ~~NILld~~~~~kl~DfGla~~ 292 (348)
|.||++++++ +.|.||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.19 E-value=7.6e-07 Score=57.90 Aligned_cols=37 Identities=35% Similarity=0.460 Sum_probs=29.3
Q ss_pred ccCcceecccccccCCCCcCCCCCcccceeecccCccc
Q 038351 76 KDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFA 113 (348)
Q Consensus 76 ~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~ 113 (348)
++|++|+|++|+++ .||.++++|++|+.|++++|+++
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 46888888888888 78888888888888888888887
|
... |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.15 E-value=5.9e-07 Score=81.24 Aligned_cols=103 Identities=23% Similarity=0.250 Sum_probs=68.6
Q ss_pred CCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCc---------cC-----
Q 038351 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGV---------IP----- 117 (348)
Q Consensus 52 ~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~---------iP----- 117 (348)
.-|+.||||.|.++- |-.+.--++.++.|+||+|.++ .+-. +..|++|+.||||+|.|+-. |-
T Consensus 284 q~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 284 QELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhhccccccchhh-hhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhHhhhhhHhhhcCEeeeehh
Confidence 346778888888773 7777777778888888888877 4533 77788888888888876421 11
Q ss_pred -------Cccccccccceeeeecccccc--ccccccccchhhHHhhhCC
Q 038351 118 -------NAIGCLNILQHLFLGYNRLQG--SISYSKWFSCLELCRVTNG 157 (348)
Q Consensus 118 -------~~l~~l~~L~~L~ls~N~lsG--~ip~~~~~~~~~~~~~~~~ 157 (348)
+.++++-+|..||++.|++.. .+...+...|.|....+++
T Consensus 361 ~N~iE~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~N 409 (490)
T KOG1259|consen 361 QNKIETLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGN 409 (490)
T ss_pred hhhHhhhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCC
Confidence 234455567788888888752 1222333458887776654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.11 E-value=9.9e-06 Score=71.24 Aligned_cols=94 Identities=20% Similarity=0.179 Sum_probs=71.6
Q ss_pred hhhHHHhhhcccccccc--eeeEEEEEecC----CeEEEEEeccCCC-CHHHHHhc-----hh-------HHHHHHHHHH
Q 038351 197 KSFDFECDVMKSTCYRN--LIKIISSRSNE----DFKVLVLEYMPRG-SLEKCLYS-----SN-------YVGFALEYLH 257 (348)
Q Consensus 197 ~~~~~E~~~l~~l~H~n--iv~l~~~~~~~----~~~~lV~Ey~~~g-sL~~~l~~-----~~-------~i~~~L~yLH 257 (348)
....+|...+..+.... +++.+++.... ...++|+|++++. +|.+++.. .. .++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 45778888888776543 34556665543 2458999999884 79888875 11 2666778888
Q ss_pred hcCCCceEecCCCcCceEEcCCC---cEEEeecCCcccc
Q 038351 258 FDYSVLIIHYDLKPSNVLFDDNI---VTHLSDFGIAKLL 293 (348)
Q Consensus 258 ~~~~~~iiHrDik~~NILld~~~---~~kl~DfGla~~~ 293 (348)
..+|+|+|+++.|||++.+. .+.++||+-++..
T Consensus 136 ---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 ---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred ---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 89999999999999999877 8899999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.10 E-value=5.6e-07 Score=83.94 Aligned_cols=87 Identities=20% Similarity=0.239 Sum_probs=56.0
Q ss_pred CCccEEEcccCcccc----cCcccccCC-ccCcceecccccccCC----CCcCCCCCcccceeecccCcccCc----cCC
Q 038351 52 PQQENLSLASNELIS----VIPSTFWNL-KDILYLNLSLNSLTGP----IPLEIENLKVLVKIYFSMNNFAGV----IPN 118 (348)
Q Consensus 52 ~~l~~l~L~~N~l~g----~ip~~~~~l-~~L~~l~l~~N~l~G~----iP~~~~~l~~L~~l~ls~N~l~G~----iP~ 118 (348)
++|+.|+|++|.+++ .+...+..+ ++|+.|+|++|++++. ++..+..+++|+.|++++|++++. ++.
T Consensus 108 ~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~ 187 (319)
T cd00116 108 SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAE 187 (319)
T ss_pred CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHH
Confidence 447777777777762 344455666 6777777777777743 333455566777777777777742 344
Q ss_pred ccccccccceeeeecccccc
Q 038351 119 AIGCLNILQHLFLGYNRLQG 138 (348)
Q Consensus 119 ~l~~l~~L~~L~ls~N~lsG 138 (348)
.+.....|+.|++++|.+++
T Consensus 188 ~l~~~~~L~~L~L~~n~i~~ 207 (319)
T cd00116 188 GLKANCNLEVLDLNNNGLTD 207 (319)
T ss_pred HHHhCCCCCEEeccCCccCh
Confidence 45555677777777777654
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=7.9e-06 Score=80.89 Aligned_cols=138 Identities=17% Similarity=0.180 Sum_probs=89.4
Q ss_pred CCccccccccCCcceEEEeEecCCceEEEEeeeeccCcc-------------------------------------chhh
Q 038351 157 GFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGA-------------------------------------FKSF 199 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~ 199 (348)
.|+ .+-|+.-+.|.||+|++++|..||||.-+..-... +-+|
T Consensus 163 ~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF 241 (538)
T KOG1235|consen 163 EFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF 241 (538)
T ss_pred hcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence 444 35789999999999999999999999876432111 0023
Q ss_pred HHHhhhcccc----cccc---eeeEEEEEe-cCCeEEEEEeccCCCCHHHHH--hchh----HHHH--HHHHHHhcCCCc
Q 038351 200 DFECDVMKST----CYRN---LIKIISSRS-NEDFKVLVLEYMPRGSLEKCL--YSSN----YVGF--ALEYLHFDYSVL 263 (348)
Q Consensus 200 ~~E~~~l~~l----~H~n---iv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l--~~~~----~i~~--~L~yLH~~~~~~ 263 (348)
.+|.+...+. +|-+ =|.+-.++. ....+.|+||||+|..+.+.- ...+ .++. .-.|++.....+
T Consensus 242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~G 321 (538)
T KOG1235|consen 242 TKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKTG 321 (538)
T ss_pred HHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhcC
Confidence 4444433322 3444 122222222 234679999999998775542 2211 1222 224555555778
Q ss_pred eEecCCCcCceEEcC----CCcEEEeecCCcccccc
Q 038351 264 IIHYDLKPSNVLFDD----NIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 264 iiHrDik~~NILld~----~~~~kl~DfGla~~~~~ 295 (348)
++|.|-.|-||++.. ++++.+-|||+.+.+..
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999983 67899999999987643
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.08 E-value=4.7e-07 Score=84.43 Aligned_cols=87 Identities=22% Similarity=0.218 Sum_probs=41.5
Q ss_pred CCCccEEEcccCcccccCcccccCCcc---CcceecccccccC----CCCcCCCCC-cccceeecccCcccCc----cCC
Q 038351 51 PPQQENLSLASNELISVIPSTFWNLKD---ILYLNLSLNSLTG----PIPLEIENL-KVLVKIYFSMNNFAGV----IPN 118 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~ip~~~~~l~~---L~~l~l~~N~l~G----~iP~~~~~l-~~L~~l~ls~N~l~G~----iP~ 118 (348)
+++|+.|+|++|.+++..+..+..+.+ |+.|+|++|++++ .+...+..+ ++|+.|++++|.+++. ++.
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 445555555555555444444444444 5555555555542 222333344 5555555555555532 222
Q ss_pred ccccccccceeeeeccccc
Q 038351 119 AIGCLNILQHLFLGYNRLQ 137 (348)
Q Consensus 119 ~l~~l~~L~~L~ls~N~ls 137 (348)
.+..+..|+.|++++|+++
T Consensus 160 ~~~~~~~L~~L~l~~n~l~ 178 (319)
T cd00116 160 ALRANRDLKELNLANNGIG 178 (319)
T ss_pred HHHhCCCcCEEECcCCCCc
Confidence 3333344555555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.06 E-value=5.8e-05 Score=67.90 Aligned_cols=125 Identities=14% Similarity=0.123 Sum_probs=82.4
Q ss_pred cccCCc-ceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhccccc-ccceeeEEEEEecCCeEEEEEeccCCCCHHH
Q 038351 164 ISRGGF-GSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKVLVLEYMPRGSLEK 241 (348)
Q Consensus 164 lG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 241 (348)
|..|.. ..||+....+ ..+.+|...... .....+|+++++.+. +--+.+++++....+..++|||+++|.++..
T Consensus 6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 334444 7899987654 577777764332 345778999888875 3346677887777677899999999887764
Q ss_pred HHh--c----hhHHHHHHHHHHh-------------------------------------------------------cC
Q 038351 242 CLY--S----SNYVGFALEYLHF-------------------------------------------------------DY 260 (348)
Q Consensus 242 ~l~--~----~~~i~~~L~yLH~-------------------------------------------------------~~ 260 (348)
... . ..++++.+.-||. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 321 0 0011111111110 01
Q ss_pred CCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 261 SVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 261 ~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
.+.++|+|+.|.||+++++....|.||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 24489999999999999987788999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.06 E-value=3e-07 Score=89.38 Aligned_cols=80 Identities=21% Similarity=0.337 Sum_probs=47.3
Q ss_pred ccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceeeeec
Q 038351 54 QENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLGY 133 (348)
Q Consensus 54 l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ls~ 133 (348)
|+.|.+++|+++ .+|.+|+.+..|..||.|.|++. ++|..++.+.+|..|.++.|++. .+|.+++.| .|..||+|.
T Consensus 145 Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfSc 220 (722)
T KOG0532|consen 145 LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSC 220 (722)
T ss_pred ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeeccc
Confidence 455555555544 35555555555555555555555 55555555555555555555555 566666654 366778888
Q ss_pred cccc
Q 038351 134 NRLQ 137 (348)
Q Consensus 134 N~ls 137 (348)
|+++
T Consensus 221 Nkis 224 (722)
T KOG0532|consen 221 NKIS 224 (722)
T ss_pred Ccee
Confidence 8776
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.05 E-value=6.5e-06 Score=90.02 Aligned_cols=91 Identities=16% Similarity=0.127 Sum_probs=81.5
Q ss_pred CCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceee
Q 038351 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLF 130 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ 130 (348)
+.+|+.|+|++|.+. .+|..+.++++|+.|+|++|+..+.+|. ++.+++|+.|+|++|..-..+|.++..+.+|+.|+
T Consensus 610 ~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~ 687 (1153)
T PLN03210 610 PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLD 687 (1153)
T ss_pred ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEe
Confidence 568999999999987 5899999999999999999887889985 89999999999999988899999999999999999
Q ss_pred eeccccccccccc
Q 038351 131 LGYNRLQGSISYS 143 (348)
Q Consensus 131 ls~N~lsG~ip~~ 143 (348)
+++|+.-+.+|..
T Consensus 688 L~~c~~L~~Lp~~ 700 (1153)
T PLN03210 688 MSRCENLEILPTG 700 (1153)
T ss_pred CCCCCCcCccCCc
Confidence 9998766677753
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.3e-06 Score=81.63 Aligned_cols=89 Identities=22% Similarity=0.209 Sum_probs=82.3
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
.+|++|+.|+|++|.+++.=+..|..+.+|+.|.|..|++.----..|..++.|+.|+|.+|+++-.-|.++..+.+|..
T Consensus 271 ~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~ 350 (498)
T KOG4237|consen 271 KKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLST 350 (498)
T ss_pred hhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeee
Confidence 78999999999999999999999999999999999999998555566889999999999999999999999999999999
Q ss_pred eeeeccccc
Q 038351 129 LFLGYNRLQ 137 (348)
Q Consensus 129 L~ls~N~ls 137 (348)
|+|-.|.+.
T Consensus 351 l~l~~Np~~ 359 (498)
T KOG4237|consen 351 LNLLSNPFN 359 (498)
T ss_pred eehccCccc
Confidence 999888764
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.99 E-value=1.1e-06 Score=85.63 Aligned_cols=93 Identities=28% Similarity=0.335 Sum_probs=84.2
Q ss_pred ecCCCCCCCCCCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCC
Q 038351 39 ILCPRYNYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPN 118 (348)
Q Consensus 39 ~~~~~~~~~~~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~ 118 (348)
.++.++ +.++.|..|+.+.|++- ++|+.++.|++|+.|++..|++. .+|.+++. -.|..||+|.|+++ .||.
T Consensus 157 ~lp~~i----g~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lDfScNkis-~iPv 228 (722)
T KOG0532|consen 157 SLPEEI----GLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLDFSCNKIS-YLPV 228 (722)
T ss_pred cCCccc----ccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-CceeeeecccCcee-ecch
Confidence 345555 88899999999999988 59999999999999999999999 99999995 45899999999999 9999
Q ss_pred ccccccccceeeeeccccccc
Q 038351 119 AIGCLNILQHLFLGYNRLQGS 139 (348)
Q Consensus 119 ~l~~l~~L~~L~ls~N~lsG~ 139 (348)
.+.++..|++|.|.+|.|+.+
T Consensus 229 ~fr~m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 229 DFRKMRHLQVLQLENNPLQSP 249 (722)
T ss_pred hhhhhhhheeeeeccCCCCCC
Confidence 999999999999999999853
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.93 E-value=7.1e-05 Score=65.59 Aligned_cols=125 Identities=18% Similarity=0.095 Sum_probs=89.4
Q ss_pred ccccCCcceEEEeEecCCceEEEEeeeecc------CccchhhHHHhhhcccccccc--eeeEEEEEe-c----CCeEEE
Q 038351 163 LISRGGFGSIHKARIQDRMEFSVKGFHLQC------SGAFKSFDFECDVMKSTCYRN--LIKIISSRS-N----EDFKVL 229 (348)
Q Consensus 163 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~-~----~~~~~l 229 (348)
--|+||.+.|++....+. .+-+|+-.... ......|.+|+..+.++...+ +.+.+ ++. . .-..+|
T Consensus 25 N~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 25 NYRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred CcCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 356788999999877655 57777664221 223567999999999887433 44444 332 1 124689
Q ss_pred EEeccCC-CCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCc--EEEeecCCccc
Q 038351 230 VLEYMPR-GSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIV--THLSDFGIAKL 292 (348)
Q Consensus 230 V~Ey~~~-gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~--~kl~DfGla~~ 292 (348)
|+|-+++ -+|.+++... ..++++++-|| ..++.|+|+-+.||+++.++. ++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9997764 4788876431 12788899999 899999999999999986666 89999977654
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.93 E-value=3.7e-06 Score=81.23 Aligned_cols=87 Identities=28% Similarity=0.395 Sum_probs=64.0
Q ss_pred CCCCCccEEEcccCcccccCcccccCCc-cCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLK-DILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~-~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
..++.++.|++.+|+++ .||+..+.++ +|+.|+++.|++. .+|..++.+++|+.|++++|+++ .+|...+.+..|.
T Consensus 113 ~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~ 189 (394)
T COG4886 113 LELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLN 189 (394)
T ss_pred hcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhh
Confidence 44466777777777777 4777777774 7777777777777 77777777777777777777777 6666666677777
Q ss_pred eeeeecccccc
Q 038351 128 HLFLGYNRLQG 138 (348)
Q Consensus 128 ~L~ls~N~lsG 138 (348)
.|++++|+++-
T Consensus 190 ~L~ls~N~i~~ 200 (394)
T COG4886 190 NLDLSGNKISD 200 (394)
T ss_pred heeccCCcccc
Confidence 77777777763
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.92 E-value=5.3e-05 Score=66.71 Aligned_cols=134 Identities=13% Similarity=0.098 Sum_probs=82.7
Q ss_pred hhCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchh---------hHHHhhhccccccccee---eEEEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKS---------FDFECDVMKSTCYRNLI---KIISSR 221 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~H~niv---~l~~~~ 221 (348)
..++|...+++-......|.+...+ +..+++|..........+. ..+++..+.+++...+. .++...
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 3556777777776666666655554 4678888775443222221 22334434444322222 222221
Q ss_pred -----ecCCeEEEEEeccCCCCHHHHHhch----hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 222 -----SNEDFKVLVLEYMPRGSLEKCLYSS----NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 222 -----~~~~~~~lV~Ey~~~gsL~~~l~~~----~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
.-....++||||++|..|.+..... ..+.+++.=+| ..++.|+|..|.|+++++++ +++.||+..+.
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIEDIDEDLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchhcCHHHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EEEEECccccc
Confidence 1224457999999998887654322 23566677777 88999999999999999655 88999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.91 E-value=4.3e-06 Score=80.75 Aligned_cols=84 Identities=30% Similarity=0.398 Sum_probs=65.4
Q ss_pred CCCC-CccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccc
Q 038351 49 LRPP-QQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~-~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
+.++ +|+.|++++|.+. .+|..+++++.|+.|+++.|+++ .+|...+.+++|+.|++++|+++ .||..+..+..|+
T Consensus 136 ~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~ 212 (394)
T COG4886 136 GLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALE 212 (394)
T ss_pred ccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhh
Confidence 4453 7888888888877 47777888888888888888888 78777778888888888888887 7777776677788
Q ss_pred eeeeeccc
Q 038351 128 HLFLGYNR 135 (348)
Q Consensus 128 ~L~ls~N~ 135 (348)
.+.+++|+
T Consensus 213 ~l~~~~N~ 220 (394)
T COG4886 213 ELDLSNNS 220 (394)
T ss_pred hhhhcCCc
Confidence 88888875
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.91 E-value=6.9e-07 Score=72.00 Aligned_cols=91 Identities=22% Similarity=0.233 Sum_probs=66.0
Q ss_pred CCCCCccEEEcccCcccccCcccccCCc-cCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLK-DILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~-~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
.+...|+..+|++|.|.- .|..|.... .++.|+|++|.++ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|.
T Consensus 50 ~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~ 126 (177)
T KOG4579|consen 50 SKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLD 126 (177)
T ss_pred hCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHH
Confidence 444567777888888874 666665553 6788888888888 88888888888888888888887 5667777777777
Q ss_pred eeeeeccccccccccc
Q 038351 128 HLFLGYNRLQGSISYS 143 (348)
Q Consensus 128 ~L~ls~N~lsG~ip~~ 143 (348)
.|+.-.|... +||..
T Consensus 127 ~Lds~~na~~-eid~d 141 (177)
T KOG4579|consen 127 MLDSPENARA-EIDVD 141 (177)
T ss_pred HhcCCCCccc-cCcHH
Confidence 7776665543 45543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.90 E-value=8.4e-05 Score=65.61 Aligned_cols=128 Identities=21% Similarity=0.308 Sum_probs=81.6
Q ss_pred cccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccc--eeeEEEEEec---CCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRN--LIKIISSRSN---EDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~---~~~~~lV~Ey~~~ 236 (348)
+.++.|..+.||+....+ ..+++|..... .....+..|..++..+.... +.+++.++.. ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 568889999999999888 58889986543 33466778888888886443 5677765433 3457899999998
Q ss_pred CCHHH----------------HHh---chh------------H-------------------------HHH-HHHHHHh-
Q 038351 237 GSLEK----------------CLY---SSN------------Y-------------------------VGF-ALEYLHF- 258 (348)
Q Consensus 237 gsL~~----------------~l~---~~~------------~-------------------------i~~-~L~yLH~- 258 (348)
.++.. .+. ... . +.. .++.++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87766 000 000 0 111 2223322
Q ss_pred ---cCCCceEecCCCcCceEEc-CCCcEEEeecCCccc
Q 038351 259 ---DYSVLIIHYDLKPSNVLFD-DNIVTHLSDFGIAKL 292 (348)
Q Consensus 259 ---~~~~~iiHrDik~~NILld-~~~~~kl~DfGla~~ 292 (348)
.....++|+|+.+.||+++ +++.+.|.||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1356799999999999999 566668999988754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00018 Score=62.54 Aligned_cols=125 Identities=19% Similarity=0.270 Sum_probs=86.9
Q ss_pred CCCccccccccCCc-ceEEEeEecCCceEEEEeeee---cc--------C----------ccchhhHHHhhhccccc---
Q 038351 156 NGFSEDNLISRGGF-GSIHKARIQDRMEFSVKGFHL---QC--------S----------GAFKSFDFECDVMKSTC--- 210 (348)
Q Consensus 156 ~~f~~~~~lG~G~f-g~Vy~~~~~~~~~vavK~~~~---~~--------~----------~~~~~~~~E~~~l~~l~--- 210 (348)
.+++..+.||.|.- |.|||+++.+. .+|+|.+.. .. . .....|..|++...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~-~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGR-IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCe-EEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67778899999999 99999998655 999999321 10 0 11246788999888876
Q ss_pred ccce--eeEEEEEecC------------------CeEEEEEeccCCCCHHHHHhchhHHHHHHHHHHhcCCCceEecCCC
Q 038351 211 YRNL--IKIISSRSNE------------------DFKVLVLEYMPRGSLEKCLYSSNYVGFALEYLHFDYSVLIIHYDLK 270 (348)
Q Consensus 211 H~ni--v~l~~~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~i~~~L~yLH~~~~~~iiHrDik 270 (348)
+.++ |+.+||..-. ..+.||.||++... ......+.+.++-+|..+..+|+-+|+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----~~~~~~~~~~~~dl~~~~k~gI~~~Dv~ 191 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----PLQIRDIPQMLRDLKILHKLGIVPRDVK 191 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----ccchhHHHHHHHHHHHHHHCCeeeccCc
Confidence 3455 8999987432 23578999997755 1111123333333333348999999999
Q ss_pred cCceEEcCCCcEEEeecCCc
Q 038351 271 PSNVLFDDNIVTHLSDFGIA 290 (348)
Q Consensus 271 ~~NILld~~~~~kl~DfGla 290 (348)
+.|.. .-+|+|||.+
T Consensus 192 ~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 192 PRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ccccc-----CCEEEecccC
Confidence 99986 5689999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00027 Score=61.66 Aligned_cols=129 Identities=22% Similarity=0.253 Sum_probs=88.8
Q ss_pred ccccccccCCcceEEEeEecCCceEEEEeeeecc----------------CccchhhHHHhhhccccc------ccceee
Q 038351 159 SEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQC----------------SGAFKSFDFECDVMKSTC------YRNLIK 216 (348)
Q Consensus 159 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~ 216 (348)
+....||+|+.-.||.- ++.....||...... ....++..+|+.-...+. +.+|.+
T Consensus 4 ~~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 34568999999999974 344455677665443 122456677777665555 889999
Q ss_pred EEEEEecCCeEEEEEeccCC------CCHHHHHhchh---HHHHHH----HHHHhcCCCceEecCCCcCceEEcCC--C-
Q 038351 217 IISSRSNEDFKVLVLEYMPR------GSLEKCLYSSN---YVGFAL----EYLHFDYSVLIIHYDLKPSNVLFDDN--I- 280 (348)
Q Consensus 217 l~~~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~---~i~~~L----~yLH~~~~~~iiHrDik~~NILld~~--~- 280 (348)
++|+..++.-..+|+|.+.. -+|.+++.... .+.++| +||- +..|+.+|++|+||++... +
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~---~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLL---DHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHH---HcCCeecCCCcccEEEEecCCCc
Confidence 99999999999999998743 36788876432 233333 4554 7789999999999999642 2
Q ss_pred -cEEEee-cCCccc
Q 038351 281 -VTHLSD-FGIAKL 292 (348)
Q Consensus 281 -~~kl~D-fGla~~ 292 (348)
.+.|+| ||-...
T Consensus 159 ~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 159 FRLVLIDGLGEKEL 172 (199)
T ss_pred eEEEEEeCCCCccc
Confidence 466777 554433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.76 E-value=2e-06 Score=69.38 Aligned_cols=90 Identities=24% Similarity=0.259 Sum_probs=61.7
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
.+.|-++.|+|++|.++. +|.++..+++|+.|+++.|.|. ..|..+..|.+|.+||..+|.+. +||..+..-+....
T Consensus 74 ~kf~t~t~lNl~~neisd-vPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al 150 (177)
T KOG4579|consen 74 IKFPTATTLNLANNEISD-VPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPAL 150 (177)
T ss_pred hccchhhhhhcchhhhhh-chHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHH
Confidence 445677778888888774 7878888888888888888887 67777777778888887777765 66655444444444
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
.++.++.+.+.-|
T Consensus 151 ~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 151 IKLGNEPLGDETK 163 (177)
T ss_pred HHhcCCcccccCc
Confidence 5555555555433
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00019 Score=65.20 Aligned_cols=124 Identities=14% Similarity=0.085 Sum_probs=74.5
Q ss_pred cccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccce-eeEEEEEecCCeEEEEEeccCCCCHHHH
Q 038351 164 ISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNL-IKIISSRSNEDFKVLVLEYMPRGSLEKC 242 (348)
Q Consensus 164 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~gsL~~~ 242 (348)
+..|-...+|+.. .++..+++|..........-...+|.++++.+....+ .+++..+. -++||||+++..+...
T Consensus 4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 4567778899887 4455777886543322211245778888888864333 34444432 3689999988665321
Q ss_pred ----HhchhHHHHH---------------------------------------HHHHHhc-----CCCceEecCCCcCce
Q 038351 243 ----LYSSNYVGFA---------------------------------------LEYLHFD-----YSVLIIHYDLKPSNV 274 (348)
Q Consensus 243 ----l~~~~~i~~~---------------------------------------L~yLH~~-----~~~~iiHrDik~~NI 274 (348)
......+++. ++.+... ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 0000001111 1111111 123589999999999
Q ss_pred EEcCCCcEEEeecCCcccc
Q 038351 275 LFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 275 Lld~~~~~kl~DfGla~~~ 293 (348)
++++++ +.+.||..|..-
T Consensus 159 l~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred EEeCCC-CEEEeccccCcC
Confidence 999877 789999988653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00017 Score=61.17 Aligned_cols=127 Identities=13% Similarity=0.109 Sum_probs=86.7
Q ss_pred cccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhccccccccee-eEEEEEecCCeEEEEEeccCCCC
Q 038351 160 EDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLI-KIISSRSNEDFKVLVLEYMPRGS 238 (348)
Q Consensus 160 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~Ey~~~gs 238 (348)
..+.|++|.+|.||++.+..+ ++|+|.-... .....+..|++++..+.-.++. +++.|-. -++.|||+.|-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGG-EVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeeccCc-eEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence 447899999999999998876 7788765433 3457789999999888765543 4444433 245599999988
Q ss_pred HHHHHhc--hhHHHHHHHHHHhcCCCceEecCCC-cCceEEcCCCcEEEeecCCcccc
Q 038351 239 LEKCLYS--SNYVGFALEYLHFDYSVLIIHYDLK-PSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 239 L~~~l~~--~~~i~~~L~yLH~~~~~~iiHrDik-~~NILld~~~~~kl~DfGla~~~ 293 (348)
|.+.-.. ...+...++-.--....+|-|..+. |...++-.+..+.|+||--|+..
T Consensus 99 L~~~~~~~~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 99 LGKLEIGGDRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhcccHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 8776553 4444333332111126778888886 44445545558999999988754
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.0002 Score=63.98 Aligned_cols=126 Identities=21% Similarity=0.166 Sum_probs=78.2
Q ss_pred ccccCCcceEEEeEecCCceEEEEeeeeccCccc------------------------hhhHHHhhhcccccc--cceee
Q 038351 163 LISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAF------------------------KSFDFECDVMKSTCY--RNLIK 216 (348)
Q Consensus 163 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~~E~~~l~~l~H--~niv~ 216 (348)
.|++|.-+.||+|.-.++..+|||++........ ....+|...|.++.- =.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 4667778899999998999999999864422110 012345555555532 22333
Q ss_pred EEEEEecCCeEEEEEeccCCC-----CHHHHHhch----hHHHHHHHHHHhcC-CCceEecCCCcCceEEcCCCcEEEee
Q 038351 217 IISSRSNEDFKVLVLEYMPRG-----SLEKCLYSS----NYVGFALEYLHFDY-SVLIIHYDLKPSNVLFDDNIVTHLSD 286 (348)
Q Consensus 217 l~~~~~~~~~~~lV~Ey~~~g-----sL~~~l~~~----~~i~~~L~yLH~~~-~~~iiHrDik~~NILld~~~~~kl~D 286 (348)
-+.+. .-.|||||+... .|.+.-... ..-...+++++-.. ..++||+|++.-|||+. ++.+.++|
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID 209 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIID 209 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEE
Confidence 33332 236999998543 222221111 11222344444332 47899999999999999 88999999
Q ss_pred cCCcccc
Q 038351 287 FGIAKLL 293 (348)
Q Consensus 287 fGla~~~ 293 (348)
||-|...
T Consensus 210 ~~QaV~~ 216 (268)
T COG1718 210 VSQAVTI 216 (268)
T ss_pred Ccccccc
Confidence 9987654
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=1.9e-05 Score=83.31 Aligned_cols=89 Identities=28% Similarity=0.276 Sum_probs=52.9
Q ss_pred CCCccEEEcccCcc-cccCccc-ccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 51 PPQQENLSLASNEL-ISVIPST-FWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 51 ~~~l~~l~L~~N~l-~g~ip~~-~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
++.|++|-+..|.. ...||.+ |-.++.|++||||+|.=-+.+|.++++|-+|++|+++.-.++ .+|..+.+|..|.+
T Consensus 544 ~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~ 622 (889)
T KOG4658|consen 544 NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIY 622 (889)
T ss_pred CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhe
Confidence 44566666666652 2334443 444666666666666655666666666666666666666666 66666666666666
Q ss_pred eeeecccccccc
Q 038351 129 LFLGYNRLQGSI 140 (348)
Q Consensus 129 L~ls~N~lsG~i 140 (348)
||+.++....++
T Consensus 623 Lnl~~~~~l~~~ 634 (889)
T KOG4658|consen 623 LNLEVTGRLESI 634 (889)
T ss_pred eccccccccccc
Confidence 666655543333
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 348 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-18 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-14 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-14 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-08 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-06 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-06 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 7e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-06 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 8e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-06 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 8e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-05 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-05 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-05 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-05 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-05 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-05 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-05 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-05 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-05 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-04 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-04 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-04 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-04 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-04 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-04 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-04 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-04 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-04 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-04 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-04 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-04 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-04 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-04 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-04 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-04 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-04 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-04 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-04 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-04 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-42
Identities = 66/221 (29%), Positives = 106/221 (47%), Gaps = 32/221 (14%)
Query: 144 KWFSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCS-GAFKSFDFE 202
K FS EL ++ FS N++ RGGFG ++K R+ D +VK + + G F E
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 203 CDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------------- 248
+++ +RNL+++ ++LV YM GS+ CL
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 249 VGFA--LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED-HFMIQTQT 305
+G A L YLH IIH D+K +N+L D+ + DFG+AKL+ +D H + T
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH--VTTAV 195
Query: 306 LATIGYMA------------SYVYSFGIMLLEVFTRKKPTN 334
TIG++A + V+ +G+MLLE+ T ++ +
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-40
Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 143 SKWFSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFE 202
S ++L TN F LI G FG ++K ++D + ++K + S + F+ E
Sbjct: 26 SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 203 CDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------------- 248
+ + + +L+ +I + +L+ +YM G+L++ LY S+
Sbjct: 86 IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 249 VGFA--LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTL 306
+G A L YLH IIH D+K N+L D+N V ++DFGI+K D + T
Sbjct: 146 IGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202
Query: 307 ATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335
T+GY+ S VYSFG++L EV + +
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-37
Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 136 LQGSISYSKWFSCLELCRVTNGFSE------DNLISRGGFGSIHKARIQDRMEFSVK--- 186
L+ S + FS EL VTN F E N + GGFG ++K + + +VK
Sbjct: 5 LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-TVAVKKLA 63
Query: 187 -GFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYS 245
+ + FD E VM + NL++++ S+ D LV YMP GSL L
Sbjct: 64 AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 246 SNY-------------VGFA--LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIA 290
+ G A + +LH ++ IH D+K +N+L D+ +SDFG+A
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 291 KLLIREDHFMIQTQTLATIGYMA-----------SYVYSFGIMLLEVFTRKKPTNK 335
+ + ++ ++ + T YMA S +YSFG++LLE+ T ++
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 51/244 (20%), Positives = 90/244 (36%), Gaps = 45/244 (18%)
Query: 134 NRLQGSISYSKWFSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCS 193
S L + + +RG FG + KA++ + +VK F +Q
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE-YVAVKIFPIQ-- 58
Query: 194 GAFKSFDFECDV--MKSTCYRNLIKII----SSRSNEDFKVLVLEYMPRGSLEKCLYSSN 247
+S+ E +V + + N+++ I S + L+ + +GSL L ++
Sbjct: 59 -DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV 117
Query: 248 ---------YVGFA--LEYLHFDYSVL-------IIHYDLKPSNVLFDDNIVTHLSDFGI 289
A L YLH D L I H D+K NVL +N+ ++DFG+
Sbjct: 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177
Query: 290 AKLLIREDHFMIQTQTLATIGYMA-------------SY----VYSFGIMLLEVFTRKKP 332
A + T YMA ++ +Y+ G++L E+ +R
Sbjct: 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237
Query: 333 TNKI 336
+
Sbjct: 238 ADGP 241
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 53/230 (23%), Positives = 90/230 (39%), Gaps = 45/230 (19%)
Query: 135 RLQGSISYSKW---FSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQ 191
QG++ + L + I G FG++H+A + +VK Q
Sbjct: 22 YFQGAMDGDDMDIPWCDLNIKEK---------IGAGSFGTVHRAEWHGS-DVAVKILMEQ 71
Query: 192 C--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY- 248
+ F E +MK + N++ + + + +V EY+ RGSL + L+ S
Sbjct: 72 DFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR 131
Query: 249 --------VGFAL------EYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294
+ A YLH + + I+H +LK N+L D + DFG+++L
Sbjct: 132 EQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190
Query: 295 REDHFMIQTQTLATIGYMA-------SY-----VYSFGIMLLEVFTRKKP 332
T +MA VYSFG++L E+ T ++P
Sbjct: 191 STFLSS--KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-27
Identities = 40/202 (19%), Positives = 75/202 (37%), Gaps = 42/202 (20%)
Query: 164 ISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKII--S 219
++ G + K R Q + VK ++ KS DF EC ++ + N++ ++
Sbjct: 18 LNENHSGELWKGRWQGN-DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 220 SRSNEDFKVLVLEYMPRGSLEKCLYSSNY--------VGFAL------EYLHFDYSVLII 265
L+ +MP GSL L+ V FAL +LH LI
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135
Query: 266 HYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------ 313
+ L +V+ D+++ +S + + ++A
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDTN 188
Query: 314 ---SYVYSFGIMLLEVFTRKKP 332
+ ++SF ++L E+ TR+ P
Sbjct: 189 RRSADMWSFAVLLWELVTREVP 210
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-26
Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 38/203 (18%)
Query: 158 FSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKI 217
+ ++ RG FG + KA+ + + + ++K + K+F E + + N++K+
Sbjct: 10 IEVEEVVGRGAFGVVCKAKWRAK-DVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKL 66
Query: 218 ISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY---------VGFAL------EYLHFDYSV 262
+ N LV+EY GSL L+ + + + L YLH
Sbjct: 67 YGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 263 LIIHYDLKPSNVLFDDN-IVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA-------S 314
+IH DLKP N+L V + DFG A + + H + A +MA +
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSAA---WMAPEVFEGSN 179
Query: 315 Y-----VYSFGIMLLEVFTRKKP 332
Y V+S+GI+L EV TR+KP
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKP 202
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-25
Identities = 53/236 (22%), Positives = 85/236 (36%), Gaps = 53/236 (22%)
Query: 146 FSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDV 205
+ E + LI RG +G+++K + +R +VK F ++F E ++
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER-PVAVKVFSFA---NRQNFINEKNI 58
Query: 206 MKSTCYR--NLIKII-----SSRSNEDFKVLVLEYMPRGSLEKCLYS-----SNYVGFA- 252
+ N+ + I + +LV+EY P GSL K L + A
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH 118
Query: 253 -----LEYLHFDYSVL------IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301
L YLH + I H DL NVL ++ +SDFG++ L
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 302 QTQTLA------TIGYMA-------------------SYVYSFGIMLLEVFTRKKP 332
+ A TI YMA +Y+ G++ E+F R
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 47/199 (23%), Positives = 84/199 (42%), Gaps = 36/199 (18%)
Query: 164 ISRGGFGSIHKARIQDRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSR 221
I G FG+++K + + +VK ++ ++F E V++ T + N++ +
Sbjct: 32 IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 222 SNEDFKVLVLEYMPRGSLEKCLYSSNY-------VGFAL------EYLHFDYSVLIIHYD 268
+ +V ++ SL L++S + A +YLH + IIH D
Sbjct: 90 TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 269 LKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA--------------- 313
LK +N+ ++ + DFG+A R Q +I +MA
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 314 SYVYSFGIMLLEVFTRKKP 332
S VY+FGI+L E+ T + P
Sbjct: 206 SDVYAFGIVLYELMTGQLP 224
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-24
Identities = 47/215 (21%), Positives = 85/215 (39%), Gaps = 48/215 (22%)
Query: 158 FSEDNLISRGGFGSIHKARIQDR-MEFSVKGFHLQCSGA-------FKSFDFECDVMKST 209
+ I +GGFG +HK R+ ++K L S F+ F E +M +
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 210 CYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------VGFAL------EYL 256
+ N++K+ N +V+E++P G L L + + L EY+
Sbjct: 81 NHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 257 HFDYSVLIIHYDLKPSNVLFD-----DNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
+ + I+H DL+ N+ + ++DFG+++ H + + L +
Sbjct: 139 Q-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---SVHSV--SGLLGNFQW 192
Query: 312 MA---------SY-----VYSFGIMLLEVFTRKKP 332
MA SY YSF ++L + T + P
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-24
Identities = 51/204 (25%), Positives = 81/204 (39%), Gaps = 40/204 (19%)
Query: 164 ISRGGFGSIHKARIQDRMEFSVKGFHLQC----SGAFKSFDFECDVMKSTCYRNLIKIIS 219
I GGFG +++A E +VK S ++ E + + N+I +
Sbjct: 15 IGIGGFGKVYRAFWIGD-EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 220 SRSNEDFKVLVLEYMPRGSLEKCLYSSNY-----VGFAL------EYLHFDYSVLIIHYD 268
E LV+E+ G L + L V +A+ YLH + V IIH D
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRD 133
Query: 269 LKPSNVLFDDNIVTH--------LSDFGIAKLLIREDHFMIQTQTLATIGYMA------- 313
LK SN+L + ++DFG+A RE H + +MA
Sbjct: 134 LKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAPEVIRAS 189
Query: 314 SY-----VYSFGIMLLEVFTRKKP 332
+ V+S+G++L E+ T + P
Sbjct: 190 MFSKGSDVWSYGVLLWELLTGEVP 213
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-23
Identities = 41/238 (17%), Positives = 84/238 (35%), Gaps = 57/238 (23%)
Query: 137 QGSISYSKW---FSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQ-- 191
Q SI +W F LE+ + I +G FG ++ R E +++ ++
Sbjct: 20 QTSIFLQEWDIPFEQLEIGEL---------IGKGRFGQVYHGRW--HGEVAIRLIDIERD 68
Query: 192 CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY--- 248
K+F E + T + N++ + + + ++ +L + +
Sbjct: 69 NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLD 128
Query: 249 ----VGFAL------EYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298
A YLH + I+H DLK NV +D+ V ++DFG+ +
Sbjct: 129 VNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQA 184
Query: 299 FMIQTQTLA---TIGYMA----------------SY-----VYSFGIMLLEVFTRKKP 332
+ + + ++A + V++ G + E+ R+ P
Sbjct: 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-22
Identities = 43/214 (20%), Positives = 75/214 (35%), Gaps = 46/214 (21%)
Query: 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYR--NLIKIIS 219
+ +G +G + + Q +VK F + KS+ E ++ + R N++ I+
Sbjct: 14 ECVGKGRYGEVWRGSWQGE-NVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIA 69
Query: 220 SRSNEDFKV----LVLEYMPRGSLEKCLYSSNY-----------VGFALEYLHFDYSVL- 263
S L+ Y GSL L + + L +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 264 ----IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA--TIGYMA---- 313
I H DLK N+L N ++D G+A + + + + T YMA
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 314 ---------SY-----VYSFGIMLLEVFTRKKPT 333
+++FG++L EV R
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 6e-22
Identities = 43/214 (20%), Positives = 81/214 (37%), Gaps = 46/214 (21%)
Query: 161 DNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYR--NLIKII 218
I +G FG + + + + E +VK F + +S+ E ++ ++ R N++ I
Sbjct: 47 QESIGKGRFGEVWRGKWRGE-EVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFI 102
Query: 219 SSRSNEDFKV----LVLEYMPRGSL-----------EKCLYSSNYVGFALEYLHFDYSVL 263
++ + ++ LV +Y GSL E + + L +LH +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 264 -----IIHYDLKPSNVLFDDNIVTHLSDFGIAKLL--IREDHFMIQTQTLATIGYMA--- 313
I H DLK N+L N ++D G+A + + + T YMA
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 314 -----------SY----VYSFGIMLLEVFTRKKP 332
S+ +Y+ G++ E+ R
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 8e-22
Identities = 46/214 (21%), Positives = 77/214 (35%), Gaps = 46/214 (21%)
Query: 161 DNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYR--NLIKII 218
I +G +G + + + + +VK F S+ E ++ ++ R N++ I
Sbjct: 42 VKQIGKGRYGEVWMGKWRGE-KVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFI 97
Query: 219 SSRSNEDFKV----LVLEYMPRGSLEKCLYSSNY-----------VGFALEYLHFDYSVL 263
++ L+ +Y GSL L S+ L +LH +
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 264 -----IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA--TIGYMA--- 313
I H DLK N+L N ++D G+A I + + + T YM
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 314 -----------SY----VYSFGIMLLEVFTRKKP 332
SY +YSFG++L EV R
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 55/233 (23%), Positives = 86/233 (36%), Gaps = 53/233 (22%)
Query: 141 SYSKW---FSCLELCRVTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAF 196
S S L V + +G FG K + +K
Sbjct: 1 SMPHRIFRPSDLIHGEV---------LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ 51
Query: 197 KSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------V 249
++F E VM+ + N++K I + + EY+ G+L + S + V
Sbjct: 52 RTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRV 111
Query: 250 GFAL------EYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH----- 298
FA YLH S+ IIH DL N L +N ++DFG+A+L++ E
Sbjct: 112 SFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168
Query: 299 ----FMIQTQTLATIG---YMA-------SY-----VYSFGIMLLEVFTRKKP 332
+ + +G +MA SY V+SFGI+L E+ R
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 2e-20
Identities = 21/88 (23%), Positives = 33/88 (37%), Gaps = 2/88 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDIL-YLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFA 113
++ N + IP ++ + + + +S N LTG IP NL L + S N
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLE 210
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQGSIS 141
G G Q + L N L +
Sbjct: 211 GDASVLFGSDKNTQKIHLAKNSLAFDLG 238
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 3e-20
Identities = 21/84 (25%), Positives = 36/84 (42%), Gaps = 1/84 (1%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVI 116
+ L+ N L F + K+ ++L+ NSL + ++ K L + N G +
Sbjct: 202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTL 260
Query: 117 PNAIGCLNILQHLFLGYNRLQGSI 140
P + L L L + +N L G I
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEI 284
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 9e-20
Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 1/87 (1%)
Query: 55 ENLSLAS-NELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFA 113
L + N L+ IP L + YL ++ +++G IP + +K LV + FS N +
Sbjct: 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALS 138
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQGSI 140
G +P +I L L + NR+ G+I
Sbjct: 139 GTLPPSISSLPNLVGITFDGNRISGAI 165
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-19
Identities = 26/87 (29%), Positives = 42/87 (48%), Gaps = 1/87 (1%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L + + IP +K ++ L+ S N+L+G +P I +L LV I F N +G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 115 VIPNAIG-CLNILQHLFLGYNRLQGSI 140
IP++ G + + + NRL G I
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKI 190
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-18
Identities = 25/86 (29%), Positives = 44/86 (51%), Gaps = 2/86 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+++++ N L IP TF NL + +++LS N L G + + K KI+ + N+ A
Sbjct: 177 TSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSI 140
+ +G L L L NR+ G++
Sbjct: 236 DLGK-VGLSKNLNGLDLRNNRIYGTL 260
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 4e-18
Identities = 23/90 (25%), Positives = 37/90 (41%), Gaps = 2/90 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVK-IYFSMNNFA 113
L + N L +P + +L +++ + N ++G IP + L + S N
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQGSISYS 143
G IP LN L + L N L+G S
Sbjct: 188 GKIPPTFANLN-LAFVDLSRNMLEGDASVL 216
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 3e-13
Identities = 25/89 (28%), Positives = 40/89 (44%), Gaps = 3/89 (3%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTG--PIPLEIENLKVLVKIYFS-MNN 111
+ + V+ T + L+LS +L PIP + NL L +Y +NN
Sbjct: 29 PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88
Query: 112 FAGVIPNAIGCLNILQHLFLGYNRLQGSI 140
G IP AI L L +L++ + + G+I
Sbjct: 89 LVGPIPPAIAKLTQLHYLYITHTNVSGAI 117
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 4e-13
Identities = 22/81 (27%), Positives = 33/81 (40%), Gaps = 2/81 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ + LA N L + K++ L+L N + G +P + LK L + S NN G
Sbjct: 224 QKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 115 VIPNAIGCLNILQHLFLGYNR 135
IP G L N+
Sbjct: 283 EIPQ-GGNLQRFDVSAYANNK 302
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 30/97 (30%), Positives = 46/97 (47%), Gaps = 1/97 (1%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ L L +N IP T N +++ L+LS N L+G IP + +L L + +N G
Sbjct: 397 QELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEG 456
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLEL 151
IP + + L+ L L +N L G I +C L
Sbjct: 457 EIPQELMYVKTLETLILDFNDLTGEIPSG-LSNCTNL 492
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 29/88 (32%), Positives = 41/88 (46%), Gaps = 2/88 (2%)
Query: 55 ENLSLASNELISVIPSTFWN--LKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNF 112
L L+SN I + L L N TG IP + N LV ++ S N
Sbjct: 371 LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYL 430
Query: 113 AGVIPNAIGCLNILQHLFLGYNRLQGSI 140
+G IP+++G L+ L+ L L N L+G I
Sbjct: 431 SGTIPSSLGSLSKLRDLKLWLNMLEGEI 458
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 30/86 (34%), Positives = 42/86 (48%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+L L+ N L IPS+ +L + L L LN L G IP E+ +K L + N+ G
Sbjct: 421 VSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTG 480
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSI 140
IP+ + L + L NRL G I
Sbjct: 481 EIPSGLSNCTNLNWISLSNNRLTGEI 506
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 37/108 (34%), Positives = 46/108 (42%), Gaps = 4/108 (3%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+L L N L IP +K + L L N LTG IP + N L I S N G
Sbjct: 445 RDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTG 504
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLELCRV---TNGFS 159
IP IG L L L L N G+I ++ C L + TN F+
Sbjct: 505 EIPKWIGRLENLAILKLSNNSFSGNIP-AELGDCRSLIWLDLNTNLFN 551
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 28/84 (33%), Positives = 42/84 (50%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVI 116
L ++ N L IP ++ + LNL N ++G IP E+ +L+ L + S N G I
Sbjct: 637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRI 696
Query: 117 PNAIGCLNILQHLFLGYNRLQGSI 140
P A+ L +L + L N L G I
Sbjct: 697 PQAMSALTMLTEIDLSNNNLSGPI 720
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 20/88 (22%), Positives = 35/88 (39%)
Query: 53 QQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNF 112
++ + + E + L N++ G +N ++ + S N
Sbjct: 585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML 644
Query: 113 AGVIPNAIGCLNILQHLFLGYNRLQGSI 140
+G IP IG + L L LG+N + GSI
Sbjct: 645 SGYIPKEIGSMPYLFILNLGHNDISGSI 672
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 23/97 (23%), Positives = 42/97 (43%), Gaps = 2/97 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLE-IENLKVLVKIYFSMNNFA 113
L L+ N +P F + + L LS N+ +G +P++ + ++ L + S N F+
Sbjct: 297 TGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS 356
Query: 114 GVIPNAIG-CLNILQHLFLGYNRLQGSISYSKWFSCL 149
G +P ++ L L L N G I + +
Sbjct: 357 GELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK 393
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 27/89 (30%), Positives = 44/89 (49%)
Query: 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNN 111
+ ++ S TF N +++L++S N L+G IP EI ++ L + N+
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 112 FAGVIPNAIGCLNILQHLFLGYNRLQGSI 140
+G IP+ +G L L L L N+L G I
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRI 696
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 33/86 (38%), Positives = 45/86 (52%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
E L L N+L IPS N ++ +++LS N LTG IP I L+ L + S N+F+G
Sbjct: 469 ETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSG 528
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSI 140
IP +G L L L N G+I
Sbjct: 529 NIPAELGDCRSLIWLDLNTNLFNGTI 554
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 30/107 (28%), Positives = 46/107 (42%), Gaps = 2/107 (1%)
Query: 47 PPLRPPQQENLSLASNELISVIPSTFW-NLKDILYLNLSLNSLTGPIPLEIENLKVLVKI 105
PPL + LSLA N+ IP + L+LS N G +P + +L +
Sbjct: 264 PPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESL 323
Query: 106 YFSMNNFAGVIP-NAIGCLNILQHLFLGYNRLQGSISYSKWFSCLEL 151
S NNF+G +P + + + L+ L L +N G + S L
Sbjct: 324 ALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASL 370
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 4/93 (4%)
Query: 55 ENLSLASNELISVIP-STFWNLKDILYLNLSLNSLTGPIPLEIENLKV-LVKIYFSMNNF 112
E+L+L+SN +P T ++ + L+LS N +G +P + NL L+ + S NNF
Sbjct: 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNF 380
Query: 113 AGVIPNAIG--CLNILQHLFLGYNRLQGSISYS 143
+G I + N LQ L+L N G I +
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 18/90 (20%), Positives = 40/90 (44%), Gaps = 3/90 (3%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
++L+++ N++ + ++ +L++S N+ + IP + + L + S N +G
Sbjct: 181 KHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSG 237
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYSK 144
AI L+ L + N+ G I
Sbjct: 238 DFSRAISTCTELKLLNISSNQFVGPIPPLP 267
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 29/97 (29%), Positives = 42/97 (43%), Gaps = 3/97 (3%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
E L ++SN + IP + + +L++S N L+G I L + S N F G
Sbjct: 203 EFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLEL 151
IP L LQ+L L N+ G I +C L
Sbjct: 262 PIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTL 296
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 21/96 (21%), Positives = 41/96 (42%), Gaps = 6/96 (6%)
Query: 55 ENLSLASNELISVIPS--TFWNLKDILYLNLSLNSLTGPIPLEIE-NLKVLVKIYFSMNN 111
+L L+ N L + + + + + +LN+S N+L P + L L + S N+
Sbjct: 103 TSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162
Query: 112 FAGVIPNAI---GCLNILQHLFLGYNRLQGSISYSK 144
+G L+HL + N++ G + S+
Sbjct: 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSR 198
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 21/100 (21%), Positives = 39/100 (39%), Gaps = 6/100 (6%)
Query: 57 LSLASNEL---ISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFA 113
+ L+S L S + S+ +L + L LS + + G + + L + S N+ +
Sbjct: 55 IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLS 113
Query: 114 GVIPNA--IGCLNILQHLFLGYNRLQGSISYSKWFSCLEL 151
G + +G + L+ L + N L S L
Sbjct: 114 GPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSL 153
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 25/105 (23%), Positives = 41/105 (39%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+SL++N L IP L+++ L LS NS +G IP E+ + + L+ + + N F G
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLELCRVTNGFS 159
IP A+ + + I F
Sbjct: 553 TIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ 597
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 6e-13
Identities = 23/92 (25%), Positives = 40/92 (43%), Gaps = 4/92 (4%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIP--LEIENLKVLVKIYFSMNNF 112
E+L L+++ + + F + L+LS NSL+GP+ + + L + S N
Sbjct: 80 ESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTL 138
Query: 113 AGVIPNAIGC-LNILQHLFLGYNRLQGSISYS 143
+ G LN L+ L L N + G+
Sbjct: 139 DFPGKVSGGLKLNSLEVLDLSANSISGANVVG 170
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 6e-13
Identities = 20/90 (22%), Positives = 35/90 (38%), Gaps = 6/90 (6%)
Query: 55 ENLSLASNELISVIP-STFWNLKDILYLNLSLNSLTGPIPLEIE---NLKVLVKIYFSMN 110
+ L+++SN L S L + L+LS NS++G + L + S N
Sbjct: 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN 188
Query: 111 NFAGVIPNAIGCLNILQHLFLGYNRLQGSI 140
+G + + L+ L + N I
Sbjct: 189 KISGDVD--VSRCVNLEFLDVSSNNFSTGI 216
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 23/64 (35%), Positives = 34/64 (53%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L+L N++ IP +L+ + L+LS N L G IP + L +L +I S NN +G
Sbjct: 659 FILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG 718
Query: 115 VIPN 118
IP
Sbjct: 719 PIPE 722
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 19/93 (20%), Positives = 37/93 (39%), Gaps = 4/93 (4%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVI 116
L L++N IP+ + + +++L+L+ N G IP + + + N AG
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKI----AANFIAGKR 574
Query: 117 PNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
I + + N L+ S+ + L
Sbjct: 575 YVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 15/89 (16%), Positives = 32/89 (35%), Gaps = 6/89 (6%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMN--NFAG 114
L L +N IP+ + ++ N + G + I+N + + + + N F G
Sbjct: 543 LDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQG 598
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYS 143
+ + L+ + G S +
Sbjct: 599 IRSEQLNRLSTRNPCNITSRVYGGHTSPT 627
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 42/215 (19%), Positives = 73/215 (33%), Gaps = 42/215 (19%)
Query: 162 NLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISS 220
+ RG FG +H+ + Q + +VK L+ E ++ + +
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 221 RSNEDFKVLVLEYMPRGSLEKCL---------YSSNYVG---FALEYLHFDYSVLIIHYD 268
+ + +E + GSL + + + Y+G LEYLH + I+H D
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGD 175
Query: 269 LKPSNVLFDDN-IVTHLSDFGIAKLLIREDHFMIQTQTLATIG---YMA-------SY-- 315
+K NVL + L DFG A L + G +MA
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 235
Query: 316 ---VYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
++S M+L + P ++Q
Sbjct: 236 KVDIWSSCCMMLHMLNGCHP-----WTQYFRGPLC 265
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 45/225 (20%), Positives = 87/225 (38%), Gaps = 46/225 (20%)
Query: 158 FSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMK-STCYRNLIK 216
F +++ G G+I + D + +VK +C F D E +++ S + N+I+
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82
Query: 217 IISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF-------------ALEYLHFDYSVL 263
+ + F+ + +E +L++ + ++ L +LH S+
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 264 IIHYDLKPSNVLF-----DDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMA---- 313
I+H DLKP N+L I +SDFG+ K L H + + T G++A
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 314 ------SY-----VYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
+ ++S G + V + F + +A
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH----PFGKSLQRQAN 239
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 45/223 (20%), Positives = 80/223 (35%), Gaps = 53/223 (23%)
Query: 153 RVTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCY 211
R F E LI GGFG + KA+ D + +K A + E + +
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDH 63
Query: 212 RNLIKIISSRSNEDFKV----------------LVLEYMPRGSLEKCLYSSNYVGF---- 251
N++ D+ + +E+ +G+LE+ +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 252 ----------ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301
++Y+H S +I+ DLKPSN+ D + DFG+ L +
Sbjct: 124 ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-- 178
Query: 302 QTQTLATIGYMA-------SY-----VYSFGIMLLEVFTRKKP 332
T++ T+ YM+ Y +Y+ G++L E+
Sbjct: 179 -TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 42/204 (20%)
Query: 163 LISRGGFGSIHKARIQDRMEF-SVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSR 221
++ +G +G ++ R ++K + S + E + K ++N+++ + S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 222 SNEDFKVLVLEYMPRGSLEKCLYS------------SNYV-----GFALEYLHFDYSVLI 264
S F + +E +P GSL L S Y G L+YLH I
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG--LKYLH---DNQI 143
Query: 265 IHYDLKPSNVLFD-DNIVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMA--------- 313
+H D+K NVL + + V +SDFG +K L T+T T+ YMA
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRL---AGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 314 SY-----VYSFGIMLLEVFTRKKP 332
Y ++S G ++E+ T K P
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPP 224
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 38/204 (18%), Positives = 72/204 (35%), Gaps = 49/204 (24%)
Query: 163 LISRGGFGSIHKA---RIQDRMEFSVKGFHLQCSGAFKS-FDFECDVMKSTCYRNLIKII 218
I+ GG G I+ A + R +KG ++ E + + ++++I
Sbjct: 87 CIAHGGLGWIYLALDRNVNGR-PVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 219 -----SSRSNEDFKVLVLEYMPRGSLEKCL-----------YSSNYVGFALEYLHFDYSV 262
+ R + +V+EY+ SL++ Y + AL YLH S+
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLE-ILPALSYLH---SI 201
Query: 263 LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT---LATIGYMA------ 313
+++ DLKP N++ + + L D G + T G+ A
Sbjct: 202 GLVYNDLKPENIMLTEEQLK-LIDLGAVSRI---------NSFGYLYGTPGFQAPEIVRT 251
Query: 314 -----SYVYSFGIMLLEVFTRKKP 332
+ +Y+ G L +
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLPT 275
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-15
Identities = 48/206 (23%), Positives = 79/206 (38%), Gaps = 42/206 (20%)
Query: 161 DNLISRGGFGSIHKAR-IQDRMEFSVKGFHL--QCSGAFKSFDFECDVMKSTCYRNLIKI 217
D I RG F +++K + +E + + F E +++K + N+++
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 218 ISS----RSNEDFKVLVLEYMPRGSLEKCLYSSNYVG------------FALEYLHFDYS 261
S + VLV E M G+L+ L + L++LH +
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TRT 149
Query: 262 VLIIHYDLKPSNVLFDDNI-VTHLSDFGIAKLLIREDHFMIQTQTLATIG---YMA---- 313
IIH DLK N+ + D G+A L + A IG +MA
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-------KRASFAKAVIGTPEFMAPEMY 202
Query: 314 --SY-----VYSFGIMLLEVFTRKKP 332
Y VY+FG+ +LE+ T + P
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-15
Identities = 41/200 (20%), Positives = 77/200 (38%), Gaps = 36/200 (18%)
Query: 163 LISRGGFGSIHKAR-IQDRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIIS 219
I G FG + +D ++ +K ++ S + E V+ + + N+++
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 220 SRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHFDYSVLII 265
S +V++Y G L K + + V F AL+++H I+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147
Query: 266 HYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMA-------SY-- 315
H D+K N+ + L DFGIA++L + T Y++ Y
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL---ARACIGTPYYLSPEICENKPYNN 204
Query: 316 ---VYSFGIMLLEVFTRKKP 332
+++ G +L E+ T K
Sbjct: 205 KSDIWALGCVLYELCTLKHA 224
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 17/86 (19%), Positives = 30/86 (34%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+L + N + + P L + LNL N L+ L +++ N+
Sbjct: 52 TSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK 111
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSI 140
+ N L L L +N L +
Sbjct: 112 IKNNPFVKQKNLITLDLSHNGLSSTK 137
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 24/94 (25%), Positives = 40/94 (42%), Gaps = 1/94 (1%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIP-LEIENLKVLVKIYFSMNNFAGV 115
L+L N++ + F L + L+L LN + + E L+ + +IY S N + +
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445
Query: 116 IPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
N+ + LQ L L L+ S F L
Sbjct: 446 TRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPL 479
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 23/87 (26%), Positives = 35/87 (40%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ L+L NEL + TF ++ L+L NS+ K L+ + S N +
Sbjct: 76 KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSIS 141
L LQ L L N++Q S
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKS 162
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 2/92 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKD--ILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNF 112
NLSL++++L + +TF LK + L+LS N+L L L + NN
Sbjct: 225 RNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNI 284
Query: 113 AGVIPNAIGCLNILQHLFLGYNRLQGSISYSK 144
+ +++ L +++L L + + SIS +
Sbjct: 285 QHLFSHSLHGLFNVRYLNLKRSFTKQSISLAS 316
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 20/93 (21%), Positives = 32/93 (34%), Gaps = 1/93 (1%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L+L SN + F +L ++ ++L LN+L N L + N
Sbjct: 539 HILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITS 598
Query: 115 VIPNAIG-CLNILQHLFLGYNRLQGSISYSKWF 146
V G L L + +N + WF
Sbjct: 599 VEKKVFGPAFRNLTELDMRFNPFDCTCESIAWF 631
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 16/89 (17%), Positives = 33/89 (37%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L+L N+L + + F + L++ N+++ P + L +L + N +
Sbjct: 28 TVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQ 87
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYS 143
+ L L L N +Q +
Sbjct: 88 LSDKTFAFCTNLTELHLMSNSIQKIKNNP 116
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 19/97 (19%), Positives = 35/97 (36%), Gaps = 8/97 (8%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLT--------GPIPLEIENLKVLVKIY 106
L L++N + ++ L+ + L+L N+L G ++ L L +
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILN 542
Query: 107 FSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYS 143
N F + L L+ + LG N L +
Sbjct: 543 LESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 24/106 (22%), Positives = 38/106 (35%), Gaps = 9/106 (8%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNL---------SLNSLTGPIPLEIENLKVLVKI 105
E L N + + + L ++ YLNL SL SL + LK L +
Sbjct: 275 EYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHL 334
Query: 106 YFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLEL 151
N+ G+ N L L++L L + ++ F L
Sbjct: 335 NMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAH 380
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 15/106 (14%), Positives = 40/106 (37%), Gaps = 7/106 (6%)
Query: 55 ENLSLASNELISVIPSTF--WNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNF 112
+ L L++N++ ++ + + L LS N + P + L ++ +
Sbjct: 148 QELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL 207
Query: 113 AGVIPNAIG---CLNILQHLFLGYNRLQGSISYSKWFSCLELCRVT 155
+ + +++L L ++L + + F L+ +T
Sbjct: 208 GPSLTEKLCLELANTSIRNLSLSNSQLSTTS--NTTFLGLKWTNLT 251
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 20/105 (19%), Positives = 36/105 (34%), Gaps = 9/105 (8%)
Query: 48 PLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIY- 106
L+ L L+ N L V +F L + Y L N++ + L + +
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303
Query: 107 --------FSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYS 143
S+ + + + L L+HL + N + G S
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNM 348
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 22/101 (21%), Positives = 45/101 (44%), Gaps = 4/101 (3%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLN--SLTGPIPLEIENLKV--LVKIYFSMN 110
E+L++ N++ + + F L ++ YL+LS + SL +L L + + N
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKN 391
Query: 111 NFAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLEL 151
+ + +A L L+ L LG N + ++ +W +
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENI 432
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 18/91 (19%), Positives = 29/91 (31%), Gaps = 3/91 (3%)
Query: 53 QQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNF 112
E + +L V N+ LNL+ N L L + N
Sbjct: 5 SHEVADCSHLKLTQVPDDLPTNIT---VLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 113 AGVIPNAIGCLNILQHLFLGYNRLQGSISYS 143
+ + P L +L+ L L +N L +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKT 92
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 22/99 (22%), Positives = 35/99 (35%), Gaps = 10/99 (10%)
Query: 55 ENLSLASNEL--ISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNN- 111
+ L L L + PS F L+++ L+LS N++ +E L+ L + NN
Sbjct: 457 QRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNL 516
Query: 112 -------FAGVIPNAIGCLNILQHLFLGYNRLQGSISYS 143
G + L+ L L L N
Sbjct: 517 ARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 15/83 (18%), Positives = 24/83 (28%)
Query: 58 SLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIP 117
L + L + LNL N ++L L I +NN +
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 118 NAIGCLNILQHLFLGYNRLQGSI 140
+ L+ L L N +
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVE 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 20/97 (20%), Positives = 38/97 (39%)
Query: 47 PPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIY 106
P P +NL L+ N L + +F++ ++ L+LS + ++L L +
Sbjct: 23 PDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLI 82
Query: 107 FSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYS 143
+ N + A L+ LQ L L ++
Sbjct: 83 LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 24/98 (24%), Positives = 43/98 (43%), Gaps = 1/98 (1%)
Query: 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNN 111
P+ + L L+ E+ ++ + +L + L L+ N + L L K+ N
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 112 FAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
A + IG L L+ L + +N +Q S ++FS L
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNL 148
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 17/88 (19%), Positives = 31/88 (35%), Gaps = 1/88 (1%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFAGV 115
L ++ F L + L ++ NS +I L+ L + S +
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485
Query: 116 IPNAIGCLNILQHLFLGYNRLQGSISYS 143
P A L+ LQ L + +N ++
Sbjct: 486 SPTAFNSLSSLQVLNMSHNNFFSLDTFP 513
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 19/93 (20%), Positives = 36/93 (38%), Gaps = 2/93 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L L+ +L + P+ F +L + LN+S N+ + L L + +S+N+
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 532
Query: 115 VIPNAIG-CLNILQHLFLGYNRLQGSISYSKWF 146
+ + L L L N + + F
Sbjct: 533 SKKQELQHFPSSLAFLNLTQNDFACTCE-HQSF 564
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 21/98 (21%), Positives = 38/98 (38%), Gaps = 4/98 (4%)
Query: 55 ENLSLASNELISVIP-STFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFA 113
E+L + L + S F +L++++YL++S L L + + N+F
Sbjct: 399 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458
Query: 114 GVI-PNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLE 150
P+ L L L L +L+ F+ L
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLS--PTAFNSLS 494
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 17/85 (20%), Positives = 37/85 (43%), Gaps = 2/85 (2%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFAGV 115
L L+ N +I+ + S F L+ + +L+ ++L + +L+ L+ + S +
Sbjct: 378 LDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436
Query: 116 IPNAIGCLNILQHLFLGYNRLQGSI 140
L+ L+ L + N Q +
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENF 461
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 26/87 (29%), Positives = 38/87 (43%), Gaps = 1/87 (1%)
Query: 55 ENLSLASNELI-SVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFA 113
E L +A N + +P F L+++ +L+LS L P +L L + S NNF
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 507
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQGSI 140
+ CLN LQ L N + S
Sbjct: 508 SLDTFPYKCLNSLQVLDYSLNHIMTSK 534
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 24/127 (18%), Positives = 49/127 (38%), Gaps = 11/127 (8%)
Query: 55 ENLSLASNELISV-IPSTFWNLKDILYLNLSLNSLTGPIPLEIENLK----VLVKIYFSM 109
+ L++A N + S +P F NL ++ +L+LS N + ++ L + + + S+
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 110 NNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLELCRVT----NGFSEDNLIS 165
N + P A + L L L N ++ L V F + +
Sbjct: 187 NPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVM-KTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 166 RGGFGSI 172
+ ++
Sbjct: 245 KFDKSAL 251
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 17/92 (18%), Positives = 36/92 (39%), Gaps = 4/92 (4%)
Query: 55 ENLSLASNEL--ISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNF 112
E L L+ N L + + + YL+LS N + + L+ L + F +N
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL 408
Query: 113 AGVIPNAIGC-LNILQHLFLGYNRLQGSISYS 143
+ ++ L L +L + + + + +
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 22/95 (23%), Positives = 39/95 (41%), Gaps = 6/95 (6%)
Query: 52 PQQENLSLASNELISVIPSTFWNLK----DILYLNLSLNSLTGPIPLEIENLKVLVKIYF 107
E+L L+SN++ S+ + L L L+LSLN + P + ++ L K+
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTL 207
Query: 108 SMNNFAG-VIPNAIGCLNILQHLFLGYNRLQGSIS 141
N + V+ I L L+ L + +
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 20/98 (20%), Positives = 34/98 (34%), Gaps = 7/98 (7%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMN--NF 112
++L L + + +LK L+ S G +L L + S N +F
Sbjct: 307 QHLELVNCKFGQFPTLKLKSLK-----RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSF 361
Query: 113 AGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLE 150
G + L++L L +N + S LE
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLE 399
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 9e-05
Identities = 20/107 (18%), Positives = 36/107 (33%), Gaps = 10/107 (9%)
Query: 55 ENLSLASNEL-ISVIPSTFWNLKDILYLNLSLNSLTGPIPLE------IENLKVLVKIYF 107
L+L +N ++V+ + L + L L LE +E L L F
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262
Query: 108 S---MNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLEL 151
++ + I + CL + L ++ +S F L
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHL 309
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 11/99 (11%), Positives = 20/99 (20%), Gaps = 3/99 (3%)
Query: 47 PPLRPPQQENLSLASNELI-SVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKI 105
L E LA + I F L ++ +L ++ +
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF--SYNFGWQHL 309
Query: 106 YFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYSK 144
F + L L +
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPS 348
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 19/107 (17%), Positives = 37/107 (34%), Gaps = 9/107 (8%)
Query: 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIP----LEIENLKVL---V 103
P +L L+ N + + P F ++ + L L N + + + L+V +
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234
Query: 104 KIYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSI-SYSKWFSCL 149
+ + N +A+ L L L + F+CL
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-14
Identities = 45/206 (21%), Positives = 72/206 (34%), Gaps = 39/206 (18%)
Query: 163 LISRGGFGSIHKAR-IQDRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIIS 219
I G +G K R D K + E ++++ + N+++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 220 SRSNEDFKVL--VLEYMPRGSLEKCLYSSNYVG----------------FALEYLH--FD 259
+ L V+EY G L + AL+ H D
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 260 YSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMA----- 313
++H DLKP+NV D L DFG+A++L +H +T T YM+
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---NHDTSFAKTFVGTPYYMSPEQMN 189
Query: 314 --SY-----VYSFGIMLLEVFTRKKP 332
SY ++S G +L E+ P
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-14
Identities = 47/218 (21%), Positives = 87/218 (39%), Gaps = 43/218 (19%)
Query: 163 LISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDF---ECDVMKSTCYRNLIKII 218
I RG F +++A + D + ++K + K+ E D++K + N+IK
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 219 SSRSNEDFKVLVLEYMPRGSLEKCL--YSSNYVGF--------------ALEYLHFDYSV 262
+S ++ +VLE G L + + + ALE++H S
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155
Query: 263 LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMA-------- 313
++H D+KP+NV V L D G+ + +L T YM+
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFF---SSKTTAAHSLVGTPYYMSPERIHENG 212
Query: 314 ----SYVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
S ++S G +L E+ + P F+ + ++ +L
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSL 246
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 43/225 (19%), Positives = 78/225 (34%), Gaps = 48/225 (21%)
Query: 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQC--SGAFKSFDFECDVMK--STCYRNLIKI 217
I GG + + + + +++K +L+ + S+ E + +I++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 218 ISSRSNEDFKVLVLEYMPRGSLEKCL-----YSSNYVGF-------ALEYLHFDYSVLII 265
+ + +V+E L L A+ +H I+
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIV 149
Query: 266 HYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------ 313
H DLKP+N L D ++ L DFGIA + + +++ + T+ YM
Sbjct: 150 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 208
Query: 314 -----------SYVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
S V+S G +L + K P F N I L
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKL 249
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 15/85 (17%), Positives = 35/85 (41%), Gaps = 2/85 (2%)
Query: 55 ENLSLASNELISV-IPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFA 113
+ + + N L + + ++ +K + L N L G +P + L + + N
Sbjct: 308 QIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT 366
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQG 138
+ N G +++L +N+L+
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKLKY 391
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 12/84 (14%), Positives = 25/84 (29%), Gaps = 5/84 (5%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ ++ ++ W N L+ +NLK L +
Sbjct: 209 RQFYMGNSPFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT 263
Query: 115 VIPNAIGCLNILQHLFLGYNRLQG 138
+P + L +Q + + NR
Sbjct: 264 KLPTFLKALPEMQLINVACNRGIS 287
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 21/111 (18%), Positives = 34/111 (30%), Gaps = 10/111 (9%)
Query: 55 ENLSLASNELISVIPSTF--WNLKDILYLNLSLNSLTG-------PIPLEIENLKVLVKI 105
ENLS A N+L IP+ F ++ + ++ S N + P+ + I
Sbjct: 380 ENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI 438
Query: 106 YFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLELCRVTN 156
S N + + L + L N L S
Sbjct: 439 NLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYL 489
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 17/92 (18%), Positives = 31/92 (33%), Gaps = 8/92 (8%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTG-------PIPLEIENLKVLVKIYF 107
+++L++N++ F + +NL N LT +N +L I
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495
Query: 108 SMNNFAGVIPN-AIGCLNILQHLFLGYNRLQG 138
N + + L L + L YN
Sbjct: 496 RFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK 527
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 14/95 (14%), Positives = 37/95 (38%), Gaps = 9/95 (9%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLT--------GPIPLEIENLKVLVKIY 106
++ + + ++ +P+ L ++ +N++ N + + + IY
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311
Query: 107 FSMNNFAGV-IPNAIGCLNILQHLFLGYNRLQGSI 140
NN + ++ + L L YN+L+G +
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKL 346
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 18/91 (19%), Positives = 31/91 (34%), Gaps = 8/91 (8%)
Query: 55 ENLSLASNELISVIPS-TFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIY------F 107
++ L N+L + L ++ ++LS NS + P + N L
Sbjct: 491 TSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDA 549
Query: 108 SMNNFAGVIPNAIGCLNILQHLFLGYNRLQG 138
N P I L L +G N ++
Sbjct: 550 QGNRTLREWPEGITLCPSLTQLQIGSNDIRK 580
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 15/100 (15%), Positives = 31/100 (31%), Gaps = 8/100 (8%)
Query: 47 PPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIY 106
EN + + + NLKD+ + + +P ++ L + I
Sbjct: 220 AENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLIN 279
Query: 107 FSMNNFAGV--------IPNAIGCLNILQHLFLGYNRLQG 138
+ N +Q +++GYN L+
Sbjct: 280 VACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKT 319
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 12/90 (13%), Positives = 26/90 (28%), Gaps = 7/90 (7%)
Query: 56 NLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGV 115
+ + + T + ++ +NLS N ++ L I N +
Sbjct: 413 EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEI 472
Query: 116 -------IPNAIGCLNILQHLFLGYNRLQG 138
+L + L +N+L
Sbjct: 473 PKNSLKDENENFKNTYLLTSIDLRFNKLTK 502
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 18/104 (17%), Positives = 36/104 (34%), Gaps = 4/104 (3%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L N+L +P+ F + + LNL+ N +T + + + F+ N
Sbjct: 333 GMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY 391
Query: 115 VIPNAIGCLNI--LQHLFLGYNRLQGSISYSKWFSCLELCRVTN 156
IPN ++ + + YN + + + N
Sbjct: 392 -IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN 434
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 12/84 (14%), Positives = 24/84 (28%), Gaps = 5/84 (5%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFA 113
N + P + L + N + + +I N+ VL N
Sbjct: 545 NQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITPNISVL---DIKDNPNI 600
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQ 137
+ + + L Y++ Q
Sbjct: 601 SIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 13/92 (14%), Positives = 24/92 (26%), Gaps = 6/92 (6%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGP----IPLEIENLKVLVKIYFSMN 110
LSL +P L ++ L L + P I +
Sbjct: 84 TGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRM 143
Query: 111 NFAGVIPNAIGCLNI--LQHLFLGYNRLQGSI 140
++ + + L + + Q SI
Sbjct: 144 HYQKTFVDYDPREDFSDLIKDCINSDPQQKSI 175
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 10/88 (11%), Positives = 23/88 (26%), Gaps = 3/88 (3%)
Query: 55 ENLSLASNELISVIPS--TFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNF 112
E + D++ ++ + I +I NN
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 113 AGVIPNAIGCLNILQHLFLGYNRLQGSI 140
+ A+ L L+ ++G +
Sbjct: 196 TF-VSKAVMRLTKLRQFYMGNSPFVAEN 222
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 20/100 (20%), Positives = 29/100 (29%), Gaps = 15/100 (15%)
Query: 55 ENLSLASNELISV-------IPSTFWNLKDILYLNLSLNSLTG-PIPLEIENLKVLVKIY 106
+++L N L + F N + ++L N LT L LV I
Sbjct: 460 SSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGID 519
Query: 107 FSMNNFAGVIPNAIG------CLNILQHLFLGYNRLQGSI 140
S N+F+ P I NR
Sbjct: 520 LSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREW 558
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 10/97 (10%), Positives = 24/97 (24%), Gaps = 6/97 (6%)
Query: 47 PPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIY 106
P + S+ I + + N++T + + L L + Y
Sbjct: 154 PREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFY 212
Query: 107 FSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYS 143
+ F ++ Y + +
Sbjct: 213 MGNSPFVAENI-----CEAWENENSEYAQQYKTEDLK 244
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 11/89 (12%), Positives = 24/89 (26%), Gaps = 4/89 (4%)
Query: 56 NLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG- 114
N + + + + + + L+L +G +P I L L + +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 115 ---VIPNAIGCLNILQHLFLGYNRLQGSI 140
P I + Q +
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTF 149
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 9/90 (10%), Positives = 17/90 (18%), Gaps = 6/90 (6%)
Query: 55 ENLSLASNEL----ISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKV--LVKIYFS 108
E L+L S+ P L+K +
Sbjct: 108 EVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCIN 167
Query: 109 MNNFAGVIPNAIGCLNILQHLFLGYNRLQG 138
+ I + + N +
Sbjct: 168 SDPQQKSIKKSSRITLKDTQIGQLSNNITF 197
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 12/62 (19%), Positives = 25/62 (40%)
Query: 82 NLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSIS 141
N L+ + + + + + +G +P+AIG L L+ L LG + + +
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 142 YS 143
Sbjct: 123 LF 124
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 38/227 (16%), Positives = 82/227 (36%), Gaps = 54/227 (23%)
Query: 153 RVTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFK-SFDFECDVMKSTC 210
R F + RGGFG + +A+ D +++K L + E +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 211 YRNLIKIISSRSNEDFKV------------LVLEYMPRGSLEKCLYSSNYVGF------- 251
+ +++ ++ ++ + ++ + +L+ + +
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 252 --------ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303
A+E+LH S ++H DLKPSN+ F + V + DFG+ + +++
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 304 QTLATIG----------YMA-------SY-----VYSFGIMLLEVFT 328
+ YM+ SY ++S G++L E+
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 42/225 (18%), Positives = 77/225 (34%), Gaps = 48/225 (21%)
Query: 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQC--SGAFKSFDFECDVMK--STCYRNLIKI 217
I GG + + + + +++K +L+ + S+ E + +I++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 218 ISSRSNEDFKVLVLEYMPRGSLEKCL-----YSSNYVGF-------ALEYLHFDYSVLII 265
+ + +V+E L L A+ +H I+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIV 177
Query: 266 HYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------ 313
H DLKP+N L D ++ L DFGIA + + +++ + + YM
Sbjct: 178 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE 236
Query: 314 -----------SYVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
S V+S G +L + K P F N I L
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKL 277
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-13
Identities = 44/226 (19%), Positives = 77/226 (34%), Gaps = 50/226 (22%)
Query: 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQC--SGAFKSFDFECDVMK--STCYRNLIKI 217
I GG + + + + +++K +L+ + S+ E + +I++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 218 ISSRSNEDFKVLVLEYMPRGSLEKCL-----YSSNYVGF-------ALEYLHFDYSVLII 265
+ + +V+E L L A+ +H I+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIV 130
Query: 266 HYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMA----------- 313
H DLKP+N L D ++ L DFGIA ++ D + + T+ YM
Sbjct: 131 HSDLKPANFLIVDGML-KLIDFGIAN-QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188
Query: 314 ------------SYVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
S V+S G +L + K P F N I L
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQISKL 230
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 7e-13
Identities = 41/202 (20%), Positives = 75/202 (37%), Gaps = 34/202 (16%)
Query: 158 FSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHL-QCSGAFKSFDFECDVMKSTCYRNLI 215
F + + + G G + K + + K HL E V+ ++
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 216 KIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVG------------FALEYLHFDYSVL 263
+ ++ + +E+M GSL++ L + + L YL +
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-- 152
Query: 264 IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMA-------SY 315
I+H D+KPSN+L + L DFG++ LI + T YM+ Y
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHY 207
Query: 316 -----VYSFGIMLLEVFTRKKP 332
++S G+ L+E+ + P
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYP 229
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-13
Identities = 46/195 (23%), Positives = 85/195 (43%), Gaps = 36/195 (18%)
Query: 167 GGFGSIHKARIQDRMEFS-----VKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKI--IS 219
G FGS+ R + + VK + F+ E +++KS + N++K +
Sbjct: 21 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80
Query: 220 SRSNEDFKVLVLEYMPRGSL-------EKCLYSSNYVGFAL------EYLHFDYSVLIIH 266
+ L++EY+P GSL ++ + + + EYL + IH
Sbjct: 81 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIH 137
Query: 267 YDLKPSNVLFDDNIVTHLSDFGIAKLLIR-EDHFMIQTQTLATIGYMA------------ 313
DL N+L ++ + DFG+ K+L + ++ F ++ + I + A
Sbjct: 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA 197
Query: 314 SYVYSFGIMLLEVFT 328
S V+SFG++L E+FT
Sbjct: 198 SDVWSFGVVLYELFT 212
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 44/208 (21%), Positives = 82/208 (39%), Gaps = 50/208 (24%)
Query: 166 RGGFGSIHKARIQDRMEFS----VKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKII- 218
G FGS+ + ++ S VK L S + +F E MK + N+I+++
Sbjct: 44 EGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG 103
Query: 219 ----SSRSNEDFKVLVLEYMPRGSL------------EKCLYSSNYVGFAL------EYL 256
S +++L +M G L K + + F + EYL
Sbjct: 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL 163
Query: 257 ---HFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
+F +H DL N + D++ ++DFG++K + D++ + ++A
Sbjct: 164 SNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 314 ------------SYVYSFGIMLLEVFTR 329
S V++FG+ + E+ TR
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIATR 245
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 45/195 (23%), Positives = 86/195 (44%), Gaps = 36/195 (18%)
Query: 167 GGFGSIHKARIQDRMEFS-----VKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKI--IS 219
G FGS+ R + + VK + F+ E +++KS + N++K +
Sbjct: 52 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 111
Query: 220 SRSNEDFKVLVLEYMPRGSL-------EKCLYSSNYVGFAL------EYLHFDYSVLIIH 266
+ L++EY+P GSL ++ + + + EYL + IH
Sbjct: 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIH 168
Query: 267 YDLKPSNVLFDDNIVTHLSDFGIAKLLIR-EDHFMIQTQTLATIGYMA------------ 313
DL N+L ++ + DFG+ K+L + ++++ ++ + I + A
Sbjct: 169 RDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA 228
Query: 314 SYVYSFGIMLLEVFT 328
S V+SFG++L E+FT
Sbjct: 229 SDVWSFGVVLYELFT 243
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 47/193 (24%), Positives = 84/193 (43%), Gaps = 32/193 (16%)
Query: 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSR 221
+ +G FG + ++K + + ++F E VMK + L+++ +
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 222 SNEDFKVLVLEYMPRGSLEKCLYSSNY--------VGFA------LEYLHFDYSVLIIHY 267
S E + V EYM +GSL L V A + Y+ + +H
Sbjct: 332 SEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 268 DLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SY 315
DL+ +N+L +N+V ++DFG+A+ LI ++ + + I + A S
Sbjct: 388 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 316 VYSFGIMLLEVFT 328
V+SFGI+L E+ T
Sbjct: 447 VWSFGILLTELTT 459
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 46/195 (23%), Positives = 85/195 (43%), Gaps = 36/195 (18%)
Query: 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKIIS 219
+ G FG + A + +VK G+ F E +VMK+ + L+K+ +
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 220 SRSNEDFKVLVLEYMPRGSLEKCLYSSNY--------VGFAL------EYLHFDYSVLII 265
+ E + + E+M +GSL L S + F+ ++ I
Sbjct: 251 VVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYI 306
Query: 266 HYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------ 313
H DL+ +N+L ++V ++DFG+A+ +I ++ + + I + A
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 314 SYVYSFGIMLLEVFT 328
S V+SFGI+L+E+ T
Sbjct: 366 SDVWSFGILLMEIVT 380
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 16/104 (15%), Positives = 35/104 (33%), Gaps = 10/104 (9%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
E+ + + ++ NLKD+ + L +P + +L L + + N
Sbjct: 470 EDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529
Query: 115 V---------IPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
+ + +Q ++GYN L+ S +
Sbjct: 530 AAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKM 572
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 16/95 (16%), Positives = 29/95 (30%), Gaps = 5/95 (5%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ + A++ + W N L NLK L +
Sbjct: 451 QIIYFANSPFTYDNIAVDWED-----ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMT 505
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
+P+ + L LQ L + NR + ++ L
Sbjct: 506 QLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 17/91 (18%), Positives = 29/91 (31%), Gaps = 8/91 (8%)
Query: 55 ENLSLASNELISVIPS-TFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSM---- 109
+ L N+L S+ L + +++S N + P + N L
Sbjct: 731 TTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDA 789
Query: 110 --NNFAGVIPNAIGCLNILQHLFLGYNRLQG 138
N P I L L +G N ++
Sbjct: 790 EGNRILRQWPTGITTCPSLIQLQIGSNDIRK 820
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 17/93 (18%), Positives = 32/93 (34%), Gaps = 6/93 (6%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTG-PIPLEIENLKVLVKIYFSMNNFA 113
+L L N++ + + L S N L P +++ V+ + FS N
Sbjct: 598 TDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIG 657
Query: 114 GVIPNAIGCLNI-----LQHLFLGYNRLQGSIS 141
N ++ + L YN +Q +
Sbjct: 658 SEGRNISCSMDDYKGINASTVTLSYNEIQKFPT 690
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 17/103 (16%), Positives = 33/103 (32%), Gaps = 10/103 (9%)
Query: 45 NYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLT-------GPIPLEIE 97
+ + ++L+ NE+ F I + LS N +T P +
Sbjct: 666 SMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYK 725
Query: 98 NLKVLVKIYFSMNNFAGVIPNAIGCLNI--LQHLFLGYNRLQG 138
N +L I N + + + L ++ + YN
Sbjct: 726 NTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS 767
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 10/85 (11%), Positives = 27/85 (31%), Gaps = 3/85 (3%)
Query: 55 ENLSLASNELISVIPS-TFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFA 113
+ + N L S + + + L+ N + + L + N
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH-LE-AFGTNVKLTDLKLDYNQIE 608
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQG 138
+ + + ++ L +N+L+
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKY 633
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 6e-09
Identities = 13/90 (14%), Positives = 29/90 (32%), Gaps = 8/90 (8%)
Query: 55 ENLSLASNELISVIPSTFW--NLKDILYLNLSLNSLTG-----PIPLEIENLKVLVKIYF 107
E L + N+L IP+ F ++ + ++ S N + ++ +
Sbjct: 622 EGLGFSHNKL-KYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTL 680
Query: 108 SMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
S N + + + L N +
Sbjct: 681 SYNEIQKFPTELFATGSPISTIILSNNLMT 710
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 15/108 (13%), Positives = 32/108 (29%), Gaps = 13/108 (12%)
Query: 55 ENLSLASNELISVIPSTF-----WNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSM 109
++ + N++ S + + + + LS N + + I S
Sbjct: 647 GSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSN 706
Query: 110 NNF-------AGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLE 150
N +L + L +N+L S+S + L
Sbjct: 707 NLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLP 753
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 5e-07
Identities = 17/100 (17%), Positives = 29/100 (29%), Gaps = 15/100 (15%)
Query: 55 ENLSLASNELISV-------IPSTFWNLKDILYLNLSLNSLTG-PIPLEIENLKVLVKIY 106
+ L++N + S+ + N + ++L N LT L L +
Sbjct: 700 STIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMD 759
Query: 107 FSMNNFAGVIPNAIG------CLNILQHLFLGYNRLQGSI 140
S N F+ P I NR+
Sbjct: 760 VSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQW 798
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 7e-07
Identities = 19/87 (21%), Positives = 34/87 (39%), Gaps = 6/87 (6%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+N S + + I S WN N L+ ++++N + + + G
Sbjct: 284 KNWRYYSGTINNTIHSLNWNF------NKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKG 337
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSIS 141
+P+AIG L L+ L G + S
Sbjct: 338 RVPDAIGQLTELKVLSFGTHSETVSGR 364
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 12/81 (14%), Positives = 22/81 (27%), Gaps = 1/81 (1%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVI 116
LSLA +P L ++ L+ +S T L + +
Sbjct: 328 LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHY 387
Query: 117 PN-AIGCLNILQHLFLGYNRL 136
+ L L + +
Sbjct: 388 KKMFLDYDQRLNLSDLLQDAI 408
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 17/105 (16%), Positives = 32/105 (30%), Gaps = 21/105 (20%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
++ + E+ + + +LKD + N +T I I+ L L IYF+ + F
Sbjct: 405 QDAINRNPEMKPIKKDSRISLKD-TQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTY 462
Query: 115 V-------------------IPNAIGCLNILQHLFLGYNRLQGSI 140
+ L L + L +
Sbjct: 463 DNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 10/85 (11%), Positives = 28/85 (32%), Gaps = 5/85 (5%)
Query: 54 QENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNF 112
+ N ++ P+ ++ L + N + + ++ L +L + N
Sbjct: 784 RHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTPQLYIL---DIADNPN 839
Query: 113 AGVIPNAIGCLNILQHLFLGYNRLQ 137
+ ++ L Y++ Q
Sbjct: 840 ISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 11/86 (12%), Positives = 23/86 (26%)
Query: 56 NLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGV 115
N + + N + L+L+ G +P I L L + F ++
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362
Query: 116 IPNAIGCLNILQHLFLGYNRLQGSIS 141
+R++
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYK 388
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 30/174 (17%), Positives = 65/174 (37%), Gaps = 40/174 (22%)
Query: 198 SFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF------ 251
+ + M +N + + S + + + ++ + +L+ + +
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166
Query: 252 ---------ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF--- 299
A+E+LH S ++H DLKPSN+ F + V + DFG+ + +++
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 300 -------MIQTQTLATIGYMA-------SY-----VYSFGIMLLEVFTRKKPTN 334
T + T YM+ +Y ++S G++L E+
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 27/97 (27%), Positives = 41/97 (42%), Gaps = 18/97 (18%)
Query: 249 VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT-LA 307
+G AL+ H + H D+KP N+L + +L DFGIA D + Q +
Sbjct: 143 IGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVG 197
Query: 308 TIGYMA------------SYVYSFGIMLLEVFTRKKP 332
T+ YMA + +Y+ +L E T P
Sbjct: 198 TLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 47/193 (24%), Positives = 84/193 (43%), Gaps = 32/193 (16%)
Query: 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSR 221
+ +G FG + ++K + + ++F E VMK + L+++ +
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 222 SNEDFKVLVLEYMPRGSLEKCLYSSNY--------VGFA------LEYLHFDYSVLIIHY 267
S E +V EYM +GSL L V A + Y+ + +H
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 268 DLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SY 315
DL+ +N+L +N+V ++DFG+A+ LI ++ + + I + A S
Sbjct: 305 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 316 VYSFGIMLLEVFT 328
V+SFGI+L E+ T
Sbjct: 364 VWSFGILLTELTT 376
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 45/206 (21%), Positives = 86/206 (41%), Gaps = 42/206 (20%)
Query: 160 EDNLISRGGFGSIHKARIQDRMEFS----VKGFHLQCSG-AFKSFDFECDVMKSTCYRNL 214
D +I +G FG ++ D+ + +K ++F E +M+ + N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 215 IKIIS-SRSNEDFKVLVLEYMPRGSL-------EKCLYSSNYVGFAL------EYL---H 257
+ +I E ++L YM G L ++ + + F L EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 258 FDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLAT--IGYMA-- 313
F +H DL N + D++ ++DFG+A+ ++ +++ +Q A + + A
Sbjct: 145 F------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 314 ----------SYVYSFGIMLLEVFTR 329
S V+SFG++L E+ TR
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTR 224
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 34/179 (18%), Positives = 61/179 (34%), Gaps = 31/179 (17%)
Query: 163 LISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISS- 220
+ GGF + + D +++K + E D+ + + N++++++
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 221 --RSNEDFKV-LVLEYMPRGSLEKCLYSSNYVGF----------------ALEYLHFDYS 261
+ L+L + RG+L + G LE +H +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 262 VLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL---IREDHFMIQTQTLA----TIGYMA 313
H DLKP+N+L D L D G + + Q A TI Y A
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-12
Identities = 47/199 (23%), Positives = 74/199 (37%), Gaps = 42/199 (21%)
Query: 164 ISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGA-FKSFDFECDVMKSTC-YRNLIKIISS 220
I RG +GS++K +VK K + DV+ + +++ +
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 221 RSNEDFKVLVLEYMPRGSLEKCLYSS----------NYVGF-------ALEYLHFDYSVL 263
E + +E M S +K +G AL +L +
Sbjct: 90 LFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-- 146
Query: 264 IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA---------- 313
IIH D+KPSN+L D + L DFGI+ L+ + +T+ YMA
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS---IAKTRDAGCRPYMAPERIDPSASR 203
Query: 314 -SY-----VYSFGIMLLEV 326
Y V+S GI L E+
Sbjct: 204 QGYDVRSDVWSLGITLYEL 222
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 7e-12
Identities = 40/209 (19%), Positives = 82/209 (39%), Gaps = 51/209 (24%)
Query: 166 RGGFGSIHKARIQDRMEFS----VKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKII- 218
+G FGS+ +A+++ VK + +F E MK + ++ K++
Sbjct: 33 KGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVG 92
Query: 219 -----SSRSNEDFKVLVLEYMPRGSL------------EKCLYSSNYVGFAL------EY 255
++ +++L +M G L L V F + EY
Sbjct: 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEY 152
Query: 256 L---HFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM 312
L +F IH DL N + +++ ++DFG+++ + D++ + + ++
Sbjct: 153 LSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 313 A------------SYVYSFGIMLLEVFTR 329
A S V++FG+ + E+ TR
Sbjct: 207 ALESLADNLYTVHSDVWAFGVTMWEIMTR 235
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-12
Identities = 46/216 (21%), Positives = 82/216 (37%), Gaps = 41/216 (18%)
Query: 164 ISRGGFGSIHKAR-IQDRMEFSVKGFHL-QCSGAFKSFDFECDVMKSTC-YRNLIKIISS 220
+ G G + K R + +VK K + DV+ + +++ +
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 221 RSNEDFKVLVLEYMPRGSL-----------EKCL-YSSNYVGFALEYLHFDYSVLIIHYD 268
+ +E M + E+ L + + AL YL + +IH D
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRD 150
Query: 269 LKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SY- 315
+KPSN+L D+ L DFGI+ L+ + + ++ YMA Y
Sbjct: 151 VKPSNILLDERGQIKLCDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 316 ----VYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
V+S GI L+E+ T + P + + + D + L
Sbjct: 208 IRADVWSLGISLVELATGQFP----YKNCKTDFEVL 239
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 9e-12
Identities = 19/95 (20%), Positives = 38/95 (40%), Gaps = 1/95 (1%)
Query: 47 PPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIY 106
L E+++L + ++ +TF + L+L+ L+ +P + L L K+
Sbjct: 249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLV 307
Query: 107 FSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSIS 141
S N F + + L HL + N + +
Sbjct: 308 LSANKFENLCQISASNFPSLTHLSIKGNTKRLELG 342
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 16/84 (19%), Positives = 31/84 (36%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L L ++ + TF + + L L+ N L + K L ++F +
Sbjct: 60 TFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS 119
Query: 115 VIPNAIGCLNILQHLFLGYNRLQG 138
+ + L+ L+LG N +
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISS 143
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 19/96 (19%), Positives = 34/96 (35%), Gaps = 2/96 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ L L + +S +PS L + L LS N + N L + N
Sbjct: 281 QELDLTATH-LSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRL 339
Query: 115 VI-PNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
+ + L L+ L L ++ ++ S + L
Sbjct: 340 ELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNL 375
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 15/84 (17%), Positives = 31/84 (36%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ L L +N LI + + K + +L ++ + + N K L +Y N+ +
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 115 VIPNAIGCLNILQHLFLGYNRLQG 138
+ L+ L N +
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHY 167
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 21/92 (22%), Positives = 39/92 (42%), Gaps = 3/92 (3%)
Query: 55 ENLSLASNELISVIPS-TFWNLKDILYLNLSLNSLT--GPIPLEIENLKVLVKIYFSMNN 111
+LS+ N + + NL+++ L+LS + + L++ NL L + S N
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE 387
Query: 112 FAGVIPNAIGCLNILQHLFLGYNRLQGSISYS 143
+ A L+ L L + RL+ + S
Sbjct: 388 PLSLKTEAFKECPQLELLDLAFTRLKVKDAQS 419
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 17/93 (18%), Positives = 35/93 (37%)
Query: 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMN 110
P E L + N L ++ +TF L ++ +L+L+ + ++ L + + N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 111 NFAGVIPNAIGCLNILQHLFLGYNRLQGSISYS 143
+ A+ L+HLF +
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIP 124
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 23/92 (25%), Positives = 48/92 (52%), Gaps = 2/92 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
E L L+ +L S+ F +LK + +++LS N LT + +LK + + + N+ +
Sbjct: 479 EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISI 537
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYSKWF 146
++P+ + L+ + + L N L + S + +F
Sbjct: 538 ILPSLLPILSQQRTINLRQNPLDCTCS-NIYF 568
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 15/97 (15%), Positives = 29/97 (29%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
++L + S+ N K + L L N ++ + + L + F N
Sbjct: 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLEL 151
+ + L +L L N + F
Sbjct: 168 LSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVF 204
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 26/100 (26%), Positives = 39/100 (39%), Gaps = 6/100 (6%)
Query: 55 ENLSLASNELISVIP-STFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFA 113
E L LA L S F NL + LNLS + L + L L + N+F
Sbjct: 403 ELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP 462
Query: 114 GVI---PNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLE 150
N++ L L+ L L + L ++ F+ L+
Sbjct: 463 KGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHA--FTSLK 500
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 18/106 (16%), Positives = 35/106 (33%), Gaps = 7/106 (6%)
Query: 48 PLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKV--LVKI 105
L+ +L+L N+ I+ I ++ LN I ++N + L
Sbjct: 175 SLQQATNLSLNLNGND-IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLG 233
Query: 106 YFSMNNFAGVIPNAIG--CLNILQHLFLGYNRLQGSISYSKWFSCL 149
F + + P C ++ + L + S + F C
Sbjct: 234 TFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT--FHCF 277
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 17/87 (19%), Positives = 32/87 (36%), Gaps = 4/87 (4%)
Query: 55 ENLSLASNELISVI---PSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNN 111
++L+L N ++ L + L LS L+ +LK++ + S N
Sbjct: 452 QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNR 511
Query: 112 FAGVIPNAIGCLNILQHLFLGYNRLQG 138
A+ L + +L L N +
Sbjct: 512 LTSSSIEALSHLKGI-YLNLASNHISI 537
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 21/95 (22%), Positives = 37/95 (38%), Gaps = 1/95 (1%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ L L+ E+ ++ + L + L L+ N + P L L + A
Sbjct: 59 QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
+ IG L L+ L + +N + S +FS L
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIH-SCKLPAYFSNL 152
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 18/87 (20%), Positives = 34/87 (39%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+N+ L+ N L + +F N ++ +L+LS + L L + + N
Sbjct: 35 KNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS 94
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSIS 141
P + L L++L +L S
Sbjct: 95 FSPGSFSGLTSLENLVAVETKLASLES 121
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 16/88 (18%), Positives = 27/88 (30%), Gaps = 1/88 (1%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFAGV 115
L ++ F L + L ++ NS + N L + S +
Sbjct: 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQI 488
Query: 116 IPNAIGCLNILQHLFLGYNRLQGSISYS 143
L+ LQ L + +N L S
Sbjct: 489 SWGVFDTLHRLQLLNMSHNNLLFLDSSH 516
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 19/86 (22%), Positives = 33/86 (38%), Gaps = 2/86 (2%)
Query: 55 ENLSLASNELISVIP-STFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFA 113
++L + L V S F +L+ +LYL++S + L L + + N+F
Sbjct: 402 QHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFK 461
Query: 114 GVIP-NAIGCLNILQHLFLGYNRLQG 138
N L L L +L+
Sbjct: 462 DNTLSNVFANTTNLTFLDLSKCQLEQ 487
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 19/92 (20%), Positives = 28/92 (30%), Gaps = 1/92 (1%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L L+ +L + F L + LN+S N+L L L + S N
Sbjct: 476 TFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET 535
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYSKWF 146
L L N + I + F
Sbjct: 536 SKGILQHFPKSLAFFNLTNNSVA-CICEHQKF 566
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 15/87 (17%), Positives = 34/87 (39%), Gaps = 2/87 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLE-IENLKVLVKIYFSMNNFA 113
+L L+ N ++ + F L+++ +L+ ++L +L+ L+ + S N
Sbjct: 379 RHLDLSFNG-AIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQGSI 140
L L L + N + +
Sbjct: 438 IDFDGIFLGLTSLNTLKMAGNSFKDNT 464
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 20/85 (23%), Positives = 32/85 (37%), Gaps = 1/85 (1%)
Query: 55 ENLSLASNELISVIPS-TFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFA 113
L +A N S F N ++ +L+LS L + L L + S NN
Sbjct: 451 NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLL 510
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQG 138
+ + L L L +NR++
Sbjct: 511 FLDSSHYNQLYSLSTLDCSFNRIET 535
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 21/91 (23%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 55 ENLSLASNELISV-IPSTFWNLKDILYLNLSLNSLTGPIPLEIENLK----VLVKIYFSM 109
+ L++A N + S +P+ F NL ++++++LS N + +++ L+ V + + S+
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190
Query: 110 NNFAGVIPNAIGCLNILQHLFLGYNRLQGSI 140
N + A + L L L N +I
Sbjct: 191 NPIDFIQDQAFQGIK-LHELTLRGNFNSSNI 220
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 20/93 (21%), Positives = 29/93 (31%), Gaps = 5/93 (5%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVI 116
+L V + K ++LS N L N L + S +
Sbjct: 16 YQCMDQKLSKVPDDIPSSTK---NIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72
Query: 117 PNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
A L+ L +L L N +Q FS L
Sbjct: 73 DKAWHGLHHLSNLILTGNPIQSFS--PGSFSGL 103
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 24/99 (24%), Positives = 41/99 (41%), Gaps = 5/99 (5%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLT--GPIPLEIENLKVLVKIYFSMNNF 112
++L+L N+ I L + YL+LS N+L+ G L + S N
Sbjct: 331 KSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA 388
Query: 113 AGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLEL 151
++ L LQHL ++ L+ +S + S +L
Sbjct: 389 -IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL 426
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 13/94 (13%), Positives = 24/94 (25%), Gaps = 5/94 (5%)
Query: 48 PLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYF 107
L + L S F L ++ ++L+ S+ + +
Sbjct: 257 GLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDV--PKHFKWQSLSI 314
Query: 108 SMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSIS 141
L L+ L L N+ S
Sbjct: 315 IRCQLKQFPTLD---LPFLKSLTLTMNKGSISFK 345
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 20/115 (17%), Positives = 31/115 (26%), Gaps = 9/115 (7%)
Query: 55 ENLSLASNELISVIPST-FWNLKDILYLNLSLNSLTGPIPLEIENLKVLVK--------I 105
L+L N S I T NL + L L LEI ++
Sbjct: 207 HELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEF 266
Query: 106 YFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLELCRVTNGFSE 160
+ N CL + + L ++ K F L + +
Sbjct: 267 RLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQ 321
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 23/98 (23%), Positives = 36/98 (36%), Gaps = 10/98 (10%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
++LS+ +L LK L L++N + I + L L + S N +
Sbjct: 310 QSLSIIRCQLKQFPTLDLPFLK---SLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSF 364
Query: 115 VIPNAIGCLNI--LQHLFLGYNRLQGSISYSKWFSCLE 150
+ L L+HL L +N S F LE
Sbjct: 365 SGCCSYSDLGTNSLRHLDLSFNGAIIM---SANFMGLE 399
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 40/176 (22%), Positives = 74/176 (42%), Gaps = 29/176 (16%)
Query: 161 DNLISRGGFGSIHKAR-IQDRMEFSVKGFH-LQCSGAFKSFDFECDVMKSTCYRNLIKI- 217
+++ +G ++ + R + F++K F+ + E +V+K ++N++K+
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 218 -ISSRSNEDFKVLVLEYMPRGSLEKCLYS-SNYVGF--------------ALEYLHFDYS 261
I + KVL++E+ P GSL L SN G + +L
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130
Query: 262 VLIIHYDLKPSNVLF----DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
I+H ++KP N++ D V L+DFG A+ L +D T Y+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQF--VSLYGTEEYLH 183
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 42/205 (20%)
Query: 161 DNLISRGGFGSIHKARIQDRMEFS----VKGFHLQCS-GAFKSFDFECDVMKSTCYRNLI 215
+ +I RG FG ++ + D VK + G F E +MK + N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 216 KIISSRSNEDFKVL-VLEYMPRGSLEKCLYSS-------NYVGFAL------EYL---HF 258
++ + L VL YM G L + + + +GF L +YL F
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF 149
Query: 259 DYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLAT--IGYMA--- 313
+H DL N + D+ ++DFG+A+ + ++++ + +T A + +MA
Sbjct: 150 ------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 314 ---------SYVYSFGIMLLEVFTR 329
S V+SFG++L E+ TR
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTR 228
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 37/171 (21%), Positives = 68/171 (39%), Gaps = 29/171 (16%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVK---------GFHLQCSGAFKSFDFECDVMKS-TCYRNL 214
RG + + E++VK + ++ E D+++ + + N+
Sbjct: 27 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86
Query: 215 IKIISSRSNEDFKVLVLEYMPRGSL-----EKCLYS----SNYVG---FALEYLHFDYSV 262
I++ + F LV + M +G L EK S + + LH +
Sbjct: 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KL 143
Query: 263 LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
I+H DLKP N+L DD++ L+DFG + + + + T Y+A
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEKL--REVCGTPSYLA 191
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 43/193 (22%), Positives = 77/193 (39%), Gaps = 36/193 (18%)
Query: 164 ISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSN 223
I G FG +H ++ + ++K + + + + F E +VM + L+++
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 224 EDFKVLVLEYMPRGSL-------EKCLYSSNYVGFA---------LEYLHFDYSVLIIHY 267
+ LV E+M G L + +G LE IH
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------IHR 128
Query: 268 DLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SY 315
DL N L +N V +SDFG+ + + +D + T T + + + S
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 316 VYSFGIMLLEVFT 328
V+SFG+++ EVF+
Sbjct: 188 VWSFGVLMWEVFS 200
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 42/196 (21%), Positives = 80/196 (40%), Gaps = 36/196 (18%)
Query: 162 NLISRGGFGSIHKARIQDR-MEFSVKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKII 218
+ + G +G +++ + + +VK + +F E VMK + NL++++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 219 SSRSNEDFKVLVLEYMPRGSLEKCLYSSN--------YVGFAL------EYLHFDYSVLI 264
+ E ++ E+M G+L L N + A EYL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 339
Query: 265 IHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA----------- 313
IH +L N L +N + ++DFG+++ L+ D + I + A
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 314 -SYVYSFGIMLLEVFT 328
S V++FG++L E+ T
Sbjct: 399 KSDVWAFGVLLWEIAT 414
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 37/223 (16%), Positives = 81/223 (36%), Gaps = 52/223 (23%)
Query: 139 SISYSKW---FSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGA 195
+ Y W L + + G FG + + + + + ++K G+
Sbjct: 13 GLGYGSWEIDPKDLTFLKE---------LGTGQFGVVKYGKWRGQYDVAIKMIK---EGS 60
Query: 196 FKSFDF--ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL-------EKCLYSS 246
+F E VM + + L+++ + + ++ EYM G L +
Sbjct: 61 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ 120
Query: 247 NYVGFA---------LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297
+ LE F +H DL N L +D V +SDFG+++ + +D
Sbjct: 121 QLLEMCKDVCEAMEYLESKQF------LHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDD 173
Query: 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
+ + + + S +++FG+++ E+++
Sbjct: 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 35/233 (15%), Positives = 67/233 (28%), Gaps = 53/233 (22%)
Query: 158 FSEDNLISRGGFGSIHKAR------IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCY 211
+L+ G F +++A +++ +F +K F + +K +
Sbjct: 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQ 126
Query: 212 RNLIKIISSRSNEDFKVLVLEYMPRGSL-----------EKCLYSSNYVGF------ALE 254
+K S+ ++ VLV E G+L EK + + F +E
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186
Query: 255 YLHFDYSVLIIHYDLKPSNVLFDDNIVTH-----------LSDFGIAKLLIREDHFMIQT 303
+H IIH D+KP N + + + L D G + + I T
Sbjct: 187 QVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243
Query: 304 QTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIFFSQRNDI 344
T G+ + + +
Sbjct: 244 AKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM----KVKNEGGE 292
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 47/225 (20%), Positives = 81/225 (36%), Gaps = 56/225 (24%)
Query: 153 RVTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCY 211
R + F E ++ +G FG + KAR D +++K + E ++ S +
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNH 61
Query: 212 RNLIKIISS-------------RSNEDFKVLVLEYMPRGSL------EKCLYSSNYVGF- 251
+ +++ ++ + + +EY G+L E +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 252 ------ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT 305
AL Y+H S IIH DLKP N+ D++ + DFG+AK + R +
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 306 LA------------TIGYMA--------SY-----VYSFGIMLLE 325
T Y+A Y +YS GI+ E
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 46/195 (23%), Positives = 81/195 (41%), Gaps = 37/195 (18%)
Query: 167 GGFGSIHKARIQDRMEFS-----VKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKI-- 217
G FG + + + VK +S + E D++++ + ++IK
Sbjct: 42 GHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRS-GWKQEIDILRTLYHEHIIKYKG 100
Query: 218 ISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-----VGFAL------EYLHFDYSVLIIH 266
+ LV+EY+P GSL L + + FA YLH + IH
Sbjct: 101 CCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH---AQHYIH 157
Query: 267 YDLKPSNVLFDDNIVTHLSDFGIAKLLIR-EDHFMIQTQTLATIGYMA------------ 313
DL NVL D++ + + DFG+AK + +++ ++ + + + A
Sbjct: 158 RDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYA 217
Query: 314 SYVYSFGIMLLEVFT 328
S V+SFG+ L E+ T
Sbjct: 218 SDVWSFGVTLYELLT 232
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 40/197 (20%)
Query: 167 GGFGSIHKARIQDRMEFS-----VKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKI-- 217
G FGS+ R + + VK LQ SG + DF E ++K+ ++K
Sbjct: 34 GNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVKYRG 91
Query: 218 ISSRSNEDFKVLVLEYMPRGSL-------EKCLYSSNYVGFAL------EYLHFDYSVLI 264
+S LV+EY+P G L L +S + ++ EYL S
Sbjct: 92 VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRC 148
Query: 265 IHYDLKPSNVLFDDNIVTHLSDFGIAKLL-IREDHFMIQTQTLATIGYMA---------- 313
+H DL N+L + ++DFG+AKLL + +D+++++ + I + A
Sbjct: 149 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS 208
Query: 314 --SYVYSFGIMLLEVFT 328
S V+SFG++L E+FT
Sbjct: 209 RQSDVWSFGVVLYELFT 225
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 35/171 (20%), Positives = 67/171 (39%), Gaps = 25/171 (14%)
Query: 163 LISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-YRNLIKIISS 220
+++ GGF +++A+ + E+++K ++ E MK + N+++ S+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 221 RS-------NEDFKVLVLEYMPRGSLEKCLYSSNYVGF---------------ALEYLHF 258
S + L+L + +G L + L G A++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 259 DYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATI 309
IIH DLK N+L + L DFG A + + Q A +
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 41/200 (20%), Positives = 84/200 (42%), Gaps = 39/200 (19%)
Query: 164 ISRGGFGSIHKARIQDRMEFS-----VKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIK 216
+ G FG + R + + VK + G + D E +++++ + N++K
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA-DLKKEIEILRNLYHENIVK 87
Query: 217 I--ISSRSNEDFKVLVLEYMPRGSL-------EKCLYSSNYVGFAL------EYLHFDYS 261
I + + L++E++P GSL + + + +A+ +YL S
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---S 144
Query: 262 VLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR-EDHFMIQTQTLATIGYMA------- 313
+H DL NVL + + DFG+ K + ++++ ++ + + + A
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS 204
Query: 314 -----SYVYSFGIMLLEVFT 328
S V+SFG+ L E+ T
Sbjct: 205 KFYIASDVWSFGVTLHELLT 224
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 40/204 (19%), Positives = 68/204 (33%), Gaps = 37/204 (18%)
Query: 158 FSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDF--ECDVMKSTC-YRN 213
F + + G +G + K R +D ++VK G E + +
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 214 LIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------------VGFALEYLHFDY 260
+++ + L E SL++ + AL +LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH--- 174
Query: 261 SVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMA------ 313
S ++H D+KP+N+ L DFG+ L + YMA
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG----AGEVQEGDPRYMAPELLQG 230
Query: 314 SY-----VYSFGIMLLEVFTRKKP 332
SY V+S G+ +LEV +
Sbjct: 231 SYGTAADVFSLGLTILEVACNMEL 254
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 34/175 (19%), Positives = 65/175 (37%), Gaps = 30/175 (17%)
Query: 164 ISRGGFGSIHKAR-IQDRMEFSVK-----GFHLQCSGAFKSFDFECDVMKSTCYRNLIKI 217
I +G F + + + +F+VK F + + E + + +++++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 218 ISSRSNEDFKVLVLEYMPRGSL-----EKCLYSSNY-----------VGFALEYLHFDYS 261
+ + S++ +V E+M L ++ Y + AL Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---D 148
Query: 262 VLIIHYDLKPSNVLF---DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
IIH D+KP VL +++ L FG+A L + T +MA
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGTPHFMA 201
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 40/195 (20%), Positives = 81/195 (41%), Gaps = 35/195 (17%)
Query: 158 FSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIK 216
I G G + AR + +VK L+ + E +M+ + N+++
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 217 IISSRSNEDFKVLVLEYMPRGSL----EKCLYSSNYVGF-------ALEYLHFDYSVLII 265
+ S + +++E++ G+L + + + AL YLH + +I
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLH---AQGVI 163
Query: 266 HYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIG---YMA-------SY 315
H D+K ++L + LSDFG + ++ + + ++L +G +MA Y
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKD---VPKRKSL--VGTPYWMAPEVISRSLY 218
Query: 316 -----VYSFGIMLLE 325
++S GIM++E
Sbjct: 219 ATEVDIWSLGIMVIE 233
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 48/224 (21%), Positives = 88/224 (39%), Gaps = 48/224 (21%)
Query: 138 GSISYSKW---FSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDR-MEFSVKGFHLQCS 193
GS +Y KW + + + + G +G +++ + + +VK
Sbjct: 1 GSPNYDKWEMERTDITMKHK---------LGGGQYGEVYEGVWKKYSLTVAVKTLK---E 48
Query: 194 GAFKSFDF--ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN---- 247
+ +F E VMK + NL++++ + E ++ E+M G+L L N
Sbjct: 49 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV 108
Query: 248 ----YVGFAL------EYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297
+ A EYL IH DL N L +N + ++DFG+++ L+ D
Sbjct: 109 SAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGD 164
Query: 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTR 329
+ I + A S V++FG++L E+ T
Sbjct: 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 208
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 40/176 (22%), Positives = 74/176 (42%), Gaps = 29/176 (16%)
Query: 161 DNLISRGGFGSIHKAR-IQDRMEFSVKGFH-LQCSGAFKSFDFECDVMKSTCYRNLIKI- 217
+++ +G ++ + R + F++K F+ + E +V+K ++N++K+
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 218 -ISSRSNEDFKVLVLEYMPRGSLEKCLYS-SNYVGF--------------ALEYLHFDYS 261
I + KVL++E+ P GSL L SN G + +L
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130
Query: 262 VLIIHYDLKPSNVLF----DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
I+H ++KP N++ D V L+DFG A+ L +D T Y+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQF--VSLYGTEEYLH 183
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 4e-11
Identities = 44/193 (22%), Positives = 81/193 (41%), Gaps = 36/193 (18%)
Query: 164 ISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKIISSR 221
+ G FG + + +VK G+ F E ++MK ++ L+++ +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 222 SNEDFKVLVLEYMPRGSLEKCLYSSNY--------VGFAL------EYLHFDYSVLIIHY 267
+ E + + EYM GSL L + + + A ++ IH
Sbjct: 78 TQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 268 DLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SY 315
DL+ +N+L D + ++DFG+A+ LI ++ + + I + A S
Sbjct: 134 DLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 316 VYSFGIMLLEVFT 328
V+SFGI+L E+ T
Sbjct: 193 VWSFGILLTEIVT 205
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 46/193 (23%), Positives = 81/193 (41%), Gaps = 31/193 (16%)
Query: 158 FSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIK 216
++ I +G G+++ A + E +++ +LQ + E VM+ N++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 217 IISSRSNEDFKVLVLEYMPRGSL----EKCLYSSNYVGF-------ALEYLHFDYSVLII 265
+ S D +V+EY+ GSL + + ALE+LH S +I
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 266 HYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMA-------SY-- 315
H D+K N+L + L+DFG + E + T+ T +MA +Y
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 316 ---VYSFGIMLLE 325
++S GIM +E
Sbjct: 196 KVDIWSLGIMAIE 208
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 6e-11
Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 42/205 (20%)
Query: 161 DNLISRGGFGSIHKARIQDRMEFS----VKGFHLQCS-GAFKSFDFECDVMKSTCYRNLI 215
+ +I RG FG ++ + D VK + G F E +MK + N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 216 KIISSRSNEDFKVL-VLEYMPRGSLEKCLYSSNY-------VGFAL------EYL---HF 258
++ + L VL YM G L + + + +GF L ++L F
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 213
Query: 259 DYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLAT--IGYMA--- 313
+H DL N + D+ ++DFG+A+ + ++ + +T A + +MA
Sbjct: 214 ------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 314 ---------SYVYSFGIMLLEVFTR 329
S V+SFG++L E+ TR
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTR 292
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 36/166 (21%), Positives = 63/166 (37%), Gaps = 26/166 (15%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNE 224
G FG +H+ F K + + E +M + LI + + ++
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120
Query: 225 DFKVLVLEYMPRGSL------EKCLYSSNYVGF-------ALEYLHFDYSVLIIHYDLKP 271
VL+LE++ G L E S V L+++H I+H D+KP
Sbjct: 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKP 177
Query: 272 SNVLF----DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
N++ ++ + DFG+A L ++ T AT + A
Sbjct: 178 ENIMCETKKASSVK--IIDFGLATKLNPDEIV---KVTTATAEFAA 218
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 22/99 (22%)
Query: 229 LVLEYMPRGSL-----------EK--CLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVL 275
+V++ + G L E+ L+ + AL+YL + IIH D+KP N+L
Sbjct: 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICE-LVMALDYLQ---NQRIIHRDMKPDNIL 147
Query: 276 FDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMA 313
D++ H++DF IA +L RE Q T+A T YMA
Sbjct: 148 LDEHGHVHITDFNIAAMLPRET----QITTMAGTKPYMA 182
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 7e-11
Identities = 29/97 (29%), Positives = 44/97 (45%), Gaps = 16/97 (16%)
Query: 249 VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT-LA 307
AL + H IIH D+KP+N++ + DFGIA+ + + + QT +
Sbjct: 125 ACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 308 TIGYMA------------SYVYSFGIMLLEVFTRKKP 332
T Y++ S VYS G +L EV T + P
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 62.4 bits (151), Expect = 7e-11
Identities = 49/210 (23%), Positives = 78/210 (37%), Gaps = 44/210 (20%)
Query: 161 DNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGA-FKSFDFECDVMKSTCYRNLIKII 218
+ GGFG + + + ++K + S + + E +MK + N++
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 219 ------SSRSNEDFKVLVLEYMPRGSLEKCLYS-SNYVGF--------------ALEYLH 257
+ D +L +EY G L K L N G AL YLH
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 258 FDYSVLIIHYDLKPSNVLFD---DNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA- 313
IIH DLKP N++ ++ + D G AK L + T+ + T+ Y+A
Sbjct: 139 ---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELC--TEFVGTLQYLAP 192
Query: 314 ------SY-----VYSFGIMLLEVFTRKKP 332
Y +SFG + E T +P
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 38/196 (19%), Positives = 66/196 (33%), Gaps = 42/196 (21%)
Query: 153 RVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVM-KSTCY 211
+ N + ++ G G++ +VK + E ++ +S +
Sbjct: 12 SLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDH 68
Query: 212 RNLIKIISSRSNEDFKVLVLEYMPRGSL-----EKCLYSSNYVGF--------------A 252
N+I+ S + + F + LE +L K + N
Sbjct: 69 PNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 253 LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTH-------------LSDFGIAKLLIREDH- 298
+ +LH S+ IIH DLKP N+L + +SDFG+ K L
Sbjct: 128 VAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 299 FMIQTQTLA-TIGYMA 313
F + T G+ A
Sbjct: 185 FRTNLNNPSGTSGWRA 200
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 23/164 (14%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNE 224
G F + + F++K + S + E V+K + N++ + +
Sbjct: 19 SGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST 78
Query: 225 DFKVLVLEYMPRGSL-----EKCLYS----SNYVG---FALEYLHFDYSVLIIHYDLKPS 272
LV++ + G L E+ +Y+ S + A++YLH I+H DLKP
Sbjct: 79 THYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPE 135
Query: 273 NVLF---DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
N+L+ ++N ++DFG++K + ++ M + T GY+A
Sbjct: 136 NLLYLTPEENSKIMITDFGLSK--MEQNGIM--STACGTPGYVA 175
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 43/170 (25%), Positives = 71/170 (41%), Gaps = 28/170 (16%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVK--------GFHLQCSGAFKSFDFECDVMKS-TCYRNLI 215
RG + + EF+VK Q ++ E +++ + ++I
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163
Query: 216 KIISSRSNEDFKVLVLEYMPRGSL-----EKCLYS----SNYVG---FALEYLHFDYSVL 263
+I S + F LV + M +G L EK S + + A+ +LH +
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH---ANN 220
Query: 264 IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
I+H DLKP N+L DDN+ LSDFG + + + + T GY+A
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSC-HLEPGEKL--RELCGTPGYLA 267
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 18/97 (18%)
Query: 249 VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT-LA 307
+ +++ H + I+H D+KP N+L D N + DFGIAK L + + QT L
Sbjct: 120 ILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLG 174
Query: 308 TIGYMA------------SYVYSFGIMLLEVFTRKKP 332
T+ Y + + +YS GI+L E+ + P
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 37/166 (22%), Positives = 65/166 (39%), Gaps = 26/166 (15%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNE 224
G FG +HK ++ + K + + E VM + NLI++ + ++
Sbjct: 99 GGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK 158
Query: 225 DFKVLVLEYMPRGSL------EKCLYSSNYVGF-------ALEYLHFDYSVLIIHYDLKP 271
+ VLV+EY+ G L E + + ++H Y I+H DLKP
Sbjct: 159 NDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKP 215
Query: 272 SNVLF----DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
N+L I + DFG+A+ + + T ++A
Sbjct: 216 ENILCVNRDAKQIK--IIDFGLAR-RYKPREKL--KVNFGTPEFLA 256
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 36/166 (21%), Positives = 68/166 (40%), Gaps = 24/166 (14%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFH--LQCSGAFKSFDFECDVMKSTCYRNLIKIISSRS 222
+G F + + +EF+ K + + F+ + E + + + N++++ S
Sbjct: 39 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 98
Query: 223 NEDFKVLVLEYMPRGSL-----EKCLYS----SNYVG---FALEYLHFDYSVLIIHYDLK 270
E F LV + + G L + YS S+ + ++ Y H S I+H +LK
Sbjct: 99 EESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLK 155
Query: 271 PSNVLF---DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
P N+L L+DFG+A + + T GY++
Sbjct: 156 PENLLLASKAKGAAVKLADFGLAI-EVNDSEAW--HGFAGTPGYLS 198
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 45/199 (22%), Positives = 74/199 (37%), Gaps = 43/199 (21%)
Query: 164 ISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGA-FKSFDFECDVMKSTC-YRNLIKIISS 220
+ RG +G + K R + +VK + K + D+ T + +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 221 RSNEDFKVLVLEYMPRGSLEKCL----------------YSSNYVGFALEYLHFDYSVLI 264
E + +E M SL+K + + ALE+LH S +
Sbjct: 75 LFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131
Query: 265 IHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMA---------- 313
IH D+KPSNVL + + DFGI+ L+ + + A YMA
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDD----VAKDIDAGCKPYMAPERINPELNQ 187
Query: 314 -SY-----VYSFGIMLLEV 326
Y ++S GI ++E+
Sbjct: 188 KGYSVKSDIWSLGITMIEL 206
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 2e-10
Identities = 43/208 (20%), Positives = 73/208 (35%), Gaps = 44/208 (21%)
Query: 161 DNLISRGGFGSIHKARIQDRMEFS-----VKGFHLQCSGAFKSFDF--ECDVMKSTCYRN 213
++ G FG+++K E +K S + E VM S +
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMASVDNPH 78
Query: 214 LIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------VGFA------LEYL---H 257
+ +++ + L+ + MP G L + + + + YL
Sbjct: 79 VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 258 FDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA---- 313
+H DL NVL ++DFG+AKLL E+ I +MA
Sbjct: 138 L------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 314 --------SYVYSFGIMLLEVFTR-KKP 332
S V+S+G+ + E+ T KP
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 3e-10
Identities = 46/195 (23%), Positives = 76/195 (38%), Gaps = 40/195 (20%)
Query: 164 ISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKIISSR 221
+ G FG + + + + + +VK G+ +F E M + L+K
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 222 SNEDFKVLVLEYMPRGSL-------EKCLYSSNYVGFA---------LEYLHFDYSVLII 265
S E +V EY+ G L K L S + LE F I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------I 126
Query: 266 HYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------ 313
H DL N L D ++ +SDFG+ + + +D ++ T + + A
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 314 SYVYSFGIMLLEVFT 328
S V++FGI++ EVF+
Sbjct: 186 SDVWAFGILMWEVFS 200
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 39/190 (20%), Positives = 72/190 (37%), Gaps = 36/190 (18%)
Query: 164 ISRGGFGSIHKAR-IQDRMEFSVKGF---HLQCSGAFKSFDFECDVMKSTCYRNLIKIIS 219
+ +G FG + + E +VK ++ +S E ++K + N++K+
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 220 SRSNEDFKVLVLEYMPRGSL-----EKCLYSSNYVGF-------ALEYLHFDYSVLIIHY 267
++ + LV E G L + +S + Y+H I+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH---KNKIVHR 150
Query: 268 DLKPSNVLF---DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------SY--- 315
DLKP N+L + + DFG++ M + T Y+A +Y
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLST-HFEASKKM--KDKIGTAYYIAPEVLHGTYDEK 207
Query: 316 --VYSFGIML 323
V+S G++L
Sbjct: 208 CDVWSTGVIL 217
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 49/224 (21%), Positives = 82/224 (36%), Gaps = 44/224 (19%)
Query: 136 LQGSISYSKW---FSCLELCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ 191
L ++ KW L L I RG FG + R++ D +VK
Sbjct: 100 LHRAVPKDKWVLNHEDLVLGEQ---------IGRGNFGEVFSGRLRADNTLVAVKSCRET 150
Query: 192 CSGAFKSFDF--ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYS---- 245
K+ F E ++K + N++++I + + +V+E + G L +
Sbjct: 151 LPPDLKA-KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR 209
Query: 246 ---SNYVGFA------LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296
+ +EYL S IH DL N L + V +SDFG+++
Sbjct: 210 LRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266
Query: 297 DHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
+ + + A S V+SFGI+L E F+
Sbjct: 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 34/164 (20%), Positives = 59/164 (35%), Gaps = 22/164 (13%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNE 224
G FG +H+ F+ K ++ E M + L+ + + ++
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226
Query: 225 DFKVLVLEYMPRGSL------EKCLYS----SNYVG---FALEYLHFDYSVLIIHYDLKP 271
+ V++ E+M G L E S Y+ L ++H + +H DLKP
Sbjct: 227 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKP 283
Query: 272 SNVLFDDNIVTHL--SDFGIAKLLIREDHFMIQTQTLATIGYMA 313
N++F L DFG+ L + T T + A
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAA 324
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-10
Identities = 42/199 (21%), Positives = 77/199 (38%), Gaps = 38/199 (19%)
Query: 167 GGFGSIHKARIQDRMEFS-----VKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKIIS 219
G FG++HK E +K SG + S + ++++++
Sbjct: 24 GVFGTVHKGVWIPEGESIKIPVCIKVIE-DKSGRQSFQAVTDHMLAIGSLDHAHIVRLLG 82
Query: 220 SRSNEDFKVLVLEYMPRGSL-------EKCLYSSNYVGFAL------EYLHFDYSVLIIH 266
+ LV +Y+P GSL L + + + YL ++H
Sbjct: 83 LCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVH 138
Query: 267 YDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------S 314
+L NVL ++DFG+A LL +D ++ ++ I +MA S
Sbjct: 139 RNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQS 198
Query: 315 YVYSFGIMLLEVFTR-KKP 332
V+S+G+ + E+ T +P
Sbjct: 199 DVWSYGVTVWELMTFGAEP 217
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 7e-10
Identities = 31/166 (18%), Positives = 65/166 (39%), Gaps = 23/166 (13%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGF--HLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRS 222
+G F + + + E++ + + + E + + + N++++ S S
Sbjct: 21 KGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS 80
Query: 223 NEDFKVLVLEYMPRGSL-----EKCLYS----SNYVG---FALEYLHFDYSVLIIHYDLK 270
E L+ + + G L + YS S+ + A+ + H + ++H +LK
Sbjct: 81 EEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH---QMGVVHRNLK 137
Query: 271 PSNVLF---DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
P N+L L+DFG+A + E T GY++
Sbjct: 138 PENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FGFAGTPGYLS 181
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 8e-10
Identities = 34/143 (23%), Positives = 55/143 (38%), Gaps = 39/143 (27%)
Query: 229 LVLEYMPRGSLEKCLY-----SSNYVGF-------ALEYLHFDYSVLIIHYDLKPSNVLF 276
+L+ M G L L S + F LE++H + +++ DLKP+N+L
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILL 325
Query: 277 DDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMASYV-------------YSFGIM 322
D++ +SD G+A ++ + T GYMA V +S G M
Sbjct: 326 DEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 380
Query: 323 LLEVFTRKKPTNKIFFSQRNDIK 345
L ++ P F Q
Sbjct: 381 LFKLLRGHSP-----FRQHKTKD 398
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 9e-10
Identities = 36/166 (21%), Positives = 69/166 (41%), Gaps = 24/166 (14%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFHLQ--CSGAFKSFDFECDVMKSTCYRNLIKIISSRS 222
+G F + + +EF+ K + + + F+ + E + + + N++++ S
Sbjct: 16 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 75
Query: 223 NEDFKVLVLEYMPRGSL-----EKCLYS----SNYVG---FALEYLHFDYSVLIIHYDLK 270
E F LV + + G L + YS S+ + ++ Y H S I+H +LK
Sbjct: 76 EESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLK 132
Query: 271 PSNVLF---DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
P N+L L+DFG+A + + T GY++
Sbjct: 133 PENLLLASKAKGAAVKLADFGLAI-EVNDSEAW--HGFAGTPGYLS 175
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 9e-10
Identities = 41/186 (22%), Positives = 73/186 (39%), Gaps = 31/186 (16%)
Query: 150 ELCRVTNGFSED----NLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECD 204
+L R + F++ I G + + MEF+VK + E +
Sbjct: 12 QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIE 67
Query: 205 VMKSTC-YRNLIKIISSRSNEDFKVLVLEYMPRGSL-----EKCLYS----SNY---VGF 251
++ + N+I + + + +V E M G L + +S S +
Sbjct: 68 ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITK 127
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLF----DDNIVTHLSDFGIAKLLIREDHFMIQTQTLA 307
+EYLH + ++H DLKPSN+L+ + + DFG AK L E+ +
Sbjct: 128 TVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MTPCY 182
Query: 308 TIGYMA 313
T ++A
Sbjct: 183 TANFVA 188
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 49/207 (23%), Positives = 83/207 (40%), Gaps = 41/207 (19%)
Query: 160 EDNLISRGGFGSIHKARIQDRMEFS---VKGFHLQCSGAFKSFDF--ECDVMKSTCYRNL 214
ED + G FG++ K Q + VK + + + E +VM+ +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 215 IKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY------VGFA---------LEYLHFD 259
+++I E + LV+E G L K L + + + LE +F
Sbjct: 81 VRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF- 138
Query: 260 YSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR-EDHFMIQTQTLATIGYMA----- 313
+H DL NVL +SDFG++K L E+++ QT + + A
Sbjct: 139 -----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 314 -------SYVYSFGIMLLEVFTR-KKP 332
S V+SFG+++ E F+ +KP
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 13/98 (13%), Positives = 27/98 (27%), Gaps = 21/98 (21%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
L LH ++H L+P +++ D L+ F + A
Sbjct: 223 LLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD-GASAVSPIGRGFAPPET 278
Query: 312 MASY-----------------VYSFGIMLLEVFTRKKP 332
A ++ G+ + ++ P
Sbjct: 279 TAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 24/98 (24%), Positives = 43/98 (43%), Gaps = 1/98 (1%)
Query: 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNN 111
P+ + L L+ E+ ++ + +L + L L+ N + L L K+ N
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 112 FAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
A + IG L L+ L + +N +Q S ++FS L
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNL 148
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 17/88 (19%), Positives = 38/88 (43%), Gaps = 2/88 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFA 113
+ L L+ N +I+ + S F L+ + +L+ ++L + +L+ L+ + S +
Sbjct: 376 KYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQGSIS 141
L+ L+ L + N Q +
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFL 462
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 19/87 (21%), Positives = 35/87 (40%)
Query: 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMN 110
P +NL L+ N L + +F++ ++ L+LS + ++L L + + N
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 111 NFAGVIPNAIGCLNILQHLFLGYNRLQ 137
+ A L+ LQ L L
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLA 113
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 17/86 (19%), Positives = 33/86 (38%), Gaps = 4/86 (4%)
Query: 55 ENLSLASNEL--ISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNF 112
E L L+ N L + + + YL+LS N + + L+ L + F +N
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL 408
Query: 113 AGVIP-NAIGCLNILQHLFLGYNRLQ 137
+ + L L +L + + +
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTR 434
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 32/176 (18%), Positives = 66/176 (37%), Gaps = 9/176 (5%)
Query: 55 ENLSLASNELISV-IPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVL----VKIYFSM 109
+ L++A N + S +P F NL ++ +L+LS N + ++ L + + + S+
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 110 NNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKW--FSCLELCR-VTNGFSEDNLISR 166
N + P A + L L L N ++ + + LE+ R V F + + +
Sbjct: 187 NPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245
Query: 167 GGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRS 222
++ EF + F+ +V + I+ + S
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS 301
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 22/94 (23%), Positives = 34/94 (36%), Gaps = 1/94 (1%)
Query: 55 ENLSLASNELISVIPS-TFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFA 113
E L +A N F L+++ +L+LS L P +L L + + N
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK 507
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFS 147
V L LQ ++L N S + S
Sbjct: 508 SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 541
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 24/111 (21%), Positives = 44/111 (39%), Gaps = 6/111 (5%)
Query: 41 CPRYNYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLT--GPIPLEIEN 98
C +P L+ + L+ SN+ + + +L + +L+LS N L+ G
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 99 LKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
L + S N + + L L+HL ++ L+ +S F L
Sbjct: 372 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSL 420
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 42/172 (24%), Positives = 69/172 (40%), Gaps = 31/172 (18%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFH---LQCSGAFKSFDF-----ECDVMKSTCYRNLIK 216
G G + A + + ++K A ++ E +++K + +IK
Sbjct: 20 SGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 79
Query: 217 IISSRSNEDFKVLVLEYMPRGSL-----EKCLYS----SNYVG---FALEYLHFDYSVLI 264
I + ED+ +VLE M G L Y A++YLH I
Sbjct: 80 IKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGI 135
Query: 265 IHYDLKPSNVLF---DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
IH DLKP NVL +++ + ++DFG +K ++ E M T Y+A
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLM--RTLCGTPTYLA 184
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 33/166 (19%), Positives = 69/166 (41%), Gaps = 24/166 (14%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFH--LQCSGAFKSFDFECDVMKSTCYRNLIKIISSRS 222
+G FG + K + + E++VK + + + E +++K + N++K+
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91
Query: 223 NEDFKVLVLEYMPRGSL-----EKCLYSSNYVGF-------ALEYLHFDYSVLIIHYDLK 270
+ +V E G L ++ +S + + Y+H I+H DLK
Sbjct: 92 DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLK 148
Query: 271 PSNVLF---DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
P N+L + + + DFG++ +++ M + T Y+A
Sbjct: 149 PENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYIA 191
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 47/203 (23%), Positives = 81/203 (39%), Gaps = 36/203 (17%)
Query: 158 FSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHL-QCSGAFKSFDFECDVMKSTCYRNLI 215
F++ I +G FG + K + + ++K L + + E V+ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 216 KIISSRSNEDFKVLVLEYMPRGS----LEKCLYSSNYVGF-------ALEYLHFDYSVLI 264
K S + +++EY+ GS LE + L+YLH S
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLH---SEKK 140
Query: 265 IHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIG---YMA-------S 314
IH D+K +NVL ++ L+DFG+A L I+ T +G +MA +
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTF--VGTPFWMAPEVIKQSA 195
Query: 315 Y-----VYSFGIMLLEVFTRKKP 332
Y ++S GI +E+ + P
Sbjct: 196 YDSKADIWSLGITAIELARGEPP 218
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 40/198 (20%), Positives = 74/198 (37%), Gaps = 35/198 (17%)
Query: 164 ISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKIISS 220
+ G +G + R +E ++K + E V+K + N++K+
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 221 RSNEDFKVLVLEYMPRGSL-----EKCLYSSNYVGF-------ALEYLHFDYSVLIIHYD 268
++ LV+E G L + ++ + YLH I+H D
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRD 161
Query: 269 LKPSNVLF---DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------SY---- 315
LKP N+L + + + + DFG++ + M + L T Y+A Y
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSA-VFENQKKM--KERLGTAYYIAPEVLRKKYDEKC 218
Query: 316 -VYSFGIMLLEVFTRKKP 332
V+S G++L + P
Sbjct: 219 DVWSIGVILFILLAGYPP 236
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 39/208 (18%), Positives = 77/208 (37%), Gaps = 50/208 (24%)
Query: 166 RGGFGSIHKARIQDRMEFS------VKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKII 218
+G FG +++ + ++ +K + S F E VMK ++++++
Sbjct: 35 QGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94
Query: 219 SSRSNEDFKVLVLEYMPRGSL----------------EKCLYSSNYVGFAL------EYL 256
S ++++E M RG L S + A YL
Sbjct: 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 154
Query: 257 ---HFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
F +H DL N + ++ + DFG+ + + D++ + L + +M+
Sbjct: 155 NANKF------VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 314 ------------SYVYSFGIMLLEVFTR 329
S V+SFG++L E+ T
Sbjct: 209 PESLKDGVFTTYSDVWSFGVVLWEIATL 236
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 39/204 (19%), Positives = 87/204 (42%), Gaps = 32/204 (15%)
Query: 158 FSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIK 216
+ + G FG ++KA+ + + K + + + E +++ + + ++K
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 217 IISSRSNEDFKVLVLEYMPRGSL-------EKCL------YSSNYVGFALEYLHFDYSVL 263
++ + ++ +++E+ P G++ ++ L + AL +LH S
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKR 137
Query: 264 IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED----------HFM----IQTQTLATI 309
IIH DLK NVL L+DFG++ ++ ++M + +T+
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 310 GY-MASYVYSFGIMLLEVFTRKKP 332
Y + ++S GI L+E+ + P
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEPP 221
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 3e-09
Identities = 43/232 (18%), Positives = 87/232 (37%), Gaps = 56/232 (24%)
Query: 139 SISYSKWF---SCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFS----VKGFHLQ 191
S+ ++ + L R+ + G FG +++ + VK
Sbjct: 1 SMGGPQYGIAREDVVLNRI---------LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD 51
Query: 192 CSGAFKSFDF--ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY- 248
C+ K F E +MK+ + +++K+I E + ++E P G L L +
Sbjct: 52 CTLDNKE-KFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLERNKNS 109
Query: 249 ------VGFA---------LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293
V ++ LE ++ +H D+ N+L L DFG+++
Sbjct: 110 LKVLTLVLYSLQICKAMAYLESINC------VHRDIAVRNILVASPECVKLGDFGLSR-Y 162
Query: 294 IREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTR-KKP 332
I ++ + + T I +M+ S V+ F + + E+ + K+P
Sbjct: 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 40/172 (23%), Positives = 70/172 (40%), Gaps = 31/172 (18%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFH--------LQCSGAFKSFDFECDVMKSTCYRNLIK 216
G G + A + + +++ + + + + E +++K + +IK
Sbjct: 145 SGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204
Query: 217 IISSRSNEDFKVLVLEYMPRGSL-----EKCLYS----SNYVG---FALEYLHFDYSVLI 264
I + ED+ +VLE M G L Y A++YLH I
Sbjct: 205 IKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGI 260
Query: 265 IHYDLKPSNVLF---DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
IH DLKP NVL +++ + ++DFG +K ++ E M T Y+A
Sbjct: 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLM--RTLCGTPTYLA 309
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 50/204 (24%), Positives = 74/204 (36%), Gaps = 44/204 (21%)
Query: 166 RGGFGSIHKA--RIQDRMEFSV-----KGFHLQCSGAFKSFDFECDVMKSTCYRNLIKII 218
G FG + + SV K L A F E + M S +RNLI++
Sbjct: 28 DGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLY 87
Query: 219 SSRSNEDFKVLVLEYMPRGSLEKCLYS-------SNYVGFA---------LEYLHFDYSV 262
K +V E P GSL L +A LE F
Sbjct: 88 GVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF---- 142
Query: 263 LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR-EDHFMIQTQTLATIGYMA-------- 313
IH DL N+L + + DFG+ + L + +DH+++Q + A
Sbjct: 143 --IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 314 ----SYVYSFGIMLLEVFTR-KKP 332
S + FG+ L E+FT ++P
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEP 224
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 32/154 (20%), Positives = 58/154 (37%), Gaps = 21/154 (13%)
Query: 163 LISRGGFGSIHKAR-IQDRMEFSVKGFH---LQCSGAFKSFDFECDVMKSTCYRNLIKII 218
+ +GGF + + F+ K L + E + +S +++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 219 SSRSNEDFKVLVLEYMPRGSL-------------EKCLYSSNYVGFALEYLHFDYSVLII 265
+ DF +VLE R SL E Y V +YLH +I
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-GCQYLH---RNRVI 163
Query: 266 HYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299
H DLK N+ ++++ + DFG+A + +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 36/151 (23%), Positives = 55/151 (36%), Gaps = 43/151 (28%)
Query: 229 LVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHFDYSVLIIHYDLKPSNV 274
LVL M G L+ +Y GF LE LH I++ DLKP N+
Sbjct: 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENI 317
Query: 275 LFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMASYV------------YSFGI 321
L DD+ +SD G+A + + T+GYMA V ++ G
Sbjct: 318 LLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGC 373
Query: 322 MLLEVFT---------RKKPTNKIFFSQRND 343
+L E+ +K ++ +
Sbjct: 374 LLYEMIAGQSPFQQRKKKIKREEVERLVKEV 404
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 42/246 (17%), Positives = 85/246 (34%), Gaps = 52/246 (21%)
Query: 126 LQHLFLGYNRLQGSISYSKWFSCLELCRVTNGFSEDNLISRG--GFGSIHKAR-IQDRME 182
H + QG S+ C EL V I +G +++ AR
Sbjct: 4 HHHHHMENLYFQGMSSFLPEGGCYELLTV---------IGKGFEDLMTVNLARYKPTGEY 54
Query: 183 FSVKGFHLQCSGAFKSFDF---ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL 239
+V+ +L+ + + + F E V K + N++ ++ ++ +V +M GS
Sbjct: 55 VTVRRINLE-ACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA 113
Query: 240 EKCLYSSNYVGF--------------ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLS 285
+ + + G AL+Y+H + +H +K S++L + +LS
Sbjct: 114 KDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLS 170
Query: 286 DFGIAKLLIREDH-----FMIQTQTLATIGYMA---------SY-----VYSFGIMLLEV 326
+I ++ + +++ Y +YS GI E+
Sbjct: 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 230
Query: 327 FTRKKP 332
P
Sbjct: 231 ANGHVP 236
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 16/83 (19%), Positives = 33/83 (39%), Gaps = 2/83 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ + + L + S + ++ L+LS N L+ ++ L + S N
Sbjct: 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE 72
Query: 115 VIPNAIGCLNILQHLFLGYNRLQ 137
+ + L+ L+ L L N +Q
Sbjct: 73 TLD--LESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 7e-08
Identities = 16/84 (19%), Positives = 31/84 (36%), Gaps = 3/84 (3%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTG-PIPLEIENLKVLVKIYFSMNNFA 113
+N+ LA+N++ + + YL+L LN + + L + N
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQ 137
+ + L+ L L N+L
Sbjct: 183 -DVKGQVVFAK-LKTLDLSSNKLA 204
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 11/71 (15%), Positives = 24/71 (33%)
Query: 68 IPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127
I N ++ +SL + ++ + ++ S N + + + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 128 HLFLGYNRLQG 138
L L N L
Sbjct: 62 LLNLSSNVLYE 72
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 15/96 (15%), Positives = 38/96 (39%), Gaps = 9/96 (9%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L L +N + I L+ + N+++ + + IY + N
Sbjct: 83 RTLDLNNNYV-----QELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANNKITM 134
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLE 150
+ GC + +Q+L L N + ++++++ + +
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSD 169
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 14/85 (16%), Positives = 33/85 (38%), Gaps = 3/85 (3%)
Query: 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNN 111
+ + L L+SN+ ++ + F + + +++L N L I + + L N
Sbjct: 191 AKLKTLDLSSNK-LAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNG 248
Query: 112 FA-GVIPNAIGCLNILQHLFLGYNR 135
F G + + +Q + +
Sbjct: 249 FHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 45/204 (22%), Positives = 73/204 (35%), Gaps = 42/204 (20%)
Query: 164 ISRGGFGSIHKARIQDRMEFS-----VKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKI 217
+ G FG+++K E +K S A K E VM S ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 218 ISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------VGFA------LEYL---HFDYS 261
+ + L+ + MP G L + + + + YL
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138
Query: 262 VLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA-------- 313
+H DL NVL ++DFG+AKLL E+ I +MA
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 314 ----SYVYSFGIMLLEVFTR-KKP 332
S V+S+G+ + E+ T KP
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 42/172 (24%), Positives = 70/172 (40%), Gaps = 34/172 (19%)
Query: 163 LISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDF-----ECDVMKSTCYRNLIK 216
+ RG +++ + + +++K K+ D E V+ + N+IK
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLK-------KTVDKKIVRTEIGVLLRLSHPNIIK 112
Query: 217 IISSRSNEDFKVLVLEYMPRGSL-----EKCLYS----SNYVG---FALEYLHFDYSVLI 264
+ LVLE + G L EK YS ++ V A+ YLH I
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH---ENGI 169
Query: 265 IHYDLKPSNVLF---DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
+H DLKP N+L+ + ++DFG++K ++ M T GY A
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSK-IVEHQVLM--KTVCGTPGYCA 218
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 38/171 (22%), Positives = 66/171 (38%), Gaps = 29/171 (16%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFH-LQCSGAFKSFDF-----ECDVMKSTCYRNLIKII 218
G F + K R +E++ K Q + + E +++ + N+I +
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81
Query: 219 SSRSNEDFKVLVLEYMPRGSL-----EKCLYS----SNYVG---FALEYLHFDYSVLIIH 266
N VL+LE + G L +K S ++++ + YLH I H
Sbjct: 82 DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAH 138
Query: 267 YDLKPSNVLFDDNIVTH----LSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
+DLKP N++ D + L DFG+A I + T ++A
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFGTPEFVA 186
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 5e-09
Identities = 46/198 (23%), Positives = 79/198 (39%), Gaps = 41/198 (20%)
Query: 158 FSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIK 216
F + G +GS++KA + ++K ++ + E +M+ +++K
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88
Query: 217 IISSRSNEDFKVLVLEYMPRGSL-------EKCLYSSNYVGF-------ALEYLHFDYSV 262
S +V+EY GS+ K L + + + LEYLH +
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL-TEDEIATILQSTLKGLEYLH---FM 144
Query: 263 LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIG---YMA------ 313
IH D+K N+L + L+DFG+A L M + T+ IG +MA
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT---MAKRNTV--IGTPFWMAPEVIQE 199
Query: 314 -SY-----VYSFGIMLLE 325
Y ++S GI +E
Sbjct: 200 IGYNCVADIWSLGITAIE 217
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 5e-09
Identities = 33/174 (18%), Positives = 66/174 (37%), Gaps = 48/174 (27%)
Query: 200 DF--ECDVMKS-TCYRNLIKIISSRSNEDFKVLVLEYMPRGSL----------------- 239
E V+ + N++ ++ + + +++ EY G L
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 240 -------EKCLYSSNYVGFAL------EYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSD 286
E L + + F+ +L S IH DL N+L +T + D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICD 188
Query: 287 FGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
FG+A+ + + +++++ + +MA S V+S+GI L E+F+
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 42/204 (20%), Positives = 79/204 (38%), Gaps = 43/204 (21%)
Query: 164 ISRGGFGSIHKARIQ---DRMEFSVKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKII 218
+ G FGS+ + + +++ ++K A + E +M ++++I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE-EMMREAQIMHQLDNPYIVRLI 402
Query: 219 SSRSNEDFKVLVLEYMPRGSLEKCLYS-------SNYVGFA---------LEYLHFDYSV 262
E +LV+E G L K L SN LE +F
Sbjct: 403 GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF---- 457
Query: 263 LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED-HFMIQTQTLATIGYMA-------- 313
+H +L NVL + +SDFG++K L +D ++ ++ + + A
Sbjct: 458 --VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 314 ----SYVYSFGIMLLEVFTR-KKP 332
S V+S+G+ + E + +KP
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 6e-09
Identities = 30/173 (17%), Positives = 68/173 (39%), Gaps = 50/173 (28%)
Query: 200 DF--ECDVMKS-TCYRNLIKIISSRSNEDFKVLVLEYMPRGSL----------------- 239
E +M + N++ ++ + ++ +++ EY G L
Sbjct: 95 ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF 154
Query: 240 ---EKCLYSSNYVGFAL------EYL---HFDYSVLIIHYDLKPSNVLFDDNIVTHLSDF 287
+ + + F+ +L + IH D+ NVL + V + DF
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDF 208
Query: 288 GIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
G+A+ ++ + +++++ + +MA S V+S+GI+L E+F+
Sbjct: 209 GLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 25/103 (24%), Positives = 39/103 (37%), Gaps = 1/103 (0%)
Query: 48 PLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIY 106
P E L L+ N + +V S+F L+ + L L I E NL L +
Sbjct: 20 PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILD 79
Query: 107 FSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
+ + P+A L L L L + L ++ +F L
Sbjct: 80 LGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL 122
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 25/98 (25%), Positives = 39/98 (39%), Gaps = 1/98 (1%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ L+LA N++ + F+ L ++ LNLS N L L + I N+ A
Sbjct: 293 KVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAI 352
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLELC 152
+ L LQ L L N L +I + + L
Sbjct: 353 IQDQTFKFLEKLQTLDLRDNALT-TIHFIPSIPDIFLS 389
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 30/115 (26%), Positives = 42/115 (36%), Gaps = 7/115 (6%)
Query: 43 RYNYPPLRPPQQENLSLASNELISVIPS-TFWNLKDILYLNLSLNSLTGPIPLEI----- 96
Y LR P + L L N S T + L L N L E+
Sbjct: 417 DILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVF 476
Query: 97 ENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLEL 151
E L L +Y + N + P L L+ L L NRL +S++ + LE+
Sbjct: 477 EGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEI 530
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 26/102 (25%), Positives = 35/102 (34%), Gaps = 6/102 (5%)
Query: 55 ENLSLASNEL--ISVIPSTFWNLKDILYLNLSLNSLTG-PIPLEIENLKVLVKIYFSMNN 111
L L L + F NLK + L+LS N + + L L I FS N
Sbjct: 100 FELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQ 159
Query: 112 FAGVIPNAIGCLNI--LQHLFLGYNRLQGSISYSKWFSCLEL 151
V + + L L L N L +S W C+
Sbjct: 160 IFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVD-WGKCMNP 200
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 18/95 (18%), Positives = 36/95 (37%), Gaps = 10/95 (10%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ L N + + TF L+ + L+L N+LT I + + I+ S N
Sbjct: 341 AYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVT 395
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
+ + + L NRL+ ++ + +
Sbjct: 396 LPKINLT----ANLIHLSENRLE-NLDILYFLLRV 425
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 20/88 (22%), Positives = 31/88 (35%), Gaps = 2/88 (2%)
Query: 52 PQQENLSLASNELISVIPSTFWNLKD--ILYLNLSLNSLTGPIPLEIENLKVLVKIYFSM 109
+ + +TF L + +L+LS + E LK L + +
Sbjct: 240 HHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAY 299
Query: 110 NNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
N + A L+ LQ L L YN L
Sbjct: 300 NKINKIADEAFYGLDNLQVLNLSYNLLG 327
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 18/80 (22%), Positives = 33/80 (41%), Gaps = 5/80 (6%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVI 116
L+L+ N L + S F+ L + Y++L N + + L+ L + N
Sbjct: 319 LNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL---- 374
Query: 117 PNAIGCLNILQHLFLGYNRL 136
I + + +FL N+L
Sbjct: 375 -TTIHFIPSIPDIFLSGNKL 393
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 6e-09
Identities = 38/126 (30%), Positives = 53/126 (42%), Gaps = 35/126 (27%)
Query: 229 LVLEYMPRGSLEKCLYS--SNYVGF--------------ALEYLHFDYSVLIIHYDLKPS 272
LV+ M G + +Y+ + GF LE+LH II+ DLKP
Sbjct: 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPE 318
Query: 273 NVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMA-------SYVYS-----F 319
NVL DD+ +SD G+A L +T+ A T G+MA Y +S
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQT---KTKGYAGTPGFMAPELLLGEEYDFSVDYFAL 375
Query: 320 GIMLLE 325
G+ L E
Sbjct: 376 GVTLYE 381
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 6e-09
Identities = 41/204 (20%), Positives = 73/204 (35%), Gaps = 43/204 (21%)
Query: 164 ISRGGFGSIHKARIQDRMEFS---VKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKII 218
+ G FGS+ + + R + +K A + E +M ++++I
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE-EMMREAQIMHQLDNPYIVRLI 76
Query: 219 SSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------VGFA---------LEYLHFDYSV 262
E LV+E G L K L LE +F
Sbjct: 77 GVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF---- 131
Query: 263 LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR-EDHFMIQTQTLATIGYMA-------- 313
+H DL NVL + +SDFG++K L + ++ ++ + + A
Sbjct: 132 --VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 314 ----SYVYSFGIMLLEVFTR-KKP 332
S V+S+G+ + E + +KP
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKP 213
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 6e-09
Identities = 38/171 (22%), Positives = 66/171 (38%), Gaps = 29/171 (16%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFHL-QCSGAFKSFDF-----ECDVMKSTCYRNLIKII 218
G F + K R +E++ K Q + + E +++ + N+I +
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81
Query: 219 SSRSNEDFKVLVLEYMPRGSL-----EKCLYS----SNYVG---FALEYLHFDYSVLIIH 266
N VL+LE + G L +K S ++++ + YLH I H
Sbjct: 82 DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAH 138
Query: 267 YDLKPSNVLFDDNIVTH----LSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
+DLKP N++ D + L DFG+A I + T ++A
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFGTPEFVA 186
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 6e-09
Identities = 40/202 (19%), Positives = 76/202 (37%), Gaps = 44/202 (21%)
Query: 166 RGGFGSIHKARIQDRMEFS----VKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKIIS 219
G FG +H+ + +K S + + F E M+ + +++K+I
Sbjct: 25 EGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEALTMRQFDHPHIVKLIG 83
Query: 220 SRSNEDFKVLVLEYMPRGSL-------EKCLYSSNYVGFA------LEYL---HFDYSVL 263
+ + ++E G L + L ++ + +A L YL F
Sbjct: 84 VITENPVWI-IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF----- 137
Query: 264 IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA---------- 313
+H D+ NVL N L DFG+++ + + + ++ I +MA
Sbjct: 138 -VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 314 --SYVYSFGIMLLEVFTR-KKP 332
S V+ FG+ + E+ KP
Sbjct: 196 SASDVWMFGVCMWEILMHGVKP 217
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 6e-09
Identities = 38/164 (23%), Positives = 63/164 (38%), Gaps = 22/164 (13%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNE 224
RG +G + A R+ + K F E ++MKS + N+I++ + +
Sbjct: 19 RGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN 78
Query: 225 DFKVLVLEYMPRGSL-----EKCLYSSNYVGF-------ALEYLHFDYSVLIIHYDLKPS 272
LV+E G L K ++ + A+ Y H + + H DLKP
Sbjct: 79 TDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPE 135
Query: 273 NVLF---DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
N LF + L DFG+A + M + T Y++
Sbjct: 136 NFLFLTDSPDSPLKLIDFGLAA-RFKPGKMM--RTKVGTPYYVS 176
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 6e-09
Identities = 32/154 (20%), Positives = 58/154 (37%), Gaps = 21/154 (13%)
Query: 163 LISRGGFGSIHKAR-IQDRMEFSVKGF---HLQCSGAFKSFDFECDVMKSTCYRNLIKII 218
+ +GGF + + F+ K L + E + +S +++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 219 SSRSNEDFKVLVLEYMPRGSL-------------EKCLYSSNYVGFALEYLHFDYSVLII 265
+ DF +VLE R SL E Y V +YLH +I
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-GCQYLH---RNRVI 137
Query: 266 HYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299
H DLK N+ ++++ + DFG+A + +
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 7e-09
Identities = 40/170 (23%), Positives = 65/170 (38%), Gaps = 25/170 (14%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKS-TCYRNLIKIISSRSN 223
G + + E++VK Q E +++ +RN++++I
Sbjct: 23 EGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE 82
Query: 224 EDFKVLVLEYMPRGSL-----EKCLYS----SNY---VGFALEYLHFDYSVLIIHYDLKP 271
ED LV E M GS+ ++ ++ S V AL++LH + I H DLKP
Sbjct: 83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKP 139
Query: 272 SNVLF---DDNIVTHLSDFGIAKLLIREDHF-MIQTQTLATI----GYMA 313
N+L + + DF + + I T L T YMA
Sbjct: 140 ENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 8e-09
Identities = 43/175 (24%), Positives = 75/175 (42%), Gaps = 52/175 (29%)
Query: 200 DF--ECDVMKS-TCYRNLIKIISSRSNEDFKVLVLEYMPRGSL----------------- 239
D E ++MK ++N+I ++ + + + +++EY +G+L
Sbjct: 120 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 179
Query: 240 -----EKCLYSSNYVGFAL------EYL---HFDYSVLIIHYDLKPSNVLFDDNIVTHLS 285
E+ L S + V A EYL IH DL NVL ++ V ++
Sbjct: 180 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKIA 233
Query: 286 DFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
DFG+A+ + D++ T + +MA S V+SFG++L E+FT
Sbjct: 234 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 9e-09
Identities = 37/202 (18%), Positives = 73/202 (36%), Gaps = 46/202 (22%)
Query: 162 NLISRGGFGSIHKAR-IQDRMEFSVK-------------GFHLQCSGAFKSFDFECDVMK 207
+ G +G + + E ++K + + E ++K
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 208 STCYRNLIKIISSRSNEDFKVLVLEYMPRGSL-----EKCLYSSNYVGF-------ALEY 255
S + N+IK+ ++ + LV E+ G L + + + Y
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICY 161
Query: 256 LHFDYSVLIIHYDLKPSNVLF---DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM 312
LH I+H D+KP N+L + + + DFG++ +D+ + L T Y+
Sbjct: 162 LH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS-FFSKDYKL--RDRLGTAYYI 215
Query: 313 A------SY-----VYSFGIML 323
A Y V+S G+++
Sbjct: 216 APEVLKKKYNEKCDVWSCGVIM 237
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 9e-09
Identities = 16/92 (17%), Positives = 36/92 (39%), Gaps = 11/92 (11%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+++++ + L+ +P T + L L+ N L +P I +L L ++
Sbjct: 107 QHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELT 164
Query: 115 VIPNAIGCLNI---------LQHLFLGYNRLQ 137
+P + + LQ L L + ++
Sbjct: 165 ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR 196
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 8e-07
Identities = 17/83 (20%), Positives = 29/83 (34%), Gaps = 2/83 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLS-LNSLTGPIPLEIENLKVLVKIYFSMNNFA 113
E L L + P F + L L ++L +PL+I L L K+
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNL 290
Query: 114 GVIPNAIGCLNILQHLFLGYNRL 136
+P+ I L + + +
Sbjct: 291 SRLPSLIAQLPANCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 13/80 (16%), Positives = 29/80 (36%), Gaps = 1/80 (1%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
++L + ++ L + + +L + L+L + P L ++ +
Sbjct: 209 KSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267
Query: 115 VIPNAIGCLNILQHLFLGYN 134
+P I L L+ L L
Sbjct: 268 TLPLDIHRLTQLEKLDLRGC 287
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 3e-06
Identities = 20/92 (21%), Positives = 36/92 (39%), Gaps = 11/92 (11%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLS-LNSLT--------GPIPLEIENLKVLVKI 105
E L+LA N L + +P++ +L + L++ LT E + L L +
Sbjct: 130 ETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSL 188
Query: 106 YFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
+P +I L L+ L + + L
Sbjct: 189 RLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 9e-09
Identities = 39/165 (23%), Positives = 69/165 (41%), Gaps = 25/165 (15%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKS-TCYRNLIKIISSRSN 223
G F K + F+VK + + E +K + N++K+ +
Sbjct: 21 EGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHD 77
Query: 224 EDFKVLVLEYMPRGSL-----EKCLYS----SNY---VGFALEYLHFDYSVLIIHYDLKP 271
+ LV+E + G L +K +S S + A+ ++H V ++H DLKP
Sbjct: 78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKP 134
Query: 272 SNVLF---DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
N+LF +DN+ + DFG A+L ++ + T+ Y A
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAA 177
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 32/154 (20%), Positives = 67/154 (43%), Gaps = 20/154 (12%)
Query: 163 LISRGGFGSIHKAR-IQDRMEFSVKGFH---LQCSGAFKSFDFECDVMKSTCYRNLIKII 218
L+ +G F +++A I +E ++K + +G + E + + +++++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 219 SSRSNEDFKVLVLEYMPRGSLEKCLY----------SSNY---VGFALEYLHFDYSVLII 265
+ + ++ LVLE G + + L + ++ + + YLH S I+
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134
Query: 266 HYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299
H DL SN+L N+ ++DFG+A L
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 47/211 (22%), Positives = 79/211 (37%), Gaps = 55/211 (26%)
Query: 167 GGFGSIHKARIQDRMEFS------VKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISS 220
G FG + A + VK A K F E +++ + + +++K
Sbjct: 26 GAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGV 85
Query: 221 RSNEDFKVLVLEYMPRGSL----------------------EKCLYSSNYVGFAL----- 253
+ D ++V EYM G L + L S + A
Sbjct: 86 CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG 145
Query: 254 -EYL---HFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATI 309
YL HF +H DL N L N++ + DFG+++ + D++ + T+ I
Sbjct: 146 MVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 310 GYMA------------SYVYSFGIMLLEVFT 328
+M S V+SFG++L E+FT
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 11/96 (11%), Positives = 22/96 (22%), Gaps = 24/96 (25%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
L S ++H P N+ + L D + +
Sbjct: 206 LAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW------KVGTRGPASSVPVT 256
Query: 312 MAS----------Y-----VYSFGIMLLEVFTRKKP 332
A + + G+ + V+ P
Sbjct: 257 YAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 42/171 (24%), Positives = 69/171 (40%), Gaps = 27/171 (15%)
Query: 164 ISRGGFGSIHKAR-IQDRMEFSVKGFH-LQCSGAFKSFDFECDVMKSTCYRNLIKIISSR 221
+ G FG +H +E +K + + + + E +V+KS + N+IKI
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 222 SNEDFKVLVLEYMPRGSL-EKCLYSSNYVGF---------------ALEYLHFDYSVLII 265
+ +V+E G L E+ + + AL Y H + ++
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VV 146
Query: 266 HYDLKPSNVLF---DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
H DLKP N+LF + + DFG+A+ L + D T T YMA
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEHS--TNAAGTALYMA 194
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 44/216 (20%), Positives = 79/216 (36%), Gaps = 59/216 (27%)
Query: 166 RGGFGSIHKARIQDRMEFSVKGFHL---------QCSGAFKSFDFECDVMKS-TCYRNLI 215
G FG + A + K E ++MK ++N+I
Sbjct: 45 EGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 104
Query: 216 KIISSRSNEDFKVLVLEYMPRGSL----------------------EKCLYSSNYVGFAL 253
++ + + + +++EY +G+L E+ + + V
Sbjct: 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 164
Query: 254 ------EYL---HFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304
EYL IH DL NVL +N V ++DFG+A+ + D++ T
Sbjct: 165 QLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 305 TLATIGYMA------------SYVYSFGIMLLEVFT 328
+ +MA S V+SFG+++ E+FT
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 33/168 (19%), Positives = 70/168 (41%), Gaps = 24/168 (14%)
Query: 164 ISRGGFGSIHKAR-IQDRMEFSVKGFHLQ--CSGAFKSFDFECDVMKSTCYRNLIKIISS 220
+ +G FG + K + + E++VK + + + E +++K + N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 221 RSNEDFKVLVLEYMPRGSL-----EKCLYSSNYVGF-------ALEYLHFDYSVLIIHYD 268
+ +V E G L ++ +S + + Y+H I+H D
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRD 146
Query: 269 LKPSNVLF---DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
LKP N+L + + + DFG++ +++ M + T Y+A
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYIA 191
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 40/200 (20%), Positives = 71/200 (35%), Gaps = 41/200 (20%)
Query: 164 ISRGGFGSIHKAR-IQDRMEFSVKGFHL-QCSGAFKSFDFECDVMKSTCYRNLIKIISSR 221
I G + A + + ++K +L +C + E M + N++ +S
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 222 SNEDFKVLVLEYMPRGSLEKCLYSSNYVGF--------------------ALEYLHFDYS 261
+D LV++ + GS+ + G LEYLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---K 139
Query: 262 VLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIG---YMA----- 313
IH D+K N+L ++ ++DFG++ L +G +MA
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 314 ---SY-----VYSFGIMLLE 325
Y ++SFGI +E
Sbjct: 200 QVRGYDFKADIWSFGITAIE 219
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 30/99 (30%), Positives = 44/99 (44%), Gaps = 19/99 (19%)
Query: 229 LVLEYMPRGSL------EKCL-------YSSNYVGFALEYLHFDYSVLIIHYDLKPSNVL 275
L Y G L Y++ V ALEYLH IIH DLKP N+L
Sbjct: 107 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV-SALEYLH---GKGIIHRDLKPENIL 162
Query: 276 FDDNIVTHLSDFGIAKLLIREDHFMIQTQTL-ATIGYMA 313
++++ ++DFG AK+L E + + T Y++
Sbjct: 163 LNEDMHIQITDFGTAKVLSPESKQA-RANSFVGTAQYVS 200
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 44/212 (20%), Positives = 80/212 (37%), Gaps = 41/212 (19%)
Query: 158 FSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCY-RNLI 215
F L+ G +G ++K R ++ ++K + + E +++K + RN+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIA 84
Query: 216 K-----IISSRSNEDFKV-LVLEYMPRGSLEKCLYSSNYVGF--------------ALEY 255
I + D ++ LV+E+ GS+ + ++ L +
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 256 LHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED----------HFM----I 301
LH +IH D+K NVL +N L DFG++ L R ++M I
Sbjct: 145 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 302 QTQTLATIGY-MASYVYSFGIMLLEVFTRKKP 332
Y S ++S GI +E+ P
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 16/83 (19%), Positives = 33/83 (39%), Gaps = 2/83 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ + + L + S + ++ L+LS N L+ ++ L + S N
Sbjct: 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE 72
Query: 115 VIPNAIGCLNILQHLFLGYNRLQ 137
+ + L+ L+ L L N +Q
Sbjct: 73 TLD--LESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 16/84 (19%), Positives = 31/84 (36%), Gaps = 3/84 (3%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTG-PIPLEIENLKVLVKIYFSMNNFA 113
+N+ LA+N++ + + YL+L LN + + L + N
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQ 137
+ + L+ L L N+L
Sbjct: 183 -DVKGQVVFAK-LKTLDLSSNKLA 204
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 9e-07
Identities = 11/70 (15%), Positives = 24/70 (34%)
Query: 68 IPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127
I N ++ +SL + ++ + ++ S N + + + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 128 HLFLGYNRLQ 137
L L N L
Sbjct: 62 LLNLSSNVLY 71
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 6e-06
Identities = 15/96 (15%), Positives = 38/96 (39%), Gaps = 9/96 (9%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L L +N + I L+ + N+++ + + IY + N
Sbjct: 83 RTLDLNNNYV-----QELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANNKITM 134
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLE 150
+ GC + +Q+L L N + ++++++ + +
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSD 169
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 14/85 (16%), Positives = 33/85 (38%), Gaps = 3/85 (3%)
Query: 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNN 111
+ + L L+SN+ ++ + F + + +++L N L I + + L N
Sbjct: 191 AKLKTLDLSSNK-LAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNG 248
Query: 112 FA-GVIPNAIGCLNILQHLFLGYNR 135
F G + + +Q + +
Sbjct: 249 FHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 35/235 (14%), Positives = 76/235 (32%), Gaps = 67/235 (28%)
Query: 153 RVTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDF--ECDVMKST 209
R T F E I G FGS+ K D +++K +G+ + E
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 210 CY-RNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF----------------A 252
++++ S+ + +D ++ EY GSL + + +
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 253 LEYLHFDYSVLIIHYDLKPSNVLFDDN-------------------IVTHLSDFGIAKLL 293
L Y+H S+ ++H D+KPSN+ ++ + D G +
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 294 IREDHFMIQTQTLATIG---YMA--------SY-----VYSFGIMLLEVFTRKKP 332
+ G ++A ++ +++ + ++ +
Sbjct: 185 ---------SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 2e-08
Identities = 38/171 (22%), Positives = 65/171 (38%), Gaps = 29/171 (16%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVK------GFHLQCSGAFKSFDFECDVMKSTCYRNLIKII 218
G F + K R E++ K + + + + E ++++ + N+I +
Sbjct: 15 SGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH 74
Query: 219 SSRSNEDFKVLVLEYMPRGSL-EKCLYSSNY-----VGF------ALEYLHFDYSVLIIH 266
N+ VL+LE + G L + + F + YLH I H
Sbjct: 75 DIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAH 131
Query: 267 YDLKPSNVLFDDNIVTH----LSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
+DLKP N++ D V + L DFGIA I + T ++A
Sbjct: 132 FDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEF--KNIFGTPEFVA 179
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 52/219 (23%), Positives = 86/219 (39%), Gaps = 50/219 (22%)
Query: 140 ISYSKW---FSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAF 196
S W L+L + I +G FG + + + +VK ++
Sbjct: 11 FYRSGWALNMKELKLLQT---------IGKGEFGDVMLGDYRGN-KVAVKC--IKNDATA 58
Query: 197 KSFDFECDVMKSTCYRNLIKIISSRSNEDFKV-LVLEYMPRGSL--------EKCLYSSN 247
++F E VM + NL++++ E + +V EYM +GSL L
Sbjct: 59 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 118
Query: 248 YVGFAL------EYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301
+ F+L EYL +H DL NVL ++ V +SDFG+ K +
Sbjct: 119 LLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASST 170
Query: 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
Q + + A S V+SFGI+L E+++
Sbjct: 171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 35/171 (20%), Positives = 63/171 (36%), Gaps = 29/171 (16%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFH-LQCSGAFKSFDF-----ECDVMKSTCYRNLIKII 218
G F + K R ++++ K + + + E ++K + N+I +
Sbjct: 21 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 219 SSRSNEDFKVLVLEYMPRGSL-EKCLYSSNY-----VGF------ALEYLHFDYSVLIIH 266
N+ +L+LE + G L + + F + YLH I H
Sbjct: 81 EVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAH 137
Query: 267 YDLKPSNVLFDDNIVTH----LSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
+DLKP N++ D V + DFG+A I + T ++A
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEF--KNIFGTPEFVA 185
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 36/172 (20%), Positives = 73/172 (42%), Gaps = 29/172 (16%)
Query: 163 LISRGGFGSIHKARIQDRMEF----SVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKII 218
+I RG FG + ++++ + + + + F E DV+ + + + +
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 219 SSRSNEDFKVLVLEYMPRGSL------------EK--CLYSSNYVGFALEYLHFDYSVLI 264
+ +++ LV++Y G L E+ Y + V A++ +H +
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMV-IAIDSVH---QLHY 196
Query: 265 IHYDLKPSNVLFDDN--IVTHLSDFGIAKLLIREDHFMIQTQTL-ATIGYMA 313
+H D+KP N+L D N I L+DFG L+ + +Q+ T Y++
Sbjct: 197 VHRDIKPDNILMDMNGHIR--LADFGSCLKLMEDG--TVQSSVAVGTPDYIS 244
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 31/173 (17%), Positives = 69/173 (39%), Gaps = 47/173 (27%)
Query: 200 DF--ECDVMKS-TCYRNLIKIISSRSNEDFKVLV-LEYMPRGSL---------------- 239
E ++ + N++ ++ + + ++V +E+ G+L
Sbjct: 76 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 240 ------EKCLYSSNYVGFAL------EYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDF 287
+ L + + ++ E+L S IH DL N+L + V + DF
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 288 GIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
G+A+ + ++ ++ + + +MA S V+SFG++L E+F+
Sbjct: 193 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 44/221 (19%), Positives = 86/221 (38%), Gaps = 50/221 (22%)
Query: 147 SCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFS----VKGFHLQCS-GAFKSFDF 201
+ + + +V + G FG + R++ + +K + + + F
Sbjct: 45 TNISIDKV---------VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 202 ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------VGFA-- 252
E +M + N+I++ + ++V EYM GSL+ L + VG
Sbjct: 96 EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 253 -------LEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL-IREDHFMIQTQ 304
L + + +H DL N+L + N+V +SDFG+ ++L +
Sbjct: 156 IASGMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG 209
Query: 305 TLATIGYMA------------SYVYSFGIMLLEVFTR-KKP 332
I + + S V+S+GI+L EV + ++P
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 48/205 (23%), Positives = 80/205 (39%), Gaps = 43/205 (20%)
Query: 164 ISRGGFGSIHKARIQDRMEFS----VKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKI 217
I G G + R++ + +K + + DF E +M + N+I++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR-DFLSEASIMGQFDHPNIIRL 115
Query: 218 ISSRSNEDFKVLVLEYMPRGSL-------EKCLYSSNYVGFA------LEYL---HFDYS 261
+ ++V EYM GSL + VG + YL +
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY--- 172
Query: 262 VLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI-REDHFMIQTQTLATIGYMA------- 313
+H DL NVL D N+V +SDFG++++L D T I + A
Sbjct: 173 ---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 314 -----SYVYSFGIMLLEVFTR-KKP 332
S V+SFG+++ EV ++P
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 47/193 (24%), Positives = 78/193 (40%), Gaps = 40/193 (20%)
Query: 164 ISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKII--SSR 221
I +G FG + + + +VK ++ ++F E VM + NL++++
Sbjct: 201 IGKGEFGDVMLGDYRGN-KVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 222 SNEDFKVLVLEYMPRGSL--------EKCLYSSNYVGFAL------EYLHFDYSVLIIHY 267
+V EYM +GSL L + F+L EYL +H
Sbjct: 258 EKGGL-YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 313
Query: 268 DLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SY 315
DL NVL ++ V +SDFG+ K + Q + + A S
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 368
Query: 316 VYSFGIMLLEVFT 328
V+SFGI+L E+++
Sbjct: 369 VWSFGILLWEIYS 381
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 21/101 (20%), Positives = 37/101 (36%), Gaps = 7/101 (6%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L L N++ + + L + L+L N L+ +P + +LK+L +Y NN
Sbjct: 220 YRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNITK 278
Query: 115 VIPNAIGCLNI------LQHLFLGYNRLQGSISYSKWFSCL 149
V N + + L N + F C+
Sbjct: 279 VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCV 319
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 23/98 (23%), Positives = 37/98 (37%), Gaps = 5/98 (5%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFA 113
L L +N++ + F L+ + L +S N L IP + +L L N
Sbjct: 81 YALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNLPSSLVEL---RIHDNRIR 136
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLEL 151
V L + + +G N L+ S F L+L
Sbjct: 137 KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKL 174
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 17/91 (18%), Positives = 34/91 (37%), Gaps = 1/91 (1%)
Query: 47 PPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIY 106
P P L L N++ ++ + L L N + + L L +++
Sbjct: 188 PKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELH 247
Query: 107 FSMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
N + +P + L +LQ ++L N +
Sbjct: 248 LDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 20/93 (21%), Positives = 34/93 (36%), Gaps = 6/93 (6%)
Query: 47 PPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLT-GPIPLEI-ENLKVLVK 104
PP P L + N + V F L+++ + + N L + LK L
Sbjct: 118 PPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNY 176
Query: 105 IYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
+ S G+ + L L L +N++Q
Sbjct: 177 LRISEAKLTGIPKDL---PETLNELHLDHNKIQ 206
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 25/111 (22%), Positives = 41/111 (36%), Gaps = 22/111 (19%)
Query: 202 ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF---------- 251
E ++ + +N D ++ EYM S+ K +
Sbjct: 93 ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 252 ----------ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292
+ Y+H + + I H D+KPSN+L D N LSDFG ++
Sbjct: 153 IKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEY 201
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 16/83 (19%), Positives = 28/83 (33%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L L + ++ +F L + L +S + L + + N
Sbjct: 179 IVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA 238
Query: 115 VIPNAIGCLNILQHLFLGYNRLQ 137
V A+ L L+ L L YN +
Sbjct: 239 VPYLAVRHLVYLRFLNLSYNPIS 261
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 20/98 (20%), Positives = 39/98 (39%), Gaps = 3/98 (3%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFA 113
++L + N+L+ + F L + L L +LT IP E +L L+ + N
Sbjct: 131 KSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRHLNIN 189
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLEL 151
+ + L L+ L + + +++ L L
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMT-PNCLYGLNL 226
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 28/87 (32%), Positives = 38/87 (43%), Gaps = 2/87 (2%)
Query: 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMN 110
P E L L N + +V P F NL ++ L L N L IPL + L L K+ S N
Sbjct: 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISEN 114
Query: 111 NFAGVIPNAIGCLNILQHLFLGYNRLQ 137
++ L L+ L +G N L
Sbjct: 115 KIVILLDYMFQDLYNLKSLEVGDNDLV 141
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 24/93 (25%), Positives = 39/93 (41%), Gaps = 2/93 (2%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVI 116
L L SN L + F L ++ L++S N + + ++L L + N+ +
Sbjct: 85 LGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYIS 144
Query: 117 PNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
A LN L+ L L L SI ++ S L
Sbjct: 145 HRAFSGLNSLEQLTLEKCNLT-SIP-TEALSHL 175
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 14/83 (16%), Positives = 34/83 (40%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ L ++ + + ++ L+++ +LT L + +L L + S N +
Sbjct: 203 KVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIST 262
Query: 115 VIPNAIGCLNILQHLFLGYNRLQ 137
+ + + L LQ + L +L
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQLA 285
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 17/87 (19%), Positives = 32/87 (36%)
Query: 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMN 110
P + L L N + ++ F + + L L+ N ++ P NL L + N
Sbjct: 31 PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90
Query: 111 NFAGVIPNAIGCLNILQHLFLGYNRLQ 137
+ L+ L L + N++
Sbjct: 91 RLKLIPLGVFTGLSNLTKLDISENKIV 117
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 44/216 (20%), Positives = 79/216 (36%), Gaps = 59/216 (27%)
Query: 166 RGGFGSIHKARIQDRMEFSVKGFHL---------QCSGAFKSFDFECDVMKS-TCYRNLI 215
G FG + A + K E ++MK ++N+I
Sbjct: 91 EGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 150
Query: 216 KIISSRSNEDFKVLVLEYMPRGSL----------------------EKCLYSSNYVGFAL 253
++ + + + +++EY +G+L E+ + + V
Sbjct: 151 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 210
Query: 254 ------EYL---HFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304
EYL IH DL NVL +N V ++DFG+A+ + D++ T
Sbjct: 211 QLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 305 TLATIGYMA------------SYVYSFGIMLLEVFT 328
+ +MA S V+SFG+++ E+FT
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 43/210 (20%), Positives = 77/210 (36%), Gaps = 54/210 (25%)
Query: 167 GGFGSIHKARIQDRMEFS------VKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISS 220
G FG + A + + VK A + F E +++ ++++++
Sbjct: 52 GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGV 111
Query: 221 RSNEDFKVLVLEYMPRGSL---------------------EKCLYSSNYVGFAL------ 253
+ ++V EYM G L L + A
Sbjct: 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGM 171
Query: 254 EYL---HFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIG 310
YL HF +H DL N L +V + DFG+++ + D++ + +T+ I
Sbjct: 172 VYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 311 YMA------------SYVYSFGIMLLEVFT 328
+M S V+SFG++L E+FT
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-08
Identities = 29/118 (24%), Positives = 51/118 (43%), Gaps = 28/118 (23%)
Query: 202 ECDVMKSTCYRNLIKIIS--SRSNEDFKVLVLEYMPRGSL------------EKCLYSSN 247
E ++K + N++K++ NED +V E + +G + + Y
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFY--- 142
Query: 248 YVGF-----ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300
F +EYLH IIH D+KPSN+L ++ ++DFG++ D +
Sbjct: 143 ---FQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL 194
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 33/167 (19%), Positives = 67/167 (40%), Gaps = 29/167 (17%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFK-SFDFECDVMKSTCYRNLIKIISSRSN 223
RG FG +H+ + + K ++ G + E ++ +RN++ + S +
Sbjct: 15 RGEFGIVHRCVETSSKKTYMAK--FVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 224 EDFKVLVLEYMPRGSL------EKCLYS----SNYVG---FALEYLHFDYSVLIIHYDLK 270
+ V++ E++ + + +YV AL++LH I H+D++
Sbjct: 73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIR 129
Query: 271 PSNVLF----DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
P N+++ I + +FG A+ L D+F Y A
Sbjct: 130 PENIIYQTRRSSTIK--IIEFGQARQLKPGDNF---RLLFTAPEYYA 171
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 5e-08
Identities = 39/214 (18%), Positives = 76/214 (35%), Gaps = 58/214 (27%)
Query: 166 RGGFGSIHKARIQDRMEFS------VKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKI 217
FG ++K + +K + G + +F E + + N++ +
Sbjct: 19 EDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE-EFRHEAMLRARLQHPNVVCL 77
Query: 218 ISSRSNEDFKVLVLEYMPRGSL----------------------EKCLYSSNYVGFAL-- 253
+ + + ++ Y G L + L ++V
Sbjct: 78 LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQI 137
Query: 254 ----EYL---HFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTL 306
EYL H +H DL NVL D + +SD G+ + + D++ + +L
Sbjct: 138 AAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 307 ATIGYMA------------SYVYSFGIMLLEVFT 328
I +MA S ++S+G++L EVF+
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 7e-08
Identities = 38/196 (19%), Positives = 74/196 (37%), Gaps = 43/196 (21%)
Query: 167 GGFGSIHKARIQDRMEFS----VKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIKIISS 220
G FG +H+ + +K S + + F E M+ + +++K+I
Sbjct: 401 GQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEALTMRQFDHPHIVKLIGV 459
Query: 221 RSNEDFKVLVLEYMPRGSL-------EKCLYSSNYVGFA------LEYL---HFDYSVLI 264
+ +++E G L + L ++ + +A L YL F
Sbjct: 460 ITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF------ 512
Query: 265 IHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA----------- 313
+H D+ NVL N L DFG+++ + + + ++ I +MA
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 314 -SYVYSFGIMLLEVFT 328
S V+ FG+ + E+
Sbjct: 572 ASDVWMFGVCMWEILM 587
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 35/125 (28%), Positives = 61/125 (48%), Gaps = 19/125 (15%)
Query: 202 ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL----------EK--CLYSSNYV 249
E D+M ++++ + ++ + +V+EYMP G L EK Y++ V
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVV 178
Query: 250 GFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTL-AT 308
AL+ +H S+ IH D+KP N+L D + L+DFG + +E M++ T T
Sbjct: 179 -LALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG--MVRCDTAVGT 232
Query: 309 IGYMA 313
Y++
Sbjct: 233 PDYIS 237
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 8e-08
Identities = 40/189 (21%), Positives = 78/189 (41%), Gaps = 37/189 (19%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFH---LQCSGAFKSFDFECDVMKSTCYRNLIKIISSR 221
+G FG+++ AR Q + ++K L+ +G E ++ + N++++
Sbjct: 19 KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78
Query: 222 SNEDFKVLVLEYMPRGSLEKCL---------YSSNY---VGFALEYLHFDYSVLIIHYDL 269
+ L+LEY P G++ + L ++ Y + AL Y H S +IH D+
Sbjct: 79 HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDI 135
Query: 270 KPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTL-ATIGYMA-------SY-----V 316
KP N+L ++DFG + + L T+ Y+ + +
Sbjct: 136 KPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLDYLPPEMIEGRMHDEKVDL 190
Query: 317 YSFGIMLLE 325
+S G++ E
Sbjct: 191 WSLGVLCYE 199
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 9e-08
Identities = 33/168 (19%), Positives = 63/168 (37%), Gaps = 45/168 (26%)
Query: 200 DF--ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL-------------EKCLY 244
DF E ++ ++N+++ I + +++E M G L L
Sbjct: 79 DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLA 138
Query: 245 SSNYVGFAL------EYL---HFDYSVLIIHYDLKPSNVL---FDDNIVTHLSDFGIAKL 292
+ + A +YL HF IH D+ N L V + DFG+A+
Sbjct: 139 MLDLLHVARDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192
Query: 293 LIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
+ R ++ + + +M + +SFG++L E+F+
Sbjct: 193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 22/85 (25%), Positives = 30/85 (35%), Gaps = 2/85 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTG-PIPLEIENLKVLVKIYFSMNNFA 113
E+L L+ N L S+ S F L + YLNL N + NL L +
Sbjct: 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136
Query: 114 GVIP-NAIGCLNILQHLFLGYNRLQ 137
I L L L + L+
Sbjct: 137 SEIRRIDFAGLTSLNELEIKALSLR 161
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 14/85 (16%), Positives = 34/85 (40%), Gaps = 1/85 (1%)
Query: 55 ENLSLASNELISVIP-STFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFA 113
+ L + + E S I F L + L + SL +++++ + + ++ A
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQG 138
++ L+ +++L L L
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 18/99 (18%), Positives = 40/99 (40%), Gaps = 1/99 (1%)
Query: 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMN 110
++L L+ N++ + ++ L L + + +L L + S N
Sbjct: 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84
Query: 111 NFAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
+ + + + G L+ L++L L N Q ++ + F L
Sbjct: 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNL 122
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 16/98 (16%), Positives = 31/98 (31%), Gaps = 3/98 (3%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L + L + + + L+ + + + + + ++LK L + S N
Sbjct: 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVE 348
Query: 115 VI---PNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
G LQ L L N L+ + L
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL 386
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 18/85 (21%), Positives = 34/85 (40%), Gaps = 6/85 (7%)
Query: 55 ENLSLASNEL--ISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNF 112
+ L L+ N L + LK++ L++S N+ P+P + + + + S
Sbjct: 364 QTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI 422
Query: 113 AGVIPNAIGCLNILQHLFLGYNRLQ 137
V+ I L+ L + N L
Sbjct: 423 R-VVKTCI--PQTLEVLDVSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 14/111 (12%), Positives = 37/111 (33%), Gaps = 2/111 (1%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L + + L + + +++DI +L L L+ + + + L + + N A
Sbjct: 151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210
Query: 115 VIPNAIGCLNILQHLFLGYNRLQ--GSISYSKWFSCLELCRVTNGFSEDNL 163
+ + + + R S+++ L + D+
Sbjct: 211 FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDC 261
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 23/101 (22%), Positives = 35/101 (34%), Gaps = 6/101 (5%)
Query: 47 PPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIY 106
P E L +++N L L+ L +S N L +P + VL+ +
Sbjct: 426 KTCIPQTLEVLDVSNNNL-DSFSLFLPRLQ---ELYISRNKLKT-LP-DASLFPVLLVMK 479
Query: 107 FSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFS 147
S N V L LQ ++L N S + S
Sbjct: 480 ISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 520
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 1e-07
Identities = 33/101 (32%), Positives = 46/101 (45%), Gaps = 25/101 (24%)
Query: 229 LVLEYMPRGSL-----------EK--CLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVL 275
L+LEY+ G L E C Y + + AL +LH II+ DLKP N++
Sbjct: 98 LILEYLSGGELFMQLEREGIFMEDTACFYLAE-ISMALGHLH---QKGIIYRDLKPENIM 153
Query: 276 FDDN--IVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMA 313
+ + L+DFG+ K I + T T TI YMA
Sbjct: 154 LNHQGHVK--LTDFGLCKESIHDGT---VTHTFCGTIEYMA 189
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 34/168 (20%), Positives = 63/168 (37%), Gaps = 45/168 (26%)
Query: 200 DF--ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL-------------EKCLY 244
DF E ++ ++N+++ I + ++LE M G L L
Sbjct: 120 DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 179
Query: 245 SSNYVGFAL------EYL---HFDYSVLIIHYDLKPSNVL---FDDNIVTHLSDFGIAKL 292
+ + A +YL HF IH D+ N L V + DFG+A+
Sbjct: 180 MLDLLHVARDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARD 233
Query: 293 LIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
+ R ++ + + +M + +SFG++L E+F+
Sbjct: 234 IYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 20/101 (19%), Positives = 37/101 (36%), Gaps = 7/101 (6%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L L+ N + +V + N + L+L+ N L +P + + K + +Y NN +
Sbjct: 219 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISA 277
Query: 115 VIPNAIGCLNI------LQHLFLGYNRLQGSISYSKWFSCL 149
+ N + L N +Q F C+
Sbjct: 278 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 318
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 20/91 (21%), Positives = 39/91 (42%), Gaps = 1/91 (1%)
Query: 47 PPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIY 106
P PP L L N++ V ++ L ++ L LS NS++ + N L +++
Sbjct: 187 PQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 246
Query: 107 FSMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
+ N +P + +Q ++L N +
Sbjct: 247 LNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 22/84 (26%), Positives = 36/84 (42%), Gaps = 5/84 (5%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFA 113
L L +N++ + P F L + L LS N L +P ++ + L+ L N
Sbjct: 79 HTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQEL---RVHENEIT 134
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQ 137
V + LN + + LG N L+
Sbjct: 135 KVRKSVFNGLNQMIVVELGTNPLK 158
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 21/93 (22%), Positives = 33/93 (35%), Gaps = 5/93 (5%)
Query: 47 PPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLT-GPIPLEI-ENLKVLVK 104
P P + L + NE+ V S F L ++ + L N L I + +K L
Sbjct: 116 PEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY 175
Query: 105 IYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
I + N + L L L N++
Sbjct: 176 IRIADTNITTIPQGL---PPSLTELHLDGNKIT 205
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 15/87 (17%), Positives = 31/87 (35%), Gaps = 9/87 (10%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTG------PIPLEIENLKVLVKIYFSMN 110
L L +N+L +P + K I + L N+++ P + N
Sbjct: 245 LHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 303
Query: 111 N--FAGVIPNAIGCLNILQHLFLGYNR 135
+ + P+ C+ + + LG +
Sbjct: 304 PVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 24/91 (26%), Positives = 37/91 (40%), Gaps = 3/91 (3%)
Query: 47 PPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIY 106
P PP L L +N++ + F NLK++ L L N ++ P L L ++Y
Sbjct: 47 PKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 106
Query: 107 FSMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
S N +P LQ L + N +
Sbjct: 107 LSKNQLK-ELPE--KMPKTLQELRVHENEIT 134
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 34/179 (18%), Positives = 65/179 (36%), Gaps = 53/179 (29%)
Query: 200 DF--ECDVMKS-TCYRNLIKIISSRSNEDFKVLVLEYMPRGSL----------------- 239
E +M + N++ ++ + + L+ EY G L
Sbjct: 94 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 153
Query: 240 ------------EKCLYSSNYVGFAL------EYLHFDYSVLIIHYDLKPSNVLFDDNIV 281
L + + FA E+L +H DL NVL V
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKV 210
Query: 282 THLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
+ DFG+A+ ++ + +++++ + +MA S V+S+GI+L E+F+
Sbjct: 211 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 1e-07
Identities = 18/87 (20%), Positives = 35/87 (40%), Gaps = 5/87 (5%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+L+L +N +S S N+ + YL ++ + + P I NL L + + N
Sbjct: 135 YSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED 191
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSIS 141
+ P + L L + N++
Sbjct: 192 ISP--LASLTSLHYFTAYVNQITDITP 216
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 2e-07
Identities = 18/84 (21%), Positives = 34/84 (40%), Gaps = 4/84 (4%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L + +N++ + + +L + LN+ N ++ + NL L ++ + N
Sbjct: 246 TWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGN 301
Query: 115 VIPNAIGCLNILQHLFLGYNRLQG 138
IG L L LFL N +
Sbjct: 302 EDMEVIGGLTNLTTLFLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 2e-07
Identities = 17/83 (20%), Positives = 34/83 (40%), Gaps = 4/83 (4%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ L++ SN++ + S NL + L L+ N L I L L ++ S N+
Sbjct: 268 KMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
Query: 115 VIPNAIGCLNILQHLFLGYNRLQ 137
+ P + L+ + ++
Sbjct: 326 IRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 6e-07
Identities = 23/87 (26%), Positives = 40/87 (45%), Gaps = 6/87 (6%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
E L+L N++ + P NL + L + N +T L +NL L ++Y + +N +
Sbjct: 69 EYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISAL--QNLTNLRELYLNEDNISD 124
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSIS 141
+ P + L + L LG N +S
Sbjct: 125 ISP--LANLTKMYSLNLGANHNLSDLS 149
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 19/84 (22%), Positives = 36/84 (42%), Gaps = 6/84 (7%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+LSL N++ + P +L + Y +N +T P+ N+ L + N
Sbjct: 180 YSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPV--ANMTRLNSLKIGNNKITD 235
Query: 115 VIPNAIGCLNILQHLFLGYNRLQG 138
+ P + L+ L L +G N++
Sbjct: 236 LSP--LANLSQLTWLEIGTNQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 16/86 (18%), Positives = 39/86 (45%), Gaps = 5/86 (5%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
NL + +N I+ I + NL ++ L L+ ++++ PL NL + + N+
Sbjct: 91 TNLYIGTN-KITDISA-LQNLTNLRELYLNEDNISDISPL--ANLTKMYSLNLGANHNLS 146
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSI 140
+ + + L +L + ++++
Sbjct: 147 DLSP-LSNMTGLNYLTVTESKVKDVT 171
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 8e-05
Identities = 17/89 (19%), Positives = 34/89 (38%), Gaps = 6/89 (6%)
Query: 56 NLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGV 115
L+ + + P +L + + L S+T + E L+ + K+ + A +
Sbjct: 4 TLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVTQ--EELESITKLVVAGEKVASI 59
Query: 116 IPNAIGCLNILQHLFLGYNRLQGSISYSK 144
I L L++L L N++ S
Sbjct: 60 --QGIEYLTNLEYLNLNGNQITDISPLSN 86
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 1e-07
Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 25/101 (24%)
Query: 229 LVLEYMPRGSL-----------EK--CLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVL 275
L+L+++ G L E+ Y + + AL++LH S+ II+ DLKP N+L
Sbjct: 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHLH---SLGIIYRDLKPENIL 158
Query: 276 FDDN--IVTHLSDFGIAKLLIREDHFMIQTQTL-ATIGYMA 313
D+ I L+DFG++K I + + + T+ YMA
Sbjct: 159 LDEEGHIK--LTDFGLSKESIDHEK---KAYSFCGTVEYMA 194
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 46/206 (22%), Positives = 82/206 (39%), Gaps = 44/206 (21%)
Query: 164 ISRGGFGSIHKARIQDRMEFS-----VKGFHLQCSGAFKSFDF--ECDVMKSTCYRNLIK 216
I G FG ++K ++ +K + + DF E +M + N+I+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV-DFLGEAGIMGQFSHHNIIR 110
Query: 217 IISSRSNEDFKVLVLEYMPRGSL-------EKCLYSSNYVGFA---------LEYLHFDY 260
+ S +++ EYM G+L + VG L +++
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY-- 168
Query: 261 SVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ-TLATIGYMA------ 313
+H DL N+L + N+V +SDFG++++L + T I + A
Sbjct: 169 ----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 314 ------SYVYSFGIMLLEVFTR-KKP 332
S V+SFGI++ EV T ++P
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 17/83 (20%), Positives = 37/83 (44%), Gaps = 2/83 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ L+ NEL ++ F ++ + L +S N L + L + + L + S N+
Sbjct: 257 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL- 314
Query: 115 VIPNAIGCLNILQHLFLGYNRLQ 137
+ + L++L+L +N +
Sbjct: 315 HVERNQPQFDRLENLYLDHNSIV 337
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 8e-07
Identities = 14/94 (14%), Positives = 35/94 (37%), Gaps = 2/94 (2%)
Query: 45 NYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLV 103
+ + Q+ ++ ++ + + + + + + LNL+ + I +
Sbjct: 44 GFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQ 102
Query: 104 KIYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
K+Y N + P+ + +L L L N L
Sbjct: 103 KLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 23/84 (27%), Positives = 35/84 (41%), Gaps = 2/84 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFA 113
+ L + N + + P F N+ + L L N L+ +P I N L + S NN
Sbjct: 102 QKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE 160
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQ 137
+ + LQ+L L NRL
Sbjct: 161 RIEDDTFQATTSLQNLQLSSNRLT 184
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 15/84 (17%), Positives = 33/84 (39%), Gaps = 2/84 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFA 113
E L+L ++ + F I L + N++ +P + +N+ +L + N+ +
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS 136
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQ 137
+ L L + N L+
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLE 160
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 20/83 (24%), Positives = 33/83 (39%), Gaps = 5/83 (6%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
E L + N + V L L L N+LT + N LV++ S N
Sbjct: 214 EELDASHNSINVVRGPVNVELT---ILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEK 268
Query: 115 VIPNAIGCLNILQHLFLGYNRLQ 137
++ + + L+ L++ NRL
Sbjct: 269 IMYHPFVKMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 17/93 (18%), Positives = 34/93 (36%), Gaps = 6/93 (6%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
E L +++N + + + + L+LS N L + L +Y N+
Sbjct: 281 ERLYISNNR-LVALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVT 338
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYSKWFS 147
+ + + L++L L +N S F
Sbjct: 339 LKLST---HHTLKNLTLSHNDWD-CNSLRALFR 367
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 21/83 (25%), Positives = 33/83 (39%), Gaps = 11/83 (13%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+NL L+SN L V S +L + N+S N L+ + + ++ S N+
Sbjct: 174 QNLQLSSNRLTHVDLSLIPSLF---HANVSYNLLS-----TLAIPIAVEELDASHNSINV 225
Query: 115 VIPNAIGCLNILQHLFLGYNRLQ 137
V L L L +N L
Sbjct: 226 VRGPV---NVELTILKLQHNNLT 245
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 9/100 (9%), Positives = 32/100 (32%), Gaps = 5/100 (5%)
Query: 41 CPRYNYPPLRPPQQ---ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI- 96
P Y ++ + L + + +++ +P +
Sbjct: 13 QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALL 71
Query: 97 ENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLGYNRL 136
++ + + + + + A + +Q L++G+N +
Sbjct: 72 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI 111
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 27/99 (27%), Positives = 45/99 (45%), Gaps = 20/99 (20%)
Query: 229 LVLEYMPRGSL-----------EK--CLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVL 275
V+EY G L E Y + V AL+YLH + + +++ DLK N++
Sbjct: 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIV-SALDYLHSEKN--VVYRDLKLENLM 281
Query: 276 FDDNIVTHLSDFGIAKLLIREDHFMIQTQTL-ATIGYMA 313
D + ++DFG+ K I++ +T T Y+A
Sbjct: 282 LDKDGHIKITDFGLCKEGIKDGA---TMKTFCGTPEYLA 317
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 39/210 (18%), Positives = 72/210 (34%), Gaps = 52/210 (24%)
Query: 166 RGGFGSIHKARIQDRMEFS--------VKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKI 217
+G F I K ++ ++ +K +SF +M +++L+
Sbjct: 18 QGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLN 77
Query: 218 ISSRSNEDFKVLVLEYMPRGSL-------EKCLYSSNYVGFA---------LEYLHFDYS 261
D +LV E++ GSL + C+ + A LE
Sbjct: 78 YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL--- 134
Query: 262 VLIIHYDLKPSNVL--------FDDNIVTHLSDFGIAKLLIREDHF------M----IQT 303
IH ++ N+L + LSD GI+ ++ +D + I+
Sbjct: 135 ---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIEN 191
Query: 304 QTLATIGYMASYVYSFGIMLLEVFTR-KKP 332
+ A+ +SFG L E+ + KP
Sbjct: 192 PKNLNL---ATDKWSFGTTLWEICSGGDKP 218
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 36/172 (20%), Positives = 72/172 (41%), Gaps = 29/172 (16%)
Query: 163 LISRGGFGSIHKARIQDRMEF----SVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKII 218
+I RG F + +++ + + + + G F E DV+ + R + ++
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 219 SSRSNEDFKVLVLEYMPRGSL-------EKCL-------YSSNYVGFALEYLHFDYSVLI 264
+ +E++ LV+EY G L + + Y + V A++ +H +
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIV-MAIDSVH---RLGY 183
Query: 265 IHYDLKPSNVLFDDNIVTH--LSDFGIAKLLIREDHFMIQTQTL-ATIGYMA 313
+H D+KP N+L D H L+DFG L + +++ T Y++
Sbjct: 184 VHRDIKPDNILLDRC--GHIRLADFGSCLKLRADG--TVRSLVAVGTPDYLS 231
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 49/217 (22%), Positives = 87/217 (40%), Gaps = 59/217 (27%)
Query: 161 DNLISRGGFGSIHKARIQDRMEFS---VKGFHLQCSGAFKSFDF--ECDVMKS-TCYRNL 214
++I G FG + KARI+ +K S DF E +V+ + N+
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-DFAGELEVLCKLGHHPNI 88
Query: 215 IKIISSRSNEDFKVLVLEYMPRGSL----------------------EKCLYSSNYVGFA 252
I ++ + + + L +EY P G+L L S + FA
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 253 L------EYL---HFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303
+YL F IH DL N+L +N V ++DFG+++ ++ ++ +T
Sbjct: 149 ADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 199
Query: 304 QTLATIGYMA------------SYVYSFGIMLLEVFT 328
+ +MA S V+S+G++L E+ +
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 41/182 (22%), Positives = 74/182 (40%), Gaps = 59/182 (32%)
Query: 200 DF--ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL------------------ 239
D E +V+K + ++IK+ + S + +L++EY GSL
Sbjct: 72 DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 240 ------------EKCLYSSNYVGFAL------EYL---HFDYSVLIIHYDLKPSNVLFDD 278
E+ L + + FA +YL +H DL N+L +
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAE 185
Query: 279 NIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEV 326
+SDFG+++ + ED ++ ++Q + +MA S V+SFG++L E+
Sbjct: 186 GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 327 FT 328
T
Sbjct: 246 VT 247
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 17/83 (20%), Positives = 37/83 (44%), Gaps = 2/83 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ L+ NEL ++ F ++ + L +S N L + L + + L + S N+
Sbjct: 251 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL- 308
Query: 115 VIPNAIGCLNILQHLFLGYNRLQ 137
+ + L++L+L +N +
Sbjct: 309 HVERNQPQFDRLENLYLDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 8e-07
Identities = 23/84 (27%), Positives = 35/84 (41%), Gaps = 2/84 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFA 113
+ L + N + + P F N+ + L L N L+ +P I N L + S NN
Sbjct: 96 QKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE 154
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQ 137
+ + LQ+L L NRL
Sbjct: 155 RIEDDTFQATTSLQNLQLSSNRLT 178
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 14/94 (14%), Positives = 35/94 (37%), Gaps = 2/94 (2%)
Query: 45 NYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLV 103
+ + Q+ ++ ++ + + + + + + LNL+ + I +
Sbjct: 38 GFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQ 96
Query: 104 KIYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
K+Y N + P+ + +L L L N L
Sbjct: 97 KLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 15/84 (17%), Positives = 33/84 (39%), Gaps = 2/84 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFA 113
E L+L ++ + F I L + N++ +P + +N+ +L + N+ +
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS 130
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQ 137
+ L L + N L+
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE 154
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 17/93 (18%), Positives = 34/93 (36%), Gaps = 6/93 (6%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
E L +++N + + + + L+LS N L + L +Y N+
Sbjct: 275 ERLYISNNR-LVALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV- 331
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYSKWFS 147
+ + + L++L L +N S F
Sbjct: 332 TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFR 361
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 21/84 (25%), Positives = 33/84 (39%), Gaps = 5/84 (5%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFA 113
L L N+L S+ F N + L++S N+L I + + L + S N
Sbjct: 120 TVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT 178
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQ 137
V + + L H + YN L
Sbjct: 179 HV---DLSLIPSLFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 20/83 (24%), Positives = 33/83 (39%), Gaps = 5/83 (6%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
E L + N + V L L L N+LT + N LV++ S N
Sbjct: 208 EELDASHNSINVVRGPVNVELT---ILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEK 262
Query: 115 VIPNAIGCLNILQHLFLGYNRLQ 137
++ + + L+ L++ NRL
Sbjct: 263 IMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 6/82 (7%), Positives = 28/82 (34%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
++ + L + + +++ +++ + + + +
Sbjct: 24 YDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE 83
Query: 115 VIPNAIGCLNILQHLFLGYNRL 136
+ A + +Q L++G+N +
Sbjct: 84 IDTYAFAYAHTIQKLYMGFNAI 105
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 26/101 (25%), Positives = 39/101 (38%), Gaps = 4/101 (3%)
Query: 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLT--GPIPLEIENLKVLVKIYFS 108
P L L SN+L S+ F L + L+LS N L+ G L + S
Sbjct: 27 PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86
Query: 109 MNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
N + + L L+HL ++ L+ +S F L
Sbjct: 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSL 125
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 17/84 (20%), Positives = 29/84 (34%), Gaps = 1/84 (1%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFA 113
L ++ F L + L ++ NS +I L+ L + S
Sbjct: 129 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQ 137
+ P A L+ LQ L + +N
Sbjct: 189 QLSPTAFNSLSSLQVLNMSHNNFF 212
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 18/98 (18%), Positives = 40/98 (40%), Gaps = 2/98 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFA 113
+ L L+ N +I+ + S F L+ + +L+ ++L + +L+ L+ + S +
Sbjct: 81 KYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 139
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLEL 151
L+ L+ L + N Q + + L
Sbjct: 140 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 177
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 18/84 (21%), Positives = 32/84 (38%), Gaps = 1/84 (1%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L L+ +L + P+ F +L + LN+S N+ + L L + +S+N+
Sbjct: 178 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 237
Query: 115 VIPNAIGCLNI-LQHLFLGYNRLQ 137
+ L L L N
Sbjct: 238 SKKQELQHFPSSLAFLNLTQNDFA 261
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 28/101 (27%), Positives = 45/101 (44%), Gaps = 25/101 (24%)
Query: 229 LVLEYMPRGSL-----------EK--CLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVL 275
V+EY G L E+ Y + + ALEYLH S +++ D+K N++
Sbjct: 82 FVMEYANGGELFFHLSRERVFTEERARFYGAE-IVSALEYLH---SRDVVYRDIKLENLM 137
Query: 276 FDDN--IVTHLSDFGIAKLLIREDHFMIQTQTL-ATIGYMA 313
D + I ++DFG+ K I + +T T Y+A
Sbjct: 138 LDKDGHIK--ITDFGLCKEGISDGA---TMKTFCGTPEYLA 173
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 39/192 (20%), Positives = 74/192 (38%), Gaps = 19/192 (9%)
Query: 149 LELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKS 208
+E C+ G L S+ +K + + + K +S
Sbjct: 106 VEFCK--FGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD--LKRRLDSITSSQS 161
Query: 209 TCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGFALEYLHFDYSVLIIHYD 268
+ ++ S E+ + Y +LE + S V +E+L S IH D
Sbjct: 162 SASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 218
Query: 269 LKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYV 316
L N+L + V + DFG+A+ + ++ ++ + + +MA S V
Sbjct: 219 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 278
Query: 317 YSFGIMLLEVFT 328
+SFG++L E+F+
Sbjct: 279 WSFGVLLWEIFS 290
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 22/87 (25%), Positives = 40/87 (45%), Gaps = 6/87 (6%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ LSL N+L + T +L ++ L+L+ N ++ PL L L ++ N +
Sbjct: 224 DELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPL--SGLTKLTELKLGANQISN 279
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSIS 141
+ P + L L +L L N+L+
Sbjct: 280 ISP--LAGLTALTNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 23/84 (27%), Positives = 41/84 (48%), Gaps = 6/84 (7%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
NL L N+L + P NLK++ YL L N+++ P+ +L L +++F N +
Sbjct: 290 TNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFYNNKVSD 345
Query: 115 VIPNAIGCLNILQHLFLGYNRLQG 138
V + L + L G+N++
Sbjct: 346 VSS--LANLTNINWLSAGHNQISD 367
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 22/90 (24%), Positives = 37/90 (41%), Gaps = 6/90 (6%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+L LA+N++ ++ P L + L L N ++ PL L L + + N
Sbjct: 246 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA--GLTALTNLELNENQLED 301
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYSK 144
+ P I L L +L L +N + S
Sbjct: 302 ISP--ISNLKNLTYLTLYFNNISDISPVSS 329
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 24/84 (28%), Positives = 37/84 (44%), Gaps = 6/84 (7%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L L +N++ ++ P L + L L+ N L P I NLK L + NN +
Sbjct: 268 TELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD 323
Query: 115 VIPNAIGCLNILQHLFLGYNRLQG 138
+ P + L LQ LF N++
Sbjct: 324 ISP--VSSLTKLQRLFFYNNKVSD 345
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 18/84 (21%), Positives = 34/84 (40%), Gaps = 6/84 (7%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
++ ++N+L + P NL ++ + ++ N + PL NL L + N
Sbjct: 71 TQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPL--ANLTNLTGLTLFNNQITD 126
Query: 115 VIPNAIGCLNILQHLFLGYNRLQG 138
+ P + L L L L N +
Sbjct: 127 IDP--LKNLTNLNRLELSSNTISD 148
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 20/84 (23%), Positives = 38/84 (45%), Gaps = 7/84 (8%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L+L +N++ + P NL ++ L LS N+++ L L L ++ F N
Sbjct: 115 TGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISAL--SGLTSLQQLSFG-NQVTD 169
Query: 115 VIPNAIGCLNILQHLFLGYNRLQG 138
+ P + L L+ L + N++
Sbjct: 170 LKP--LANLTTLERLDISSNKVSD 191
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 14/87 (16%), Positives = 27/87 (31%), Gaps = 6/87 (6%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L + + +L + L + +E L L +I FS N
Sbjct: 27 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNNQLTD 82
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSIS 141
+ P + L L + + N++
Sbjct: 83 ITP--LKNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 9e-05
Identities = 18/86 (20%), Positives = 34/86 (39%), Gaps = 6/86 (6%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
E L ++SN++ S L ++ L + N ++ PL L L ++ + N
Sbjct: 180 ERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKD 235
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSI 140
+ + L L L L N++
Sbjct: 236 IGT--LASLTNLTDLDLANNQISNLA 259
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 9e-05
Identities = 21/84 (25%), Positives = 37/84 (44%), Gaps = 7/84 (8%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ LS N++ + P NL + L++S N ++ L L L + + N +
Sbjct: 159 QQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISD 213
Query: 115 VIPNAIGCLNILQHLFLGYNRLQG 138
+ P +G L L L L N+L+
Sbjct: 214 ITP--LGILTNLDELSLNGNQLKD 235
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 12/90 (13%), Positives = 29/90 (32%), Gaps = 5/90 (5%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ ++ + I+ I T L + + L ++T + +L + +
Sbjct: 4 GSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK- 59
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYSK 144
+ + LN L + N+L
Sbjct: 60 -SIDGVEYLNNLTQINFSNNQLTDITPLKN 88
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 13/75 (17%), Positives = 32/75 (42%), Gaps = 4/75 (5%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ L +N++ S+ NL +I +L+ N ++ P + NL + ++ + +
Sbjct: 334 QRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389
Query: 115 VIPNAIGCLNILQHL 129
N ++I +
Sbjct: 390 APVNYKANVSIPNTV 404
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 43/221 (19%), Positives = 76/221 (34%), Gaps = 64/221 (28%)
Query: 166 RGGFGSIHKARIQDRMEFS------VKGFHLQCSG-AFKSFDFECDVMKSTCYRNLIKII 218
G FG + +AR + + VK + S F E +M N++K++
Sbjct: 57 EGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLL 116
Query: 219 SSRSNEDFKVLVLEYMPRGSL------------------------------EKCLYSSNY 248
+ L+ EYM G L L +
Sbjct: 117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQ 176
Query: 249 VGFAL------EYL---HFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299
+ A YL F +H DL N L +N+V ++DFG+++ + D++
Sbjct: 177 LCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFT 328
I +M S V+++G++L E+F+
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 24/101 (23%)
Query: 229 LVLEYMPRGSL-----------EK--CLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVL 275
L+L+Y+ G L E +Y + ALE+LH + II+ D+K N+L
Sbjct: 136 LILDYINGGELFTHLSQRERFTEHEVQIYVGE-IVLALEHLH---KLGIIYRDIKLENIL 191
Query: 276 FDDN--IVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMA 313
D N +V L+DFG++K + ++ TI YMA
Sbjct: 192 LDSNGHVV--LTDFGLSKEFVADETER--AYDFCGTIEYMA 228
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 5e-07
Identities = 38/169 (22%), Positives = 63/169 (37%), Gaps = 27/169 (15%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDF--ECDVMKS-TCYRNLIKIISSR 221
RG F + + E++ K + G + E V++ +I +
Sbjct: 39 RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98
Query: 222 SNEDFKVLVLEYMPRGSL-EKCL------YSSNYVGF-------ALEYLHFDYSVLIIHY 267
N +L+LEY G + CL S N V + YLH + I+H
Sbjct: 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHL 155
Query: 268 DLKPSNVLFDDNIVTH---LSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
DLKP N+L + DFG+++ I + + + T Y+A
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSR-KIGHACEL--REIMGTPEYLA 201
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 34/101 (33%), Positives = 47/101 (46%), Gaps = 25/101 (24%)
Query: 229 LVLEYMPRGSL-----------EK--CLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVL 275
VL+Y+ G L E Y++ + AL YLH S+ I++ DLKP N+L
Sbjct: 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAE-IASALGYLH---SLNIVYRDLKPENIL 171
Query: 276 FDDN--IVTHLSDFGIAKLLIREDHFMIQTQTL-ATIGYMA 313
D IV L+DFG+ K I + T T T Y+A
Sbjct: 172 LDSQGHIV--LTDFGLCKENIEHNS---TTSTFCGTPEYLA 207
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 50/214 (23%), Positives = 84/214 (39%), Gaps = 50/214 (23%)
Query: 154 VTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDF------ECDVM 206
V + + + G +GS+ A + + +VK + S F+S E ++
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLL 82
Query: 207 KSTCYRNLIKI----ISSRSNEDFK--VLVLEYMPRGSLEKCLYSSNYVGF--------- 251
K + N+I + +RS E+F LV M L +
Sbjct: 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 252 --ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATI 309
L+Y+H S IIH DLKPSN+ +++ + DFG+A+ M T +AT
Sbjct: 142 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADEM--TGYVATR 193
Query: 310 GYMA--------SY-----VYSFGIMLLEVFTRK 330
Y A Y ++S G ++ E+ T +
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 7e-07
Identities = 35/143 (24%), Positives = 64/143 (44%), Gaps = 19/143 (13%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGF---HLQCSGAFKSFDFECDVMKSTCYRNLIKIISSR 221
+G FG+++ AR Q++ ++K L+ G E ++ + N++++ +
Sbjct: 24 KGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83
Query: 222 SNEDFKVLVLEYMPRGSLEKCL---------YSSNY---VGFALEYLHFDYSVLIIHYDL 269
+ L+LE+ PRG L K L S+ + + AL Y H +IH D+
Sbjct: 84 HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDI 140
Query: 270 KPSNVLFDDNIVTHLSDFGIAKL 292
KP N+L ++DFG +
Sbjct: 141 KPENLLMGYKGELKIADFGWSVH 163
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 8e-07
Identities = 11/62 (17%), Positives = 22/62 (35%), Gaps = 9/62 (14%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
L LH ++H L+P +++ D L+ F R+ + + G+
Sbjct: 218 LLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV---RDGAR---VVSSVSRGF 268
Query: 312 MA 313
Sbjct: 269 EP 270
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 9e-07
Identities = 22/101 (21%), Positives = 33/101 (32%), Gaps = 7/101 (6%)
Query: 47 PPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLE-------IENL 99
P + LS+A ++ + L+LS N G L L
Sbjct: 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTL 203
Query: 100 KVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSI 140
+VL M +GV LQ L L +N L+ +
Sbjct: 204 QVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 5e-05
Identities = 17/92 (18%), Positives = 30/92 (32%), Gaps = 10/92 (10%)
Query: 55 ENLSLASNELI-------SVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYF 107
L L+ N + ++ P F L+ + N + + +G L +
Sbjct: 176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDL 235
Query: 108 SMNNFAGVIPNAIGCLNI--LQHLFLGYNRLQ 137
S N+ A C L L L + L+
Sbjct: 236 SHNSLRD-AAGAPSCDWPSQLNSLNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 20/87 (22%), Positives = 29/87 (33%), Gaps = 8/87 (9%)
Query: 55 ENLSLASNELISVIP-STFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNF 112
+ L L+ N L + + LNLS L +P + L VL S N
Sbjct: 231 QGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPAKLSVL---DLSYNRL 286
Query: 113 AGVIPNAIGCLNILQHLFLGYNRLQGS 139
P+ + +L L N S
Sbjct: 287 DR-NPSPDELPQ-VGNLSLKGNPFLDS 311
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 9e-07
Identities = 41/174 (23%), Positives = 71/174 (40%), Gaps = 36/174 (20%)
Query: 153 RVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDF-ECDVMKSTCY 211
+ ++ +I G FG + +A++ + E ++K K F E +M+ +
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKH 91
Query: 212 RNLIKII------SSRSNEDFKVLVLEYMP--------RGSLEKCLYSSNYVGF------ 251
N++ + + +E F LVLEY+P + K +
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 252 -ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTH---LSDFGIAKLLIREDHFMI 301
+L Y+H S+ I H D+KP N+L D + L DFG AK+LI +
Sbjct: 152 RSLAYIH---SIGICHRDIKPQNLLLDPP--SGVLKLIDFGSAKILI-AGEPNV 199
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 46/202 (22%), Positives = 76/202 (37%), Gaps = 32/202 (15%)
Query: 158 FSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDF---ECDVMKSTCYRN 213
FS+ I G FG+++ AR +++ ++K + + + E ++ + N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 214 LIKIISSRSNEDFKVLVLEYMPRGSL------EKCLYSSNYVGF-------ALEYLHFDY 260
I+ E LV+EY GS K + L YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 171
Query: 261 SVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM----------IQTQTLATIG 310
S +IH D+K N+L + + L DFG A ++ + F+ I
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYD 231
Query: 311 YMASYVYSFGIMLLEVFTRKKP 332
V+S GI +E+ RK P
Sbjct: 232 GKVD-VWSLGITCIELAERKPP 252
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 28/121 (23%), Positives = 49/121 (40%), Gaps = 30/121 (24%)
Query: 202 ECDVMKSTCYRNLIK---IISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVG-------- 250
E +++ ++N+I+ ++ + + +V+EY G E + + V
Sbjct: 56 EIQLLRRLRHKNVIQLVDVLYNEEKQKM-YMVMEYCVCGMQE--ML--DSVPEKRFPVCQ 110
Query: 251 ----F-----ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL--IREDHF 299
F LEYLH S I+H D+KP N+L +S G+A+ L D
Sbjct: 111 AHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT 167
Query: 300 M 300
Sbjct: 168 C 168
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 35/176 (19%), Positives = 65/176 (36%), Gaps = 43/176 (24%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDF--ECDVMKSTC-YRNLIKII--- 218
G G + + + + ++K + S E D +++ I+
Sbjct: 39 LGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCILDVY 91
Query: 219 -SSRSNEDFKVLVLEYMPRGSL-------EKCLYS----SNYV---GFALEYLHFDYSVL 263
+ + ++++E M G L ++ + + G A+++LH S
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHN 148
Query: 264 IIHYDLKPSNVLF---DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMASYV 316
I H D+KP N+L+ + + V L+DFG AK L T Y YV
Sbjct: 149 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--------ETTQNALQTPCYTPYYV 196
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 31/113 (27%), Positives = 47/113 (41%), Gaps = 30/113 (26%)
Query: 213 NLIKII------SSRSNEDFKVLVLEYMP--------RGSLEKCLYSSNYVGF------- 251
N++++ + +E + LVL+Y+P S K YV
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTH---LSDFGIAKLLIREDHFMI 301
+L Y+H S I H D+KP N+L D + T L DFG AK L+ +
Sbjct: 168 SLAYIH---SFGICHRDIKPQNLLLDPD--TAVLKLCDFGSAKQLV-RGEPNV 214
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 22/100 (22%), Positives = 41/100 (41%), Gaps = 2/100 (2%)
Query: 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMN 110
L+L N++ + ++F +L+ + L LS N + L L + N
Sbjct: 63 STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122
Query: 111 NFAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLE 150
+ A L+ L+ L+L N ++ SI S F+ +
Sbjct: 123 RLTTIPNGAFVYLSKLKELWLRNNPIE-SIP-SYAFNRIP 160
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 24/87 (27%), Positives = 43/87 (49%), Gaps = 3/87 (3%)
Query: 52 PQQENLSLASNELISVIPS-TFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMN 110
P L L + +S I F L ++ YLNL++ +L IP + L L ++ S N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGN 217
Query: 111 NFAGVIPNAIGCLNILQHLFLGYNRLQ 137
+ + + P + L LQ L++ +++Q
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQIQ 244
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 21/83 (25%), Positives = 33/83 (39%), Gaps = 2/83 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
L+LA L + L + L+LS N L+ P + L L K++ +
Sbjct: 188 RYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV 245
Query: 115 VIPNAIGCLNILQHLFLGYNRLQ 137
+ NA L L + L +N L
Sbjct: 246 IERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 23/88 (26%), Positives = 35/88 (39%), Gaps = 3/88 (3%)
Query: 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMN 110
E L L+ N + ++ F L ++ L L N LT IP L L +++ N
Sbjct: 88 RHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNN 146
Query: 111 NFAGVIPNAIGCLNILQHLFLG-YNRLQ 137
+ A + L+ L LG RL
Sbjct: 147 PIESIPSYAFNRIPSLRRLDLGELKRLS 174
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 19/86 (22%), Positives = 39/86 (45%)
Query: 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNN 111
+ + L L+ N L ++ P +F L + L + + + +NL+ LV+I + NN
Sbjct: 207 IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN 266
Query: 112 FAGVIPNAIGCLNILQHLFLGYNRLQ 137
+ + L+ L+ + L +N
Sbjct: 267 LTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 20/87 (22%), Positives = 41/87 (47%), Gaps = 3/87 (3%)
Query: 52 PQQENLSLASNELISVIPS-TFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMN 110
P L L + + I F L ++ YLNL + ++ +P + L L ++ S N
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGN 228
Query: 111 NFAGVIPNAIGCLNILQHLFLGYNRLQ 137
+F + P + L+ L+ L++ +++
Sbjct: 229 HFPEIRPGSFHGLSSLKKLWVMNSQVS 255
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 20/87 (22%), Positives = 33/87 (37%)
Query: 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMN 110
P L+L N + + TF +L + L L NS+ L L + N
Sbjct: 74 PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133
Query: 111 NFAGVIPNAIGCLNILQHLFLGYNRLQ 137
+ A L+ L+ L+L N ++
Sbjct: 134 WLTVIPSGAFEYLSKLRELWLRNNPIE 160
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 18/83 (21%), Positives = 30/83 (36%), Gaps = 2/83 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ L+L + + L + L +S N P L L K++ + +
Sbjct: 199 KYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL 256
Query: 115 VIPNAIGCLNILQHLFLGYNRLQ 137
+ NA L L L L +N L
Sbjct: 257 IERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 23/88 (26%), Positives = 33/88 (37%), Gaps = 3/88 (3%)
Query: 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMN 110
E L L N + + F L + L L N LT IP E L L +++ N
Sbjct: 99 HHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNN 157
Query: 111 NFAGVIPNAIGCLNILQHLFLG-YNRLQ 137
+ A + L L LG +L+
Sbjct: 158 PIESIPSYAFNRVPSLMRLDLGELKKLE 185
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 27/131 (20%), Positives = 43/131 (32%), Gaps = 18/131 (13%)
Query: 213 NLIKIISSRSNEDFKV--LVLEYMPRGSLEKCLYSSNY-----VGF-------ALEYLHF 258
L +I F +VLE L+K + + + ++H
Sbjct: 89 RLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIH- 146
Query: 259 DYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMASYVYS 318
IIH DLKP+N L + + + DFG+A+ + E I
Sbjct: 147 --ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 319 FGIMLLEVFTR 329
+ V TR
Sbjct: 205 KKQLTSHVVTR 215
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 30/99 (30%), Positives = 41/99 (41%), Gaps = 21/99 (21%)
Query: 229 LVLEYMPRGSL-----------EK--CLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVL 275
V+E++ G L E Y++ + AL +LH II+ DLK NVL
Sbjct: 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAE-IISALMFLH---DKGIIYRDLKLDNVL 156
Query: 276 FDDNIVTHLSDFGIAKLLIREDHFMIQTQTL-ATIGYMA 313
D L+DFG+ K I T T T Y+A
Sbjct: 157 LDHEGHCKLADFGMCKEGICNGV---TTATFCGTPDYIA 192
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-06
Identities = 16/82 (19%), Positives = 32/82 (39%), Gaps = 1/82 (1%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
E L + ++ S L + L++S ++ I +I L + I S N
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150
Query: 115 VIPNAIGCLNILQHLFLGYNRL 136
I + L L+ L + ++ +
Sbjct: 151 DI-MPLKTLPELKSLNIQFDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-05
Identities = 14/87 (16%), Positives = 30/87 (34%), Gaps = 2/87 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
++L++ + + + L ++ L + +T + L L + S +
Sbjct: 69 KDLTINNIH-ATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSIS 141
I I L + + L YN I
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDIM 153
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 3e-04
Identities = 13/86 (15%), Positives = 29/86 (33%), Gaps = 4/86 (4%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
++LA+ + + +I L ++ T P+ L L ++ +
Sbjct: 47 TYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNPI--SGLSNLERLRIMGKDVTS 102
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSI 140
+ L L L + ++ SI
Sbjct: 103 DKIPNLSGLTSLTLLDISHSAHDDSI 128
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 23/104 (22%), Positives = 41/104 (39%), Gaps = 2/104 (1%)
Query: 47 PPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKI 105
P L P + L+ N + + ++F L+D+ +L + + I L L+ +
Sbjct: 26 PEL-PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIIL 84
Query: 106 YFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
N F + A L L+ L L L G++ +F L
Sbjct: 85 KLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPL 128
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 6e-06
Identities = 20/98 (20%), Positives = 41/98 (41%), Gaps = 2/98 (2%)
Query: 41 CPRYNYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENL 99
+ + L + L+ +++ +++ S F + D+ L L+ N + I L
Sbjct: 264 PDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGL 322
Query: 100 KVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
L+K+ S N + L+ L+ L L YN ++
Sbjct: 323 THLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 29/84 (34%), Positives = 42/84 (50%), Gaps = 2/84 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFA 113
E L+LA NE+ + + FW L +L LNLS N L I + ENL L + S N+
Sbjct: 302 EQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIR 360
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQ 137
+ + L L+ L L N+L+
Sbjct: 361 ALGDQSFLGLPNLKELALDTNQLK 384
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 19/90 (21%)
Query: 217 IISSRSNEDFKV-LVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHFDYS 261
+SR++ + KV LV E++ + L L + G L++LH +
Sbjct: 83 CATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---A 138
Query: 262 VLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291
I+H DLKP N+L L+DFG+A+
Sbjct: 139 NCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 32/99 (32%), Positives = 43/99 (43%), Gaps = 21/99 (21%)
Query: 229 LVLEYMPRGSL-----------EK--CLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVL 275
V+EY+ G L E+ YS+ + AL YLH II+ DLK NVL
Sbjct: 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-ISLALNYLH---ERGIIYRDLKLDNVL 142
Query: 276 FDDNIVTHLSDFGIAKLLIREDHFMIQTQTL-ATIGYMA 313
D L+D+G+ K +R T T T Y+A
Sbjct: 143 LDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIA 178
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 23/89 (25%), Positives = 35/89 (39%), Gaps = 9/89 (10%)
Query: 48 PLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYF 107
P P + L ++ N L S +P LK L +S N LT +P+ L L
Sbjct: 217 PALPSGLKELIVSGNRLTS-LPVLPSELK---ELMVSGNRLTS-LPMLPSGLLSL---SV 268
Query: 108 SMNNFAGVIPNAIGCLNILQHLFLGYNRL 136
N +P ++ L+ + L N L
Sbjct: 269 YRNQLT-RLPESLIHLSSETTVNLEGNPL 296
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 26/89 (29%), Positives = 38/89 (42%), Gaps = 12/89 (13%)
Query: 48 PLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYF 107
P+ PP + LS++ N+L S +P+ L L N LT +P+ L+ L
Sbjct: 137 PVLPPGLQELSVSDNQLAS-LPALPSELC---KLWAYNNQLTS-LPMLPSGLQEL---SV 188
Query: 108 SMNNFAGVIPNAIGCLNILQHLFLGYNRL 136
S N A +P L L+ NRL
Sbjct: 189 SDNQLA-SLPTLPSE---LYKLWAYNNRL 213
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 5e-06
Identities = 21/90 (23%), Positives = 33/90 (36%), Gaps = 12/90 (13%)
Query: 48 PLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYF 107
P PP+ L ++ N+L S +P L ++ + L L P L L +
Sbjct: 77 PALPPELRTLEVSGNQLTS-LPVLPPGLLELSIFSNPLTHL----PALPSGLCKL---WI 128
Query: 108 SMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
N +P LQ L + N+L
Sbjct: 129 FGNQLT-SLPVLPPG---LQELSVSDNQLA 154
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 6e-06
Identities = 16/92 (17%), Positives = 28/92 (30%), Gaps = 8/92 (8%)
Query: 50 RPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSM 109
L++ + L ++ ++ L + N+LT +P L+ L S
Sbjct: 38 LNNGNAVLNVGESGLTTLPDCLPAHIT---TLVIPDNNLTS-LPALPPELRTL---EVSG 90
Query: 110 NNFAGVIPNAIGCLNILQHLFLGYNRLQGSIS 141
N +P L L L S
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLPALPS 121
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 8e-06
Identities = 25/90 (27%), Positives = 36/90 (40%), Gaps = 12/90 (13%)
Query: 48 PLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYF 107
P+ P + LS++ N+L S +P+ L + N L SL P LK L
Sbjct: 177 PMLPSGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSL----PALPSGLKEL---IV 228
Query: 108 SMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
S N +P L+ L + NRL
Sbjct: 229 S-GNRLTSLPVLPSE---LKELMVSGNRLT 254
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 23/99 (23%), Positives = 35/99 (35%), Gaps = 12/99 (12%)
Query: 39 ILCPRYNYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIEN 98
I + P P L + N+L S +P L+ L++S N L +P
Sbjct: 108 IFSNPLTHLPALPSGLCKLWIFGNQLTS-LPVLPPGLQ---ELSVSDNQLAS-LPALPSE 162
Query: 99 LKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
L L + N +P LQ L + N+L
Sbjct: 163 LCKL---WAYNNQLT-SLPMLPSG---LQELSVSDNQLA 194
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 5e-05
Identities = 25/90 (27%), Positives = 35/90 (38%), Gaps = 12/90 (13%)
Query: 48 PLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYF 107
P P + L +N L S +P+ LK L +S N LT +P+ LK L
Sbjct: 197 PTLPSELYKLWAYNNRLTS-LPALPSGLK---ELIVSGNRLTS-LPVLPSELKEL---MV 248
Query: 108 SMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
S N +P L L + N+L
Sbjct: 249 S-GNRLTSLPMLPSGL---LSLSVYRNQLT 274
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 36/176 (20%), Positives = 68/176 (38%), Gaps = 42/176 (23%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDF--ECDVMKSTC-YRNLIKII--- 218
G G + + + + +F++K E ++ ++++I+
Sbjct: 72 LGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVY 124
Query: 219 -SSRSNEDFKVLVLEYMPRGSL-------EKCLYS----SNYV---GFALEYLHFDYSVL 263
+ + ++V+E + G L ++ S + G A++YLH S+
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 181
Query: 264 IIHYDLKPSNVLF---DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMASYV 316
I H D+KP N+L+ N + L+DFG AK +L T Y YV
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-------ETTSHNSLTTPCYTPYYV 230
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 38/219 (17%), Positives = 70/219 (31%), Gaps = 49/219 (22%)
Query: 154 VTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYR- 212
+ + ++ IS G +G++ + + ++K S + R
Sbjct: 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 213 ----------NLIK---IISSRSNEDFK--VLVLEYMPRGSLEKCLYSSNY------VGF 251
N++ I LV E M L + ++ + +
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY 138
Query: 252 -------ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQ 304
L LH ++H DL P N+L DN + DF +A+ D T
Sbjct: 139 FMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANK--TH 192
Query: 305 TLATIGYMA--------SY-----VYSFGIMLLEVFTRK 330
+ Y A + ++S G ++ E+F RK
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 32/99 (32%), Positives = 43/99 (43%), Gaps = 21/99 (21%)
Query: 229 LVLEYMPRGSL-----------EK--CLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVL 275
V+EY+ G L E+ YS+ + AL YLH II+ DLK NVL
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-ISLALNYLH---ERGIIYRDLKLDNVL 185
Query: 276 FDDNIVTHLSDFGIAKLLIREDHFMIQTQTL-ATIGYMA 313
D L+D+G+ K +R T T T Y+A
Sbjct: 186 LDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIA 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 3e-06
Identities = 28/99 (28%), Positives = 42/99 (42%), Gaps = 21/99 (21%)
Query: 229 LVLEYMPRGSL-----------EK--CLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVL 275
V+EY+ G L E Y++ + L +L S II+ DLK NV+
Sbjct: 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE-IAIGLFFLQ---SKGIIYRDLKLDNVM 153
Query: 276 FDDNIVTHLSDFGIAKLLIREDHFMIQTQTL-ATIGYMA 313
D ++DFG+ K I + T+T T Y+A
Sbjct: 154 LDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYIA 189
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 23/83 (27%), Positives = 36/83 (43%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+ L L N L ++ TF +L ++ +L L N ++ L L ++ N A
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 115 VIPNAIGCLNILQHLFLGYNRLQ 137
V P+A L L L+L N L
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 19/88 (21%), Positives = 31/88 (35%), Gaps = 1/88 (1%)
Query: 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMN 110
P + + L N + V ++F +++ L L N L L +L ++ S N
Sbjct: 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 111 NFAGVIP-NAIGCLNILQHLFLGYNRLQ 137
+ L L L L LQ
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ 118
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 22/87 (25%), Positives = 33/87 (37%), Gaps = 1/87 (1%)
Query: 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMN 110
L L SN L + + F L + L+LS N+ + L L ++
Sbjct: 56 RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC 115
Query: 111 NFAGVIPNAIGCLNILQHLFLGYNRLQ 137
+ P L LQ+L+L N LQ
Sbjct: 116 GLQELGPGLFRGLAALQYLYLQDNALQ 142
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 23/84 (27%), Positives = 34/84 (40%), Gaps = 2/84 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFA 113
L L L + P F L + YL L N+L +P + +L L ++ N +
Sbjct: 108 HTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRIS 166
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQ 137
V A L+ L L L NR+
Sbjct: 167 SVPERAFRGLHSLDRLLLHQNRVA 190
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 1e-04
Identities = 22/81 (27%), Positives = 34/81 (41%), Gaps = 2/81 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFA 113
+L L N + SV F L + L L N + + +L L+ +Y NN +
Sbjct: 156 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLS 214
Query: 114 GVIPNAIGCLNILQHLFLGYN 134
+ A+ L LQ+L L N
Sbjct: 215 ALPTEALAPLRALQYLRLNDN 235
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 28/101 (27%), Positives = 45/101 (44%), Gaps = 25/101 (24%)
Query: 229 LVLEYMPRGSL-----------EK--CLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVL 275
V+EY+ G L Y++ + L++LH S I++ DLK N+L
Sbjct: 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE-IILGLQFLH---SKGIVYRDLKLDNIL 150
Query: 276 FDDN--IVTHLSDFGIAKLLIREDHFMIQTQTL-ATIGYMA 313
D + I ++DFG+ K + D +T T T Y+A
Sbjct: 151 LDKDGHIK--IADFGMCKENMLGDA---KTNTFCGTPDYIA 186
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 24/108 (22%), Positives = 38/108 (35%), Gaps = 22/108 (20%)
Query: 214 LIKIISSRSNEDFK----VLVLEYMP--------RGSLEKCLYSSNYVGF-------ALE 254
L + D + +V+EY+P + + ++
Sbjct: 84 LQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIG 143
Query: 255 YLHFDYSVLIIHYDLKPSNVLFD-DNIVTHLSDFGIAKLLIREDHFMI 301
LH SV + H D+KP NVL + + L DFG AK L +
Sbjct: 144 CLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-PSEPNV 189
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 23/92 (25%), Positives = 40/92 (43%), Gaps = 18/92 (19%)
Query: 213 NLIKIISSRSNEDFKV--LVLEYMPRGSLEKCLYSSNYVG------F------ALEYLHF 258
++ I+ + E F +VLE +K + Y+ ++Y+H
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH- 173
Query: 259 DYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIA 290
S I+H DLKP+N L + + + DFG+A
Sbjct: 174 --SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 5e-06
Identities = 34/101 (33%), Positives = 47/101 (46%), Gaps = 28/101 (27%)
Query: 229 LVLEYMPRGSL-----------EK--CLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVL 275
++++Y+ G L Y++ V ALEYLH S II+ DLKP N+L
Sbjct: 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE-VCLALEYLH---SKDIIYRDLKPENIL 138
Query: 276 FDDN--IVTHLSDFGIAKLLIREDHFMIQTQTL-ATIGYMA 313
D N I ++DFG AK + T TL T Y+A
Sbjct: 139 LDKNGHIK--ITDFGFAKYVPD------VTYTLCGTPDYIA 171
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 5e-06
Identities = 29/138 (21%), Positives = 50/138 (36%), Gaps = 26/138 (18%)
Query: 183 FSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKC 242
F G + + + +I + S + +++EY+P +L K
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKV 127
Query: 243 LY---------SSNYVGF-------ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTH--- 283
L N + A+ ++H S+ I H D+KP N+L + +
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSK--DNTLK 182
Query: 284 LSDFGIAKLLIREDHFMI 301
L DFG AK LI +
Sbjct: 183 LCDFGSAKKLI-PSEPSV 199
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 24/91 (26%), Positives = 39/91 (42%), Gaps = 12/91 (13%)
Query: 47 PPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIY 106
P PPQ L + N LIS +P +L+ YL+ N L+ +P +LK L
Sbjct: 75 PDNLPPQITVLEITQNALIS-LPELPASLE---YLDACDNRLST-LPELPASLKHL---D 126
Query: 107 FSMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
N ++P +L+++ N+L
Sbjct: 127 VDNNQLT-MLPELPA---LLEYINADNNQLT 153
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 9e-05
Identities = 22/90 (24%), Positives = 37/90 (41%), Gaps = 12/90 (13%)
Query: 48 PLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYF 107
P P ++L + +N+L +P L+ Y+N N LT +P +L+VL
Sbjct: 116 PELPASLKHLDVDNNQLTM-LPELPALLE---YINADNNQLTM-LPELPTSLEVL---SV 167
Query: 108 SMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
N +P L + L + N L+
Sbjct: 168 RNNQL-TFLPELPESL---EALDVSTNLLE 193
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 18/89 (20%), Positives = 34/89 (38%), Gaps = 14/89 (15%)
Query: 53 QQENLSLAS---NELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFS 108
+ E +L NE +S++ + L L+ +L+ +P + + VL +
Sbjct: 35 KWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLSS-LPDNLPPQITVL---EIT 88
Query: 109 MNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
N +P L++L NRL
Sbjct: 89 QNAL-ISLPELPAS---LEYLDACDNRLS 113
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 6e-06
Identities = 31/166 (18%), Positives = 55/166 (33%), Gaps = 44/166 (26%)
Query: 164 ISRGGFGSIHKAR---------IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNL 214
+R G +++A + +FS+K + F +F K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 215 IK-----------IISSRSNED-FKVLVLEYMPRGSLEKCLYSSNYVGF----------- 251
K + ++D ++ LVL + R SL+ L S
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACR 167
Query: 252 ---ALEYLHFDYSVLIIHYDLKPSNVLF---DDNIVTHLSDFGIAK 291
ALE+LH +H ++ N+ D + V L+ +G A
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 7e-06
Identities = 24/91 (26%), Positives = 38/91 (41%), Gaps = 18/91 (19%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
+++LH S IIH DLKPSN++ + + DFG+A+ M T + T Y
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMM--TPYVVTRYY 192
Query: 312 -----MASYVY-------SFGIMLLEVFTRK 330
+ Y S G ++ E+
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 7e-06
Identities = 32/158 (20%), Positives = 64/158 (40%), Gaps = 35/158 (22%)
Query: 166 RGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDF--ECDVMKSTC-YRNLIKII--- 218
G G + + + + +F++K E ++ ++++I+
Sbjct: 28 LGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVY 80
Query: 219 -SSRSNEDFKVLVLEYMPRGSL-------EKCLYS----SNY---VGFALEYLHFDYSVL 263
+ + ++V+E + G L ++ S +G A++YLH S+
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 137
Query: 264 IIHYDLKPSNVLF---DDNIVTHLSDFGIAKLLIREDH 298
I H D+KP N+L+ N + L+DFG AK E +
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKY 175
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 27/99 (27%), Positives = 41/99 (41%), Gaps = 21/99 (21%)
Query: 229 LVLEYMPRGSL-------------EKCLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVL 275
V+EY+ G L Y++ + L +L S II+ DLK NV+
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE-IAIGLFFLQ---SKGIIYRDLKLDNVM 474
Query: 276 FDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMA 313
D ++DFG+ K I + T+T T Y+A
Sbjct: 475 LDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYIA 510
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 8e-06
Identities = 28/99 (28%), Positives = 44/99 (44%), Gaps = 24/99 (24%)
Query: 229 LVLEYMPRGSL-------------EKCLYSSNYVGFALEYLHFDYSVLIIHYDLKPSNVL 275
+V+EY+ G + Y++ + EYLH S+ +I+ DLKP N+L
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLH---SLDLIYRDLKPENLL 173
Query: 276 FDDNIVTHLSDFGIAKLLIREDHFMIQTQTL-ATIGYMA 313
D ++DFG AK + +T TL T +A
Sbjct: 174 IDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALA 206
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 8e-06
Identities = 22/77 (28%), Positives = 36/77 (46%), Gaps = 18/77 (23%)
Query: 229 LVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHFDYSVLIIHYDLKPSNV 274
LV E++ + L+K + +S G L + H S ++H DLKP N+
Sbjct: 79 LVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNL 134
Query: 275 LFDDNIVTHLSDFGIAK 291
L + L+DFG+A+
Sbjct: 135 LINTEGAIKLADFGLAR 151
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 26/105 (24%), Positives = 43/105 (40%), Gaps = 20/105 (19%)
Query: 48 PLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPL------------- 94
P PP E+L + N L +P +LK +L N +L +L+ PL
Sbjct: 87 PELPPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK 145
Query: 95 --EIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
E++N L I N+ +P+ L+ + G N+L+
Sbjct: 146 LPELQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE 186
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 16/83 (19%), Positives = 31/83 (37%), Gaps = 8/83 (9%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
E ++ +N+L +P NL + + NSL +P +L+ + N
Sbjct: 176 EFIAAGNNQL-EELPE-LQNLPFLTAIYADNNSLKK-LPDLPLSLESI---VAGNNIL-- 227
Query: 115 VIPNAIGCLNILQHLFLGYNRLQ 137
+ L L ++ N L+
Sbjct: 228 EELPELQNLPFLTTIYADNNLLK 250
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 15/100 (15%), Positives = 26/100 (26%), Gaps = 18/100 (18%)
Query: 55 ENLSLASNELISVIPSTFWNLKDIL-------------YLNLSLNSLTGPIPLEIENLKV 101
A +E P +++ L L+ L+ +P +L+
Sbjct: 37 TEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLES 95
Query: 102 LVKIYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSIS 141
L S N+ +P L L L
Sbjct: 96 L---VASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP 131
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 16/87 (18%), Positives = 28/87 (32%), Gaps = 7/87 (8%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
E++ +N L +P NL + + N L +P +L+ L N
Sbjct: 218 ESIVAGNNIL-EELPE-LQNLPFLTTIYADNNLLKT-LPDLPPSLEAL---NVRDNYLTD 271
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSIS 141
+P L L ++ L
Sbjct: 272 -LPELPQSLTFLDVSENIFSGLSELPP 297
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 8e-06
Identities = 28/109 (25%), Positives = 44/109 (40%), Gaps = 27/109 (24%)
Query: 202 ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL-------------EKCLYSSNY 248
E + K + N++K R + + L LEY G L + +
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF---- 110
Query: 249 VGF-----ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292
F + YLH + I H D+KP N+L D+ +SDFG+A +
Sbjct: 111 --FHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATV 154
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 9e-06
Identities = 34/161 (21%), Positives = 57/161 (35%), Gaps = 30/161 (18%)
Query: 153 RVTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCY 211
V F I G FG + + + ++K ++ E K
Sbjct: 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGS 63
Query: 212 RNLI-KIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGFAL--------------EYL 256
+ I ++ + +VLE + SLE L+ F+L EY+
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELLGP-SLED-LFDLCDRTFSLKTVLMIAIQLISRMEYV 121
Query: 257 HFDYSVLIIHYDLKPSNVLF------DDNIVTHLSDFGIAK 291
H S +I+ D+KP N L ++ H+ DF +AK
Sbjct: 122 H---SKNLIYRDVKPENFLIGRPGNKTQQVI-HIIDFALAK 158
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 21/87 (24%), Positives = 39/87 (44%), Gaps = 2/87 (2%)
Query: 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMN 110
P+ + L L+ E+ ++ + +L + L L+ N + + L L L K+
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVET 110
Query: 111 NFAGVIPNAIGCLNILQHLFLGYNRLQ 137
N A + IG L L+ L + +N +Q
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 3e-04
Identities = 20/88 (22%), Positives = 36/88 (40%), Gaps = 2/88 (2%)
Query: 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSM 109
P +NL L+ N L + +F++ ++ L+LS + I ++L L + +
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTG 85
Query: 110 NNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
N + A L+ LQ L L
Sbjct: 86 NPIQSLALGAFSGLSSLQKLVAVETNLA 113
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 26/112 (23%), Positives = 50/112 (44%), Gaps = 18/112 (16%)
Query: 202 ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL-------------EKCLYSSNY 248
E +K + ++IK+ S +V+EY+ G L E
Sbjct: 66 EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125
Query: 249 VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300
+ ++Y H +++H DLKP NVL D ++ ++DFG++ ++ + F+
Sbjct: 126 L-SGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFL 172
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 48/213 (22%), Positives = 85/213 (39%), Gaps = 48/213 (22%)
Query: 154 VTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDF------ECDVM 206
V + I G G + A ++K + S F++ E +M
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK----KLSRPFQNQTHAKRAYRELVLM 115
Query: 207 KSTCYRNLIKII----SSRSNEDFK--VLVLEYMP-------RGSLEKCLYSSNYVGF-- 251
K ++N+I ++ ++ E+F+ LV+E M + L+ S Y+ +
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS--YLLYQM 173
Query: 252 --ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATI 309
+++LH S IIH DLKPSN++ + + DFG+A+ M T + T
Sbjct: 174 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMM--TPYVVTR 227
Query: 310 GYMA-------SY-----VYSFGIMLLEVFTRK 330
Y A Y ++S G ++ E+ K
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 24/90 (26%), Positives = 40/90 (44%), Gaps = 19/90 (21%)
Query: 217 IISSRSNEDFKV-LVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHFDYS 261
SR++ + K+ LV E++ + L L G L++LH
Sbjct: 83 CTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR- 140
Query: 262 VLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291
++H DLKP N+L + L+DFG+A+
Sbjct: 141 --VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 21/66 (31%), Positives = 32/66 (48%), Gaps = 7/66 (10%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLF--DDNIVTHLSDFGIAKLLIREDHFMIQ--TQTLA 307
AL YLH + I H D+KP N LF + + L DFG++K + ++ T
Sbjct: 180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
Query: 308 TIGYMA 313
T ++A
Sbjct: 237 TPYFVA 242
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 30/93 (32%), Positives = 44/93 (47%), Gaps = 22/93 (23%)
Query: 213 NLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHF 258
L+ +SN LV ++M LE + ++ + LEYLH
Sbjct: 76 GLLDAFGHKSN---ISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLH- 129
Query: 259 DYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291
I+H DLKP+N+L D+N V L+DFG+AK
Sbjct: 130 --QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 28/150 (18%), Positives = 52/150 (34%), Gaps = 30/150 (20%)
Query: 164 ISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLI-KIISSR 221
I G FG I + + + + ++K + E K I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 222 SNEDFKVLVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHFDYSVLIIHY 267
VLV++ + SLE L F ++ +H +++
Sbjct: 76 QEGLHNVLVIDLLGP-SLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 130
Query: 268 DLKPSNVLF------DDNIVTHLSDFGIAK 291
D+KP N L + N++ ++ DFG+ K
Sbjct: 131 DIKPDNFLIGRPNSKNANMI-YVVDFGMVK 159
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 18/88 (20%), Positives = 35/88 (39%), Gaps = 2/88 (2%)
Query: 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSM 109
P + L N + + P F K + ++LS N ++ + + + L+ L +
Sbjct: 31 PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYG 89
Query: 110 NNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
N + + L LQ L L N++
Sbjct: 90 NKITELPKSLFEGLFSLQLLLLNANKIN 117
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 1e-04
Identities = 22/82 (26%), Positives = 39/82 (47%), Gaps = 2/82 (2%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFAGV 115
+ L++N++ + P F L+ + L L N +T +P + E L L + + N +
Sbjct: 61 IDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKINCL 119
Query: 116 IPNAIGCLNILQHLFLGYNRLQ 137
+A L+ L L L N+LQ
Sbjct: 120 RVDAFQDLHNLNLLSLYDNKLQ 141
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 27/112 (24%), Positives = 51/112 (45%), Gaps = 18/112 (16%)
Query: 202 ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL-------------EKCLYSSNY 248
E +K + ++IK+ S +V+EY+ G L E
Sbjct: 61 EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120
Query: 249 VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300
+ A++Y H +++H DLKP NVL D ++ ++DFG++ ++ + F+
Sbjct: 121 L-SAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFL 167
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 28/109 (25%), Positives = 44/109 (40%), Gaps = 27/109 (24%)
Query: 202 ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSL-------------EKCLYSSNY 248
E + K + N++K R + + L LEY G L + +
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF---- 110
Query: 249 VGF-----ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292
F + YLH + I H D+KP N+L D+ +SDFG+A +
Sbjct: 111 --FHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATV 154
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 23/87 (26%), Positives = 34/87 (39%), Gaps = 3/87 (3%)
Query: 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMN 110
P L L+ N L + +T + LNL LT + ++ L VL + S N
Sbjct: 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHN 87
Query: 111 NFAGVIPNAIGCLNILQHLFLGYNRLQ 137
+P L L L + +NRL
Sbjct: 88 QLQ-SLPLLGQTLPALTVLDVSFNRLT 113
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 8e-05
Identities = 24/86 (27%), Positives = 36/86 (41%), Gaps = 3/86 (3%)
Query: 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNN 111
+ L+L EL + L + L+LS N L +PL + L L + S N
Sbjct: 55 TRLTQLNLDRAELTKL--QVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNR 111
Query: 112 FAGVIPNAIGCLNILQHLFLGYNRLQ 137
+ A+ L LQ L+L N L+
Sbjct: 112 LTSLPLGALRGLGELQELYLKGNELK 137
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 35/149 (23%), Positives = 57/149 (38%), Gaps = 36/149 (24%)
Query: 204 DVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF------ALEYLH 257
D++K R + +N DFK L + + + AL+Y H
Sbjct: 98 DIVKDPVSRTPALVFEHVNNTDFKQL----YQTLTDYDIRF------YMYEILKALDYCH 147
Query: 258 FDYSVLIIHYDLKPSNVLFD-DNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA--- 313
S+ I+H D+KP NV+ D ++ L D+G+A+ +A+ +
Sbjct: 148 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEY--NVRVASRYFKGPEL 201
Query: 314 -----SYVY-----SFGIMLLEVFTRKKP 332
Y Y S G ML + RK+P
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 47/213 (22%), Positives = 88/213 (41%), Gaps = 49/213 (23%)
Query: 154 VTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDF------ECDVM 206
+ + + G +GS+ A + + ++K + S F+S F E ++
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK----KLSRPFQSEIFAKRAYRELLLL 77
Query: 207 KSTCYRNLIKI----ISSRSNEDFK--VLVLEYMPRGSLEKCLY---SSNYVGF------ 251
K + N+I + + S +F LV+ +M L+K + S + +
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQML 136
Query: 252 -ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIG 310
L+Y+H S ++H DLKP N+ +++ + DFG+A+ D M T + T
Sbjct: 137 KGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH---ADAEM--TGYVVTRW 188
Query: 311 YMA--------SY-----VYSFGIMLLEVFTRK 330
Y A Y ++S G ++ E+ T K
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 33/167 (19%), Positives = 60/167 (35%), Gaps = 44/167 (26%)
Query: 163 LISRGGFGSIHKAR------IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIK 216
I +GGFG I+ A + VK F F K + I+
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 217 I---------------ISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF---------- 251
+ ++ + ++ ++++ L+K +Y +N F
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQK-IYEANAKRFSRKTVLQLSL 159
Query: 252 ----ALEYLHFDYSVLIIHYDLKPSNVLF---DDNIVTHLSDFGIAK 291
LEY+H +H D+K SN+L + + V +L D+G+A
Sbjct: 160 RILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 27/115 (23%), Positives = 45/115 (39%), Gaps = 23/115 (20%)
Query: 202 ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY-----------MPRGSLEKCLYSSNYVG 250
E ++ + N+IK++ N+ F LV+E L++ L +S
Sbjct: 79 EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL-ASYI-- 135
Query: 251 F-----ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300
F A+ YL IIH D+K N++ ++ L DFG A +
Sbjct: 136 FRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAA-YLERGKLF 186
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 24/106 (22%), Positives = 36/106 (33%), Gaps = 8/106 (7%)
Query: 47 PPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLT--GPIPLEIENLKVLVK 104
P P L+ N + LK + L L N L + L +N+ L
Sbjct: 348 CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLET 407
Query: 105 IYFSMNNF-AGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
+ S+N+ + + L L N L GS+ F CL
Sbjct: 408 LDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV-----FRCL 448
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 9e-05
Identities = 25/119 (21%), Positives = 44/119 (36%), Gaps = 7/119 (5%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGV- 115
L L+ N + S+ F +D+ YL++S N L + + L + S N+F +
Sbjct: 81 LRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN---ISCCPMASLRHLDLSFNDFDVLP 137
Query: 116 IPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLELCRVTNGFSEDNLISRGGFGSIHK 174
+ G L L L L + + + + L L + I G S+
Sbjct: 138 VCKEFGNLTKLTFLGLSAAKFR-QLDLLP-VAHLHLSCILLDL-VSYHIKGGETESLQI 193
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 26/101 (25%), Positives = 45/101 (44%), Gaps = 15/101 (14%)
Query: 202 ECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVG-------F--- 251
E +MK + N++K+ E L++EY G + L + + F
Sbjct: 64 EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123
Query: 252 --ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIA 290
A++Y H I+H DLK N+L D ++ ++DFG +
Sbjct: 124 VSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFS 161
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 19/49 (38%), Positives = 32/49 (65%), Gaps = 4/49 (8%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300
A+EY H I+H DLKP N+L DDN+ ++DFG++ ++ + +F+
Sbjct: 120 AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSN-IMTDGNFL 164
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 19/65 (29%), Positives = 34/65 (52%), Gaps = 5/65 (7%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
A++ LH +IH DLKPSN+L + N + DFG+A+++ ++ ++
Sbjct: 124 AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPTGQQSG 178
Query: 312 MASYV 316
M +V
Sbjct: 179 MVEFV 183
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 38/145 (26%), Positives = 65/145 (44%), Gaps = 31/145 (21%)
Query: 213 NLIKIISSRSNEDFK--VLVLEYMPRGSLEKCLYSSN-------YVGF----ALEYLHFD 259
+ II + + E K +V + M L K L + + Y + L+Y+H
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 260 YSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE-DHFMIQTQTLATIGYMA----- 313
S ++H DLKPSN+L + + DFG+A++ + DH T+ +AT Y A
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 314 ---SY-----VYSFGIMLLEVFTRK 330
Y ++S G +L E+ + +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 24/84 (28%), Positives = 39/84 (46%), Gaps = 2/84 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFA 113
L L N+L ++ F LK++ L ++ N L +P+ + + L L ++ N
Sbjct: 64 RLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK 122
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQ 137
+ P L L +L LGYN LQ
Sbjct: 123 SLPPRVFDSLTKLTYLSLGYNELQ 146
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 25/88 (28%), Positives = 38/88 (43%), Gaps = 2/88 (2%)
Query: 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSM 109
P + L L SN+L S+ F L + L L+ N L +P I + LK L ++ +
Sbjct: 36 PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTD 94
Query: 110 NNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
N + L L L L N+L+
Sbjct: 95 NKLQALPIGVFDQLVNLAELRLDRNQLK 122
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 5e-05
Identities = 22/84 (26%), Positives = 39/84 (46%), Gaps = 2/84 (2%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFA 113
+L L+ N L + F + ++ YL+LS N L + + +L+ L + N+
Sbjct: 67 HSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIV 125
Query: 114 GVIPNAIGCLNILQHLFLGYNRLQ 137
V NA + LQ L+L N++
Sbjct: 126 VVDRNAFEDMAQLQKLYLSQNQIS 149
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 8e-04
Identities = 23/87 (26%), Positives = 37/87 (42%), Gaps = 5/87 (5%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFA 113
L L+SN L ++ F +L+ + L L N + + E++ L K+Y S N +
Sbjct: 91 RYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQIS 149
Query: 114 GVIPNAIG---CLNILQHLFLGYNRLQ 137
I L L L L N+L+
Sbjct: 150 RFPVELIKDGNKLPKLMLLDLSSNKLK 176
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 13/86 (15%), Positives = 19/86 (22%), Gaps = 30/86 (34%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
A + H + PS V +S G LA
Sbjct: 141 AADAAH---RAGVALSIDHPSRVR--------VSIDGDVV--------------LAYPAT 175
Query: 312 MA-----SYVYSFGIMLLEVFTRKKP 332
M + G L + + P
Sbjct: 176 MPDANPQDDIRGIGASLYALLVNRWP 201
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 14/85 (16%), Positives = 30/85 (35%), Gaps = 2/85 (2%)
Query: 55 ENLSLASNELISVIP-STFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNF 112
L+L N ++ S F +L + L + I + L L ++ ++
Sbjct: 127 TFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186
Query: 113 AGVIPNAIGCLNILQHLFLGYNRLQ 137
P ++ + + HL L +
Sbjct: 187 QSYEPKSLKSIQNVSHLILHMKQHI 211
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 20/100 (20%), Positives = 41/100 (41%), Gaps = 3/100 (3%)
Query: 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSM 109
++L L++N + + S ++ L L+ N + I + +L L + S
Sbjct: 51 TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSY 109
Query: 110 NNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
N + + + L+ L L L N + ++ + FS L
Sbjct: 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHL 148
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 11/88 (12%), Positives = 33/88 (37%), Gaps = 1/88 (1%)
Query: 52 PQQENLSLASNELISVIPS-TFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMN 110
+ + L + + + + I F L + L + + L P +++++ + + M
Sbjct: 149 TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMK 208
Query: 111 NFAGVIPNAIGCLNILQHLFLGYNRLQG 138
++ + + ++ L L L
Sbjct: 209 QHILLLEIFVDVTSSVECLELRDTDLDT 236
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 27/92 (29%), Positives = 42/92 (45%), Gaps = 21/92 (22%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
L Y+H + IIH DLKP N+ +++ + DFG+A+ D M T + T Y
Sbjct: 140 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEM--TGYVVTRWY 191
Query: 312 MA--------SY-----VYSFGIMLLEVFTRK 330
A Y ++S G ++ E+ T K
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 7e-05
Identities = 19/89 (21%), Positives = 32/89 (35%), Gaps = 2/89 (2%)
Query: 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSM 109
P L +L + F D+ + +S N + I ++ NL L +I
Sbjct: 29 PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 110 NNFAGVIP-NAIGCLNILQHLFLGYNRLQ 137
N I A L LQ+L + ++
Sbjct: 89 ANNLLYINPEAFQNLPNLQYLLISNTGIK 117
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 5e-04
Identities = 33/242 (13%), Positives = 71/242 (29%), Gaps = 41/242 (16%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLE-IENLKV-LVKIYFSMNNF 112
+ L +++ + + + + L++ N I L V ++ + N
Sbjct: 107 QYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166
Query: 113 AGVIPNAIGCLNILQHLFLGYNRLQ----GSISYSKWFSCLELCRVTNGFSEDNLISRGG 168
+ +A + + N L+ + L++ R + G
Sbjct: 167 QEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISR--TRIHS---LPSYG 221
Query: 169 FGSIHKARIQDRMEFSVKGFHLQCSGAFKSF----------DFECDVMKSTCYRNLIKII 218
++ K R + ++L+ + C + N + I
Sbjct: 222 LENLKKLRARST-------YNLKKLPTLEKLVALMEASLTYPSHCC-----AFANWRRQI 269
Query: 219 --------SSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGFALEYLHFDYSVLIIHYDLK 270
S ++ + R SL + SS GF + Y FDY + D+
Sbjct: 270 SELHPICNKSILRQEVDYMTQARGQRSSLAEDNESSYSRGFDMTYTEFDYDLCNEVVDVT 329
Query: 271 PS 272
S
Sbjct: 330 CS 331
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 9e-05
Identities = 23/92 (25%), Positives = 34/92 (36%), Gaps = 22/92 (23%)
Query: 213 NLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHF 258
NL+++ + LV EY ++ L G A+ + H
Sbjct: 66 NLLEVFRRKRR---LHLVFEYCDH-TVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH- 119
Query: 259 DYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIA 290
IH D+KP N+L + V L DFG A
Sbjct: 120 --KHNCIHRDVKPENILITKHSVIKLCDFGFA 149
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 9e-05
Identities = 27/100 (27%), Positives = 43/100 (43%), Gaps = 30/100 (30%)
Query: 213 NLIKIISSRSNEDFKV-----LVLEYMPRGSLE---KCLYSSNYVGF------------- 251
NLI+I ++++ + LV ++ E L S+ V F
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFC-----EHDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 252 -ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIA 290
L Y+H I+H D+K +NVL + V L+DFG+A
Sbjct: 135 NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 33/180 (18%), Positives = 66/180 (36%), Gaps = 49/180 (27%)
Query: 150 ELCRVTNGFSEDNL-ISRGGFGSIHKARIQDRM---EFSVKGFHLQCSGAFKSFDF---- 201
E RV + F + + RG +G ++KA+ +D ++++K +
Sbjct: 14 ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK--------QIEGTGISMSA 65
Query: 202 --ECDVMKSTCYRN---LIKIISSRSNEDFKVLVLEYMP---RGSLEKCLYSSNYVGF-- 251
E +++ + N L K+ S ++ L+ +Y ++ S
Sbjct: 66 CREIALLRELKHPNVISLQKVFLSHADRKV-WLLFDYAEHDLWHIIKFHRASKANKKPVQ 124
Query: 252 ---------------ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTH----LSDFGIAKL 292
+ YLH + ++H DLKP+N+L ++D G A+L
Sbjct: 125 LPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 1e-04
Identities = 22/95 (23%), Positives = 35/95 (36%), Gaps = 23/95 (24%)
Query: 213 NLIKIISSRSNEDFKVLVLEYMP---RGSLEKCLYSSNYVGF--------------ALEY 255
L +I + + LV E+M + ++ + G L +
Sbjct: 67 RLYDVIHTENK---LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 256 LHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIA 290
H I+H DLKP N+L + L DFG+A
Sbjct: 124 CH---ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 18/103 (17%), Positives = 38/103 (36%), Gaps = 4/103 (3%)
Query: 47 PPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIY 106
P + L+++ N + + S +L + L +S N + + + L +
Sbjct: 16 PKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLD 75
Query: 107 FSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
S N + + L+HL L +N ++ K F +
Sbjct: 76 LSHNKLVKISCHP---TVNLKHLDLSFNAFD-ALPICKEFGNM 114
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 22/106 (20%), Positives = 38/106 (35%), Gaps = 8/106 (7%)
Query: 47 PPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLT--GPIPLEIENLKVLVK 104
P + +L ++N L + +L ++ L L +N L I +K L +
Sbjct: 319 CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQ 378
Query: 105 IYFSMNNFAGVIPNAI-GCLNILQHLFLGYNRLQGSISYSKWFSCL 149
+ S N+ + L L + N L +I F CL
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTI-----FRCL 419
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 9e-04
Identities = 13/93 (13%), Positives = 32/93 (34%)
Query: 57 LSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVI 116
+ S+ + ++ N +++ L + + + FS N +
Sbjct: 281 HQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTV 340
Query: 117 PNAIGCLNILQHLFLGYNRLQGSISYSKWFSCL 149
G L L+ L L N+L+ ++ + +
Sbjct: 341 FENCGHLTELETLILQMNQLKELSKIAEMTTQM 373
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 27/130 (20%), Positives = 45/130 (34%), Gaps = 30/130 (23%)
Query: 228 VLVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHFDYSVLIIHYDLKPSN 273
V+V E + +L + + G L+Y+H IIH D+KP N
Sbjct: 106 VMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPEN 162
Query: 274 VLFDDNIVTH------LSDFGIAKLLIREDHFMIQTQTL----ATIGYMASY---VYSFG 320
VL + ++D G A IQT+ +G ++S
Sbjct: 163 VLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTA 222
Query: 321 IMLLEVFTRK 330
++ E+ T
Sbjct: 223 CLIFELITGD 232
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 40/148 (27%), Positives = 60/148 (40%), Gaps = 28/148 (18%)
Query: 164 ISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLI-KIISSR 221
I G FG I+ I E ++K ++ E + K I I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 222 SNEDFKVLVLEYMPRGSLEKCLYSSNYVGFAL--------------EYLHFDYSVLIIHY 267
+ D+ V+V+E + SLE L++ F+L EY+H S IH
Sbjct: 75 AEGDYNVMVMELLGP-SLED-LFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 129
Query: 268 DLKPSNVLF----DDNIVTHLSDFGIAK 291
D+KP N L N+V ++ DFG+AK
Sbjct: 130 DVKPDNFLMGLGKKGNLV-YIIDFGLAK 156
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 2e-04
Identities = 18/88 (20%), Positives = 29/88 (32%), Gaps = 5/88 (5%)
Query: 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLE-IENLKVLVKIYFSM 109
+ L L + I VI + L ++ S N + L+ L+ L + +
Sbjct: 18 AVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKTLLVNN 73
Query: 110 NNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
N + L L L L N L
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 26/93 (27%), Positives = 41/93 (44%), Gaps = 22/93 (23%)
Query: 213 NLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHF 258
+LI +I S LV E+M + L+K L + G + + H
Sbjct: 83 SLIDVIHSERC---LTLVFEFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 259 DYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291
I+H DLKP N+L + + L+DFG+A+
Sbjct: 138 HR---ILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 41.7 bits (99), Expect = 2e-04
Identities = 22/77 (28%), Positives = 34/77 (44%), Gaps = 19/77 (24%)
Query: 229 LVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHFDYSVLIIHYDLKPSNV 274
LV E+ + L+K S N L + H S ++H DLKP N+
Sbjct: 78 LVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNL 132
Query: 275 LFDDNIVTHLSDFGIAK 291
L + N L++FG+A+
Sbjct: 133 LINRNGELKLANFGLAR 149
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 16/50 (32%), Positives = 20/50 (40%), Gaps = 6/50 (12%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHL--SDFGIAKLLIREDHF 299
+ Y H S+ I H DLK N L D + L DFG +K
Sbjct: 128 GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQ 173
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 24/94 (25%), Positives = 48/94 (51%), Gaps = 18/94 (19%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFD-DNIVTHLSDFGIAKLLIRE-DHFMIQTQTLATI 309
L+Y+H S ++H DLKP+N+ + +++V + DFG+A+++ H ++ L T
Sbjct: 132 GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 310 GYMA--------SY-----VYSFGIMLLEVFTRK 330
Y + +Y +++ G + E+ T K
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 41.3 bits (98), Expect = 2e-04
Identities = 20/77 (25%), Positives = 33/77 (42%), Gaps = 19/77 (24%)
Query: 229 LVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHFDYSVLIIHYDLKPSNV 274
LV E++ + L+K L G + Y H ++H DLKP N+
Sbjct: 77 LVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNL 131
Query: 275 LFDDNIVTHLSDFGIAK 291
L + ++DFG+A+
Sbjct: 132 LINREGELKIADFGLAR 148
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 2e-04
Identities = 24/93 (25%), Positives = 38/93 (40%), Gaps = 22/93 (23%)
Query: 213 NLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHF 258
L II + + LV EY+ + L++ L L Y H
Sbjct: 64 TLHDIIHTEKS---LTLVFEYLDK-DLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCH- 117
Query: 259 DYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291
++H DLKP N+L ++ L+DFG+A+
Sbjct: 118 --RQKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 13/43 (30%), Positives = 25/43 (58%), Gaps = 7/43 (16%)
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLF---DDNIVTHLSDFGIAK 291
LEY+H +H D+K +N+L + + V +L+D+G++
Sbjct: 163 VLEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 26/92 (28%), Positives = 41/92 (44%), Gaps = 2/92 (2%)
Query: 47 PPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKI 105
P P E L L S L ++ +TF L + +LNL N L + + ++L L +
Sbjct: 30 PSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTL 88
Query: 106 YFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137
+ N A + L L L+LG N+L+
Sbjct: 89 GLANNQLASLPLGVFDHLTQLDKLYLGGNQLK 120
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 33/168 (19%), Positives = 57/168 (33%), Gaps = 46/168 (27%)
Query: 152 CRVTNGFSEDNLISRGGFGSIHKARIQDRMEF-SVKGFHLQCSGAFKSFDFECDVMKSTC 210
+ + L+ G +G + K R +D ++K F + ++K
Sbjct: 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE---------SDDDKMVKKIA 71
Query: 211 YR--------------NLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF----- 251
R NL+++ + LV E++ ++ L G
Sbjct: 72 MREIKLLKQLRHENLVNLLEVCKKKKR---WYLVFEFVDH-TILDDLELFP-NGLDYQVV 126
Query: 252 ---------ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIA 290
+ + H S IIH D+KP N+L + V L DFG A
Sbjct: 127 QKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 39/159 (24%), Positives = 63/159 (39%), Gaps = 28/159 (17%)
Query: 153 RVTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCY 211
RV N F I G FG I+ IQ E ++K +++ +E + +
Sbjct: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQG 61
Query: 212 RNLI-KIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF--------------ALEYL 256
I + D+ VLV++ + SLE L++ +E++
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLLGP-SLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 257 HFDYSVLIIHYDLKPSNVLF----DDNIVTHLSDFGIAK 291
H S +H D+KP N L N V ++ DFG+AK
Sbjct: 120 H---SKSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAK 154
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 18/79 (22%), Positives = 32/79 (40%), Gaps = 19/79 (24%)
Query: 229 LVLEYMP---RGSLEKC--LYSSNYVGF------ALEYLHFDYSVLIIHYDLKPSNVLFD 277
L+ EY + ++K + F + + H S +H DLKP N+L
Sbjct: 110 LIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLS 166
Query: 278 DNIVTH-----LSDFGIAK 291
+ + + DFG+A+
Sbjct: 167 VSDASETPVLKIGDFGLAR 185
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 22/91 (24%), Positives = 46/91 (50%), Gaps = 17/91 (18%)
Query: 213 NLIKIISSRSNEDFKV--LVLEYMPRGSLEKCLYSSN-------YVGF----ALEYLHFD 259
N++ +++ ++ + LV +YM L + ++ YV + ++YLH
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLH-- 126
Query: 260 YSVLIIHYDLKPSNVLFDDNIVTHLSDFGIA 290
S ++H D+KPSN+L + ++DFG++
Sbjct: 127 -SGGLLHRDMKPSNILLNAECHVKVADFGLS 156
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 40.5 bits (94), Expect = 7e-04
Identities = 21/96 (21%), Positives = 38/96 (39%), Gaps = 7/96 (7%)
Query: 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
++LSL N + + +L + L L N +T L L L + N +
Sbjct: 112 KSLSLEHNGISDING--LVHLPQLESLYLGNNKITDITVL--SRLTKLDTLSLEDNQISD 167
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLE 150
++P + L LQ+L+L N + + L+
Sbjct: 168 IVP--LAGLTKLQNLYLSKNHIS-DLRALAGLKNLD 200
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 39.2 bits (92), Expect = 8e-04
Identities = 19/89 (21%), Positives = 35/89 (39%), Gaps = 2/89 (2%)
Query: 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSM 109
PP + L L L ++ F NL +I + +S++ + NL + I
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 110 NNFAGVIP-NAIGCLNILQHLFLGYNRLQ 137
I +A+ L +L+ L + L+
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK 118
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 348 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.98 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.98 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.98 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.98 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.98 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.98 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.98 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.98 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.98 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.98 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.98 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.98 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.98 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.98 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.98 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.98 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.98 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.98 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.98 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.98 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.98 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.98 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.98 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.98 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.98 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.98 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.98 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.98 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.98 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.98 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.98 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.98 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.98 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.98 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.98 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.98 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.98 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.98 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.96 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.75 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.73 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.7 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.68 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.6 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.59 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.56 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.54 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.52 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.52 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.5 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.5 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.48 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.48 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.48 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.47 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.46 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.46 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.45 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.45 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.43 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.42 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.42 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.41 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.4 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.4 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.4 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.4 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.4 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.39 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.38 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.38 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.38 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.38 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.37 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.36 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.36 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.36 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.34 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.33 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.32 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.32 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.31 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.31 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.3 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.3 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.29 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.29 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.29 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.29 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.29 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.29 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.28 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.28 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.28 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.28 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.28 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.28 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.28 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.27 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.27 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.26 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.26 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.26 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.26 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.25 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.25 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.23 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.22 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.22 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.22 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.22 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.22 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.21 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.2 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.2 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.2 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.18 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.18 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.18 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.18 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.17 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.17 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.16 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.16 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.15 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.15 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.15 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.14 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.14 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.14 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.13 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.13 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.13 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.13 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.12 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.1 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.1 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.1 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.09 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.08 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.06 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.04 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.03 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.03 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.01 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.99 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.99 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.98 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.97 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.97 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.96 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.95 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.95 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.95 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.94 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.93 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.93 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.92 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.91 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.88 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.84 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.81 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.8 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.75 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.75 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.74 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.68 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.66 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.63 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.61 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.57 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.44 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.37 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.32 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.3 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.26 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.22 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.13 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.11 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.1 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.05 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.02 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.99 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.98 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.92 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.91 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.9 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.83 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.74 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.66 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.64 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.63 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.25 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.22 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.21 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.21 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.19 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.19 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.02 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.96 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.93 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.78 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.76 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.72 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.7 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.58 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.1 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.87 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 95.7 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.42 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.32 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 93.9 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 91.39 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 89.17 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 88.99 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 88.45 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 87.27 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 84.71 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 83.95 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.27 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=340.75 Aligned_cols=179 Identities=26% Similarity=0.458 Sum_probs=153.9
Q ss_pred CCCccccccccCCcceEEEeEec------CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
++|...+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++++|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45677889999999999999864 477899999976555556789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch-------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEE
Q 038351 230 VLEYMPRGSLEKCLYSS-------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHL 284 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~-------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl 284 (348)
|||||++|+|.++|+.. .+++.||+||| +.+||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence 99999999999998642 14889999999 788999999999999999999999
Q ss_pred eecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 285 SDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 285 ~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
+|||+|+...............||+.||| +|||||||++|||+| |+.||....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999998765444444455678999998 899999999999999 899997643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=336.90 Aligned_cols=179 Identities=25% Similarity=0.363 Sum_probs=157.8
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeec---cCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ---CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
.++|+..+.||+|+||+||+|+.. +++.||||.+... .....+.+.+|+++|++++|||||++++++.+++..|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 357999999999999999999965 7889999999643 233456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 231 LEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
||||++|+|.++++... +++.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999987532 3888999999 78999999999999999999999999999998765444
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.......+||+.||| +||||+||++|||+||+.||...
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 237 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 344567789999998 89999999999999999999753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=341.09 Aligned_cols=178 Identities=26% Similarity=0.470 Sum_probs=145.3
Q ss_pred CCCccccccccCCcceEEEeEec------CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
++|...+.||+|+||+||+|+++ +++.||||.++.......+.|.+|+++|++++|||||+++++|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35666788999999999999864 478899999976555556789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch---------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcE
Q 038351 230 VLEYMPRGSLEKCLYSS---------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVT 282 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~---------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ 282 (348)
|||||++|+|.++++.. .+++.||+||| +.+||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence 99999999999988642 13889999999 7889999999999999999999
Q ss_pred EEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 283 HLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 283 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
||+|||+|+...............||+.||| +|||||||++|||+| |+.||...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~ 264 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL 264 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC
Confidence 9999999998765444444456789999998 999999999999999 89999764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=338.76 Aligned_cols=176 Identities=23% Similarity=0.275 Sum_probs=157.0
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
..|+..+.||+|+||+||+|+.. +++.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45888899999999999999975 68999999998766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeec
Q 038351 235 PRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303 (348)
Q Consensus 235 ~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 303 (348)
++|+|.+++... .+++.||+||| +.+||||||||+|||++.++.+||+|||+|+.+..... ...
T Consensus 154 ~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~ 228 (346)
T 4fih_A 154 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRK 228 (346)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBC
T ss_pred CCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--ccc
Confidence 999999988643 24888999999 78999999999999999999999999999998754332 235
Q ss_pred ccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 304 QTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 304 ~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..+||+.||| +||||+||++|||+||+.||...
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 273 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 273 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 6789999998 89999999999999999999653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=334.44 Aligned_cols=177 Identities=21% Similarity=0.356 Sum_probs=151.4
Q ss_pred CccccccccCCcceEEEeEec------CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 158 FSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
++..+.||+|+||+||+|++. +++.||||+++.... ...+.|.+|+.++++++|||||+++|+|..++..+||
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 445578999999999999863 467899999965433 3346799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhch----------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcE
Q 038351 231 LEYMPRGSLEKCLYSS----------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVT 282 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~----------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ 282 (348)
||||++|+|.++|+.. .+++.||+||| +.+||||||||+|||+++++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCCE
Confidence 9999999999998532 24899999999 7889999999999999999999
Q ss_pred EEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 283 HLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 283 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
||+|||+|+.+.............||+.||| +|||||||++|||+| |+.||....
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 9999999998765444444456789999998 999999999999999 899997643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=339.12 Aligned_cols=176 Identities=22% Similarity=0.324 Sum_probs=147.9
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
++|+..+.||+|+||+||+|+.. +++.||||.+..... ...+.+.+|++++++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57889999999999999999965 689999999975432 234678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 233 YMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 233 y~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
||++|+|.+++... .+++.||+||| +.+||||||||+|||++.++.+||+|||+|+.+.....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 99999999998532 13788999999 78999999999999999999999999999997643221
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....+||+.||| +||||+||++|||+||+.||...
T Consensus 181 --~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 228 (350)
T 4b9d_A 181 --LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228 (350)
T ss_dssp --HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred --cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 2245679999998 99999999999999999999754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=332.02 Aligned_cols=175 Identities=27% Similarity=0.421 Sum_probs=143.4
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
+++...+.||+|+||+||+|++++ .||||.++.... ...+.|.+|++++++++|||||+++++|.. +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 456677899999999999998764 589998864432 234679999999999999999999998864 568999999
Q ss_pred cCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 234 MPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 234 ~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
|++|+|.++|+.. .+++.||+||| +.+||||||||+|||+++++.+||+|||+|+.........
T Consensus 113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999998643 24889999999 7889999999999999999999999999998765433333
Q ss_pred eecccccccCccc---------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 301 IQTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....+||+.||| +|||||||++|||+||+.||...
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~ 240 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI 240 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC
Confidence 3456789999998 79999999999999999999764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=340.97 Aligned_cols=176 Identities=23% Similarity=0.275 Sum_probs=157.3
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
..|+..+.||+|+||.||+|+.. +++.||||++........+.+.+|+++|++++|||||+++++|.+++..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 46888999999999999999975 68999999998766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeec
Q 038351 235 PRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303 (348)
Q Consensus 235 ~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 303 (348)
++|+|.++++.. .+++.||+||| +.+||||||||+|||++.++.+||+|||+|+.+..... ...
T Consensus 231 ~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~ 305 (423)
T 4fie_A 231 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRK 305 (423)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBC
T ss_pred CCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--ccc
Confidence 999999988643 24888999999 78999999999999999999999999999998754332 235
Q ss_pred ccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 304 QTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 304 ~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..+||+.||| +|||||||++|||++|+.||...
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 350 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 350 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 6789999998 89999999999999999999653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=329.23 Aligned_cols=175 Identities=22% Similarity=0.278 Sum_probs=147.7
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
.+.|...+.||+|+||+||+|+.. +++.||||.++.. ....+|++++++++|||||++++++.+++..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~-----~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT-----TCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHH-----HhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 345777889999999999999975 6889999999753 2235799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCC-cEEEeecCCccccccCCce-
Q 038351 234 MPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI-VTHLSDFGIAKLLIREDHF- 299 (348)
Q Consensus 234 ~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DfGla~~~~~~~~~- 299 (348)
|++|+|.++++... +++.||+||| +.+||||||||+|||++.++ .+||+|||+|+.+......
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999999987532 3888999999 88999999999999999987 6999999999987543221
Q ss_pred --eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 300 --MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 300 --~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
......+||+.||| +|||||||++|||+||+.||....
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 260 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 12234679999998 899999999999999999997643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=327.48 Aligned_cols=176 Identities=26% Similarity=0.376 Sum_probs=145.3
Q ss_pred CCCccccccccCCcceEEEeEec----CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ----DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
++|+..+.||+|+||+||+|+.. +++.||+|.++... ......+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57899999999999999999853 46789999986432 2234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 230 VLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
|||||++|+|.+++.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+|+......
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 999999999999987532 3888999999 7899999999999999999999999999998764322
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. .....+||+.||| +||||+||++|||+||+.||...
T Consensus 181 ~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 181 K--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 2 2346789999998 89999999999999999999753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=321.73 Aligned_cols=170 Identities=26% Similarity=0.365 Sum_probs=144.2
Q ss_pred ccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEec----CCeEEEEE
Q 038351 159 SEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSN----EDFKVLVL 231 (348)
Q Consensus 159 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~ 231 (348)
...+.||+|+||+||+|+.. ++..||+|.+..... ...+.|.+|++++++++|||||+++++|.+ ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999975 688999999965432 234678999999999999999999999865 35689999
Q ss_pred eccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCc--eEecCCCcCceEEcC-CCcEEEeecCCccccccC
Q 038351 232 EYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVL--IIHYDLKPSNVLFDD-NIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~--iiHrDik~~NILld~-~~~~kl~DfGla~~~~~~ 296 (348)
|||++|+|.++++... +++.||+||| +.+ ||||||||+|||++. ++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 9999999999987532 4888999999 555 999999999999984 799999999999865332
Q ss_pred CceeeecccccccCccc-----------cccHHHHHHHHHHHcCCCCCcc
Q 038351 297 DHFMIQTQTLATIGYMA-----------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~a-----------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.....+||+.||| +|||||||++|||+||+.||..
T Consensus 186 ----~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~ 231 (290)
T 3fpq_A 186 ----FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp ----SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ----ccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2245789999998 8999999999999999999965
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=317.70 Aligned_cols=174 Identities=22% Similarity=0.382 Sum_probs=138.9
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||+||+|+.. +++.||+|.+.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999864 78999999996442 223456899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||| +|+|.+.+.... +++.||+||| +.+|+||||||+|||+++++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-- 166 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC--
Confidence 999 689998886532 4888999999 7899999999999999999999999999998764322
Q ss_pred eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....+||+.||| +||||+||++|||+||+.||+..
T Consensus 167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 2345789999998 89999999999999999999764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=319.59 Aligned_cols=177 Identities=23% Similarity=0.266 Sum_probs=141.9
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCC----eEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNED----FKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~ 231 (348)
.+|...+.||+|+||+||+|++ +++.||||++..... ....++.|+..+.+++|||||+++++|..++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3466778999999999999998 578999999864322 1123455777788999999999999998654 579999
Q ss_pred eccCCCCHHHHHhch-----------hHHHHHHHHHHhc-----CCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 232 EYMPRGSLEKCLYSS-----------NYVGFALEYLHFD-----YSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~-----~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
|||++|+|.++++.. .+++.||+|||.. +.++||||||||+|||+|.++.+||+|||+|+....
T Consensus 81 Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 999999999998753 2488999999954 345999999999999999999999999999988754
Q ss_pred CCcee--eecccccccCccc------------------cccHHHHHHHHHHHcCCCCCc
Q 038351 296 EDHFM--IQTQTLATIGYMA------------------SYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 296 ~~~~~--~~~~~~gt~~y~a------------------sDV~S~Gvvl~elltG~~P~~ 334 (348)
..... .....+||+.||| +|||||||++|||+||++||.
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 43321 2234679999997 699999999999999988764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=324.41 Aligned_cols=179 Identities=22% Similarity=0.388 Sum_probs=153.0
Q ss_pred CCCccccccccCCcceEEEeEecC------CceEEEEeeeeccC-ccchhhHHHhhhcccccc-cceeeEEEEEecC-Ce
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQD------RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCY-RNLIKIISSRSNE-DF 226 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~-~~ 226 (348)
++|+..+.||+|+||+||+|++.. ++.||||.+..... ...+.|.+|+++|++++| ||||+++++|..+ +.
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~ 143 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 143 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence 567888999999999999998643 36799999865433 234679999999999976 8999999999764 56
Q ss_pred EEEEEeccCCCCHHHHHhch----------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC
Q 038351 227 KVLVLEYMPRGSLEKCLYSS----------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD 278 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~----------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~ 278 (348)
.+||||||++|+|.++|+.. .+++.||+||| +.+||||||||+|||+++
T Consensus 144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE 220 (353)
T ss_dssp CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccceeeCC
Confidence 89999999999999998642 14889999999 789999999999999999
Q ss_pred CCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 279 NIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 279 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
++.+||+|||+|+.+..+..........||+.||| +|||||||++|||+| |+.||....
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999998766555555567789999998 999999999999998 999997643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=310.45 Aligned_cols=175 Identities=22% Similarity=0.414 Sum_probs=137.6
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc-cchhhHHHhhhcccccccceeeEEEEEecCC-------
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG-AFKSFDFECDVMKSTCYRNLIKIISSRSNED------- 225 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------- 225 (348)
.++|+..+.||+|+||+||+|+.. +++.||||+++..... ..+.+.+|+++|++++|||||++++++...+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 346888999999999999999975 7889999999755432 3467889999999999999999999987544
Q ss_pred -----eEEEEEeccCCCCHHHHHhch---------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEe
Q 038351 226 -----FKVLVLEYMPRGSLEKCLYSS---------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLS 285 (348)
Q Consensus 226 -----~~~lV~Ey~~~gsL~~~l~~~---------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~ 285 (348)
..|+|||||++|+|.+++... .+++.||+||| +.+||||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEc
Confidence 379999999999999988642 14788999999 7899999999999999999999999
Q ss_pred ecCCccccccCCce----------eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 286 DFGIAKLLIREDHF----------MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 286 DfGla~~~~~~~~~----------~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
|||+|+.+...... ...+..+||+.||| +|||||||++|||++ ||..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 99999987543221 11234679999998 899999999999997 7754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=324.71 Aligned_cols=176 Identities=23% Similarity=0.346 Sum_probs=150.1
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHH---HhhhcccccccceeeEEEEEecCCeE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDF---ECDVMKSTCYRNLIKIISSRSNEDFK 227 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~ 227 (348)
.++|+..++||+|+||+||+|+.. +++.||+|.+.... ........+ ++++++.++|||||+++++|.+++..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999975 68899999996432 122223333 46677888999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 228 VLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
|+|||||++|+|.++|.... +|+.||+||| +.+||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999987532 3788999999 89999999999999999999999999999988754
Q ss_pred CCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 296 EDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
.. ..+.+||+.||| +||||+||++|||+||++||....
T Consensus 345 ~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~ 395 (689)
T 3v5w_A 345 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395 (689)
T ss_dssp CC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred CC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 245789999998 899999999999999999997643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=311.31 Aligned_cols=177 Identities=26% Similarity=0.320 Sum_probs=148.0
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEec------CC
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSN------ED 225 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~ 225 (348)
.++|+..+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999975 789999999964432 234568899999999999999999998764 36
Q ss_pred eEEEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
..|||||||+ |+|.+++.... +++.||+||| +.+||||||||+|||++.++.+||+|||+|+.+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 7899999996 68999887532 4888999999 789999999999999999999999999999876
Q ss_pred ccCCc--eeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 294 IREDH--FMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 294 ~~~~~--~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
..... .......+||+.||| +||||+||++|||+||++||..
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g 265 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 265 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC
Confidence 43221 122346789999998 8999999999999999999965
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=304.47 Aligned_cols=179 Identities=23% Similarity=0.280 Sum_probs=148.7
Q ss_pred HhhhCCCccccccccCCcceEEEeEec----CCceEEEEeeeeccCccchhhHHHhhhcccc-cccceeeEEEEEecCCe
Q 038351 152 CRVTNGFSEDNLISRGGFGSIHKARIQ----DRMEFSVKGFHLQCSGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDF 226 (348)
Q Consensus 152 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 226 (348)
....+.|+..+.||+|+||+||+|+.+ .++.||+|.+... .....+.+|+++|+.+ +||||+++++++..+++
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 346688999999999999999999853 4678999988543 2345688999999988 59999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhch---------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCC-CcEEEeecCCccccccC
Q 038351 227 KVLVLEYMPRGSLEKCLYSS---------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN-IVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~---------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DfGla~~~~~~ 296 (348)
.++|||||++|+|.++++.- .+++.||+||| +.+|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 99999999999999988642 24888999999 8899999999999999876 79999999999865432
Q ss_pred Cc--------------------------eeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 297 DH--------------------------FMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 297 ~~--------------------------~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.. ....+..+||+.|+| +||||+||++|||+||+.||..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 11 011234579999998 7999999999999999999854
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=316.90 Aligned_cols=176 Identities=20% Similarity=0.295 Sum_probs=154.5
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
.++|+..+.||+|+||.||+|+.+ +++.||+|.+........+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999875 7889999999765444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCC--CcEEEeecCCccccccCCc
Q 038351 234 MPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN--IVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 234 ~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~--~~~kl~DfGla~~~~~~~~ 298 (348)
|++|+|.+++... .+++.||+||| +.+|+||||||+|||++.+ +.+||+|||+|+.+.....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 9999999988643 23788999999 7899999999999999854 8999999999998754432
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....+||+.||| +||||+||++|||++|++||...
T Consensus 313 ---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~ 359 (573)
T 3uto_A 313 ---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 359 (573)
T ss_dssp ---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 245689999998 89999999999999999999753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=279.48 Aligned_cols=186 Identities=31% Similarity=0.511 Sum_probs=160.9
Q ss_pred hhHHhhhCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEE
Q 038351 149 LELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 149 ~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 228 (348)
.++..++++|+..+.||+|+||.||+|+.+++..||+|++........+.+.+|++++++++||||+++++++...+..+
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 45667889999999999999999999998889999999987665555678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 229 LVLEYMPRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
+||||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 999999999998887532 23788999999 78999999999999999999999999999987
Q ss_pred cccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 293 LIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
..............||+.|+| +|||||||++|||+||+.||....
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~ 245 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence 543333223344567888887 899999999999999999997643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=280.50 Aligned_cols=183 Identities=22% Similarity=0.324 Sum_probs=154.8
Q ss_pred hhhHHhhhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecC
Q 038351 148 CLELCRVTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNE 224 (348)
Q Consensus 148 ~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 224 (348)
|.+.....++|...+.||+|+||.||+|+. .+++.||||.+..... ...+.+.+|++++++++||||+++++++...
T Consensus 7 ~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 86 (328)
T 3fe3_A 7 CADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE 86 (328)
T ss_dssp ----CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ccccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 344455567899999999999999999997 5789999999965432 2345688999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 225 DFKVLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 225 ~~~~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
+..++||||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNE 163 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence 9999999999999999988543 24888999999 78999999999999999999999999999987
Q ss_pred cccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 293 LIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...... ....+||+.|+| +||||+||++|||+||+.||+..
T Consensus 164 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 217 (328)
T 3fe3_A 164 FTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217 (328)
T ss_dssp GSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 654322 245678888876 89999999999999999999764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=275.29 Aligned_cols=188 Identities=33% Similarity=0.538 Sum_probs=161.5
Q ss_pred cchhhHHhhhCCCccccccccCCcceEEEeEecCCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecC
Q 038351 146 FSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNE 224 (348)
Q Consensus 146 ~~~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 224 (348)
|+..++...+++|+..+.||+|+||.||+|+..+++.||||.+..... .....+.+|++++++++||||+++++++...
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 455788889999999999999999999999988899999999865432 2345789999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecC
Q 038351 225 DFKVLVLEYMPRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFG 288 (348)
Q Consensus 225 ~~~~lV~Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfG 288 (348)
+..++||||+++|+|.++++.. .+++.||+|||..+..+|+||||||+||+++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 9999999999999999998653 137889999996666699999999999999999999999999
Q ss_pred CccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCc
Q 038351 289 IAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 289 la~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~ 334 (348)
+++....... .......||+.|+| +|||||||++|||+||+.||+
T Consensus 180 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 180 LAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp SCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 9987653322 22345568999987 899999999999999999996
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=288.94 Aligned_cols=183 Identities=21% Similarity=0.326 Sum_probs=155.8
Q ss_pred hHHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeec---cCccchhhHHHhhhcccccccceeeEEEEEecCC
Q 038351 150 ELCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ---CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNED 225 (348)
Q Consensus 150 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 225 (348)
++....++|+..++||+|+||+||+|+.. +++.||+|.+... .......+.+|..++..++||||++++++|.+++
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 34445678999999999999999999976 4788999998643 2233456889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
..++|||||++|+|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 999999999999999999752 13788999999 78899999999999999999999999999987
Q ss_pred cccCCceeeecccccccCccc-----------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 293 LIREDHFMIQTQTLATIGYMA-----------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~a-----------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...... ......+||+.|+| +|||||||++|||+||+.||...
T Consensus 225 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 284 (437)
T 4aw2_A 225 LMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284 (437)
T ss_dssp CCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence 654332 22344678998887 79999999999999999999653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=272.10 Aligned_cols=178 Identities=25% Similarity=0.332 Sum_probs=155.5
Q ss_pred hhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
..++|+..+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 346899999999999999999985 5788999999976665566778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 233 YMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 233 y~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
|+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 172 (297)
T 3fxz_A 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 172 (297)
T ss_dssp CCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred CCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--c
Confidence 99999999988642 24788999999 77999999999999999999999999999987654322 2
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....||+.|+| +|||||||++|||+||+.||...
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 219 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 345678888887 89999999999999999999653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=286.64 Aligned_cols=182 Identities=25% Similarity=0.366 Sum_probs=155.4
Q ss_pred HHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeec---cCccchhhHHHhhhcccccccceeeEEEEEecCCe
Q 038351 151 LCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ---CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDF 226 (348)
Q Consensus 151 ~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 226 (348)
+....++|...+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|+++++.++||||+++++++.+++.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3345678999999999999999999976 5788999998642 22344668899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 227 KVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
.++|||||++|+|.++++.. .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 99999999999999988642 23788999999 78999999999999999999999999999987654
Q ss_pred CCceeeecccccccCccc----------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 296 EDHFMIQTQTLATIGYMA----------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a----------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
... ......+||+.|+| +|||||||++|||+||+.||...
T Consensus 221 ~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 276 (410)
T 3v8s_A 221 EGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276 (410)
T ss_dssp TSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence 332 23346678998887 79999999999999999999653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=277.12 Aligned_cols=176 Identities=23% Similarity=0.303 Sum_probs=151.5
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeec---cCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ---CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||.||+|+.. +++.||+|.+... .......+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888999999999999999976 6889999999654 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+++|+|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 160 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-
Confidence 999999999888643 23788999999 78999999999999999999999999999986433222
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....+||+.|+| +|||||||++|||++|+.||...
T Consensus 161 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 208 (337)
T 1o6l_A 161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence 2245678888887 89999999999999999999653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=278.97 Aligned_cols=177 Identities=24% Similarity=0.305 Sum_probs=147.5
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeec---cCccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ---CSGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 229 (348)
.++|+..+.||+|+||.||+|+.. +++.||+|.+... .....+.+..|.++++.+ +||||+++++++...+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999975 6889999999753 223445678899999988 69999999999999999999
Q ss_pred EEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 230 VLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
|||||++|+|.+++.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 999999999998886532 3788999999 7899999999999999999999999999998643222
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......+||+.|+| +||||+||++|||+||+.||...
T Consensus 179 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 227 (353)
T 3txo_A 179 --VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence 22345679999998 89999999999999999999754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=283.53 Aligned_cols=183 Identities=22% Similarity=0.336 Sum_probs=155.6
Q ss_pred hHHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCC
Q 038351 150 ELCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNED 225 (348)
Q Consensus 150 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 225 (348)
+.....++|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|.+++.+++||||+++++++.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 33445678999999999999999999975 78899999996432 233466889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
..++|||||++|+|.+++.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence 9999999999999999986521 3788999999 78999999999999999999999999999987
Q ss_pred cccCCceeeecccccccCccc-------------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 293 LIREDHFMIQTQTLATIGYMA-------------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~a-------------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...... ......+||+.|+| +|||||||++|||+||+.||...
T Consensus 212 ~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 273 (412)
T 2vd5_A 212 LRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273 (412)
T ss_dssp CCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence 754332 12234678888876 69999999999999999999654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=278.01 Aligned_cols=180 Identities=26% Similarity=0.417 Sum_probs=150.5
Q ss_pred hCCCccccccccCCcceEEEeEec--------CCceEEEEeeeeccC-ccchhhHHHhhhcccc-cccceeeEEEEEecC
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ--------DRMEFSVKGFHLQCS-GAFKSFDFECDVMKST-CYRNLIKIISSRSNE 224 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 224 (348)
.++|...+.||+|+||.||+|+.. ++..||||.++.... ...+.+.+|+++++++ +||||++++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 356788899999999999999852 456799999864422 2346789999999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhch----------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEE
Q 038351 225 DFKVLVLEYMPRGSLEKCLYSS----------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLF 276 (348)
Q Consensus 225 ~~~~lV~Ey~~~gsL~~~l~~~----------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILl 276 (348)
+..++||||+++|+|.+++... .+++.||+||| +.+|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence 9999999999999999998642 24888999999 7899999999999999
Q ss_pred cCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 277 DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 277 d~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
+.++.+||+|||+++...............+|+.|+| +|||||||++|||+| |+.||....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999987654333222334456777887 899999999999999 999997643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=272.52 Aligned_cols=177 Identities=24% Similarity=0.338 Sum_probs=148.5
Q ss_pred hCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCC----eEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNED----FKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV 230 (348)
.++|+..+.||+|+||.||+|+.. ++.||||.+..... ....+..|+.++++++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 457888999999999999999876 68999999864432 2345667999999999999999999998754 46999
Q ss_pred EeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCC----------ceEecCCCcCceEEcCCCcEEEeecCC
Q 038351 231 LEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSV----------LIIHYDLKPSNVLFDDNIVTHLSDFGI 289 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~----------~iiHrDik~~NILld~~~~~kl~DfGl 289 (348)
|||+++|+|.++++.. .+++.||+||| +. +|+||||||+||+++.++.+||+|||+
T Consensus 101 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 9999999999998653 24888999999 66 999999999999999999999999999
Q ss_pred ccccccCCceeeecccccccCccc-----------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 290 AKLLIREDHFMIQTQTLATIGYMA-----------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 290 a~~~~~~~~~~~~~~~~gt~~y~a-----------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
++...............||+.|+| +|||||||++|||+||+.||+..
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 987755443333344678888887 49999999999999999999754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=280.72 Aligned_cols=176 Identities=23% Similarity=0.345 Sum_probs=149.6
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 229 (348)
.++|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|..++.++ +||||+++++++..++..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357888999999999999999976 57889999997543 22345678899999887 79999999999999999999
Q ss_pred EEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 230 VLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
||||+++|+|..++.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 999999999998886532 3788999999 7899999999999999999999999999998643222
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
. .....+||+.|+| +|||||||++|||++|+.||+.
T Consensus 208 ~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 208 D--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp C--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred C--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 2 2346789999997 8999999999999999999964
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=276.47 Aligned_cols=177 Identities=19% Similarity=0.177 Sum_probs=148.3
Q ss_pred hhCCCccccccccCCcceEEEeE------ecCCceEEEEeeeeccCccchhhHHHhhhccccc---ccceeeEEEEEecC
Q 038351 154 VTNGFSEDNLISRGGFGSIHKAR------IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC---YRNLIKIISSRSNE 224 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~ 224 (348)
..++|...+.||+|+||.||+|+ ..+++.||+|.+... ....+..|++++.+++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45678889999999999999994 456889999998643 3456777777777666 99999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhch-----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC---------
Q 038351 225 DFKVLVLEYMPRGSLEKCLYSS-----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD--------- 278 (348)
Q Consensus 225 ~~~~lV~Ey~~~gsL~~~l~~~-----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~--------- 278 (348)
+..++|||||++|+|.+++... .+++.||+||| +.+|+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccc
Confidence 9999999999999999998631 13888999999 889999999999999998
Q ss_pred --CCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 279 --NIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 279 --~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
++.+||+|||+|+.+.............||+.|+| +|||||||++|||+||+.||...
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 89999999999987643333334456779999998 89999999999999999998654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=270.64 Aligned_cols=173 Identities=27% Similarity=0.372 Sum_probs=150.9
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57888999999999999999975 68899999996542 234466788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 999999999998653 23788999999 889999999999999999999999999999876432
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....+||+.|+| +||||+||++|||++|+.||...
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 206 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 206 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 234678999987 89999999999999999999653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=269.96 Aligned_cols=174 Identities=23% Similarity=0.283 Sum_probs=151.8
Q ss_pred CccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 158 FSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
|+..+.||+|+||.||+|+.. +++.||||.+........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 566678999999999999976 7899999999766555667789999999999999999999999999999999999999
Q ss_pred CCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeeccc
Q 038351 237 GSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT 305 (348)
Q Consensus 237 gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~ 305 (348)
++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... .....
T Consensus 127 ~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~ 201 (321)
T 2c30_A 127 GALTDIVSQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSL 201 (321)
T ss_dssp CBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCC
T ss_pred CCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccc
Confidence 9999988642 24888999999 77999999999999999999999999999987654322 22455
Q ss_pred ccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 306 LATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 306 ~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.||+.|+| +|||||||++|||+||+.||...
T Consensus 202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~ 244 (321)
T 2c30_A 202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244 (321)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 78888887 89999999999999999999653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=272.34 Aligned_cols=181 Identities=23% Similarity=0.345 Sum_probs=152.8
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
..++|+..+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3568999999999999999999876 788999999864432 23467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.+......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999998887643 24888999999 789999999999999999999999999999876543333
Q ss_pred eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 300 MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 300 ~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
.......||+.|+| +|||||||++|||+||+.||+...
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 33345678888876 899999999999999999997543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=274.24 Aligned_cols=179 Identities=23% Similarity=0.346 Sum_probs=151.8
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccc-cccceeeEEEEEecCCeE
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFK 227 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 227 (348)
...++|...+.||+|+||.||+|+.. +++.||+|.++... ....+.+..|.+++.++ +||||+++++++...+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999976 68899999997542 23446678899999877 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 228 VLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
++||||+++|+|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 9999999999999988652 23788999999 78999999999999999999999999999986532
Q ss_pred CCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 296 EDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
... .....+||+.|+| +||||+||++|||++|+.||...
T Consensus 171 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (345)
T 1xjd_A 171 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221 (345)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence 221 2345678999987 89999999999999999999753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=273.70 Aligned_cols=178 Identities=22% Similarity=0.340 Sum_probs=152.9
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc------cchhhHHHhhhcccccccceeeEEEEEecCC
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG------AFKSFDFECDVMKSTCYRNLIKIISSRSNED 225 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 225 (348)
...+.|...+.||+|+||.||+|+.. ++..||+|.+...... ..+.+.+|++++++++||||+++++++...+
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 34567899999999999999999976 6889999999754322 2356889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC----cEEEeecCC
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI----VTHLSDFGI 289 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~----~~kl~DfGl 289 (348)
..++||||+++|+|.+++... .+++.||+||| +.+|+||||||+||++++++ .+||+|||+
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 999999999999999998653 23888999999 78999999999999998877 799999999
Q ss_pred ccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 290 AKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 290 a~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
++....... .....||+.|+| +||||+||++|||++|+.||...
T Consensus 166 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~ 221 (361)
T 2yab_A 166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (361)
T ss_dssp CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 987654322 245678999987 89999999999999999999653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=277.28 Aligned_cols=175 Identities=26% Similarity=0.387 Sum_probs=150.8
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|...+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888899999999999999876 57889999986432 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+++|+|.+++.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 170 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ- 170 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc-
Confidence 9999999999887532 3788999999 78999999999999999999999999999987643322
Q ss_pred eeecccccccCccc---------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....||+.|+| +|||||||++|||+||+.||...
T Consensus 171 --~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 171 --ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp --BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred --eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 245567877776 79999999999999999999743
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=267.37 Aligned_cols=180 Identities=25% Similarity=0.366 Sum_probs=151.7
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
.++|...+.||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++||||+++++++..++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 356788899999999999999975 6889999988655445567799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 234 MPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 234 ~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
+++|+|.++++.. .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999998752 23888999999 7889999999999999999999999999998764322211
Q ss_pred ------------eecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 301 ------------IQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 301 ------------~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
......||+.|+| +|||||||++|||++|..|+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 1114568888887 899999999999999999987643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=265.50 Aligned_cols=178 Identities=25% Similarity=0.413 Sum_probs=146.9
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc---cchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG---AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
.++|+..+.||+|+||.||+|+.. ++..||+|.+...... ..+.+.+|+.++++++||||+++++++..++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467889999999999999999865 6889999998644322 235688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 231 LEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
|||+++++|.+++.... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999999999886532 3788999999 78899999999999999999999999999987643221
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.......||+.|+| +||||+||++|||+||+.||+..
T Consensus 167 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 215 (294)
T 4eqm_A 167 -TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred -cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 12234568888887 89999999999999999999754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=273.39 Aligned_cols=175 Identities=23% Similarity=0.348 Sum_probs=149.7
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc---cchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG---AFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 230 (348)
++|...+.||+|+||.||+|+.. +++.||+|.+...... ..+.+.+|..++.++ +||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888899999999999999976 6889999999754322 235578899999887 899999999999999999999
Q ss_pred EeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 231 LEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
|||+++|+|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 9999999999888643 13788999999 78999999999999999999999999999986432221
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.....+||+.|+| +||||+||++|||++|+.||+.
T Consensus 166 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 166 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred --cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 2345678999987 8999999999999999999964
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=263.01 Aligned_cols=188 Identities=33% Similarity=0.502 Sum_probs=159.7
Q ss_pred cchhhHHhhhCCCccc------cccccCCcceEEEeEecCCceEEEEeeeecc----CccchhhHHHhhhccccccccee
Q 038351 146 FSCLELCRVTNGFSED------NLISRGGFGSIHKARIQDRMEFSVKGFHLQC----SGAFKSFDFECDVMKSTCYRNLI 215 (348)
Q Consensus 146 ~~~~~~~~~~~~f~~~------~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv 215 (348)
|...++..++++|+.. +.||+|+||.||+|+. ++..||+|.+.... ....+.+.+|++++++++||||+
T Consensus 15 ~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 93 (307)
T 2nru_A 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93 (307)
T ss_dssp CCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeE
Confidence 4557888999999887 8999999999999987 57789999986432 12346688999999999999999
Q ss_pred eEEEEEecCCeEEEEEeccCCCCHHHHHhch---------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC
Q 038351 216 KIISSRSNEDFKVLVLEYMPRGSLEKCLYSS---------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI 280 (348)
Q Consensus 216 ~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~---------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~ 280 (348)
++++++...+..++||||+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~ 170 (307)
T 2nru_A 94 ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAF 170 (307)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTC
T ss_pred EEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcCCC
Confidence 9999999999999999999999999988632 13788999999 78999999999999999999
Q ss_pred cEEEeecCCccccccCCceeeecccccccCccc-----------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 281 VTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA-----------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 281 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a-----------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
.+||+|||+++...............||+.|+| +|||||||++|||+||+.||+...
T Consensus 171 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred cEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 999999999987654333333345568888887 899999999999999999997643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=272.72 Aligned_cols=177 Identities=23% Similarity=0.284 Sum_probs=151.6
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 229 (348)
.++|...+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|.+++..+ +||+|+++++++...+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467889999999999999999976 47889999997542 23446678899999888 79999999999999999999
Q ss_pred EEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 230 VLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
||||+++|+|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 99999999999988642 23888999999 7899999999999999999999999999998643222
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. .....+||+.|+| +|||||||++|||++|+.||...
T Consensus 176 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 176 V--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 1 2345678999987 89999999999999999999753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=273.83 Aligned_cols=177 Identities=28% Similarity=0.349 Sum_probs=143.2
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhh-cccccccceeeEEEEEecCCeEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDV-MKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
.++|...+.||+|+||.||+|+.. ++..||+|.+..... .....+..|..+ ++.++||||+++++++...+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 457889999999999999999976 578899999965432 233456677776 678899999999999999999999
Q ss_pred EEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 230 VLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
||||+++|+|.+++.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 999999999999886532 3788999999 7899999999999999999999999999998643322
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. .....+||+.|+| +|||||||++|||++|+.||...
T Consensus 194 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 242 (373)
T 2r5t_A 194 S--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242 (373)
T ss_dssp C--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred C--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 1 2345679999987 89999999999999999999653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-34 Score=264.51 Aligned_cols=176 Identities=24% Similarity=0.324 Sum_probs=135.6
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.++|+..+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467899999999999999999865 688999999975433 344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhchh------------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 233 YMPRGSLEKCLYSSN------------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 233 y~~~gsL~~~l~~~~------------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
|++ |+|.+++.... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59988875431 4888999999 7899999999999999999999999999998764
Q ss_pred cCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.... ......+|+.|+| +|||||||++|||+||+.||...
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3221 1233456777776 89999999999999999999653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=271.32 Aligned_cols=174 Identities=22% Similarity=0.297 Sum_probs=151.5
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
.++|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 357888999999999999999975 68899999986442 23446788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 231 LEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
|||+++|+|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 9999999999988652 23788999999 789999999999999999999999999999876432
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....+||+.|+| +|||||||++|||++|+.||...
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 241 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence 234578888887 89999999999999999999653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=266.23 Aligned_cols=176 Identities=29% Similarity=0.419 Sum_probs=141.4
Q ss_pred hCCCccccccccCCcceEEEeEecCCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.++|+..+.||+|+||.||+|+. ++..||||.+..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 45788889999999999999987 577899999865432 223568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhchh---------------HHHHHHHHHHhcCCCc--eEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 233 YMPRGSLEKCLYSSN---------------YVGFALEYLHFDYSVL--IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 233 y~~~gsL~~~l~~~~---------------~i~~~L~yLH~~~~~~--iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
|+++|+|.+++.... +++.||+||| +.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999999999886532 3788999999 677 99999999999999999999999999986543
Q ss_pred CCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 296 EDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.. .......||+.|+| +|||||||++|||+||+.||...
T Consensus 192 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~ 242 (309)
T 3p86_A 192 TF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred cc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 21 12344568888887 89999999999999999999764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=270.29 Aligned_cols=177 Identities=24% Similarity=0.355 Sum_probs=141.8
Q ss_pred hCCCccccccccCCcceEEEeEe----cCCceEEEEeeeecc----CccchhhHHHhhhcccccccceeeEEEEEecCCe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARI----QDRMEFSVKGFHLQC----SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDF 226 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 226 (348)
.++|+..+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|++++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35788899999999999999987 478899999986432 2234567889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 227 KVLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
.++||||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 99999999999999888643 13788999999 7799999999999999999999999999998653
Q ss_pred cCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.... ......||+.|+| +|||||||++|||++|+.||...
T Consensus 173 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 224 (327)
T 3a62_A 173 HDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence 3221 2245578888987 89999999999999999999754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=265.90 Aligned_cols=179 Identities=23% Similarity=0.322 Sum_probs=148.4
Q ss_pred hhhCCCccccccccCCcceEEEeEecCCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
...++|+..+.||+|+||.||+|+..+++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 35578999999999999999999998899999999864432 2246688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 231 LEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
|||+++ +|.+.+... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 999975 787776542 24888999999 7899999999999999999999999999998764322
Q ss_pred ceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 298 HFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
. ......+|+.|+| +||||+||++|||+||+.||....
T Consensus 174 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 224 (311)
T 3niz_A 174 R--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT 224 (311)
T ss_dssp C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence 1 2234456777776 899999999999999999997543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=275.54 Aligned_cols=180 Identities=24% Similarity=0.356 Sum_probs=149.2
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.++|...+.||+|+||.||+|+.. +++.||||.+..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 356778899999999999999986 788999999864322 234578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 233 YMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 233 y~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|+++|+|.++++... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 999999999886532 3788999999 788999999999999999999999999999865432111
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
.......+++.|+| +|||||||++|||+| |+.||....
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 11112234566776 899999999999999 999997643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=267.94 Aligned_cols=176 Identities=19% Similarity=0.321 Sum_probs=151.7
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
..++|...+.||+|+||.||+|+.. ++..+|+|.+.... .....+.+|+++++.++||||+++++++...+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 4578999999999999999999976 67889999886432 234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcC--CCcEEEeecCCccccccCC
Q 038351 233 YMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDD--NIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 233 y~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~--~~~~kl~DfGla~~~~~~~ 297 (348)
|+++|+|.+++.... +++.||+||| +.+|+||||||+||+++. ++.+||+|||+++......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 999999999986532 3888999999 789999999999999987 7899999999998875433
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. .....||+.|+| +|||||||++|||+||+.||...
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 206 (321)
T 1tki_A 159 N---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp E---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred c---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC
Confidence 2 234568888887 89999999999999999999654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=280.64 Aligned_cols=177 Identities=23% Similarity=0.297 Sum_probs=142.1
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeec---cCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ---CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
.++|+..+.||+|+||.||+|+.. ++..||+|.+... .......+.+|++++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 457889999999999999999865 6889999999653 223446678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhch------------hHHHHHHHHHHhcCC-CceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 231 LEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYS-VLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~-~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
||||++|+|.+++... .+++.||+||| + .+|+||||||+|||++.++.+||+|||+++......
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 9999999999888643 23888999999 5 789999999999999999999999999998653322
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. ......||+.|+| +|||||||++|||+||+.||...
T Consensus 304 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 352 (446)
T 4ejn_A 304 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 2 2345678999987 89999999999999999999654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=270.18 Aligned_cols=177 Identities=20% Similarity=0.294 Sum_probs=149.4
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc-----CccchhhHHHhhhcccccccceeeEEEEEecCCeE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC-----SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFK 227 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 227 (348)
..+.|...+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3457888999999999999999875 68899999986432 11346789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCc---EEEeecC
Q 038351 228 VLVLEYMPRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIV---THLSDFG 288 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~---~kl~DfG 288 (348)
++|||||++|+|.+.+... .+++.||+||| +.+|+||||||+||+++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999998776432 13788999999 789999999999999986554 9999999
Q ss_pred CccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 289 IAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 289 la~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
+++....... ......||+.|+| +|||||||++|||+||+.||..
T Consensus 179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (351)
T 3c0i_A 179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 235 (351)
T ss_dssp TCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred ceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence 9987754322 2244578889987 8999999999999999999965
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=265.83 Aligned_cols=177 Identities=21% Similarity=0.344 Sum_probs=151.5
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc------cchhhHHHhhhcccccccceeeEEEEEecCCe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG------AFKSFDFECDVMKSTCYRNLIKIISSRSNEDF 226 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 226 (348)
..+.|...+.||+|+||.||+|+.. ++..||+|.+...... ..+.+.+|++++++++||||+++++++...+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3456888999999999999999976 6889999998654322 24568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC----cEEEeecCCc
Q 038351 227 KVLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI----VTHLSDFGIA 290 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~----~~kl~DfGla 290 (348)
.++||||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++ .+||+|||++
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 99999999999999998643 23888999999 78999999999999999877 7999999999
Q ss_pred cccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 291 KLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+....... .....||+.|+| +|||||||++|||+||+.||...
T Consensus 166 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 220 (326)
T 2y0a_A 166 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220 (326)
T ss_dssp EECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred eECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 87653322 234568888887 89999999999999999999653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=265.23 Aligned_cols=179 Identities=21% Similarity=0.371 Sum_probs=147.2
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCC------
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNED------ 225 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 225 (348)
..++|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++...+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3467888999999999999999986 789999999975432 34567899999999999999999999986543
Q ss_pred ---------------------------------------------------eEEEEEeccCCCCHHHHHhch--------
Q 038351 226 ---------------------------------------------------FKVLVLEYMPRGSLEKCLYSS-------- 246 (348)
Q Consensus 226 ---------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~-------- 246 (348)
..++|||||++|+|.+++...
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 379999999999999987642
Q ss_pred -------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce----------eeeccccccc
Q 038351 247 -------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF----------MIQTQTLATI 309 (348)
Q Consensus 247 -------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~gt~ 309 (348)
.+++.||+||| +.+|+||||||+||+++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 24888999999 789999999999999999999999999999887543211 1223456888
Q ss_pred Cccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 310 GYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 310 ~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.|+| +|||||||++|||++|..|+..
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~ 278 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH
Confidence 8887 8999999999999999888643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=266.92 Aligned_cols=178 Identities=26% Similarity=0.448 Sum_probs=146.3
Q ss_pred CCCccccccccCCcceEEEeEec----CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ----DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
++|...+.||+|+||.||+|+.. .+..||||.+..... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 46778899999999999999974 345699999875422 2346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 231 LEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
|||+++|+|.++++... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 99999999999986432 3788999999 7889999999999999999999999999998765432
Q ss_pred ce-eeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 298 HF-MIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 298 ~~-~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.. .......+|+.|+| +|||||||++|||++ |+.||...
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 21 12223345667877 899999999999999 99999654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=271.19 Aligned_cols=171 Identities=22% Similarity=0.363 Sum_probs=142.4
Q ss_pred cccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCC
Q 038351 160 EDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGS 238 (348)
Q Consensus 160 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 238 (348)
..+.||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3578999999999999864 688999999976544455779999999999999999999999999999999999999999
Q ss_pred HHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEE--cCCCcEEEeecCCccccccCCceeeec
Q 038351 239 LEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLF--DDNIVTHLSDFGIAKLLIREDHFMIQT 303 (348)
Q Consensus 239 L~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILl--d~~~~~kl~DfGla~~~~~~~~~~~~~ 303 (348)
|.+++.... +++.||+||| +.+|+||||||+|||+ ++++.+||+|||+++....... ..
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~ 246 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LK 246 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cc
Confidence 988875432 4888999999 7889999999999999 5678999999999987754322 23
Q ss_pred ccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 304 QTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 304 ~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...||+.|+| +|||||||++|||+||+.||...
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 291 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 4568889987 89999999999999999999653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=268.57 Aligned_cols=176 Identities=25% Similarity=0.398 Sum_probs=150.0
Q ss_pred hCCCccccccccCCcceEEEeEe-cCCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
.++|...+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|+++++.++||||+++++++..++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46788999999999999999997 578899999986432 23346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 231 LEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
|||+ +|+|.+++... .+++.||+||| +.+|+||||||+||++++++.+||+|||+++.......
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 9999 78998877543 24888999999 67899999999999999999999999999987654322
Q ss_pred eeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 299 FMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
....+||+.|+| +|||||||++|||++|+.||+...
T Consensus 164 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 212 (336)
T 3h4j_B 164 ---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212 (336)
T ss_dssp ---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred ---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc
Confidence 234567888876 899999999999999999997653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=264.41 Aligned_cols=177 Identities=20% Similarity=0.240 Sum_probs=150.7
Q ss_pred hCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEEEe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.++|...+.||+|+||.||+|+. .+++.||||.+.... ..+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46789999999999999999996 578899999886442 346789999999999 89999999999999999999999
Q ss_pred ccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCc-----EEEeecCCccccc
Q 038351 233 YMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIV-----THLSDFGIAKLLI 294 (348)
Q Consensus 233 y~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~-----~kl~DfGla~~~~ 294 (348)
|+ +++|.+++... .+++.||+||| +.+|+||||||+||+++.++. +||+|||+++.+.
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 99999988742 23888999999 779999999999999998887 9999999998765
Q ss_pred cCCce-----eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 295 REDHF-----MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 295 ~~~~~-----~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
..... .......||+.|+| +|||||||++|||+||+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~ 221 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence 43221 11245678999987 899999999999999999998653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=256.00 Aligned_cols=177 Identities=25% Similarity=0.368 Sum_probs=151.7
Q ss_pred hCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
.++|+..+.||+|+||.||+|+.+++..||+|.+..... ..+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 457888899999999999999999988999999875432 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 235 PRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 235 ~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
++++|.+++.... +++.||+||| +.+|+||||||+||+++.++.++|+|||+++....... ..
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VS 161 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EE
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-hc
Confidence 9999999886532 3788999999 78999999999999999999999999999987654322 22
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.....+|+.|+| +||||||+++|||+| |+.||+..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence 234445667876 899999999999999 99999754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=271.97 Aligned_cols=177 Identities=20% Similarity=0.292 Sum_probs=152.0
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
..++|...+.||+|+||.||+|+.. ++..+|+|.+..........+.+|++++++++||||+++++++...+..++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 4567899999999999999999875 688899999875543445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcC--CCcEEEeecCCccccccCC
Q 038351 233 YMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDD--NIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 233 y~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~--~~~~kl~DfGla~~~~~~~ 297 (348)
|+++|+|.+++.... +++.||+||| +.+|+||||||+|||++. .+.+||+|||+++......
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 999999999886432 3888999999 789999999999999974 5789999999998875433
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. .....||+.|+| +|||||||++|||+||+.||...
T Consensus 206 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 253 (387)
T 1kob_A 206 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253 (387)
T ss_dssp C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred c---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC
Confidence 2 234468888987 89999999999999999999753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=261.56 Aligned_cols=175 Identities=23% Similarity=0.300 Sum_probs=145.3
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
++|...+.||+|+||.||+|+..+++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888899999999999999998899999999864432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 234 MPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 234 ~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
+++ +|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--
Confidence 975 888877642 24888999999 78999999999999999999999999999987642211
Q ss_pred eecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 301 IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......+|+.|+| +||||+||++|||+||+.||...
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1233456777766 89999999999999999999753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=266.47 Aligned_cols=185 Identities=24% Similarity=0.321 Sum_probs=151.3
Q ss_pred hhHHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeec-----cCccchhhHHHhhhcccccccceeeEEEEEe
Q 038351 149 LELCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ-----CSGAFKSFDFECDVMKSTCYRNLIKIISSRS 222 (348)
Q Consensus 149 ~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 222 (348)
.++....++|...+.||+|+||.||+|+.. ++..||+|.+... .....+.+.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 456677889999999999999999999875 6788999998643 2234567899999999999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHhc----------------------------------------------------hhHHH
Q 038351 223 NEDFKVLVLEYMPRGSLEKCLYS----------------------------------------------------SNYVG 250 (348)
Q Consensus 223 ~~~~~~lV~Ey~~~gsL~~~l~~----------------------------------------------------~~~i~ 250 (348)
..+..++||||+++|+|.+++.. ..+++
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 99999999999999999998841 12478
Q ss_pred HHHHHHHhcCCCceEecCCCcCceEEcCCC--cEEEeecCCccccccCCc--eeeecccccccCccc-------------
Q 038351 251 FALEYLHFDYSVLIIHYDLKPSNVLFDDNI--VTHLSDFGIAKLLIREDH--FMIQTQTLATIGYMA------------- 313 (348)
Q Consensus 251 ~~L~yLH~~~~~~iiHrDik~~NILld~~~--~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~a------------- 313 (348)
.||+||| +.+|+||||||+||+++.++ .+||+|||+++.+..... ........||+.|+|
T Consensus 179 ~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 179 SALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 8999999 77899999999999998766 899999999987643211 112234557777766
Q ss_pred -cccHHHHHHHHHHHcCCCCCccc
Q 038351 314 -SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 314 -sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+|||||||++|||+||+.||...
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~ 279 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGV 279 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCC
Confidence 89999999999999999999654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=271.18 Aligned_cols=178 Identities=20% Similarity=0.372 Sum_probs=151.3
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
...++|...+.||+|+||.||+|+.. ++..||+|.+..... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34567899999999999999999875 688999999975432 234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCC---CcEEEeecCCccccc
Q 038351 230 VLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN---IVTHLSDFGIAKLLI 294 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~---~~~kl~DfGla~~~~ 294 (348)
||||+++|+|.+.+... .+++.||+||| +.+|+||||||+||+++.+ +.+||+|||+++...
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 99999999999887643 24888999999 7799999999999999865 459999999998765
Q ss_pred cCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.... .....||+.|+| +|||||||++|||+||+.||...
T Consensus 183 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 233 (362)
T 2bdw_A 183 DSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233 (362)
T ss_dssp TCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 3322 234678999987 89999999999999999999653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=262.27 Aligned_cols=177 Identities=24% Similarity=0.363 Sum_probs=144.0
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--------------------------ccchhhHHHhhhcc
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--------------------------GAFKSFDFECDVMK 207 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 207 (348)
.++|...+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468899999999999999999865 688999999864321 12356889999999
Q ss_pred cccccceeeEEEEEec--CCeEEEEEeccCCCCHHHHHhc-----------hhHHHHHHHHHHhcCCCceEecCCCcCce
Q 038351 208 STCYRNLIKIISSRSN--EDFKVLVLEYMPRGSLEKCLYS-----------SNYVGFALEYLHFDYSVLIIHYDLKPSNV 274 (348)
Q Consensus 208 ~l~H~niv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~-----------~~~i~~~L~yLH~~~~~~iiHrDik~~NI 274 (348)
+++||||+++++++.. .+..++||||+++++|.+++.. ..+++.||+||| +.+|+||||||+||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNL 168 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHE
Confidence 9999999999999987 5689999999999988765432 234889999999 77899999999999
Q ss_pred EEcCCCcEEEeecCCccccccCCceeeecccccccCccc---------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 275 LFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 275 Lld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+++.++.+||+|||+++....... ......||+.|+| +|||||||++|||++|+.||...
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999999987654322 1234567777775 69999999999999999999753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-34 Score=269.01 Aligned_cols=176 Identities=22% Similarity=0.272 Sum_probs=142.2
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
..++|...+.||+|+||.||+++.. +++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 4568999999999999999999976 78899999986543 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCc--EEEeecCCccccccCCc
Q 038351 233 YMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIV--THLSDFGIAKLLIREDH 298 (348)
Q Consensus 233 y~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~--~kl~DfGla~~~~~~~~ 298 (348)
|+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++. +||+|||+++......
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~- 172 (361)
T 3uc3_A 97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 172 (361)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence 99999999988543 23888999999 788999999999999987765 9999999998543221
Q ss_pred eeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......||+.|+| +||||+||++|||++|+.||...
T Consensus 173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (361)
T 3uc3_A 173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP 221 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--
T ss_pred --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCC
Confidence 2234568888887 79999999999999999999753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=271.90 Aligned_cols=179 Identities=25% Similarity=0.443 Sum_probs=137.8
Q ss_pred hCCCccccccccCCcceEEEeEec----CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ----DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
.++|+..+.||+|+||.||+|+.. ++..||||.++.... ...+.|.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357888999999999999999865 577899999865422 234678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 230 VLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
||||+++|+|.++++... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 999999999999986532 3788999999 778999999999999999999999999999876543
Q ss_pred Ccee-eecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 297 DHFM-IQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 297 ~~~~-~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.... ......+++.|+| +|||||||++|||++ |+.||...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 2211 1112234567776 899999999999998 99999654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=265.67 Aligned_cols=180 Identities=24% Similarity=0.398 Sum_probs=151.7
Q ss_pred hCCCccccccccCCcceEEEeEe------cCCceEEEEeeeecc-CccchhhHHHhhhcccc-cccceeeEEEEEecCCe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARI------QDRMEFSVKGFHLQC-SGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDF 226 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 226 (348)
.++|...+.||+|+||.||+|+. .++..||+|.+.... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46788889999999999999986 246689999996442 23457789999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhch-----------------------------------hHHHHHHHHHHhcCCCceEecCCCc
Q 038351 227 KVLVLEYMPRGSLEKCLYSS-----------------------------------NYVGFALEYLHFDYSVLIIHYDLKP 271 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~-----------------------------------~~i~~~L~yLH~~~~~~iiHrDik~ 271 (348)
.++||||+++|+|.+++... .+++.||+||| +.+|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCh
Confidence 99999999999999988643 13788999999 78999999999
Q ss_pred CceEEcCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 272 SNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 272 ~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
+||+++.++.+||+|||+++...............+|+.|+| +|||||||++|||+| |+.||....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999999987765444334445567778887 899999999999998 999997653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=258.20 Aligned_cols=176 Identities=26% Similarity=0.405 Sum_probs=149.8
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
++|+..+.||+|+||.||+|+..++..||+|.+.... ...+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5678889999999999999999888899999987443 234678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeee
Q 038351 236 RGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302 (348)
Q Consensus 236 ~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 302 (348)
+++|.+++.... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS 164 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHST
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-cccc
Confidence 999999986432 3788999999 7889999999999999999999999999998764321 1122
Q ss_pred cccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 303 TQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 303 ~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
....+|+.|+| +||||+||++|||+| |+.||+..
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~ 211 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 33445666776 899999999999999 99999764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=283.48 Aligned_cols=176 Identities=24% Similarity=0.386 Sum_probs=152.9
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
.++|...+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467889999999999999999975 78899999996432 23345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 231 LEYMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
|||+++|+|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 9999999999988642 13788999999 779999999999999999999999999999877543
Q ss_pred CceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 297 DHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.. ....+||+.|+| +|||||||++|||+||+.||...
T Consensus 340 ~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 340 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp CC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred cc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 22 234579999998 89999999999999999999764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=263.11 Aligned_cols=178 Identities=22% Similarity=0.365 Sum_probs=145.2
Q ss_pred CCCccccccccCCcceEEEeEec-CCce----EEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRME----FSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
++|...+.||+|+||.||+|+.. ++.. ||+|.+.... ......+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57888899999999999999864 3443 7778775332 234567889999999999999999999986 456899
Q ss_pred EEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 230 VLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
||||+++|+|.+++.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 999999999999887532 3888999999 778999999999999999999999999999987554
Q ss_pred CceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 297 DHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
..........+|..|+| +|||||||++|||+| |+.||....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 43333345567778887 899999999999999 999997643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=277.65 Aligned_cols=177 Identities=24% Similarity=0.432 Sum_probs=149.4
Q ss_pred hhCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
..++|...+.||+|+||.||+|+.+++..||||.++... ...+.|.+|++++++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 345677889999999999999999988999999997543 34578999999999999999999999986 5678999999
Q ss_pred cCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 234 MPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 234 ~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|++|+|.++++... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-Y 339 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-H
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-e
Confidence 99999999987532 3788999999 7789999999999999999999999999998764321 1
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.......+++.|+| +|||||||++|||+| |+.||...
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~ 389 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 11223345667776 899999999999999 99999764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=265.10 Aligned_cols=180 Identities=23% Similarity=0.385 Sum_probs=142.5
Q ss_pred hhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCc---cchhhHHHhhhcccccccceeeEEEEEecCC----
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSG---AFKSFDFECDVMKSTCYRNLIKIISSRSNED---- 225 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 225 (348)
..++|+..+.||+|+||.||+|+. .+++.||+|.+...... ....+.+|++++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 356789999999999999999996 57889999999754322 2346889999999999999999999987654
Q ss_pred eEEEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
..++||||+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 349999999999999988643 23788999999 778999999999999999999999999999876
Q ss_pred ccCCce-eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 294 IREDHF-MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 294 ~~~~~~-~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...... .......||+.|+| +|||||||++|||+||+.||...
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 222 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 543221 12234568888987 89999999999999999999754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=270.98 Aligned_cols=182 Identities=22% Similarity=0.384 Sum_probs=151.4
Q ss_pred hhhCCCccccccccCCcceEEEeEe------cCCceEEEEeeeeccC-ccchhhHHHhhhcccc-cccceeeEEEEEecC
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARI------QDRMEFSVKGFHLQCS-GAFKSFDFECDVMKST-CYRNLIKIISSRSNE 224 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 224 (348)
...++|...+.||+|+||.||+|++ .+++.||||.+..... ...+.+.+|+++++++ +||||+++++++...
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 3467889999999999999999973 3567899999965432 2345689999999999 789999999999876
Q ss_pred C-eEEEEEeccCCCCHHHHHhchh--------------------------------------------------------
Q 038351 225 D-FKVLVLEYMPRGSLEKCLYSSN-------------------------------------------------------- 247 (348)
Q Consensus 225 ~-~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------------------------- 247 (348)
+ ..++||||+++|+|.++++...
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 5 4899999999999999886431
Q ss_pred ----------------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeeccc
Q 038351 248 ----------------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT 305 (348)
Q Consensus 248 ----------------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~ 305 (348)
+++.||+||| +.+|+||||||+||+++.++.+||+|||+++..............
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 4788999999 779999999999999999999999999999876554444444556
Q ss_pred ccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 306 LATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 306 ~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
.||+.|+| +|||||||++|||+| |+.||....
T Consensus 256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 67888887 899999999999999 999997643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=260.33 Aligned_cols=181 Identities=27% Similarity=0.413 Sum_probs=152.0
Q ss_pred hCCCccccccccCCcceEEEeEe------cCCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARI------QDRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFK 227 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 227 (348)
.++|...+.||+|+||.||+|+. .++..||+|.+..... ...+.+.+|++++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45788889999999999999985 2457899999864432 2346788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhch------------------------------------hHHHHHHHHHHhcCCCceEecCCCc
Q 038351 228 VLVLEYMPRGSLEKCLYSS------------------------------------NYVGFALEYLHFDYSVLIIHYDLKP 271 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~------------------------------------~~i~~~L~yLH~~~~~~iiHrDik~ 271 (348)
++||||+++|+|.+++... .+++.||+||| +.+|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence 9999999999999988642 13888999999 77899999999
Q ss_pred CceEEcCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccccc
Q 038351 272 SNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIFF 338 (348)
Q Consensus 272 ~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~~ 338 (348)
+||+++.++.+||+|||+++...............+|+.|+| +|||||||++|||+| |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987755443333344456777876 899999999999999 9999976543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=262.13 Aligned_cols=176 Identities=23% Similarity=0.345 Sum_probs=147.7
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCC--eEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNED--FKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV 230 (348)
.++|...+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 356888999999999999999976 58899999986543 233566889999999999999999999998765 78999
Q ss_pred EeccCCCCHHHHHhchh---------------HHHHHHHHHHhcCCCceEecCCCcCceEE----cCCCcEEEeecCCcc
Q 038351 231 LEYMPRGSLEKCLYSSN---------------YVGFALEYLHFDYSVLIIHYDLKPSNVLF----DDNIVTHLSDFGIAK 291 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~---------------~i~~~L~yLH~~~~~~iiHrDik~~NILl----d~~~~~kl~DfGla~ 291 (348)
|||+++++|.+++.... +++.||+||| +.+|+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999987532 3888999999 7899999999999999 788889999999998
Q ss_pred ccccCCceeeecccccccCccc--------------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 292 LLIREDHFMIQTQTLATIGYMA--------------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~a--------------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....... .....||+.|+| +|||||||++|||+||+.||...
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 226 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 7654332 123456666654 79999999999999999999753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=276.00 Aligned_cols=176 Identities=20% Similarity=0.351 Sum_probs=152.5
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
.++|...+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 457888999999999999999976 78999999996442 22345788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 231 LEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
|||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 9999999999988653 24888999999 88999999999999999999999999999987654321
Q ss_pred eeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....+||+.|+| +||||+||++|||++|+.||+..
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 219 (476)
T 2y94_A 172 ---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219 (476)
T ss_dssp ---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence 234568888876 89999999999999999999764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=276.06 Aligned_cols=179 Identities=18% Similarity=0.281 Sum_probs=150.4
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
...++|+..+.||+|+||.||+|+.. ++..+|+|.+..... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 45677899999999999999999864 788999999865432 234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEc---CCCcEEEeecCCccccc
Q 038351 230 VLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFD---DNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld---~~~~~kl~DfGla~~~~ 294 (348)
|||||++|+|.+.+... .+++.||+||| +.+|+||||||+|||++ +++.+||+|||+++...
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999998887643 24888999999 78999999999999998 46789999999998765
Q ss_pred cCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.... ......||+.|+| +||||+||++|||++|+.||...
T Consensus 165 ~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~ 216 (444)
T 3soa_A 165 GEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE 216 (444)
T ss_dssp TTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc
Confidence 4322 2245678999987 89999999999999999999653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=265.88 Aligned_cols=181 Identities=25% Similarity=0.405 Sum_probs=151.1
Q ss_pred hhhCCCccccccccCCcceEEEeEec------CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCC
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNED 225 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 225 (348)
...++|...+.||+|+||.||+|+.. +++.||+|.++.... ...+.+.+|++++++++||||+++++++...+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578889999999999999999875 347899999875432 23467899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhch------------------------------------hHHHHHHHHHHhcCCCceEecCC
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS------------------------------------NYVGFALEYLHFDYSVLIIHYDL 269 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~------------------------------------~~i~~~L~yLH~~~~~~iiHrDi 269 (348)
..++||||+++|+|.+++... .+++.||+||| +.+|+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence 999999999999999988642 23788999999 789999999
Q ss_pred CcCceEEcCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 270 KPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 270 k~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
||+||+++.++.+||+|||+++...............+|+.|+| +|||||||++|||+| |+.||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999987654332223344557778876 899999999999999 99999754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=255.67 Aligned_cols=177 Identities=24% Similarity=0.332 Sum_probs=153.2
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
..++|...+.||+|+||.||+|+.. ++..+|+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4567889999999999999999976 567899999976655666789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEE---cCCCcEEEeecCCccccccCC
Q 038351 233 YMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLF---DDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 233 y~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILl---d~~~~~kl~DfGla~~~~~~~ 297 (348)
|+++++|.+.+... .+++.||+||| +.+|+||||||+||++ +.++.++|+|||+++......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 99999998877542 23788999999 7889999999999999 788999999999998765432
Q ss_pred ceeeecccccccCccc-----------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA-----------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a-----------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. .....||+.|+| +||||||++++||+||+.||...
T Consensus 164 ~---~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (277)
T 3f3z_A 164 M---MRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAP 210 (277)
T ss_dssp C---BCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c---hhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCC
Confidence 2 234567888886 89999999999999999999764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=264.65 Aligned_cols=180 Identities=25% Similarity=0.343 Sum_probs=142.2
Q ss_pred hCCCccccccccCCcceEEEeEec-CCc----eEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCCeEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRM----EFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 228 (348)
.++|+..+.||+|+||.||+|+.. ++. .||+|.+.... ....+.+.+|++++++++||||++++++|.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 356888899999999999999864 333 35888775432 234567999999999999999999999998765 78
Q ss_pred EEEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 229 LVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
+|+||+++|+|.+++.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 9999999999999886522 3888999999 77999999999999999999999999999988754
Q ss_pred CCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccccc
Q 038351 296 EDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIFF 338 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~~ 338 (348)
...........+|+.|+| +|||||||++|||+| |+.||+....
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 225 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH
Confidence 443333344456778887 899999999999999 9999976543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=279.77 Aligned_cols=177 Identities=24% Similarity=0.366 Sum_probs=152.8
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
.++|...+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|++++++++||||+++++++...+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888899999999999999975 68899999996442 23346688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 231 LEYMPRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
|||+++|+|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999988642 13788999999 7899999999999999999999999999998765
Q ss_pred cCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.... .....+||+.|+| +|||||||++|||+||+.||...
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 4322 2234589999998 89999999999999999999764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=272.25 Aligned_cols=178 Identities=21% Similarity=0.367 Sum_probs=148.0
Q ss_pred CCCccccccccCCcceEEEeEec------CCceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCCeEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 228 (348)
++|...+.||+|+||.||+|+.. ++..||||.+.... ......+.+|+.++++++||||+++++++...+..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 46788899999999999999853 46689999986432 233456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhch-------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC---cEEEee
Q 038351 229 LVLEYMPRGSLEKCLYSS-------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI---VTHLSD 286 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~-------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~---~~kl~D 286 (348)
+||||+++|+|.+++... .+++.||+||| +.+|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 999999999999988643 24788999999 78999999999999999554 599999
Q ss_pred cCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 287 FGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 287 fGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
||+++...............+|+.|+| +|||||||++|||+| |+.||...
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~ 290 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999986643332223344557788887 899999999999998 99999764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=256.97 Aligned_cols=177 Identities=21% Similarity=0.397 Sum_probs=147.4
Q ss_pred hCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
.++|+..+.||+|+||.||+|+..++..||+|.+..... ..+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 457888899999999999999999998999999975432 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 235 PRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 235 ~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
++++|.+++.... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 177 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS 177 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHS
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-ccc
Confidence 9999999987521 3788999999 7899999999999999999999999999998764321 111
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.....+|+.|+| +||||+|+++|||+| |+.||...
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 223345566776 899999999999999 99999764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=263.66 Aligned_cols=178 Identities=24% Similarity=0.312 Sum_probs=151.5
Q ss_pred hhhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccC--------ccchhhHHHhhhcccccccceeeEEEEEec
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCS--------GAFKSFDFECDVMKSTCYRNLIKIISSRSN 223 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 223 (348)
...++|...+.||+|+||.||+|+. .++..||||.+..... ...+.+.+|++++++++||||+++++++..
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 3567899999999999999999986 4788999999875432 133568889999999999999999999999
Q ss_pred CCeEEEEEeccCCC-CHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCc
Q 038351 224 EDFKVLVLEYMPRG-SLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIA 290 (348)
Q Consensus 224 ~~~~~lV~Ey~~~g-sL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla 290 (348)
.+..++||||+..| +|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 99999999999877 999888653 24888999999 779999999999999999999999999999
Q ss_pred cccccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 291 KLLIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+....... .....||+.|+| +|||||||++|||++|+.||...
T Consensus 178 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 178 AYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp EECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred eECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 87654322 234567888876 79999999999999999999753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=285.33 Aligned_cols=177 Identities=23% Similarity=0.280 Sum_probs=151.9
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeec---cCccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ---CSGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 229 (348)
.++|+..+.||+|+||.||+|+.. +++.||||.+... .....+.+..|.+++..+ +||+|+++++++...+..++
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 357888899999999999999976 5778999999743 233456678899999887 69999999999999999999
Q ss_pred EEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 230 VLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
||||+++|+|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 99999999999988753 23888999999 7899999999999999999999999999998643322
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. .....+||+.|+| +|||||||++|||+||+.||...
T Consensus 497 ~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 497 V--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp C--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred c--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence 2 2356789999998 89999999999999999999754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=265.66 Aligned_cols=176 Identities=23% Similarity=0.326 Sum_probs=135.9
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
...+.|...+.||+|+||.||+|+.. +++.||+|.+.... ..+.+.+|++++++++||||+++++++...+..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 45677999999999999999999976 57889999987442 3466888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC---CCcEEEeecCCccccccC
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD---NIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~DfGla~~~~~~ 296 (348)
||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++. ++.+||+|||+++.....
T Consensus 128 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 999999999988653 23888999999 778999999999999975 889999999999876432
Q ss_pred CceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 297 DHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. ......||+.|+| +|||||||++|||+||+.||...
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 253 (349)
T 2w4o_A 205 V---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred c---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 1 1234567888886 89999999999999999999654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=268.08 Aligned_cols=179 Identities=26% Similarity=0.419 Sum_probs=149.9
Q ss_pred hCCCccccccccCCcceEEEeEec--------CCceEEEEeeeeccC-ccchhhHHHhhhcccc-cccceeeEEEEEecC
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ--------DRMEFSVKGFHLQCS-GAFKSFDFECDVMKST-CYRNLIKIISSRSNE 224 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 224 (348)
.++|...+.||+|+||.||+|+.. .+..||||++..... ...+.+.+|+++++++ +||||+++++++..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 357788899999999999999852 345799999865432 2346788999999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhch----------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEE
Q 038351 225 DFKVLVLEYMPRGSLEKCLYSS----------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLF 276 (348)
Q Consensus 225 ~~~~lV~Ey~~~gsL~~~l~~~----------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILl 276 (348)
+..++||||+++|+|.+++... .+++.||+||| +.+|+||||||+||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence 9999999999999999998642 13888999999 7799999999999999
Q ss_pred cCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 277 DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 277 d~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
+.++.+||+|||+++...............+|+.|+| +|||||||+++||+| |+.||...
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999987654333233344456777876 899999999999999 99999754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=255.42 Aligned_cols=172 Identities=22% Similarity=0.303 Sum_probs=143.1
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc--cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG--AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
++|+..+.||+|+||+||+|+.. +++.||+|.+...... ..+.+.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47888999999999999999975 6889999999754332 23668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 233 YMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 233 y~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|+++ ++.+.+... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence 9975 555544321 24888999999 77999999999999999999999999999987643221
Q ss_pred eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCC
Q 038351 300 MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPT 333 (348)
Q Consensus 300 ~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~ 333 (348)
......||+.|+| +|||||||++|||+||..|+
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred -cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 2234456777776 89999999999999999886
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=276.81 Aligned_cols=178 Identities=24% Similarity=0.385 Sum_probs=151.1
Q ss_pred hCCCccccccccCCcceEEEeEecC-CceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQD-RMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
..+|...+.||+|+||.||+|+... +..||||.+.... ...+.|.+|++++++++||||++++++|...+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3457778899999999999999874 7889999986543 3457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 234 MPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 234 ~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|++|+|.++++.. .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-Y 373 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-E
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-e
Confidence 9999999998642 14888999999 7899999999999999999999999999998765432 2
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
.......+++.|+| +|||||||++|||+| |+.||....
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~ 424 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence 22334445677887 899999999999999 999997643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=263.20 Aligned_cols=175 Identities=25% Similarity=0.391 Sum_probs=147.2
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEE
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 230 (348)
...++|...+.||+|+||.||+|+.. +++.||+|.+.... ....+|++++.++ +||||+++++++.+.+..++|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 34567889999999999999999976 68899999986442 3456788888888 799999999999999999999
Q ss_pred EeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCC----CcEEEeecCCccccc
Q 038351 231 LEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN----IVTHLSDFGIAKLLI 294 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~----~~~kl~DfGla~~~~ 294 (348)
||||++|+|.+.+.... +++.||+||| +.+|+||||||+||++.++ +.+||+|||+++...
T Consensus 95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999886532 3788999999 7899999999999998543 359999999998765
Q ss_pred cCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.... ......||+.|+| +|||||||++|||++|+.||...
T Consensus 172 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 172 AENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp CTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 4322 2235678999987 89999999999999999999753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=267.85 Aligned_cols=180 Identities=18% Similarity=0.224 Sum_probs=150.7
Q ss_pred hhCCCccccccccC--CcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEE
Q 038351 154 VTNGFSEDNLISRG--GFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 154 ~~~~f~~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 228 (348)
..++|+..+.||+| +||.||+|+.. +++.||||.+..... ...+.+.+|++++++++||||+++++++..++..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45678899999999 99999999976 788999999975432 23456788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 229 LVLEYMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
+|||||++|+|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||.+....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999988643 13888999999 7889999999999999999999999999987653
Q ss_pred cCCce-----eeecccccccCccc--------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHF-----MIQTQTLATIGYMA--------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~-----~~~~~~~gt~~y~a--------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..... .......||+.|+| +|||||||++|||+||+.||...
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 32211 11123356777776 79999999999999999999764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=268.53 Aligned_cols=180 Identities=22% Similarity=0.293 Sum_probs=138.9
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhccccc-ccceeeEEEEEecCC--e
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTC-YRNLIKIISSRSNED--F 226 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~ 226 (348)
...++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45678999999999999999999864 68899999985432 223456788999999998 999999999998654 6
Q ss_pred EEEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 227 KVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
.++|||||+ ++|.++++.. .+++.||+||| +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 899999997 5898887642 24888999999 78999999999999999999999999999987532
Q ss_pred CC-------------------ceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 296 ED-------------------HFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 296 ~~-------------------~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.. .....+...||+.|+| +||||+||+++||++|++||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 11 0111234578888887 89999999999999999999653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=267.03 Aligned_cols=177 Identities=24% Similarity=0.338 Sum_probs=149.7
Q ss_pred hCCCccccccccCCcceEEEeEe----cCCceEEEEeeeecc----CccchhhHHHhhhcccc-cccceeeEEEEEecCC
Q 038351 155 TNGFSEDNLISRGGFGSIHKARI----QDRMEFSVKGFHLQC----SGAFKSFDFECDVMKST-CYRNLIKIISSRSNED 225 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 225 (348)
.++|...+.||+|+||.||+|+. .+++.||||.++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35788899999999999999987 478899999986432 23346678899999999 5999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
..++||||+++|+|.+++.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 9999999999999999886532 4888999999 778999999999999999999999999999876
Q ss_pred ccCCceeeecccccccCccc--------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 294 IREDHFMIQTQTLATIGYMA--------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~a--------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
..... .......||+.|+| +|||||||++|||+||+.||..
T Consensus 210 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 264 (355)
T 1vzo_A 210 VADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264 (355)
T ss_dssp CGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred ccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 43222 12234568888876 7999999999999999999964
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=262.18 Aligned_cols=181 Identities=24% Similarity=0.432 Sum_probs=133.9
Q ss_pred hhCCCccccccccCCcceEEEeEecCCc----eEEEEeeeec--cCccchhhHHHhhhcccccccceeeEEEEEecCCeE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQDRM----EFSVKGFHLQ--CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFK 227 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~----~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 227 (348)
..++|+..+.||+|+||.||+|+..... .||||.+... .....+.+.+|++++++++||||+++++++...+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 4567999999999999999999866432 7999998654 233457789999999999999999999999887655
Q ss_pred ------EEEEeccCCCCHHHHHhch------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEE
Q 038351 228 ------VLVLEYMPRGSLEKCLYSS------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTH 283 (348)
Q Consensus 228 ------~lV~Ey~~~gsL~~~l~~~------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~k 283 (348)
++||||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence 9999999999999888532 13788999999 77999999999999999999999
Q ss_pred EeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 284 LSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 284 l~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
|+|||+++...............+++.|+| +|||||||++|||+| |+.||....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 999999987654333222334445667776 899999999999999 999997643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=260.11 Aligned_cols=179 Identities=26% Similarity=0.425 Sum_probs=144.4
Q ss_pred hCCCccccccccCCcceEEEeEe-----cCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecC--CeE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARI-----QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNE--DFK 227 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 227 (348)
.++|+..+.||+|+||.||+|++ .++..||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35788889999999999999984 36789999998755544557789999999999999999999998653 568
Q ss_pred EEEEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 228 VLVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
++||||+++|+|.+++.... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 99999999999999886532 3888999999 7899999999999999999999999999998765
Q ss_pred cCCce-eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHF-MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~-~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..... .......++..|+| +|||||||++|||+||..|+...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 43221 11223345666776 89999999999999999998654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=259.60 Aligned_cols=180 Identities=23% Similarity=0.376 Sum_probs=152.1
Q ss_pred hCCCccccccccCCcceEEEeEe------cCCceEEEEeeeeccC-ccchhhHHHhhhcccc-cccceeeEEEEEecCCe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARI------QDRMEFSVKGFHLQCS-GAFKSFDFECDVMKST-CYRNLIKIISSRSNEDF 226 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 226 (348)
.++|...+.||+|+||.||+|+. .++..||+|.+..... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 45788889999999999999985 3567899999865432 2346788999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhchh------------------------------HHHHHHHHHHhcCCCceEecCCCcCceEE
Q 038351 227 KVLVLEYMPRGSLEKCLYSSN------------------------------YVGFALEYLHFDYSVLIIHYDLKPSNVLF 276 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~~------------------------------~i~~~L~yLH~~~~~~iiHrDik~~NILl 276 (348)
.++||||+++|+|.+++.... +++.||+||| +.+|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence 999999999999999886421 3788999999 7899999999999999
Q ss_pred cCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 277 DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 277 d~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
+.++.+||+|||+++...............+|+.|+| +|||||||+++||+| |+.||....
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999988765443333344556777876 899999999999999 999997643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=257.34 Aligned_cols=180 Identities=22% Similarity=0.278 Sum_probs=144.4
Q ss_pred hCCCcc-ccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEEE
Q 038351 155 TNGFSE-DNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 155 ~~~f~~-~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 231 (348)
.+.|.. .+.||+|+||.||+|+.. +++.||||.+........+.+.+|++++.++ +||||+++++++..++..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 346666 478999999999999854 7889999999766555567789999999884 7999999999999999999999
Q ss_pred eccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCc---EEEeecCCccccccC
Q 038351 232 EYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIV---THLSDFGIAKLLIRE 296 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~---~kl~DfGla~~~~~~ 296 (348)
||+++|+|.+++.... +++.||+||| +.+|+||||||+||+++.++. +||+|||+++.....
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 9999999999886432 3888999999 779999999999999998766 999999999865422
Q ss_pred Cce-----eeecccccccCccc-----------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 297 DHF-----MIQTQTLATIGYMA-----------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 297 ~~~-----~~~~~~~gt~~y~a-----------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
... .......||+.|+| +|||||||++|||+||+.||....
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 111 11123457888876 699999999999999999997643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=255.18 Aligned_cols=176 Identities=28% Similarity=0.402 Sum_probs=145.8
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.++|...+.||+|+||.||+|+.. ++..+|+|.+..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 457888999999999999999875 688999999875543 345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEE---cCCCcEEEeecCCcccc
Q 038351 233 YMPRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLF---DDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 233 y~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILl---d~~~~~kl~DfGla~~~ 293 (348)
|+++|+|.+.+... .+++.||+||| +.+|+||||||+||++ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999887532 13788999999 7899999999999999 45688999999999876
Q ss_pred ccCCceeeecccccccCccc-----------cccHHHHHHHHHHHcCCCCCccc
Q 038351 294 IREDHFMIQTQTLATIGYMA-----------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~a-----------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..... .....||+.|+| +|||||||+++||++|+.||...
T Consensus 178 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~ 228 (285)
T 3is5_A 178 KSDEH---STNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228 (285)
T ss_dssp ------------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCccc---CcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence 43221 234567888876 89999999999999999999754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=260.81 Aligned_cols=179 Identities=26% Similarity=0.431 Sum_probs=150.0
Q ss_pred hCCCccccccccCCcceEEEeEec--------CCceEEEEeeeeccC-ccchhhHHHhhhcccc-cccceeeEEEEEecC
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ--------DRMEFSVKGFHLQCS-GAFKSFDFECDVMKST-CYRNLIKIISSRSNE 224 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 224 (348)
.++|...+.||+|+||.||+|+.. ++..||+|.+..... ...+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 457888899999999999999863 467899999864432 2346688999999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhch----------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEE
Q 038351 225 DFKVLVLEYMPRGSLEKCLYSS----------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLF 276 (348)
Q Consensus 225 ~~~~lV~Ey~~~gsL~~~l~~~----------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILl 276 (348)
+..++||||+++|+|.+++... .+++.||+||| +.+|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence 9999999999999999998642 13888999999 7899999999999999
Q ss_pred cCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 277 DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 277 d~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
+.++.+||+|||+++...............+|+.|+| +|||||||++|||+| |+.||...
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 9999999999999987754433333344456777876 899999999999999 99999764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=262.89 Aligned_cols=177 Identities=23% Similarity=0.335 Sum_probs=144.4
Q ss_pred hCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCc--cchhhHHHhhhcccccc--cceeeEEEEEecCCeEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSG--AFKSFDFECDVMKSTCY--RNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV 230 (348)
.+.|+..+.||+|+||.||++...++..||||.+...... ..+.+.+|++++++++| |||+++++++..++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568899999999999999999989999999998754322 34668899999999987 9999999999999999999
Q ss_pred EeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 231 LEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
|| +.+++|.+++... .+++.||+||| +.+|+||||||+|||++ ++.+||+|||+++.......
T Consensus 88 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred Ee-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 99 5688999988653 23888999999 77899999999999997 57899999999987754433
Q ss_pred eeeecccccccCccc-----------------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA-----------------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a-----------------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
........||+.|+| +|||||||++|||+||+.||+..
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 333345668888876 59999999999999999999764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-33 Score=258.08 Aligned_cols=177 Identities=23% Similarity=0.339 Sum_probs=151.3
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc------cchhhHHHhhhcccccccceeeEEEEEecCCe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG------AFKSFDFECDVMKSTCYRNLIKIISSRSNEDF 226 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 226 (348)
..++|...+.||+|+||.||+|+.. ++..||+|.+...... ..+.+.+|++++++++||||+++++++...+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 4567888999999999999999976 6889999999754322 24568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCC----cEEEeecCCc
Q 038351 227 KVLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI----VTHLSDFGIA 290 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~----~~kl~DfGla 290 (348)
.++||||+++++|.+++.... +++.||+||| +.+|+||||||+||+++.++ .+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999999999986532 3888999999 77999999999999999887 7999999999
Q ss_pred cccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 291 KLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+....... .....||+.|+| +|||||||++|||+||+.||...
T Consensus 167 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 167 HEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp EECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred eecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 87654322 234567888876 89999999999999999999653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=259.38 Aligned_cols=185 Identities=22% Similarity=0.374 Sum_probs=153.2
Q ss_pred hhHHhhhCCCccccccccCCcceEEEeEec------CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEE
Q 038351 149 LELCRVTNGFSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSR 221 (348)
Q Consensus 149 ~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~ 221 (348)
.+.....++|...+.||+|+||.||+|+.. ++..||+|.+..... .....+.+|++++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344455678999999999999999999864 367899999864322 2345688999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCCHHHHHhch----------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCC
Q 038351 222 SNEDFKVLVLEYMPRGSLEKCLYSS----------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN 279 (348)
Q Consensus 222 ~~~~~~~lV~Ey~~~gsL~~~l~~~----------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~ 279 (348)
...+..++||||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCC
Confidence 9999999999999999999988642 13788999999 7799999999999999999
Q ss_pred CcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 280 IVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 280 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
+.+||+|||+++...............+|+.|+| +|||||||++|||+| |+.||...
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 9999999999987654333333334456777776 899999999999999 89999764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=272.92 Aligned_cols=176 Identities=25% Similarity=0.423 Sum_probs=143.6
Q ss_pred hCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
.++|...+.||+|+||.||+|+..++..||||.++... ...+.|.+|++++++++||||+++++++.. +..++|||||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 35677788999999999999999988889999987543 234679999999999999999999999876 6789999999
Q ss_pred CCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 235 PRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 235 ~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
++|+|.++++... +++.||+||| +.+|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT 336 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-ee
Confidence 9999999987421 3888999999 7889999999999999999999999999998764322 11
Q ss_pred eecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 301 IQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
......+++.|+| +|||||||++|||+| |+.||...
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 2233445667776 899999999999999 99999764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=252.84 Aligned_cols=181 Identities=23% Similarity=0.345 Sum_probs=151.6
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
..++|+..+.||+|+||.||+|+.. ++..||+|.+..... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3467888999999999999999976 688999999865432 33467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 999999998887643 23888999999 789999999999999999999999999999876433222
Q ss_pred eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 300 MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 300 ~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
.......||+.|+| +|||||||++|||+||+.||+...
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 22234456666655 899999999999999999997643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=268.96 Aligned_cols=172 Identities=29% Similarity=0.410 Sum_probs=144.7
Q ss_pred hCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCC-eEEEEEec
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNED-FKVLVLEY 233 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~Ey 233 (348)
.++|...+.||+|+||.||+|... +..||||.++... ..+.|.+|++++++++||||+++++++...+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 356778899999999999999986 6689999986543 4578999999999999999999999987765 78999999
Q ss_pred cCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 234 MPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 234 ~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|++|+|.++++... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 343 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence 99999999887421 3788999999 7899999999999999999999999999998643211
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
....+++.|+| +|||||||++|||+| |+.||....
T Consensus 344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 391 (450)
T 1k9a_A 344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred ---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 12245677776 899999999999999 999997653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=264.29 Aligned_cols=180 Identities=19% Similarity=0.211 Sum_probs=143.0
Q ss_pred hhCCCccccccccCCcceEEEeEecC------CceEEEEeeeeccCcc-----------chhhHHHhhhcccccccceee
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQD------RMEFSVKGFHLQCSGA-----------FKSFDFECDVMKSTCYRNLIK 216 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~ 216 (348)
..++|...+.||+|+||.||+|+... ++.||||.+....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35589999999999999999998765 4789999986442111 122344556677889999999
Q ss_pred EEEEEecC----CeEEEEEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEc--
Q 038351 217 IISSRSNE----DFKVLVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFD-- 277 (348)
Q Consensus 217 l~~~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld-- 277 (348)
+++++... ...++||||+ +++|.+++.... +++.||+||| +.+|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecC
Confidence 99998764 5589999999 999999886531 3889999999 77999999999999999
Q ss_pred CCCcEEEeecCCccccccCCcee-----eecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 278 DNIVTHLSDFGIAKLLIREDHFM-----IQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 278 ~~~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
.++.+||+|||+++.+....... ......||+.|+| +|||||||++|||+||+.||+...
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 88999999999998765432211 1134458999988 799999999999999999998643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=253.76 Aligned_cols=179 Identities=25% Similarity=0.338 Sum_probs=143.8
Q ss_pred hhCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhccc--ccccceeeEEEEEec----CCeE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKS--TCYRNLIKIISSRSN----EDFK 227 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~----~~~~ 227 (348)
..++|+..+.||+|+||.||+|+. +++.||||.+... ....+..|.+++.. ++||||+++++++.. ....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 356889999999999999999987 6789999998643 23455666666655 789999999998654 3568
Q ss_pred EEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhc-----CCCceEecCCCcCceEEcCCCcEEEeecCCcc
Q 038351 228 VLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFD-----YSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~-----~~~~iiHrDik~~NILld~~~~~kl~DfGla~ 291 (348)
++||||+++|+|.++++.. .+++.||+|||.. ++.+|+||||||+|||++.++.+||+|||+++
T Consensus 82 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp EEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence 9999999999999998643 2488899999943 26789999999999999999999999999998
Q ss_pred ccccCCcee--eecccccccCccc------------------cccHHHHHHHHHHHcC----------CCCCccc
Q 038351 292 LLIREDHFM--IQTQTLATIGYMA------------------SYVYSFGIMLLEVFTR----------KKPTNKI 336 (348)
Q Consensus 292 ~~~~~~~~~--~~~~~~gt~~y~a------------------sDV~S~Gvvl~elltG----------~~P~~~~ 336 (348)
......... ......||+.|+| +|||||||++|||+|| +.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 765433221 1223467777775 6999999999999999 8888654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=250.38 Aligned_cols=173 Identities=26% Similarity=0.489 Sum_probs=143.5
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCcc-------chhhHHHhhhcccccccceeeEEEEEecCCe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGA-------FKSFDFECDVMKSTCYRNLIKIISSRSNEDF 226 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 226 (348)
.++|+..+.||+|+||.||+|+.. +++.||+|.+....... .+.+.+|++++++++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467888999999999999999974 78899999986543322 267889999999999999999999997665
Q ss_pred EEEEEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCc--eEecCCCcCceEEcCCCc-----EEEee
Q 038351 227 KVLVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVL--IIHYDLKPSNVLFDDNIV-----THLSD 286 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~--iiHrDik~~NILld~~~~-----~kl~D 286 (348)
++||||+++|+|.+.+.... +++.||+||| +.+ |+||||||+||+++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 69999999999988875432 3788999999 667 999999999999988776 99999
Q ss_pred cCCccccccCCceeeecccccccCccc--------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 287 FGIAKLLIREDHFMIQTQTLATIGYMA--------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 287 fGla~~~~~~~~~~~~~~~~gt~~y~a--------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
||+++..... .....||+.|+| +|||||||++|||++|+.||+...
T Consensus 173 fg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 173 FGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp CTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 9999854321 233456666665 899999999999999999997643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=257.48 Aligned_cols=171 Identities=30% Similarity=0.452 Sum_probs=138.3
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
++|+..+.||+|+||.||+|+.. ++.||+|.+... ...+.+.+|++++++++||||+++++++.. ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 46778899999999999999875 678999998532 345678999999999999999999998874 4799999999
Q ss_pred CCCHHHHHhchh---------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCc-EEEeecCCccccccCCce
Q 038351 236 RGSLEKCLYSSN---------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIV-THLSDFGIAKLLIREDHF 299 (348)
Q Consensus 236 ~gsL~~~l~~~~---------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~-~kl~DfGla~~~~~~~~~ 299 (348)
+|+|.+++.... ++++||+|||..+..+|+||||||+||+++.++. +||+|||+++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 999999987431 3788999999655489999999999999998876 799999999765422
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....||+.|+| +|||||||++|||+||+.||+..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 123457888876 89999999999999999999754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-33 Score=258.24 Aligned_cols=168 Identities=24% Similarity=0.342 Sum_probs=132.3
Q ss_pred ccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhccccc-ccceeeEEEEEecCCeEEEEEeccCCCC
Q 038351 161 DNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKVLVLEYMPRGS 238 (348)
Q Consensus 161 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gs 238 (348)
.+.||+|+||.||+|+.. +++.||||.+... ....+.+|+++++++. ||||+++++++..++..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999975 6889999998643 3466788999999997 9999999999999999999999999999
Q ss_pred HHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCC---cEEEeecCCccccccCCceeeec
Q 038351 239 LEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI---VTHLSDFGIAKLLIREDHFMIQT 303 (348)
Q Consensus 239 L~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~---~~kl~DfGla~~~~~~~~~~~~~ 303 (348)
|.+++.... +++.||+||| +.+|+||||||+||+++.++ .+||+|||+++....... ...
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~ 167 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLK 167 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--ccc
Confidence 999886532 3888999999 78999999999999997665 899999999987643222 223
Q ss_pred ccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 304 QTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 304 ~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...||+.|+| +|||||||++|||+||+.||...
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 212 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 4557788876 79999999999999999999753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-32 Score=249.69 Aligned_cols=176 Identities=17% Similarity=0.186 Sum_probs=150.0
Q ss_pred hCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEEEe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.++|...+.||+|+||.||+|+. .+++.||+|.+... ...+.+.+|+++++++ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46789999999999999999996 57889999988643 2346788999999999 79999999999999999999999
Q ss_pred ccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCc-----EEEeecCCccccc
Q 038351 233 YMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIV-----THLSDFGIAKLLI 294 (348)
Q Consensus 233 y~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~-----~kl~DfGla~~~~ 294 (348)
|+ +++|.+++.... +++.||+||| +.+|+||||||+||+++.++. +||+|||+++...
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99 999999987421 3888999999 889999999999999987766 9999999998775
Q ss_pred cCCce-----eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHF-----MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~-----~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..... .......||+.|+| +|||||||++|||+||+.||...
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 221 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence 43221 12345568889987 89999999999999999999774
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=259.87 Aligned_cols=175 Identities=21% Similarity=0.285 Sum_probs=140.2
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
++|...+.||+|+||.||+|+.. ++..||+|.+..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999976 788999999864432 2234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 234 MPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 234 ~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
++ |+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-- 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-- 155 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--
Confidence 97 5888877542 24788999999 78999999999999999999999999999986543221
Q ss_pred eecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 301 IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......||+.|+| +||||+||++|||+||+.||...
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS 204 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1223456666765 89999999999999999999754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=253.74 Aligned_cols=176 Identities=24% Similarity=0.326 Sum_probs=144.9
Q ss_pred hhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccC-----ccchhhHHHhhhccccc---ccceeeEEEEEecC
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCS-----GAFKSFDFECDVMKSTC---YRNLIKIISSRSNE 224 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~ 224 (348)
..++|+..+.||+|+||.||+|+. .+++.||+|.+..... .....+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999996 4788999999865432 12346778888887776 99999999999876
Q ss_pred C-----eEEEEEeccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEe
Q 038351 225 D-----FKVLVLEYMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLS 285 (348)
Q Consensus 225 ~-----~~~lV~Ey~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~ 285 (348)
. ..++||||++ |+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence 5 5899999997 5999887653 23788999999 7789999999999999999999999
Q ss_pred ecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 286 DFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 286 DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
|||+++...... ......||+.|+| +|||||||++|||+||+.||...
T Consensus 163 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 222 (308)
T 3g33_A 163 DFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 222 (308)
T ss_dssp SCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred eCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999998764322 2245678888887 89999999999999999999653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=8.4e-33 Score=255.97 Aligned_cols=177 Identities=23% Similarity=0.255 Sum_probs=143.8
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc--cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG--AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
.++|+..+.||+|+||.||+|+.. +++.||+|++...... ..+.+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 357889999999999999999976 5889999988544322 2356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence 999999998877542 24788999999 78999999999999999999999999999987653222
Q ss_pred eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......||+.|+| +||||+||++|||+||+.||...
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 1223456666665 89999999999999999999654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.5e-33 Score=265.52 Aligned_cols=176 Identities=22% Similarity=0.333 Sum_probs=144.9
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccC--ccchhhHHHhhhccccc--ccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTC--YRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~ 231 (348)
..|+..+.||+|+||.||+|...++..||||.+..... ...+.+.+|++++++++ ||||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 35888999999999999999988899999999865432 23467899999999997 599999999999999999999
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
| +.+++|.+++... .+++.||+||| +.+|+||||||+|||++ ++.+||+|||+++.+......
T Consensus 136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9 5688999988642 24888999999 88999999999999996 578999999999877543332
Q ss_pred eeecccccccCccc-----------------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA-----------------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a-----------------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.......||+.|+| +|||||||++|||++|+.||...
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 23345568888876 59999999999999999999764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=5.8e-33 Score=262.73 Aligned_cols=175 Identities=24% Similarity=0.330 Sum_probs=148.6
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.++|...+.||+|+||.||+|+.. ++..||+|.+..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357888999999999999999976 688999999875432 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhchh------------HHHHHHHHHHhcCCC-ceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 233 YMPRGSLEKCLYSSN------------YVGFALEYLHFDYSV-LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 233 y~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~-~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|+++++|.+++.... +++.||+||| +. +|+||||||+||+++.++.+||+|||+++......
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 186 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 186 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc--
Confidence 999999999886531 3788999999 53 79999999999999999999999999997654321
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....||+.|+| +|||||||++|||+||+.||...
T Consensus 187 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 187 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred --ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 234567888876 89999999999999999999754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.9e-33 Score=266.12 Aligned_cols=176 Identities=23% Similarity=0.345 Sum_probs=148.6
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCC--eEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNED--FKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV 230 (348)
.++|...+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 356888999999999999999976 58899999986443 233466789999999999999999999998765 78999
Q ss_pred EeccCCCCHHHHHhchh---------------HHHHHHHHHHhcCCCceEecCCCcCceEE----cCCCcEEEeecCCcc
Q 038351 231 LEYMPRGSLEKCLYSSN---------------YVGFALEYLHFDYSVLIIHYDLKPSNVLF----DDNIVTHLSDFGIAK 291 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~---------------~i~~~L~yLH~~~~~~iiHrDik~~NILl----d~~~~~kl~DfGla~ 291 (348)
|||+++|+|.+++.... +++.||+||| +.+|+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999987532 3788999999 7889999999999999 788889999999998
Q ss_pred ccccCCceeeecccccccCccc--------------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 292 LLIREDHFMIQTQTLATIGYMA--------------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~a--------------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....... .....||+.|+| +|||||||++|||+||+.||...
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 7654322 234567888875 69999999999999999999753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=251.65 Aligned_cols=176 Identities=23% Similarity=0.363 Sum_probs=146.8
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
..++|+..+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|++++++++||||+++++++...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4567889999999999999999876 56789999986432 2234668899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 230 VLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
||||+++|+|.+.+... .+++.||+||| +.+|+||||||+||+++.++.++|+|||++.......
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 99999999999887642 23888999999 8899999999999999999999999999986543321
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....||+.|+| +||||||+++|||++|+.||+..
T Consensus 164 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 210 (279)
T 3fdn_A 164 ----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC
Confidence 234467777776 89999999999999999999754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=271.43 Aligned_cols=178 Identities=22% Similarity=0.343 Sum_probs=147.4
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
...+.|...+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|++++++++||||+++++++...+..++
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34567889999999999999999976 67889999986543 2335678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC---CCcEEEeecCCccccc
Q 038351 230 VLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD---NIVTHLSDFGIAKLLI 294 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~DfGla~~~~ 294 (348)
|||||++|+|.+.+... .+++.||+||| +.+|+||||||+|||++. ++.+||+|||+++...
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 99999999998877542 23888999999 789999999999999976 4559999999998765
Q ss_pred cCCceeeecccccccCccc-----------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHFMIQTQTLATIGYMA-----------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~a-----------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.... .....||+.|+| +||||+||++|||++|+.||...
T Consensus 191 ~~~~---~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 240 (494)
T 3lij_A 191 NQKK---MKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQ 240 (494)
T ss_dssp TTBC---BCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcc---ccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 4322 245678999987 89999999999999999999753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4e-33 Score=260.74 Aligned_cols=181 Identities=23% Similarity=0.400 Sum_probs=151.4
Q ss_pred hhCCCccccccccCCcceEEEeEecC------CceEEEEeeeeccC-ccchhhHHHhhhcccc-cccceeeEEEEEecCC
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQD------RMEFSVKGFHLQCS-GAFKSFDFECDVMKST-CYRNLIKIISSRSNED 225 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 225 (348)
..++|...+.||+|+||.||+|+... ...||+|.+..... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 34678889999999999999998643 24799999864432 2346688999999999 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhch--------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCC
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS--------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN 279 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~--------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~ 279 (348)
..++||||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCC
Confidence 999999999999999988643 14788999999 7799999999999999999
Q ss_pred CcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 280 IVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 280 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
+.+||+|||+++...............+|+.|+| +|||||||++|||+| |+.||....
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 9999999999987654443333344556777876 899999999999999 999997643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=249.31 Aligned_cols=176 Identities=23% Similarity=0.408 Sum_probs=148.3
Q ss_pred hCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
.++|...+.||+|+||.||+|+..++..||+|.+.... ...+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 35678889999999999999999888899999986443 345778999999999999999999999874 5689999999
Q ss_pred CCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 235 PRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 235 ~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
++++|.+++.... +++.||+||| +.+|+||||||+||++++++.+||+|||+++...... ..
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT 165 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-cc
Confidence 9999999987532 3788999999 7899999999999999999999999999998765432 22
Q ss_pred eecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 301 IQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
......++..|+| +|||||||+++||+| |+.||...
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 2233445667776 899999999999999 99999754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=250.91 Aligned_cols=178 Identities=23% Similarity=0.379 Sum_probs=142.7
Q ss_pred hhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
..++|...+.||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 345788999999999999999987 478899999986432 2234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 230 VLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
||||+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999988753 13888999999 779999999999999999999999999999876432
Q ss_pred CceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 297 DHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.. ......||+.|+| +|||||||++|||+||+.||+..
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 215 (278)
T 3cok_A 166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCC
T ss_pred CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCh
Confidence 21 1123456777765 89999999999999999999754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=265.46 Aligned_cols=171 Identities=22% Similarity=0.357 Sum_probs=136.5
Q ss_pred hCCCccc-cccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcc-cccccceeeEEEEEec----CCeE
Q 038351 155 TNGFSED-NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMK-STCYRNLIKIISSRSN----EDFK 227 (348)
Q Consensus 155 ~~~f~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~----~~~~ 227 (348)
.++|... +.||+|+||.||+|+.. ++..||||.+.. ...+.+|++++. ..+||||+++++++.. .+..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3456555 68999999999999875 688899999863 245778888874 4579999999998875 5678
Q ss_pred EEEEeccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcC---CCcEEEeecCCc
Q 038351 228 VLVLEYMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDD---NIVTHLSDFGIA 290 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~DfGla 290 (348)
++|||||++|+|.+++.... +++.||+||| +.+|+||||||+|||++. ++.+||+|||++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 99999999999999987532 3788999999 789999999999999997 789999999999
Q ss_pred cccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 291 KLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+...... .....+||+.|+| +|||||||++|||+||+.||...
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 8764322 2245567888887 89999999999999999999654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=260.95 Aligned_cols=180 Identities=27% Similarity=0.316 Sum_probs=151.0
Q ss_pred chhhHHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhccccc-----ccceeeEEEE
Q 038351 147 SCLELCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-----YRNLIKIISS 220 (348)
Q Consensus 147 ~~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~~~ 220 (348)
...+.....++|...+.||+|+||.||+|+.. +++.||||.+... ....+.+..|++++++++ ||||++++++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 33455566789999999999999999999974 6889999998632 223356778999988886 9999999999
Q ss_pred EecCCeEEEEEeccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcC--------
Q 038351 221 RSNEDFKVLVLEYMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDD-------- 278 (348)
Q Consensus 221 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~-------- 278 (348)
+...+..++||||+ +++|.+++.... +++.||+||| +.+|+||||||+|||++.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccccccc
Confidence 99999999999999 999999886432 3788999999 789999999999999975
Q ss_pred -----------------CCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcC
Q 038351 279 -----------------NIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTR 329 (348)
Q Consensus 279 -----------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG 329 (348)
++.+||+|||+++..... .....||+.|+| +|||||||++|||+||
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 789999999999865432 234567888887 8999999999999999
Q ss_pred CCCCccc
Q 038351 330 KKPTNKI 336 (348)
Q Consensus 330 ~~P~~~~ 336 (348)
+.||...
T Consensus 256 ~~pf~~~ 262 (360)
T 3llt_A 256 SLLFRTH 262 (360)
T ss_dssp SCSCCCS
T ss_pred CCCCCCC
Confidence 9999653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=250.48 Aligned_cols=176 Identities=26% Similarity=0.389 Sum_probs=145.7
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
++|....+||+|+||.||+|+.. ++..||+|.+........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555669999999999999964 67899999997665555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch---------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC-CCcEEEeecCCccccccCCc
Q 038351 235 PRGSLEKCLYSS---------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD-NIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 235 ~~gsL~~~l~~~---------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DfGla~~~~~~~~ 298 (348)
++++|.+++... .+++.||+||| +.+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999999988643 13788999999 779999999999999997 89999999999987643211
Q ss_pred eeeecccccccCccc--------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA--------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a--------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......||+.|+| +|||||||++|||+||+.||...
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 1233456776765 89999999999999999999653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.4e-33 Score=261.65 Aligned_cols=171 Identities=27% Similarity=0.343 Sum_probs=144.7
Q ss_pred CCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCc---cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSG---AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
..|+..+.||+|+||.||+|+. .+++.||||.+...... ..+.+.+|++++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4578889999999999999996 57889999998654322 2356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 232 EYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
||++ |++.+.+... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9997 6887776432 23788999999 778999999999999999999999999999876432
Q ss_pred eeeecccccccCccc---------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....||+.|+| +|||||||++|||+||+.||...
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 256 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 23457777765 89999999999999999998653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.5e-33 Score=268.94 Aligned_cols=179 Identities=22% Similarity=0.291 Sum_probs=145.4
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecC-----
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNE----- 224 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 224 (348)
...++|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 35678999999999999999999875 678899999964322 2346788999999999999999999999876
Q ss_pred CeEEEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 225 DFKVLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 225 ~~~~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
+..++||||++ |+|.++++... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 57899999996 59999887532 3888999999 77899999999999999999999999999987
Q ss_pred cccCCce--------------------eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 293 LIREDHF--------------------MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 293 ~~~~~~~--------------------~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
....... ...+...||+.|+| +||||+||++|||++|..||..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 6533211 11245678888887 8999999999999997777654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=252.96 Aligned_cols=178 Identities=21% Similarity=0.375 Sum_probs=146.1
Q ss_pred CCCccccccccCCcceEEEeEe-----cCCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecC--CeE
Q 038351 156 NGFSEDNLISRGGFGSIHKARI-----QDRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNE--DFK 227 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 227 (348)
+.|+..+.||+|+||.||+|++ .+++.||+|.+..... ...+.+.+|++++++++||||+++++++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3577889999999999999984 4688999999964432 3446789999999999999999999999876 678
Q ss_pred EEEEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 228 VLVLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
++||||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999999998432 13788999999 7899999999999999999999999999998875
Q ss_pred cCCce-eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHF-MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~-~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..... .......+|..|+| +||||+||++|||+||+.|+...
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 232 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP 232 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcch
Confidence 44322 22334556777876 89999999999999999986543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.1e-33 Score=271.28 Aligned_cols=172 Identities=22% Similarity=0.310 Sum_probs=130.5
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecC-----C
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNE-----D 225 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~ 225 (348)
..++|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++... .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3468999999999999999999865 788999999864322 2346788999999999999999999999543 5
Q ss_pred eEEEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
..++||||+ +++|.++++... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 789999998 568988876532 4888999999 779999999999999999999999999999876
Q ss_pred ccCCce-------------------------eeecccccccCccc-------------cccHHHHHHHHHHHcC
Q 038351 294 IREDHF-------------------------MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTR 329 (348)
Q Consensus 294 ~~~~~~-------------------------~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG 329 (348)
...... ...+..+||+.|+| +|||||||++|||+||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 422110 11234567888987 8999999999999993
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=249.42 Aligned_cols=177 Identities=20% Similarity=0.366 Sum_probs=149.6
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
..++|+..+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|++++++++||||+++++++..++..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4678999999999999999999875 688999999865432 2346688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCc---EEEeecCCcccccc
Q 038351 231 LEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIV---THLSDFGIAKLLIR 295 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~---~kl~DfGla~~~~~ 295 (348)
|||+++++|.+.+... .+++.||+||| +.+|+||||||+||+++.++. +||+|||++.....
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 9999999998877543 23888999999 788999999999999986655 99999999987643
Q ss_pred CCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 296 EDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
... .....||+.|+| +||||+|++++||++|+.||...
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 210 (284)
T 3kk8_A 161 SEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210 (284)
T ss_dssp SCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Ccc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC
Confidence 322 234567888876 89999999999999999999653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.98 E-value=7.1e-33 Score=268.15 Aligned_cols=178 Identities=22% Similarity=0.311 Sum_probs=140.6
Q ss_pred HhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--------ccchhhHHHhhhcccccccceeeEEEEEe
Q 038351 152 CRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--------GAFKSFDFECDVMKSTCYRNLIKIISSRS 222 (348)
Q Consensus 152 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 222 (348)
....++|...+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345678999999999999999999865 678999999864321 12346889999999999999999999986
Q ss_pred cCCeEEEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCC---CcEEEeec
Q 038351 223 NEDFKVLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN---IVTHLSDF 287 (348)
Q Consensus 223 ~~~~~~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~---~~~kl~Df 287 (348)
. +..++|||||++|+|.+++... .+++.||+||| +.+|+||||||+|||++.+ ..+||+||
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred c-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence 4 4579999999999998877542 24889999999 7789999999999999754 45999999
Q ss_pred CCccccccCCceeeecccccccCccc---------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 288 GIAKLLIREDHFMIQTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 288 Gla~~~~~~~~~~~~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
|+++...... ......||+.|+| +|||||||++|||+||+.||...
T Consensus 287 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 287 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred ccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 9998764322 2234567777766 79999999999999999999754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=248.46 Aligned_cols=170 Identities=19% Similarity=0.321 Sum_probs=144.3
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecC--CeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNE--DFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 231 (348)
++|...+.||+|+||.||+|+.+ +..||+|.+..... ...+.+.+|++++++++||||+++++++... +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46888899999999999999986 77899999875432 2345789999999999999999999999887 7889999
Q ss_pred eccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCc--eEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 232 EYMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVL--IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~--iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
||+++|+|.+++.... +++.||+||| +.+ |+||||||+||+++.++.++++|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999987532 3788999999 666 99999999999999999999999998765322
Q ss_pred CCceeeecccccccCccc---------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 296 EDHFMIQTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....||+.|+| +|||||||++|||+||+.||...
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 22345666665 89999999999999999999754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=260.42 Aligned_cols=173 Identities=25% Similarity=0.342 Sum_probs=140.7
Q ss_pred hhhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEec--------
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSN-------- 223 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-------- 223 (348)
...++|...+.||+|+||.||+|+. .+++.||+|++.... ....+|+++++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999986 578999999986432 334579999999999999999999844
Q ss_pred ------------------------------CCeEEEEEeccCCCCHHHHHhch----------------hHHHHHHHHHH
Q 038351 224 ------------------------------EDFKVLVLEYMPRGSLEKCLYSS----------------NYVGFALEYLH 257 (348)
Q Consensus 224 ------------------------------~~~~~lV~Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH 257 (348)
....++||||++ |+|.+.+... .+++.||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 334889999998 5877766531 24888999999
Q ss_pred hcCCCceEecCCCcCceEEc-CCCcEEEeecCCccccccCCceeeecccccccCccc-------------cccHHHHHHH
Q 038351 258 FDYSVLIIHYDLKPSNVLFD-DNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA-------------SYVYSFGIML 323 (348)
Q Consensus 258 ~~~~~~iiHrDik~~NILld-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl 323 (348)
+.+|+||||||+||+++ .++.+||+|||+++....... .....+|+.|+| +||||+||++
T Consensus 159 ---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 ---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp ---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred ---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 88999999999999998 689999999999987644322 234456777776 8999999999
Q ss_pred HHHHcCCCCCccc
Q 038351 324 LEVFTRKKPTNKI 336 (348)
Q Consensus 324 ~elltG~~P~~~~ 336 (348)
|||++|+.||...
T Consensus 233 ~ell~g~~pf~~~ 245 (383)
T 3eb0_A 233 GELILGKPLFSGE 245 (383)
T ss_dssp HHHHHSSCSSCCS
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=256.47 Aligned_cols=180 Identities=25% Similarity=0.346 Sum_probs=139.3
Q ss_pred hCCCccccccccCCcceEEEeEec-CCce----EEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCCeEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRME----FSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 228 (348)
.++|+..+.||+|+||.||+|+.. ++.. ||+|.+.... ....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 457889999999999999999864 4443 5777664332 334567899999999999999999999998765 78
Q ss_pred EEEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 229 LVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
+|+||+++|+|.+++.... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 9999999999999886532 3888999999 77899999999999999999999999999987654
Q ss_pred CCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccccc
Q 038351 296 EDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIFF 338 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~~ 338 (348)
...........+|+.|+| +|||||||++|||+| |+.||+....
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 225 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 333223334456677876 899999999999999 9999986543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.98 E-value=9.5e-33 Score=250.48 Aligned_cols=177 Identities=28% Similarity=0.401 Sum_probs=137.4
Q ss_pred hCCCccccccccCCcceEEEeEecCCceEEEEeeeeccC----ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCS----GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
.++|+..+.||+|+||.||+|+.. +..||||.+..... ...+.+.+|++++++++||||+++++++..++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888999999999999999975 77899999864422 2246788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC--------CCcEEEeecCCcc
Q 038351 231 LEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD--------NIVTHLSDFGIAK 291 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~--------~~~~kl~DfGla~ 291 (348)
|||+++++|.+++... .+++.||+|||.....+|+||||||+||+++. ++.+||+|||+++
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp EECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 9999999999988643 24888999999543334999999999999986 6789999999998
Q ss_pred ccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 292 LLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....... ....||+.|+| +||||||++++||+||+.||...
T Consensus 165 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (271)
T 3dtc_A 165 EWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217 (271)
T ss_dssp ---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred ccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 7643221 24467888876 89999999999999999999764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.5e-33 Score=250.06 Aligned_cols=176 Identities=26% Similarity=0.403 Sum_probs=148.9
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
++|...+.||+|+||.||+|+..++..||+|.+..... ..+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 46788899999999999999998888999999875432 34678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeee
Q 038351 236 RGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302 (348)
Q Consensus 236 ~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 302 (348)
+++|.+++.... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS 162 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHST
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-cccc
Confidence 999999886532 3788999999 7889999999999999999999999999998764321 1111
Q ss_pred cccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 303 TQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 303 ~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
....++..|+| +||||||+++|||+| |+.||...
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 23345566765 899999999999999 89999754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.8e-33 Score=253.76 Aligned_cols=172 Identities=21% Similarity=0.270 Sum_probs=143.8
Q ss_pred hCCCccccccccCCcceEEEeEecC-C-------ceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQD-R-------MEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDF 226 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 226 (348)
.++|...+.||+|+||.||+|+... + ..||+|.+........+.+.+|++++++++||||+++++++..++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3568888999999999999998653 2 4699999876555566789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCc--------EEEe
Q 038351 227 KVLVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIV--------THLS 285 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~--------~kl~ 285 (348)
.++||||+++|+|.+++.... +++.||+||| +.+|+||||||+||+++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 999999999999999986532 3788999999 788999999999999998887 9999
Q ss_pred ecCCccccccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCC-CCcc
Q 038351 286 DFGIAKLLIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKK-PTNK 335 (348)
Q Consensus 286 DfGla~~~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~-P~~~ 335 (348)
|||+++..... ....+|+.|+| +|||||||++|||+||.. |+..
T Consensus 164 Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~ 221 (289)
T 4fvq_A 164 DPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221 (289)
T ss_dssp CCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence 99999765321 22345666665 899999999999999554 4433
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=256.90 Aligned_cols=178 Identities=20% Similarity=0.321 Sum_probs=151.0
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
..++|...+.||+|+||.||+++.. ++..+|+|.+..... ...+.+.+|++++++++||||+++++++...+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3457888999999999999999976 577899999865422 234668899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 230 VLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
||||+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 99999999999887642 23888999999 7799999999999999999999999999998764322
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. ......||+.|+| +|||||||++|||+||+.||+..
T Consensus 196 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 244 (335)
T 2owb_A 196 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244 (335)
T ss_dssp C--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred c--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence 2 1234567888886 89999999999999999999754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=250.98 Aligned_cols=177 Identities=20% Similarity=0.325 Sum_probs=150.0
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
.++|...+.||+|+||.||+|+.. +++.+|+|.+..... ...+.+.+|++++++++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 457888899999999999999976 577899998865422 2345688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 231 LEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
|||+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 9999999999887642 23888999999 77999999999999999999999999999987643222
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......||+.|+| +||||||+++|||+||+.||+..
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 218 (294)
T 2rku_A 171 --RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218 (294)
T ss_dssp --CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred --ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1234567888876 89999999999999999999764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=269.67 Aligned_cols=178 Identities=20% Similarity=0.340 Sum_probs=149.0
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-------------ccchhhHHHhhhcccccccceeeEE
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-------------GAFKSFDFECDVMKSTCYRNLIKII 218 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~ 218 (348)
...++|...+.||+|+||.||+|+.. ++..||+|.+..... ...+.+.+|++++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45678999999999999999999976 578899999864321 2235688999999999999999999
Q ss_pred EEEecCCeEEEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC---cEE
Q 038351 219 SSRSNEDFKVLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI---VTH 283 (348)
Q Consensus 219 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~---~~k 283 (348)
+++...+..++|||||++|+|.+.+... .+++.||+||| +.+|+||||||+||+++.++ .+|
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence 9999999999999999999998887543 23888999999 78999999999999998765 699
Q ss_pred EeecCCccccccCCceeeecccccccCccc-----------cccHHHHHHHHHHHcCCCCCccc
Q 038351 284 LSDFGIAKLLIREDHFMIQTQTLATIGYMA-----------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 284 l~DfGla~~~~~~~~~~~~~~~~gt~~y~a-----------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
|+|||+++....... .....||+.|+| +||||+||++|||++|+.||...
T Consensus 190 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 250 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQ 250 (504)
T ss_dssp ECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEECCCCEEcCCCCc---cccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999987654322 245568999987 89999999999999999999754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=256.22 Aligned_cols=178 Identities=26% Similarity=0.403 Sum_probs=149.6
Q ss_pred CCCccccccccCCcceEEEeEe-----cCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEe--cCCeEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARI-----QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRS--NEDFKV 228 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~ 228 (348)
++|+..+.||+|+||.||+|++ .++..||||.+........+.+.+|++++++++||||+++++++. ..+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788889999999999999984 468899999997655445567899999999999999999999887 456789
Q ss_pred EEEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 229 LVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
+||||+++++|.+++.... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 9999999999999886521 3788999999 78999999999999999999999999999987654
Q ss_pred CCce-eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 296 EDHF-MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 296 ~~~~-~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.... .......+|+.|+| +|||||||++|||+||+.||...
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 3322 12233456777876 89999999999999999998653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=249.34 Aligned_cols=175 Identities=22% Similarity=0.343 Sum_probs=149.2
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
.++|...+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357888899999999999999976 57789999986432 22346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 231 LEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
|||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence 9999999999888643 23888999999 8899999999999999999999999999997654321
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....|++.|+| +||||||+++|||++|+.||+..
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 215 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence 234557777776 89999999999999999999754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=252.23 Aligned_cols=176 Identities=27% Similarity=0.410 Sum_probs=136.2
Q ss_pred hCCCccccccccCCcceEEEeEecCCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.++|+..+.||+|+||.||+|+... .+|+|.+..... ...+.+.+|++++++++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4578899999999999999998654 599998865432 2346789999999999999999999965 4566899999
Q ss_pred ccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 233 YMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 233 y~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|+++++|.+++.... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++........
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 999999999885432 3788999999 788999999999999999999999999999865432222
Q ss_pred eeecccccccCccc---------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.......||+.|+| +|||||||+++||+||+.||...
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 228 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence 22234557777765 79999999999999999999764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=248.76 Aligned_cols=176 Identities=23% Similarity=0.343 Sum_probs=146.8
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc------cchhhHHHhhhcccccccceeeEEEEEecCCeE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG------AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFK 227 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 227 (348)
.++|...+.||+|+||.||+|+.. +++.||+|.+...... ..+.+.+|++++++++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356888899999999999999976 6889999998654321 246688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC----cEEEeecCCcc
Q 038351 228 VLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI----VTHLSDFGIAK 291 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~----~~kl~DfGla~ 291 (348)
++||||+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++ .+||+|||+++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 9999999999999988642 23888999999 78999999999999998877 89999999998
Q ss_pred ccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 292 LLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....... .....+|+.|+| +||||||++++||+||+.||...
T Consensus 161 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 214 (283)
T 3bhy_A 161 KIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 214 (283)
T ss_dssp ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred eccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence 7643221 233457777776 89999999999999999999754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.8e-33 Score=271.62 Aligned_cols=177 Identities=23% Similarity=0.338 Sum_probs=151.6
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
..++|...+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3457888999999999999999976 78899999986442 2345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEE---cCCCcEEEeecCCccccc
Q 038351 230 VLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLF---DDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILl---d~~~~~kl~DfGla~~~~ 294 (348)
||||+++|+|.+.+... .+++.||+||| +.+|+||||||+||++ +.++.+||+|||+++...
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 99999999999887543 23888999999 7789999999999999 567899999999998765
Q ss_pred cCCceeeecccccccCccc-----------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHFMIQTQTLATIGYMA-----------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~a-----------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.... .....||+.|+| +||||+||++|||++|+.||...
T Consensus 181 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 230 (484)
T 3nyv_A 181 ASKK---MKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGA 230 (484)
T ss_dssp CCCS---HHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccc---cccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCC
Confidence 4322 234568888887 89999999999999999999753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=7e-33 Score=276.22 Aligned_cols=176 Identities=25% Similarity=0.423 Sum_probs=147.6
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
++|...+.||+|+||.||+|++.++..||||.++... ...+.|.+|+++|++++||||+++++++.. +..++|||||+
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~ 344 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 344 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence 4567778999999999999999988899999997543 234679999999999999999999999876 67899999999
Q ss_pred CCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 236 RGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 236 ~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+|+|.++++... +++.||+||| +.+|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~ 420 (535)
T 2h8h_A 345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTA 420 (535)
T ss_dssp TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHT
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eec
Confidence 999999987421 3888999999 7889999999999999999999999999998764321 111
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
.....++..|+| +|||||||++|||+| |+.||....
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~ 469 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 469 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 223345667776 899999999999999 999997643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-32 Score=258.70 Aligned_cols=179 Identities=25% Similarity=0.404 Sum_probs=151.5
Q ss_pred HHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc--------cchhhHHHhhhcccc-cccceeeEEEE
Q 038351 151 LCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG--------AFKSFDFECDVMKST-CYRNLIKIISS 220 (348)
Q Consensus 151 ~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~H~niv~l~~~ 220 (348)
.....++|...+.||+|+||.||+|+.. ++..||||.+...... ..+.+.+|+++++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3455678999999999999999999986 7899999998654321 134578899999999 79999999999
Q ss_pred EecCCeEEEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecC
Q 038351 221 RSNEDFKVLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFG 288 (348)
Q Consensus 221 ~~~~~~~~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfG 288 (348)
+...+..++||||+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecC
Confidence 99999999999999999999988643 13888999999 7799999999999999999999999999
Q ss_pred CccccccCCceeeecccccccCccc------------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 289 IAKLLIREDHFMIQTQTLATIGYMA------------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 289 la~~~~~~~~~~~~~~~~gt~~y~a------------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
+++.+..... .....||+.|+| +|||||||++|||+||+.||..
T Consensus 246 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 307 (365)
T 2y7j_A 246 FSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307 (365)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence 9987654322 234567777765 7999999999999999999965
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=255.79 Aligned_cols=173 Identities=22% Similarity=0.249 Sum_probs=139.3
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc--cchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG--AFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 230 (348)
.++|+..+.||+|+||+||+|+.. +++.||||++...... ....+..|+..+.++ +||||++++++|...+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357888999999999999999986 7899999987543222 223455566655555 899999999999999999999
Q ss_pred EeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 231 LEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
|||+ +++|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999 67888877542 24888999999 6789999999999999999999999999998764322
Q ss_pred ceeeecccccccCccc-----------cccHHHHHHHHHHHcCCCCCc
Q 038351 298 HFMIQTQTLATIGYMA-----------SYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a-----------sDV~S~Gvvl~elltG~~P~~ 334 (348)
......||+.|+| +|||||||++|||++|..|+.
T Consensus 212 ---~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 212 ---AGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp ------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred ---CCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 2234568888887 799999999999999976653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=269.73 Aligned_cols=178 Identities=21% Similarity=0.336 Sum_probs=149.9
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
...++|...+.||+|+||.||+|+.. +++.||||.+.... ......+.+|++++++++||||+++++++...+..++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 34567889999999999999999976 78899999986432 2345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEc---CCCcEEEeecCCccccc
Q 038351 230 VLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFD---DNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld---~~~~~kl~DfGla~~~~ 294 (348)
|||||++|+|.+.+... .+++.||+||| +.+|+||||||+|||++ .++.+||+|||+++...
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 99999999998877542 23788999999 78999999999999995 46679999999998764
Q ss_pred cCCceeeecccccccCccc-----------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHFMIQTQTLATIGYMA-----------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~a-----------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
... ......||+.|+| +||||+||++|||++|+.||...
T Consensus 176 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 225 (486)
T 3mwu_A 176 QNT---KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGK 225 (486)
T ss_dssp CC-------CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCC---ccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 332 2234568888887 89999999999999999999653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=257.33 Aligned_cols=178 Identities=21% Similarity=0.279 Sum_probs=139.6
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
...++|...+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 44568999999999999999999865 788999999864432 234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEE-----cCCCcEEEeecCCccc
Q 038351 230 VLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLF-----DDNIVTHLSDFGIAKL 292 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILl-----d~~~~~kl~DfGla~~ 292 (348)
||||++ |+|.+++... .+++.||+||| +.+|+||||||+||++ +..+.+||+|||+++.
T Consensus 111 v~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 999997 5998887643 24888999999 7799999999999999 4556699999999987
Q ss_pred cccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 293 LIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...... ......+|+.|+| +|||||||++|||++|+.||...
T Consensus 187 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 187 FGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp HC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 643221 1233456777766 89999999999999999999653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=251.69 Aligned_cols=178 Identities=24% Similarity=0.356 Sum_probs=135.1
Q ss_pred hCCCccccccccCCcceEEEeEecC----CceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQD----RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
.++|...+.||+|+||.||+|+... +..||+|....... ...+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4578888999999999999998643 45689998764322 23466889999999999999999999984 567899
Q ss_pred EEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 230 VLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
||||+++|+|.+++.... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 999999999999886432 3788999999 789999999999999999999999999999876432
Q ss_pred CceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 297 DHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
... ......+|+.|+| +|||||||++|||++ |+.||+...
T Consensus 170 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~ 222 (281)
T 1mp8_A 170 TYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC
Confidence 211 1223345667776 899999999999997 999997643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=258.29 Aligned_cols=178 Identities=22% Similarity=0.191 Sum_probs=140.6
Q ss_pred hCCCccccccccCCcceEEEeEec----CCceEEEEeeeeccCc-----------cchhhHHHhhhcccccccceeeEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ----DRMEFSVKGFHLQCSG-----------AFKSFDFECDVMKSTCYRNLIKIIS 219 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~~ 219 (348)
.++|...+.||+|+||.||+|+.. ++..+|+|........ ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357889999999999999999975 5778999988654321 1234667888899999999999999
Q ss_pred EEec----CCeEEEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCC--c
Q 038351 220 SRSN----EDFKVLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI--V 281 (348)
Q Consensus 220 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~--~ 281 (348)
++.. ....++||||+ +++|.+++.... +++.||+||| +.+|+||||||+||+++.++ .
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCc
Confidence 9987 78899999999 999999887532 3889999999 77999999999999999877 9
Q ss_pred EEEeecCCccccccCCce-----eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 282 THLSDFGIAKLLIREDHF-----MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 282 ~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+||+|||+++.+...... .......||+.|+| +|||||||++|||+||+.||+..
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 999999999876432211 11134568888987 89999999999999999999653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=253.57 Aligned_cols=176 Identities=22% Similarity=0.325 Sum_probs=146.7
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
..++|...+.||+|+||.||+|+.. +++.||+|.+........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3457888999999999999999975 788999999976544445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEE---cCCCcEEEeecCCccccccCC
Q 038351 233 YMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLF---DDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 233 y~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILl---d~~~~~kl~DfGla~~~~~~~ 297 (348)
|+++++|.+++... .+++.||+||| +.+|+||||||+||++ ++++.++|+|||+++......
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 99999999887542 13788999999 7799999999999999 788999999999997653221
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....||+.|+| +||||+||++|||+||+.||...
T Consensus 164 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 164 ----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp ----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 123456777765 89999999999999999999653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=258.09 Aligned_cols=179 Identities=26% Similarity=0.356 Sum_probs=143.0
Q ss_pred HhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-----ccchhhHHHhhhcccccccceeeEEEEEecCC
Q 038351 152 CRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-----GAFKSFDFECDVMKSTCYRNLIKIISSRSNED 225 (348)
Q Consensus 152 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 225 (348)
....++|...+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++...+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 345678999999999999999999975 688999999864322 12356889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
..++||||+++ +|.+.+... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 99999999986 888877643 23888999999 77899999999999999999999999999987
Q ss_pred cccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 293 LIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...... ......+|+.|+| +|||||||++|||++|++||...
T Consensus 162 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 162 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp TTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 643221 2234567777776 89999999999999999998653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-33 Score=271.01 Aligned_cols=176 Identities=23% Similarity=0.229 Sum_probs=140.8
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecC------
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNE------ 224 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 224 (348)
..++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 4578999999999999999999865 68899999996542 22346788999999999999999999999754
Q ss_pred CeEEEEEeccCCCCHHHHHhc----------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 225 DFKVLVLEYMPRGSLEKCLYS----------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 225 ~~~~lV~Ey~~~gsL~~~l~~----------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
...++|||||++ ++.+.+.. ..+++.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CeEEEEEeCCCC-CHHHHHhhcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 457999999976 46555442 234888999999 7789999999999999999999999999998764
Q ss_pred cCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
... ..+...||+.|+| +||||+||++|||++|+.||...
T Consensus 216 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 216 TSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp -CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 322 2345678888887 89999999999999999999753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=253.84 Aligned_cols=181 Identities=24% Similarity=0.320 Sum_probs=141.2
Q ss_pred HhhhCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhc--ccccccceeeEEEEEecC----C
Q 038351 152 CRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVM--KSTCYRNLIKIISSRSNE----D 225 (348)
Q Consensus 152 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l--~~l~H~niv~l~~~~~~~----~ 225 (348)
....++|+..+.||+|+||.||+|+.. +..||||.+.... ...+..|.+++ ..++||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 345578999999999999999999876 7899999985432 23344455544 445899999999999887 7
Q ss_pred eEEEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhc-----CCCceEecCCCcCceEEcCCCcEEEeecCC
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFD-----YSVLIIHYDLKPSNVLFDDNIVTHLSDFGI 289 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~-----~~~~iiHrDik~~NILld~~~~~kl~DfGl 289 (348)
..++||||+++|+|.++++.. .+++.||+|||.. +.++|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 899999999999999998642 2388899999932 122999999999999999999999999999
Q ss_pred ccccccCCcee--eecccccccCccc------------------cccHHHHHHHHHHHcC----------CCCCccc
Q 038351 290 AKLLIREDHFM--IQTQTLATIGYMA------------------SYVYSFGIMLLEVFTR----------KKPTNKI 336 (348)
Q Consensus 290 a~~~~~~~~~~--~~~~~~gt~~y~a------------------sDV~S~Gvvl~elltG----------~~P~~~~ 336 (348)
++......... ......||+.|+| +|||||||++|||+|| +.||...
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 97764332211 1224568888876 5999999999999999 6676553
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=254.90 Aligned_cols=181 Identities=22% Similarity=0.392 Sum_probs=150.5
Q ss_pred hhCCCccccccccCCcceEEEeEe------cCCceEEEEeeeeccC-ccchhhHHHhhhcccc-cccceeeEEEEEecCC
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARI------QDRMEFSVKGFHLQCS-GAFKSFDFECDVMKST-CYRNLIKIISSRSNED 225 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 225 (348)
..++|...+.||+|+||.||+|+. .+++.||+|.+..... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 456788999999999999999974 3567899999865432 2345688999999999 6999999999988754
Q ss_pred -eEEEEEeccCCCCHHHHHhchh----------------------------HHHHHHHHHHhcCCCceEecCCCcCceEE
Q 038351 226 -FKVLVLEYMPRGSLEKCLYSSN----------------------------YVGFALEYLHFDYSVLIIHYDLKPSNVLF 276 (348)
Q Consensus 226 -~~~lV~Ey~~~gsL~~~l~~~~----------------------------~i~~~L~yLH~~~~~~iiHrDik~~NILl 276 (348)
..++||||+++|+|.+++.... +++.||+||| +.+|+||||||+||++
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILL 181 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEE
Confidence 5899999999999999886421 4888999999 7799999999999999
Q ss_pred cCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 277 DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 277 d~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
+.++.+||+|||+++...............+|+.|+| +|||||||++|||+| |+.||....
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999987654443333445567778876 899999999999998 999997643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=259.04 Aligned_cols=181 Identities=22% Similarity=0.284 Sum_probs=143.7
Q ss_pred hhHHhhhCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCcc-----------chhhHHHhhhcccccccceeeE
Q 038351 149 LELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGA-----------FKSFDFECDVMKSTCYRNLIKI 217 (348)
Q Consensus 149 ~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l 217 (348)
.++....++|...+.||+|+||.||+|+..++..||||++....... .+.+.+|++++++++||||+++
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 94 (362)
T 3pg1_A 15 AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL 94 (362)
T ss_dssp HHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred HHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence 56778889999999999999999999998889999999986543221 2568899999999999999999
Q ss_pred EEEEec-----CCeEEEEEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCC
Q 038351 218 ISSRSN-----EDFKVLVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN 279 (348)
Q Consensus 218 ~~~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~ 279 (348)
++++.. ....++||||++ |+|.+.+.... +++.||+||| +.+|+||||||+||+++.+
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~ 170 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADN 170 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcCC
Confidence 999853 346899999997 68887776432 3888999999 7789999999999999999
Q ss_pred CcEEEeecCCccccccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 280 IVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 280 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+.+||+|||+++...... ......+|+.|+| +|||||||++|||+||+.||...
T Consensus 171 ~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 171 NDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp CCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999998653322 1233456666665 89999999999999999999764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=255.85 Aligned_cols=179 Identities=22% Similarity=0.294 Sum_probs=145.6
Q ss_pred hhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEec-------
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSN------- 223 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------- 223 (348)
..++|...+.||+|+||.||+|+. .+++.||+|++..... .....+.+|++++++++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 346889999999999999999997 4788999998854432 234567899999999999999999999887
Q ss_pred -CCeEEEEEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCC
Q 038351 224 -EDFKVLVLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGI 289 (348)
Q Consensus 224 -~~~~~lV~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGl 289 (348)
.+..++||||+++ ++.+.+... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 4568999999975 676665542 24888999999 78999999999999999999999999999
Q ss_pred ccccccCCc--eeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 290 AKLLIREDH--FMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 290 a~~~~~~~~--~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
++....... ........||+.|+| +|||||||++|||+||+.||...
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 987642211 112234456777776 89999999999999999999754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=252.56 Aligned_cols=180 Identities=22% Similarity=0.242 Sum_probs=143.2
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc---cchhhHHHhhhcccccccceeeEEEEEecCCeEE
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG---AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 228 (348)
...++|...+.||+|+||.||+|+.. +++.||+|.+...... ..+.+.+|++++++++||||+++++++..++..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34578999999999999999999975 6889999998644322 2366889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 229 LVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
+||||+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 999999999999988643 13788999999 778999999999999999999999999999876432
Q ss_pred CceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 297 DHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.. .......||+.|+| +||||||+++|||+||+.||...
T Consensus 188 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 188 KL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred cc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 21 11233456777775 89999999999999999999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=254.99 Aligned_cols=177 Identities=23% Similarity=0.300 Sum_probs=143.1
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc--cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG--AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
.++|+..+.||+|+||.||+|+.. +++.||+|.+...... ..+.+.+|++++++++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 356888899999999999999976 5889999998644322 2345778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 179 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 179 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-
Confidence 999999888876432 24888999999 78999999999999999999999999999987643222
Q ss_pred eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......||+.|+| +||||+||++|||+||+.||...
T Consensus 180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1233456777765 89999999999999999999754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=274.88 Aligned_cols=171 Identities=23% Similarity=0.404 Sum_probs=138.6
Q ss_pred ccccCCcceEEEeEec---CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCCCC
Q 038351 163 LISRGGFGSIHKARIQ---DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGS 238 (348)
Q Consensus 163 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 238 (348)
.||+|+||.||+|.+. ++..||||.++.... ...+.+.+|++++++++||||++++++|.. +..++|||||++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 566799999975432 345779999999999999999999999976 56899999999999
Q ss_pred HHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce-eeecc
Q 038351 239 LEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF-MIQTQ 304 (348)
Q Consensus 239 L~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~-~~~~~ 304 (348)
|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+...... .....
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 99998642 13888999999 789999999999999999999999999999876433221 11122
Q ss_pred cccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 305 TLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 305 ~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
..+++.|+| +|||||||++|||+| |+.||....
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 334577887 899999999999998 999997653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-32 Score=246.13 Aligned_cols=173 Identities=20% Similarity=0.319 Sum_probs=145.1
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccc-cccceeeEEEEEecCCeEE
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 228 (348)
+..++|...+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+..+.++ +||||+++++++..++..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 34567889999999999999999976 788999999875422 2346688899999998 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC--------------
Q 038351 229 LVLEYMPRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD-------------- 278 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~-------------- 278 (348)
+||||+++++|.+++... .+++.||+||| +.+|+||||||+||+++.
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC---------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999999988653 13888999999 789999999999999984
Q ss_pred -----CCcEEEeecCCccccccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCc
Q 038351 279 -----NIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 279 -----~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~ 334 (348)
...+||+|||+++...... ...||+.|+| +|||||||+++||++|++|+.
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred cccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 4479999999998764322 2346666655 899999999999999998764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=251.08 Aligned_cols=180 Identities=23% Similarity=0.335 Sum_probs=132.9
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
..++|...+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3568999999999999999999864 68899999986443 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch--------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcc
Q 038351 232 EYMPRGSLEKCLYSS--------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~--------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~ 291 (348)
||+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999988631 13788999999 7799999999999999999999999999997
Q ss_pred ccccCCce---eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 292 LLIREDHF---MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 292 ~~~~~~~~---~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
........ .......||+.|+| +|||||||++|||+||+.||...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence 76432211 11234457777876 89999999999999999999763
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=250.04 Aligned_cols=179 Identities=24% Similarity=0.368 Sum_probs=151.2
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
..++|+..+.||+|+||.||+|+.. ++..||+|.+... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4567888899999999999999976 4788999998643 2345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 233 YMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 233 y~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
|+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++.++|+|||+++.......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 99999999988641 13788999999 77899999999999999999999999999987654322
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
.......+|+.|+| +||||||+++|||++ |+.||....
T Consensus 167 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~ 217 (288)
T 3kfa_A 167 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217 (288)
T ss_dssp -EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred -ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 22334445667776 899999999999999 999997643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-32 Score=251.19 Aligned_cols=172 Identities=22% Similarity=0.292 Sum_probs=145.2
Q ss_pred hCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCccchhhHHHhhhccccc-ccceeeEEEEEec--CCeEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-YRNLIKIISSRSN--EDFKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lV 230 (348)
.++|+..+.||+|+||.||+|+. .+++.||+|.+... ..+.+.+|++++++++ ||||+++++++.. ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 35788899999999999999986 57889999998632 3467899999999998 9999999999987 6678999
Q ss_pred EeccCCCCHHHHHhch---------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC-cEEEeecCCccccccCCcee
Q 038351 231 LEYMPRGSLEKCLYSS---------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI-VTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~---------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DfGla~~~~~~~~~~ 300 (348)
|||+++++|.+++..- .+++.||+||| +.+|+||||||+||+++.++ .+||+|||+++.......
T Consensus 112 ~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-- 186 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-- 186 (330)
T ss_dssp EECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--
T ss_pred EeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--
Confidence 9999999999887542 24888999999 78899999999999999776 899999999987654322
Q ss_pred eecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 301 IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 301 ~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.....+|..|+| +|||||||++|||+||+.||..
T Consensus 187 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 187 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp -CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred -cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 133456666665 8999999999999999999943
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-32 Score=248.80 Aligned_cols=179 Identities=20% Similarity=0.263 Sum_probs=144.0
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc----CccchhhHHHhhhcccccccceeeEEEEEe--cCCe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC----SGAFKSFDFECDVMKSTCYRNLIKIISSRS--NEDF 226 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~ 226 (348)
..++|...+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|++++++++||||+++++++. ..+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4578999999999999999999975 67899999986432 233467899999999999999999999984 4567
Q ss_pred EEEEEeccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 227 KVLVLEYMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
.++||||++++ +.+.+... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 89999999876 65555431 24888999999 77999999999999999999999999999987
Q ss_pred cccCCceeeecccccccCccc--------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 293 LIREDHFMIQTQTLATIGYMA--------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~a--------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..............||+.|+| +|||||||++|||+||+.||+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 643222222334557777765 89999999999999999999753
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-32 Score=260.01 Aligned_cols=177 Identities=25% Similarity=0.423 Sum_probs=133.9
Q ss_pred CCccccccccCCcceEEEeEec--C--CceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEec-CCeEEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ--D--RMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSN-EDFKVLV 230 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~--~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV 230 (348)
.|...+.||+|+||.||+|+.. + ...||+|.+.... ....+.+.+|+.++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3556789999999999999864 2 2458899886432 2345678999999999999999999998754 5678999
Q ss_pred EeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 231 LEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
|||+++|+|.++++.. .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999998653 24889999999 7899999999999999999999999999998764322
Q ss_pred ce--eeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 298 HF--MIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 298 ~~--~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.. .......+|+.|+| +|||||||++|||+| |.+||...
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 11 11233456677876 899999999999999 77788654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-32 Score=247.14 Aligned_cols=176 Identities=22% Similarity=0.355 Sum_probs=143.7
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
.++|...+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467889999999999999999976 78899999986432 23346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 231 LEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
|||+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 9999999999988642 23888999999 67899999999999999999999999999987643221
Q ss_pred eeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....+|+.|+| +||||||++++||++|+.||+..
T Consensus 167 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 167 ---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 122345555544 89999999999999999999764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-32 Score=247.70 Aligned_cols=173 Identities=26% Similarity=0.338 Sum_probs=143.8
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEec----CCeEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSN----EDFKVL 229 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~l 229 (348)
.|...+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|++++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4667788999999999999875 677899999865432 234668899999999999999999998865 456899
Q ss_pred EEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCc--eEecCCCcCceEEc-CCCcEEEeecCCccccc
Q 038351 230 VLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVL--IIHYDLKPSNVLFD-DNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~--iiHrDik~~NILld-~~~~~kl~DfGla~~~~ 294 (348)
||||+++|+|.+++... .+++.||+||| +.+ |+||||||+||+++ +++.+||+|||++....
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 99999999999988652 23888999999 666 99999999999998 78999999999997654
Q ss_pred cCCceeeecccccccCccc-----------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHFMIQTQTLATIGYMA-----------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~a-----------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
... .....||+.|+| +||||+||++|||+||+.||...
T Consensus 184 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 184 ASF----AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp TTS----BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccc----cccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 322 234457778876 89999999999999999999753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=254.84 Aligned_cols=173 Identities=29% Similarity=0.390 Sum_probs=136.6
Q ss_pred hCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhH--HHhhhcccccccceeeEEEEEec-----CCeE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFD--FECDVMKSTCYRNLIKIISSRSN-----EDFK 227 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~H~niv~l~~~~~~-----~~~~ 227 (348)
.++|...+.||+|+||.||+|+. +++.||||.+.... ...+. .|+..+..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 45788899999999999999976 57899999986432 23333 44555667899999999985532 3367
Q ss_pred EEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCC---------ceEecCCCcCceEEcCCCcEEEeec
Q 038351 228 VLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSV---------LIIHYDLKPSNVLFDDNIVTHLSDF 287 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~---------~iiHrDik~~NILld~~~~~kl~Df 287 (348)
++||||+++|+|.+++... .+++.||+||| +. +|+||||||+|||++.++.+||+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 8999999999999988643 24889999999 55 9999999999999999999999999
Q ss_pred CCccccccCCc------eeeecccccccCccc-------------------cccHHHHHHHHHHHcCCCCCc
Q 038351 288 GIAKLLIREDH------FMIQTQTLATIGYMA-------------------SYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 288 Gla~~~~~~~~------~~~~~~~~gt~~y~a-------------------sDV~S~Gvvl~elltG~~P~~ 334 (348)
|+++.+..... ........||+.|+| +|||||||++|||+||+.||.
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 99987653221 112234467888876 699999999999999987753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=246.46 Aligned_cols=172 Identities=24% Similarity=0.436 Sum_probs=146.2
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEec---------
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSN--------- 223 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------- 223 (348)
...+|+..+.||+|+||.||+|+.. +++.||+|.+.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4467888999999999999999986 78899999986432 568899999999999999999998864
Q ss_pred -------CCeEEEEEeccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcE
Q 038351 224 -------EDFKVLVLEYMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVT 282 (348)
Q Consensus 224 -------~~~~~lV~Ey~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ 282 (348)
....++||||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCE
Confidence 34579999999999999998643 13788999999 7799999999999999999999
Q ss_pred EEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 283 HLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 283 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
||+|||+++....... .....||+.|+| +|||||||++|||+||..|+..
T Consensus 162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 9999999987654322 234467888876 8999999999999999998753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=261.05 Aligned_cols=172 Identities=14% Similarity=0.132 Sum_probs=137.5
Q ss_pred hCCCccccccccCCcceEEEeEe-cCCceEEEEeeeec---cCccchhhHHHh---hhcccccccceeeEE-------EE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQ---CSGAFKSFDFEC---DVMKSTCYRNLIKII-------SS 220 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------~~ 220 (348)
.++|...+.||+|+||.||+|+. .+++.||||.+... .....+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788889999999999999996 56899999999743 223446788999 667777899999998 66
Q ss_pred EecCC-----------------eEEEEEeccCCCCHHHHHhch-------------------hHHHHHHHHHHhcCCCce
Q 038351 221 RSNED-----------------FKVLVLEYMPRGSLEKCLYSS-------------------NYVGFALEYLHFDYSVLI 264 (348)
Q Consensus 221 ~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~-------------------~~i~~~L~yLH~~~~~~i 264 (348)
+..++ ..++||||+ +|+|.+++... .+++.||+||| +.+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 66553 278999999 68999988642 13788999999 7789
Q ss_pred EecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecccccccCccc-----------------------cccHHHHH
Q 038351 265 IHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA-----------------------SYVYSFGI 321 (348)
Q Consensus 265 iHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a-----------------------sDV~S~Gv 321 (348)
+||||||+|||++.++.+||+|||+++.... ......| +.|+| +|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 1123344 55554 69999999
Q ss_pred HHHHHHcCCCCCccc
Q 038351 322 MLLEVFTRKKPTNKI 336 (348)
Q Consensus 322 vl~elltG~~P~~~~ 336 (348)
++|||+||+.||...
T Consensus 302 il~elltg~~Pf~~~ 316 (377)
T 3byv_A 302 VIYWIWCADLPITKD 316 (377)
T ss_dssp HHHHHHHSSCCC---
T ss_pred HHHHHHHCCCCCccc
Confidence 999999999999654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-32 Score=248.11 Aligned_cols=177 Identities=24% Similarity=0.338 Sum_probs=151.1
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.+.|...+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888899999999999999864 688999999875432 345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 233 YMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 233 y~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
|+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 101 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 175 (303)
T 3a7i_A 101 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--K 175 (303)
T ss_dssp CCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--C
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcccc--c
Confidence 99999999988642 23888999999 77999999999999999999999999999987653321 2
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....||+.|+| +|||||||+++||+||+.||...
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 222 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence 234567777776 89999999999999999999754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=262.11 Aligned_cols=170 Identities=25% Similarity=0.348 Sum_probs=137.7
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecC------CeEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNE------DFKV 228 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~ 228 (348)
.+|...+.||+|+||.||+|+.. +++.||||++.... ..+.+|++++++++||||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 36888899999999999999985 68899999986432 3345799999999999999999988542 2367
Q ss_pred EEEeccCCCCHHHHHhc----------------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCC-CcEEEeecCCcc
Q 038351 229 LVLEYMPRGSLEKCLYS----------------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN-IVTHLSDFGIAK 291 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~----------------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DfGla~ 291 (348)
+||||+++ ++.+.+.. ..+++.||+||| +.+|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999976 66555432 124888999999 8899999999999999955 678999999998
Q ss_pred ccccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 292 LLIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.+..... .....||+.|+| +|||||||++|||++|+.||...
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~ 260 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 7643322 234567888876 79999999999999999999754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-32 Score=251.35 Aligned_cols=175 Identities=27% Similarity=0.464 Sum_probs=142.3
Q ss_pred CCCccccccccCCcceEEEeEec-CCce--EEEEeeeec-cCccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRME--FSVKGFHLQ-CSGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 230 (348)
++|...+.||+|+||.||+|+.. ++.. +|+|.+... .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888899999999999999865 4554 488888643 233456789999999999 899999999999999999999
Q ss_pred EeccCCCCHHHHHhchh----------------------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcE
Q 038351 231 LEYMPRGSLEKCLYSSN----------------------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVT 282 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~----------------------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ 282 (348)
|||+++|+|.+++.... +++.||+||| +.+|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence 99999999999986532 3788999999 7899999999999999999999
Q ss_pred EEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 283 HLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 283 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
||+|||+++..... .......+++.|+| +|||||||++|||+| |+.||...
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 245 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 245 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC
Confidence 99999999753221 11223345667776 899999999999998 99999654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=251.84 Aligned_cols=181 Identities=23% Similarity=0.403 Sum_probs=136.5
Q ss_pred hhCCCccccccccCCcceEEEeEec----CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCC--
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ----DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNED-- 225 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-- 225 (348)
..++|...+.||+|+||.||+|+.. ++..||+|.+..... ...+.+.+|++++++++||||+++++++...+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 4567888899999999999999864 345799999865432 23466889999999999999999999998755
Q ss_pred ---eEEEEEeccCCCCHHHHHhch------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEE
Q 038351 226 ---FKVLVLEYMPRGSLEKCLYSS------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHL 284 (348)
Q Consensus 226 ---~~~lV~Ey~~~gsL~~~l~~~------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl 284 (348)
..++||||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEE
Confidence 359999999999999988321 23888999999 889999999999999999999999
Q ss_pred eecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 285 SDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 285 ~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
+|||+++...............+++.|+| +|||||||++|||+| |+.||....
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 254 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 99999987654332222333445666766 799999999999999 999987643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-32 Score=249.30 Aligned_cols=178 Identities=25% Similarity=0.324 Sum_probs=137.7
Q ss_pred hhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccC---ccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
...+|...+.||+|+||.||+|+. .++..||+|.+..... ...+.+.+|++++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 345788999999999999999986 4788999999864322 234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 230 VLEYMPRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
||||+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999988631 13788999999 789999999999999999999999999999876
Q ss_pred ccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 294 IREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..... ......|++.|+| +|||||||++|||+||+.||...
T Consensus 187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 43221 1233457777876 89999999999999999999653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=250.57 Aligned_cols=178 Identities=21% Similarity=0.298 Sum_probs=139.6
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEe-----------
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRS----------- 222 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~----------- 222 (348)
.++|...+.||+|+||.||+|+.. +++.||+|.+........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467889999999999999999976 48899999987655455677899999999999999999999874
Q ss_pred ---cCCeEEEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEc-CCCcEEEeec
Q 038351 223 ---NEDFKVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFD-DNIVTHLSDF 287 (348)
Q Consensus 223 ---~~~~~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld-~~~~~kl~Df 287 (348)
..+..++||||++ |+|.+++... .+++.||+||| +.+|+||||||+||+++ +++.+||+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 3467899999997 6999887652 24888999999 77999999999999997 5679999999
Q ss_pred CCccccccCCce-eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 288 GIAKLLIREDHF-MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 288 Gla~~~~~~~~~-~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
|+++........ .......+|..|+| +|||||||++|||+||+.||...
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 228 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA 228 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence 999876432111 11123345666765 89999999999999999999754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=252.72 Aligned_cols=178 Identities=26% Similarity=0.427 Sum_probs=147.4
Q ss_pred CCCccccccccCCcceEEEeEe-----cCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCC--eEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARI-----QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNED--FKV 228 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~ 228 (348)
++|...+.||+|+||.||+|+. .++..||+|.+........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4577889999999999999984 368899999997655555577999999999999999999999987654 789
Q ss_pred EEEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 229 LVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
+||||+++++|.+++.... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 9999999999999886532 3788999999 78999999999999999999999999999988754
Q ss_pred CCcee-eecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 296 EDHFM-IQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 296 ~~~~~-~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..... ......++..|+| +|||||||+++||+||+.|+...
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 251 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 251 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 33221 1223345666776 89999999999999999998643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=260.81 Aligned_cols=172 Identities=25% Similarity=0.349 Sum_probs=138.5
Q ss_pred hCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCC------eEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNED------FKV 228 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~ 228 (348)
..+|...+.||+|+||.||+|+...+..+|+|++.... ....+|+++++.++||||+++++++...+ ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 34688899999999999999999877789999885432 23457999999999999999999986533 378
Q ss_pred EEEeccCCCCHHHHHhc---------------hhHHHHHHHHHHhcCCCceEecCCCcCceEEc-CCCcEEEeecCCccc
Q 038351 229 LVLEYMPRGSLEKCLYS---------------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFD-DNIVTHLSDFGIAKL 292 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~---------------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld-~~~~~kl~DfGla~~ 292 (348)
+||||++++.+...... ..+++.||+||| +.+|+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999987533322210 124889999999 78999999999999999 799999999999987
Q ss_pred cccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 293 LIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...... .....+|+.|+| +||||+||++|||++|+.||...
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 245 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 643322 234556777776 89999999999999999999764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=260.14 Aligned_cols=174 Identities=23% Similarity=0.277 Sum_probs=140.2
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCC-----
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNED----- 225 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 225 (348)
..++|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 4567899999999999999999974 788999999854322 22456889999999999999999999998753
Q ss_pred -eEEEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 226 -FKVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 226 -~~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
..++||||+ +++|.++++.. .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 78999887642 24888999999 789999999999999999999999999999875
Q ss_pred ccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 294 IREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
... .....+|+.|+| +||||+||+++||++|+.||...
T Consensus 179 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 179 DSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp CSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 432 234556777776 89999999999999999999753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=248.08 Aligned_cols=176 Identities=24% Similarity=0.319 Sum_probs=145.1
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
..++|+..+.||+|+||.||+|+.. ++..||+|.+... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567888999999999999999876 5889999998653 245778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 233 YMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 233 y~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence 99999999988632 13788999999 78899999999999999999999999999987643221
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......||+.|+| +|||||||++|||++|+.||...
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 2234457777776 89999999999999999999753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=251.56 Aligned_cols=178 Identities=21% Similarity=0.342 Sum_probs=143.9
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
..+.|+..+.||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4567888999999999999999986 588999999876655566789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 233 YMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 233 y~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 172 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ- 172 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc-
Confidence 99999999887542 23888999999 77999999999999999999999999999764321110
Q ss_pred eeecccccccCccc-----------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA-----------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a-----------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......||+.|+| +|||||||++|||+||+.||...
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 225 (302)
T 2j7t_A 173 -KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225 (302)
T ss_dssp -C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 1122345555544 89999999999999999999754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=254.15 Aligned_cols=179 Identities=20% Similarity=0.222 Sum_probs=143.8
Q ss_pred hCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEe----cCCeEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRS----NEDFKVL 229 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~----~~~~~~l 229 (348)
.++|...+.||+|+||.||+++. .+++.||+|.+........+.+.+|++++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 45788999999999999999997 578899999987655555677899999999999999999999987 3457899
Q ss_pred EEeccCCCCHHHHHhch----------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 230 VLEYMPRGSLEKCLYSS----------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
||||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999888642 13888999999 779999999999999999999999999998765
Q ss_pred ccCCce-------eeecccccccCccc---------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 294 IREDHF-------MIQTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 294 ~~~~~~-------~~~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...... .......||+.|+| +|||||||++|||++|+.||+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 249 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV 249 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhh
Confidence 321000 00011224444543 89999999999999999999753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-32 Score=246.47 Aligned_cols=177 Identities=23% Similarity=0.396 Sum_probs=144.6
Q ss_pred CCcccc-ccccCCcceEEEeEec---CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 157 GFSEDN-LISRGGFGSIHKARIQ---DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 157 ~f~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
+|...+ .||+|+||.||+|+.. ++..||+|.+..... ...+.+.+|++++++++||||+++++++ ..+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 444555 8999999999999854 577899999975432 2456788999999999999999999999 456689999
Q ss_pred eccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 232 EYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
||+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 999999999988532 13888999999 77999999999999999999999999999987754332
Q ss_pred ee-eecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 299 FM-IQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 299 ~~-~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
.. ......+|+.|+| +|||||||++|||+| |+.||....
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 218 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 21 1223345677876 899999999999999 999997643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-32 Score=252.76 Aligned_cols=176 Identities=24% Similarity=0.322 Sum_probs=142.0
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--------ccchhhHHHhhhcccccccceeeEEEEEecC
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--------GAFKSFDFECDVMKSTCYRNLIKIISSRSNE 224 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 224 (348)
..++|...+.||+|+||.||+|+.. +++.||||.+..... .....+.+|++++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4467889999999999999999875 578999999854321 2234688999999999999999999998776
Q ss_pred CeEEEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCc---EEEeecCC
Q 038351 225 DFKVLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIV---THLSDFGI 289 (348)
Q Consensus 225 ~~~~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~---~kl~DfGl 289 (348)
+ .++||||+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++. +||+|||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 5 89999999999999887643 24888999999 789999999999999987654 99999999
Q ss_pred ccccccCCceeeecccccccCccc---------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 290 AKLLIREDHFMIQTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 290 a~~~~~~~~~~~~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
++....... .....||+.|+| +|||||||++|||+||+.||...
T Consensus 164 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (322)
T 2ycf_A 164 SKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222 (322)
T ss_dssp CEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred ceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 987643211 123346666654 89999999999999999999754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-32 Score=253.65 Aligned_cols=178 Identities=25% Similarity=0.433 Sum_probs=139.4
Q ss_pred CCCccccccccCCcceEEEeEecC-----CceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQD-----RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
.+|...+.||+|+||.||+|+... +..||+|.+..... .....+.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456677999999999999998653 24599999864432 234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 230 VLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
||||+++|+|.+++.... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 999999999999986531 3788999999 778999999999999999999999999999876533
Q ss_pred Cce-eeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 297 DHF-MIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 297 ~~~-~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
... .......+|+.|+| +|||||||++|||+| |+.||...
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 254 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence 211 11122234566766 899999999999999 99999654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=257.41 Aligned_cols=173 Identities=11% Similarity=0.067 Sum_probs=129.6
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC---ccchhhHHHhhhcccc--cccceeeEE-------EEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---GAFKSFDFECDVMKST--CYRNLIKII-------SSR 221 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~H~niv~l~-------~~~ 221 (348)
...|...+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+++++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888899999999999999965 788999999976533 2235567785444444 699988865 444
Q ss_pred ecC-----------------CeEEEEEeccCCCCHHHHHhch-------------------hHHHHHHHHHHhcCCCceE
Q 038351 222 SNE-----------------DFKVLVLEYMPRGSLEKCLYSS-------------------NYVGFALEYLHFDYSVLII 265 (348)
Q Consensus 222 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~-------------------~~i~~~L~yLH~~~~~~ii 265 (348)
..+ ...++|||||+ |+|.+++... .+++.||+||| +.+|+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence 332 33799999998 8999988742 24788999999 78899
Q ss_pred ecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecccccccCccc--------------cccHHHHHHHHHHHcCCC
Q 038351 266 HYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA--------------SYVYSFGIMLLEVFTRKK 331 (348)
Q Consensus 266 HrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a--------------sDV~S~Gvvl~elltG~~ 331 (348)
||||||+|||++.++.+||+|||+++..... .....+|+.|+| +|||||||++|||+||+.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876321 113445577776 899999999999999999
Q ss_pred CCccc
Q 038351 332 PTNKI 336 (348)
Q Consensus 332 P~~~~ 336 (348)
||...
T Consensus 292 Pf~~~ 296 (371)
T 3q60_A 292 PFGLV 296 (371)
T ss_dssp STTBC
T ss_pred CCCCc
Confidence 99876
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=249.94 Aligned_cols=176 Identities=24% Similarity=0.389 Sum_probs=145.8
Q ss_pred CccccccccCCcceEEEeEec-----CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEec--CCeEEE
Q 038351 158 FSEDNLISRGGFGSIHKARIQ-----DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSN--EDFKVL 229 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~l 229 (348)
|+..+.||+|+||.||++.+. +++.||||.+..... ...+.+.+|++++++++||||+++++++.. ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 378899999999999988643 678899999975432 234668999999999999999999999987 467899
Q ss_pred EEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 230 VLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
||||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp EECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 99999999999998653 24888999999 78899999999999999999999999999988754332
Q ss_pred e-eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 F-MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~-~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. .......+|..|+| +|||||||++|||+||+.||...
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 2 12234456777776 79999999999999999998754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=246.18 Aligned_cols=178 Identities=22% Similarity=0.350 Sum_probs=148.7
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC---------ccchhhHHHhhhccccc-ccceeeEEEEE
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS---------GAFKSFDFECDVMKSTC-YRNLIKIISSR 221 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~~~~ 221 (348)
...++|...+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999975 688999999865431 11345788999999996 99999999999
Q ss_pred ecCCeEEEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCC
Q 038351 222 SNEDFKVLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGI 289 (348)
Q Consensus 222 ~~~~~~~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGl 289 (348)
...+..++||||+++++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence 9999999999999999999988653 13788999999 78999999999999999999999999999
Q ss_pred ccccccCCceeeecccccccCccc------------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 290 AKLLIREDHFMIQTQTLATIGYMA------------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 290 a~~~~~~~~~~~~~~~~gt~~y~a------------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
++....... .....+|+.|+| +||||||++++||++|+.||...
T Consensus 171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 171 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 987643322 123446666654 79999999999999999998653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=254.15 Aligned_cols=179 Identities=20% Similarity=0.368 Sum_probs=143.6
Q ss_pred hCCCccccccccCCcceEEEeEe------cCCceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEecCCeE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARI------QDRMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFK 227 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 227 (348)
.++|...+.||+|+||.||+|+. .++..||||.+.... ......+.+|+.++++++||||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 45788999999999999999984 356789999986432 23345788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhch-------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC---CCcEEEe
Q 038351 228 VLVLEYMPRGSLEKCLYSS-------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD---NIVTHLS 285 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~-------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~ 285 (348)
++||||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999999998643 13788999999 779999999999999984 4569999
Q ss_pred ecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 286 DFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 286 DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
|||+++...............+|+.|+| +|||||||++|||+| |+.||...
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 249 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence 9999986644332222334456777876 899999999999998 99999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-32 Score=261.07 Aligned_cols=176 Identities=21% Similarity=0.289 Sum_probs=131.3
Q ss_pred hhCCCcc-ccccccCCcceEEEeEec---CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEe--cCCeE
Q 038351 154 VTNGFSE-DNLISRGGFGSIHKARIQ---DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRS--NEDFK 227 (348)
Q Consensus 154 ~~~~f~~-~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~ 227 (348)
..+.|.. .++||+|+||.||+|+.. ++..||+|.+... .....+.+|++++++++||||+++++++. .....
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 3344554 458999999999999975 5788999998643 23457889999999999999999999995 46789
Q ss_pred EEEEeccCCCCHHHHHhch---------------------hHHHHHHHHHHhcCCCceEecCCCcCceEE----cCCCcE
Q 038351 228 VLVLEYMPRGSLEKCLYSS---------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLF----DDNIVT 282 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~---------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILl----d~~~~~ 282 (348)
++||||++ |+|.+.+... .+++.||+||| +.+|+||||||+|||+ +.++.+
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 99999996 4787766421 13888999999 7789999999999999 778999
Q ss_pred EEeecCCccccccCCc-eeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 283 HLSDFGIAKLLIREDH-FMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 283 kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
||+|||+++....... ........||+.|+| +|||||||++|||+||+.||..
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 9999999987643211 112234567888876 8999999999999999999964
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-32 Score=257.24 Aligned_cols=176 Identities=22% Similarity=0.225 Sum_probs=138.2
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCC-----
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNED----- 225 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 225 (348)
..++|...+.||+|+||.||+|+.. +++.||||.+..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3568999999999999999999865 688999999875322 23456889999999999999999999998765
Q ss_pred -eEEEEEeccCCCCHHHHHhch----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 226 -FKVLVLEYMPRGSLEKCLYSS----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 226 -~~~lV~Ey~~~gsL~~~l~~~----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
..++||||+++ +|.+.+... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred cceEEEEEcCCC-CHHHHHhhccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 78999999974 787776532 24888999999 7799999999999999999999999999998764
Q ss_pred cCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
... ......||+.|+| +|||||||++|||+||+.||...
T Consensus 179 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 179 TSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 321 2234567888877 89999999999999999999653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-32 Score=245.69 Aligned_cols=178 Identities=23% Similarity=0.388 Sum_probs=142.7
Q ss_pred hhCCCccccccccCCcceEEEeEecC----CceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQD----RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 228 (348)
..++|...+.||+|+||.||+|+... +..||+|.+..... ...+.+.+|++++++++||||+++++++..+ ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 34678888999999999999998643 34599999865422 2346788999999999999999999998754 568
Q ss_pred EEEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 229 LVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
+||||+++++|.+++.... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 9999999999999886432 3788999999 78999999999999999999999999999987644
Q ss_pred CCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 296 EDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 296 ~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
... .......+|+.|+| +|||||||++|||+| |+.||...
T Consensus 166 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 166 EDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 221 11233445667776 899999999999998 99999643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=254.92 Aligned_cols=174 Identities=25% Similarity=0.343 Sum_probs=146.8
Q ss_pred hCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCcc---c--------------hhhHHHhhhcccccccceeeE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGA---F--------------KSFDFECDVMKSTCYRNLIKI 217 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~--------------~~~~~E~~~l~~l~H~niv~l 217 (348)
.++|...+.||+|+||.||+|+. ++..||+|.+....... . +.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 89999999996442221 1 778999999999999999999
Q ss_pred EEEEecCCeEEEEEeccCCCCHHHH------Hhch--------------hHHHHHHHHHHhcCC-CceEecCCCcCceEE
Q 038351 218 ISSRSNEDFKVLVLEYMPRGSLEKC------LYSS--------------NYVGFALEYLHFDYS-VLIIHYDLKPSNVLF 276 (348)
Q Consensus 218 ~~~~~~~~~~~lV~Ey~~~gsL~~~------l~~~--------------~~i~~~L~yLH~~~~-~~iiHrDik~~NILl 276 (348)
++++...+..++||||+++|+|.++ +... .+++.||+||| + .+|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence 9999999999999999999999887 5431 23888999999 5 899999999999999
Q ss_pred cCCCcEEEeecCCccccccCCceeeecccccccCcc--------------ccccHHHHHHHHHHHcCCCCCccc
Q 038351 277 DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM--------------ASYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 277 d~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~--------------asDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+.++.+||+|||+++..... ......||..|+ ++|||||||+++||+||+.||...
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999876432 112334454444 389999999999999999999754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=243.94 Aligned_cols=179 Identities=24% Similarity=0.279 Sum_probs=143.2
Q ss_pred hhhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEE-ecCCeEEEE
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSR-SNEDFKVLV 230 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV 230 (348)
...++|+..+.||+|+||.||+|+. .+++.||+|.+.... ..+.+.+|++++++++|++++..+.++ ...+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 4567899999999999999999996 578899999865432 335688999999999988777666655 667888999
Q ss_pred EeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEE---cCCCcEEEeecCCccccc
Q 038351 231 LEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLF---DDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILl---d~~~~~kl~DfGla~~~~ 294 (348)
|||+ +++|.+++... .+++.||+||| +.+|+||||||+||++ ++++.+||+|||+++...
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999 99999988632 23888999999 7889999999999999 789999999999998765
Q ss_pred cCCce-----eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 295 REDHF-----MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 295 ~~~~~-----~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
..... .......||+.|+| +|||||||++|||+||+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 43221 12235568888887 799999999999999999997643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-32 Score=274.46 Aligned_cols=172 Identities=26% Similarity=0.406 Sum_probs=138.5
Q ss_pred cccccCCcceEEEeEec---CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQ---DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
+.||+|+||.||+|.+. .++.||||.++.... ...+.+.+|++++++++||||+++++++.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 467899999865432 234679999999999999999999999975 457899999999
Q ss_pred CCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc-eeeec
Q 038351 237 GSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH-FMIQT 303 (348)
Q Consensus 237 gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~-~~~~~ 303 (348)
|+|.+++.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+..... .....
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 99999986432 3888999999 77899999999999999999999999999987754322 12223
Q ss_pred ccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 304 QTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 304 ~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
...+|+.|+| +|||||||++|||+| |+.||....
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 577 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 577 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 3445677887 899999999999999 999997653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-32 Score=255.47 Aligned_cols=180 Identities=22% Similarity=0.276 Sum_probs=148.7
Q ss_pred hhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecC-----C
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNE-----D 225 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~ 225 (348)
...++|+..+.||+|+||.||+|+.. ++..||+|.+..... ...+.+.+|++++++++||||+++++++... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 44568999999999999999999865 678899999864332 2336788999999999999999999999765 4
Q ss_pred eEEEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
..++||||++ |+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEcccC-cCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 6899999997 5898887643 24888999999 7899999999999999999999999999998765
Q ss_pred cCCcee-eecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHFM-IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~~-~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...... ......||+.|+| +||||+||++|||+||+.||...
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 235 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 235 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence 332211 1234567888876 79999999999999999999754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-32 Score=256.12 Aligned_cols=174 Identities=17% Similarity=0.211 Sum_probs=144.9
Q ss_pred hCCCccccccccCCcceEEEeEecC---------CceEEEEeeeeccCccchhhHHHhhhcccccccceee---------
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQD---------RMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIK--------- 216 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~--------- 216 (348)
.++|...+.||+|+||.||+|+... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3678999999999999999999764 789999998643 56889999999999999987
Q ss_pred ------EEEEEec-CCeEEEEEeccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceE
Q 038351 217 ------IISSRSN-EDFKVLVLEYMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVL 275 (348)
Q Consensus 217 ------l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NIL 275 (348)
+++++.. ++..++||||+ +++|.+++... .+++.||+||| +.+|+||||||+||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence 6777765 78899999999 99999998753 13888999999 779999999999999
Q ss_pred EcCCC--cEEEeecCCccccccCCcee-----eecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 276 FDDNI--VTHLSDFGIAKLLIREDHFM-----IQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 276 ld~~~--~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
++.++ .+||+|||+++.+....... ......||+.|+| +|||||||++|||+||+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 89999999998765432211 1133468888887 89999999999999999999875
Q ss_pred c
Q 038351 337 F 337 (348)
Q Consensus 337 ~ 337 (348)
.
T Consensus 272 ~ 272 (352)
T 2jii_A 272 L 272 (352)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=247.21 Aligned_cols=180 Identities=22% Similarity=0.346 Sum_probs=144.9
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEe--cCCeEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRS--NEDFKVL 229 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~l 229 (348)
.++|+..+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++. ..+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 457888999999999999999975 688999999975432 23456889999999999999999999875 4678999
Q ss_pred EEeccCCCCHHHHHhchh----------------HHHHHHHHHHhcC--CCceEecCCCcCceEEcCCCcEEEeecCCcc
Q 038351 230 VLEYMPRGSLEKCLYSSN----------------YVGFALEYLHFDY--SVLIIHYDLKPSNVLFDDNIVTHLSDFGIAK 291 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~----------------~i~~~L~yLH~~~--~~~iiHrDik~~NILld~~~~~kl~DfGla~ 291 (348)
||||+++++|.+++.... +++.||+|||... ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999886421 3788999999432 1239999999999999999999999999998
Q ss_pred ccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 292 LLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....... ......||+.|+| +||||||+++|||+||+.||...
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 7643221 1123457777776 89999999999999999999764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=245.39 Aligned_cols=177 Identities=25% Similarity=0.407 Sum_probs=142.4
Q ss_pred CCCcccc-ccccCCcceEEEeEec---CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 156 NGFSEDN-LISRGGFGSIHKARIQ---DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 156 ~~f~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
++|...+ .||+|+||.||+|... ++..||||.+..... ...+.+.+|++++++++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4566666 9999999999999643 467899999865432 2246789999999999999999999999 5667899
Q ss_pred EEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 230 VLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
||||+++++|.+++.... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 999999999999886532 3888999999 7799999999999999999999999999998775433
Q ss_pred cee-eecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 298 HFM-IQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 298 ~~~-~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
... ......+++.|+| +||||||+++|||+| |+.||...
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 224 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 221 1222345667776 899999999999999 99999764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=249.94 Aligned_cols=182 Identities=24% Similarity=0.304 Sum_probs=146.5
Q ss_pred hhHHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccc-cccceeeEEEEEec---
Q 038351 149 LELCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKST-CYRNLIKIISSRSN--- 223 (348)
Q Consensus 149 ~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~--- 223 (348)
.++....++|...+.||+|+||.||+|+.. +++.||+|.+.... ...+.+.+|+++++++ +||||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 344556788999999999999999999974 78899999986543 3447789999999999 79999999999976
Q ss_pred ---CCeEEEEEeccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEee
Q 038351 224 ---EDFKVLVLEYMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSD 286 (348)
Q Consensus 224 ---~~~~~lV~Ey~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~D 286 (348)
.+..++||||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEee
Confidence 46889999999999999988642 13788999999 77899999999999999999999999
Q ss_pred cCCccccccCCceeeecccccccCccc-----------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 287 FGIAKLLIREDHFMIQTQTLATIGYMA-----------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 287 fGla~~~~~~~~~~~~~~~~gt~~y~a-----------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
||++........ ......||+.|+| +|||||||++|||+||+.||...
T Consensus 173 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 173 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp CTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 999987643211 1223456666665 79999999999999999999653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=243.20 Aligned_cols=172 Identities=29% Similarity=0.409 Sum_probs=137.8
Q ss_pred hCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecC-CeEEEEEec
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNE-DFKVLVLEY 233 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~Ey 233 (348)
.++|+..+.||+|+||.||+++.. +..||+|.+... ...+.+.+|++++++++||||+++++++... +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 357888899999999999999875 778999998643 2457789999999999999999999997654 578999999
Q ss_pred cCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 234 MPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 234 ~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
+++++|.+++.... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 99999999886432 3788999999 7889999999999999999999999999998654321
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
....+++.|+| +||||||++++||+| |+.||....
T Consensus 172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 22345666765 899999999999998 999997643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-32 Score=247.64 Aligned_cols=179 Identities=26% Similarity=0.437 Sum_probs=141.3
Q ss_pred hCCCccccccccCCcceEEEeEecC----CceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEe-cCCeEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQD----RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRS-NEDFKV 228 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~ 228 (348)
..+|...+.||+|+||.||+|+..+ ...+|+|.+..... ...+.+.+|++++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3467788999999999999998643 23578888764322 33467889999999999999999999865 456789
Q ss_pred EEEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 229 LVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
+||||+++|+|.++++... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 9999999999999986521 3788999999 78999999999999999999999999999987643
Q ss_pred CCc--eeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 296 EDH--FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 296 ~~~--~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
... ........+|+.|+| +||||+||++|||+| |.+||...
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 236 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence 221 112234456677876 899999999999999 55666543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=248.72 Aligned_cols=179 Identities=27% Similarity=0.356 Sum_probs=147.8
Q ss_pred HHhhhCCCccccccccCCcceEEEeEe--cCCceEEEEeeeeccC--ccchhhHHHhhhcccc---cccceeeEEEEEe-
Q 038351 151 LCRVTNGFSEDNLISRGGFGSIHKARI--QDRMEFSVKGFHLQCS--GAFKSFDFECDVMKST---CYRNLIKIISSRS- 222 (348)
Q Consensus 151 ~~~~~~~f~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~- 222 (348)
+..+.++|...+.||+|+||.||+|+. .+++.||+|.+..... .....+.+|+++++.+ +||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred ccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 345678899999999999999999997 4678899999865432 2345677888888777 7999999999987
Q ss_pred ----cCCeEEEEEeccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEE
Q 038351 223 ----NEDFKVLVLEYMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHL 284 (348)
Q Consensus 223 ----~~~~~~lV~Ey~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl 284 (348)
.....++||||++ |+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEE
Confidence 5567899999997 6999887642 13788999999 779999999999999999999999
Q ss_pred eecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 285 SDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 285 ~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+|||+++...... ......||+.|+| +|||||||++|||+||+.||...
T Consensus 162 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 162 ADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp CSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999998764322 1234567778876 89999999999999999999753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-32 Score=250.94 Aligned_cols=178 Identities=21% Similarity=0.256 Sum_probs=136.5
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhccccc-ccceeeEEEEEe--------cC
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-YRNLIKIISSRS--------NE 224 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~--------~~ 224 (348)
..+|...+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457888899999999999999965 78899999986655455577899999999996 999999999984 34
Q ss_pred CeEEEEEeccCCCCHHHHHhch---------------hHHHHHHHHHHhcCCCc--eEecCCCcCceEEcCCCcEEEeec
Q 038351 225 DFKVLVLEYMPRGSLEKCLYSS---------------NYVGFALEYLHFDYSVL--IIHYDLKPSNVLFDDNIVTHLSDF 287 (348)
Q Consensus 225 ~~~~lV~Ey~~~gsL~~~l~~~---------------~~i~~~L~yLH~~~~~~--iiHrDik~~NILld~~~~~kl~Df 287 (348)
...++||||+. |+|.+++... .+++.||+||| +.+ |+||||||+||+++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence 45899999995 7898877541 13788999999 667 999999999999999999999999
Q ss_pred CCccccccCCcee----------eecccccccCccc---------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 288 GIAKLLIREDHFM----------IQTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 288 Gla~~~~~~~~~~----------~~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
|+++......... ......||+.|+| +|||||||++|||+||+.||+..
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9998764322110 0112345666654 89999999999999999999753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=250.61 Aligned_cols=182 Identities=20% Similarity=0.236 Sum_probs=135.8
Q ss_pred hhHHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCe-
Q 038351 149 LELCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDF- 226 (348)
Q Consensus 149 ~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~- 226 (348)
.+.....++|...+.||+|+||.||+|+.. ++..||||++.... .....+..|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 445667789999999999999999999975 68899999885432 334567778888899999999999999865433
Q ss_pred ------EEEEEeccCCCCHHHHHhc----------------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcC-CCcEE
Q 038351 227 ------KVLVLEYMPRGSLEKCLYS----------------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD-NIVTH 283 (348)
Q Consensus 227 ------~~lV~Ey~~~gsL~~~l~~----------------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~-~~~~k 283 (348)
.++||||+++ ++.+.+.. ..+++.||+||| .++.+|+||||||+|||++. ++.+|
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcEE
Confidence 7899999986 55443331 123778899998 34789999999999999997 89999
Q ss_pred EeecCCccccccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 284 LSDFGIAKLLIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 284 l~DfGla~~~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
|+|||+++....... .....||+.|+| +|||||||++|||+||+.||...
T Consensus 173 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp ECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 999999987654322 234557777776 89999999999999999999764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=250.59 Aligned_cols=181 Identities=20% Similarity=0.288 Sum_probs=147.6
Q ss_pred hHHhhhCCCccc-cccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhccccc-ccceeeEEEEEecC
Q 038351 150 ELCRVTNGFSED-NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTC-YRNLIKIISSRSNE 224 (348)
Q Consensus 150 ~~~~~~~~f~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 224 (348)
......+.|... +.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+.++.+++ ||||+++++++...
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 444556667766 88999999999999876 688999999865432 23467889999999995 69999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC---CCcEEEeec
Q 038351 225 DFKVLVLEYMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD---NIVTHLSDF 287 (348)
Q Consensus 225 ~~~~lV~Ey~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~Df 287 (348)
+..++||||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++. ++.+||+||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 9999999999999998887432 23888999999 779999999999999998 789999999
Q ss_pred CCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 288 GIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 288 Gla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
|+++....... .....||+.|+| +|||||||++|||+||+.||...
T Consensus 179 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (327)
T 3lm5_A 179 GMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236 (327)
T ss_dssp GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99987643322 234568888876 89999999999999999999654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=242.62 Aligned_cols=177 Identities=24% Similarity=0.280 Sum_probs=146.5
Q ss_pred hhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEE-ecCCeEEEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSR-SNEDFKVLVL 231 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~ 231 (348)
..++|...+.||+|+||.||+|+. .+++.||+|.+.... ..+.+.+|++++++++|++++..+.++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 457899999999999999999996 578899999886443 335789999999999988866665555 5677889999
Q ss_pred eccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEE---cCCCcEEEeecCCcccccc
Q 038351 232 EYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLF---DDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILl---d~~~~~kl~DfGla~~~~~ 295 (348)
||+ +++|.+++... .+++.||+||| +.+|+||||||+||++ +.++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999 99999988632 13888999999 7899999999999999 5889999999999987654
Q ss_pred CCce-----eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 296 EDHF-----MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 296 ~~~~-----~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.... .......||+.|+| +|||||||++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence 3321 11245568888987 79999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=246.09 Aligned_cols=174 Identities=25% Similarity=0.422 Sum_probs=139.4
Q ss_pred CCccccccccCCcceEEEeEecC----CceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeE-EEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQD----RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFK-VLV 230 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~lV 230 (348)
.|...+.||+|+||.||+|+..+ +..+|+|.+..... ...+.+.+|++++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45566899999999999998542 33689998864332 2346788999999999999999999999876655 999
Q ss_pred EeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 231 LEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
|||+.+|+|.+++.... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 99999999999987521 3888999999 7789999999999999999999999999998664322
Q ss_pred ce--eeecccccccCccc------------cccHHHHHHHHHHHcCCCCC
Q 038351 298 HF--MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPT 333 (348)
Q Consensus 298 ~~--~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~ 333 (348)
.. .......+|+.|+| +|||||||++|||+||..|+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 11 11223445666765 89999999999999965554
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=247.46 Aligned_cols=181 Identities=23% Similarity=0.342 Sum_probs=148.2
Q ss_pred HhhhCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhccc--ccccceeeEEEEEecCC----
Q 038351 152 CRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKS--TCYRNLIKIISSRSNED---- 225 (348)
Q Consensus 152 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~---- 225 (348)
....++|...+.||+|+||.||+|+. +++.||+|.+... ....+.+|.+++.. ++||||+++++++...+
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 34567899999999999999999998 4789999998643 23567788888876 78999999999998876
Q ss_pred eEEEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhc-----CCCceEecCCCcCceEEcCCCcEEEeecCC
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFD-----YSVLIIHYDLKPSNVLFDDNIVTHLSDFGI 289 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~-----~~~~iiHrDik~~NILld~~~~~kl~DfGl 289 (348)
..++||||+++|+|.+++... .+++.||+|||.. ++.+|+||||||+||+++.++.+||+|||+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 789999999999999988642 2388899999932 257899999999999999999999999999
Q ss_pred ccccccCCcee--eecccccccCccc------------------cccHHHHHHHHHHHcC----------CCCCccc
Q 038351 290 AKLLIREDHFM--IQTQTLATIGYMA------------------SYVYSFGIMLLEVFTR----------KKPTNKI 336 (348)
Q Consensus 290 a~~~~~~~~~~--~~~~~~gt~~y~a------------------sDV~S~Gvvl~elltG----------~~P~~~~ 336 (348)
++......... ......||+.|+| +|||||||++|||+|| +.||...
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 98765433221 1234457777764 7999999999999999 7888654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=243.41 Aligned_cols=178 Identities=26% Similarity=0.388 Sum_probs=137.3
Q ss_pred hCCCccccccccCCcceEEEeEec--CC--ceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ--DR--MEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFK 227 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 227 (348)
.++|+..+.||+|+||.||+|++. ++ ..||+|.++... ....+.+.+|++++++++||||+++++++..++ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357888899999999999999853 23 368999886542 223467889999999999999999999998765 7
Q ss_pred EEEEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 228 VLVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
++||||+++++|.+++.... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 89999999999999886532 3788999999 7799999999999999999999999999998775
Q ss_pred cCCce-eeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 295 REDHF-MIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 295 ~~~~~-~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
..... .......+|..|+| +||||||+++|||+| |+.||...
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 43322 12233446667876 899999999999999 99999754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=245.40 Aligned_cols=162 Identities=10% Similarity=-0.032 Sum_probs=139.5
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc---cchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG---AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
.++|...+.||+|+||.||+|+.. +++.||+|.+...... ..+.+.+|++++++++||||+++++++..++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999976 5889999999754332 236788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhch----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 231 LEYMPRGSLEKCLYSS----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
|||+++++|.++++.. .+++.||+||| +.+|+||||||+||+++.++.+||++++...
T Consensus 110 ~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~~~--------- 177 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATMP--------- 177 (286)
T ss_dssp EECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCCCT---------
T ss_pred EEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEeccccC---------
Confidence 9999999999998652 24888999999 7899999999999999999999998665432
Q ss_pred eecccccccCccccccHHHHHHHHHHHcCCCCCccc
Q 038351 301 IQTQTLATIGYMASYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~asDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+.-.++|||||||++|||+||+.||...
T Consensus 178 --------~~~~~~Di~slG~il~elltg~~Pf~~~ 205 (286)
T 3uqc_A 178 --------DANPQDDIRGIGASLYALLVNRWPLPEA 205 (286)
T ss_dssp --------TCCHHHHHHHHHHHHHHHHHSEECSCCC
T ss_pred --------CCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 1123489999999999999999999764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-31 Score=258.17 Aligned_cols=178 Identities=22% Similarity=0.280 Sum_probs=148.3
Q ss_pred hhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCccchhhHHHhhhcccccc-cceeeEEEEEecCCeEEEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCY-RNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~ 231 (348)
..++|...+.||+|+||.||+|+. .++..||||.+.... ....+..|+++++.++| +++..+..++...+..++||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 457899999999999999999996 578899999876443 33568899999999987 56667777778888999999
Q ss_pred eccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEE---cCCCcEEEeecCCcccccc
Q 038351 232 EYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLF---DDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILl---d~~~~~kl~DfGla~~~~~ 295 (348)
||+ +++|.+++... .+++.||+||| +.+|+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999 99999988632 24888999999 7799999999999999 6889999999999988754
Q ss_pred CCce-----eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 296 EDHF-----MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 296 ~~~~-----~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
.... .......||+.|+| +|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~ 217 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 3321 12235678999987 799999999999999999998754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=251.10 Aligned_cols=179 Identities=23% Similarity=0.278 Sum_probs=145.6
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecC-----Ce
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNE-----DF 226 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 226 (348)
..++|...+.||+|+||.||+|+.. +++.||||.+..... .....+.+|++++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999999999999976 688999999864322 2345678999999999999999999988764 67
Q ss_pred EEEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 227 KVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
.++||||++ ++|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 899999997 5898877542 24888999999 77999999999999999999999999999987643
Q ss_pred CCcee--------eecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 296 EDHFM--------IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 296 ~~~~~--------~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..... ......||+.|+| +|||||||++|||++|+.||...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 21110 1123467777876 89999999999999999999754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=244.25 Aligned_cols=174 Identities=25% Similarity=0.290 Sum_probs=131.5
Q ss_pred hCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCc-c-chhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSG-A-FKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
.++|+..+.||+|+||.||+|+. .+++.||+|.+...... . .+.+..+...++.++||||+++++++..++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46788899999999999999997 47889999998654222 1 223444555688899999999999999999999999
Q ss_pred eccCCCCHHHHHhch----------------hHHHHHHHHHHhcCCC-ceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 232 EYMPRGSLEKCLYSS----------------NYVGFALEYLHFDYSV-LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~~~-~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
||++ |+|.+++... .+++.||+||| +. +|+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 5887766431 23888999999 55 89999999999999999999999999998764
Q ss_pred cCCceeeecccccccCccc----------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 295 REDHFMIQTQTLATIGYMA----------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~a----------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.... .....||+.|+| +|||||||++|||+||+.||+.
T Consensus 162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 3221 123356666665 7999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=246.47 Aligned_cols=179 Identities=23% Similarity=0.290 Sum_probs=149.2
Q ss_pred hHHhhhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCc------cchhhHHHhhhccccc--ccceeeEEEE
Q 038351 150 ELCRVTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSG------AFKSFDFECDVMKSTC--YRNLIKIISS 220 (348)
Q Consensus 150 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~~~ 220 (348)
+.....++|...+.||+|+||.||+|+. .+++.||||.+...... ..+.+.+|++++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3445567899999999999999999986 47889999999654322 2356788999999996 5999999999
Q ss_pred EecCCeEEEEEeccCC-CCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEc-CCCcEEEee
Q 038351 221 RSNEDFKVLVLEYMPR-GSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFD-DNIVTHLSD 286 (348)
Q Consensus 221 ~~~~~~~~lV~Ey~~~-gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld-~~~~~kl~D 286 (348)
+..++..++|+||+.+ ++|.+++... .+++.||+||| +.+|+||||||+||+++ +++.+||+|
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999999976 8999887642 24888999999 78999999999999999 789999999
Q ss_pred cCCccccccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 287 FGIAKLLIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 287 fGla~~~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
||+++...... .....||+.|+| +|||||||++|||+||+.||+.
T Consensus 194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 99998765322 234567888876 7999999999999999999965
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=257.77 Aligned_cols=173 Identities=20% Similarity=0.237 Sum_probs=144.2
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccc------cccceeeEEEEEecCCe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKST------CYRNLIKIISSRSNEDF 226 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~~ 226 (348)
...+|+..+.||+|+||.||+|+.. +++.||||.+.... ...+.+.+|+++++.+ .|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 4567899999999999999999865 58899999986432 2235677788887777 56799999999999999
Q ss_pred EEEEEeccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCc--EEEeecCCc
Q 038351 227 KVLVLEYMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIV--THLSDFGIA 290 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~--~kl~DfGla 290 (348)
.++||||+. ++|.+++.... +++.||+||| +.+|+||||||+|||++.++. +||+|||++
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999996 68888776432 3888999999 678999999999999999887 999999999
Q ss_pred cccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 291 KLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+..... .....||+.|+| +|||||||++|||+||++||...
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 765322 234568888887 89999999999999999999754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-32 Score=256.73 Aligned_cols=175 Identities=25% Similarity=0.298 Sum_probs=129.5
Q ss_pred hhhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecC-----
Q 038351 153 RVTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNE----- 224 (348)
Q Consensus 153 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 224 (348)
...++|...+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++++++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 3457899999999999999999986 4788999999864322 2345688999999999999999999998754
Q ss_pred -CeEEEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 225 -DFKVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 225 -~~~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
...++|+||+ +++|.++++.. .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred CCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 5679999999 67888776532 24889999999 78999999999999999999999999999987
Q ss_pred cccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 293 LIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.... .....||+.|+| +||||+||+++||+||+.||...
T Consensus 182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 233 (367)
T 2fst_X 182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 5432 234467777766 89999999999999999999653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=247.20 Aligned_cols=179 Identities=23% Similarity=0.330 Sum_probs=140.1
Q ss_pred hHHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC------ccchhhHHHhhhcccc----cccceeeEE
Q 038351 150 ELCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS------GAFKSFDFECDVMKST----CYRNLIKII 218 (348)
Q Consensus 150 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~ 218 (348)
+.....++|...+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34456778999999999999999999864 688999999865432 1235577899999988 899999999
Q ss_pred EEEecCCeEEEEEec-cCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEc-CCCcEEE
Q 038351 219 SSRSNEDFKVLVLEY-MPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFD-DNIVTHL 284 (348)
Q Consensus 219 ~~~~~~~~~~lV~Ey-~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld-~~~~~kl 284 (348)
+++...+..++|+|| +++++|.+++.... +++.||+||| +.+|+||||||+||+++ .++.+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEE
Confidence 999999999999999 78999999886432 3888999999 67899999999999999 8999999
Q ss_pred eecCCccccccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 285 SDFGIAKLLIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 285 ~DfGla~~~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
+|||+++...... .....||..|+| +|||||||++|||+||+.||+.
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 9999998765432 234457777775 8999999999999999999965
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=252.42 Aligned_cols=173 Identities=21% Similarity=0.227 Sum_probs=141.9
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhccccc--------ccceeeEEEEEe---
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC--------YRNLIKIISSRS--- 222 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~--- 222 (348)
.++|...+.||+|+||.||+|+.. +++.||+|.+... ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 467899999999999999999864 6889999998643 223467889999999986 788999999987
Q ss_pred -cCCeEEEEEeccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCC-ceEecCCCcCceEEcCCC------
Q 038351 223 -NEDFKVLVLEYMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSV-LIIHYDLKPSNVLFDDNI------ 280 (348)
Q Consensus 223 -~~~~~~lV~Ey~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~-~iiHrDik~~NILld~~~------ 280 (348)
.....++||||+ ++++.+.+... .+++.||+||| +. +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhh
Confidence 556899999999 55665554322 23888999999 66 899999999999999775
Q ss_pred -------------------------------------------cEEEeecCCccccccCCceeeecccccccCccc----
Q 038351 281 -------------------------------------------VTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA---- 313 (348)
Q Consensus 281 -------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a---- 313 (348)
.+||+|||+++..... .....||+.|+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence 7999999999876432 234567888887
Q ss_pred --------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 314 --------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 314 --------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
+|||||||++|||+||+.||+...
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 899999999999999999997543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=255.31 Aligned_cols=175 Identities=22% Similarity=0.318 Sum_probs=138.5
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEEEecc
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
+.|...+.||+|+||+||.+...+++.||||++... ..+.+.+|++++.++ +||||+++++++..++..++|||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345556889999999998877778999999998643 235678899999876 7999999999999999999999999
Q ss_pred CCCCHHHHHhch-------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCC-------------CcE
Q 038351 235 PRGSLEKCLYSS-------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN-------------IVT 282 (348)
Q Consensus 235 ~~gsL~~~l~~~-------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~-------------~~~ 282 (348)
. |+|.+++... .+++.||+||| +.+|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 6999887642 23788999999 7899999999999999754 589
Q ss_pred EEeecCCccccccCCcee--eecccccccCccc-------------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 283 HLSDFGIAKLLIREDHFM--IQTQTLATIGYMA-------------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 283 kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~a-------------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
||+|||+++......... ......||+.|+| +|||||||++|||+| |+.||....
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 999999998875432211 1223467777775 799999999999999 999997643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=252.60 Aligned_cols=174 Identities=22% Similarity=0.289 Sum_probs=142.4
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc--cchhhHHHhhhcccccccceeeEEEEEecCCeE---
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG--AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFK--- 227 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~--- 227 (348)
..++|...+.||+|+||.||+|+.. +++.||+|.+...... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4578889999999999999999865 6889999998654322 246788999999999999999999999887654
Q ss_pred ---EEEEeccCCCCHHHHHhch----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 228 ---VLVLEYMPRGSLEKCLYSS----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 228 ---~lV~Ey~~~gsL~~~l~~~----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
++||||++ ++|.+.+... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGMEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred eeEEEEEcccc-ccHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999997 6887776432 24889999999 7799999999999999999999999999998654
Q ss_pred cCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.. .....||+.|+| +|||||||++|||+||+.||+..
T Consensus 196 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 196 AE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 32 234566777776 89999999999999999999754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=245.53 Aligned_cols=178 Identities=23% Similarity=0.333 Sum_probs=142.1
Q ss_pred hhCCCccccccccCCcceEEEeEecCCceEEEEeeeeccC--ccchhhHHHhhhcccccc--cceeeEEEEEecCCeEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCY--RNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~l 229 (348)
..++|+..+.||+|+||.||+++..++..||+|.+..... ...+.+.+|++++++++| |||+++++++...+..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 4567889999999999999999998899999999865432 234678899999999985 999999999999999999
Q ss_pred EEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 230 VLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
||| +.+++|.+++... .+++.||+||| +.+|+||||||+||++++ +.+||+|||+++......
T Consensus 106 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred EEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence 999 5688999888643 24888999999 779999999999999975 899999999998765433
Q ss_pred ceeeecccccccCccc-----------------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 298 HFMIQTQTLATIGYMA-----------------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a-----------------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.........||+.|+| +|||||||++|||+||+.||...
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 2222233456666654 79999999999999999999764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-31 Score=244.41 Aligned_cols=173 Identities=20% Similarity=0.241 Sum_probs=145.9
Q ss_pred hhCCCccccccccCCcceEEEeEe--cCCceEEEEeeeeccCccchhhHHHhhhcccccccc------eeeEEEEEecCC
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARI--QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRN------LIKIISSRSNED 225 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~ 225 (348)
..++|+..+.||+|+||.||+|.. .+++.||+|.+.... ...+.+.+|++++++++|++ ++++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 456899999999999999999986 367899999986432 23466888999999998876 999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcC-------------
Q 038351 226 FKVLVLEYMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDD------------- 278 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~------------- 278 (348)
..++||||+ +++|.+++.... +++.||+||| +.+|+||||||+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999 889998876432 3788999999 779999999999999987
Q ss_pred ------CCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 279 ------NIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 279 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
++.+||+|||+++..... .....||+.|+| +|||||||++|||+||+.||...
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 668999999999875432 134567888876 89999999999999999999753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=240.64 Aligned_cols=180 Identities=21% Similarity=0.329 Sum_probs=149.6
Q ss_pred HHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeE
Q 038351 151 LCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFK 227 (348)
Q Consensus 151 ~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 227 (348)
.....++|...+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++...+..
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 3445678999999999999999999976 788999999865432 3456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCC---CcEEEeecCCccc
Q 038351 228 VLVLEYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDN---IVTHLSDFGIAKL 292 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~---~~~kl~DfGla~~ 292 (348)
++||||+++++|.+.+... .+++.||+||| +.+|+||||||+||+++.+ +.+||+|||+++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999998877532 23888999999 7799999999999999754 4799999999987
Q ss_pred cccCCceeeecccccccCccc-----------cccHHHHHHHHHHHcCCCCCccc
Q 038351 293 LIREDHFMIQTQTLATIGYMA-----------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~a-----------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...... .....+|+.|+| +||||||++++||++|+.||...
T Consensus 174 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (287)
T 2wei_A 174 FQQNTK---MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGK 225 (287)
T ss_dssp BCCCSS---CSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCCc---cccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence 643321 123346666765 79999999999999999999653
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-31 Score=255.16 Aligned_cols=175 Identities=25% Similarity=0.421 Sum_probs=139.7
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEEEecc
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
.+|...++||+|+||+||.....+++.||||++... ....+.+|+++++++ +||||+++++++...+..++|||||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTT---TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 468888999999999977666678899999998543 234578899999999 7999999999999999999999999
Q ss_pred CCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEc-----CCCcEEEeecCCccccccC
Q 038351 235 PRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFD-----DNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 235 ~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld-----~~~~~kl~DfGla~~~~~~ 296 (348)
+ |+|.+++.... +++.||+||| +.+|+||||||+||+++ ....+||+|||+++.....
T Consensus 101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 6 59999886432 4888999999 77899999999999994 3346889999999876533
Q ss_pred Cc-eeeecccccccCccc---------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 297 DH-FMIQTQTLATIGYMA---------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 297 ~~-~~~~~~~~gt~~y~a---------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
.. ........||+.|+| +|||||||++|||+| |+.||....
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~ 234 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence 21 122344568888876 799999999999999 999996543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-31 Score=240.70 Aligned_cols=171 Identities=27% Similarity=0.392 Sum_probs=136.6
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEec---------
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSN--------- 223 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------- 223 (348)
..++|+..+.||+|+||.||+|+.. +++.||+|.+.... ...+.+.+|++++++++||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4567889999999999999999975 78899999986432 334678899999999999999999998865
Q ss_pred ----CCeEEEEEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEee
Q 038351 224 ----EDFKVLVLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSD 286 (348)
Q Consensus 224 ----~~~~~lV~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~D 286 (348)
.+..++||||+++|+|.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEee
Confidence 35689999999999999998632 13788999999 77899999999999999999999999
Q ss_pred cCCccccccCCc------------eeeecccccccCccc-------------cccHHHHHHHHHHHc
Q 038351 287 FGIAKLLIREDH------------FMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFT 328 (348)
Q Consensus 287 fGla~~~~~~~~------------~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~ellt 328 (348)
||+++....... ........||+.|+| +|||||||++|||++
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 999987642210 011223456667765 899999999999998
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=248.77 Aligned_cols=178 Identities=22% Similarity=0.262 Sum_probs=145.3
Q ss_pred HHhhhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhccccc-cc-----ceeeEEEEEec
Q 038351 151 LCRVTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-YR-----NLIKIISSRSN 223 (348)
Q Consensus 151 ~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~ 223 (348)
.....++|...+.||+|+||.||+|+.. +++.||||.+.... .....+..|+++++.++ |+ +|+++++++..
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 3445678999999999999999999865 67889999986332 23456777888888775 44 49999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEc--CCCcEEEeec
Q 038351 224 EDFKVLVLEYMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFD--DNIVTHLSDF 287 (348)
Q Consensus 224 ~~~~~lV~Ey~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld--~~~~~kl~Df 287 (348)
.+..++||||++ |+|.+++.... +++.||+|||. ++.+|+||||||+|||++ .++.+||+||
T Consensus 128 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 128 RNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 999999999996 59998886532 37889999983 357899999999999994 5788999999
Q ss_pred CCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 288 GIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 288 Gla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
|+++..... .....||+.|+| +|||||||++|||+||+.||...
T Consensus 206 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 206 GSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999876432 234567888877 89999999999999999999753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=242.98 Aligned_cols=174 Identities=29% Similarity=0.360 Sum_probs=132.4
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhh-hcccccccceeeEEEEEecCCeEEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECD-VMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
.++|...+.||+|+||.||+|+.. +++.||||.+..... .....+..|+. +++.++||||+++++++..++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 357888899999999999999975 788999999975432 22345556665 778889999999999999999999999
Q ss_pred eccCCCCHHHHHhc-----------------hhHHHHHHHHHHhcCCC-ceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 232 EYMPRGSLEKCLYS-----------------SNYVGFALEYLHFDYSV-LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 232 Ey~~~gsL~~~l~~-----------------~~~i~~~L~yLH~~~~~-~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
||+++ +|.+++.. ..+++.||+||| +. +|+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 77776642 123788999999 55 8999999999999999999999999999876
Q ss_pred ccCCceeeecccccccCccc----------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 294 IREDHFMIQTQTLATIGYMA----------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~a----------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
..... .....||+.|+| +|||||||++|||+||+.||..
T Consensus 177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 43221 122345555554 7999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-31 Score=266.49 Aligned_cols=177 Identities=24% Similarity=0.357 Sum_probs=142.5
Q ss_pred hCCCccccccccCCcceEEEeEecC----CceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQD----RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
.++|...+.||+|+||.||+|+... +..||+|.+..... ...+.+.+|+.++++++||||+++++++. ++..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 4568888999999999999998742 45789998764322 23467889999999999999999999985 466899
Q ss_pred EEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 230 VLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
||||+++|+|.+++.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 999999999999886432 3888999999 779999999999999999999999999999876443
Q ss_pred CceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 297 DHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.. .......+|+.|+| +|||||||++|||++ |+.||...
T Consensus 545 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 545 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 22 12223445677887 899999999999997 99999754
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=243.77 Aligned_cols=177 Identities=20% Similarity=0.276 Sum_probs=140.9
Q ss_pred hhCCCccccccccCCcceEEEeEecCCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
..++|...+.||+|+||.||+|+..+ .+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 35678899999999999999998765 58999886442 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 232 EYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
||+++++|.+++.... +++.||+||| +.+|+||||||+||+++ ++.+||+|||+++.......
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 9999999999987532 3888999999 77999999999999998 67999999999876532111
Q ss_pred ---eeeecccccccCccc---------------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 ---FMIQTQTLATIGYMA---------------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ---~~~~~~~~gt~~y~a---------------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
........||+.|+| +|||||||++|||+||+.||+..
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 246 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 111122335555543 79999999999999999999764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-31 Score=269.49 Aligned_cols=174 Identities=22% Similarity=0.272 Sum_probs=144.6
Q ss_pred hCCCccccccccCCcceEEEeEec--CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCe-----
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ--DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDF----- 226 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 226 (348)
.++|...+.||+|+||.||+|+.. +++.||||.+..... .....+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 468999999999999999999975 588999998864322 234568899999999999999999999987655
Q ss_pred EEEEEeccCCCCHHHHHhch----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 227 KVLVLEYMPRGSLEKCLYSS----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
.++||||+++++|.+++... .+++.||+||| +.+|+||||||+|||++.+ .+||+|||+++.....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 79999999999998776532 34888999999 7789999999999999986 8999999999876432
Q ss_pred CceeeecccccccCccc-----------cccHHHHHHHHHHHcCCCCCccccc
Q 038351 297 DHFMIQTQTLATIGYMA-----------SYVYSFGIMLLEVFTRKKPTNKIFF 338 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~a-----------sDV~S~Gvvl~elltG~~P~~~~~~ 338 (348)
....||+.|+| +|||||||+++||++|..||...+.
T Consensus 235 ------~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~ 281 (681)
T 2pzi_A 235 ------GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYV 281 (681)
T ss_dssp ------SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEEC
T ss_pred ------CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccc
Confidence 34568889987 8999999999999999999876543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=238.75 Aligned_cols=163 Identities=21% Similarity=0.368 Sum_probs=135.7
Q ss_pred hhCCCccc-cccccCCcceEEEeEe-cCCceEEEEeeeeccCccchhhHHHhhhc-ccccccceeeEEEEEec----CCe
Q 038351 154 VTNGFSED-NLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVM-KSTCYRNLIKIISSRSN----EDF 226 (348)
Q Consensus 154 ~~~~f~~~-~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~----~~~ 226 (348)
..++|... +.||+|+||.||+|+. .+++.||+|.+.. ...+.+|++++ +..+||||+++++++.. ...
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 34566665 7899999999999987 4788999999863 25677888887 66689999999999876 677
Q ss_pred EEEEEeccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcC---CCcEEEeecCC
Q 038351 227 KVLVLEYMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDD---NIVTHLSDFGI 289 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~DfGl 289 (348)
.++||||+++|+|.+++.... +++.||+||| +.+|+||||||+||+++. ++.+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 899999999999999886532 3788999999 788999999999999998 78999999999
Q ss_pred ccccccCCceeeecccccccCccccccHHHHHHHHHHHcCCCCCccc
Q 038351 290 AKLLIREDHFMIQTQTLATIGYMASYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 290 a~~~~~~~~~~~~~~~~gt~~y~asDV~S~Gvvl~elltG~~P~~~~ 336 (348)
++..... ..-.++|||||||++|||+||+.||...
T Consensus 167 a~~~~~~------------~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 167 AKETTGE------------KYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp CEECTTC------------GGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred ccccccc------------cCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 9765421 1123589999999999999999999653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-31 Score=247.69 Aligned_cols=174 Identities=22% Similarity=0.283 Sum_probs=141.1
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc--cchhhHHHhhhcccccccceeeEEEEEecCCe----
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG--AFKSFDFECDVMKSTCYRNLIKIISSRSNEDF---- 226 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 226 (348)
..++|...+.||+|+||.||+|+.. +++.||||.+...... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 3467889999999999999999975 6889999998653222 24568899999999999999999999987654
Q ss_pred --EEEEEeccCCCCHHHHHhc----------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 227 --KVLVLEYMPRGSLEKCLYS----------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 227 --~~lV~Ey~~~gsL~~~l~~----------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
.++||||++ ++|.+.+.. ..+++.||+||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred eeEEEEecccc-CCHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 499999997 577766542 234889999999 7789999999999999999999999999998654
Q ss_pred cCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 295 REDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.. .....+|+.|+| +|||||||++|||+||+.||...
T Consensus 178 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 178 AE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred CC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22 123456777765 89999999999999999999754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=242.97 Aligned_cols=172 Identities=22% Similarity=0.311 Sum_probs=127.5
Q ss_pred hhhCCCccc-cccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHh-hhcccccccceeeEEEEEec----CC
Q 038351 153 RVTNGFSED-NLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFEC-DVMKSTCYRNLIKIISSRSN----ED 225 (348)
Q Consensus 153 ~~~~~f~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~----~~ 225 (348)
...++|... ++||+|+||.||+|+.. +++.||+|.+... ....+|+ ..++.+.||||+++++++.. ..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 356778884 57999999999999976 6889999998642 2223333 34566789999999999876 45
Q ss_pred eEEEEEeccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcC---CCcEEEeecC
Q 038351 226 FKVLVLEYMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDD---NIVTHLSDFG 288 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~DfG 288 (348)
..++||||+++|+|.+++.... +++.||+||| +.+|+||||||+||+++. ++.+||+|||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 6899999999999999986532 3788999999 779999999999999976 4559999999
Q ss_pred CccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 289 IAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 289 la~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+++...... .....+|+.|+| +|||||||++|||+||+.||...
T Consensus 177 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (336)
T 3fhr_A 177 FAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232 (336)
T ss_dssp TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 998754321 234567888876 79999999999999999999654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-30 Score=241.14 Aligned_cols=173 Identities=20% Similarity=0.255 Sum_probs=143.7
Q ss_pred hhCCCccccccccCCcceEEEeEec-CC-ceEEEEeeeeccCccchhhHHHhhhcccccccc------eeeEEEEEecCC
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DR-MEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRN------LIKIISSRSNED 225 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~ 225 (348)
..++|...+.||+|+||.||+|+.. ++ ..||+|.+.... ...+.+.+|++++++++|++ ++.+.+++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 3568999999999999999999875 33 689999986432 23466888999999999877 999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEE---------------
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLF--------------- 276 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILl--------------- 276 (348)
..++||||+ ++++.+.+... .+++.||+||| +.+|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccc
Confidence 999999999 66676665432 13888999999 8899999999999999
Q ss_pred ----cCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 277 ----DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 277 ----d~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+.++.+||+|||+++..... .....||+.|+| +|||||||++|||+||+.||...
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 67889999999999865332 134567888887 89999999999999999999754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=245.90 Aligned_cols=172 Identities=19% Similarity=0.250 Sum_probs=140.8
Q ss_pred hCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCccchhhHHHhhhccccc-----------ccceeeEEEEEe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-----------YRNLIKIISSRS 222 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~ 222 (348)
.++|...+.||+|+||.||+|+. .+++.||||.+.... ...+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 45788999999999999999996 478899999986332 23466788999998887 899999999988
Q ss_pred cCC----eEEEEEeccCCCCHHHHHhch--------------hHHHHHHHHHHhcCCC-ceEecCCCcCceEEc------
Q 038351 223 NED----FKVLVLEYMPRGSLEKCLYSS--------------NYVGFALEYLHFDYSV-LIIHYDLKPSNVLFD------ 277 (348)
Q Consensus 223 ~~~----~~~lV~Ey~~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~-~iiHrDik~~NILld------ 277 (348)
..+ ..++||||+ +++|.+++... .+++.||+||| +. +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence 654 789999999 88999887642 23888999999 65 899999999999994
Q ss_pred CCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 278 DNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 278 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..+.+||+|||+++..... .....||+.|+| +|||||||++|||+||+.||+..
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 4458999999999876432 234467888887 89999999999999999999754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-30 Score=236.12 Aligned_cols=174 Identities=25% Similarity=0.313 Sum_probs=125.7
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc-cc-hhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG-AF-KSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
.++|+..+.||+|+||.||+|+.. +++.||||.+...... .. +.+..+..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 457888899999999999999975 7889999998654322 12 23344455688889999999999999999999999
Q ss_pred eccCCCCHHHHHhc-------------hhHHHHHHHHHHhcCCC-ceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 232 EYMPRGSLEKCLYS-------------SNYVGFALEYLHFDYSV-LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 232 Ey~~~gsL~~~l~~-------------~~~i~~~L~yLH~~~~~-~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
||+ ++.+...... ..+++.||+||| +. +|+||||||+||+++.++.+||+|||+++......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999 4455444332 124888999999 53 89999999999999999999999999997664322
Q ss_pred ceeeecccccccCccc-----------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 298 HFMIQTQTLATIGYMA-----------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a-----------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
. .....+|+.|+| +|||||||++|||+||+.||+.
T Consensus 180 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 180 A---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred c---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 1 123346666654 7999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-30 Score=259.45 Aligned_cols=175 Identities=26% Similarity=0.384 Sum_probs=144.5
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc-CccchhhHHHhhhcccccccceeeEEEEEec------CCe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC-SGAFKSFDFECDVMKSTCYRNLIKIISSRSN------EDF 226 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~ 226 (348)
.++|...+.||+|+||.||+|+.. ++..||||.+.... ....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999874 68899999986432 2234668899999999999999999999765 677
Q ss_pred EEEEEeccCCCCHHHHHhchh---------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCc---EEEeecC
Q 038351 227 KVLVLEYMPRGSLEKCLYSSN---------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIV---THLSDFG 288 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~~---------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~---~kl~DfG 288 (348)
.++||||+++|+|.+++.... +++.||+||| +.+|+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999987521 3788999999 788999999999999997654 8999999
Q ss_pred CccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 289 IAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 289 la~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
+++....... .....||+.|+| +|||||||++|||+||+.||..
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 9987654322 234567777776 8999999999999999999964
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-31 Score=247.89 Aligned_cols=171 Identities=18% Similarity=0.170 Sum_probs=136.7
Q ss_pred hCCCccccccccCCcceEEEeEecCCceEEEEeeeeccC--------ccchhhHHHhhhccccc---------ccceeeE
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCS--------GAFKSFDFECDVMKSTC---------YRNLIKI 217 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------H~niv~l 217 (348)
.++|...+.||+|+||+||+|+. +++.||||.+..... ...+.+.+|+++++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45688889999999999999998 678999999976532 12367889999998886 7777777
Q ss_pred EEEEe------------------------------cCCeEEEEEeccCCCCHHHHHhch-----------hHHHHHHHHH
Q 038351 218 ISSRS------------------------------NEDFKVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYL 256 (348)
Q Consensus 218 ~~~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yL 256 (348)
.+.+. ..+..++|||||++|++.+.+... .+++.||+||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 76643 267899999999999765554321 2488899999
Q ss_pred HhcCCCceEecCCCcCceEEcCCC--------------------cEEEeecCCccccccCCceeeecccccccCccc---
Q 038351 257 HFDYSVLIIHYDLKPSNVLFDDNI--------------------VTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA--- 313 (348)
Q Consensus 257 H~~~~~~iiHrDik~~NILld~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a--- 313 (348)
|. +.+|+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|
T Consensus 178 H~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 178 EA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDL 248 (336)
T ss_dssp HH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGG
T ss_pred HH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChhh
Confidence 92 35799999999999999887 8999999999876432 3367888887
Q ss_pred --------cccHHHHHH-HHHHHcCCCCCcc
Q 038351 314 --------SYVYSFGIM-LLEVFTRKKPTNK 335 (348)
Q Consensus 314 --------sDV~S~Gvv-l~elltG~~P~~~ 335 (348)
+||||++++ .+++++|..||..
T Consensus 249 ~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 249 FTGDGDYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp GCCCSSHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred hcCCCccceehhhhhCCCCcccccccCCCcc
Confidence 899998777 7889999999865
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-28 Score=234.43 Aligned_cols=173 Identities=14% Similarity=0.113 Sum_probs=127.1
Q ss_pred hhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccC---ccchhhHHHhhhcccccc-cce--------------
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCY-RNL-------------- 214 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~ni-------------- 214 (348)
.+..|...+.||+|+||.||+|+. .+++.||||.+..... ...+.+.+|+.+++.++| +|.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 344577788999999999999995 4788999998873322 235778899999999977 211
Q ss_pred -------eeEEEEEec-----CCeEEEEEeccCCCCHHHHHhch-------------------hHHHHHHHHHHhcCCCc
Q 038351 215 -------IKIISSRSN-----EDFKVLVLEYMPRGSLEKCLYSS-------------------NYVGFALEYLHFDYSVL 263 (348)
Q Consensus 215 -------v~l~~~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~-------------------~~i~~~L~yLH~~~~~~ 263 (348)
..+..++.. ....+++|+++ +++|.+++... .+++.||+||| +.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYG 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 111111111 12356777765 67998887411 24788999999 789
Q ss_pred eEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeecccccccCccc----------------------cccHHHHH
Q 038351 264 IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA----------------------SYVYSFGI 321 (348)
Q Consensus 264 iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a----------------------sDV~S~Gv 321 (348)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+| +|||||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999999865322 123344 55543 79999999
Q ss_pred HHHHHHcCCCCCccc
Q 038351 322 MLLEVFTRKKPTNKI 336 (348)
Q Consensus 322 vl~elltG~~P~~~~ 336 (348)
++|||+||+.||...
T Consensus 306 il~elltg~~Pf~~~ 320 (413)
T 3dzo_A 306 AIYWIWCADLPNTDD 320 (413)
T ss_dssp HHHHHHHSSCCCCTT
T ss_pred HHHHHHHCCCCCCCc
Confidence 999999999999764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.4e-29 Score=249.03 Aligned_cols=165 Identities=16% Similarity=0.092 Sum_probs=118.3
Q ss_pred cccCCcceEEEeE-ecCCceEEEEeeeeccC----------ccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEEE
Q 038351 164 ISRGGFGSIHKAR-IQDRMEFSVKGFHLQCS----------GAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 164 lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 231 (348)
.+.|++|.+..++ .-.|..+++|.+..... ...++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666666554 33578899999864321 1235689999999999 6999999999999999999999
Q ss_pred eccCCCCHHHHHhchh---------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeee
Q 038351 232 EYMPRGSLEKCLYSSN---------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~---------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 302 (348)
||++|++|.+.|.... +|+.||+|+| +.+||||||||+|||+++++.+||+|||+|+....... ..
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~ 396 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WP 396 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CS
T ss_pred ecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cc
Confidence 9999999999997642 4888999999 88999999999999999999999999999987754322 23
Q ss_pred cccccccCccc-----------cccHHHHHHHHHHHcCCCCC
Q 038351 303 TQTLATIGYMA-----------SYVYSFGIMLLEVFTRKKPT 333 (348)
Q Consensus 303 ~~~~gt~~y~a-----------sDV~S~Gvvl~elltG~~P~ 333 (348)
...+||++||| +|+||+|+++++|.++..|+
T Consensus 397 ~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp HHHHHHHHHHHHHHC-----------------CCCCTTHHHH
T ss_pred cCceechhhccHHHhCCCCCCcccccccccchhhhccccchh
Confidence 45679999987 79999999888776665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.4e-25 Score=220.79 Aligned_cols=168 Identities=17% Similarity=0.152 Sum_probs=128.3
Q ss_pred ccccccCCcceEEEeEecCCceEEEEeeeeccCc--------cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 161 DNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSG--------AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 161 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.+.||+|+||.||+|.. .+..+++|+....... ..+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 46899999999999954 4667888876433211 12447899999999999999966666667777899999
Q ss_pred ccCCCCHHHHHhc----hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee-----eec
Q 038351 233 YMPRGSLEKCLYS----SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM-----IQT 303 (348)
Q Consensus 233 y~~~gsL~~~l~~----~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~-----~~~ 303 (348)
||++++|.+++.. ..+++.||+||| +.+|+||||||+|||++. .+||+|||+++......... ...
T Consensus 420 ~~~ggsL~~~l~~~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~ 494 (540)
T 3en9_A 420 YINGKLAKDVIEDNLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKK 494 (540)
T ss_dssp CCCSEEHHHHSTTCTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhh
Confidence 9999999999876 345889999999 788999999999999999 99999999999875422111 124
Q ss_pred ccccccCccc--------------cccHHHHHHHHHHHcCCCCCc
Q 038351 304 QTLATIGYMA--------------SYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 304 ~~~gt~~y~a--------------sDV~S~Gvvl~elltG~~P~~ 334 (348)
...||+.||| +|+||..+-.++.+.++.+|.
T Consensus 495 ~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 495 AVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 5679999998 677888888888877777764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.1e-21 Score=179.79 Aligned_cols=134 Identities=16% Similarity=0.103 Sum_probs=106.4
Q ss_pred HHhhhCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCc------------------cchhhHHHhhhccccccc
Q 038351 151 LCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSG------------------AFKSFDFECDVMKSTCYR 212 (348)
Q Consensus 151 ~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~H~ 212 (348)
+......|+..+.||+|+||.||+|+..++..||+|.++..... ....+.+|++++++++|
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~- 163 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG- 163 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence 33445566777999999999999999988999999998643211 13458899999999984
Q ss_pred ceeeEEEEEecCCeEEEEEeccCCCCHHHHHhch------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEee
Q 038351 213 NLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSS------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSD 286 (348)
Q Consensus 213 niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~D 286 (348)
+++.+++.. +..++||||+++|+|.+ +... .+++.||+||| +.+|+||||||+|||++ ++.+||+|
T Consensus 164 --~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 164 --LAVPKVYAW-EGNAVLMELIDAKELYR-VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp --SSSCCEEEE-ETTEEEEECCCCEEGGG-CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred --CCcCeEEec-cceEEEEEecCCCcHHH-cchhhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 444444433 45699999999999988 4332 34889999999 78999999999999999 99999999
Q ss_pred cCCcccc
Q 038351 287 FGIAKLL 293 (348)
Q Consensus 287 fGla~~~ 293 (348)
||+|+..
T Consensus 236 FG~a~~~ 242 (282)
T 1zar_A 236 FPQSVEV 242 (282)
T ss_dssp CTTCEET
T ss_pred CCCCeEC
Confidence 9999765
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.2e-18 Score=157.34 Aligned_cols=129 Identities=20% Similarity=0.155 Sum_probs=98.4
Q ss_pred CccccccccCCcceEEEeEe-cCCce--EEEEeeeeccCcc------------------------chhhHHHhhhccccc
Q 038351 158 FSEDNLISRGGFGSIHKARI-QDRME--FSVKGFHLQCSGA------------------------FKSFDFECDVMKSTC 210 (348)
Q Consensus 158 f~~~~~lG~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l~ 210 (348)
|+..+.||+|+||.||+|.. .++.. ||||.++...... ...+.+|++++.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56678999999999999998 68888 9999874331110 125788999999999
Q ss_pred ccce--eeEEEEEecCCeEEEEEeccCC-C----CHHHHHhc---------hhHHHHHHHHHHhcCCCceEecCCCcCce
Q 038351 211 YRNL--IKIISSRSNEDFKVLVLEYMPR-G----SLEKCLYS---------SNYVGFALEYLHFDYSVLIIHYDLKPSNV 274 (348)
Q Consensus 211 H~ni--v~l~~~~~~~~~~~lV~Ey~~~-g----sL~~~l~~---------~~~i~~~L~yLH~~~~~~iiHrDik~~NI 274 (348)
|+++ +.+++. +..+|||||+.+ | +|.+.... ..+++.|++|||. +.+|+||||||+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlkp~NI 202 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQ--EAELVHADLSEYNI 202 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCSTTSE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHE
Confidence 8864 444543 356899999942 4 77776543 1247888999984 46899999999999
Q ss_pred EEcCCCcEEEeecCCccccc
Q 038351 275 LFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 275 Lld~~~~~kl~DfGla~~~~ 294 (348)
|+++ .++|+|||+|....
T Consensus 203 Ll~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 203 MYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp EESS--SEEECCCTTCEETT
T ss_pred EEcC--cEEEEECcccccCC
Confidence 9998 99999999998653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.75 E-value=7.3e-19 Score=163.16 Aligned_cols=133 Identities=24% Similarity=0.356 Sum_probs=114.6
Q ss_pred CCcccccCcccCCcccCC--C----CC-----CcEEEEeccccee-e--ecCCCCCCCCCCCCCccEEEccc-CcccccC
Q 038351 4 RSHSVLHGWKINHLVRQK--P----TH-----KAVTNITFGLLVF-I--ILCPRYNYPPLRPPQQENLSLAS-NELISVI 68 (348)
Q Consensus 4 ~~~~~~~~w~~~~~~~~~--~----~~-----~~v~~~~~~~~~~-~--~~~~~~~~~~~~~~~l~~l~L~~-N~l~g~i 68 (348)
||. .+.+|+.+ .+||. | |+ ++|+.+.+....+ + .+.+.+ +.+++|+.|+|++ |+++|.+
T Consensus 20 ~~~-~l~~W~~~-~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l----~~l~~L~~L~L~~~n~l~~~~ 93 (313)
T 1ogq_A 20 NPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL----ANLPYLNFLYIGGINNLVGPI 93 (313)
T ss_dssp CCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGG----GGCTTCSEEEEEEETTEESCC
T ss_pred Ccc-cccCCCCC-CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhH----hCCCCCCeeeCCCCCcccccC
Confidence 565 79999874 35776 6 11 5677777765443 2 455555 8899999999995 9999999
Q ss_pred cccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceeeeecccccccccc
Q 038351 69 PSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISY 142 (348)
Q Consensus 69 p~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ls~N~lsG~ip~ 142 (348)
|..|+++++|++|+|++|+++|.+|..++++++|++|++++|+++|.+|..+..+++|+.|++++|+++|.+|.
T Consensus 94 p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 167 (313)
T 1ogq_A 94 PPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167 (313)
T ss_dssp CGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCG
T ss_pred ChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998884
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=2.6e-18 Score=177.97 Aligned_cols=98 Identities=30% Similarity=0.405 Sum_probs=95.0
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|+|+|.||.+|+++++|+.|+|++|+|+|.||.+++++++|+.||||+|+|+|.||.+++.++.|+.
T Consensus 629 ~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~ 708 (768)
T 3rgz_A 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTE 708 (768)
T ss_dssp SSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSE
T ss_pred hccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCE
Confidence 78999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeeecccccccccccccc
Q 038351 129 LFLGYNRLQGSISYSKWF 146 (348)
Q Consensus 129 L~ls~N~lsG~ip~~~~~ 146 (348)
|++++|+++|.||....|
T Consensus 709 L~ls~N~l~g~iP~~~~~ 726 (768)
T 3rgz_A 709 IDLSNNNLSGPIPEMGQF 726 (768)
T ss_dssp EECCSSEEEEECCSSSSG
T ss_pred EECcCCcccccCCCchhh
Confidence 999999999999976543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.70 E-value=1e-17 Score=169.96 Aligned_cols=130 Identities=15% Similarity=0.138 Sum_probs=111.5
Q ss_pred ccccCcccCCcccCCC---------CCCcEEEEeccccee-eecCCCCCCCCCCCCCccEEEcccC--------------
Q 038351 7 SVLHGWKINHLVRQKP---------THKAVTNITFGLLVF-IILCPRYNYPPLRPPQQENLSLASN-------------- 62 (348)
Q Consensus 7 ~~~~~w~~~~~~~~~~---------~~~~v~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~L~~N-------------- 62 (348)
....+|+.+ .+||.| ..++|+.|.++..++ |.+++.+ +.+++|+.|+|++|
T Consensus 55 ~~~~~W~~~-~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l----~~L~~L~~L~Ls~N~~~~~~~~~~~~~~ 129 (636)
T 4eco_A 55 QPGANWNFN-KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAI----GQLTELEVLALGSHGEKVNERLFGPKGI 129 (636)
T ss_dssp ---CCCCCS-SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGG----GGCTTCCEEESCCGGGGGTCCSBSTTSB
T ss_pred ccCCCCCCC-CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHH----hcCccceEEECcCCccccCCcccccccc
Confidence 345578865 356666 246899999987774 6777777 99999999999988
Q ss_pred ----------------------------------------------------------------cccccCcccccCCccC
Q 038351 63 ----------------------------------------------------------------ELISVIPSTFWNLKDI 78 (348)
Q Consensus 63 ----------------------------------------------------------------~l~g~ip~~~~~l~~L 78 (348)
+|+| ||++|+++++|
T Consensus 130 ~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L 208 (636)
T 4eco_A 130 SANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKL 208 (636)
T ss_dssp CTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTC
T ss_pred ccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCC
Confidence 5567 99999999999
Q ss_pred cceecccccccCC-----------------CCcCCC--CCcccceeecccCcccCccCCccccccccceeeeeccc-ccc
Q 038351 79 LYLNLSLNSLTGP-----------------IPLEIE--NLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLGYNR-LQG 138 (348)
Q Consensus 79 ~~l~l~~N~l~G~-----------------iP~~~~--~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ls~N~-lsG 138 (348)
++|+|++|+|+|. ||.+++ ++++|++|++++|+++|.+|.+++++++|+.|++++|+ ++|
T Consensus 209 ~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~ 288 (636)
T 4eco_A 209 RQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISG 288 (636)
T ss_dssp CEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCH
T ss_pred CEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCcc
Confidence 9999999999997 999999 99999999999999999999999999999999999998 998
Q ss_pred -cccc
Q 038351 139 -SISY 142 (348)
Q Consensus 139 -~ip~ 142 (348)
.+|.
T Consensus 289 ~~lp~ 293 (636)
T 4eco_A 289 EQLKD 293 (636)
T ss_dssp HHHHH
T ss_pred ccchH
Confidence 7874
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.6e-17 Score=173.39 Aligned_cols=115 Identities=18% Similarity=0.126 Sum_probs=104.6
Q ss_pred CCcEEEEeccccee-eecCCCCCCCCCCCCCccEEEc-ccCccccc----------------------------------
Q 038351 24 HKAVTNITFGLLVF-IILCPRYNYPPLRPPQQENLSL-ASNELISV---------------------------------- 67 (348)
Q Consensus 24 ~~~v~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~L-~~N~l~g~---------------------------------- 67 (348)
.++|+.|.++..++ |.+++.+ +.|++|+.|+| ++|.++|.
T Consensus 322 ~~~V~~L~Ls~~~L~G~ip~~l----~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~ 397 (876)
T 4ecn_A 322 NGRVTGLSLAGFGAKGRVPDAI----GQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397 (876)
T ss_dssp TSCEEEEECTTTCCEEEECGGG----GGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGG
T ss_pred CCCEEEEECccCCCCCcCchHH----hccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcc
Confidence 37899999987774 6788887 99999999999 88877776
Q ss_pred ------------------------------------------CcccccCCccCcceecccccccC---------------
Q 038351 68 ------------------------------------------IPSTFWNLKDILYLNLSLNSLTG--------------- 90 (348)
Q Consensus 68 ------------------------------------------ip~~~~~l~~L~~l~l~~N~l~G--------------- 90 (348)
||++|++|++|++|+|++|+|+|
T Consensus 398 ~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~ 477 (876)
T 4ecn_A 398 LNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYA 477 (876)
T ss_dssp GGSCHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHH
T ss_pred hhhhHHHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccc
Confidence 89999999999999999999999
Q ss_pred --CCCcCCC--CCcccceeecccCcccCccCCccccccccceeeeeccc-ccc-cccc
Q 038351 91 --PIPLEIE--NLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLGYNR-LQG-SISY 142 (348)
Q Consensus 91 --~iP~~~~--~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ls~N~-lsG-~ip~ 142 (348)
.||.+++ ++++|+.|+|++|++.|.+|.+++.+++|+.|++++|+ ++| .+|.
T Consensus 478 ~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~ 535 (876)
T 4ecn_A 478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKA 535 (876)
T ss_dssp HHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHH
T ss_pred cccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchH
Confidence 4999998 99999999999999999999999999999999999998 998 7774
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=2.4e-16 Score=163.19 Aligned_cols=137 Identities=19% Similarity=0.211 Sum_probs=106.4
Q ss_pred CCCcccccCcccCCcccCCCC-----CCcEEEEeccccee-ee---cCCCC-------------C------CCCCCCCCc
Q 038351 3 QRSHSVLHGWKINHLVRQKPT-----HKAVTNITFGLLVF-II---LCPRY-------------N------YPPLRPPQQ 54 (348)
Q Consensus 3 ~~~~~~~~~w~~~~~~~~~~~-----~~~v~~~~~~~~~~-~~---~~~~~-------------~------~~~~~~~~l 54 (348)
.||. .|.+|+.+ .+||.|. .++|+.|.++..++ +. +++.+ + ...+.+++|
T Consensus 25 ~~~~-~l~~W~~~-~~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~~l~~~~~~l~~L 102 (768)
T 3rgz_A 25 PDKN-LLPDWSSN-KNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASL 102 (768)
T ss_dssp SCTT-SSTTCCTT-SCGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEEECCCCCCCCTTC
T ss_pred CCcc-cccCCCCC-CCCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccccCCcCCCcCCCchhhccCCCC
Confidence 3777 89999843 4688883 46799999866553 33 32210 0 123889999
Q ss_pred cEEEcccCcccccCcc--cccCCccCcceecccccccCCCCcCC-CCCcccceeecccCcccCccCCc---cccccccce
Q 038351 55 ENLSLASNELISVIPS--TFWNLKDILYLNLSLNSLTGPIPLEI-ENLKVLVKIYFSMNNFAGVIPNA---IGCLNILQH 128 (348)
Q Consensus 55 ~~l~L~~N~l~g~ip~--~~~~l~~L~~l~l~~N~l~G~iP~~~-~~l~~L~~l~ls~N~l~G~iP~~---l~~l~~L~~ 128 (348)
++|+|++|.++|.+|. .|++|++|++|||++|+++|.+|..+ +++++|++|++++|+++|.+|.. +..+++|+.
T Consensus 103 ~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~ 182 (768)
T 3rgz_A 103 TSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKH 182 (768)
T ss_dssp CEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCE
T ss_pred CEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCE
Confidence 9999999999999999 99999999999999999999999887 88999999999999999888876 666666666
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|++++|++++.+|
T Consensus 183 L~Ls~n~l~~~~~ 195 (768)
T 3rgz_A 183 LAISGNKISGDVD 195 (768)
T ss_dssp EECCSSEEESCCB
T ss_pred EECCCCcccccCC
Confidence 6666666655444
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=4.5e-17 Score=154.47 Aligned_cols=129 Identities=16% Similarity=0.043 Sum_probs=91.8
Q ss_pred CCccccccccCCcceEEEeEecCCceEEEEeeeeccCc-----cc---------hh--------hHHHhhhcccccccce
Q 038351 157 GFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSG-----AF---------KS--------FDFECDVMKSTCYRNL 214 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----~~---------~~--------~~~E~~~l~~l~H~ni 214 (348)
-|+..+.||+|+||.||+|...+|+.||||.++..... .. .. ..+|...|.++.+..+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 38889999999999999999999999999987532110 00 01 1235555666544433
Q ss_pred e--eEEEEEecCCeEEEEEeccCCCCHHHHHhch------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC------
Q 038351 215 I--KIISSRSNEDFKVLVLEYMPRGSLEKCLYSS------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI------ 280 (348)
Q Consensus 215 v--~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~------ 280 (348)
. +.++. . ..+|||||+++++|.+..... .+++.++.||| ..+||||||||.|||+++++
T Consensus 176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~~d~~ 248 (397)
T 4gyi_A 176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDAEDPS 248 (397)
T ss_dssp SCCCEEEE--E--TTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECSSCTT
T ss_pred CCCeeeec--c--CceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCccccc
Confidence 2 22221 1 237999999998887654322 24788999999 67899999999999998776
Q ss_pred ----cEEEeecCCccc
Q 038351 281 ----VTHLSDFGIAKL 292 (348)
Q Consensus 281 ----~~kl~DfGla~~ 292 (348)
.+.|+||+-+..
T Consensus 249 ~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 249 SITLTPIIIXFPQMVS 264 (397)
T ss_dssp SEEEEEEECCCTTCEE
T ss_pred ccccceEEEEeCCccc
Confidence 388999986644
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.60 E-value=1.1e-15 Score=131.66 Aligned_cols=93 Identities=25% Similarity=0.264 Sum_probs=80.5
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|.|++.+|..|+++++|++|+|++|++++..|..+..+++|+.|+|++|++++.+|..+..+++|+.
T Consensus 51 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 130 (192)
T 1w8a_A 51 GRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTS 130 (192)
T ss_dssp GGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCE
T ss_pred ccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCE
Confidence 67888888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|++++|++++..+
T Consensus 131 L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 131 LNLASNPFNCNCH 143 (192)
T ss_dssp EECTTCCBCCSGG
T ss_pred EEeCCCCccCcCc
Confidence 8888888888765
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.59 E-value=8.9e-16 Score=143.31 Aligned_cols=132 Identities=17% Similarity=0.260 Sum_probs=107.7
Q ss_pred CCcccccCcc---cCCcccCCC---------------CCCcEEEEecccceeeecCCCCCCCCCCCCCccEEEcccCccc
Q 038351 4 RSHSVLHGWK---INHLVRQKP---------------THKAVTNITFGLLVFIILCPRYNYPPLRPPQQENLSLASNELI 65 (348)
Q Consensus 4 ~~~~~~~~w~---~~~~~~~~~---------------~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~L~~N~l~ 65 (348)
||.+.+.+|. .....+|.| ...+|+.+.+....+..+.+.+ +.+++|+.|+|++|.++
T Consensus 42 ~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~~lp~~l----~~l~~L~~L~L~~n~l~ 117 (328)
T 4fcg_A 42 DRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLPQFPDQA----FRLSHLQHMTIDAAGLM 117 (328)
T ss_dssp CCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCSSCCSCG----GGGTTCSEEEEESSCCC
T ss_pred CchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCchhcChhh----hhCCCCCEEECCCCCcc
Confidence 5666778885 333345666 1256788888665555555555 77899999999999999
Q ss_pred ccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCcccc---------ccccceeeeecccc
Q 038351 66 SVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGC---------LNILQHLFLGYNRL 136 (348)
Q Consensus 66 g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~---------l~~L~~L~ls~N~l 136 (348)
.||..|+++++|++|+|++|+++ .||..++++++|++|++++|++.|.+|..+.. +++|+.|++++|++
T Consensus 118 -~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l 195 (328)
T 4fcg_A 118 -ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195 (328)
T ss_dssp -CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECC
T ss_pred -chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCc
Confidence 89999999999999999999999 99999999999999999999999999988775 88999999999998
Q ss_pred cccccc
Q 038351 137 QGSISY 142 (348)
Q Consensus 137 sG~ip~ 142 (348)
+ .+|.
T Consensus 196 ~-~lp~ 200 (328)
T 4fcg_A 196 R-SLPA 200 (328)
T ss_dssp C-CCCG
T ss_pred C-cchH
Confidence 8 6664
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.1e-16 Score=157.41 Aligned_cols=89 Identities=19% Similarity=0.067 Sum_probs=67.0
Q ss_pred CCCCCccEEEcccCcccccCccccc-CCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFW-NLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~-~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
+.+++|+.|+|++|.|+|.+|..++ ++++|++|+|++|++++..+ +..+++|+.|+|++|+|++ +|+.+..+++|+
T Consensus 141 ~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~ 217 (487)
T 3oja_A 141 GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVT 217 (487)
T ss_dssp GGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCS
T ss_pred cCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCcc
Confidence 6677888888888888887777776 67777777777777776522 3357888888888888886 445588888888
Q ss_pred eeeeeccccccccc
Q 038351 128 HLFLGYNRLQGSIS 141 (348)
Q Consensus 128 ~L~ls~N~lsG~ip 141 (348)
.|++++|++++ +|
T Consensus 218 ~L~Ls~N~l~~-lp 230 (487)
T 3oja_A 218 WISLRNNKLVL-IE 230 (487)
T ss_dssp EEECTTSCCCE-EC
T ss_pred EEEecCCcCcc-cc
Confidence 88888888886 44
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.54 E-value=2.4e-15 Score=139.32 Aligned_cols=94 Identities=29% Similarity=0.507 Sum_probs=91.4
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCcccccc-ccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLN-ILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~-~L~ 127 (348)
+.+++|+.|+|++|.++|.+|..|+++++|++|+|++|+++|.+|..++.+++|++|++++|+++|.+|..++.+. .|+
T Consensus 98 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~ 177 (313)
T 1ogq_A 98 AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT 177 (313)
T ss_dssp GGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCC
T ss_pred hcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCc
Confidence 8899999999999999999999999999999999999999999999999999999999999999999999999998 999
Q ss_pred eeeeecccccccccc
Q 038351 128 HLFLGYNRLQGSISY 142 (348)
Q Consensus 128 ~L~ls~N~lsG~ip~ 142 (348)
.|++++|+++|.+|.
T Consensus 178 ~L~L~~N~l~~~~~~ 192 (313)
T 1ogq_A 178 SMTISRNRLTGKIPP 192 (313)
T ss_dssp EEECCSSEEEEECCG
T ss_pred EEECcCCeeeccCCh
Confidence 999999999998884
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.2e-14 Score=135.70 Aligned_cols=93 Identities=14% Similarity=0.064 Sum_probs=75.5
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|.+++ +|+.++++++|++|+|++|++.|.+|..++.+++|+.|++++|++.+.+|..+..+++|+.
T Consensus 203 ~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~ 281 (328)
T 4fcg_A 203 ANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEK 281 (328)
T ss_dssp GGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCE
T ss_pred cCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCE
Confidence 667788888888888885 7777888888888888888888888888888888888888888888888888888888888
Q ss_pred eeeecccccccccc
Q 038351 129 LFLGYNRLQGSISY 142 (348)
Q Consensus 129 L~ls~N~lsG~ip~ 142 (348)
|++++|++.|.+|.
T Consensus 282 L~L~~n~~~~~iP~ 295 (328)
T 4fcg_A 282 LDLRGCVNLSRLPS 295 (328)
T ss_dssp EECTTCTTCCCCCG
T ss_pred EeCCCCCchhhccH
Confidence 88888888888774
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=3.7e-14 Score=124.71 Aligned_cols=93 Identities=16% Similarity=0.168 Sum_probs=57.1
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++..|..|+++++|++|+|++|++++..|..+..+++|++|+|++|++++..|..+..+++|+.
T Consensus 54 ~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 133 (220)
T 2v70_A 54 KKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRL 133 (220)
T ss_dssp GGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSE
T ss_pred ccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCE
Confidence 45566666666666666655556666666666666666666555555666666666666666666666666666666666
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|+|++|++++..|
T Consensus 134 L~L~~N~l~~~~~ 146 (220)
T 2v70_A 134 LSLYDNQITTVAP 146 (220)
T ss_dssp EECTTSCCCCBCT
T ss_pred EECCCCcCCEECH
Confidence 6666666665444
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.50 E-value=6.3e-14 Score=118.25 Aligned_cols=91 Identities=24% Similarity=0.294 Sum_probs=84.5
Q ss_pred CCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceee
Q 038351 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLF 130 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ 130 (348)
.++|+.|+|++|+|++..|..|+++++|++|+|++|+|++-.|..+..+++|++|+|++|+|++..|..+..+++|+.|+
T Consensus 29 ~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 108 (170)
T 3g39_A 29 PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIW 108 (170)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEE
Confidence 58999999999999998899999999999999999999976666789999999999999999987777899999999999
Q ss_pred eeccccccccc
Q 038351 131 LGYNRLQGSIS 141 (348)
Q Consensus 131 ls~N~lsG~ip 141 (348)
|++|++++..+
T Consensus 109 L~~N~~~c~c~ 119 (170)
T 3g39_A 109 LLNNPWDCACS 119 (170)
T ss_dssp CCSSCBCTTBG
T ss_pred eCCCCCCCCch
Confidence 99999998655
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=3.6e-14 Score=124.79 Aligned_cols=92 Identities=23% Similarity=0.157 Sum_probs=56.2
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|.+++..|..|.++++|++|+|++|++++..|..+..+++|+.|+|++|++++..|..+..+++|+.
T Consensus 78 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 157 (220)
T 2v70_A 78 EGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLST 157 (220)
T ss_dssp TTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCE
T ss_pred CCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCE
Confidence 55566666666666666555555666666666666666666555666666666666666666666655666666666666
Q ss_pred eeeecccccccc
Q 038351 129 LFLGYNRLQGSI 140 (348)
Q Consensus 129 L~ls~N~lsG~i 140 (348)
|++++|.+++..
T Consensus 158 L~L~~N~l~c~c 169 (220)
T 2v70_A 158 LNLLANPFNCNC 169 (220)
T ss_dssp EECCSCCEECSG
T ss_pred EEecCcCCcCCC
Confidence 666666665543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.48 E-value=1e-13 Score=121.86 Aligned_cols=93 Identities=23% Similarity=0.190 Sum_probs=75.0
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++..|..|.++++|++|+|++|++++-.+..+..+++|+.|+|++|++++..|..+..+++|+.
T Consensus 53 ~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 132 (220)
T 2v9t_B 53 SPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNL 132 (220)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred hCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCE
Confidence 66788888888888888877888888888888888888888433344677888888888888888888888888888888
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|+|++|++++..+
T Consensus 133 L~L~~N~l~~~~~ 145 (220)
T 2v9t_B 133 LSLYDNKLQTIAK 145 (220)
T ss_dssp EECCSSCCSCCCT
T ss_pred EECCCCcCCEECH
Confidence 8888888876544
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.2e-13 Score=117.15 Aligned_cols=91 Identities=22% Similarity=0.305 Sum_probs=82.5
Q ss_pred CCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceee
Q 038351 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLF 130 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ 130 (348)
.++|+.|+|++|.|++.+|..|+++++|++|+|++|+|++-.|..+..+++|+.|+|++|+|++..|..+..+++|+.|+
T Consensus 32 ~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~ 111 (174)
T 2r9u_A 32 PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIY 111 (174)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEE
Confidence 48999999999999998899999999999999999999975555678999999999999999976666799999999999
Q ss_pred eeccccccccc
Q 038351 131 LGYNRLQGSIS 141 (348)
Q Consensus 131 ls~N~lsG~ip 141 (348)
+++|+++...+
T Consensus 112 L~~N~~~c~~~ 122 (174)
T 2r9u_A 112 LYNNPWDCECR 122 (174)
T ss_dssp CCSSCBCTTBG
T ss_pred eCCCCcccccc
Confidence 99999987543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.48 E-value=7.4e-14 Score=120.12 Aligned_cols=92 Identities=24% Similarity=0.255 Sum_probs=85.8
Q ss_pred CCCccEEEcccCcccccCcc-cccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCcccccccccee
Q 038351 51 PPQQENLSLASNELISVIPS-TFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHL 129 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~ip~-~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L 129 (348)
.++|+.|+|++|++++..|. .|+++++|++|+|++|++++.+|..+..+++|+.|+|++|+|++..|..+..+++|+.|
T Consensus 28 ~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 107 (192)
T 1w8a_A 28 PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTL 107 (192)
T ss_dssp CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEE
T ss_pred CCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEE
Confidence 35999999999999986665 49999999999999999999999999999999999999999999999999999999999
Q ss_pred eeecccccccccc
Q 038351 130 FLGYNRLQGSISY 142 (348)
Q Consensus 130 ~ls~N~lsG~ip~ 142 (348)
++++|++++.+|.
T Consensus 108 ~L~~N~l~~~~~~ 120 (192)
T 1w8a_A 108 NLYDNQISCVMPG 120 (192)
T ss_dssp ECCSSCCCEECTT
T ss_pred ECCCCcCCeeCHH
Confidence 9999999998774
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.4e-13 Score=116.46 Aligned_cols=93 Identities=24% Similarity=0.228 Sum_probs=70.7
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|.+++..|..|+++++|+.|+|++|++++..|..+..+++|+.|++++|++++..|..+..+++|+.
T Consensus 49 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 128 (177)
T 2o6r_A 49 DKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQK 128 (177)
T ss_dssp TTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred cCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCE
Confidence 66778888888888887655556778888888888888888666666778888888888888887555555677788888
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|++++|++.+..|
T Consensus 129 L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 129 IWLHTNPWDCSCP 141 (177)
T ss_dssp EECCSSCBCCCHH
T ss_pred EEecCCCeeccCc
Confidence 8888888887665
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.3e-14 Score=147.41 Aligned_cols=91 Identities=30% Similarity=0.327 Sum_probs=82.3
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.|+ .||.+|++|++|++|+|++|+|+ .||.+|+.|++|++|+|++|.|+ .||..++.+++|+.
T Consensus 244 ~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~ 320 (727)
T 4b8c_D 244 FKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQF 320 (727)
T ss_dssp GGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCC
T ss_pred cCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccE
Confidence 67889999999999999 89999999999999999999999 89999999999999999999986 88999999999999
Q ss_pred eeeecccccccccc
Q 038351 129 LFLGYNRLQGSISY 142 (348)
Q Consensus 129 L~ls~N~lsG~ip~ 142 (348)
|+|++|+|+|.+|.
T Consensus 321 L~L~~N~l~~~~p~ 334 (727)
T 4b8c_D 321 LGVEGNPLEKQFLK 334 (727)
T ss_dssp EECTTSCCCSHHHH
T ss_pred EeCCCCccCCCChH
Confidence 99999999887764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.46 E-value=5.1e-14 Score=115.70 Aligned_cols=111 Identities=19% Similarity=0.076 Sum_probs=89.2
Q ss_pred CcEEEEecccceee--ecCCCCCCCCCCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCccc
Q 038351 25 KAVTNITFGLLVFI--ILCPRYNYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVL 102 (348)
Q Consensus 25 ~~v~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L 102 (348)
..++.+.++.-... .+...+ +.+++|+.|+|++|.+++. ..++++++|++|+|++|++++.+|..++.+++|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~----~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L 90 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLT----DEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNL 90 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCC----TTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTC
T ss_pred ccCeEEEccCCcCChhHHHHHH----hhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCC
Confidence 44566666544432 344444 7789999999999999885 788999999999999999998888888889999
Q ss_pred ceeecccCcccC-ccCCccccccccceeeeeccccccccc
Q 038351 103 VKIYFSMNNFAG-VIPNAIGCLNILQHLFLGYNRLQGSIS 141 (348)
Q Consensus 103 ~~l~ls~N~l~G-~iP~~l~~l~~L~~L~ls~N~lsG~ip 141 (348)
+.|++++|++++ ..|..+..+++|+.|++++|++++..+
T Consensus 91 ~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 91 THLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp CEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred CEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 999999999988 366889999999999999999887544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=6.2e-14 Score=140.25 Aligned_cols=91 Identities=21% Similarity=0.166 Sum_probs=87.0
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCcc-CCccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVI-PNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~i-P~~l~~l~~L~ 127 (348)
+.+++|+.|+|++|.|+ .||..|++|++|+.|+|++|+|++ || .++.+++|+.|+|++|+|++.+ |..++.+++|+
T Consensus 460 ~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~ 536 (567)
T 1dce_A 460 EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLV 536 (567)
T ss_dssp GGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCC
T ss_pred cccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCC
Confidence 88999999999999999 899999999999999999999997 88 8999999999999999999998 99999999999
Q ss_pred eeeeecccccccccc
Q 038351 128 HLFLGYNRLQGSISY 142 (348)
Q Consensus 128 ~L~ls~N~lsG~ip~ 142 (348)
.|+|++|++++.+|.
T Consensus 537 ~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 537 LLNLQGNSLCQEEGI 551 (567)
T ss_dssp EEECTTSGGGGSSSC
T ss_pred EEEecCCcCCCCccH
Confidence 999999999998664
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.2e-13 Score=119.05 Aligned_cols=88 Identities=23% Similarity=0.332 Sum_probs=66.4
Q ss_pred CCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceee
Q 038351 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLF 130 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ 130 (348)
.++|+.|+|++|+|+ .||..|.++++|++|+|++|++++-.|..|..+++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 30 ~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 108 (193)
T 2wfh_A 30 PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLS 108 (193)
T ss_dssp CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEE
Confidence 357777777777776 5777777777777777777777766667777777777777777777777777777777777777
Q ss_pred eeccccccc
Q 038351 131 LGYNRLQGS 139 (348)
Q Consensus 131 ls~N~lsG~ 139 (348)
|++|++++.
T Consensus 109 L~~N~l~~~ 117 (193)
T 2wfh_A 109 LHGNDISVV 117 (193)
T ss_dssp CCSSCCCBC
T ss_pred CCCCCCCee
Confidence 777777743
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=3.6e-13 Score=115.99 Aligned_cols=91 Identities=26% Similarity=0.292 Sum_probs=85.3
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++..|..|.++++|++|+|++|++++-.|..|..+++|+.|+|++|++++..+..+..+++|+.
T Consensus 51 ~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 130 (193)
T 2wfh_A 51 SNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSH 130 (193)
T ss_dssp GGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCE
T ss_pred hcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccE
Confidence 77899999999999999988889999999999999999999888889999999999999999999766677999999999
Q ss_pred eeeeccccccc
Q 038351 129 LFLGYNRLQGS 139 (348)
Q Consensus 129 L~ls~N~lsG~ 139 (348)
|++++|.+...
T Consensus 131 L~L~~N~~~C~ 141 (193)
T 2wfh_A 131 LAIGANPLYCD 141 (193)
T ss_dssp EECCSSCEECS
T ss_pred EEeCCCCeecC
Confidence 99999999864
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.42 E-value=5.2e-13 Score=118.03 Aligned_cols=86 Identities=22% Similarity=0.254 Sum_probs=49.3
Q ss_pred CCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceeee
Q 038351 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFL 131 (348)
Q Consensus 52 ~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~l 131 (348)
++|+.|+|++|++++..|..|.++++|++|+|++|++++-.|..+..+++|+.|+|++|+|++..|..+..+++|+.|++
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 55566666666666655555666666666666666664333334455666666666666665544445555556666666
Q ss_pred eccccc
Q 038351 132 GYNRLQ 137 (348)
Q Consensus 132 s~N~ls 137 (348)
++|+++
T Consensus 120 s~N~l~ 125 (229)
T 3e6j_A 120 CCNKLT 125 (229)
T ss_dssp CSSCCC
T ss_pred cCCccc
Confidence 666555
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.42 E-value=6.3e-14 Score=142.15 Aligned_cols=93 Identities=17% Similarity=0.313 Sum_probs=74.5
Q ss_pred CCCCCccEEEcccCccccc-----------------Cccccc--CCccCcceecccccccCCCCcCCCCCcccceeeccc
Q 038351 49 LRPPQQENLSLASNELISV-----------------IPSTFW--NLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSM 109 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~-----------------ip~~~~--~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~ 109 (348)
+++++|+.|+|++|.|+|. ||++++ ++++|++|+|++|+++|.+|.+++++++|+.|++++
T Consensus 203 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~ 282 (636)
T 4eco_A 203 MRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVAC 282 (636)
T ss_dssp GGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTT
T ss_pred hcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcC
Confidence 7788888888888888886 888888 888888888888888888888888888888888888
Q ss_pred Cc-ccC-ccCCccccc------cccceeeeecccccccccc
Q 038351 110 NN-FAG-VIPNAIGCL------NILQHLFLGYNRLQGSISY 142 (348)
Q Consensus 110 N~-l~G-~iP~~l~~l------~~L~~L~ls~N~lsG~ip~ 142 (348)
|+ ++| .+|..++.+ ++|+.|++++|+++ .+|.
T Consensus 283 n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~ 322 (636)
T 4eco_A 283 NRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPV 322 (636)
T ss_dssp CTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCC
T ss_pred CCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCc
Confidence 87 888 777777665 67777777777777 5664
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.41 E-value=7.2e-13 Score=118.51 Aligned_cols=90 Identities=24% Similarity=0.251 Sum_probs=49.6
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|.+++..|..|.++++|++|+|++|++++-.|..+..+++|+.|++++|++++..|..+..+++|+.
T Consensus 56 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 135 (251)
T 3m19_A 56 RGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKE 135 (251)
T ss_dssp TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccE
Confidence 44555555555555555555545555555555555555555444444555555555555555555444444555555555
Q ss_pred eeeecccccc
Q 038351 129 LFLGYNRLQG 138 (348)
Q Consensus 129 L~ls~N~lsG 138 (348)
|++++|++++
T Consensus 136 L~Ls~N~l~~ 145 (251)
T 3m19_A 136 LRLNTNQLQS 145 (251)
T ss_dssp EECCSSCCCC
T ss_pred EECcCCcCCc
Confidence 5555555554
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.40 E-value=6.8e-13 Score=117.25 Aligned_cols=92 Identities=26% Similarity=0.287 Sum_probs=81.1
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.|++..+..|.++++|++|+|++|++++-.|..+..+++|+.|++++|+|+ .||..+..+++|+.
T Consensus 61 ~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~ 139 (229)
T 3e6j_A 61 DSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTH 139 (229)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSE
T ss_pred hCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCE
Confidence 78899999999999997654556799999999999999999776777899999999999999999 89999999999999
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|++++|++++..+
T Consensus 140 L~L~~N~l~~~~~ 152 (229)
T 3e6j_A 140 LALDQNQLKSIPH 152 (229)
T ss_dssp EECCSSCCCCCCT
T ss_pred EECCCCcCCccCH
Confidence 9999999986443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.40 E-value=8.5e-13 Score=114.49 Aligned_cols=90 Identities=26% Similarity=0.268 Sum_probs=52.4
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|++++..+..|.++++|++|+|++|++++..|..+..+++|+.|++++|++++..|..+..+++|+.
T Consensus 49 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 128 (208)
T 2o6s_A 49 DELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKD 128 (208)
T ss_dssp TTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCE
Confidence 45566666666666666443334556666666666666666444444556666666666666666555555555666666
Q ss_pred eeeecccccc
Q 038351 129 LFLGYNRLQG 138 (348)
Q Consensus 129 L~ls~N~lsG 138 (348)
|++++|++++
T Consensus 129 L~l~~N~l~~ 138 (208)
T 2o6s_A 129 LRLYQNQLKS 138 (208)
T ss_dssp EECCSSCCSC
T ss_pred EECCCCccce
Confidence 6666666554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.40 E-value=9.1e-13 Score=114.31 Aligned_cols=94 Identities=21% Similarity=0.184 Sum_probs=85.7
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++..|..|+++++|++|+|++|++++-.|..+..+++|+.|++++|++++..+..+..+++|+.
T Consensus 73 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 152 (208)
T 2o6s_A 73 NKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQY 152 (208)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred CCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccE
Confidence 67899999999999999866667899999999999999999777777899999999999999999877777999999999
Q ss_pred eeeecccccccccc
Q 038351 129 LFLGYNRLQGSISY 142 (348)
Q Consensus 129 L~ls~N~lsG~ip~ 142 (348)
|++++|.+.+..|.
T Consensus 153 L~l~~N~~~~~~~~ 166 (208)
T 2o6s_A 153 IWLHDNPWDCTCPG 166 (208)
T ss_dssp EECCSCCBCCCTTT
T ss_pred EEecCCCeecCCCC
Confidence 99999999988774
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.40 E-value=8.5e-13 Score=119.54 Aligned_cols=92 Identities=25% Similarity=0.272 Sum_probs=49.9
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|.+++..|..|+++++|++|+|++|++++..|..++.+++|+.|++++|++++..|..+..+++|+.
T Consensus 106 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 185 (272)
T 3rfs_A 106 DKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKD 185 (272)
T ss_dssp TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCE
Confidence 44555555555555555544444555555555555555555444444555555555555555555544444555555555
Q ss_pred eeeecccccccc
Q 038351 129 LFLGYNRLQGSI 140 (348)
Q Consensus 129 L~ls~N~lsG~i 140 (348)
|++++|++++..
T Consensus 186 L~L~~N~l~~~~ 197 (272)
T 3rfs_A 186 LRLYQNQLKSVP 197 (272)
T ss_dssp EECCSSCCSCCC
T ss_pred EECCCCcCCccC
Confidence 555555555433
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.40 E-value=3.8e-13 Score=125.92 Aligned_cols=90 Identities=19% Similarity=0.176 Sum_probs=81.7
Q ss_pred CCCCCccEEEccc-CcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccc
Q 038351 49 LRPPQQENLSLAS-NELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~-N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
+.+++|+.|+|++ |.|++..|..|++|++|+.|+|++|+|+|.+|..|++|++|+.|+|++|+|++..|..+..+. |+
T Consensus 28 ~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~ 106 (347)
T 2ifg_A 28 PGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQ 106 (347)
T ss_dssp CSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CC
T ss_pred CCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ce
Confidence 8889999999996 999998888999999999999999999999999999999999999999999976555565555 99
Q ss_pred eeeeeccccccc
Q 038351 128 HLFLGYNRLQGS 139 (348)
Q Consensus 128 ~L~ls~N~lsG~ 139 (348)
.|+|++|++...
T Consensus 107 ~l~l~~N~~~c~ 118 (347)
T 2ifg_A 107 ELVLSGNPLHCS 118 (347)
T ss_dssp EEECCSSCCCCC
T ss_pred EEEeeCCCccCC
Confidence 999999999854
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.39 E-value=9.8e-13 Score=117.65 Aligned_cols=93 Identities=26% Similarity=0.218 Sum_probs=80.3
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++..|..|.++++|++|+|++|++++-.|..+..+++|+.|++++|++++..|..+..+++|+.
T Consensus 80 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 159 (251)
T 3m19_A 80 DDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQT 159 (251)
T ss_dssp TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCE
Confidence 77889999999999999877778889999999999999999666666788999999999999999777778889999999
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|++++|++++..+
T Consensus 160 L~L~~N~l~~~~~ 172 (251)
T 3m19_A 160 LSLSTNQLQSVPH 172 (251)
T ss_dssp EECCSSCCSCCCT
T ss_pred EECCCCcCCccCH
Confidence 9999999886544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.38 E-value=3.3e-13 Score=113.09 Aligned_cols=89 Identities=27% Similarity=0.225 Sum_probs=63.2
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCc-cCCccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGV-IPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~-iP~~l~~l~~L~ 127 (348)
..+++|+.|+|++|.+++. ..++++++|++|+|++|++++.+|..+..+++|+.|++++|++++. .+..+..+++|+
T Consensus 46 ~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~ 123 (168)
T 2ell_A 46 AEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLK 123 (168)
T ss_dssp GGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCC
T ss_pred HhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCC
Confidence 5667777777777777764 6677777777777777777776777666677777777777777653 336677777777
Q ss_pred eeeeeccccccc
Q 038351 128 HLFLGYNRLQGS 139 (348)
Q Consensus 128 ~L~ls~N~lsG~ 139 (348)
.|++++|++++.
T Consensus 124 ~L~l~~N~l~~~ 135 (168)
T 2ell_A 124 SLDLFNCEVTNL 135 (168)
T ss_dssp EEECCSSGGGTS
T ss_pred EEEeeCCcCcch
Confidence 777777777654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.38 E-value=1.3e-12 Score=114.72 Aligned_cols=91 Identities=18% Similarity=0.143 Sum_probs=84.3
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.|++..+..|..+++|++|+|++|++++..|..+..+++|+.|+|++|+|++..|..+..+++|+.
T Consensus 77 ~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 156 (220)
T 2v9t_B 77 QGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQT 156 (220)
T ss_dssp TTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred hCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCE
Confidence 88999999999999999644445789999999999999999999999999999999999999999988889999999999
Q ss_pred eeeeccccccc
Q 038351 129 LFLGYNRLQGS 139 (348)
Q Consensus 129 L~ls~N~lsG~ 139 (348)
|++++|.+...
T Consensus 157 L~L~~N~~~c~ 167 (220)
T 2v9t_B 157 MHLAQNPFICD 167 (220)
T ss_dssp EECCSSCEECS
T ss_pred EEeCCCCcCCC
Confidence 99999998764
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.38 E-value=1.4e-12 Score=118.18 Aligned_cols=93 Identities=24% Similarity=0.203 Sum_probs=80.4
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|.+++..|..|+++++|++|+|++|++++..|..++.+++|++|++++|++++..|..+..+++|+.
T Consensus 82 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 161 (272)
T 3rfs_A 82 KELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTE 161 (272)
T ss_dssp TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCE
Confidence 77889999999999999877777889999999999999999777777889999999999999999877777888899999
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|++++|++++..+
T Consensus 162 L~l~~n~l~~~~~ 174 (272)
T 3rfs_A 162 LDLSYNQLQSLPE 174 (272)
T ss_dssp EECCSSCCCCCCT
T ss_pred EECCCCCcCccCH
Confidence 9999999886544
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.3e-12 Score=110.52 Aligned_cols=91 Identities=25% Similarity=0.284 Sum_probs=82.5
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
...++|+.|+|++|++++..|..|+++++|++|+|++|++++-.|..++.+++|+.|++++|++++..|..+..+++|+.
T Consensus 25 ~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 104 (177)
T 2o6r_A 25 GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKE 104 (177)
T ss_dssp TCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCE
Confidence 44589999999999999866667899999999999999999766677899999999999999999888888999999999
Q ss_pred eeeeccccccc
Q 038351 129 LFLGYNRLQGS 139 (348)
Q Consensus 129 L~ls~N~lsG~ 139 (348)
|++++|++++.
T Consensus 105 L~l~~N~l~~~ 115 (177)
T 2o6r_A 105 LALDTNQLKSV 115 (177)
T ss_dssp EECCSSCCSCC
T ss_pred EECcCCcceEe
Confidence 99999999854
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.37 E-value=5e-13 Score=109.71 Aligned_cols=88 Identities=19% Similarity=0.191 Sum_probs=83.0
Q ss_pred CCCCCccEEEcccCccc-ccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccc
Q 038351 49 LRPPQQENLSLASNELI-SVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~-g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
..+++|+.|+|++|.++ |.+|..+.++++|+.|+|++|++++. ..++.+++|++|++++|++++.+|..+..+++|+
T Consensus 14 ~~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~ 91 (149)
T 2je0_A 14 RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLT 91 (149)
T ss_dssp CCGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCC
T ss_pred CCCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCC
Confidence 44588999999999999 89999999999999999999999976 7899999999999999999999999999999999
Q ss_pred eeeeecccccc
Q 038351 128 HLFLGYNRLQG 138 (348)
Q Consensus 128 ~L~ls~N~lsG 138 (348)
.|++++|++++
T Consensus 92 ~L~ls~N~i~~ 102 (149)
T 2je0_A 92 HLNLSGNKIKD 102 (149)
T ss_dssp EEECTTSCCCS
T ss_pred EEECCCCcCCC
Confidence 99999999987
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.5e-13 Score=143.54 Aligned_cols=93 Identities=18% Similarity=0.222 Sum_probs=80.3
Q ss_pred CCCCCccEEEcccCcccc-----------------cCccccc--CCccCcceecccccccCCCCcCCCCCcccceeeccc
Q 038351 49 LRPPQQENLSLASNELIS-----------------VIPSTFW--NLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSM 109 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g-----------------~ip~~~~--~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~ 109 (348)
+++++|+.|+|++|.|+| .||++++ +|++|++|+|++|+++|.+|.+++++++|+.|++++
T Consensus 445 ~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~ 524 (876)
T 4ecn_A 445 QRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC 524 (876)
T ss_dssp GGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTT
T ss_pred hcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcC
Confidence 788899999999999988 4888888 899999999999999999998899999999999999
Q ss_pred Cc-ccC-ccCCcccccc-------ccceeeeecccccccccc
Q 038351 110 NN-FAG-VIPNAIGCLN-------ILQHLFLGYNRLQGSISY 142 (348)
Q Consensus 110 N~-l~G-~iP~~l~~l~-------~L~~L~ls~N~lsG~ip~ 142 (348)
|+ |+| .+|..++.+. +|+.|++++|+++ .+|.
T Consensus 525 N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~ 565 (876)
T 4ecn_A 525 NRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPA 565 (876)
T ss_dssp CTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCC
T ss_pred CCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCC
Confidence 87 888 8888777776 8888888888888 6775
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=3.4e-13 Score=135.33 Aligned_cols=90 Identities=22% Similarity=0.243 Sum_probs=76.4
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
.++++|+.|+|++|+|++..|..|.+|++|++|+|++|+|++-.|..|.++++|++|++++|++++..|..++.+++|+.
T Consensus 73 ~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~ 152 (635)
T 4g8a_A 73 FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 152 (635)
T ss_dssp TTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCE
T ss_pred hCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCe
Confidence 77888889999988888866667888889999999999888666677888889999999999888877778888889999
Q ss_pred eeeecccccc
Q 038351 129 LFLGYNRLQG 138 (348)
Q Consensus 129 L~ls~N~lsG 138 (348)
|++++|++++
T Consensus 153 L~Ls~N~l~~ 162 (635)
T 4g8a_A 153 LNVAHNLIQS 162 (635)
T ss_dssp EECCSSCCCC
T ss_pred eccccCcccc
Confidence 9999988865
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.36 E-value=7.9e-13 Score=110.75 Aligned_cols=89 Identities=22% Similarity=0.186 Sum_probs=83.4
Q ss_pred CCCCCccEEEcccCccc-ccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccc
Q 038351 49 LRPPQQENLSLASNELI-SVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~-g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
..+++|+.|+|++|.++ |.||..+.++++|+.|+|++|++++. ..++.+++|+.|++++|++++.+|..+..+++|+
T Consensus 21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 98 (168)
T 2ell_A 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98 (168)
T ss_dssp SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence 45689999999999999 89999999999999999999999975 7899999999999999999999999998899999
Q ss_pred eeeeeccccccc
Q 038351 128 HLFLGYNRLQGS 139 (348)
Q Consensus 128 ~L~ls~N~lsG~ 139 (348)
.|++++|++++.
T Consensus 99 ~L~Ls~N~l~~~ 110 (168)
T 2ell_A 99 HLNLSGNKLKDI 110 (168)
T ss_dssp EEECBSSSCCSS
T ss_pred EEeccCCccCcc
Confidence 999999999873
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=6.9e-12 Score=112.57 Aligned_cols=140 Identities=14% Similarity=0.065 Sum_probs=109.8
Q ss_pred HhhhCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhccccc-ccceeeEEEEEecCCeEEEE
Q 038351 152 CRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 152 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV 230 (348)
......|.....++.|+.+.||++... +..+++|............+.+|+++++.+. +..+.++++++...+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344567877788888888999999755 5789999886533233457899999999885 67788999999988999999
Q ss_pred EeccCCCCHHHHHh---c----hhHHHHHHHHHHhc--------------------------------------------
Q 038351 231 LEYMPRGSLEKCLY---S----SNYVGFALEYLHFD-------------------------------------------- 259 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~---~----~~~i~~~L~yLH~~-------------------------------------------- 259 (348)
|||++|.++.+.+. . ...+++++..||..
T Consensus 89 ~e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 89 MSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp EECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred EEecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 99999999987631 1 23477889999971
Q ss_pred ------------CCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 260 ------------YSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 260 ------------~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
....++|+|+++.||++++...+.|.||+.+..
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 114589999999999998766667999998754
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=2.2e-12 Score=124.78 Aligned_cols=93 Identities=24% Similarity=0.201 Sum_probs=47.3
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|.+++..|..|+++++|++|+|++|++++.+|..+..+++|+.|++++|++++..|..+..+++|+.
T Consensus 320 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 399 (455)
T 3v47_A 320 WGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQK 399 (455)
T ss_dssp TTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred cCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccE
Confidence 34455555555555555444445555555555555555555544555555555555555555555433334445555555
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|++++|++++.+|
T Consensus 400 L~l~~N~l~~~~~ 412 (455)
T 3v47_A 400 IWLHTNPWDCSCP 412 (455)
T ss_dssp EECCSSCBCCCTT
T ss_pred EEccCCCcccCCC
Confidence 5555555555444
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=2e-12 Score=129.69 Aligned_cols=90 Identities=20% Similarity=0.218 Sum_probs=50.1
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccc-cccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCL-NILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l-~~L~ 127 (348)
..+++|+.|+|++|+|++.+|..|++|++|+.|+|++|+|++-.|..+..+++|++||+++|+|++.+|..+..+ ++|+
T Consensus 491 ~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~ 570 (635)
T 4g8a_A 491 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLA 570 (635)
T ss_dssp TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCC
T ss_pred hhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCC
Confidence 445555555555555555555555555555555555555555555555555555555555555555555555554 3455
Q ss_pred eeeeecccccc
Q 038351 128 HLFLGYNRLQG 138 (348)
Q Consensus 128 ~L~ls~N~lsG 138 (348)
.|++++|.++.
T Consensus 571 ~L~L~~Np~~C 581 (635)
T 4g8a_A 571 FLNLTQNDFAC 581 (635)
T ss_dssp EEECTTCCBCC
T ss_pred EEEeeCCCCcc
Confidence 55555555543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=3.5e-12 Score=128.00 Aligned_cols=108 Identities=19% Similarity=0.210 Sum_probs=58.4
Q ss_pred cEEEEecccceeeecCC-CCCCCCCCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccce
Q 038351 26 AVTNITFGLLVFIILCP-RYNYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVK 104 (348)
Q Consensus 26 ~v~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~ 104 (348)
.++.+.++.-....+.+ .+ .++++|+.|+|++|.+++..|..|+++++|++|+|++|++++.+|..++++++|++
T Consensus 33 ~l~~L~Ls~n~l~~~~~~~~----~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 108 (606)
T 3vq2_A 33 STKNIDLSFNPLKILKSYSF----SNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLEN 108 (606)
T ss_dssp TCCEEECTTSCCCEECTTTT----TTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCE
T ss_pred CcCEEECCCCCcCEeChhhc----cCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCE
Confidence 35555554333323322 23 55556666666666665555555556666666666666665555555555555555
Q ss_pred eecccCcccCccCCccccccccceeeeeccccc
Q 038351 105 IYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137 (348)
Q Consensus 105 l~ls~N~l~G~iP~~l~~l~~L~~L~ls~N~ls 137 (348)
|++++|++++..|..++.+.+|+.|++++|++.
T Consensus 109 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 141 (606)
T 3vq2_A 109 LVAVETKLASLESFPIGQLITLKKLNVAHNFIH 141 (606)
T ss_dssp EECTTSCCCCSSSSCCTTCTTCCEEECCSSCCC
T ss_pred EEccCCccccccccccCCCCCCCEEeCCCCccc
Confidence 555555555544455555555555555555554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.1e-12 Score=113.10 Aligned_cols=91 Identities=15% Similarity=0.114 Sum_probs=62.6
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.++ .++.+.++++|++|+|++|++++..|..++.+++|+.|++++|++++..|..+..+++|+.
T Consensus 63 ~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~ 140 (197)
T 4ezg_A 63 EYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNS 140 (197)
T ss_dssp GGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCE
T ss_pred hcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCE
Confidence 55677777777777443 3446777777777777777777766777777777777777777777777777777777777
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|++++|++-+.+|
T Consensus 141 L~L~~n~~i~~~~ 153 (197)
T 4ezg_A 141 IDLSYNGAITDIM 153 (197)
T ss_dssp EECCSCTBCCCCG
T ss_pred EEccCCCCccccH
Confidence 7777776444444
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.31 E-value=3.3e-12 Score=117.29 Aligned_cols=93 Identities=19% Similarity=0.181 Sum_probs=79.9
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccC-CCCcCCCCCcccceeecccCcccCccCCccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTG-PIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G-~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
..+++|+.|+|++|.+++.+|..+.++++|++|+|++|++++ .+|..+..+++|+.|++++|++++..|..+..+++|+
T Consensus 123 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 202 (306)
T 2z66_A 123 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 202 (306)
T ss_dssp TTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred hhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCC
Confidence 678888999999999888888888888899999999998887 5788888888999999999988888888888888888
Q ss_pred eeeeeccccccccc
Q 038351 128 HLFLGYNRLQGSIS 141 (348)
Q Consensus 128 ~L~ls~N~lsG~ip 141 (348)
.|++++|++++..+
T Consensus 203 ~L~L~~N~l~~~~~ 216 (306)
T 2z66_A 203 VLNMSHNNFFSLDT 216 (306)
T ss_dssp EEECTTSCCSBCCS
T ss_pred EEECCCCccCccCh
Confidence 89998888876443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.31 E-value=7.1e-13 Score=122.47 Aligned_cols=90 Identities=18% Similarity=0.093 Sum_probs=79.2
Q ss_pred CCCCccEEEcccCcccccCcccc--cCCccCcceecccccccCCCCcCCCCC-----cccceeecccCcccCccCCcccc
Q 038351 50 RPPQQENLSLASNELISVIPSTF--WNLKDILYLNLSLNSLTGPIPLEIENL-----KVLVKIYFSMNNFAGVIPNAIGC 122 (348)
Q Consensus 50 ~~~~l~~l~L~~N~l~g~ip~~~--~~l~~L~~l~l~~N~l~G~iP~~~~~l-----~~L~~l~ls~N~l~G~iP~~l~~ 122 (348)
.+++|+.|+|++|.++|.+|..+ +++++|++|+|++|++++. |..++.+ ++|++|++++|++++..|..++.
T Consensus 93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~ 171 (312)
T 1wwl_A 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV 171 (312)
T ss_dssp TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence 57889999999999999999887 8899999999999999977 8888877 89999999999999888889999
Q ss_pred ccccceeeeecccccccc
Q 038351 123 LNILQHLFLGYNRLQGSI 140 (348)
Q Consensus 123 l~~L~~L~ls~N~lsG~i 140 (348)
+++|+.|++++|++.|.+
T Consensus 172 l~~L~~L~Ls~N~l~~~~ 189 (312)
T 1wwl_A 172 FPALSTLDLSDNPELGER 189 (312)
T ss_dssp CSSCCEEECCSCTTCHHH
T ss_pred CCCCCEEECCCCCcCcch
Confidence 999999999999987763
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.30 E-value=6.4e-12 Score=115.03 Aligned_cols=89 Identities=25% Similarity=0.258 Sum_probs=70.9
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|.|+ .+|..+.++++|++|+|++|++++-.|..+..+++|+.|++++|++++..|..+..+++|+.
T Consensus 74 ~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 152 (290)
T 1p9a_G 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152 (290)
T ss_dssp SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCE
Confidence 56788888888888887 57888888888888888888888666677888888888888888888766666777888888
Q ss_pred eeeecccccc
Q 038351 129 LFLGYNRLQG 138 (348)
Q Consensus 129 L~ls~N~lsG 138 (348)
|++++|++++
T Consensus 153 L~L~~N~l~~ 162 (290)
T 1p9a_G 153 LSLANNNLTE 162 (290)
T ss_dssp EECTTSCCSC
T ss_pred EECCCCcCCc
Confidence 8888888874
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=3.4e-12 Score=123.50 Aligned_cols=90 Identities=31% Similarity=0.339 Sum_probs=53.8
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|.+++..|..|+++++|++|+|++|++++..|..++.+++|+.|++++|++++..|.++..+++|+.
T Consensus 296 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 375 (455)
T 3v47_A 296 SHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKE 375 (455)
T ss_dssp TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred ccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccE
Confidence 45556666666666666555555666666666666666665555555566666666666666665555556666666666
Q ss_pred eeeecccccc
Q 038351 129 LFLGYNRLQG 138 (348)
Q Consensus 129 L~ls~N~lsG 138 (348)
|++++|++++
T Consensus 376 L~L~~N~l~~ 385 (455)
T 3v47_A 376 LALDTNQLKS 385 (455)
T ss_dssp EECCSSCCSC
T ss_pred EECCCCcccc
Confidence 6666666554
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=6.4e-12 Score=113.71 Aligned_cols=90 Identities=22% Similarity=0.243 Sum_probs=49.4
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++..|..|.++++|++|+|++|++++..|..+.++++|+.|++++|++++..+..+..+++|+.
T Consensus 49 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 128 (276)
T 2z62_A 49 FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128 (276)
T ss_dssp TTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCE
T ss_pred ccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCE
Confidence 44555555555555555544445555555555555555555555555555555555555555555544444555555555
Q ss_pred eeeecccccc
Q 038351 129 LFLGYNRLQG 138 (348)
Q Consensus 129 L~ls~N~lsG 138 (348)
|++++|++++
T Consensus 129 L~l~~n~l~~ 138 (276)
T 2z62_A 129 LNVAHNLIQS 138 (276)
T ss_dssp EECCSSCCCC
T ss_pred EECcCCccce
Confidence 5555555543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=5.8e-12 Score=126.36 Aligned_cols=113 Identities=20% Similarity=0.168 Sum_probs=96.0
Q ss_pred EEEEecccceeeecCCCCCCCCCCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceee
Q 038351 27 VTNITFGLLVFIILCPRYNYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIY 106 (348)
Q Consensus 27 v~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ 106 (348)
.+.+.++.-...++.+.. .+++++|+.|+|++|.+++..|..|++|++|++|+|++|++++..|..++++++|++|+
T Consensus 58 L~~L~Ls~n~l~~i~~~~---~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 134 (606)
T 3vq2_A 58 LQWLDLSRCEIETIEDKA---WHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLN 134 (606)
T ss_dssp CCEEECTTCCCCEECTTT---TTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEE
T ss_pred CcEEeCCCCcccccCHHH---hhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEe
Confidence 455555433333443321 28899999999999999998899999999999999999999988889999999999999
Q ss_pred cccCcccC-ccCCccccccccceeeeecccccccccc
Q 038351 107 FSMNNFAG-VIPNAIGCLNILQHLFLGYNRLQGSISY 142 (348)
Q Consensus 107 ls~N~l~G-~iP~~l~~l~~L~~L~ls~N~lsG~ip~ 142 (348)
+++|++++ .+|..++++++|+.|++++|++++..|.
T Consensus 135 L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~ 171 (606)
T 3vq2_A 135 VAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171 (606)
T ss_dssp CCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred CCCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence 99999986 8899999999999999999999986553
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.29 E-value=4.2e-12 Score=119.76 Aligned_cols=89 Identities=26% Similarity=0.305 Sum_probs=71.0
Q ss_pred CCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCcccccccccee
Q 038351 50 RPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHL 129 (348)
Q Consensus 50 ~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L 129 (348)
.+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++-.|..|..+++|+.|+|++|++++..|..+..+.+|+.|
T Consensus 62 ~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 141 (361)
T 2xot_A 62 RLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL 141 (361)
T ss_dssp CCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred cccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE
Confidence 67788888888888887666778888888888888888886666677888888888888888887777788888888888
Q ss_pred eeecccccc
Q 038351 130 FLGYNRLQG 138 (348)
Q Consensus 130 ~ls~N~lsG 138 (348)
+|++|++++
T Consensus 142 ~L~~N~l~~ 150 (361)
T 2xot_A 142 YLSQNQISR 150 (361)
T ss_dssp ECCSSCCCS
T ss_pred ECCCCcCCe
Confidence 888887775
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=7e-12 Score=113.46 Aligned_cols=92 Identities=23% Similarity=0.245 Sum_probs=70.7
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccC-ccCCccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG-VIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G-~iP~~l~~l~~L~ 127 (348)
..+++|+.|+|++|.+++..|..|.++++|++|+|++|++++..+..++.+++|+.|++++|++++ .+|..+..+++|+
T Consensus 73 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~ 152 (276)
T 2z62_A 73 QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE 152 (276)
T ss_dssp TTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCC
T ss_pred cCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCC
Confidence 667778888888888877777777888888888888888877666677788888888888888776 4677787788888
Q ss_pred eeeeecccccccc
Q 038351 128 HLFLGYNRLQGSI 140 (348)
Q Consensus 128 ~L~ls~N~lsG~i 140 (348)
.|++++|++++..
T Consensus 153 ~L~Ls~N~l~~~~ 165 (276)
T 2z62_A 153 HLDLSSNKIQSIY 165 (276)
T ss_dssp EEECCSSCCCEEC
T ss_pred EEECCCCCCCcCC
Confidence 8888888777643
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=2.9e-12 Score=128.18 Aligned_cols=85 Identities=29% Similarity=0.315 Sum_probs=80.4
Q ss_pred CccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceeeee
Q 038351 53 QQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLG 132 (348)
Q Consensus 53 ~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ls 132 (348)
.|+.|+|++|.|++ ||. |+++++|+.|+|++|+|+ .||..++.+++|+.|+|++|+|++ || .++.+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 57899999999998 887 999999999999999999 999999999999999999999998 88 89999999999999
Q ss_pred cccccccc-cc
Q 038351 133 YNRLQGSI-SY 142 (348)
Q Consensus 133 ~N~lsG~i-p~ 142 (348)
+|++++.+ |.
T Consensus 517 ~N~l~~~~~p~ 527 (567)
T 1dce_A 517 NNRLQQSAAIQ 527 (567)
T ss_dssp SSCCCSSSTTG
T ss_pred CCCCCCCCCcH
Confidence 99999876 63
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.29 E-value=6.3e-12 Score=115.41 Aligned_cols=93 Identities=28% Similarity=0.349 Sum_probs=70.0
Q ss_pred CCCCCccEEEcccCcccc-cCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccc
Q 038351 49 LRPPQQENLSLASNELIS-VIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g-~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
..+++|+.|+|++|.+++ .+|..+.++++|++|+|++|++++..|..+..+++|+.|++++|++++..+..+..+++|+
T Consensus 147 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 226 (306)
T 2z66_A 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ 226 (306)
T ss_dssp TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCC
T ss_pred ccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCC
Confidence 667777777777777776 5677777777777777777777777777777777777777777777776666777777777
Q ss_pred eeeeeccccccccc
Q 038351 128 HLFLGYNRLQGSIS 141 (348)
Q Consensus 128 ~L~ls~N~lsG~ip 141 (348)
.|++++|++++..|
T Consensus 227 ~L~L~~N~l~~~~~ 240 (306)
T 2z66_A 227 VLDYSLNHIMTSKK 240 (306)
T ss_dssp EEECTTSCCCBCSS
T ss_pred EeECCCCCCcccCH
Confidence 77777777777655
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.28 E-value=3.3e-12 Score=131.43 Aligned_cols=91 Identities=23% Similarity=0.333 Sum_probs=85.7
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..++.|+.|+|++|.++ .||.+++++++|++|+|++|+|+ .||.+|++|++|++|+|++|+|+ .||..++.+++|++
T Consensus 221 ~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~ 297 (727)
T 4b8c_D 221 YDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKY 297 (727)
T ss_dssp -CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSE
T ss_pred ccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCE
Confidence 67899999999999999 79999999999999999999999 99999999999999999999999 99999999999999
Q ss_pred eeeeccccccccccc
Q 038351 129 LFLGYNRLQGSISYS 143 (348)
Q Consensus 129 L~ls~N~lsG~ip~~ 143 (348)
|+|++|+++ .+|..
T Consensus 298 L~L~~N~l~-~lp~~ 311 (727)
T 4b8c_D 298 FYFFDNMVT-TLPWE 311 (727)
T ss_dssp EECCSSCCC-CCCSS
T ss_pred EECCCCCCC-ccChh
Confidence 999999997 67753
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=6.4e-12 Score=114.25 Aligned_cols=94 Identities=23% Similarity=0.242 Sum_probs=77.8
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++..|..|.++++|++|+|++|++++..|..++.+++|+.|++++|++++..+..+..+++|+.
T Consensus 102 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 181 (285)
T 1ozn_A 102 HGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181 (285)
T ss_dssp TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred cCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCE
Confidence 67888888888888888877888888888888888888888666667888888888888888888666667888888888
Q ss_pred eeeecccccccccc
Q 038351 129 LFLGYNRLQGSISY 142 (348)
Q Consensus 129 L~ls~N~lsG~ip~ 142 (348)
|++++|++++..|.
T Consensus 182 L~l~~n~l~~~~~~ 195 (285)
T 1ozn_A 182 LLLHQNRVAHVHPH 195 (285)
T ss_dssp EECCSSCCCEECTT
T ss_pred EECCCCcccccCHh
Confidence 88888888876553
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.28 E-value=5.6e-12 Score=106.21 Aligned_cols=89 Identities=19% Similarity=0.172 Sum_probs=79.8
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+ ..+.|++++|.|+. ||..+. ++|++|+|++|++++..|..|..+++|+.|+|++|+|++..|..+..+++|+.
T Consensus 7 C~C-~~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~ 82 (170)
T 3g39_A 7 CSC-SGTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQ 82 (170)
T ss_dssp CEE-ETTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CCc-CCCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCE
Confidence 444 45789999999986 998885 88999999999999999999999999999999999999877777899999999
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|+|++|++++..+
T Consensus 83 L~L~~N~l~~~~~ 95 (170)
T 3g39_A 83 LSLNDNQLKSIPR 95 (170)
T ss_dssp EECCSSCCCCCCT
T ss_pred EECCCCccCEeCH
Confidence 9999999997544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=5.5e-12 Score=125.33 Aligned_cols=93 Identities=20% Similarity=0.218 Sum_probs=57.9
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceeccccccc-CCCCcCCCCCcccceeecccCcccCccCCccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLT-GPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~-G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
..+++|+.|+|++|.+++.+|..+.++++|+.|+|++|+++ |.+|..+..+++|+.|++++|++++.+|.++..+++|+
T Consensus 418 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 497 (570)
T 2z63_A 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497 (570)
T ss_dssp TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred hcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCC
Confidence 45566666666666666666666666666666666666665 45666666666666666666666666666666666666
Q ss_pred eeeeeccccccccc
Q 038351 128 HLFLGYNRLQGSIS 141 (348)
Q Consensus 128 ~L~ls~N~lsG~ip 141 (348)
.|++++|++++..|
T Consensus 498 ~L~l~~n~l~~~~~ 511 (570)
T 2z63_A 498 VLNMASNQLKSVPD 511 (570)
T ss_dssp EEECCSSCCSCCCT
T ss_pred EEeCCCCcCCCCCH
Confidence 66666666665433
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=4.2e-12 Score=125.81 Aligned_cols=93 Identities=20% Similarity=0.164 Sum_probs=61.9
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccC-ccCCccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG-VIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G-~iP~~l~~l~~L~ 127 (348)
+.+++|+.|+|++|.+++..|..|+++++|++|+|++|++++..|..++++++|++|++++|++++ .+|..++.+++|+
T Consensus 47 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~ 126 (549)
T 2z81_A 47 RACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126 (549)
T ss_dssp SSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCC
T ss_pred hcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCcc
Confidence 666677777777777776666667777777777777777766655556667777777777776665 4566666666666
Q ss_pred eeeeeccccccccc
Q 038351 128 HLFLGYNRLQGSIS 141 (348)
Q Consensus 128 ~L~ls~N~lsG~ip 141 (348)
.|++++|++.+.+|
T Consensus 127 ~L~L~~n~~~~~~~ 140 (549)
T 2z81_A 127 TLRIGNVETFSEIR 140 (549)
T ss_dssp EEEEEESSSCCEEC
T ss_pred EEECCCCccccccC
Confidence 66666666555554
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.28 E-value=1e-11 Score=110.66 Aligned_cols=135 Identities=14% Similarity=0.087 Sum_probs=100.1
Q ss_pred hhCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccc--eeeEEEEEecCCeEEEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRN--LIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lV~ 231 (348)
....+....+.+.|..+.||++...++..+++|..... ....+..|+++++.+.+.+ +.+++++....+..++||
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 33445544444466679999998877888999986532 3356889999999887554 567889888888899999
Q ss_pred eccCCCCHHHHHhc------hhHHHHHHHHHHhcC---------------------------------------------
Q 038351 232 EYMPRGSLEKCLYS------SNYVGFALEYLHFDY--------------------------------------------- 260 (348)
Q Consensus 232 Ey~~~gsL~~~l~~------~~~i~~~L~yLH~~~--------------------------------------------- 260 (348)
||+++.++. ... ...++..+..||...
T Consensus 95 e~i~G~~l~--~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 95 GEVPGQDLL--SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp ECCSSEETT--TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred EecCCcccC--cCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 999998885 211 223667777887432
Q ss_pred ----------CCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 261 ----------SVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 261 ----------~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
...++|+|++|.||+++++..+.|.||+.+...
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 123999999999999988766779999998653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1e-11 Score=112.88 Aligned_cols=92 Identities=26% Similarity=0.190 Sum_probs=72.6
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceeccccc-ccCCCCcCCCCCcccceeecccCcccCccCCccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNS-LTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~-l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
..+++|+.|+|++|.+++..|..|+++++|++|+|++|+ ++...|..+..+++|+.|++++|++++..|..+..+++|+
T Consensus 53 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 132 (285)
T 1ozn_A 53 RACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132 (285)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred ccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCC
Confidence 677888888888888888778888888888888888887 5544477788888888888888888877777888888888
Q ss_pred eeeeecccccccc
Q 038351 128 HLFLGYNRLQGSI 140 (348)
Q Consensus 128 ~L~ls~N~lsG~i 140 (348)
.|++++|++++..
T Consensus 133 ~L~l~~n~l~~~~ 145 (285)
T 1ozn_A 133 YLYLQDNALQALP 145 (285)
T ss_dssp EEECCSSCCCCCC
T ss_pred EEECCCCcccccC
Confidence 8888888877543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.28 E-value=7.7e-12 Score=105.82 Aligned_cols=89 Identities=22% Similarity=0.213 Sum_probs=78.4
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+. .+.+++++|.|+ .||..+. ++|+.|+|++|++++.+|..|+.+++|+.|+|++|+|++..|..+..+++|+.
T Consensus 10 C~C~-~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~ 85 (174)
T 2r9u_A 10 CSCD-QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQ 85 (174)
T ss_dssp SEEC-SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred CEEC-CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhE
Confidence 4443 378999999995 6999886 89999999999999999999999999999999999999866666789999999
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|+|++|++++..+
T Consensus 86 L~L~~N~l~~l~~ 98 (174)
T 2r9u_A 86 LDLNDNHLKSIPR 98 (174)
T ss_dssp EECCSSCCCCCCT
T ss_pred EECCCCccceeCH
Confidence 9999999996443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.28 E-value=3.3e-12 Score=110.02 Aligned_cols=89 Identities=18% Similarity=0.194 Sum_probs=67.8
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++..|..|+++++|++|+|++|++++.+|..++.+++|+.|++++|++.+.+| .+..+++|+.
T Consensus 85 ~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~ 163 (197)
T 4ezg_A 85 SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKS 163 (197)
T ss_dssp TTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCE
T ss_pred hcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCE
Confidence 667777777777777777777777777777777777777777777777777777777777777555666 5777777777
Q ss_pred eeeecccccc
Q 038351 129 LFLGYNRLQG 138 (348)
Q Consensus 129 L~ls~N~lsG 138 (348)
|++++|++++
T Consensus 164 L~l~~n~i~~ 173 (197)
T 4ezg_A 164 LNIQFDGVHD 173 (197)
T ss_dssp EECTTBCCCC
T ss_pred EECCCCCCcC
Confidence 7777777765
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.27 E-value=1e-11 Score=113.71 Aligned_cols=109 Identities=23% Similarity=0.234 Sum_probs=89.5
Q ss_pred cEEEEecccceeeecCC-CCCCCCCCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccce
Q 038351 26 AVTNITFGLLVFIILCP-RYNYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVK 104 (348)
Q Consensus 26 ~v~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~ 104 (348)
.++.+.+..-.+..+.+ .+ ..+++|+.|+|++|.+++ +|.. +.+++|++|+|++|+++ .+|..+..+++|+.
T Consensus 32 ~l~~L~L~~N~l~~~~~~~~----~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~ 104 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLATL----MPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTV 104 (290)
T ss_dssp TCCEEECTTSCCSEEEGGGG----TTCTTCCEEECTTSCCCE-EECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCE
T ss_pred CCCEEEcCCCcCCccCHHHh----hcCCCCCEEECCCCccCc-ccCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCE
Confidence 45666664443333332 34 778999999999999997 5544 89999999999999998 89999999999999
Q ss_pred eecccCcccCccCCccccccccceeeeeccccccccc
Q 038351 105 IYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSIS 141 (348)
Q Consensus 105 l~ls~N~l~G~iP~~l~~l~~L~~L~ls~N~lsG~ip 141 (348)
|++++|++++..|..+..+++|+.|++++|++++..+
T Consensus 105 L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~ 141 (290)
T 1p9a_G 105 LDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141 (290)
T ss_dssp EECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCT
T ss_pred EECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccCh
Confidence 9999999998888899999999999999999986433
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.27 E-value=2.8e-12 Score=129.03 Aligned_cols=93 Identities=17% Similarity=0.136 Sum_probs=56.6
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++..|..|+++++|++|+|++|++++..|..++.+++|++|+|++|.|++..|..++.+++|+.
T Consensus 72 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~ 151 (597)
T 3oja_B 72 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTT 151 (597)
T ss_dssp HHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCE
Confidence 34556666666666666655556666666666666666666655555666666666666666666433334466666666
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|++++|++++..|
T Consensus 152 L~Ls~N~l~~~~~ 164 (597)
T 3oja_B 152 LSMSNNNLERIED 164 (597)
T ss_dssp EECCSSCCCBCCT
T ss_pred EEeeCCcCCCCCh
Confidence 6666666665444
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=7.2e-12 Score=130.96 Aligned_cols=93 Identities=23% Similarity=0.301 Sum_probs=71.5
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcC--CCCCcccceeecccCcccCccC-Cccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLE--IENLKVLVKIYFSMNNFAGVIP-NAIGCLNI 125 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~--~~~l~~L~~l~ls~N~l~G~iP-~~l~~l~~ 125 (348)
+++++|+.|+|++|.+++.+|..|++|++|++|+|++|++++.+|.. ++++++|+.|++++|++++..| ..++++++
T Consensus 70 ~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~ 149 (844)
T 3j0a_A 70 RNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNS 149 (844)
T ss_dssp SSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSS
T ss_pred cCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCC
Confidence 67777888888888888777778888888888888888888777665 7778888888888888877654 46777888
Q ss_pred cceeeeeccccccccc
Q 038351 126 LQHLFLGYNRLQGSIS 141 (348)
Q Consensus 126 L~~L~ls~N~lsG~ip 141 (348)
|+.|++++|++++..|
T Consensus 150 L~~L~Ls~N~i~~~~~ 165 (844)
T 3j0a_A 150 LKSIDFSSNQIFLVCE 165 (844)
T ss_dssp CCEEEEESSCCCCCCS
T ss_pred CCEEECCCCcCCeeCH
Confidence 8888888887776554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.26 E-value=6.6e-12 Score=117.42 Aligned_cols=89 Identities=17% Similarity=0.129 Sum_probs=80.1
Q ss_pred CCCCccEEEcccC-cccccCcccccCCccCcceeccc-ccccCCCCcCCCCCcccceeecccCcccCccCCccccccccc
Q 038351 50 RPPQQENLSLASN-ELISVIPSTFWNLKDILYLNLSL-NSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 50 ~~~~l~~l~L~~N-~l~g~ip~~~~~l~~L~~l~l~~-N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
.|.. ..++++++ +|++ ||. |+.+++|+.|+|++ |+|++-.|..|+.|++|+.|+|++|+|+|..|..+..+++|+
T Consensus 7 ~C~~-~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 83 (347)
T 2ifg_A 7 PHGS-SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83 (347)
T ss_dssp CSSS-SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred cccC-CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCC
Confidence 4544 35689998 8986 999 99999999999996 999988889999999999999999999999999999999999
Q ss_pred eeeeeccccccccc
Q 038351 128 HLFLGYNRLQGSIS 141 (348)
Q Consensus 128 ~L~ls~N~lsG~ip 141 (348)
.|+|++|+|++..+
T Consensus 84 ~L~l~~N~l~~~~~ 97 (347)
T 2ifg_A 84 RLNLSFNALESLSW 97 (347)
T ss_dssp EEECCSSCCSCCCS
T ss_pred EEeCCCCccceeCH
Confidence 99999999997543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.26 E-value=1.8e-11 Score=110.56 Aligned_cols=93 Identities=22% Similarity=0.209 Sum_probs=77.3
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++..|..|.++++|++|+|++|++++..|..++.+++|+.|++++|++++..+..+..+++|+.
T Consensus 82 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 161 (270)
T 2o6q_A 82 KELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKE 161 (270)
T ss_dssp SSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccce
Confidence 56888999999999988766667788889999999999998777777888899999999999888766666888888888
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|++++|++++..+
T Consensus 162 L~L~~n~l~~~~~ 174 (270)
T 2o6q_A 162 LRLYNNQLKRVPE 174 (270)
T ss_dssp EECCSSCCSCCCT
T ss_pred eEecCCcCcEeCh
Confidence 9998888886443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.26 E-value=1.1e-11 Score=124.68 Aligned_cols=91 Identities=23% Similarity=0.200 Sum_probs=84.4
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|.+++..|..|+++++|++|+|++|++++-.|..++++++|++|++++|.+++..|..++.+++|+.
T Consensus 96 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 175 (597)
T 3oja_B 96 AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQN 175 (597)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCE
T ss_pred cCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcE
Confidence 78999999999999999988888999999999999999999544455799999999999999999999999999999999
Q ss_pred eeeeccccccc
Q 038351 129 LFLGYNRLQGS 139 (348)
Q Consensus 129 L~ls~N~lsG~ 139 (348)
|++++|++++.
T Consensus 176 L~L~~N~l~~~ 186 (597)
T 3oja_B 176 LQLSSNRLTHV 186 (597)
T ss_dssp EECTTSCCSBC
T ss_pred EECcCCCCCCc
Confidence 99999999874
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.25 E-value=2.3e-11 Score=109.91 Aligned_cols=93 Identities=26% Similarity=0.272 Sum_probs=83.7
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|.++...+..|.++++|++|+|++|++++-.|..+..+++|+.|++++|++++..|..+..+++|+.
T Consensus 58 ~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 137 (270)
T 2o6q_A 58 HRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTY 137 (270)
T ss_dssp SSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCE
Confidence 78999999999999999644445689999999999999999766777899999999999999999998899999999999
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|++++|++++..+
T Consensus 138 L~Ls~n~l~~~~~ 150 (270)
T 2o6q_A 138 LSLGYNELQSLPK 150 (270)
T ss_dssp EECCSSCCCCCCT
T ss_pred EECCCCcCCccCH
Confidence 9999999986433
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=1.2e-11 Score=124.05 Aligned_cols=108 Identities=18% Similarity=0.211 Sum_probs=88.6
Q ss_pred EEEEecccceeeecCC-CCCCCCCCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCccccee
Q 038351 27 VTNITFGLLVFIILCP-RYNYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKI 105 (348)
Q Consensus 27 v~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l 105 (348)
++.+.++.-.+..+.+ .+ +++++|+.|+|++|.+++..|..|+++++|++|+|++|++++..|..++++++|++|
T Consensus 35 l~~L~Ls~n~i~~~~~~~~----~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 110 (606)
T 3t6q_A 35 TECLEFSFNVLPTIQNTTF----SRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHL 110 (606)
T ss_dssp CCEEECTTCCCSEECTTTS----TTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEE
T ss_pred CcEEEccCCccCcCChhHh----ccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEe
Confidence 4555554333333332 34 788999999999999998888899999999999999999998889899999999999
Q ss_pred ecccCcccCccCCccccccccceeeeecccccc
Q 038351 106 YFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQG 138 (348)
Q Consensus 106 ~ls~N~l~G~iP~~l~~l~~L~~L~ls~N~lsG 138 (348)
++++|++++..|..++.+++|++|++++|++++
T Consensus 111 ~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~ 143 (606)
T 3t6q_A 111 FFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143 (606)
T ss_dssp ECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCC
T ss_pred eccccCcccCCcchhccCCcccEEECCCCcccc
Confidence 999999998778888888899999999998887
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=4.8e-12 Score=124.70 Aligned_cols=107 Identities=22% Similarity=0.214 Sum_probs=89.0
Q ss_pred CcEEEEecccceeeecCC-CCCCCCCCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccc
Q 038351 25 KAVTNITFGLLVFIILCP-RYNYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLV 103 (348)
Q Consensus 25 ~~v~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~ 103 (348)
..++.+.+..-....+.+ .+ ..+++|+.|+|++|.+++..|..|+++++|++|||++|+++ .||.. .+++|+
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~----~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~ 93 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDI----LSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLK 93 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHH----TTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCS
T ss_pred ccccEEECCCCcccccChhhc----cccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCcc
Confidence 456666665443333322 23 77899999999999999988999999999999999999999 78887 899999
Q ss_pred eeecccCcccC-ccCCccccccccceeeeecccccc
Q 038351 104 KIYFSMNNFAG-VIPNAIGCLNILQHLFLGYNRLQG 138 (348)
Q Consensus 104 ~l~ls~N~l~G-~iP~~l~~l~~L~~L~ls~N~lsG 138 (348)
+|++++|++++ .+|..++.+++|+.|++++|++++
T Consensus 94 ~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~ 129 (520)
T 2z7x_B 94 HLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK 129 (520)
T ss_dssp EEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG
T ss_pred EEeccCCccccccchhhhccCCcceEEEecCcccch
Confidence 99999999998 689999999999999999998876
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=2e-11 Score=119.06 Aligned_cols=93 Identities=27% Similarity=0.184 Sum_probs=73.3
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++..|..|+++++|++|+|++|++++-.+..+.++++|+.|++++|++++..|..+..+++|+.
T Consensus 53 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 132 (477)
T 2id5_A 53 ASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKS 132 (477)
T ss_dssp TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCE
Confidence 67788888888888888877888888888888888888888544455778888888888888888877878888888888
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|++++|++++..|
T Consensus 133 L~l~~n~l~~~~~ 145 (477)
T 2id5_A 133 LEVGDNDLVYISH 145 (477)
T ss_dssp EEECCTTCCEECT
T ss_pred EECCCCccceeCh
Confidence 8888887766443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.4e-11 Score=122.71 Aligned_cols=84 Identities=23% Similarity=0.185 Sum_probs=40.5
Q ss_pred CCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceeee
Q 038351 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFL 131 (348)
Q Consensus 52 ~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~l 131 (348)
++|+.|+|++|.+++..|..|+++++|++|+|++|++++..|..++++++|++|++++|+++ .||.. .+++|+.|++
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 44455555555555444444555555555555555555444444555555555555444444 34443 3444444444
Q ss_pred ecccccc
Q 038351 132 GYNRLQG 138 (348)
Q Consensus 132 s~N~lsG 138 (348)
++|++++
T Consensus 129 s~N~l~~ 135 (562)
T 3a79_B 129 SFNDFDV 135 (562)
T ss_dssp CSSCCSB
T ss_pred CCCCccc
Confidence 4444443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.5e-11 Score=122.12 Aligned_cols=93 Identities=23% Similarity=0.289 Sum_probs=71.2
Q ss_pred CCCCCccEEEcccCcccccCc-ccccCCccCcceecccccccCCCCcCCCCCcccceeecccCccc-CccCCcccccccc
Q 038351 49 LRPPQQENLSLASNELISVIP-STFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFA-GVIPNAIGCLNIL 126 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip-~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~-G~iP~~l~~l~~L 126 (348)
..+++|+.|+|++|.+++.+| ..+.++++|++|+|++|++++.+|..+..+++|+.|++++|.++ |.+|..+..+++|
T Consensus 393 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L 472 (570)
T 2z63_A 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472 (570)
T ss_dssp ETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC
T ss_pred cccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCC
Confidence 667777788888877777666 46777777888888888877777777777778888888887776 6777777777778
Q ss_pred ceeeeeccccccccc
Q 038351 127 QHLFLGYNRLQGSIS 141 (348)
Q Consensus 127 ~~L~ls~N~lsG~ip 141 (348)
+.|++++|++++..|
T Consensus 473 ~~L~l~~n~l~~~~~ 487 (570)
T 2z63_A 473 TFLDLSQCQLEQLSP 487 (570)
T ss_dssp CEEECTTSCCCEECT
T ss_pred CEEECCCCccccCCh
Confidence 888888777777655
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.22 E-value=2.1e-11 Score=114.99 Aligned_cols=90 Identities=27% Similarity=0.274 Sum_probs=81.2
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCcc----cccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAI----GCLN 124 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l----~~l~ 124 (348)
..+++|+.|+|++|.|++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++ +|..+ ..++
T Consensus 85 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~~~~l~ 163 (361)
T 2xot_A 85 VPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLP 163 (361)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGGGTC----CT
T ss_pred cCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHHHhcCcccCC
Confidence 789999999999999999777789999999999999999999889999999999999999999996 55554 6789
Q ss_pred ccceeeeeccccccc
Q 038351 125 ILQHLFLGYNRLQGS 139 (348)
Q Consensus 125 ~L~~L~ls~N~lsG~ 139 (348)
+|+.|+|++|++++-
T Consensus 164 ~L~~L~L~~N~l~~l 178 (361)
T 2xot_A 164 KLMLLDLSSNKLKKL 178 (361)
T ss_dssp TCCEEECCSSCCCCC
T ss_pred cCCEEECCCCCCCcc
Confidence 999999999999853
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=6.4e-12 Score=123.82 Aligned_cols=94 Identities=19% Similarity=0.137 Sum_probs=83.9
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccC--CCCcCCCCCcccceeecccCcccCccCCc-cccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTG--PIPLEIENLKVLVKIYFSMNNFAGVIPNA-IGCLNI 125 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G--~iP~~~~~l~~L~~l~ls~N~l~G~iP~~-l~~l~~ 125 (348)
..+++|+.|+|++|.+++.+|..++++++|+.|+|++|++++ .+|..++.+++|+.|++++|++++.+|.. +..+++
T Consensus 321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~ 400 (520)
T 2z7x_B 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS 400 (520)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence 578899999999999999999999999999999999999997 78888999999999999999999988875 778889
Q ss_pred cceeeeecccccccccc
Q 038351 126 LQHLFLGYNRLQGSISY 142 (348)
Q Consensus 126 L~~L~ls~N~lsG~ip~ 142 (348)
|+.|++++|++++.+|.
T Consensus 401 L~~L~Ls~N~l~~~~~~ 417 (520)
T 2z7x_B 401 LLSLNMSSNILTDTIFR 417 (520)
T ss_dssp CCEEECCSSCCCGGGGG
T ss_pred CCEEECcCCCCCcchhh
Confidence 99999999999887764
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.21 E-value=7.6e-12 Score=115.52 Aligned_cols=89 Identities=16% Similarity=0.076 Sum_probs=80.2
Q ss_pred CCCCCccEEEcccCcccccCcccccCC-----ccCcceecccccccCCCCcCCCCCcccceeecccCcccCc--cCCcc-
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNL-----KDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGV--IPNAI- 120 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l-----~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~--iP~~l- 120 (348)
+.+++|+.|+|++|.+++. |..++++ ++|++|+|++|++++..|..++.+++|+.|++++|+++|. +|..+
T Consensus 118 ~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 196 (312)
T 1wwl_A 118 ATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC 196 (312)
T ss_dssp CCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSC
T ss_pred hcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHH
Confidence 6789999999999999997 9888888 8999999999999988889999999999999999999987 45555
Q ss_pred -ccccccceeeeecccccc
Q 038351 121 -GCLNILQHLFLGYNRLQG 138 (348)
Q Consensus 121 -~~l~~L~~L~ls~N~lsG 138 (348)
..+++|+.|++++|++++
T Consensus 197 ~~~l~~L~~L~L~~N~l~~ 215 (312)
T 1wwl_A 197 PLKFPTLQVLALRNAGMET 215 (312)
T ss_dssp TTSCTTCCEEECTTSCCCC
T ss_pred hccCCCCCEEECCCCcCcc
Confidence 888999999999999884
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.3e-11 Score=129.07 Aligned_cols=113 Identities=16% Similarity=0.159 Sum_probs=97.6
Q ss_pred CcEEEEecccceeeec-CCCCCCCCCCCCCccEEEcccCcccccC-cccccCCccCcceecccccccCCCCcCCCCCccc
Q 038351 25 KAVTNITFGLLVFIIL-CPRYNYPPLRPPQQENLSLASNELISVI-PSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVL 102 (348)
Q Consensus 25 ~~v~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l~L~~N~l~g~i-p~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L 102 (348)
..++.+.++.-....+ ...+ +.+++|+.|+|++|++.+.| |..|++|++|++|+|++|++++.+|..|+++++|
T Consensus 24 ~~l~~LdLs~N~i~~i~~~~~----~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L 99 (844)
T 3j0a_A 24 NTTERLLLSFNYIRTVTASSF----PFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHL 99 (844)
T ss_dssp TTCCEEEEESCCCCEECSSSC----SSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSC
T ss_pred CCcCEEECCCCcCCccChhHC----cccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCccc
Confidence 4466666654433333 3444 88999999999999999998 7789999999999999999999999999999999
Q ss_pred ceeecccCcccCccCCc--cccccccceeeeeccccccccc
Q 038351 103 VKIYFSMNNFAGVIPNA--IGCLNILQHLFLGYNRLQGSIS 141 (348)
Q Consensus 103 ~~l~ls~N~l~G~iP~~--l~~l~~L~~L~ls~N~lsG~ip 141 (348)
++|+|++|.+++.+|.. +..+++|+.|++++|++++..+
T Consensus 100 ~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~ 140 (844)
T 3j0a_A 100 FELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL 140 (844)
T ss_dssp CCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCC
T ss_pred CEeeCcCCCCCcccccCccccccCCCCEEECCCCccccccc
Confidence 99999999999988876 9999999999999999988655
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=1.3e-11 Score=122.23 Aligned_cols=88 Identities=18% Similarity=0.120 Sum_probs=84.8
Q ss_pred CCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceee
Q 038351 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLF 130 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ 130 (348)
.++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..++++++|++|++++|++++..|..++.+++|++|+
T Consensus 25 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 104 (549)
T 2z81_A 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLN 104 (549)
T ss_dssp CTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEE
T ss_pred CCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEE
Confidence 47999999999999999999999999999999999999999999999999999999999999999988899999999999
Q ss_pred eecccccc
Q 038351 131 LGYNRLQG 138 (348)
Q Consensus 131 ls~N~lsG 138 (348)
+++|++++
T Consensus 105 Ls~n~l~~ 112 (549)
T 2z81_A 105 LMGNPYQT 112 (549)
T ss_dssp CTTCCCSS
T ss_pred CCCCcccc
Confidence 99999986
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.20 E-value=1.2e-11 Score=104.58 Aligned_cols=84 Identities=17% Similarity=0.152 Sum_probs=68.2
Q ss_pred CCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCC--cccccccccee
Q 038351 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPN--AIGCLNILQHL 129 (348)
Q Consensus 52 ~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~--~l~~l~~L~~L 129 (348)
++|+.|+|++|.+++. ..|+++++|++|+|++|++++-.|..++.+++|+.|++++|++ +.+|. .+..+++|+.|
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i-~~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL-VELGDLDPLASLKSLTYL 118 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCC-CCGGGGGGGGGCTTCCEE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcC-CcchhhHhhhcCCCCCEE
Confidence 4888999999998874 6888888999999999998854334348888999999999988 46776 78888888999
Q ss_pred eeecccccc
Q 038351 130 FLGYNRLQG 138 (348)
Q Consensus 130 ~ls~N~lsG 138 (348)
++++|+++.
T Consensus 119 ~l~~N~i~~ 127 (176)
T 1a9n_A 119 CILRNPVTN 127 (176)
T ss_dssp ECCSSGGGG
T ss_pred EecCCCCCC
Confidence 999888873
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=1.7e-11 Score=124.75 Aligned_cols=91 Identities=21% Similarity=0.139 Sum_probs=45.6
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+++++|+.|+|++|.+++..|..|++|++|++|+|++|++++-.|..|+++++|++|++++|++++..|..++.+++|++
T Consensus 46 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 125 (680)
T 1ziw_A 46 TRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLIT 125 (680)
T ss_dssp GGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCE
T ss_pred hCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCE
Confidence 44455555555555555555555555555555555555555222223555555555555555554444444555555555
Q ss_pred eeeeccccccc
Q 038351 129 LFLGYNRLQGS 139 (348)
Q Consensus 129 L~ls~N~lsG~ 139 (348)
|++++|++++.
T Consensus 126 L~Ls~n~l~~~ 136 (680)
T 1ziw_A 126 LDLSHNGLSST 136 (680)
T ss_dssp EECCSSCCSCC
T ss_pred EECCCCccccc
Confidence 55555554443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.18 E-value=5.1e-11 Score=113.13 Aligned_cols=89 Identities=25% Similarity=0.284 Sum_probs=48.2
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcC-CCCCcccceeecccCcccCccCCccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLE-IENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~-~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
+.+++|+.|+|++|.+++..|..|+++++|++|+|++|+++ .+|.. ++++++|+.|++++|++++..|..+..+++|+
T Consensus 90 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 168 (390)
T 3o6n_A 90 AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQ 168 (390)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCC
T ss_pred cCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCC
Confidence 44555555555555555544445555555555555555555 34433 35555555555555555555555555555555
Q ss_pred eeeeecccccc
Q 038351 128 HLFLGYNRLQG 138 (348)
Q Consensus 128 ~L~ls~N~lsG 138 (348)
.|++++|++++
T Consensus 169 ~L~l~~n~l~~ 179 (390)
T 3o6n_A 169 NLQLSSNRLTH 179 (390)
T ss_dssp EEECCSSCCSB
T ss_pred EEECCCCcCCc
Confidence 55555555543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=3.1e-11 Score=112.04 Aligned_cols=86 Identities=21% Similarity=0.327 Sum_probs=56.2
Q ss_pred CCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceeee
Q 038351 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFL 131 (348)
Q Consensus 52 ~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~l 131 (348)
++|+.|+|++|.+++..|..|.++++|+.|+|++|++++..|..+..+++|+.|++++|+++ .+|..+..++.|+.|++
T Consensus 192 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 270 (330)
T 1xku_A 192 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270 (330)
T ss_dssp TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEEC
Confidence 55666666666666666666666666666666666666655556666666666666666666 66666666666666666
Q ss_pred ecccccc
Q 038351 132 GYNRLQG 138 (348)
Q Consensus 132 s~N~lsG 138 (348)
++|++++
T Consensus 271 ~~N~i~~ 277 (330)
T 1xku_A 271 HNNNISA 277 (330)
T ss_dssp CSSCCCC
T ss_pred CCCcCCc
Confidence 6666654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.18 E-value=2e-11 Score=121.74 Aligned_cols=94 Identities=21% Similarity=0.202 Sum_probs=86.4
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccC--CCCcCCCCCcccceeecccCcccCccCCc-cccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTG--PIPLEIENLKVLVKIYFSMNNFAGVIPNA-IGCLNI 125 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G--~iP~~~~~l~~L~~l~ls~N~l~G~iP~~-l~~l~~ 125 (348)
+.+++|+.|+|++|.+++.+|..++++++|+.|+|++|++++ .+|..++++++|+.|++++|++++.+|.. +..+++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 678999999999999999999999999999999999999997 56788999999999999999999988875 788899
Q ss_pred cceeeeecccccccccc
Q 038351 126 LQHLFLGYNRLQGSISY 142 (348)
Q Consensus 126 L~~L~ls~N~lsG~ip~ 142 (348)
|+.|++++|++++.+|.
T Consensus 430 L~~L~l~~n~l~~~~~~ 446 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFR 446 (562)
T ss_dssp CCEEECCSSCCCGGGGS
T ss_pred CCEEECCCCCCCcchhh
Confidence 99999999999987774
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.17 E-value=1.3e-11 Score=104.29 Aligned_cols=106 Identities=18% Similarity=0.086 Sum_probs=86.6
Q ss_pred cEEEEecccceeeecCCCCCCCCCCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCc--CCCCCcccc
Q 038351 26 AVTNITFGLLVFIILCPRYNYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPL--EIENLKVLV 103 (348)
Q Consensus 26 ~v~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~--~~~~l~~L~ 103 (348)
..+.+.++.-.+..+ +.+ +.+++|+.|+|++|.+++..|..++++++|++|+|++|+++ .+|. .+..+++|+
T Consensus 43 ~L~~L~Ls~N~l~~~-~~l----~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~ 116 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL-DGF----PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLT 116 (176)
T ss_dssp CCSEEECCSSCCCEE-CCC----CCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCC
T ss_pred CCCEEECCCCCCCcc-ccc----ccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCC
Confidence 345555543333344 444 88999999999999999744444599999999999999995 7887 899999999
Q ss_pred eeecccCcccCccCCc----cccccccceeeeecccccc
Q 038351 104 KIYFSMNNFAGVIPNA----IGCLNILQHLFLGYNRLQG 138 (348)
Q Consensus 104 ~l~ls~N~l~G~iP~~----l~~l~~L~~L~ls~N~lsG 138 (348)
.|++++|.++ .+|.. +..++.|+.|+++.|....
T Consensus 117 ~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 117 YLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp EEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred EEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 9999999998 67875 9999999999999998764
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=3.1e-11 Score=121.01 Aligned_cols=89 Identities=19% Similarity=0.223 Sum_probs=85.6
Q ss_pred CCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceee
Q 038351 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLF 130 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ 130 (348)
.+.++.|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|++++|++++..|..++.+++|++|+
T Consensus 32 ~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 111 (606)
T 3t6q_A 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLF 111 (606)
T ss_dssp CTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEE
T ss_pred CCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEee
Confidence 46899999999999998899999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeccccccc
Q 038351 131 LGYNRLQGS 139 (348)
Q Consensus 131 ls~N~lsG~ 139 (348)
+++|++++.
T Consensus 112 L~~n~i~~l 120 (606)
T 3t6q_A 112 FIQTGISSI 120 (606)
T ss_dssp CTTSCCSCG
T ss_pred ccccCcccC
Confidence 999999974
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.16 E-value=4.2e-11 Score=116.20 Aligned_cols=88 Identities=23% Similarity=0.267 Sum_probs=63.5
Q ss_pred CCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceee
Q 038351 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLF 130 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ 130 (348)
.++++.|+|++|++++..|..|.++++|++|+|++|++++..|..+..+++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 74 ~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 153 (452)
T 3zyi_A 74 PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELW 153 (452)
T ss_dssp CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEE
T ss_pred CCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEE
Confidence 46677777777777776677777777777777777777766667777777777777777777765566677777777777
Q ss_pred eecccccc
Q 038351 131 LGYNRLQG 138 (348)
Q Consensus 131 ls~N~lsG 138 (348)
+++|+++.
T Consensus 154 L~~N~l~~ 161 (452)
T 3zyi_A 154 LRNNPIES 161 (452)
T ss_dssp CCSCCCCE
T ss_pred CCCCCcce
Confidence 77777663
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.16 E-value=3.1e-11 Score=111.19 Aligned_cols=88 Identities=15% Similarity=0.030 Sum_probs=80.6
Q ss_pred CCccEEEcccCcccccCcccc--cCCccCcceecccccccCCCC----cCCCCCcccceeecccCcccCccCCccccccc
Q 038351 52 PQQENLSLASNELISVIPSTF--WNLKDILYLNLSLNSLTGPIP----LEIENLKVLVKIYFSMNNFAGVIPNAIGCLNI 125 (348)
Q Consensus 52 ~~l~~l~L~~N~l~g~ip~~~--~~l~~L~~l~l~~N~l~G~iP----~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~ 125 (348)
++|+.|+|++|.++|.+|..+ +++++|++|+|++|++++.+| ..+..+++|+.|++++|++++..|..+..+++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 569999999999999999998 999999999999999999877 55678999999999999999999999999999
Q ss_pred cceeeeeccccccc
Q 038351 126 LQHLFLGYNRLQGS 139 (348)
Q Consensus 126 L~~L~ls~N~lsG~ 139 (348)
|+.|++++|++.+.
T Consensus 171 L~~L~Ls~N~l~~~ 184 (310)
T 4glp_A 171 LTSLDLSDNPGLGE 184 (310)
T ss_dssp CCEEECCSCTTCHH
T ss_pred CCEEECCCCCCccc
Confidence 99999999998763
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.15 E-value=7.1e-11 Score=114.54 Aligned_cols=94 Identities=23% Similarity=0.139 Sum_probs=80.5
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|.+++..|..|.++++|++|+|++|++++-.|..+..+++|+.|+|++|+++...+..+..+++|+.
T Consensus 96 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 175 (452)
T 3zyi_A 96 RHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMR 175 (452)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCE
T ss_pred CCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccE
Confidence 78999999999999999988899999999999999999999766777999999999999999999666667777888888
Q ss_pred eeeecccccccccc
Q 038351 129 LFLGYNRLQGSISY 142 (348)
Q Consensus 129 L~ls~N~lsG~ip~ 142 (348)
|++++|+.-+.+|.
T Consensus 176 L~l~~~~~l~~i~~ 189 (452)
T 3zyi_A 176 LDLGELKKLEYISE 189 (452)
T ss_dssp EECCCCTTCCEECT
T ss_pred EeCCCCCCccccCh
Confidence 88877655555553
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.15 E-value=3.5e-11 Score=111.80 Aligned_cols=86 Identities=17% Similarity=0.245 Sum_probs=54.5
Q ss_pred CCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceeee
Q 038351 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFL 131 (348)
Q Consensus 52 ~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~l 131 (348)
++|+.|+|++|.+++..|..|.++++|+.|+|++|++++..|..+..+++|+.|++++|+++ .+|..+..+++|+.|++
T Consensus 193 ~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 271 (332)
T 2ft3_A 193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL 271 (332)
T ss_dssp SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEEC
Confidence 45666666666666655566666666666666666666655556666666666666666666 56666666666666666
Q ss_pred ecccccc
Q 038351 132 GYNRLQG 138 (348)
Q Consensus 132 s~N~lsG 138 (348)
++|++++
T Consensus 272 ~~N~l~~ 278 (332)
T 2ft3_A 272 HTNNITK 278 (332)
T ss_dssp CSSCCCB
T ss_pred CCCCCCc
Confidence 6666654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.15 E-value=5.8e-11 Score=111.29 Aligned_cols=85 Identities=19% Similarity=0.146 Sum_probs=38.8
Q ss_pred CccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceeeee
Q 038351 53 QQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLG 132 (348)
Q Consensus 53 ~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ls 132 (348)
+|+.|+|++|++++..+..|.++++|++|+|++|++++..|..++++++|++|++++|++++..+..+..+++|+.|+++
T Consensus 53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 132 (353)
T 2z80_A 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLL 132 (353)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECT
T ss_pred cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECC
Confidence 44444444444444333344444444444444444444444444444444444444444443222224444444444444
Q ss_pred ccccc
Q 038351 133 YNRLQ 137 (348)
Q Consensus 133 ~N~ls 137 (348)
+|+++
T Consensus 133 ~n~l~ 137 (353)
T 2z80_A 133 GNPYK 137 (353)
T ss_dssp TCCCS
T ss_pred CCCCc
Confidence 44444
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.14 E-value=5.8e-11 Score=115.71 Aligned_cols=94 Identities=19% Similarity=0.186 Sum_probs=86.6
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
.-.++++.|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..+..+..+++|+.
T Consensus 29 ~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 108 (477)
T 2id5_A 29 GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTK 108 (477)
T ss_dssp CCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCE
T ss_pred CCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCE
Confidence 34578999999999999988999999999999999999999999999999999999999999999766677899999999
Q ss_pred eeeecccccccccc
Q 038351 129 LFLGYNRLQGSISY 142 (348)
Q Consensus 129 L~ls~N~lsG~ip~ 142 (348)
|++++|++.+..|.
T Consensus 109 L~Ls~n~i~~~~~~ 122 (477)
T 2id5_A 109 LDISENKIVILLDY 122 (477)
T ss_dssp EECTTSCCCEECTT
T ss_pred EECCCCccccCChh
Confidence 99999999887653
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.14 E-value=1.2e-10 Score=108.21 Aligned_cols=86 Identities=22% Similarity=0.261 Sum_probs=45.4
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|.+++..|..|+++++|++|+|++|+++ .+|..+. ++|+.|++++|++++..|..+..+++|+.
T Consensus 75 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~ 151 (332)
T 2ft3_A 75 KGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNC 151 (332)
T ss_dssp TTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCE
T ss_pred hCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCE
Confidence 44555555555555555555555555555555555555555 4554444 45555555555555443444555555555
Q ss_pred eeeeccccc
Q 038351 129 LFLGYNRLQ 137 (348)
Q Consensus 129 L~ls~N~ls 137 (348)
|++++|+++
T Consensus 152 L~l~~n~l~ 160 (332)
T 2ft3_A 152 IEMGGNPLE 160 (332)
T ss_dssp EECCSCCCB
T ss_pred EECCCCccc
Confidence 555555553
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.14 E-value=6.8e-11 Score=114.31 Aligned_cols=90 Identities=26% Similarity=0.200 Sum_probs=74.5
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
.++++|+.|+|++|+++. +| .+.++++|+.|+|++|++++..|..+..+++|+.|++++|++++..|..+..+++|+.
T Consensus 182 ~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 259 (440)
T 3zyj_A 182 EGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVE 259 (440)
T ss_dssp TTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCE
T ss_pred hcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCE
Confidence 677888888888888884 66 5788888888888888888887888888888888888888888888888888888888
Q ss_pred eeeecccccccc
Q 038351 129 LFLGYNRLQGSI 140 (348)
Q Consensus 129 L~ls~N~lsG~i 140 (348)
|+|++|++++..
T Consensus 260 L~L~~N~l~~~~ 271 (440)
T 3zyj_A 260 INLAHNNLTLLP 271 (440)
T ss_dssp EECTTSCCCCCC
T ss_pred EECCCCCCCccC
Confidence 888888887543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.13 E-value=4.4e-11 Score=105.87 Aligned_cols=108 Identities=12% Similarity=0.132 Sum_probs=85.2
Q ss_pred cEEEEecccceeeecCC-CCCCCCCCCCCccEEEcccCc-ccccCcccccCCccCcceeccc-ccccCCCCcCCCCCccc
Q 038351 26 AVTNITFGLLVFIILCP-RYNYPPLRPPQQENLSLASNE-LISVIPSTFWNLKDILYLNLSL-NSLTGPIPLEIENLKVL 102 (348)
Q Consensus 26 ~v~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~L~~N~-l~g~ip~~~~~l~~L~~l~l~~-N~l~G~iP~~~~~l~~L 102 (348)
.++.+.+..-.+..+.+ .+ +.+++|+.|+|++|. +++..|..|.++++|++|+|++ |++++-.|..+..+++|
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~----~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L 107 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAF----SNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLL 107 (239)
T ss_dssp TCCEEEEESCCCSEECTTTT----TTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTC
T ss_pred cccEEEEeCCcceEECHHHc----cCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCC
Confidence 34555554333344444 34 788999999999997 7775556899999999999998 99997666788999999
Q ss_pred ceeecccCcccCccCCccccccccc---eeeeecc-ccccc
Q 038351 103 VKIYFSMNNFAGVIPNAIGCLNILQ---HLFLGYN-RLQGS 139 (348)
Q Consensus 103 ~~l~ls~N~l~G~iP~~l~~l~~L~---~L~ls~N-~lsG~ 139 (348)
+.|++++|++++ +|. +..+.+|+ .|++++| ++++-
T Consensus 108 ~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i 146 (239)
T 2xwt_C 108 KFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSI 146 (239)
T ss_dssp CEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEE
T ss_pred CEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhc
Confidence 999999999997 887 88888887 9999999 77753
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.13 E-value=5.9e-11 Score=109.34 Aligned_cols=87 Identities=22% Similarity=0.217 Sum_probs=76.5
Q ss_pred CCCCCccEEEcccCcccc--cCccc-ccCCccCcceecccccccCCCCcCCCCC---cccceeecccCcccCccCCcccc
Q 038351 49 LRPPQQENLSLASNELIS--VIPST-FWNLKDILYLNLSLNSLTGPIPLEIENL---KVLVKIYFSMNNFAGVIPNAIGC 122 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g--~ip~~-~~~l~~L~~l~l~~N~l~G~iP~~~~~l---~~L~~l~ls~N~l~G~iP~~l~~ 122 (348)
+.+++|+.|+|++|+++. .++.. ++++++|++|||++|++++.+|..++.+ ++|+.|++++|+|+ .||..+.
T Consensus 194 ~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~- 271 (310)
T 4glp_A 194 HKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP- 271 (310)
T ss_dssp TSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC-
T ss_pred hcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc-
Confidence 578999999999999973 23333 5788999999999999999999998887 69999999999999 8899886
Q ss_pred ccccceeeeecccccc
Q 038351 123 LNILQHLFLGYNRLQG 138 (348)
Q Consensus 123 l~~L~~L~ls~N~lsG 138 (348)
++|+.|++++|++++
T Consensus 272 -~~L~~L~Ls~N~l~~ 286 (310)
T 4glp_A 272 -AKLRVLDLSSNRLNR 286 (310)
T ss_dssp -SCCSCEECCSCCCCS
T ss_pred -CCCCEEECCCCcCCC
Confidence 799999999999997
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.13 E-value=5.3e-11 Score=105.33 Aligned_cols=91 Identities=23% Similarity=0.279 Sum_probs=80.6
Q ss_pred CCCccEEEcccCcccccCcccccCCccCcceeccccc-ccCCCCcCCCCCcccceeeccc-CcccCccCCccccccccce
Q 038351 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNS-LTGPIPLEIENLKVLVKIYFSM-NNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~-l~G~iP~~~~~l~~L~~l~ls~-N~l~G~iP~~l~~l~~L~~ 128 (348)
.++|+.|+|++|++++..|..|+++++|++|+|++|+ +++-.|..+..+++|+.|++++ |++++..|..+..+++|+.
T Consensus 30 ~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~ 109 (239)
T 2xwt_C 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109 (239)
T ss_dssp CTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred CCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence 3589999999999998777799999999999999997 7755556899999999999999 9999777788999999999
Q ss_pred eeeecccccccccc
Q 038351 129 LFLGYNRLQGSISY 142 (348)
Q Consensus 129 L~ls~N~lsG~ip~ 142 (348)
|++++|++++ +|.
T Consensus 110 L~l~~n~l~~-lp~ 122 (239)
T 2xwt_C 110 LGIFNTGLKM-FPD 122 (239)
T ss_dssp EEEEEECCCS-CCC
T ss_pred EeCCCCCCcc-ccc
Confidence 9999999987 664
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=4.9e-11 Score=121.29 Aligned_cols=93 Identities=26% Similarity=0.224 Sum_probs=66.2
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+++++|+.|+|++|.+++..+..|+++++|++|+|++|++++-.|..++++++|++|++++|++++..|..+..+++|+.
T Consensus 70 ~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 149 (680)
T 1ziw_A 70 QKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQE 149 (680)
T ss_dssp HHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCE
T ss_pred hcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCE
Confidence 45677777777777777533335777777777777777777655667777777777777777777777777777777777
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|++++|++++..+
T Consensus 150 L~L~~n~l~~~~~ 162 (680)
T 1ziw_A 150 LLLSNNKIQALKS 162 (680)
T ss_dssp EECCSSCCCCBCH
T ss_pred EEccCCcccccCH
Confidence 7777777766443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.8e-11 Score=120.11 Aligned_cols=92 Identities=21% Similarity=0.126 Sum_probs=79.0
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCC-CCcccceeecccCcccCccCCccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIE-NLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~-~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
..+++|+.|+|++|.+++..|..|+++++|++|+|++|+++|.+|..+. .+++|+.|+|++|.|++..+ +..++.|+
T Consensus 117 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~ 194 (487)
T 3oja_A 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLK 194 (487)
T ss_dssp CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCC
T ss_pred cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCC
Confidence 4467889999999999998898999999999999999999998998886 79999999999999997733 33588999
Q ss_pred eeeeecccccccccc
Q 038351 128 HLFLGYNRLQGSISY 142 (348)
Q Consensus 128 ~L~ls~N~lsG~ip~ 142 (348)
.|+|++|++++..|.
T Consensus 195 ~L~Ls~N~l~~~~~~ 209 (487)
T 3oja_A 195 TLDLSSNKLAFMGPE 209 (487)
T ss_dssp EEECCSSCCCEECGG
T ss_pred EEECCCCCCCCCCHh
Confidence 999999999986554
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.10 E-value=7.6e-11 Score=110.48 Aligned_cols=92 Identities=23% Similarity=0.193 Sum_probs=81.0
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCC--cccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPN--AIGCLNIL 126 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~--~l~~l~~L 126 (348)
..+++|+.|+|++|.+++..|..|+++++|++|+|++|++++-.+..++++++|++|++++|++++ +|. .+..+++|
T Consensus 73 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L 151 (353)
T 2z80_A 73 QRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKL 151 (353)
T ss_dssp TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTC
T ss_pred ccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCC
Confidence 889999999999999999888899999999999999999995444448999999999999999994 665 88999999
Q ss_pred ceeeeeccccccccc
Q 038351 127 QHLFLGYNRLQGSIS 141 (348)
Q Consensus 127 ~~L~ls~N~lsG~ip 141 (348)
+.|++++|+.-+.++
T Consensus 152 ~~L~l~~n~~~~~~~ 166 (353)
T 2z80_A 152 QILRVGNMDTFTKIQ 166 (353)
T ss_dssp CEEEEEESSSCCEEC
T ss_pred cEEECCCCccccccC
Confidence 999999996444444
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=1.7e-10 Score=106.96 Aligned_cols=85 Identities=26% Similarity=0.356 Sum_probs=55.6
Q ss_pred CCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceeee
Q 038351 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFL 131 (348)
Q Consensus 52 ~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~l 131 (348)
+.|+.|+|++|++++..|..|+++++|++|+|++|++++..|..++++++|++|++++|+++ .+|..+. ++|+.|++
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l 128 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRV 128 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEEC
Confidence 56666777777776655556677777777777777777666666777777777777777666 5555554 45666666
Q ss_pred eccccccc
Q 038351 132 GYNRLQGS 139 (348)
Q Consensus 132 s~N~lsG~ 139 (348)
++|++++.
T Consensus 129 ~~n~l~~~ 136 (330)
T 1xku_A 129 HENEITKV 136 (330)
T ss_dssp CSSCCCBB
T ss_pred CCCccccc
Confidence 66666543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.8e-10 Score=111.25 Aligned_cols=93 Identities=23% Similarity=0.172 Sum_probs=52.9
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++..|..|.++++|++|+|++|++++-.+..+..+++|+.|++++|.++...+..+..+++|+.
T Consensus 85 ~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 164 (440)
T 3zyj_A 85 KHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRR 164 (440)
T ss_dssp SSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCE
T ss_pred hCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCE
Confidence 55566666666666666555556666666666666666666444445666666666666666665444445555555555
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|++++|+..+.++
T Consensus 165 L~l~~~~~l~~i~ 177 (440)
T 3zyj_A 165 LDLGELKRLSYIS 177 (440)
T ss_dssp EECCCCTTCCEEC
T ss_pred eCCCCCCCcceeC
Confidence 5555544333333
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.09 E-value=1.7e-10 Score=109.54 Aligned_cols=92 Identities=18% Similarity=0.181 Sum_probs=82.9
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCc-cccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNA-IGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~-l~~l~~L~ 127 (348)
..+++|+.|+|++|.+++..|..|+++++|++|+|++|++++..|..++++++|++|++++|+++ .+|.. +..+++|+
T Consensus 66 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~ 144 (390)
T 3o6n_A 66 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLT 144 (390)
T ss_dssp HHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCC
T ss_pred cccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCc
Confidence 56799999999999999987889999999999999999999888888999999999999999999 55554 68999999
Q ss_pred eeeeeccccccccc
Q 038351 128 HLFLGYNRLQGSIS 141 (348)
Q Consensus 128 ~L~ls~N~lsG~ip 141 (348)
.|++++|++++..|
T Consensus 145 ~L~L~~n~l~~~~~ 158 (390)
T 3o6n_A 145 TLSMSNNNLERIED 158 (390)
T ss_dssp EEECCSSCCCBCCT
T ss_pred EEECCCCccCccCh
Confidence 99999999987655
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.08 E-value=1.6e-10 Score=112.47 Aligned_cols=81 Identities=19% Similarity=0.220 Sum_probs=51.8
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|++++ +| ++++++|++|+|++|++++ +| ++++++|++|++++|++++ +| ++.+++|+.
T Consensus 61 ~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~ 131 (457)
T 3bz5_A 61 EKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTY 131 (457)
T ss_dssp GGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCE
T ss_pred cccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCE
Confidence 556666666666666666 34 6666666666666666665 33 6666666666666666665 34 566666666
Q ss_pred eeeecccccc
Q 038351 129 LFLGYNRLQG 138 (348)
Q Consensus 129 L~ls~N~lsG 138 (348)
|++++|++++
T Consensus 132 L~l~~N~l~~ 141 (457)
T 3bz5_A 132 LNCARNTLTE 141 (457)
T ss_dssp EECTTSCCSC
T ss_pred EECCCCccce
Confidence 6666666655
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.08 E-value=4.7e-12 Score=109.12 Aligned_cols=85 Identities=20% Similarity=0.288 Sum_probs=71.4
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|.+++ || .+.++++|++|+|++|+++ .+|..+..+++|+.|++++|++++ +| .+..+++|+.
T Consensus 45 ~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~ 119 (198)
T 1ds9_A 45 STLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRV 119 (198)
T ss_dssp HHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSE
T ss_pred hcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCE
Confidence 667888888888888887 78 8888888888888888888 788877888888888888888887 56 6788888888
Q ss_pred eeeecccccc
Q 038351 129 LFLGYNRLQG 138 (348)
Q Consensus 129 L~ls~N~lsG 138 (348)
|++++|++++
T Consensus 120 L~l~~N~i~~ 129 (198)
T 1ds9_A 120 LYMSNNKITN 129 (198)
T ss_dssp EEESEEECCC
T ss_pred EECCCCcCCc
Confidence 8888888875
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.06 E-value=2.6e-10 Score=113.81 Aligned_cols=115 Identities=20% Similarity=0.296 Sum_probs=69.1
Q ss_pred ccccCcccCCcccCCC----------C-CCcEEEEecccceeeecCCCCCCCCCCCCCccEEEcccCcccccCcccccCC
Q 038351 7 SVLHGWKINHLVRQKP----------T-HKAVTNITFGLLVFIILCPRYNYPPLRPPQQENLSLASNELISVIPSTFWNL 75 (348)
Q Consensus 7 ~~~~~w~~~~~~~~~~----------~-~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~L~~N~l~g~ip~~~~~l 75 (348)
.++.+|..+. .||.. | ..+++.|.++...+.+++..+ +++|+.|+|++|+|+ .|| ..+
T Consensus 31 ~~l~~W~~~~-~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~lp~~l------~~~L~~L~Ls~N~l~-~ip---~~l 99 (571)
T 3cvr_A 31 SAWDKWEKQA-LPGENRNEAVSLLKECLINQFSELQLNRLNLSSLPDNL------PPQITVLEITQNALI-SLP---ELP 99 (571)
T ss_dssp HHHHHHHTTC-CTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSCCCSCC------CTTCSEEECCSSCCS-CCC---CCC
T ss_pred HHHHHHhccC-CccccccchhhhccccccCCccEEEeCCCCCCccCHhH------cCCCCEEECcCCCCc-ccc---ccc
Confidence 4577786643 34421 0 125667777655444444433 366777777777776 466 346
Q ss_pred ccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceeeeeccccccccc
Q 038351 76 KDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSIS 141 (348)
Q Consensus 76 ~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ls~N~lsG~ip 141 (348)
++|++|+|++|+|++ ||. +.+ +|+.|++++|+|++ ||. .+++|+.|++++|++++ +|
T Consensus 100 ~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp 156 (571)
T 3cvr_A 100 ASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LP 156 (571)
T ss_dssp TTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC
T ss_pred CCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CC
Confidence 667777777777775 666 554 66666666666666 665 45566666666666665 44
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.06 E-value=9.5e-12 Score=107.17 Aligned_cols=88 Identities=24% Similarity=0.307 Sum_probs=81.2
Q ss_pred CCCCccEEEcccCcccccCcc------cccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccc
Q 038351 50 RPPQQENLSLASNELISVIPS------TFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCL 123 (348)
Q Consensus 50 ~~~~l~~l~L~~N~l~g~ip~------~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l 123 (348)
..+.++.++|+.|.|+|.+|. .|+++++|++|+|++|++++ +| .+..+++|+.|++++|+++ .+|..+..+
T Consensus 16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~ 92 (198)
T 1ds9_A 16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVA 92 (198)
T ss_dssp HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHH
T ss_pred hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcC
Confidence 346788889999999999998 99999999999999999997 88 8999999999999999999 799999889
Q ss_pred cccceeeeeccccccccc
Q 038351 124 NILQHLFLGYNRLQGSIS 141 (348)
Q Consensus 124 ~~L~~L~ls~N~lsG~ip 141 (348)
++|+.|++++|++++ +|
T Consensus 93 ~~L~~L~L~~N~l~~-l~ 109 (198)
T 1ds9_A 93 DTLEELWISYNQIAS-LS 109 (198)
T ss_dssp HHCSEEEEEEEECCC-HH
T ss_pred CcCCEEECcCCcCCc-CC
Confidence 999999999999987 44
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.04 E-value=1.8e-10 Score=114.97 Aligned_cols=84 Identities=25% Similarity=0.280 Sum_probs=59.9
Q ss_pred CCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCccc-------ceeecccCcccCccCCcccc
Q 038351 50 RPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVL-------VKIYFSMNNFAGVIPNAIGC 122 (348)
Q Consensus 50 ~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L-------~~l~ls~N~l~G~iP~~l~~ 122 (348)
.+++|+.|+|++|.|++ ||. |+ ++|++|+|++|+|+ .||. +.. +| +.|+|++|+|+ .||..+..
T Consensus 158 ~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~ 228 (571)
T 3cvr_A 158 LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILS 228 (571)
T ss_dssp CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGG
T ss_pred cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhc
Confidence 34566677777777666 666 55 67777777777777 6776 554 66 77888888887 57888888
Q ss_pred ccccceeeeecccccccccc
Q 038351 123 LNILQHLFLGYNRLQGSISY 142 (348)
Q Consensus 123 l~~L~~L~ls~N~lsG~ip~ 142 (348)
+++|+.|++++|++++.+|.
T Consensus 229 l~~L~~L~L~~N~l~~~~p~ 248 (571)
T 3cvr_A 229 LDPTCTIILEDNPLSSRIRE 248 (571)
T ss_dssp SCTTEEEECCSSSCCHHHHH
T ss_pred CCCCCEEEeeCCcCCCcCHH
Confidence 88888888888888887773
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.03 E-value=3.9e-10 Score=103.11 Aligned_cols=84 Identities=27% Similarity=0.430 Sum_probs=43.4
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++ +|+ ++++++|++|+|++|++++ +| .+..+++|+.|++++|++++. ..+..+++|+.
T Consensus 65 ~~l~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~ 138 (291)
T 1h6t_A 65 QYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLES 138 (291)
T ss_dssp GGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCE
T ss_pred hcCCCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCE
Confidence 445555555555555554 222 5555555555555555553 22 255555555555555555542 23445555555
Q ss_pred eeeecccccc
Q 038351 129 LFLGYNRLQG 138 (348)
Q Consensus 129 L~ls~N~lsG 138 (348)
|++++|++++
T Consensus 139 L~l~~n~l~~ 148 (291)
T 1h6t_A 139 LYLGNNKITD 148 (291)
T ss_dssp EECCSSCCCC
T ss_pred EEccCCcCCc
Confidence 5555555544
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.03 E-value=3.6e-10 Score=101.81 Aligned_cols=84 Identities=17% Similarity=0.219 Sum_probs=65.1
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|.+++ +|+ ++++++|++|+|++|++++ +|.... ++|+.|++++|++++ +| .+..+++|+.
T Consensus 60 ~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~-~~-~l~~l~~L~~ 132 (263)
T 1xeu_A 60 QFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDNNELRD-TD-SLIHLKNLEI 132 (263)
T ss_dssp GGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCSSCCSB-SG-GGTTCTTCCE
T ss_pred hhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEccCCccCC-Ch-hhcCcccccE
Confidence 677888888888888887 444 8888888888888888885 554333 788888888888886 33 5778888888
Q ss_pred eeeeccccccc
Q 038351 129 LFLGYNRLQGS 139 (348)
Q Consensus 129 L~ls~N~lsG~ 139 (348)
|++++|++++.
T Consensus 133 L~Ls~N~i~~~ 143 (263)
T 1xeu_A 133 LSIRNNKLKSI 143 (263)
T ss_dssp EECTTSCCCBC
T ss_pred EECCCCcCCCC
Confidence 88888888763
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.01 E-value=6.2e-10 Score=102.55 Aligned_cols=85 Identities=22% Similarity=0.321 Sum_probs=50.2
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++ +|. +.++++|++|+|++|++++ +| .+..+++|+.|++++|++++ +|. +..+++|+.
T Consensus 60 ~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~ 133 (308)
T 1h6u_A 60 QYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQV 133 (308)
T ss_dssp GGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCE
T ss_pred hccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCE
Confidence 455666666666666665 333 6666666666666666664 33 46666666666666666655 232 555666666
Q ss_pred eeeeccccccc
Q 038351 129 LFLGYNRLQGS 139 (348)
Q Consensus 129 L~ls~N~lsG~ 139 (348)
|++++|++++.
T Consensus 134 L~l~~n~l~~~ 144 (308)
T 1h6u_A 134 LYLDLNQITNI 144 (308)
T ss_dssp EECCSSCCCCC
T ss_pred EECCCCccCcC
Confidence 66666666543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.00 E-value=3.4e-11 Score=111.68 Aligned_cols=91 Identities=15% Similarity=0.226 Sum_probs=77.1
Q ss_pred CCCCCccEEEcccCccccc-CcccccCCccCcceecccccccCCCCcCCCCCcccceeecccC-cccCc-cCCccccccc
Q 038351 49 LRPPQQENLSLASNELISV-IPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMN-NFAGV-IPNAIGCLNI 125 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~-ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N-~l~G~-iP~~l~~l~~ 125 (348)
..+++|+.|+|++|.+++. +|..+.++++|++|+|++|++++.+|..++++++|+.|++++| .+++. +|..+..+++
T Consensus 90 ~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~ 169 (336)
T 2ast_B 90 FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 169 (336)
T ss_dssp CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTT
T ss_pred ccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCC
Confidence 6678888999998888876 8888888889999999999888888888888889999999888 67773 7777888888
Q ss_pred cceeeeecc-ccccc
Q 038351 126 LQHLFLGYN-RLQGS 139 (348)
Q Consensus 126 L~~L~ls~N-~lsG~ 139 (348)
|+.|++++| ++++.
T Consensus 170 L~~L~l~~~~~l~~~ 184 (336)
T 2ast_B 170 LDELNLSWCFDFTEK 184 (336)
T ss_dssp CCEEECCCCTTCCHH
T ss_pred CCEEcCCCCCCcChH
Confidence 888888888 77753
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.99 E-value=4e-10 Score=109.70 Aligned_cols=88 Identities=18% Similarity=0.135 Sum_probs=63.4
Q ss_pred CCCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCcccccc---
Q 038351 48 PLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLN--- 124 (348)
Q Consensus 48 ~~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~--- 124 (348)
.+.+++|+.|+|++|.+++. +++++++|+.|+|++|+++| || ++.+++|+.|++++|+|+|..+..+..+.
T Consensus 187 l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~ 260 (457)
T 3bz5_A 187 VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLH 260 (457)
T ss_dssp CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEE
T ss_pred cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEe
Confidence 46677788888888887774 37777888888888888876 66 77777888888888888776555555554
Q ss_pred ----ccceeeeeccccccccc
Q 038351 125 ----ILQHLFLGYNRLQGSIS 141 (348)
Q Consensus 125 ----~L~~L~ls~N~lsG~ip 141 (348)
.|+.+++++|++.|.+|
T Consensus 261 l~~n~L~~L~l~~n~~~~~~~ 281 (457)
T 3bz5_A 261 CIQTDLLEIDLTHNTQLIYFQ 281 (457)
T ss_dssp CTTCCCSCCCCTTCTTCCEEE
T ss_pred ccCCCCCEEECCCCccCCccc
Confidence 45666666676666666
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.99 E-value=6.7e-10 Score=100.04 Aligned_cols=84 Identities=23% Similarity=0.194 Sum_probs=66.2
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++ +|.... ++|+.|+|++|++++ +| .+..+++|+.|++++|++++. | .+..+++|+.
T Consensus 82 ~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~ 154 (263)
T 1xeu_A 82 KDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEV 154 (263)
T ss_dssp TTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCE
T ss_pred ccCCCCCEEECCCCccCC-cCcccc--CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCE
Confidence 778888888998888887 664333 788888888888886 44 588888888888888888864 4 6778888888
Q ss_pred eeeeccccccc
Q 038351 129 LFLGYNRLQGS 139 (348)
Q Consensus 129 L~ls~N~lsG~ 139 (348)
|++++|++++.
T Consensus 155 L~L~~N~i~~~ 165 (263)
T 1xeu_A 155 LDLHGNEITNT 165 (263)
T ss_dssp EECTTSCCCBC
T ss_pred EECCCCcCcch
Confidence 88888888765
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.98 E-value=6.3e-10 Score=102.52 Aligned_cols=86 Identities=20% Similarity=0.278 Sum_probs=63.8
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++ +|. +.++++|+.|+|++|++++..| ++.+++|+.|++++|++++..| +..+++|+.
T Consensus 104 ~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~ 177 (308)
T 1h6u_A 104 AGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTT 177 (308)
T ss_dssp TTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred cCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCE
Confidence 667888888888888876 553 7788888888888888875433 7777888888888888776433 777777888
Q ss_pred eeeecccccccc
Q 038351 129 LFLGYNRLQGSI 140 (348)
Q Consensus 129 L~ls~N~lsG~i 140 (348)
|++++|++++..
T Consensus 178 L~l~~n~l~~~~ 189 (308)
T 1h6u_A 178 LKADDNKISDIS 189 (308)
T ss_dssp EECCSSCCCCCG
T ss_pred EECCCCccCcCh
Confidence 888888777643
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.97 E-value=8.6e-10 Score=110.99 Aligned_cols=84 Identities=24% Similarity=0.333 Sum_probs=47.4
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|.|++ + +.+.+|++|+.|+|++|++++. ..+..|++|+.|+|++|+|++..| +..+++|+.
T Consensus 106 ~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~ 179 (605)
T 1m9s_A 106 KDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQN 179 (605)
T ss_dssp TTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred ccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCE
Confidence 455556666666665554 2 2455555555566655555543 345555666666666666655544 555555555
Q ss_pred eeeecccccc
Q 038351 129 LFLGYNRLQG 138 (348)
Q Consensus 129 L~ls~N~lsG 138 (348)
|+|++|++++
T Consensus 180 L~Ls~N~i~~ 189 (605)
T 1m9s_A 180 LYLSKNHISD 189 (605)
T ss_dssp EECCSSCCCB
T ss_pred EECcCCCCCC
Confidence 5555555554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.97 E-value=7.8e-10 Score=101.10 Aligned_cols=87 Identities=21% Similarity=0.292 Sum_probs=67.6
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|.+++ +| .++++++|++|+|++|++++ + ..+..+++|+.|++++|++++. ..+..+++|+.
T Consensus 87 ~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~ 160 (291)
T 1h6t_A 87 ANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDT 160 (291)
T ss_dssp TTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSE
T ss_pred ccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCE
Confidence 777888888888888877 44 48888888888888888885 3 4577888888888888888765 56777888888
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|++++|++++..|
T Consensus 161 L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 161 LSLEDNQISDIVP 173 (291)
T ss_dssp EECCSSCCCCCGG
T ss_pred EEccCCccccchh
Confidence 8888888876544
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.97 E-value=6.2e-10 Score=112.05 Aligned_cols=87 Identities=21% Similarity=0.295 Sum_probs=62.9
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|.|++ +| .|++|++|+.|+|++|++++ + ..+..|++|+.|+|++|++++. ..+..+++|+.
T Consensus 84 ~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~ 157 (605)
T 1m9s_A 84 TNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDT 157 (605)
T ss_dssp GGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSE
T ss_pred ccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCE
Confidence 666777777777777765 44 67777777777777777775 3 3477777777777777777764 56777778888
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|+|++|++++..|
T Consensus 158 L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 158 LSLEDNQISDIVP 170 (605)
T ss_dssp EECCSSCCCCCGG
T ss_pred EECcCCcCCCchh
Confidence 8888888877655
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.96 E-value=3.1e-10 Score=105.70 Aligned_cols=89 Identities=24% Similarity=0.333 Sum_probs=80.8
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++ + +.+..+++|++|+|++|++++ + ..+..+++|+.|++++|.+++..|..+..+++|+.
T Consensus 240 ~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 315 (347)
T 4fmz_A 240 ANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT 315 (347)
T ss_dssp TTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSE
T ss_pred hcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCE
Confidence 788999999999999987 4 479999999999999999996 4 45889999999999999999999999999999999
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|++++|++++..|
T Consensus 316 L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 316 LFLSQNHITDIRP 328 (347)
T ss_dssp EECCSSSCCCCGG
T ss_pred EEccCCccccccC
Confidence 9999999998766
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.95 E-value=7.7e-11 Score=114.69 Aligned_cols=82 Identities=18% Similarity=0.164 Sum_probs=47.3
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccC-------------cceecccccccCCCCcCCCCCcccceeecccCcccCc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDI-------------LYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGV 115 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L-------------~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~ 115 (348)
+++++|+.|+|++|.++|.+|.+++++++| ++|++++|+++| +|.. .++|+.|++++|++++
T Consensus 31 ~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~- 105 (454)
T 1jl5_A 31 ENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE- 105 (454)
T ss_dssp ---CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-
T ss_pred hcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-
Confidence 666666666666666666666666666554 666666666664 3431 2567777777777776
Q ss_pred cCCccccccccceeeeecccccc
Q 038351 116 IPNAIGCLNILQHLFLGYNRLQG 138 (348)
Q Consensus 116 iP~~l~~l~~L~~L~ls~N~lsG 138 (348)
+|..+ .+|+.|++++|++++
T Consensus 106 lp~~~---~~L~~L~l~~n~l~~ 125 (454)
T 1jl5_A 106 LPELP---QSLKSLLVDNNNLKA 125 (454)
T ss_dssp CCCCC---TTCCEEECCSSCCSC
T ss_pred ccccc---CCCcEEECCCCccCc
Confidence 66543 345555555555544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.95 E-value=6.5e-10 Score=108.10 Aligned_cols=83 Identities=27% Similarity=0.366 Sum_probs=46.5
Q ss_pred CCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccC--ccCCccccc------
Q 038351 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG--VIPNAIGCL------ 123 (348)
Q Consensus 52 ~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G--~iP~~l~~l------ 123 (348)
++|+.|+|++|.+++ ||.. +++|++|+|++|+++ .||. .+++|+.|++++|+++| .+|.++..+
T Consensus 317 ~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~ 388 (454)
T 1jl5_A 317 PSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHL 388 (454)
T ss_dssp TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC--
T ss_pred CcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccc
Confidence 467777777777776 6654 466777777777777 5776 46777888888888887 778777777
Q ss_pred -------cccceeeeecccccc--cccc
Q 038351 124 -------NILQHLFLGYNRLQG--SISY 142 (348)
Q Consensus 124 -------~~L~~L~ls~N~lsG--~ip~ 142 (348)
++|+.|++++|+++| .+|.
T Consensus 389 ~~i~~~~~~L~~L~ls~N~l~~~~~iP~ 416 (454)
T 1jl5_A 389 AEVPELPQNLKQLHVETNPLREFPDIPE 416 (454)
T ss_dssp ----------------------------
T ss_pred cccccccCcCCEEECCCCcCCccccchh
Confidence 677888888888876 6663
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.95 E-value=7.6e-10 Score=107.67 Aligned_cols=84 Identities=27% Similarity=0.410 Sum_probs=42.7
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++. |+ +..+++|+.|+|++|++++..| ++.+++|+.|++++|++++..| +..+++|+.
T Consensus 262 ~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~ 335 (466)
T 1o6v_A 262 SGLTKLTELKLGANQISNI-SP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQR 335 (466)
T ss_dssp TTCTTCSEEECCSSCCCCC-GG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCE
T ss_pred hcCCCCCEEECCCCccCcc-cc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCE
Confidence 4455555555555555542 22 5555555555555555554322 4455555555555555555444 444444555
Q ss_pred eeeecccccc
Q 038351 129 LFLGYNRLQG 138 (348)
Q Consensus 129 L~ls~N~lsG 138 (348)
|++++|++++
T Consensus 336 L~l~~n~l~~ 345 (466)
T 1o6v_A 336 LFFYNNKVSD 345 (466)
T ss_dssp EECCSSCCCC
T ss_pred eECCCCccCC
Confidence 5555444444
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.95 E-value=4.3e-10 Score=103.90 Aligned_cols=86 Identities=19% Similarity=0.065 Sum_probs=55.3
Q ss_pred CCCCCccEEEcccCcccccCccccc-CCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFW-NLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~-~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
+.+++|+.|+|++|.+++..|..+. ++++|++|+|++|++++. |. ...+++|+.|++++|++++ +|..+..+++|+
T Consensus 141 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~ 217 (317)
T 3o53_A 141 GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVT 217 (317)
T ss_dssp GGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCS
T ss_pred hccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhcccCccc
Confidence 5567777777777777776666663 566777777777776643 32 2346666666666666664 444466666666
Q ss_pred eeeeeccccc
Q 038351 128 HLFLGYNRLQ 137 (348)
Q Consensus 128 ~L~ls~N~ls 137 (348)
.|++++|+++
T Consensus 218 ~L~L~~N~l~ 227 (317)
T 3o53_A 218 WISLRNNKLV 227 (317)
T ss_dssp EEECTTSCCC
T ss_pred EEECcCCccc
Confidence 6666666666
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.94 E-value=8.3e-10 Score=102.83 Aligned_cols=87 Identities=20% Similarity=0.365 Sum_probs=75.4
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++ +|. +.++++|+.|+|++|++++ + ..+..+++|+.|++++|++++. +.+..+++|+.
T Consensus 218 ~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~ 291 (347)
T 4fmz_A 218 ANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNS 291 (347)
T ss_dssp GGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSE
T ss_pred hcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCE
Confidence 678999999999999987 444 9999999999999999986 4 4688999999999999999874 46888999999
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|++++|++.+..|
T Consensus 292 L~L~~n~l~~~~~ 304 (347)
T 4fmz_A 292 LFLNNNQLGNEDM 304 (347)
T ss_dssp EECCSSCCCGGGH
T ss_pred EECcCCcCCCcCh
Confidence 9999999987665
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.93 E-value=7.2e-11 Score=112.01 Aligned_cols=93 Identities=16% Similarity=0.079 Sum_probs=59.4
Q ss_pred CCCCCccEEEcccCccc----ccCcccccCCccCcceecccccccCC----CCcCC--CCCcccceeecccCcccC----
Q 038351 49 LRPPQQENLSLASNELI----SVIPSTFWNLKDILYLNLSLNSLTGP----IPLEI--ENLKVLVKIYFSMNNFAG---- 114 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~----g~ip~~~~~l~~L~~l~l~~N~l~G~----iP~~~--~~l~~L~~l~ls~N~l~G---- 114 (348)
..+++|+.|+|++|.++ +.+|..+.++++|++|+|++|++++. ||..+ +.+++|+.|+|++|.+++
T Consensus 213 ~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~ 292 (386)
T 2ca6_A 213 AYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR 292 (386)
T ss_dssp GGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHH
T ss_pred hcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHH
Confidence 45566666666666665 55666666666666666666666655 55555 336666666666666666
Q ss_pred ccCCcc-ccccccceeeeeccccccccc
Q 038351 115 VIPNAI-GCLNILQHLFLGYNRLQGSIS 141 (348)
Q Consensus 115 ~iP~~l-~~l~~L~~L~ls~N~lsG~ip 141 (348)
.+|..+ .++++|+.|++++|++++..+
T Consensus 293 ~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 293 TLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 466666 446666666666666665543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.93 E-value=4.6e-09 Score=98.63 Aligned_cols=132 Identities=14% Similarity=0.128 Sum_probs=94.7
Q ss_pred cccccccCCcceEEEeEecCCceEEEEeee--ecc-CccchhhHHHhhhccccc--ccceeeEEEEEecC---CeEEEEE
Q 038351 160 EDNLISRGGFGSIHKARIQDRMEFSVKGFH--LQC-SGAFKSFDFECDVMKSTC--YRNLIKIISSRSNE---DFKVLVL 231 (348)
Q Consensus 160 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~---~~~~lV~ 231 (348)
..+.++.|.++.||+....+ ..+++|+.. ... ......+.+|.++++.+. +..+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999998765 467788765 322 123457888999999887 45688999988776 4589999
Q ss_pred eccCCCCHHHH-H---------hchhHHHHHHHHHHhcC-----------------------------------------
Q 038351 232 EYMPRGSLEKC-L---------YSSNYVGFALEYLHFDY----------------------------------------- 260 (348)
Q Consensus 232 Ey~~~gsL~~~-l---------~~~~~i~~~L~yLH~~~----------------------------------------- 260 (348)
||+++.++.+. + .....++.+|..||...
T Consensus 121 e~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (359)
T 3dxp_A 121 EFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL 200 (359)
T ss_dssp ECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred EecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence 99998877321 1 11234778888888631
Q ss_pred --------------CCceEecCCCcCceEEcCCCc--EEEeecCCccc
Q 038351 261 --------------SVLIIHYDLKPSNVLFDDNIV--THLSDFGIAKL 292 (348)
Q Consensus 261 --------------~~~iiHrDik~~NILld~~~~--~kl~DfGla~~ 292 (348)
...++|+|+++.||+++.++. +.|.||+.+..
T Consensus 201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997653 68999998865
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.92 E-value=1e-09 Score=110.65 Aligned_cols=83 Identities=23% Similarity=0.243 Sum_probs=71.0
Q ss_pred CCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceee
Q 038351 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLF 130 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ 130 (348)
+++|+.|+|++|+|++ || ..+++|+.|+|++|+|+ .||. .+++|+.|++++|+|+ .||..+..+++|+.|+
T Consensus 220 ~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~ 290 (622)
T 3g06_A 220 PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVN 290 (622)
T ss_dssp CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEE
T ss_pred CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEE
Confidence 4678888888888886 77 45678888999999888 6887 6788999999999999 8899999999999999
Q ss_pred eecccccccccc
Q 038351 131 LGYNRLQGSISY 142 (348)
Q Consensus 131 ls~N~lsG~ip~ 142 (348)
+++|++++.+|.
T Consensus 291 L~~N~l~~~~~~ 302 (622)
T 3g06_A 291 LEGNPLSERTLQ 302 (622)
T ss_dssp CCSCCCCHHHHH
T ss_pred ecCCCCCCcCHH
Confidence 999999988774
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.91 E-value=4.5e-10 Score=103.77 Aligned_cols=64 Identities=19% Similarity=0.131 Sum_probs=36.6
Q ss_pred CccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccc-cccccceeeeecccccc
Q 038351 75 LKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIG-CLNILQHLFLGYNRLQG 138 (348)
Q Consensus 75 l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~-~l~~L~~L~ls~N~lsG 138 (348)
+++|+.|+|++|++++..|..++.+++|+.|++++|.+++..|..+. .++.|+.|++++|++++
T Consensus 119 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 183 (317)
T 3o53_A 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (317)
T ss_dssp CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc
Confidence 44555666666666655555555566666666666666655555443 45556666666665554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.88 E-value=1.8e-09 Score=105.05 Aligned_cols=87 Identities=26% Similarity=0.435 Sum_probs=70.0
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++..| ++++++|+.|+|++|++++..| ++.+++|+.|++++|.+++. ..+..+++|+.
T Consensus 284 ~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~ 357 (466)
T 1o6v_A 284 AGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINW 357 (466)
T ss_dssp TTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCE
T ss_pred cCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCE
Confidence 677888888888888887443 7888888888888888887766 67888888888888888875 46778888888
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|++++|++++.+|
T Consensus 358 L~l~~n~l~~~~~ 370 (466)
T 1o6v_A 358 LSAGHNQISDLTP 370 (466)
T ss_dssp EECCSSCCCBCGG
T ss_pred EeCCCCccCccch
Confidence 8888888887766
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.87 E-value=9.2e-10 Score=99.29 Aligned_cols=83 Identities=20% Similarity=0.231 Sum_probs=50.3
Q ss_pred EEcccC---cccccCcccccCCccCcceecccccccC--CCCcCCCCCcccceeecccCcccCccCCcccccc--cccee
Q 038351 57 LSLASN---ELISVIPSTFWNLKDILYLNLSLNSLTG--PIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLN--ILQHL 129 (348)
Q Consensus 57 l~L~~N---~l~g~ip~~~~~l~~L~~l~l~~N~l~G--~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~--~L~~L 129 (348)
++++.| .+.+.++-...++++|+.|+||+|+|++ .||..+..+++|+.|+|++|+|++. ..+..+. .|+.|
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L 225 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL 225 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence 555666 2333333333456667777777777776 6666666677777777777777654 2333333 66677
Q ss_pred eeeccccccccc
Q 038351 130 FLGYNRLQGSIS 141 (348)
Q Consensus 130 ~ls~N~lsG~ip 141 (348)
+|++|.+.+.+|
T Consensus 226 ~L~~Npl~~~~~ 237 (267)
T 3rw6_A 226 WLDGNSLCDTFR 237 (267)
T ss_dssp ECTTSTTGGGCS
T ss_pred EccCCcCccccC
Confidence 777777776655
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.84 E-value=3.5e-09 Score=99.19 Aligned_cols=90 Identities=22% Similarity=0.225 Sum_probs=77.3
Q ss_pred CCCccEEEcccCcccccCcc-cccCCccCcceecccccccCCCCc-CCCCCcccce-eecccCcccCccCCccccccccc
Q 038351 51 PPQQENLSLASNELISVIPS-TFWNLKDILYLNLSLNSLTGPIPL-EIENLKVLVK-IYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~ip~-~~~~l~~L~~l~l~~N~l~G~iP~-~~~~l~~L~~-l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
+++++.|+|++|+|+. ||+ .|.+|++|++|+|++|++.+.||. .|.++++|.. +.++.|+++...|..+..+++|+
T Consensus 29 ~~~l~~L~Ls~N~i~~-i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~ 107 (350)
T 4ay9_X 29 PRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQ 107 (350)
T ss_dssp CTTCSEEEEESCCCSE-ECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCC
T ss_pred CCCCCEEEccCCcCCC-cCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccc
Confidence 5789999999999996 665 689999999999999999988986 4678888764 67778999988889999999999
Q ss_pred eeeeeccccccccc
Q 038351 128 HLFLGYNRLQGSIS 141 (348)
Q Consensus 128 ~L~ls~N~lsG~ip 141 (348)
+|++++|++.+..+
T Consensus 108 ~L~l~~n~l~~~~~ 121 (350)
T 4ay9_X 108 YLLISNTGIKHLPD 121 (350)
T ss_dssp EEEEEEECCSSCCC
T ss_pred cccccccccccCCc
Confidence 99999999986443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.81 E-value=2.6e-09 Score=107.81 Aligned_cols=97 Identities=18% Similarity=0.245 Sum_probs=53.8
Q ss_pred CCCcccccCcccCCcccCCC------------C-CCcEEEEecccceeeecCCCCCCCCCCCCCccEEEcccCcccccCc
Q 038351 3 QRSHSVLHGWKINHLVRQKP------------T-HKAVTNITFGLLVFIILCPRYNYPPLRPPQQENLSLASNELISVIP 69 (348)
Q Consensus 3 ~~~~~~~~~w~~~~~~~~~~------------~-~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~L~~N~l~g~ip 69 (348)
.|...+...|..... ||.+ | ...++.+.+...++..++..+ .++|+.|+|++|+|+ .||
T Consensus 6 ~~~~~~w~~W~~~~~-~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~~lp~~l------~~~L~~L~L~~N~l~-~lp 77 (622)
T 3g06_A 6 AEYDAVWSAWRRAAP-AEESRGRAAVVQKMRACLNNGNAVLNVGESGLTTLPDCL------PAHITTLVIPDNNLT-SLP 77 (622)
T ss_dssp ----CHHHHHHHTCC-GGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCSCCCSCC------CTTCSEEEECSCCCS-CCC
T ss_pred HHHHHHHHHHHhcCC-cchhccccccCcccccccCCCCcEEEecCCCcCccChhh------CCCCcEEEecCCCCC-CCC
Confidence 345667777876543 3432 0 123566666554444443333 266777777777776 366
Q ss_pred ccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccC
Q 038351 70 STFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114 (348)
Q Consensus 70 ~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G 114 (348)
. .+++|++|+|++|+++ .||. .+++|++|++++|++++
T Consensus 78 ~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~ 115 (622)
T 3g06_A 78 A---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH 115 (622)
T ss_dssp C---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC
T ss_pred C---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC
Confidence 5 4566667777777766 4665 45566666666666554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.80 E-value=4e-10 Score=106.85 Aligned_cols=87 Identities=17% Similarity=0.182 Sum_probs=49.1
Q ss_pred CCccEEEcccCccc-ccCc---ccccCCccCcceeccccccc--C---CCCcCCCCCcccceeecccCccc----CccCC
Q 038351 52 PQQENLSLASNELI-SVIP---STFWNLKDILYLNLSLNSLT--G---PIPLEIENLKVLVKIYFSMNNFA----GVIPN 118 (348)
Q Consensus 52 ~~l~~l~L~~N~l~-g~ip---~~~~~l~~L~~l~l~~N~l~--G---~iP~~~~~l~~L~~l~ls~N~l~----G~iP~ 118 (348)
++|+.|+|++|.++ +.+| ..+.++++|++|+|++|+++ | -+|..+..+++|+.|+|++|.++ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 55666666666665 4444 34555556666666666555 2 23335555566666666666654 45555
Q ss_pred ccccccccceeeeecccccc
Q 038351 119 AIGCLNILQHLFLGYNRLQG 138 (348)
Q Consensus 119 ~l~~l~~L~~L~ls~N~lsG 138 (348)
.+..+++|+.|+|++|++++
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~ 258 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSA 258 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCH
T ss_pred HHccCCCcCEEECCCCCCch
Confidence 55555556666666655554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.75 E-value=1.6e-09 Score=101.94 Aligned_cols=89 Identities=20% Similarity=0.147 Sum_probs=55.9
Q ss_pred CCC-CccEEEcccCcccccCcccccCC-----ccCcceecccccccCCCCcCCCCC-----cccceeecccCcccCccCC
Q 038351 50 RPP-QQENLSLASNELISVIPSTFWNL-----KDILYLNLSLNSLTGPIPLEIENL-----KVLVKIYFSMNNFAGVIPN 118 (348)
Q Consensus 50 ~~~-~l~~l~L~~N~l~g~ip~~~~~l-----~~L~~l~l~~N~l~G~iP~~~~~l-----~~L~~l~ls~N~l~G~iP~ 118 (348)
.++ +|+.|+|++|.+++..+..|+.+ ++|++|+|++|++++..|..++.. ++|+.|++++|++++..+.
T Consensus 48 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~ 127 (362)
T 3goz_A 48 NTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSS 127 (362)
T ss_dssp TCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHH
T ss_pred hCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHH
Confidence 445 66777777777766666666664 667777777777766666544443 6677777777776665554
Q ss_pred cccc-----ccccceeeeecccccc
Q 038351 119 AIGC-----LNILQHLFLGYNRLQG 138 (348)
Q Consensus 119 ~l~~-----l~~L~~L~ls~N~lsG 138 (348)
.+.. ..+|+.|++++|+++.
T Consensus 128 ~l~~~l~~~~~~L~~L~Ls~N~l~~ 152 (362)
T 3goz_A 128 EFKQAFSNLPASITSLNLRGNDLGI 152 (362)
T ss_dssp HHHHHHTTSCTTCCEEECTTSCGGG
T ss_pred HHHHHHHhCCCceeEEEccCCcCCH
Confidence 4433 1466677777776664
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.75 E-value=1.3e-09 Score=100.91 Aligned_cols=86 Identities=9% Similarity=0.003 Sum_probs=80.4
Q ss_pred CCccEEEcccCcccccCcccccCCccCcceecccccccCC-CCcCCCCCcccceeecccCcccCccCCccccccccceee
Q 038351 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGP-IPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLF 130 (348)
Q Consensus 52 ~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~-iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ 130 (348)
++++.|+|++|.+++.+|. +.++++|++|+|++|++++. +|..+..+++|+.|++++|.+++.+|..++.+++|+.|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 7899999999999997665 77899999999999999987 999999999999999999999999999999999999999
Q ss_pred eecc-cccc
Q 038351 131 LGYN-RLQG 138 (348)
Q Consensus 131 ls~N-~lsG 138 (348)
+++| .+++
T Consensus 149 L~~~~~l~~ 157 (336)
T 2ast_B 149 LSGCSGFSE 157 (336)
T ss_dssp CTTCBSCCH
T ss_pred CCCCCCCCH
Confidence 9999 6775
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.74 E-value=6.5e-09 Score=95.32 Aligned_cols=167 Identities=16% Similarity=0.145 Sum_probs=107.2
Q ss_pred ccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhccccc-ccc--eeeEEEEEecCC---eEEEEEecc
Q 038351 161 DNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-YRN--LIKIISSRSNED---FKVLVLEYM 234 (348)
Q Consensus 161 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lV~Ey~ 234 (348)
.+.++.|....||+.. ..+++|..... .....+.+|.++++.+. +.. +.+++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568899999999864 46788875422 23456888999998874 322 456665554433 358999999
Q ss_pred CCCCHHHHHh----------chhHHHHHHHHHHhc---------------------------------------------
Q 038351 235 PRGSLEKCLY----------SSNYVGFALEYLHFD--------------------------------------------- 259 (348)
Q Consensus 235 ~~gsL~~~l~----------~~~~i~~~L~yLH~~--------------------------------------------- 259 (348)
+|.++.+... ...+++..+..||..
T Consensus 99 ~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 178 (304)
T 3sg8_A 99 KGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR 178 (304)
T ss_dssp CCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred CCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence 9988764221 112355556666631
Q ss_pred ----------CCCceEecCCCcCceEEcC--CCcEEEeecCCccccccCCcee---------ee---cccc---cc---c
Q 038351 260 ----------YSVLIIHYDLKPSNVLFDD--NIVTHLSDFGIAKLLIREDHFM---------IQ---TQTL---AT---I 309 (348)
Q Consensus 260 ----------~~~~iiHrDik~~NILld~--~~~~kl~DfGla~~~~~~~~~~---------~~---~~~~---gt---~ 309 (348)
....++|+|+++.||++++ ...+.|.||+.+.......... .. .... +. +
T Consensus 179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~ 258 (304)
T 3sg8_A 179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIP 258 (304)
T ss_dssp HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHH
T ss_pred HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcH
Confidence 1245899999999999998 4567899999886542210000 00 0000 11 1
Q ss_pred Cccc-----cccHHHHHHHHHHHcCCCCC
Q 038351 310 GYMA-----SYVYSFGIMLLEVFTRKKPT 333 (348)
Q Consensus 310 ~y~a-----sDV~S~Gvvl~elltG~~P~ 333 (348)
.+.+ .+.|+++.+++++.+|+.+|
T Consensus 259 ~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 259 TVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1111 57899999999999999886
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.68 E-value=2.5e-09 Score=100.65 Aligned_cols=89 Identities=25% Similarity=0.219 Sum_probs=57.1
Q ss_pred CCCccEEEcccCcccccCc----ccccCCc-cCcceecccccccCCCCcCCCCC-----cccceeecccCcccCccCCcc
Q 038351 51 PPQQENLSLASNELISVIP----STFWNLK-DILYLNLSLNSLTGPIPLEIENL-----KVLVKIYFSMNNFAGVIPNAI 120 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~ip----~~~~~l~-~L~~l~l~~N~l~G~iP~~~~~l-----~~L~~l~ls~N~l~G~iP~~l 120 (348)
.++|+.|+|++|.+++.-+ ..|.+++ +|++|+|++|++++..|..+..+ ++|+.|++++|++++..|..+
T Consensus 21 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l 100 (362)
T 3goz_A 21 PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL 100 (362)
T ss_dssp CTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH
T ss_pred CCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHH
Confidence 3446677777777666555 5556666 67777777777766666666554 667777777777666666544
Q ss_pred ccc-----cccceeeeeccccccc
Q 038351 121 GCL-----NILQHLFLGYNRLQGS 139 (348)
Q Consensus 121 ~~l-----~~L~~L~ls~N~lsG~ 139 (348)
+.. ++|+.|++++|++++.
T Consensus 101 ~~~l~~~~~~L~~L~Ls~N~l~~~ 124 (362)
T 3goz_A 101 VKTLAAIPFTITVLDLGWNDFSSK 124 (362)
T ss_dssp HHHHHTSCTTCCEEECCSSCGGGS
T ss_pred HHHHHhCCCCccEEECcCCcCCcH
Confidence 443 5666777777766554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.63 E-value=4.3e-08 Score=91.71 Aligned_cols=112 Identities=17% Similarity=0.052 Sum_probs=84.3
Q ss_pred EEEEecccceeeecCCCCCCCCCCCCCccEEEcccCcccccCcc-cccCCccCc-ceecccccccCCCCcCCCCCcccce
Q 038351 27 VTNITFGLLVFIILCPRYNYPPLRPPQQENLSLASNELISVIPS-TFWNLKDIL-YLNLSLNSLTGPIPLEIENLKVLVK 104 (348)
Q Consensus 27 v~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~L~~N~l~g~ip~-~~~~l~~L~-~l~l~~N~l~G~iP~~~~~l~~L~~ 104 (348)
++.|.+..-.+..+.++. ..++++|+.|+|++|.+.+.||. .|.+|++|+ .++++.|++++-.|..+..+++|++
T Consensus 32 l~~L~Ls~N~i~~i~~~~---f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~ 108 (350)
T 4ay9_X 32 AIELRFVLTKLRVIQKGA---FSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQY 108 (350)
T ss_dssp CSEEEEESCCCSEECTTS---STTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCE
T ss_pred CCEEEccCCcCCCcCHHH---HcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccc
Confidence 444444333234444431 27899999999999999998987 578899876 5778889999877889999999999
Q ss_pred eecccCcccCccCCccccccccceeeeeccccccccc
Q 038351 105 IYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSIS 141 (348)
Q Consensus 105 l~ls~N~l~G~iP~~l~~l~~L~~L~ls~N~lsG~ip 141 (348)
|++++|++++..+..+.....+..++++.+.--..+|
T Consensus 109 L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~ 145 (350)
T 4ay9_X 109 LLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 145 (350)
T ss_dssp EEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEEC
T ss_pred ccccccccccCCchhhcccchhhhhhhcccccccccc
Confidence 9999999998777666666677777776644333444
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.61 E-value=4.3e-09 Score=94.88 Aligned_cols=79 Identities=23% Similarity=0.278 Sum_probs=68.5
Q ss_pred CCCCccEEEcccCcccc--cCcccccCCccCcceecccccccCCCCcCCCCCc--ccceeecccCcccCccCC-------
Q 038351 50 RPPQQENLSLASNELIS--VIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLK--VLVKIYFSMNNFAGVIPN------- 118 (348)
Q Consensus 50 ~~~~l~~l~L~~N~l~g--~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~--~L~~l~ls~N~l~G~iP~------- 118 (348)
.+++|+.|+|++|.|++ .||..+.++++|+.|+|++|++++. .++..++ +|+.|+|++|.+++.+|.
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence 47899999999999999 7888999999999999999999975 4566666 999999999999998884
Q ss_pred ccccccccceee
Q 038351 119 AIGCLNILQHLF 130 (348)
Q Consensus 119 ~l~~l~~L~~L~ 130 (348)
.+..+++|+.||
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 366778887776
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.57 E-value=3.4e-09 Score=102.39 Aligned_cols=85 Identities=21% Similarity=0.166 Sum_probs=38.1
Q ss_pred CccEEEcccCccccc----CcccccCCccCcceecccccccCCCCcCCCC-----CcccceeecccCcccC----ccCCc
Q 038351 53 QQENLSLASNELISV----IPSTFWNLKDILYLNLSLNSLTGPIPLEIEN-----LKVLVKIYFSMNNFAG----VIPNA 119 (348)
Q Consensus 53 ~l~~l~L~~N~l~g~----ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~-----l~~L~~l~ls~N~l~G----~iP~~ 119 (348)
+|+.|+|++|.+++. +|..+.++++|+.|+|++|++++..+..+.. .++|+.|++++|++++ .+|..
T Consensus 314 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~ 393 (461)
T 1z7x_W 314 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT 393 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred cceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHH
Confidence 444444444444433 3344444444444444444444433333322 3444444454444443 44444
Q ss_pred cccccccceeeeeccccc
Q 038351 120 IGCLNILQHLFLGYNRLQ 137 (348)
Q Consensus 120 l~~l~~L~~L~ls~N~ls 137 (348)
+..+++|+.|++++|+++
T Consensus 394 l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 394 LLANHSLRELDLSNNCLG 411 (461)
T ss_dssp HHHCCCCCEEECCSSSCC
T ss_pred HHhCCCccEEECCCCCCC
Confidence 444444555555544444
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.44 E-value=9.9e-09 Score=99.08 Aligned_cols=88 Identities=14% Similarity=0.127 Sum_probs=40.5
Q ss_pred CCCccEEEcccCccccc----CcccccCCccCcceecccccccCCCCcCCCCC-----cccceeecccCcccCc----cC
Q 038351 51 PPQQENLSLASNELISV----IPSTFWNLKDILYLNLSLNSLTGPIPLEIENL-----KVLVKIYFSMNNFAGV----IP 117 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~----ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l-----~~L~~l~ls~N~l~G~----iP 117 (348)
+++|+.|+|++|.+++. +|..+.++++|++|+|++|++++..+..+... ++|+.|++++|.+++. +|
T Consensus 255 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 334 (461)
T 1z7x_W 255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 334 (461)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHH
Confidence 34444444444444443 44444444455555555554443333222221 3455555555554443 34
Q ss_pred Cccccccccceeeeecccccc
Q 038351 118 NAIGCLNILQHLFLGYNRLQG 138 (348)
Q Consensus 118 ~~l~~l~~L~~L~ls~N~lsG 138 (348)
..+..++.|+.|++++|++++
T Consensus 335 ~~l~~~~~L~~L~Ls~n~i~~ 355 (461)
T 1z7x_W 335 SVLAQNRFLLELQISNNRLED 355 (461)
T ss_dssp HHHHHCSSCCEEECCSSBCHH
T ss_pred HHHhhCCCccEEEccCCcccc
Confidence 444444555555555555443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.37 E-value=3.2e-08 Score=93.68 Aligned_cols=86 Identities=19% Similarity=0.165 Sum_probs=46.3
Q ss_pred CCccEEEcccCcccccCccccc-----CCccCcceecccccccC----CCCcCCCCCcccceeecccCcccC----ccCC
Q 038351 52 PQQENLSLASNELISVIPSTFW-----NLKDILYLNLSLNSLTG----PIPLEIENLKVLVKIYFSMNNFAG----VIPN 118 (348)
Q Consensus 52 ~~l~~l~L~~N~l~g~ip~~~~-----~l~~L~~l~l~~N~l~G----~iP~~~~~l~~L~~l~ls~N~l~G----~iP~ 118 (348)
++|+.|+|++|.|+..-...|+ ..++|+.|+|++|+++. .++..+..+++|++|+|++|.++. .++.
T Consensus 126 ~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~ 205 (372)
T 3un9_A 126 LRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAA 205 (372)
T ss_dssp HTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHH
T ss_pred HhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHH
Confidence 4566666666666544333332 34556666666666653 233444555566666666666553 2344
Q ss_pred ccccccccceeeeeccccc
Q 038351 119 AIGCLNILQHLFLGYNRLQ 137 (348)
Q Consensus 119 ~l~~l~~L~~L~ls~N~ls 137 (348)
.+...+.|+.|+|++|+++
T Consensus 206 ~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 206 QLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp HGGGCSCCCEEECCSSCCC
T ss_pred HHhcCCCcCeEECCCCCCC
Confidence 4555555666666666554
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=4.1e-06 Score=74.87 Aligned_cols=127 Identities=17% Similarity=0.103 Sum_probs=86.9
Q ss_pred cccCCcc-eEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhccccc-ccceeeEEEEEecCCeEEEEEeccCCCCHH
Q 038351 164 ISRGGFG-SIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFKVLVLEYMPRGSLE 240 (348)
Q Consensus 164 lG~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 240 (348)
+..|..+ .||+.... ++..+++|.-... ....+.+|...|+.+. +--+.++++++...+..++|||++++.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445554 68987765 4567888876432 3456788999888775 334678899999999999999999998776
Q ss_pred HHHhch--------hHHHHHHHHHHh---------------------------------------------------c--
Q 038351 241 KCLYSS--------NYVGFALEYLHF---------------------------------------------------D-- 259 (348)
Q Consensus 241 ~~l~~~--------~~i~~~L~yLH~---------------------------------------------------~-- 259 (348)
+..... ..++..|.-||. .
T Consensus 109 ~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 188 (272)
T 4gkh_A 109 QVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLP 188 (272)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCC
T ss_pred ccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhccc
Confidence 543210 012222222331 1
Q ss_pred --CCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 260 --YSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 260 --~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
....++|+|+.+.||++++.+.+-|.||+.+...
T Consensus 189 ~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 189 FSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp CCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred ccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 1123899999999999998877789999988653
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.26 E-value=6.9e-08 Score=96.16 Aligned_cols=87 Identities=11% Similarity=-0.013 Sum_probs=38.7
Q ss_pred CCCccEEEcc----cCccccc-----CcccccCCccCcceeccc--ccccCCCCcCCCC-CcccceeecccCcccC-ccC
Q 038351 51 PPQQENLSLA----SNELISV-----IPSTFWNLKDILYLNLSL--NSLTGPIPLEIEN-LKVLVKIYFSMNNFAG-VIP 117 (348)
Q Consensus 51 ~~~l~~l~L~----~N~l~g~-----ip~~~~~l~~L~~l~l~~--N~l~G~iP~~~~~-l~~L~~l~ls~N~l~G-~iP 117 (348)
+++|+.|+|+ .|.+++. ++..+.++++|+.|+|+. |.+++..+..++. +++|+.|++++|++++ .+|
T Consensus 402 ~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~ 481 (592)
T 3ogk_B 402 LKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLM 481 (592)
T ss_dssp CCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHH
T ss_pred CCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHH
Confidence 4455555553 4444442 333344445555555542 2244444433332 4444555555444443 233
Q ss_pred Cccccccccceeeeeccccc
Q 038351 118 NAIGCLNILQHLFLGYNRLQ 137 (348)
Q Consensus 118 ~~l~~l~~L~~L~ls~N~ls 137 (348)
..+..+++|+.|++++|+++
T Consensus 482 ~~~~~~~~L~~L~l~~n~l~ 501 (592)
T 3ogk_B 482 EFSRGCPNLQKLEMRGCCFS 501 (592)
T ss_dssp HHHTCCTTCCEEEEESCCCB
T ss_pred HHHhcCcccCeeeccCCCCc
Confidence 33344444444555444443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=4.6e-06 Score=76.43 Aligned_cols=126 Identities=13% Similarity=0.058 Sum_probs=85.6
Q ss_pred cccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhccccccc---ceeeEEEEEe-cCCeEEEEEeccCCC
Q 038351 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYR---NLIKIISSRS-NEDFKVLVLEYMPRG 237 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~-~~~~~~lV~Ey~~~g 237 (348)
+.++.|....||+. +..+++|.-.. ......+.+|.++|..+.+. .+.+.+.++. ..+..++||||++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45778888899987 46778887421 12345688999999998753 3567777774 456678999999998
Q ss_pred CHHHHHhc----------hhHHHHHHHHHHhc------------------------------------------------
Q 038351 238 SLEKCLYS----------SNYVGFALEYLHFD------------------------------------------------ 259 (348)
Q Consensus 238 sL~~~l~~----------~~~i~~~L~yLH~~------------------------------------------------ 259 (348)
++.+.... ..+++..|..||..
T Consensus 99 ~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 178 (306)
T 3tdw_A 99 ILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQS 178 (306)
T ss_dssp ECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHH
T ss_pred ECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHH
Confidence 87652110 11233333333321
Q ss_pred ---------CCCceEecCCCcCceEEcC---CCc-EEEeecCCcccc
Q 038351 260 ---------YSVLIIHYDLKPSNVLFDD---NIV-THLSDFGIAKLL 293 (348)
Q Consensus 260 ---------~~~~iiHrDik~~NILld~---~~~-~kl~DfGla~~~ 293 (348)
....++|+|+++.||+++. ++. ..|.||+.+..-
T Consensus 179 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 179 YMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3456799999999999987 455 479999988654
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.13 E-value=1.4e-07 Score=89.18 Aligned_cols=86 Identities=20% Similarity=0.215 Sum_probs=37.7
Q ss_pred CCccEEEcccCcccc----cCcccccCCccCcceecccccccC----CCCcCCCCCcccceeecccCcccC----ccCCc
Q 038351 52 PQQENLSLASNELIS----VIPSTFWNLKDILYLNLSLNSLTG----PIPLEIENLKVLVKIYFSMNNFAG----VIPNA 119 (348)
Q Consensus 52 ~~l~~l~L~~N~l~g----~ip~~~~~l~~L~~l~l~~N~l~G----~iP~~~~~l~~L~~l~ls~N~l~G----~iP~~ 119 (348)
++|+.|+|++|.|+. .++..+..+++|++|||++|+++. .++..+..+++|+.|+|++|.++. .++..
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 344455555554433 133333444445555555554443 123333444445555555554443 22333
Q ss_pred cccccccceeeeeccccc
Q 038351 120 IGCLNILQHLFLGYNRLQ 137 (348)
Q Consensus 120 l~~l~~L~~L~ls~N~ls 137 (348)
+...+.|+.|+|++|+++
T Consensus 235 L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 235 AREHPSLELLHLYFNELS 252 (372)
T ss_dssp HHHCSSCCEEECTTSSCC
T ss_pred HHhCCCCCEEeccCCCCC
Confidence 333444455555555443
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=4.4e-06 Score=77.95 Aligned_cols=78 Identities=6% Similarity=-0.027 Sum_probs=55.5
Q ss_pred ccc-ccCCcceEEEeEec-------CCceEEEEeeeecc---CccchhhHHHhhhccccccc---ceeeEEEEEecC---
Q 038351 162 NLI-SRGGFGSIHKARIQ-------DRMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYR---NLIKIISSRSNE--- 224 (348)
Q Consensus 162 ~~l-G~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~~~--- 224 (348)
+.| +.|....+|+.... ++..+++|...... ......+.+|..+++.+... .+.+++.++...
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 566 78888999998765 25678888764332 11235678899999888642 577888887665
Q ss_pred CeEEEEEeccCCCCH
Q 038351 225 DFKVLVLEYMPRGSL 239 (348)
Q Consensus 225 ~~~~lV~Ey~~~gsL 239 (348)
+..++||||+++.++
T Consensus 106 g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 106 GTPFFLMDYVEGVVP 120 (357)
T ss_dssp SSCEEEEECCCCBCC
T ss_pred CCceEEEEecCCCCh
Confidence 356899999988654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.05 E-value=5.8e-07 Score=89.43 Aligned_cols=64 Identities=9% Similarity=0.073 Sum_probs=32.2
Q ss_pred CCCCccEEEcccCccccc----CcccccCCccCcceeccccccc----CCCCcCCCCCcccceeecccCccc
Q 038351 50 RPPQQENLSLASNELISV----IPSTFWNLKDILYLNLSLNSLT----GPIPLEIENLKVLVKIYFSMNNFA 113 (348)
Q Consensus 50 ~~~~l~~l~L~~N~l~g~----ip~~~~~l~~L~~l~l~~N~l~----G~iP~~~~~l~~L~~l~ls~N~l~ 113 (348)
.+++|+.|+|++|.+++. ++..+.++++|++|+|++|.++ +.+|..+.++++|+.|++++|.++
T Consensus 162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~ 233 (592)
T 3ogk_B 162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL 233 (592)
T ss_dssp HCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGG
T ss_pred hCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHH
Confidence 345666666666655544 3334444555555555555554 233333344555555555555443
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.02 E-value=5.4e-07 Score=76.54 Aligned_cols=85 Identities=11% Similarity=0.133 Sum_probs=37.0
Q ss_pred CCccEEEcccCccccc----CcccccCCccCcceecccccccCC----CCcCCCCCcccceeec--ccCcccCc----cC
Q 038351 52 PQQENLSLASNELISV----IPSTFWNLKDILYLNLSLNSLTGP----IPLEIENLKVLVKIYF--SMNNFAGV----IP 117 (348)
Q Consensus 52 ~~l~~l~L~~N~l~g~----ip~~~~~l~~L~~l~l~~N~l~G~----iP~~~~~l~~L~~l~l--s~N~l~G~----iP 117 (348)
++|+.|+|++|.++.. |...+...++|++|+|++|+++.. |...+...++|+.|+| ++|.++.. +.
T Consensus 65 ~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~ 144 (185)
T 1io0_A 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 144 (185)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHH
Confidence 4445555555544321 223333334455555555554432 3334444444555555 44444432 22
Q ss_pred Cccccccccceeeeecccc
Q 038351 118 NAIGCLNILQHLFLGYNRL 136 (348)
Q Consensus 118 ~~l~~l~~L~~L~ls~N~l 136 (348)
..+...+.|+.|++++|.+
T Consensus 145 ~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 145 NMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp HHHHHCSSCCEEECCCSSH
T ss_pred HHHHhCCCcCEEeccCCCC
Confidence 2333334455555554444
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.99 E-value=8.1e-07 Score=75.42 Aligned_cols=90 Identities=12% Similarity=0.102 Sum_probs=74.2
Q ss_pred CCCCCccEEEcccC-ccccc----CcccccCCccCcceecccccccCC----CCcCCCCCcccceeecccCcccCc----
Q 038351 49 LRPPQQENLSLASN-ELISV----IPSTFWNLKDILYLNLSLNSLTGP----IPLEIENLKVLVKIYFSMNNFAGV---- 115 (348)
Q Consensus 49 ~~~~~l~~l~L~~N-~l~g~----ip~~~~~l~~L~~l~l~~N~l~G~----iP~~~~~l~~L~~l~ls~N~l~G~---- 115 (348)
...+.|+.|+|++| .++.. |...+...++|++|+|++|+++.. |...+...++|+.|+|++|.++..
T Consensus 33 ~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~ 112 (185)
T 1io0_A 33 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 112 (185)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHH
Confidence 55689999999999 88653 566777889999999999999752 445566678999999999999864
Q ss_pred cCCccccccccceeee--ecccccc
Q 038351 116 IPNAIGCLNILQHLFL--GYNRLQG 138 (348)
Q Consensus 116 iP~~l~~l~~L~~L~l--s~N~lsG 138 (348)
+...+.....|+.|++ ++|++..
T Consensus 113 l~~~L~~n~~L~~L~L~~~~N~i~~ 137 (185)
T 1io0_A 113 LVEALQSNTSLIELRIDNQSQPLGN 137 (185)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred HHHHHHhCCCceEEEecCCCCCCCH
Confidence 6777888889999999 7898874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=2.8e-05 Score=73.62 Aligned_cols=75 Identities=12% Similarity=0.077 Sum_probs=49.3
Q ss_pred ccccccCCcceEEEeEec-CCceEEEEeeeeccC-------ccchhhHHHhhhcccccc---cceeeEEEEEecCCeEEE
Q 038351 161 DNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-------GAFKSFDFECDVMKSTCY---RNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 161 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~~~~~~l 229 (348)
.+.+|.|.++.||++... ++..+++|....... .....+..|.++++.+.. ..+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999764 467899997642211 123456778888887742 345566654 3445689
Q ss_pred EEeccCCC
Q 038351 230 VLEYMPRG 237 (348)
Q Consensus 230 V~Ey~~~g 237 (348)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.92 E-value=7.5e-07 Score=88.58 Aligned_cols=64 Identities=17% Similarity=0.059 Sum_probs=30.8
Q ss_pred ccCCccCcceecccccccCCCCcCCCC-CcccceeecccCcccCccCCcc-ccccccceeeeecccc
Q 038351 72 FWNLKDILYLNLSLNSLTGPIPLEIEN-LKVLVKIYFSMNNFAGVIPNAI-GCLNILQHLFLGYNRL 136 (348)
Q Consensus 72 ~~~l~~L~~l~l~~N~l~G~iP~~~~~-l~~L~~l~ls~N~l~G~iP~~l-~~l~~L~~L~ls~N~l 136 (348)
+.++++|+.|+|++ ++++..+..++. +++|+.|++++|.+++..+..+ ..+++|+.|++++|++
T Consensus 428 ~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 428 VEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp HHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred HhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 44455555555544 444444444443 4555555555555544433333 3345555555555554
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.91 E-value=6.3e-05 Score=69.15 Aligned_cols=76 Identities=14% Similarity=0.074 Sum_probs=59.5
Q ss_pred cccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccc---cceeeEEEEEecCCeEEEEEeccCC
Q 038351 160 EDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCY---RNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 160 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
..+.|+.|....+|+.... +..+++|..... ....+..|.+.|+.+.. ..+++++.++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 4467899999999998864 567888876532 24568889999888853 5688899998888899999999988
Q ss_pred CCH
Q 038351 237 GSL 239 (348)
Q Consensus 237 gsL 239 (348)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.90 E-value=1.3e-05 Score=72.49 Aligned_cols=79 Identities=9% Similarity=-0.014 Sum_probs=56.7
Q ss_pred CCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccc---cceeeEEEEEecCCeEEEEEec
Q 038351 157 GFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCY---RNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~~~~~~lV~Ey 233 (348)
.....+.+|.|..+.||+.+..||+.+.+|............|..|.+.|+.+.- --+++++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 3445577899999999999999999999998654433334557889998887742 2345556543 23789999
Q ss_pred cCCCCH
Q 038351 234 MPRGSL 239 (348)
Q Consensus 234 ~~~gsL 239 (348)
++.+..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.83 E-value=3e-05 Score=71.32 Aligned_cols=126 Identities=15% Similarity=0.141 Sum_probs=76.1
Q ss_pred cccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccc--eeeEEE------EEecCCeEEEEEec
Q 038351 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRN--LIKIIS------SRSNEDFKVLVLEY 233 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~------~~~~~~~~~lV~Ey 233 (348)
+.++.|..+.||+....++ .+++|..... ...+..|.+++..+.... +.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677889999987766 4888887641 234455666666554222 333333 11245678999999
Q ss_pred cCCCCHH-----------H---HHhc-------h--------------------h-------------------------
Q 038351 234 MPRGSLE-----------K---CLYS-------S--------------------N------------------------- 247 (348)
Q Consensus 234 ~~~gsL~-----------~---~l~~-------~--------------------~------------------------- 247 (348)
+++.++. + .++. . .
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9886431 0 0110 0 0
Q ss_pred -----HHHHHHHHHHh----------cCCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 248 -----YVGFALEYLHF----------DYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 248 -----~i~~~L~yLH~----------~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
.+..++++|+. .....++|+|+++.||+++.++.+.|.||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 01123445542 1357899999999999998778899999998754
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.74 E-value=3.1e-06 Score=84.07 Aligned_cols=86 Identities=12% Similarity=0.035 Sum_probs=53.9
Q ss_pred CCCCccEEEcccCcccccCccccc-CCccCcceecccc-cccCC-CCcCCCCCcccceeecccCcccCccCCccc----c
Q 038351 50 RPPQQENLSLASNELISVIPSTFW-NLKDILYLNLSLN-SLTGP-IPLEIENLKVLVKIYFSMNNFAGVIPNAIG----C 122 (348)
Q Consensus 50 ~~~~l~~l~L~~N~l~g~ip~~~~-~l~~L~~l~l~~N-~l~G~-iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~----~ 122 (348)
.+++|+.|+|++|.+++..+..+. ++++|++|+|++| .++.. ++..+.++++|+.|++++|.+++..+..+. .
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~ 182 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT 182 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence 456777777777777776666665 5677777777776 44432 444444667777777777776665444443 3
Q ss_pred ccccceeeeeccc
Q 038351 123 LNILQHLFLGYNR 135 (348)
Q Consensus 123 l~~L~~L~ls~N~ 135 (348)
+++|+.|++++|.
T Consensus 183 ~~~L~~L~l~~~~ 195 (594)
T 2p1m_B 183 YTSLVSLNISCLA 195 (594)
T ss_dssp CCCCCEEECTTCC
T ss_pred CCcCcEEEecccC
Confidence 4466666666664
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.66 E-value=6.2e-05 Score=69.36 Aligned_cols=84 Identities=19% Similarity=0.223 Sum_probs=70.5
Q ss_pred CCCccEEEcccCcccccCcc-cccCCccCcceecccccccCCCC-cCCCCCcccc-eeecccCcccCccCCccccccccc
Q 038351 51 PPQQENLSLASNELISVIPS-TFWNLKDILYLNLSLNSLTGPIP-LEIENLKVLV-KIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~ip~-~~~~l~~L~~l~l~~N~l~G~iP-~~~~~l~~L~-~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
+++|+.|+|++|+++. ||+ .|.+|++|+.|+|+.| ++ .|+ ..|.++++|+ .+++.+ +++---+..+..+.+|+
T Consensus 225 ~~~L~~l~L~~n~i~~-I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~ 300 (329)
T 3sb4_A 225 MPNLVSLDISKTNATT-IPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLR 300 (329)
T ss_dssp CTTCCEEECTTBCCCE-ECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEE
T ss_pred cCCCeEEECCCCCcce-ecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCC
Confidence 7899999999999986 555 7999999999999998 66 565 5588999999 999988 66644457899999999
Q ss_pred eeeeecccccc
Q 038351 128 HLFLGYNRLQG 138 (348)
Q Consensus 128 ~L~ls~N~lsG 138 (348)
.++++.|++..
T Consensus 301 ~l~l~~n~i~~ 311 (329)
T 3sb4_A 301 YVLATGDKITT 311 (329)
T ss_dssp EEEECSSCCCE
T ss_pred EEEeCCCccCc
Confidence 99998888763
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.64 E-value=7.8e-06 Score=76.88 Aligned_cols=88 Identities=14% Similarity=0.068 Sum_probs=55.4
Q ss_pred CCCccEEEcccCcccccCccccc--CCccCcceeccc--ccccCCC-----CcCC--CCCcccceeecccCcccCccCCc
Q 038351 51 PPQQENLSLASNELISVIPSTFW--NLKDILYLNLSL--NSLTGPI-----PLEI--ENLKVLVKIYFSMNNFAGVIPNA 119 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~ip~~~~--~l~~L~~l~l~~--N~l~G~i-----P~~~--~~l~~L~~l~ls~N~l~G~iP~~ 119 (348)
+++|+.|+|..+.++...-..++ ++++|+.|+|+. |+..|.. -..+ +.+++|++|+|++|.++...+..
T Consensus 192 ~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~ 271 (362)
T 2ra8_A 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM 271 (362)
T ss_dssp CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHH
T ss_pred CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHH
Confidence 67888888887776554444444 677888888753 3322221 1112 24678888888888777555444
Q ss_pred cc---cccccceeeeecccccc
Q 038351 120 IG---CLNILQHLFLGYNRLQG 138 (348)
Q Consensus 120 l~---~l~~L~~L~ls~N~lsG 138 (348)
+. .++.|+.|+|+.|++.+
T Consensus 272 la~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 272 FLESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp HHHCSSGGGCSEEECCSSCCBH
T ss_pred HHhCccCCCCCEEECCCCCCCh
Confidence 43 36678888888887765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00025 Score=67.74 Aligned_cols=32 Identities=22% Similarity=0.249 Sum_probs=27.9
Q ss_pred CCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 261 SVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 261 ~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
...++|+|+++.||+++.++ ++|.||+.+..-
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 56799999999999998876 999999988653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00044 Score=63.15 Aligned_cols=128 Identities=16% Similarity=0.142 Sum_probs=76.5
Q ss_pred cccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccce--eeEEEE------EecCCeEEEEEec
Q 038351 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNL--IKIISS------RSNEDFKVLVLEY 233 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~~------~~~~~~~~lV~Ey 233 (348)
+.|+.|....+|+....++ .+++|..... .....+..|.+++..+....+ .+++.. ....+..++++||
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 3466677789999987766 6778877542 123456778888877753332 333321 1223567899999
Q ss_pred cCCCCHHH--------------HHhch------------h------------------------HHHHHHHHHHhc----
Q 038351 234 MPRGSLEK--------------CLYSS------------N------------------------YVGFALEYLHFD---- 259 (348)
Q Consensus 234 ~~~gsL~~--------------~l~~~------------~------------------------~i~~~L~yLH~~---- 259 (348)
+++..+.. .++.. . .+...++.+...
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98754310 01100 0 022334444432
Q ss_pred CCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 260 YSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 260 ~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
....++|+|+.+.||+++++..+.|.||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 135689999999999999876668999998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0016 Score=59.85 Aligned_cols=127 Identities=12% Similarity=0.091 Sum_probs=71.7
Q ss_pred cccccCCcce-EEEeEecCCceEEEEeeeeccCccchhhHHHhhhccccccc--ceeeEEEEEecCCeEEEEEeccCCCC
Q 038351 162 NLISRGGFGS-IHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYR--NLIKIISSRSNEDFKVLVLEYMPRGS 238 (348)
Q Consensus 162 ~~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~~~~~~lV~Ey~~~gs 238 (348)
+.++.|.... +|+....++..+++|...... ...+..|+.++..+... .+.+++.+....+ ++|||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 3455554443 667765445667676543221 14556778877777532 3556777644433 78999997766
Q ss_pred HHHHHhch--------hHHHHHH--------------------------------------------------HHHH---
Q 038351 239 LEKCLYSS--------NYVGFAL--------------------------------------------------EYLH--- 257 (348)
Q Consensus 239 L~~~l~~~--------~~i~~~L--------------------------------------------------~yLH--- 257 (348)
+.+.+... ..++..| +.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65433210 0011111 1111
Q ss_pred hcCCCceEecCCCcCceEEcCC----CcEEEeecCCcccc
Q 038351 258 FDYSVLIIHYDLKPSNVLFDDN----IVTHLSDFGIAKLL 293 (348)
Q Consensus 258 ~~~~~~iiHrDik~~NILld~~----~~~kl~DfGla~~~ 293 (348)
......++|+|+.+.||+++.+ ..+.|.||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 0124569999999999999874 67899999988653
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00042 Score=55.04 Aligned_cols=55 Identities=24% Similarity=0.289 Sum_probs=34.8
Q ss_pred cEEEcccCccc-ccCcccccCCccCcceecccccccCCCC-cCCCCCcccceeecccCcc
Q 038351 55 ENLSLASNELI-SVIPSTFWNLKDILYLNLSLNSLTGPIP-LEIENLKVLVKIYFSMNNF 112 (348)
Q Consensus 55 ~~l~L~~N~l~-g~ip~~~~~l~~L~~l~l~~N~l~G~iP-~~~~~l~~L~~l~ls~N~l 112 (348)
+.++.++++|+ -.||..|. ++|++|+|++|+|+ .|| ..|..+++|+.|+|++|.+
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCC
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCe
Confidence 36777777776 34665443 24677777777777 444 3455667777777776654
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.21 E-value=9.2e-05 Score=69.51 Aligned_cols=88 Identities=15% Similarity=0.102 Sum_probs=55.3
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCC--CCcccceeeccc--CcccCc--c---CCc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIE--NLKVLVKIYFSM--NNFAGV--I---PNA 119 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~--~l~~L~~l~ls~--N~l~G~--i---P~~ 119 (348)
..+|+|+.|+|++|.-. .+|+ + .+++|+.|+|+.+.++......++ .+++|+.|+|+. |+..|. + ...
T Consensus 169 ~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~ 245 (362)
T 2ra8_A 169 DAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPL 245 (362)
T ss_dssp HTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGG
T ss_pred hcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHH
Confidence 44688888888877311 3444 4 377888888887776654444444 678888888863 332222 1 111
Q ss_pred c--ccccccceeeeeccccccc
Q 038351 120 I--GCLNILQHLFLGYNRLQGS 139 (348)
Q Consensus 120 l--~~l~~L~~L~ls~N~lsG~ 139 (348)
+ ...++|+.|+|++|.+...
T Consensus 246 l~~~~~p~Lr~L~L~~~~i~~~ 267 (362)
T 2ra8_A 246 FSKDRFPNLKWLGIVDAEEQNV 267 (362)
T ss_dssp SCTTTCTTCCEEEEESCTTHHH
T ss_pred HhcCCCCCcCEEeCCCCCCchH
Confidence 2 2357888888888887643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00086 Score=60.79 Aligned_cols=123 Identities=13% Similarity=0.097 Sum_probs=77.6
Q ss_pred ccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccce-eeEEEEEecCCeEEEEEecc-CCCC
Q 038351 161 DNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNL-IKIISSRSNEDFKVLVLEYM-PRGS 238 (348)
Q Consensus 161 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~-~~gs 238 (348)
.+.|+.|....+|+. ..+++|....... .......|..+++.+....+ .++++++ .+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 567888999999998 4677887653321 12334678888877764333 4666543 33347899999 6555
Q ss_pred HHHH-Hhc----hhHHHHHHHHHHhc--------------------------------------------------CCCc
Q 038351 239 LEKC-LYS----SNYVGFALEYLHFD--------------------------------------------------YSVL 263 (348)
Q Consensus 239 L~~~-l~~----~~~i~~~L~yLH~~--------------------------------------------------~~~~ 263 (348)
+... +.. ...+++.|+-||.. ....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 5321 111 12244444445432 1234
Q ss_pred eEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 264 IIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 264 iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
++|+|+.+.||+ ..++.+.+.||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 799999999999 5666789999988764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00074 Score=62.03 Aligned_cols=79 Identities=15% Similarity=0.078 Sum_probs=67.2
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCc-ceecccccccCCC-CcCCCCCcccceeecccCcccCccCCcccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDIL-YLNLSLNSLTGPI-PLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNIL 126 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~-~l~l~~N~l~G~i-P~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L 126 (348)
.+|++|+.|+|.+| ++.-=+..|.+|++|+ .|+|+. +++ .| +..|.+|++|+.++++.|+++.--+..+..+++|
T Consensus 247 ~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L 323 (329)
T 3sb4_A 247 AQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPS 323 (329)
T ss_dssp TTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCC
T ss_pred hCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCCEEEeCCCccCccchhhhcCCcch
Confidence 78999999999998 6653344799999999 999988 777 55 4779999999999999999996666789999998
Q ss_pred ceee
Q 038351 127 QHLF 130 (348)
Q Consensus 127 ~~L~ 130 (348)
+.+.
T Consensus 324 ~~ly 327 (329)
T 3sb4_A 324 KLIY 327 (329)
T ss_dssp CEEE
T ss_pred hhhc
Confidence 8775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.02 E-value=0.00094 Score=61.10 Aligned_cols=126 Identities=14% Similarity=0.132 Sum_probs=77.3
Q ss_pred ccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccc--eeeEEEE-----EecCCeEEEEEeccC
Q 038351 163 LISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRN--LIKIISS-----RSNEDFKVLVLEYMP 235 (348)
Q Consensus 163 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~-----~~~~~~~~lV~Ey~~ 235 (348)
.++ |....||+....++..+++|...... .....+..|..++..+.... +++++.. ....+..++||||++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 455 77789999887777789999875321 12356677888877775322 3344432 122456688999998
Q ss_pred CCCHH-----HH---------Hhch--------------h--------------------------HHHHHHHHHHhc--
Q 038351 236 RGSLE-----KC---------LYSS--------------N--------------------------YVGFALEYLHFD-- 259 (348)
Q Consensus 236 ~gsL~-----~~---------l~~~--------------~--------------------------~i~~~L~yLH~~-- 259 (348)
+.++. .. ++.. . .+...++.+...
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 74331 00 0000 0 001112222211
Q ss_pred --CCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 260 --YSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 260 --~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
....++|+|+++.||+++ + .+.|.||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 245689999999999999 4 899999988754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0017 Score=61.21 Aligned_cols=126 Identities=17% Similarity=0.163 Sum_probs=75.0
Q ss_pred cccccCCcceEEEeEecC--------CceEEEEeeeeccCccchhhHHHhhhccccccc-ceeeEEEEEecCCeEEEEEe
Q 038351 162 NLISRGGFGSIHKARIQD--------RMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYR-NLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lV~E 232 (348)
+.+..|-...+|++...+ +..+++|+.... ........+|.++++.+.-. -..++++++.. .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 456678888999988652 467888875322 12345567899998888632 23567766643 39999
Q ss_pred ccCCCCHHHH-Hhc---hhHHHH---------------------------------------------------HHHHHH
Q 038351 233 YMPRGSLEKC-LYS---SNYVGF---------------------------------------------------ALEYLH 257 (348)
Q Consensus 233 y~~~gsL~~~-l~~---~~~i~~---------------------------------------------------~L~yLH 257 (348)
|+++.++..- +.. ...++. .++.|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9987554210 000 000111 122221
Q ss_pred h-----cCCCceEecCCCcCceEEcCC----CcEEEeecCCccc
Q 038351 258 F-----DYSVLIIHYDLKPSNVLFDDN----IVTHLSDFGIAKL 292 (348)
Q Consensus 258 ~-----~~~~~iiHrDik~~NILld~~----~~~kl~DfGla~~ 292 (348)
. .....++|+|+.+.||+++.+ +.+.+.||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 123458999999999999876 7889999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0011 Score=63.59 Aligned_cols=72 Identities=15% Similarity=0.117 Sum_probs=48.7
Q ss_pred ccccccCCcceEEEeEecC--------CceEEEEeeeeccCccchhhHHHhhhcccccccce-eeEEEEEecCCeEEEEE
Q 038351 161 DNLISRGGFGSIHKARIQD--------RMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNL-IKIISSRSNEDFKVLVL 231 (348)
Q Consensus 161 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~ 231 (348)
.+.|+.|....+|++...+ +..+++|+.... .....+..|..+++.+...++ .++++.+.. .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3457778888999998753 467888876321 111456689999888864444 567776542 3899
Q ss_pred eccCCCC
Q 038351 232 EYMPRGS 238 (348)
Q Consensus 232 Ey~~~gs 238 (348)
||+++.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9997643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0023 Score=59.69 Aligned_cols=73 Identities=10% Similarity=0.097 Sum_probs=44.0
Q ss_pred cccccCCcceEEEeEecCC---------ceEEEEeeeeccCccchhhHHHhhhcccccccc-eeeEEEEEecCCeEEEEE
Q 038351 162 NLISRGGFGSIHKARIQDR---------MEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRN-LIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~~---------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~ 231 (348)
+.++.|....+|+....++ ..+++|...... ........|.++++.+...+ ..++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 4567788889999886542 577777664321 11223467888888886444 34666554 2 26899
Q ss_pred eccCCCCH
Q 038351 232 EYMPRGSL 239 (348)
Q Consensus 232 Ey~~~gsL 239 (348)
||+++.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0057 Score=59.10 Aligned_cols=74 Identities=14% Similarity=0.099 Sum_probs=46.7
Q ss_pred ccccccCCcceEEEeEecC-CceEEEEeeeeccCccchhhHHHhhhcccccccce-eeEEEEEecCCeEEEEEeccCCCC
Q 038351 161 DNLISRGGFGSIHKARIQD-RMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNL-IKIISSRSNEDFKVLVLEYMPRGS 238 (348)
Q Consensus 161 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~gs 238 (348)
.+.|+.|-...+|++...+ +..+++|...... ...-....|..++..+...++ .++++.+. + .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3467778888999998775 4677888764322 111223578888888864444 57777763 2 35999998643
Q ss_pred H
Q 038351 239 L 239 (348)
Q Consensus 239 L 239 (348)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0021 Score=50.97 Aligned_cols=57 Identities=19% Similarity=0.308 Sum_probs=47.9
Q ss_pred cceeccccccc-CCCCcCCCCCcccceeecccCcccCccCCccccccccceeeeeccccc
Q 038351 79 LYLNLSLNSLT-GPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQ 137 (348)
Q Consensus 79 ~~l~l~~N~l~-G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ls~N~ls 137 (348)
..++.++++|+ -.||..+. ++|+.|+|++|+|+.--+..+..+.+|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 47899999997 68886543 47899999999999655667888999999999999875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0035 Score=57.97 Aligned_cols=32 Identities=22% Similarity=0.332 Sum_probs=27.9
Q ss_pred CceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 262 VLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 262 ~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
..++|+|+.+.||++++++.+.|.||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 56999999999999998888999999877653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.58 E-value=0.00038 Score=58.31 Aligned_cols=84 Identities=13% Similarity=0.070 Sum_probs=62.9
Q ss_pred CCccEEEcccCcccccCcccccCCccCcceeccccc-ccCCCCcCCCCC----cccceeecccC-cccCccCCccccccc
Q 038351 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNS-LTGPIPLEIENL----KVLVKIYFSMN-NFAGVIPNAIGCLNI 125 (348)
Q Consensus 52 ~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~-l~G~iP~~~~~l----~~L~~l~ls~N-~l~G~iP~~l~~l~~ 125 (348)
-+|+.|+|+++.++-.==..+..|++|++|+|+++. ++..==..|+.+ ++|+.|+|+++ ++|-.==..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999998876433467899999999999985 664333445554 47999999996 476432245778899
Q ss_pred cceeeeeccc
Q 038351 126 LQHLFLGYNR 135 (348)
Q Consensus 126 L~~L~ls~N~ 135 (348)
|+.|++++..
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 9999998754
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.10 E-value=0.017 Score=54.70 Aligned_cols=59 Identities=15% Similarity=0.149 Sum_probs=34.6
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCC-cCCCCCcccceeecccC
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIP-LEIENLKVLVKIYFSMN 110 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP-~~~~~l~~L~~l~ls~N 110 (348)
.+|++|+.++|++|+++- ||.....+++|+.+.|.. +++ .|+ ..|.++++|+.+++..|
T Consensus 177 ~~c~~L~~l~l~~n~l~~-I~~~aF~~~~L~~l~lp~-~l~-~I~~~aF~~~~~L~~l~l~~~ 236 (401)
T 4fdw_A 177 YYCYNLKKADLSKTKITK-LPASTFVYAGIEEVLLPV-TLK-EIGSQAFLKTSQLKTIEIPEN 236 (401)
T ss_dssp TTCTTCCEEECTTSCCSE-ECTTTTTTCCCSEEECCT-TCC-EECTTTTTTCTTCCCEECCTT
T ss_pred hCcccCCeeecCCCcceE-echhhEeecccCEEEeCC-chh-eehhhHhhCCCCCCEEecCCC
Confidence 556777777777776664 554444456666666653 344 343 34556666666666543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=95.70 E-value=0.02 Score=54.21 Aligned_cols=80 Identities=10% Similarity=0.121 Sum_probs=40.3
Q ss_pred CCccEEEcccCcccccCcccccCCccCcceecccccccC----CCC-cCCCCCcccceeecccCcccCccCCcccccccc
Q 038351 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTG----PIP-LEIENLKVLVKIYFSMNNFAGVIPNAIGCLNIL 126 (348)
Q Consensus 52 ~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G----~iP-~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L 126 (348)
.+|+.+.|. |+++--=+..|.+|++|+.++|++|.+.. .|+ ..|..|++|+.+++. |+++--=...+..+.+|
T Consensus 248 ~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L 325 (401)
T 4fdw_A 248 SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKV 325 (401)
T ss_dssp CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSC
T ss_pred CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCc
Confidence 456666663 34443223456666666666666655541 233 345556666666665 23332222345555556
Q ss_pred ceeeeec
Q 038351 127 QHLFLGY 133 (348)
Q Consensus 127 ~~L~ls~ 133 (348)
+.+.+..
T Consensus 326 ~~l~lp~ 332 (401)
T 4fdw_A 326 TQLTIPA 332 (401)
T ss_dssp CEEEECT
T ss_pred cEEEECc
Confidence 6665543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.42 E-value=0.033 Score=53.14 Aligned_cols=73 Identities=18% Similarity=0.179 Sum_probs=47.3
Q ss_pred cccccCCcceEEEeEecC--------CceEEEEeeeeccCccchhhHHHhhhcccccccc-eeeEEEEEecCCeEEEEEe
Q 038351 162 NLISRGGFGSIHKARIQD--------RMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRN-LIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~E 232 (348)
+.+..|-...+|+....+ +..+++|...... ...-...+|.++++.+.-.. ..++++.+. -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 456678888999998763 5678888764322 22233467888888886333 356665432 278999
Q ss_pred ccCCCCH
Q 038351 233 YMPRGSL 239 (348)
Q Consensus 233 y~~~gsL 239 (348)
|+++.++
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9988553
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.32 E-value=0.0026 Score=54.16 Aligned_cols=84 Identities=10% Similarity=0.039 Sum_probs=57.8
Q ss_pred CCCccEEEcccC-ccccc----CcccccCCccCcceecccccccCC----CCcCCCCCcccceeecccCcccCc----cC
Q 038351 51 PPQQENLSLASN-ELISV----IPSTFWNLKDILYLNLSLNSLTGP----IPLEIENLKVLVKIYFSMNNFAGV----IP 117 (348)
Q Consensus 51 ~~~l~~l~L~~N-~l~g~----ip~~~~~l~~L~~l~l~~N~l~G~----iP~~~~~l~~L~~l~ls~N~l~G~----iP 117 (348)
-+.|+.|+|++| .+... |=..+..-+.|+.|+|++|++.-. |-..|..-+.|+.|+|++|+++.. |-
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 467889999885 65421 444556667899999999988732 233344567889999999988743 33
Q ss_pred Cccccccccceeeeecc
Q 038351 118 NAIGCLNILQHLFLGYN 134 (348)
Q Consensus 118 ~~l~~l~~L~~L~ls~N 134 (348)
..+..-..|+.|+|++|
T Consensus 120 ~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHTTTTCCCSEEECCCC
T ss_pred HHHhhCCceeEEECCCC
Confidence 44555566888888765
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=93.90 E-value=0.0075 Score=51.31 Aligned_cols=87 Identities=15% Similarity=0.095 Sum_probs=63.5
Q ss_pred CCCccEEEcccCccccc----CcccccCCccCcceecccccccCC----CCcCCCCCcccceeecccC---cccC----c
Q 038351 51 PPQQENLSLASNELISV----IPSTFWNLKDILYLNLSLNSLTGP----IPLEIENLKVLVKIYFSMN---NFAG----V 115 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~----ip~~~~~l~~L~~l~l~~N~l~G~----iP~~~~~l~~L~~l~ls~N---~l~G----~ 115 (348)
=+.|+.|+|++|.+... |-..+..-+.|+.|+|+.|+++.. |-..|..-+.|+.|+|++| .+.. .
T Consensus 69 N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ 148 (197)
T 1pgv_A 69 SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMD 148 (197)
T ss_dssp CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHH
T ss_pred CCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHH
Confidence 46899999999999743 444455678899999999999863 3344666678999999865 3332 2
Q ss_pred cCCccccccccceeeeeccccc
Q 038351 116 IPNAIGCLNILQHLFLGYNRLQ 137 (348)
Q Consensus 116 iP~~l~~l~~L~~L~ls~N~ls 137 (348)
|-..+..-+.|..|++++|...
T Consensus 149 ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 149 MMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHhCCCcCeEeccCCCcc
Confidence 4455666678899999877654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=91.39 E-value=0.054 Score=45.07 Aligned_cols=69 Identities=10% Similarity=0.014 Sum_probs=48.7
Q ss_pred cCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCc-ccCccCCccccc----cccceeeeeccc
Q 038351 67 VIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNN-FAGVIPNAIGCL----NILQHLFLGYNR 135 (348)
Q Consensus 67 ~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~-l~G~iP~~l~~l----~~L~~L~ls~N~ 135 (348)
.+|...-.--.|+.||||++.++-.=-..+..+++|+.|+|+++. ++..==..++.+ ++|+.|+|+++.
T Consensus 52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~ 125 (176)
T 3e4g_A 52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCG 125 (176)
T ss_dssp GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCT
T ss_pred cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCC
Confidence 346544333469999999998775544557899999999999984 664322344443 479999999864
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=89.17 E-value=1 Score=41.49 Aligned_cols=82 Identities=15% Similarity=0.139 Sum_probs=45.6
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCC-cCCCCCcccceeecccCcccCccCCccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIP-LEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP-~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
..+..|+.+.+..+ ++--=...|.++.+|+.+.+..+ ++ .|+ ..+..+++|+.+.+.++.++--=...+..+.+|+
T Consensus 237 ~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~ 313 (379)
T 4h09_A 237 YGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLS 313 (379)
T ss_dssp TTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCC
T ss_pred cCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce-eccccccccccccccccccccccceehhhhhcCCCCCC
Confidence 34455666655543 33222234556666776666433 33 344 3456677777777776666522234566667777
Q ss_pred eeeeec
Q 038351 128 HLFLGY 133 (348)
Q Consensus 128 ~L~ls~ 133 (348)
.+.+..
T Consensus 314 ~i~lp~ 319 (379)
T 4h09_A 314 SVTLPT 319 (379)
T ss_dssp EEECCT
T ss_pred EEEcCc
Confidence 777653
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=88.99 E-value=0.85 Score=42.40 Aligned_cols=79 Identities=16% Similarity=0.164 Sum_probs=42.8
Q ss_pred CCCCCccEEEcccCcccccCc-ccccCCccCcceecccccccCCCC-cCCCCCcccceeecccCcccCcc-CCccccccc
Q 038351 49 LRPPQQENLSLASNELISVIP-STFWNLKDILYLNLSLNSLTGPIP-LEIENLKVLVKIYFSMNNFAGVI-PNAIGCLNI 125 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip-~~~~~l~~L~~l~l~~N~l~G~iP-~~~~~l~~L~~l~ls~N~l~G~i-P~~l~~l~~ 125 (348)
..+.+|+.+.+.++ ++- |+ ..|.+|++|+.++|.. +++ .|+ ..|.++++|+.+++..| ++ .| ..++..+.+
T Consensus 294 ~~~~~L~~i~l~~~-i~~-I~~~aF~~c~~L~~i~lp~-~v~-~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~ 367 (394)
T 4fs7_A 294 YGCSSLTEVKLLDS-VKF-IGEEAFESCTSLVSIDLPY-LVE-EIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCIN 367 (394)
T ss_dssp TTCTTCCEEEECTT-CCE-ECTTTTTTCTTCCEECCCT-TCC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTT
T ss_pred cccccccccccccc-cce-echhhhcCCCCCCEEEeCC-ccc-EEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCC
Confidence 34556666666543 332 33 3466666666666643 344 453 34556666666666554 33 23 235556666
Q ss_pred cceeeeec
Q 038351 126 LQHLFLGY 133 (348)
Q Consensus 126 L~~L~ls~ 133 (348)
|+.+++..
T Consensus 368 L~~i~lp~ 375 (394)
T 4fs7_A 368 LKKVELPK 375 (394)
T ss_dssp CCEEEEEG
T ss_pred CCEEEECC
Confidence 66666643
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=88.45 E-value=1.6 Score=40.49 Aligned_cols=80 Identities=14% Similarity=0.248 Sum_probs=37.5
Q ss_pred CCCCCccEEEcccCcccccCcc-cccCCccCcceecccccccCCCC-cCCCCCcccceeecccCcccCccC-Cccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPS-TFWNLKDILYLNLSLNSLTGPIP-LEIENLKVLVKIYFSMNNFAGVIP-NAIGCLNI 125 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~-~~~~l~~L~~l~l~~N~l~G~iP-~~~~~l~~L~~l~ls~N~l~G~iP-~~l~~l~~ 125 (348)
.+++.|+.+.+. +.++- |+. .|.+|++|+.++|..| ++ .|. ..|.++++|+.+.+..+ ++ .|+ .++.++.+
T Consensus 285 ~~c~~L~~i~l~-~~i~~-I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~ 358 (394)
T 4gt6_A 285 MNCPALQDIEFS-SRITE-LPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTA 358 (394)
T ss_dssp TTCTTCCEEECC-TTCCE-ECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTT
T ss_pred ccccccccccCC-Ccccc-cCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCC
Confidence 334555555553 22332 322 4555555665555432 33 333 33455556665555433 22 232 34555556
Q ss_pred cceeeeecc
Q 038351 126 LQHLFLGYN 134 (348)
Q Consensus 126 L~~L~ls~N 134 (348)
|+.+++..|
T Consensus 359 L~~i~~~~~ 367 (394)
T 4gt6_A 359 LNNIEYSGS 367 (394)
T ss_dssp CCEEEESSC
T ss_pred CCEEEECCc
Confidence 666655544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=87.27 E-value=0.56 Score=43.66 Aligned_cols=82 Identities=18% Similarity=0.199 Sum_probs=54.7
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCC-cCCCCCcccceeecccCcccCccCCccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIP-LEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP-~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
.+|.+|+.+.|..| ++--=...|.+|++|+.+.|.. +++ .|+ ..|.++++|+.+++.+|.... ..+.....|+
T Consensus 308 ~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~-sv~-~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~ 381 (394)
T 4gt6_A 308 AGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPS-SVT-KIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQ 381 (394)
T ss_dssp TTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECT-TCC-BCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC-
T ss_pred cCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECc-ccC-EEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCC
Confidence 67899999999865 5532244789999999999965 466 776 458899999999999886542 3455667788
Q ss_pred eeeeecccc
Q 038351 128 HLFLGYNRL 136 (348)
Q Consensus 128 ~L~ls~N~l 136 (348)
.+.+..|.+
T Consensus 382 ~i~i~~~~~ 390 (394)
T 4gt6_A 382 NLPVAPGSI 390 (394)
T ss_dssp ---------
T ss_pred EEEeCCCCE
Confidence 777765544
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=84.71 E-value=1.6 Score=40.05 Aligned_cols=81 Identities=7% Similarity=0.012 Sum_probs=59.4
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCC-cCCCCCcccceeecccCcccCccC-Ccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIP-LEIENLKVLVKIYFSMNNFAGVIP-NAIGCLNIL 126 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP-~~~~~l~~L~~l~ls~N~l~G~iP-~~l~~l~~L 126 (348)
..+..|+.+.+..+ +.-.-...|.+|++|+.+++..|.++ .|+ ..|.++.+|+.+.+..+ ++ .|+ .++.++.+|
T Consensus 260 ~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~-~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L 335 (379)
T 4h09_A 260 QNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIE-TLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKAL 335 (379)
T ss_dssp TTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTC
T ss_pred ceeehhcccccccc-ceeccccccccccccccccccccccc-eehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCC
Confidence 56788999988654 44322347888999999999988888 565 56889999999999754 43 343 467777888
Q ss_pred ceeeeec
Q 038351 127 QHLFLGY 133 (348)
Q Consensus 127 ~~L~ls~ 133 (348)
+.+.+..
T Consensus 336 ~~i~ip~ 342 (379)
T 4h09_A 336 STISYPK 342 (379)
T ss_dssp CCCCCCT
T ss_pred CEEEECC
Confidence 8777643
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=83.95 E-value=1.4 Score=40.79 Aligned_cols=74 Identities=12% Similarity=0.037 Sum_probs=55.0
Q ss_pred CCCCCccEEEcccCcccccCc-ccccCCccCcceecccccccCCCC-cCCCCCcccceeecccCcccCccCCcccccccc
Q 038351 49 LRPPQQENLSLASNELISVIP-STFWNLKDILYLNLSLNSLTGPIP-LEIENLKVLVKIYFSMNNFAGVIPNAIGCLNIL 126 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip-~~~~~l~~L~~l~l~~N~l~G~iP-~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L 126 (348)
.+|++|+.++|.++ ++- |+ ..|.+|++|+.++|..| ++ .|+ ..|.++++|+.+++..|-- .+...+.++++|
T Consensus 317 ~~c~~L~~i~lp~~-v~~-I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~lp~~~~--~~~~~F~~c~~L 390 (394)
T 4fs7_A 317 ESCTSLVSIDLPYL-VEE-IGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLKKVELPKRLE--QYRYDFEDTTKF 390 (394)
T ss_dssp TTCTTCCEECCCTT-CCE-ECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCCEEEEEGGGG--GGGGGBCTTCEE
T ss_pred cCCCCCCEEEeCCc-ccE-EhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCCEEEECCCCE--EhhheecCCCCC
Confidence 67899999999754 553 54 57899999999999876 66 665 5688999999999976522 234456666666
Q ss_pred ce
Q 038351 127 QH 128 (348)
Q Consensus 127 ~~ 128 (348)
+.
T Consensus 391 ~~ 392 (394)
T 4fs7_A 391 KW 392 (394)
T ss_dssp EE
T ss_pred cE
Confidence 54
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.27 E-value=0.12 Score=49.77 Aligned_cols=59 Identities=7% Similarity=0.032 Sum_probs=16.2
Q ss_pred ccccccCCcceEEEeEecC-CceEEE------Eeeeecc--CccchhhHHHhhhcccccccceeeEEEEEe
Q 038351 161 DNLISRGGFGSIHKARIQD-RMEFSV------KGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRS 222 (348)
Q Consensus 161 ~~~lG~G~fg~Vy~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 222 (348)
.+.+| ||.||++.+.. ..+||| |..+... ......+.+|..+++..+|||+++.+++..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 34555 99999999864 367888 6554321 223356888999999999999999877653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 348 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-30 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-28 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-26 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-26 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-26 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-25 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-25 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-25 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-25 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-24 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-24 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-24 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-23 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-23 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-23 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-23 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-23 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-23 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-22 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-22 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-22 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-21 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-21 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-21 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-21 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-21 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-20 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-20 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-20 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-20 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-19 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-19 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-19 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-19 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-19 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-18 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-18 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-18 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-18 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-17 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-17 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-17 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-17 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-17 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-16 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-16 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-16 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-16 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-15 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-15 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-15 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-15 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-15 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-15 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-12 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-12 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-11 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-11 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-10 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-09 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-09 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-09 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.001 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.002 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.004 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 2e-30
Identities = 46/205 (22%), Positives = 83/205 (40%), Gaps = 36/205 (17%)
Query: 158 FSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGA--FKSFDFECDVMKSTCYRNLI 215
+ I G FG+++K + + +VK ++ ++F E V++ T + N++
Sbjct: 10 ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 216 KIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------------VGFALEYLHFDYSV 262
+ S +V ++ SL L+ ++YLH
Sbjct: 68 LFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS-- 124
Query: 263 LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA--------- 313
IIH DLK +N+ +++ + DFG+A + R Q +I +MA
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 314 ------SYVYSFGIMLLEVFTRKKP 332
S VY+FGI+L E+ T + P
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLP 208
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 1e-28
Identities = 43/204 (21%), Positives = 81/204 (39%), Gaps = 32/204 (15%)
Query: 155 TNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKS-FDFECDVMKSTCYR 212
+ F + + + G G + K + + K HL+ A ++ E V+
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 213 NLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY------------VGFALEYLHFDY 260
++ + ++ + +E+M GSL++ L + V L YL +
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 261 SVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------- 313
I+H D+KPSN+L + L DFG++ LI + + T YM+
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGT 178
Query: 314 -----SYVYSFGIMLLEVFTRKKP 332
S ++S G+ L+E+ + P
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYP 202
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 1e-26
Identities = 48/222 (21%), Positives = 89/222 (40%), Gaps = 38/222 (17%)
Query: 137 QGSISYSKWFSCLELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAF 196
++ W E+ R + + +G FG + ++K
Sbjct: 4 TQGLAKDAW----EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP- 56
Query: 197 KSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------- 248
++F E VMK + L+++ + S E +V EYM +GSL L
Sbjct: 57 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQL 115
Query: 249 ------VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302
+ + Y+ +H DL+ +N+L +N+V ++DFG+A+ LI ++ + +
Sbjct: 116 VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTAR 171
Query: 303 TQTLATIGYMA------------SYVYSFGIMLLEVFTRKKP 332
I + A S V+SFGI+L E+ T+ +
Sbjct: 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 213
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (259), Expect = 2e-26
Identities = 44/201 (21%), Positives = 84/201 (41%), Gaps = 32/201 (15%)
Query: 158 FSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKI 217
+ G FG + + +VK Q S + +F E ++MK ++ L+++
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 218 ISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHFDYSVL 263
+ + E ++ EYM GSL L + + + + ++
Sbjct: 74 YAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 129
Query: 264 IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA---------- 313
IH DL+ +N+L D + ++DFG+A+ LI ++ + + I + A
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 314 --SYVYSFGIMLLEVFTRKKP 332
S V+SFGI+L E+ T +
Sbjct: 189 IKSDVWSFGILLTEIVTHGRI 209
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 103 bits (257), Expect = 6e-26
Identities = 41/226 (18%), Positives = 86/226 (38%), Gaps = 39/226 (17%)
Query: 146 FSCLELCRVTNGFSE---------DNLISRGGFGSIHKARI----QDRMEFSVKGFHLQC 192
F+ + F++ + +I G FG + + + + ++K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 193 S-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSS----- 246
+ + F E +M + N+I + + +++ E+M GSL+ L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 247 -----NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301
+ + + + +H DL N+L + N+V +SDFG+++ L +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 186
Query: 302 QTQTL---ATIGYMA------------SYVYSFGIMLLEVFTRKKP 332
T L I + A S V+S+GI++ EV + +
Sbjct: 187 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 1e-25
Identities = 43/197 (21%), Positives = 77/197 (39%), Gaps = 24/197 (12%)
Query: 158 FSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKI 217
+ I G FG +H ++ + ++K + F E +VM + L+++
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQL 65
Query: 218 ISSRSNEDFKVLVLEYMPRGSLEKCLYSS----------NYVGFALEYLHFDYSVLIIHY 267
+ LV E+M G L L + E + + +IH
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 125
Query: 268 DLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SY 315
DL N L +N V +SDFG+ + + +D + T T + + + S
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 316 VYSFGIMLLEVFTRKKP 332
V+SFG+++ EVF+ K
Sbjct: 185 VWSFGVLMWEVFSEGKI 201
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 101 bits (252), Expect = 3e-25
Identities = 46/206 (22%), Positives = 79/206 (38%), Gaps = 40/206 (19%)
Query: 158 FSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHL---QCSGAFKSFDFECDVMKSTCYRN 213
FS+ I G FG+++ AR +++ ++K Q + ++ E ++ + N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 214 LIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF------------ALEYLHFDYS 261
I+ E LV+EY + + + L YLH S
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---S 133
Query: 262 VLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA-------- 313
+IH D+K N+L + + L DFG A ++ + F+ T +MA
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMD 187
Query: 314 -------SYVYSFGIMLLEVFTRKKP 332
V+S GI +E+ RK P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPP 213
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 4e-25
Identities = 44/215 (20%), Positives = 86/215 (40%), Gaps = 37/215 (17%)
Query: 162 NLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISS 220
+ G FG ++KA+ + + + K + + + E D++ S + N++K++ +
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 221 RSNEDFKVLVLEYMPRGSLEKCLYSSNY-------------VGFALEYLHFDYSVLIIHY 267
E+ +++E+ G+++ + AL YLH IIH
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134
Query: 268 DLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM--------------IQTQTLATIGY-M 312
DLK N+LF + L+DFG++ R + +T Y
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 194
Query: 313 ASYVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
+ V+S GI L+E+ + P + N ++ L
Sbjct: 195 KADVWSLGITLIEMAEIEPP-----HHELNPMRVL 224
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 5e-25
Identities = 41/200 (20%), Positives = 79/200 (39%), Gaps = 25/200 (12%)
Query: 158 FSEDNLISRGGFGSIHKAR-IQDRMEFSVKGF---HLQCSGAFKSFDFECDVMKSTCYRN 213
F ++ G F ++ AR + E+++K H+ E DVM +
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 214 LIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN---------YVGFALEYLHFDYSVLI 264
+K+ + +++ L Y G L K + Y + L + + I
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 265 IHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA----------- 313
IH DLKP N+L ++++ ++DFG AK+L E + T Y++
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 189
Query: 314 -SYVYSFGIMLLEVFTRKKP 332
S +++ G ++ ++ P
Sbjct: 190 SSDLWALGCIIYQLVAGLPP 209
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 4e-24
Identities = 38/200 (19%), Positives = 81/200 (40%), Gaps = 30/200 (15%)
Query: 158 FSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKI 217
+ + G FG + + + + + ++K + S + F E VM + + L+++
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 218 ISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------------VGFALEYLHFDYSVLI 264
+ + ++ EYM G L L + V A+EYL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---F 121
Query: 265 IHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA----------- 313
+H DL N L +D V +SDFG+++ + +D + + + +
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 314 -SYVYSFGIMLLEVFTRKKP 332
S +++FG+++ E+++ K
Sbjct: 181 KSDIWAFGVLMWEIYSLGKM 200
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.0 bits (241), Expect = 6e-24
Identities = 46/203 (22%), Positives = 79/203 (38%), Gaps = 36/203 (17%)
Query: 161 DNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQ--CSGAFKSFDFECDVMKSTCYRNLIKI 217
D I RG F +++K + +E + + + F E +++K + N+++
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 218 I----SSRSNEDFKVLVLEYMPRGSLEKCLYSSNY------------VGFALEYLHFDYS 261
S+ + VLV E M G+L+ L + L++LH +
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TRT 132
Query: 262 VLIIHYDLKPSNVLFDD-NIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------- 313
IIH DLK N+ + D G+A L F + T +MA
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFA--KAVIGTPEFMAPEMYEEK 188
Query: 314 ----SYVYSFGIMLLEVFTRKKP 332
VY+FG+ +LE+ T + P
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYP 211
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.4 bits (242), Expect = 6e-24
Identities = 48/210 (22%), Positives = 85/210 (40%), Gaps = 34/210 (16%)
Query: 162 NLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISS 220
I +G G+++ A + E +++ +LQ + E VM+ N++ + S
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 221 RSNEDFKVLVLEYMPRGSLEKCLYSSNY-----------VGFALEYLHFDYSVLIIHYDL 269
D +V+EY+ GSL + + ALE+LH S +IH D+
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 270 KPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVY 317
K N+L + L+DFG + E + + T +MA ++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 318 SFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
S GIM +E+ + P + N ++AL
Sbjct: 201 SLGIMAIEMIEGEPP-----YLNENPLRAL 225
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.3 bits (239), Expect = 1e-23
Identities = 46/203 (22%), Positives = 82/203 (40%), Gaps = 34/203 (16%)
Query: 160 EDNLISRGGFGSIHKARIQDR---MEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNL 214
ED + G FG++ K Q + +VK + + E +VM+ +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 215 IKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY------------VGFALEYLHFDYSV 262
+++I E + +LV+E G L K L + + V ++YL
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN-- 127
Query: 263 LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE-DHFMIQTQTLATIGYMA-------- 313
+H DL NVL +SDFG++K L + +++ QT + + A
Sbjct: 128 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 314 ----SYVYSFGIMLLEVFTRKKP 332
S V+SFG+++ E F+ +
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQK 209
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (238), Expect = 2e-23
Identities = 43/204 (21%), Positives = 76/204 (37%), Gaps = 34/204 (16%)
Query: 158 FSED----NLISRGGFGSIHKAR-IQDRMEFSVKGFHL-QCSGAFKSFDFECDVMKSTCY 211
F ED + G +G + A +VK + + ++ E + K +
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62
Query: 212 RNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY------------VGFALEYLHFD 259
N++K R + + L LEY G L + + + YLH
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 260 YSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------ 313
+ I H D+KP N+L D+ +SDFG+A + + + + T+ Y+A
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 314 -------SYVYSFGIMLLEVFTRK 330
V+S GI+L + +
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGE 203
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (238), Expect = 2e-23
Identities = 43/210 (20%), Positives = 72/210 (34%), Gaps = 37/210 (17%)
Query: 158 FSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNL 214
+ I G +G K R D K + E ++++ + N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 215 IKIISSRSNEDFKVL--VLEYMPRGSLEKCLYSSNY----------------VGFALEYL 256
++ + L V+EY G L + + AL+
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 257 H--FDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA- 313
H D ++H DLKP+NV D L DFG+A++L + F + T YM+
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTPYYMSP 183
Query: 314 -----------SYVYSFGIMLLEVFTRKKP 332
S ++S G +L E+ P
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPP 213
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.9 bits (238), Expect = 2e-23
Identities = 40/203 (19%), Positives = 73/203 (35%), Gaps = 34/203 (16%)
Query: 160 EDNLISRGGFGSIHKARIQDR---MEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLI 215
D + G FGS+ + + R ++ ++K + E +M ++
Sbjct: 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72
Query: 216 KIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSV 262
++I E +LV+E G L K L V ++YL
Sbjct: 73 RLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--- 128
Query: 263 LIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMA-------- 313
+H DL NVL + +SDFG++K L +D + + + A
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 314 ----SYVYSFGIMLLEVFTRKKP 332
S V+S+G+ + E + +
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQK 211
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.3 bits (234), Expect = 5e-23
Identities = 41/203 (20%), Positives = 78/203 (38%), Gaps = 35/203 (17%)
Query: 158 FSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFH---LQCSGAFKSFDFECDVMKSTCYRN 213
F + +G FG+++ AR Q + ++K L+ +G E ++ + N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 214 LIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY------------VGFALEYLHFDYS 261
++++ + L+LEY P G++ + L + + AL Y H S
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---S 124
Query: 262 VLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA-------- 313
+IH D+KP N+L ++DFG + + T+ Y+
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG----TLDYLPPEMIEGRM 180
Query: 314 ----SYVYSFGIMLLEVFTRKKP 332
++S G++ E K P
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPP 203
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.4 bits (234), Expect = 7e-23
Identities = 49/221 (22%), Positives = 89/221 (40%), Gaps = 38/221 (17%)
Query: 139 SISYSKWFSCLELCRVTNGFSEDNLISRGGFGSIHKARIQD-RMEFSVKGFHLQCSGAFK 197
S +Y KW E+ R + + + G +G +++ + + +VK + +
Sbjct: 6 SPNYDKW----EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVE 58
Query: 198 SFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF------ 251
F E VMK + NL++++ + E ++ E+M G+L L N
Sbjct: 59 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 118
Query: 252 --------ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303
A+EYL IH DL N L +N + ++DFG+++L+ D +
Sbjct: 119 YMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHA 174
Query: 304 QTLATIGYMA------------SYVYSFGIMLLEVFTRKKP 332
I + A S V++FG++L E+ T
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 215
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (232), Expect = 1e-22
Identities = 42/204 (20%), Positives = 85/204 (41%), Gaps = 29/204 (14%)
Query: 158 FSEDNLISRGGFGSIHKARIQD-----RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCY 211
+ +I G FG ++K ++ + ++K + F E +M +
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 212 RNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN----------YVGFALEYLHFDYS 261
N+I++ S +++ EYM G+L+K L + + + + +
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 262 VLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE-DHFMIQTQTLATIGYMA------- 313
+ +H DL N+L + N+V +SDFG++++L + + + I + A
Sbjct: 129 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 188
Query: 314 -----SYVYSFGIMLLEVFTRKKP 332
S V+SFGI++ EV T +
Sbjct: 189 KFTSASDVWSFGIVMWEVMTYGER 212
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.5 bits (229), Expect = 5e-22
Identities = 41/225 (18%), Positives = 81/225 (36%), Gaps = 58/225 (25%)
Query: 163 LISRGGFGSIHKA------RIQDRMEFSVKGFHLQC-SGAFKSFDFECDVMKS-TCYRNL 214
++ G FG + A + ++ +VK + S ++ E +M + N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 215 IKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY-------------------------- 248
+ ++ + + L+ EY G L L S
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 249 ---------VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299
V +E+L +H DL NVL V + DFG+A+ ++ + ++
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKP 332
+++ + +MA S V+S+GI+L E+F+
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.1 bits (228), Expect = 8e-22
Identities = 45/202 (22%), Positives = 85/202 (42%), Gaps = 30/202 (14%)
Query: 161 DNLISRGGFGSIHKARIQD----RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLI 215
+ +I RG FG ++ + D ++ +VK + G F E +MK + N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 216 KII-SSRSNEDFKVLVLEYMPRGSLEKCLYSSN----------YVGFALEYLHFDYSVLI 264
++ +E ++VL YM G L + + + + + F S
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 265 IHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ--TQTLATIGYMA--------- 313
+H DL N + D+ ++DFG+A+ + ++ + T + +MA
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 211
Query: 314 ---SYVYSFGIMLLEVFTRKKP 332
S V+SFG++L E+ TR P
Sbjct: 212 TTKSDVWSFGVLLWELMTRGAP 233
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 91.4 bits (226), Expect = 1e-21
Identities = 42/229 (18%), Positives = 77/229 (33%), Gaps = 52/229 (22%)
Query: 156 NGFSEDNLISRGGFGSIHKAR------IQDRMEFSVKGFHLQCSGAF-KSFDFECDVMKS 208
N I G FG + +AR + +VK + S F E +M
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 209 TCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN--------------------- 247
N++K++ + L+ EYM G L + L S +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 248 ------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295
+ + +H DL N L +N+V ++DFG+++ +
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192
Query: 296 EDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKP 332
D++ I +M S V+++G++L E+F+
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.0 bits (225), Expect = 2e-21
Identities = 42/203 (20%), Positives = 78/203 (38%), Gaps = 29/203 (14%)
Query: 158 FSEDNLISRGGFGSIHKARIQD-----RMEFSVKGFHLQCSG-AFKSFDFECDVMKSTCY 211
F + ++ G FG+++K ++ ++K S A K E VM S
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 212 RNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSS----------NYVGFALEYLHFDYS 261
++ +++ + L+ + MP G L + N+ + +++
Sbjct: 71 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 262 VLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA-------- 313
++H DL NVL ++DFG+AKLL E+ I +MA
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 314 ----SYVYSFGIMLLEVFTRKKP 332
S V+S+G+ + E+ T
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSK 212
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.7 bits (222), Expect = 2e-21
Identities = 48/198 (24%), Positives = 79/198 (39%), Gaps = 38/198 (19%)
Query: 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSR 221
I +G FG + + + +VK ++ ++F E VM + NL++++
Sbjct: 13 QTIGKGEFGDVMLGDYRGN-KVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 222 SNEDFKV-LVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHFDYSVLIIH 266
E + +V EYM +GSL L S A+EYL +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126
Query: 267 YDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------S 314
DL NVL ++ V +SDFG+ K Q + + A S
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREKKFSTKS 181
Query: 315 YVYSFGIMLLEVFTRKKP 332
V+SFGI+L E+++ +
Sbjct: 182 DVWSFGILLWEIYSFGRV 199
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.2 bits (223), Expect = 4e-21
Identities = 46/219 (21%), Positives = 89/219 (40%), Gaps = 45/219 (20%)
Query: 156 NGFSEDNLISRGGFGSIHKARIQD---RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTC- 210
N ++I G FG + KARI+ RM+ ++K S + F E +V+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 211 YRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSS------------------------ 246
+ N+I ++ + + + L +EY P G+L L S
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 247 -NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQT 305
++ + + IH DL N+L +N V ++DFG+++ ++ ++ +T
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMG 186
Query: 306 LATIGYMA------------SYVYSFGIMLLEVFTRKKP 332
+ +MA S V+S+G++L E+ +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.9 bits (222), Expect = 4e-21
Identities = 43/219 (19%), Positives = 78/219 (35%), Gaps = 46/219 (21%)
Query: 164 ISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYR--NLIKIISSR 221
I +G FG + + + + E +VK F + +S+ E ++ ++ R N++ I++
Sbjct: 11 IGKGRFGEVWRGKWRGE-EVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 222 SNEDFKV----LVLEYMPRGSLEKCLYSSNY-----------VGFALEYLHFDYSVL--- 263
+ ++ LV +Y GSL L L +LH +
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 264 --IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM--IQTQTLATIGYMA------ 313
I H DLK N+L N ++D G+A + + T YMA
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 314 ------------SYVYSFGIMLLEVFTRKKPTNKIFFSQ 340
+ +Y+ G++ E+ R Q
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (218), Expect = 1e-20
Identities = 39/225 (17%), Positives = 76/225 (33%), Gaps = 53/225 (23%)
Query: 158 FSEDNLISRGGFGSIHKARI------QDRMEFSVKGFHLQCS-GAFKSFDFECDVMKS-T 209
S + G FG + +A M +VK ++ E V+
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 210 CYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF------------------ 251
+ N++ ++ + + +++ EY G L L
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 252 ------------ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299
+ +L S IH DL N+L +T + DFG+A+ + + ++
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKP 332
+++ + +MA S V+S+GI L E+F+
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 87.8 bits (217), Expect = 4e-20
Identities = 39/219 (17%), Positives = 79/219 (36%), Gaps = 33/219 (15%)
Query: 154 VTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYR 212
V + + + G FG +H+ F+ K ++ E M +
Sbjct: 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 83
Query: 213 NLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN----------YVGFALEYLHFDYSV 262
L+ + + +++ V++ E+M G L + + + Y+ + L +
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 263 LIIHYDLKPSNVLF--DDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------- 313
+H DLKP N++F + L DFG+ L + + T T + A
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAEGK 200
Query: 314 -----SYVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
+ ++S G++ + + P F ND + L
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSP-----FGGENDDETL 234
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 86.3 bits (213), Expect = 5e-20
Identities = 43/210 (20%), Positives = 87/210 (41%), Gaps = 30/210 (14%)
Query: 153 RVTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCS---GAFKSFDFECDVMKS 208
+++ + ++ GG +H AR ++ + +VK + + F E +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 209 TCYRNLIKIISSRSNED----FKVLVLEYMPRGSLEKCLYSSN---------YVGFALEY 255
+ ++ + + E +V+EY+ +L +++ + A +
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 256 LHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLA-TIGYMA- 313
L+F + IIH D+KP+N++ + DFGIA+ + + + QT + T Y++
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 314 -----------SYVYSFGIMLLEVFTRKKP 332
S VYS G +L EV T + P
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPP 213
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.5 bits (213), Expect = 8e-20
Identities = 37/213 (17%), Positives = 82/213 (38%), Gaps = 38/213 (17%)
Query: 158 FSEDNLISRGGFGSIHKA------RIQDRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTC 210
+ + +G FG +++ + + ++K + S F E VMK
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 211 YRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN-------------------YVGF 251
++++++ S ++++E M RG L+ L S G
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 252 ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGY 311
+ + + + +H DL N + ++ + DFG+ + + D++ + L + +
Sbjct: 142 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 201
Query: 312 MA------------SYVYSFGIMLLEVFTRKKP 332
M+ S V+SFG++L E+ T +
Sbjct: 202 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.3 bits (213), Expect = 1e-19
Identities = 42/206 (20%), Positives = 77/206 (37%), Gaps = 33/206 (16%)
Query: 156 NGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHL------QCSGAFKSFDFECDVMKS 208
N FS +I RGGFG ++ R +++K Q + ++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 209 TCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN---------YVGFALEYLHFD 259
++ + + D +L+ M G L L Y + L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 260 YSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMASYV--- 316
++ +++ DLKP+N+L D++ +SD G+A ++ ++ T GYMA V
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQK 179
Query: 317 ----------YSFGIMLLEVFTRKKP 332
+S G ML ++ P
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSP 205
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.9 bits (212), Expect = 1e-19
Identities = 34/195 (17%), Positives = 79/195 (40%), Gaps = 29/195 (14%)
Query: 163 LISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSR 221
+ RG FG +H+ + + K ++ + E ++ +RN++ + S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESF 70
Query: 222 SNEDFKVLVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYD 268
+ + V++ E++ + + + +S V AL++LH S I H+D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127
Query: 269 LKPSNVLFD--DNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM---------ASYVY 317
++P N+++ + + +FG A+ L D+F + A+ ++
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMW 187
Query: 318 SFGIMLLEVFTRKKP 332
S G ++ + + P
Sbjct: 188 SLGTLVYVLLSGINP 202
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 85.9 bits (212), Expect = 2e-19
Identities = 39/213 (18%), Positives = 83/213 (38%), Gaps = 39/213 (18%)
Query: 163 LISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSR 221
+ G FG +H+ F K + + E +M + LI + +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 222 SNEDFKVLVLEYMPRGSLEKCLYSSNY-------------VGFALEYLHFDYSVLIIHYD 268
++ VL+LE++ G L + + +Y L+++H I+H D
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152
Query: 269 LKPSNVLFDDNIVTH--LSDFGIAKLLIREDHFMIQTQTLATIGYMA------------S 314
+KP N++ + + + DFG+A L ++ + T AT + A +
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFYT 209
Query: 315 YVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
+++ G++ + + P F+ +D++ L
Sbjct: 210 DMWAIGVLGYVLLSGLSP-----FAGEDDLETL 237
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.0 bits (207), Expect = 3e-19
Identities = 48/202 (23%), Positives = 74/202 (36%), Gaps = 37/202 (18%)
Query: 164 ISRGGFGSIHKARI----QDRMEFSVKGFH---LQCSGAFKSFDFECDVMKSTCYRNLIK 216
+ G FG + + + +VK L A F E + M S +RNLI+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 217 IISSRSNEDFKVLVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVL 263
+ K +V E P GSL L V + YL S
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 264 IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR-EDHFMIQTQTLATIGYMA--------- 313
IH DL N+L + + DFG+ + L + +DH+++Q + A
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 314 ---SYVYSFGIMLLEVFTRKKP 332
S + FG+ L E+FT +
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQE 213
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 6e-19
Identities = 45/214 (21%), Positives = 85/214 (39%), Gaps = 35/214 (16%)
Query: 162 NLISRGGFGSIHKAR-IQDRMEFSVKGFHLQC-----SGAFKSFDFECDVMKSTCYRNLI 215
+ + G F +++KAR ++K L G ++ E +++ + N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 216 KIISSRSNEDFKVLVLEYMPRGSLEKCLYSS---------NYVGFALEYLHFDYSVLIIH 266
++ + ++ LV ++M +S Y+ L+ L + + I+H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 267 YDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------- 313
DLKP+N+L D+N V L+DFG+AK T + T Y A
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181
Query: 314 SYVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
+++ G +L E+ R +D+ L
Sbjct: 182 VDMWAVGCILAELLLRVPF-----LPGDSDLDQL 210
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.5 bits (203), Expect = 2e-18
Identities = 41/201 (20%), Positives = 76/201 (37%), Gaps = 28/201 (13%)
Query: 158 FSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFH---LQCSGAFKSFDFECDVMKSTC-YR 212
F ++ +G FG + A + F++K + + E V+ +
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 213 NLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN---------YVGFALEYLHFDYSVL 263
L + + ++ V+EY+ G L + S + Y + L F +S
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 264 IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA---------- 313
I++ DLK N+L D + ++DFG+ K + D T Y+A
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLGQKYN 181
Query: 314 --SYVYSFGIMLLEVFTRKKP 332
+SFG++L E+ + P
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSP 202
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (202), Expect = 2e-18
Identities = 38/232 (16%), Positives = 81/232 (34%), Gaps = 40/232 (17%)
Query: 151 LCRVTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCS--GAFKSFDFECDVMK 207
C + + + I +G FG + KAR + + ++K ++ G + E +++
Sbjct: 5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64
Query: 208 STCYRNLIKIISSRSNEDFKV--------LVLEYMPRGSLEKCLYSSN---------YVG 250
+ N++ +I + LV ++ +
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 124
Query: 251 FALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL--IREDHFMIQTQTLAT 308
L L++ + I+H D+K +NVL + V L+DFG+A+ + T + T
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 309 IGYM-------------ASYVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
+ Y ++ G ++ E++TR + L
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI-----MQGNTEQHQL 231
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (199), Expect = 4e-18
Identities = 38/197 (19%), Positives = 71/197 (36%), Gaps = 29/197 (14%)
Query: 163 LISRGGFGSIHKARI----QDRMEFSVKGFHLQCSGAFKS-FDFECDVMKSTCYRNLIKI 217
I G FG +H+ + ++K S + + F E M+ + +++K+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 218 ISSRSNEDFKVLVLEYMPRGSLEKCLYSSN----------YVGFALEYLHFDYSVLIIHY 267
I E+ +++E G L L Y L + S +H
Sbjct: 74 IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 132
Query: 268 DLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SY 315
D+ NVL N L DFG+++ + + + ++ I +MA S
Sbjct: 133 DIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASD 191
Query: 316 VYSFGIMLLEVFTRKKP 332
V+ FG+ + E+
Sbjct: 192 VWMFGVCMWEILMHGVK 208
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 80.5 bits (198), Expect = 7e-18
Identities = 33/205 (16%), Positives = 73/205 (35%), Gaps = 29/205 (14%)
Query: 154 VTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQ-CSGAFKSFDFECDVMKSTCY 211
+ + + +++ G F + A + + ++K + G S + E V+ +
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKH 66
Query: 212 RNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY------------VGFALEYLHFD 259
N++ + + L+++ + G L + + V A++YLH
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 260 YSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------ 313
V D++ +SDFG++K+ ED + + T GY+A
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQ 183
Query: 314 ------SYVYSFGIMLLEVFTRKKP 332
+S G++ + P
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 1e-17
Identities = 48/216 (22%), Positives = 87/216 (40%), Gaps = 33/216 (15%)
Query: 158 FSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNL 214
F + I G +G ++KAR ++K L G + E ++K + N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 215 IKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN----------YVGFALEYLHFDYSVLI 264
+K++ E+ LV E++ + + S+ Y+ L+ L F +S +
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 265 IHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA----------- 313
+H DLKP N+L + L+DFG+A+ T + T+ Y A
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGCKYYS 181
Query: 314 --SYVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
++S G + E+ TR+ F ++I L
Sbjct: 182 TAVDIWSLGCIFAEMVTRRAL-----FPGDSEIDQL 212
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.1 bits (194), Expect = 2e-17
Identities = 43/222 (19%), Positives = 82/222 (36%), Gaps = 47/222 (21%)
Query: 158 FSEDNLISRGGFGSIHKAR--------IQDRMEFSVKGFHLQCS-GAFKSFDFECDVMKS 208
+ G FG + A + +VK + E ++MK
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 209 -TCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGFALEY------------ 255
++N+I ++ + + + +++EY +G+L + L + G Y
Sbjct: 75 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134
Query: 256 -------------LHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302
+ + S IH DL NVL ++ V ++DFG+A+ + D++
Sbjct: 135 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 303 TQTLATIGYMASY------------VYSFGIMLLEVFTRKKP 332
T + +MA V+SFG++L E+FT
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.1 bits (194), Expect = 4e-17
Identities = 46/223 (20%), Positives = 85/223 (38%), Gaps = 45/223 (20%)
Query: 158 FSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIK 216
+++ +I G FG +++A+ ++K + + E +M+ + N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 217 II------SSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF---------------ALEY 255
+ + +E + LVL+Y+P + S +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 256 LHFDYSVLIIHYDLKPSNVLFD-DNIVTHLSDFGIAKLLIREDH---------FMIQTQT 305
+H S I H D+KP N+L D D V L DFG AK L+R + +
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 194
Query: 306 LATIGY-MASYVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
Y + V+S G +L E+ + F + + L
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPI-----FPGDSGVDQL 232
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 77.8 bits (191), Expect = 5e-17
Identities = 39/213 (18%), Positives = 78/213 (36%), Gaps = 41/213 (19%)
Query: 158 FSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDF---------ECDVMK 207
+ ++ RG + + E++VK + G+F + + E D+++
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 208 ST-CYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSNY------------VGFALE 254
+ N+I++ + F LV + M +G L L + +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124
Query: 255 YLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM-- 312
LH + I+H DLKP N+L DD++ L+DFG + L + T + +
Sbjct: 125 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181
Query: 313 -------------ASYVYSFGIMLLEVFTRKKP 332
++S G+++ + P
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 78.2 bits (192), Expect = 6e-17
Identities = 40/191 (20%), Positives = 79/191 (41%), Gaps = 20/191 (10%)
Query: 162 NLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKI 217
+ G FG +H R + +++K + + + E ++ + +I++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 218 ISSRSNEDFKVLVLEYMPRGSLEKCLYSSN---------YVGFALEYLHFDYSVLIIHYD 268
+ + ++++Y+ G L L S Y L + +S II+ D
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRD 129
Query: 269 LKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT------QTLATIGY-MASYVYSFGI 321
LKP N+L D N ++DFG AK + + + T + ++T Y + +SFGI
Sbjct: 130 LKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGI 189
Query: 322 MLLEVFTRKKP 332
++ E+ P
Sbjct: 190 LIYEMLAGYTP 200
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.5 bits (190), Expect = 1e-16
Identities = 41/206 (19%), Positives = 77/206 (37%), Gaps = 28/206 (13%)
Query: 153 RVT-NGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGA---FKSFDFECDVMK 207
+VT N F L+ +G FG + R +++K + A E V++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 208 STCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN---------YVGFALEYLHF 258
+T + L + + D V+EY G L L Y + L +
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 259 DYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA----- 313
+S +++ D+K N++ D + ++DFG+ K I + M T Y+A
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLE 178
Query: 314 -------SYVYSFGIMLLEVFTRKKP 332
+ G+++ E+ + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 76.8 bits (188), Expect = 1e-16
Identities = 34/195 (17%), Positives = 71/195 (36%), Gaps = 26/195 (13%)
Query: 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIIS 219
I G +G ++KA+ F++K L+ G + E ++K + N++K+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 220 SRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF---------ALEYLHFDYSVLIIHYDLK 270
+ VLV E++ + + + L + + + ++H DLK
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 271 PSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM-------------ASYVY 317
P N+L + ++DFG+A+ + T+ Y ++
Sbjct: 128 PQNLLINREGELKIADFGLARAFGIPVRKYT--HEIVTLWYRAPDVLMGSKKYSTTIDIW 185
Query: 318 SFGIMLLEVFTRKKP 332
S G + E+
Sbjct: 186 SVGCIFAEMVNGTPL 200
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.7 bits (188), Expect = 1e-16
Identities = 38/211 (18%), Positives = 83/211 (39%), Gaps = 35/211 (16%)
Query: 154 VTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSG------AFKSFDFECDVM 206
V + + + G F + K R ++++ K + + + + + E ++
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 207 KSTCYRNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN---------YVGFALEYLH 257
K + N+I + N+ +L+LE + G L L ++ L ++
Sbjct: 68 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 258 FDYSVLIIHYDLKPSNVLFDDNIVT----HLSDFGIAKLLIREDHFMIQTQTLATIGYMA 313
+ +S+ I H+DLKP N++ D V + DFG+A + + F T ++A
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVA 184
Query: 314 ------------SYVYSFGIMLLEVFTRKKP 332
+ ++S G++ + + P
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.2 bits (189), Expect = 2e-16
Identities = 39/207 (18%), Positives = 79/207 (38%), Gaps = 28/207 (13%)
Query: 154 VTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFH-LQCSGAFKSFDFECDVMKSTCY 211
V ++ + I G +G + A +++ ++K + + E ++ +
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 212 RNLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYS------------SNYVGFALEYLHFD 259
N+I I + + Y+ + LY ++ L L +
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 260 YSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI-REDHFMIQTQTLATIGYMA----- 313
+S ++H DLKPSN+L + + DFG+A++ DH T+ +AT Y A
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 314 --------SYVYSFGIMLLEVFTRKKP 332
++S G +L E+ + +
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.4 bits (182), Expect = 1e-15
Identities = 36/205 (17%), Positives = 75/205 (36%), Gaps = 46/205 (22%)
Query: 163 LISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-YRNLIKII-- 218
++ G G + + + + +F++K E ++ ++++I+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 73
Query: 219 --SSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF--------------ALEYLHFDYSV 262
+ + ++V+E + G L + F A++YLH S+
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130
Query: 263 LIIHYDLKPSNVLFD---DNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------ 313
I H D+KP N+L+ N + L+DFG AK + T Y+A
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187
Query: 314 ------SYVYSFGIMLLEVFTRKKP 332
++S G+++ + P
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPP 212
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.8 bits (180), Expect = 1e-15
Identities = 39/211 (18%), Positives = 82/211 (38%), Gaps = 31/211 (14%)
Query: 162 NLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKII 218
I G +G++ KA+ + ++K L G S E ++K ++N++++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 219 SSRSNEDFKVLVLEYMPRGSLEKCLYSSN---------YVGFALEYLHFDYSVLIIHYDL 269
++ LV E+ + + + ++ L+ L F +S ++H DL
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 270 KPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM-------------ASYV 316
KP N+L + N L++FG+A+ + + T+ Y + +
Sbjct: 128 KPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 317 YSFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
+S G + E+ +P F + L
Sbjct: 186 WSAGCIFAELANAGRP----LFPGNDVDDQL 212
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.8 bits (178), Expect = 3e-15
Identities = 40/203 (19%), Positives = 73/203 (35%), Gaps = 37/203 (18%)
Query: 163 LISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAF------KSFDFECDVMK--STCYRN 213
L+ GGFGS++ + D + ++K + E ++K S+ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 214 LIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN----------YVGFALEYLHFDYSVL 263
+I+++ D VL+LE + + LE + ++
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 264 IIHYDLKPSNVLFD-DNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA--------- 313
++H D+K N+L D + L DFG LL + T T Y
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRY 186
Query: 314 ----SYVYSFGIMLLEVFTRKKP 332
+ V+S GI+L ++ P
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIP 209
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.6 bits (177), Expect = 4e-15
Identities = 52/232 (22%), Positives = 87/232 (37%), Gaps = 42/232 (18%)
Query: 151 LCRVTNGFSEDNLISRGGFGSIHKAR--IQDRMEFSVKGFHLQCS--GAFKSFDFECDVM 206
LCR + I G +G + KAR ++K +Q G S E V+
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 207 K---STCYRNLIKII-----SSRSNEDFKVLVLEYMPRGSLEKCLYSSN----------Y 248
+ + + N++++ S E LV E++ +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 249 VGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLAT 308
+ L L F +S ++H DLKP N+L + L+DFG+A++ M T + T
Sbjct: 122 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 309 IGYMA------------SYVYSFGIMLLEVFTRKKPTNKIFFSQRNDIKALG 348
+ Y A ++S G + E+F RK F +D+ LG
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL-----FRGSSDVDQLG 225
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.2 bits (176), Expect = 5e-15
Identities = 37/224 (16%), Positives = 76/224 (33%), Gaps = 52/224 (23%)
Query: 158 FSEDNLISRGGFGSIHKAR------IQDRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTC 210
+ RG FG + +A +VK + ++ E ++
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 211 YRNLIKII--SSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF----------------- 251
+ + + + ++++E+ G+L L S
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 252 -----------ALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300
+E+L S IH DL N+L + V + DFG+A+ + ++ ++
Sbjct: 135 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 301 IQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKP 332
+ + +MA S V+SFG++L E+F+
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 71.8 bits (175), Expect = 9e-15
Identities = 40/212 (18%), Positives = 67/212 (31%), Gaps = 39/212 (18%)
Query: 153 RVTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCY 211
RV N + I G FG I+ I E ++K ++ E + K
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQG 61
Query: 212 RNLIKII-SSRSNEDFKVLVLEYMPRGSLEKCLYSSNY------------VGFALEYLHF 258
I I + D+ V+V+E + + + S + +EY+H
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 259 DYSVLIIHYDLKPSNVLF---DDNIVTHLSDFGIAKLLIRED-----HFMIQTQTLATIG 310
IH D+KP N L + ++ DFG+AK + T
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 311 YMA------------SYVYSFGIMLLEVFTRK 330
Y + + S G +L+
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGS 210
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 65.2 bits (158), Expect = 1e-12
Identities = 26/201 (12%), Positives = 54/201 (26%), Gaps = 35/201 (17%)
Query: 163 LISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKII-SS 220
I G FG I + + + + ++K + E K I +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 221 RSNEDFKVLVLEYMPRGSLEKCLYSSN---------YVGFALEYLHFDYSVLIIHYDLKP 271
VLV++ + + L + + +++ D+KP
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKP 129
Query: 272 SNVLFDDNIVTH-----LSDFGIAKLLIRED-----HFMIQTQTLATIGYMA-------- 313
N L + + DFG+ K + + T YM+
Sbjct: 130 DNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE 189
Query: 314 ----SYVYSFGIMLLEVFTRK 330
+ + G + +
Sbjct: 190 QSRRDDLEALGHVFMYFLRGS 210
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.2 bits (158), Expect = 1e-12
Identities = 38/202 (18%), Positives = 73/202 (36%), Gaps = 31/202 (15%)
Query: 162 NLISRGGFGSIHKAR----IQDRMEFSVKGFH----LQCSGAFKSFDFECDVMKSTCYR- 212
++ G +G + R +++K +Q + + E V++
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 213 NLIKIISSRSNEDFKVLVLEYMPRGSLEKCLYSSN---------YVGFALEYLHFDYSVL 263
L+ + + E L+L+Y+ G L L YVG + L + +
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 149
Query: 264 IIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM----------- 312
II+ D+K N+L D N L+DFG++K + ++
Sbjct: 150 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH 209
Query: 313 --ASYVYSFGIMLLEVFTRKKP 332
A +S G+++ E+ T P
Sbjct: 210 DKAVDWWSLGVLMYELLTGASP 231
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 62.5 bits (151), Expect = 1e-11
Identities = 38/192 (19%), Positives = 77/192 (40%), Gaps = 26/192 (13%)
Query: 164 ISRGGFGSIHKAR-IQDRMEFSVKGFHLQCS---GAFKSFDFECDVMKSTCYRNLIKIIS 219
+ G FG + + + +++K Q + E ++++ + L+K+
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 220 SRSNEDFKVLVLEYMPRGSLEKCLYSSNY------------VGFALEYLHFDYSVLIIHY 267
S + +V+EY+ G + L + EYLH S+ +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165
Query: 268 DLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM------IQTQTLATIGY-MASYVYSFG 320
DLKP N+L D ++DFG AK + + + + + + GY A ++ G
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALG 225
Query: 321 IMLLEVFTRKKP 332
+++ E+ P
Sbjct: 226 VLIYEMAAGYPP 237
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 60.2 bits (145), Expect = 7e-11
Identities = 41/210 (19%), Positives = 82/210 (39%), Gaps = 34/210 (16%)
Query: 162 NLISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCY-RNLIKIIS 219
+ RG + + +A I + + VK K E ++++ N+I +
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLAD 97
Query: 220 SRSNEDFK--VLVLEYMPRGSLEKCLYSSN---------YVGFALEYLHFDYSVLIIHYD 268
+ + LV E++ ++ + + AL+Y H S+ I+H D
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRD 154
Query: 269 LKPSNVLFD-DNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM----------ASYVY 317
+KP NV+ D ++ L D+G+A+ + ++ + G + ++
Sbjct: 155 VKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMW 214
Query: 318 SFGIMLLEVFTRKKPTNKIFFSQRNDIKAL 347
S G ML + RK+P FF ++ L
Sbjct: 215 SLGCMLASMIFRKEP----FFHGHDNYDQL 240
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.3 bits (137), Expect = 8e-10
Identities = 37/204 (18%), Positives = 65/204 (31%), Gaps = 24/204 (11%)
Query: 153 RVTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFH--LQCSGAFKSFDFECDVMKST 209
V + I G G + A ++K Q K E +MK
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 210 CYRNLIKII------SSRSNEDFKVLVLEYMPRGSLEKCLYSSN------YVGFALEYLH 257
++N+I ++ + LV+E M + + + L +
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 133
Query: 258 FDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIG------- 310
+S IIH DLKPSN++ + + DFG+A+ T
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 311 --YMASYVYSFGIMLLEVFTRKKP 332
++S G ++ E+ K
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 54.8 bits (131), Expect = 1e-09
Identities = 23/146 (15%), Positives = 42/146 (28%), Gaps = 17/146 (11%)
Query: 162 NLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFK----------SFDFECDVMKSTCY 211
L+ G ++ + E VK + + K F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 212 RNLIKIISSR------SNEDFKVLVLEYMPRGSLEKCLYSSNYVGFALEYLHFDYSVLII 265
R L K+ + ++ L + + LE + Y I+
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIV 125
Query: 266 HYDLKPSNVLFDDNIVTHLSDFGIAK 291
H DL NVL + + + DF +
Sbjct: 126 HGDLSQYNVLVSEEGI-WIIDFPQSV 150
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.3 bits (132), Expect = 3e-09
Identities = 40/206 (19%), Positives = 79/206 (38%), Gaps = 30/206 (14%)
Query: 154 VTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFH--LQCSGAFKSFDFECDVMKSTC 210
V + + + G +GS+ A + + +VK Q K E ++K
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 211 YRNLIKII-----SSRSNEDFKVLVLEYMPRGSLEKCLYSSNYVGF-----------ALE 254
+ N+I ++ + E V ++ ++ L + L+
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 255 YLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMAS 314
Y+H S IIH DLKPSN+ +++ + DFG+A+ E + T+ M +
Sbjct: 136 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLN 192
Query: 315 Y--------VYSFGIMLLEVFTRKKP 332
+ ++S G ++ E+ T +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.7 bits (128), Expect = 9e-09
Identities = 36/206 (17%), Positives = 79/206 (38%), Gaps = 30/206 (14%)
Query: 154 VTNGFSEDNLISRGGFGSIHKAR-IQDRMEFSVKGFH--LQCSGAFKSFDFECDVMKSTC 210
V + + + G +G++ A + + ++K + Q K E ++K
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 211 YRNLIKIISSRSNEDFK------VLVLEYMPRG----------SLEKCLYSSNYVGFALE 254
+ N+I ++ + ++ LV+ +M ++ + + L
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 255 YLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL-------IREDHFMIQTQTLA 307
Y+H + IIH DLKP N+ +++ + DFG+A+ + + L
Sbjct: 136 YIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILN 192
Query: 308 TIGY-MASYVYSFGIMLLEVFTRKKP 332
+ Y ++S G ++ E+ T K
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 51.2 bits (121), Expect = 7e-08
Identities = 34/212 (16%), Positives = 68/212 (32%), Gaps = 45/212 (21%)
Query: 163 LISRGGFGSIHKAR-IQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSR 221
+ G F ++ A+ + + ++K ++ + E +++ + K S
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 222 SNEDFKVLVLEY----------------------------MPRGSLEKCLYSSNYVGFAL 253
+N K+L L S + L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 254 EYLHFDYSVLIIHYDLKPSNVLFD-DNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYM 312
+Y+H IIH D+KP NVL + + +L IA L + T ++ T Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 313 A------------SYVYSFGIMLLEVFTRKKP 332
+ + ++S ++ E+ T
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 50.5 bits (119), Expect = 1e-07
Identities = 17/72 (23%), Positives = 27/72 (37%), Gaps = 1/72 (1%)
Query: 41 CPRYNYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLK 100
L L +N + +P LK + LN+S N+L G IP + NL+
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQ 291
Query: 101 VLVKIYFSMNNF 112
++ N
Sbjct: 292 RFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 46.3 bits (108), Expect = 3e-06
Identities = 18/65 (27%), Positives = 26/65 (40%), Gaps = 1/65 (1%)
Query: 72 FWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFL 131
K++ L+L N + G +P + LK L + S NN G IP G L
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAY 298
Query: 132 GYNRL 136
N+
Sbjct: 299 ANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.1 bits (92), Expect = 2e-04
Identities = 10/46 (21%), Positives = 16/46 (34%)
Query: 106 YFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLEL 151
N G +P + L L L + +N L G I ++
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDV 295
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.1 bits (113), Expect = 6e-07
Identities = 29/134 (21%), Positives = 49/134 (36%), Gaps = 1/134 (0%)
Query: 47 PPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIY 106
P PP L L +N++ + F NLK++ L L N ++ P L L ++Y
Sbjct: 26 PKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 85
Query: 107 FSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSI-SYSKWFSCLELCRVTNGFSEDNLIS 165
S N + L L+ +++ S+ + +EL S +
Sbjct: 86 LSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGA 145
Query: 166 RGGFGSIHKARIQD 179
G + RI D
Sbjct: 146 FQGMKKLSYIRIAD 159
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 38.1 bits (87), Expect = 0.001
Identities = 20/92 (21%), Positives = 39/92 (42%), Gaps = 1/92 (1%)
Query: 47 PPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIY 106
P PP L L N++ V ++ L ++ L LS NS++ + N L +++
Sbjct: 166 PQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 225
Query: 107 FSMNNFAGVIPNAIGCLNILQHLFLGYNRLQG 138
+ N +P + +Q ++L N +
Sbjct: 226 LNNNKL-VKVPGGLADHKYIQVVYLHNNNISA 256
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 4e-06
Identities = 16/73 (21%), Positives = 36/73 (49%), Gaps = 4/73 (5%)
Query: 72 FWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFL 131
NLK++ YL L N+++ P + +L L +++F+ N + +++ L + L
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 132 GYNRLQGSISYSK 144
G+N++ +
Sbjct: 359 GHNQISDLTPLAN 371
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.002
Identities = 13/59 (22%), Positives = 28/59 (47%), Gaps = 4/59 (6%)
Query: 52 PQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMN 110
+ + L A+N++ S+ NL +I +L+ N ++ PL NL + ++ +
Sbjct: 329 TKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPL--ANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 36.5 bits (83), Expect = 0.004
Identities = 31/180 (17%), Positives = 53/180 (29%), Gaps = 29/180 (16%)
Query: 6 HSVLHGWKINHLVRQKPTHKAVTNITFGLLVFIILCPRYNY-----PPLRPPQQENLSLA 60
L + + ++ L L N P + LSL
Sbjct: 168 LKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLN 227
Query: 61 SNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIP--- 117
N+L T +L ++ L+L+ N ++ PL L L ++ N + + P
Sbjct: 228 GNQLKD--IGTLASLTNLTDLDLANNQISNLAPL--SGLTKLTELKLGANQISNISPLAG 283
Query: 118 -----------------NAIGCLNILQHLFLGYNRLQGSISYSKWFSCLELCRVTNGFSE 160
+ I L L +L L +N + S L N S+
Sbjct: 284 LTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD 343
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 5e-04
Identities = 21/76 (27%), Positives = 33/76 (43%)
Query: 59 LASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPN 118
L N L ++ TF +L ++ +L L N ++ L L ++ N A V P+
Sbjct: 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195
Query: 119 AIGCLNILQHLFLGYN 134
A L L L+L N
Sbjct: 196 AFRDLGRLMTLYLFAN 211
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 6e-04
Identities = 21/88 (23%), Positives = 35/88 (39%), Gaps = 9/88 (10%)
Query: 40 LCPRYNYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENL 99
PP E L++++N+LI +P+ L+ L S N L +P +NL
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLAE-VPELPQNL 326
Query: 100 KVLVKIYFSMNNFAGVIPNAIGCLNILQ 127
K L + N P+ + L+
Sbjct: 327 KQL---HVEYNPLRE-FPDIPESVEDLR 350
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (85), Expect = 0.001
Identities = 16/83 (19%), Positives = 30/83 (36%), Gaps = 2/83 (2%)
Query: 61 SNELISVIPSTFWNLKDILYLNLSLNSLTG--PIPLEIENLKVLVKIYFSMNNFAGVIPN 118
+ + + + N+ ++L LNLS N L + ++ L + S N
Sbjct: 50 RSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSEREL 109
Query: 119 AIGCLNILQHLFLGYNRLQGSIS 141
L+ L+L N L +
Sbjct: 110 DKIKGLKLEELWLDGNSLSDTFR 132
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.9 bits (84), Expect = 0.002
Identities = 20/98 (20%), Positives = 35/98 (35%), Gaps = 9/98 (9%)
Query: 60 ASNELISV---IPSTF--WNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAG 114
+E I+V I F + + NL S+T + L + +I + ++
Sbjct: 3 LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS 60
Query: 115 VIPNAIGCLNILQHLFLGYNRLQGSISYSKWFSCLELC 152
V I L + LFL N+L + + L
Sbjct: 61 VQG--IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLF 96
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 348 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.98 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.75 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.5 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.39 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.35 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.32 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.25 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.19 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.17 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.1 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.1 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.09 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.05 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.03 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.97 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.93 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.92 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.88 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.76 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.74 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.71 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.62 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.61 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.6 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.54 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.53 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.53 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.52 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.37 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.35 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.26 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.17 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.01 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.96 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.94 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.8 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.74 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.73 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.69 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.47 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.3 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.26 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.07 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.68 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.4 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.17 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.81 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.56 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.05 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=320.88 Aligned_cols=180 Identities=23% Similarity=0.340 Sum_probs=155.1
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.++|+..+.||+|+||+||+|+.. +++.||||.+..... ...+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 457889999999999999999975 688999999965432 344678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 233 YMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 233 y~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
||++|+|.+++.... +++.||+||| +.+|+||||||+|||+++++.+||+|||+|+.........
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999999886532 3889999999 7899999999999999999999999999999876544444
Q ss_pred eecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 301 IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 301 ~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
.....+||+.||| +||||+||++|||+||+.||+...
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 4456789999998 899999999999999999997643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-42 Score=316.23 Aligned_cols=176 Identities=26% Similarity=0.339 Sum_probs=155.6
Q ss_pred CCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 156 NGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
.+|+..+.||+|+||+||+|+. .+++.||||.+........+.+.+|++++++++|||||++++++..++..++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999986 478999999998665556677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeeec
Q 038351 235 PRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQT 303 (348)
Q Consensus 235 ~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 303 (348)
++|+|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+..... ...
T Consensus 100 ~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~ 174 (293)
T d1yhwa1 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRS 174 (293)
T ss_dssp TTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBC
T ss_pred CCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--ccc
Confidence 999999887642 24889999999 78999999999999999999999999999998754332 234
Q ss_pred ccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 304 QTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 304 ~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
...||+.|+| +||||+||++|||+||+.||...
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 219 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC
Confidence 5679999998 99999999999999999999653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=314.82 Aligned_cols=175 Identities=26% Similarity=0.420 Sum_probs=143.7
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
++|...+.||+|+||+||+|+.++ .||||.++... ....+.|.+|++++++++|||||++++++.. +..++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 578888999999999999998654 59999986442 3345778999999999999999999998754 568999999
Q ss_pred cCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 234 MPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 234 ~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
|++|+|.++++.. .++++||+||| +.+||||||||+|||++.++.+||+|||+|+.........
T Consensus 85 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 85 CEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp CCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999999998642 23889999999 7899999999999999999999999999998875443333
Q ss_pred eecccccccCccc---------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 301 IQTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......||+.||| +|||||||++|||+||+.||...
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~ 212 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC
Confidence 4456678999987 79999999999999999999764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=315.77 Aligned_cols=178 Identities=25% Similarity=0.365 Sum_probs=151.1
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeec---cCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ---CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||+||+|+.. +++.||||.+... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57899999999999999999975 7889999998643 2334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|||++|+|.+++.... +++.||+||| +.+|+||||||+|||+++++.+||+|||+|+.+......
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 9999999998876532 3788999999 789999999999999999999999999999987644433
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.......||+.|+| +||||+||++|||+||+.||...
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 33456789999998 89999999999999999999753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-42 Score=310.40 Aligned_cols=174 Identities=23% Similarity=0.368 Sum_probs=152.5
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeec---cCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ---CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||+||+|+.+ +++.||+|.+... .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888899999999999999975 6889999998643 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|||++|+|.+++.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+|+......
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-- 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 160 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCc--
Confidence 9999999999886532 4889999999 7899999999999999999999999999998765332
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....||+.||| +|||||||++|||+||+.||+..
T Consensus 161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 207 (263)
T d2j4za1 161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 207 (263)
T ss_dssp --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence 235679999998 89999999999999999999754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=320.52 Aligned_cols=177 Identities=24% Similarity=0.316 Sum_probs=152.2
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
..++|+..+.||+|+||+||+|+.. +++.||+|.++.... ...+.+.+|+++|++++|||||+++++|.+++..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3568999999999999999999975 688999999975433 33467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|||++|+|.+++.... +++.||+|||+. .+|+||||||+|||+++++.+||+|||+|+......
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 159 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 159 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--
Confidence 9999999999986532 388899999941 379999999999999999999999999999765322
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....+||+.|+| +||||+||++|||+||+.||...
T Consensus 160 --~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 160 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp --C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred --cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 245689999998 89999999999999999999653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-42 Score=313.96 Aligned_cols=176 Identities=24% Similarity=0.356 Sum_probs=153.3
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
+.|+..+.||+|+||+||+|+.. ++..||||.+........+.+.+|++++++++|||||++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 45788899999999999999975 68899999998766666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 235 PRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 235 ~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
++|+|.+++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 166 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--cc
Confidence 999999887542 13888999999 7899999999999999999999999999998754321 12
Q ss_pred ecccccccCccc-----------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 302 QTQTLATIGYMA-----------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~a-----------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....||+.|+| +|||||||++|||+||+.||...
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~ 218 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence 235678888887 79999999999999999999764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-41 Score=305.68 Aligned_cols=173 Identities=23% Similarity=0.401 Sum_probs=147.9
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
++|+..+.||+|+||.||+|+++++..||||+++... ...+.|.+|++++++++|||||++++++.. +..++|||||+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 4677889999999999999999988999999986433 345779999999999999999999998755 56799999999
Q ss_pred CCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 236 RGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 236 ~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+|+|.+++.... ++++||+||| +.+|+||||||+|||+++++.+||+|||+|+.+.... ...
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~ 166 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTA 166 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EEC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc-ccc
Confidence 999998776432 3889999999 7889999999999999999999999999999875432 233
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHcCCCCCc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~ 334 (348)
.....||+.|+| +|||||||++|||+||..|+.
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 445678999998 899999999999999665543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=305.99 Aligned_cols=175 Identities=26% Similarity=0.401 Sum_probs=140.9
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
++|+..+.||+|+||.||+|++.++..||||++.... ...++|.+|++++++++|||||+++++|..++..++|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4688889999999999999999988899999987533 345779999999999999999999999999999999999999
Q ss_pred CCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeee
Q 038351 236 RGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302 (348)
Q Consensus 236 ~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 302 (348)
+|+|.+++.... +++.||+||| +.+|+||||||+|||+|+++.+||+|||+++....... ...
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS 159 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-eee
Confidence 999999876532 3889999999 78899999999999999999999999999987754332 222
Q ss_pred cccccccCccc------------cccHHHHHHHHHHHcC-CCCCcc
Q 038351 303 TQTLATIGYMA------------SYVYSFGIMLLEVFTR-KKPTNK 335 (348)
Q Consensus 303 ~~~~gt~~y~a------------sDV~S~Gvvl~elltG-~~P~~~ 335 (348)
....||+.|+| +|||||||++|||+|+ ++||..
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~ 205 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC
Confidence 34568889998 8999999999999995 555543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=308.73 Aligned_cols=179 Identities=22% Similarity=0.350 Sum_probs=139.1
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEec--CCeEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSN--EDFKVLV 230 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV 230 (348)
++|+..+.||+|+||+||+|+.. +++.||+|.+..... ...+.+.+|++++++++|||||++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57889999999999999999875 688999999865432 234568899999999999999999999865 4568999
Q ss_pred EeccCCCCHHHHHhch----------------hHHHHHHHHHHhcC--CCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 231 LEYMPRGSLEKCLYSS----------------NYVGFALEYLHFDY--SVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~----------------~~i~~~L~yLH~~~--~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
||||++|+|.+++... .+++.||+|||... ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999987532 13889999999643 24699999999999999999999999999998
Q ss_pred cccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 293 LIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+..... ......||+.||| +|||||||++|||+||+.||...
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~ 217 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 217 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC
Confidence 754322 2345779999998 99999999999999999999764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=299.47 Aligned_cols=177 Identities=21% Similarity=0.379 Sum_probs=155.3
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
++|+..+.||+|+||+||+|+++++..||||.++.... ..++|.+|++++++++||||++++++|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 68899999999999999999999999999999975433 45789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeee
Q 038351 236 RGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302 (348)
Q Consensus 236 ~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 302 (348)
+|+|.+++.... ++++||+||| +.+|+||||||+||++++++.+||+|||+++.+..... ...
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSS 158 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-eee
Confidence 999998865432 4889999999 78999999999999999999999999999987654332 233
Q ss_pred cccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 303 TQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 303 ~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
....||+.|+| +|||||||++|||+| |+.||+...
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~ 206 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC
Confidence 45668888988 999999999999998 899998654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-41 Score=311.29 Aligned_cols=179 Identities=24% Similarity=0.398 Sum_probs=151.4
Q ss_pred CCCccccccccCCcceEEEeEecC------CceEEEEeeeec-cCccchhhHHHhhhcccc-cccceeeEEEEEecCCeE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQD------RMEFSVKGFHLQ-CSGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFK 227 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 227 (348)
++|+..+.||+|+||+||+|+... ...||+|.+... .......+.+|+.++.++ +|||||++++++...+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 467788999999999999998643 236899988543 233456789999999998 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhch-----------------------------------hHHHHHHHHHHhcCCCceEecCCCcC
Q 038351 228 VLVLEYMPRGSLEKCLYSS-----------------------------------NYVGFALEYLHFDYSVLIIHYDLKPS 272 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~-----------------------------------~~i~~~L~yLH~~~~~~iiHrDik~~ 272 (348)
++|||||++|+|.++++.. .+++.||+||| +.+||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence 9999999999999998643 13889999999 789999999999
Q ss_pred ceEEcCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 273 NVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 273 NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
||+++.++.+||+|||+|+...............||+.||| +|||||||++|||+| |+.||....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999998766554444456678999998 899999999999998 899997643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-41 Score=310.05 Aligned_cols=178 Identities=22% Similarity=0.377 Sum_probs=137.3
Q ss_pred CCccccccccCCcceEEEeEecC-C---ceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQD-R---MEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
+|+..++||+|+||+||+|+.+. + ..||||.+..... ...+.|.+|+++|++++|||||+++++|..++..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 45667899999999999999753 2 3588888764322 34467999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 232 EYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
|||++|+|.+++.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 107 Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp ECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 9999999999876532 3889999999 78999999999999999999999999999998754332
Q ss_pred ee---eecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 299 FM---IQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 299 ~~---~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
.. ......||+.||| +|||||||++|||+| |+.||....
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 21 1123456888987 899999999999998 899997643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-40 Score=308.26 Aligned_cols=173 Identities=27% Similarity=0.370 Sum_probs=152.6
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeec---cCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ---CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||+||+|+.+ +++.||||.++.. .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46888999999999999999974 6899999999643 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|||++|++...+... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 999999998887643 24888999999 889999999999999999999999999999886432
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....+||+.||| +||||+||++|||+||+.||...
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 204 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 204 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc
Confidence 235679999998 89999999999999999999753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=302.25 Aligned_cols=171 Identities=26% Similarity=0.348 Sum_probs=144.1
Q ss_pred ccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEec----CCeEEEEE
Q 038351 159 SEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSN----EDFKVLVL 231 (348)
Q Consensus 159 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~ 231 (348)
+..+.||+|+||+||+|+.. ++..||+|.+..... ...+.+.+|++++++++|||||++++++.. +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45668999999999999975 678999999865432 234568999999999999999999999865 35689999
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCc--eEecCCCcCceEEc-CCCcEEEeecCCccccccC
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVL--IIHYDLKPSNVLFD-DNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~--iiHrDik~~NILld-~~~~~kl~DfGla~~~~~~ 296 (348)
|||++|+|.+++... .+++.||+||| +.+ |+||||||+|||++ +++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 999999999988653 24889999999 555 99999999999996 5789999999999875432
Q ss_pred CceeeecccccccCccc-----------cccHHHHHHHHHHHcCCCCCccc
Q 038351 297 DHFMIQTQTLATIGYMA-----------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~a-----------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. .....||+.||| +|||||||++|||+||+.||...
T Consensus 169 ~----~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 169 F----AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp S----BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred c----cCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 2 235679999998 89999999999999999999653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.6e-41 Score=307.07 Aligned_cols=174 Identities=24% Similarity=0.367 Sum_probs=149.9
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
++|+..+.||+|+||+||+|++. +++.||||+++... ...++|.+|++++++++|||||+++++|.+++..++|||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 46777899999999999999976 57889999986443 34577999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch--------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 235 PRGSLEKCLYSS--------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 235 ~~gsL~~~l~~~--------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
++|+|.+++... .+++.||+||| +.+|+||||||+|||+++++.+||+|||+|+....... .
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~-~ 171 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T 171 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-E
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCc-e
Confidence 999999988542 14889999999 77899999999999999999999999999998754332 2
Q ss_pred eecccccccCccc------------cccHHHHHHHHHHHcCCCCCc
Q 038351 301 IQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 301 ~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~ 334 (348)
......||+.|+| +|||||||++|||+||..|+.
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 3345567888887 999999999999999777754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-41 Score=311.96 Aligned_cols=176 Identities=23% Similarity=0.304 Sum_probs=154.2
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeec---cCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ---CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|+.+|++++||||+++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57889999999999999999974 7899999999643 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|||++|+|.+++.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~- 160 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCCc-
Confidence 9999999999887532 3788999999 88999999999999999999999999999987654322
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....+||+.|+| +||||+||++|||+||++||...
T Consensus 161 -~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~ 208 (337)
T d1o6la_ 161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc
Confidence 2345789999998 99999999999999999999764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-40 Score=307.75 Aligned_cols=177 Identities=21% Similarity=0.320 Sum_probs=137.4
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
..+.|+..+.||+|+||+||+|+.. +++.||||.+..... ...+.+.+|++++++++|||||++++++.+++..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4567999999999999999999975 688999999965432 33456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEc---CCCcEEEeecCCccccccC
Q 038351 232 EYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFD---DNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld---~~~~~kl~DfGla~~~~~~ 296 (348)
|||++|+|.+++.... +++.||+||| +.+|+||||||+||++. +++.+||+|||+|+.....
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999999999986532 3888999999 78999999999999994 5789999999999876433
Q ss_pred CceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 297 DHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
. ......||+.||| +||||+||++|||+||+.||...
T Consensus 164 ~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 212 (307)
T d1a06a_ 164 S---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred C---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence 2 2245679999998 99999999999999999999754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-40 Score=311.62 Aligned_cols=176 Identities=20% Similarity=0.297 Sum_probs=153.9
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
.++|+..+.||+|+||.||+|+.. +++.||||.+........+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 458999999999999999999975 7889999999765444557789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEc--CCCcEEEeecCCccccccCCc
Q 038351 234 MPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFD--DNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 234 ~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld--~~~~~kl~DfGla~~~~~~~~ 298 (348)
|++|+|.+++.... +++.||+||| +.+||||||||+|||++ .++.+||+|||+|+.+.....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 99999999885431 4889999999 78999999999999995 468899999999998754332
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....||+.||| +||||+||++|||+||+.||...
T Consensus 182 ---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 228 (350)
T d1koaa2 182 ---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 228 (350)
T ss_dssp ---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence 245678999998 99999999999999999999653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.8e-40 Score=310.65 Aligned_cols=176 Identities=20% Similarity=0.288 Sum_probs=153.1
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
.++|+..+.||+|+||.||+|+.. +++.||||.+........+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457899999999999999999974 7899999998765444456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEc--CCCcEEEeecCCccccccCCc
Q 038351 234 MPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFD--DNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 234 ~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld--~~~~~kl~DfGla~~~~~~~~ 298 (348)
|++|+|.+.+.... +++.||+||| +.+|+||||||+|||++ .++.+||+|||+|+.+.....
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 99999988775432 3888999999 78999999999999998 578999999999998765432
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....||+.|+| +||||+||++|||+||+.||...
T Consensus 185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 231 (352)
T d1koba_ 185 ---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 231 (352)
T ss_dssp ---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 245678889987 89999999999999999999653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-40 Score=305.96 Aligned_cols=171 Identities=26% Similarity=0.309 Sum_probs=148.0
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc---cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG---AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
.|+..+.||+|+||+||+|+.. +++.||||.+...... ..+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888899999999999999864 7888999998754332 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 233 YMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 233 y~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
||++|++..++... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence 99999987665432 24889999999 789999999999999999999999999999875432
Q ss_pred eecccccccCccc---------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 301 IQTQTLATIGYMA---------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 301 ~~~~~~gt~~y~a---------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....||+.||| +|||||||++|||+||+.||...
T Consensus 169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~ 217 (309)
T d1u5ra_ 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (309)
T ss_dssp --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred --CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC
Confidence 34568888887 89999999999999999999653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-40 Score=301.07 Aligned_cols=178 Identities=22% Similarity=0.405 Sum_probs=147.4
Q ss_pred CCCccccc-cccCCcceEEEeEec---CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 156 NGFSEDNL-ISRGGFGSIHKARIQ---DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 156 ~~f~~~~~-lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
++|...+. ||+|+||+||+|.++ ++..||||.++.... ...+.|.+|+++|++++|||||++++++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34555564 999999999999764 455799999865432 345679999999999999999999999875 457999
Q ss_pred EeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 231 LEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
||||++|+|.+++.... +++.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 99999999999875432 3889999999 7899999999999999999999999999999876543
Q ss_pred ce-eeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 298 HF-MIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 298 ~~-~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
.. .......||+.|+| +|||||||++|||+| |+.||....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence 32 22334568889998 899999999999998 999997653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-40 Score=299.85 Aligned_cols=177 Identities=21% Similarity=0.344 Sum_probs=152.2
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc------cchhhHHHhhhcccccccceeeEEEEEecCCe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG------AFKSFDFECDVMKSTCYRNLIKIISSRSNEDF 226 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 226 (348)
..+.|+..+.||+|+||+||+|+.+ +++.||||.+...... ..+.+.+|+++|++++|||||++++++.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4567999999999999999999975 7889999998644221 23568999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCC----cEEEeecCCc
Q 038351 227 KVLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI----VTHLSDFGIA 290 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~----~~kl~DfGla 290 (348)
.++|||||++|+|.+++.... +++.||+||| +.+|+||||||+||+++.++ .+|++|||+|
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999999999886532 3788999999 78999999999999998776 4999999999
Q ss_pred cccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 291 KLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 291 ~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
+....... .....||+.|+| +|||||||++|||+||+.||...
T Consensus 165 ~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 219 (293)
T d1jksa_ 165 HKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 219 (293)
T ss_dssp EECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC
Confidence 88754322 245578888987 99999999999999999999754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.1e-40 Score=308.84 Aligned_cols=176 Identities=23% Similarity=0.343 Sum_probs=149.3
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHH---HhhhcccccccceeeEEEEEecCCeEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDF---ECDVMKSTCYRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~ 228 (348)
++|+..+.||+|+||.||+|+.. +++.||||.+.... ......+.+ |+++++.++|||||++++++..++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57899999999999999999975 68999999986432 122233334 467788889999999999999999999
Q ss_pred EEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 229 LVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
+|||||++|+|.+++.... +++.||+||| +.+||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999999999886532 3888999999 889999999999999999999999999999876543
Q ss_pred CceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccccc
Q 038351 297 DHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKIFF 338 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~~~ 338 (348)
. .....||+.|+| +|||||||++|||+||+.||.....
T Consensus 161 ~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 161 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp C----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred c----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 2 245679999988 8999999999999999999976543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-40 Score=298.46 Aligned_cols=171 Identities=27% Similarity=0.416 Sum_probs=140.8
Q ss_pred cccccCCcceEEEeEecC---CceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccCC
Q 038351 162 NLISRGGFGSIHKARIQD---RMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMPR 236 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 236 (348)
+.||+|+||+||+|.+++ ++.||||.++.... ...+.|.+|++++++++|||||+++++|..+ ..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 579999999999998653 46799999864322 2346799999999999999999999998754 56899999999
Q ss_pred CCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce-eeec
Q 038351 237 GSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF-MIQT 303 (348)
Q Consensus 237 gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~-~~~~ 303 (348)
|+|.++++... +++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+...... ....
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 99999887532 3899999999 788999999999999999999999999999987544332 2234
Q ss_pred ccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 304 QTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 304 ~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
...||+.|+| +|||||||++|||+| |+.||...
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~ 214 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC
Confidence 4568999998 999999999999998 89999764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-39 Score=304.19 Aligned_cols=173 Identities=22% Similarity=0.301 Sum_probs=152.2
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeec---cCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQ---CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 231 (348)
++|+..+.||+|+||.||+|+.+ +++.||||.+... .....+.+.+|+++|++++|||||++++++...+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57899999999999999999975 7899999998643 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 232 EYMPRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
||+.+|+|.+.+... .+++.||.||| +.+||||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 999999999888653 23888999999 789999999999999999999999999999987532
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....||+.||| +|||||||++|||+||+.||...
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence 235679999998 89999999999999999999653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=297.40 Aligned_cols=177 Identities=25% Similarity=0.400 Sum_probs=139.4
Q ss_pred CCCccccccccCCcceEEEeEecCC-----ceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDR-----MEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
+.|+..++||+|+||.||+|+++.. ..||||++..... .....|.+|++++++++|||||++++++...+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577889999999999999987642 4699999864432 234568999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 230 VLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
|||||.+|++.+.+... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999998876543 23889999999 789999999999999999999999999999987543
Q ss_pred Cce-eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 297 DHF-MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 297 ~~~-~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
... .......||+.|+| +|||||||++|||+||..|+..
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence 221 22234567889998 9999999999999997666543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.2e-39 Score=292.97 Aligned_cols=176 Identities=23% Similarity=0.363 Sum_probs=151.7
Q ss_pred CCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCcc---------chhhHHHhhhccccc-ccceeeEEEEEecC
Q 038351 156 NGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGA---------FKSFDFECDVMKSTC-YRNLIKIISSRSNE 224 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 224 (348)
++|+..+.||+|+||+||+|+. .+++.||||.+....... .+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788999999999999999996 478899999997543221 235788999999997 99999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 225 DFKVLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 225 ~~~~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
+..|+|||||++|+|.++++... ++++||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 99999999999999999986532 3889999999 78899999999999999999999999999988
Q ss_pred cccCCceeeecccccccCccc------------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 293 LIREDHFMIQTQTLATIGYMA------------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~a------------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
...... .....||+.|+| +||||+||++|||+||+.||....
T Consensus 160 ~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 160 LDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 754322 244567888876 799999999999999999997653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-39 Score=295.66 Aligned_cols=174 Identities=25% Similarity=0.403 Sum_probs=141.6
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEeccC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYMP 235 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 235 (348)
++|+..+.||+|+||+||+|+.+++..||||.++... ...+.|.+|++++++++|||||+++++|.. +..++|||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 4678889999999999999999988899999986443 345789999999999999999999999854 56799999999
Q ss_pred CCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 236 RGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 236 ~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+|+|..++.... +++.||+||| +.+|+||||||+|||+|+++.+||+|||+|+....... ..
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA 170 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCc-ee
Confidence 999988876432 3889999999 77899999999999999999999999999987654322 22
Q ss_pred ecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 302 QTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 302 ~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.....||+.|+| +|||||||++|||+||..|+..
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence 344568899997 9999999999999997666543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-39 Score=299.15 Aligned_cols=175 Identities=19% Similarity=0.320 Sum_probs=150.7
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
.++|...+.||+|+||+||+|+.. +++.||||.++... .....+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467899999999999999999975 68899999996543 2235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcC--CCcEEEeecCCccccccCCc
Q 038351 234 MPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDD--NIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 234 ~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~--~~~~kl~DfGla~~~~~~~~ 298 (348)
|++|+|.+++.... +++.||+||| +.+|+||||||+|||++. ...+||+|||+++.......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 99999999986532 3889999999 789999999999999985 45899999999988754332
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....+|+.|+| +||||+||++|||+||+.||...
T Consensus 160 ---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~ 206 (321)
T d1tkia_ 160 ---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp ---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC
Confidence 234568888887 89999999999999999999764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-39 Score=298.32 Aligned_cols=176 Identities=23% Similarity=0.362 Sum_probs=150.9
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeecc---CccchhhHHHhhhcc-cccccceeeEEEEEecCCeEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC---SGAFKSFDFECDVMK-STCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lV 230 (348)
++|...+.||+|+||+||+|+.. +++.||||.++... ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888999999999999999975 78899999996432 334456777777765 68999999999999999999999
Q ss_pred EeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCc
Q 038351 231 LEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDH 298 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~ 298 (348)
||||++|+|.++++... +++.||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 99999999999987532 3889999999 78999999999999999999999999999987653322
Q ss_pred eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 299 FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 299 ~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......||+.|+| +||||+||++|||+||+.||...
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~ 206 (320)
T d1xjda_ 159 --KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 206 (320)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC
Confidence 2345679999997 89999999999999999999754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-39 Score=296.92 Aligned_cols=180 Identities=26% Similarity=0.412 Sum_probs=151.3
Q ss_pred hhCCCccccccccCCcceEEEeEec------CCceEEEEeeeeccCc-cchhhHHHhhhcccccccceeeEEEEEecCCe
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQCSG-AFKSFDFECDVMKSTCYRNLIKIISSRSNEDF 226 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 226 (348)
-.++|+..+.||+|+||+||+|+.+ +++.||||+++..... ..+.|.+|++++++++||||++++++|...+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3567899999999999999999864 4578999998654332 34679999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhch------------------------------------hHHHHHHHHHHhcCCCceEecCCC
Q 038351 227 KVLVLEYMPRGSLEKCLYSS------------------------------------NYVGFALEYLHFDYSVLIIHYDLK 270 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~------------------------------------~~i~~~L~yLH~~~~~~iiHrDik 270 (348)
.++||||+++|+|.++++.. .+++.||+||| +.+|||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEc
Confidence 99999999999999988531 13788999999 7899999999
Q ss_pred cCceEEcCCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCC-CCCccc
Q 038351 271 PSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRK-KPTNKI 336 (348)
Q Consensus 271 ~~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~-~P~~~~ 336 (348)
|+|||+|.++.+||+|||+|+.+.........+...||+.|+| +|||||||++|||+||. +||...
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 9999999999999999999987755444444456678889987 89999999999999996 567653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=294.92 Aligned_cols=178 Identities=25% Similarity=0.343 Sum_probs=143.4
Q ss_pred CCCccccccccCCcceEEEeEec-CCc----eEEEEeeeec-cCccchhhHHHhhhcccccccceeeEEEEEecCCeEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRM----EFSVKGFHLQ-CSGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVL 229 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 229 (348)
.+|+..++||+|+||+||+|++. +++ .||+|++... .....+.|.+|++++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46899999999999999999865 333 5888988543 334457899999999999999999999999875 4678
Q ss_pred EEeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 230 VLEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
++||+.+|+|.+.+... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 89999999998876643 24889999999 778999999999999999999999999999987654
Q ss_pred CceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 297 DHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
..........||+.|+| +|||||||++|||+| |++||+...
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence 44433445568999998 999999999999999 899997653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-39 Score=293.68 Aligned_cols=171 Identities=26% Similarity=0.320 Sum_probs=142.5
Q ss_pred ccccccCCcceEEEeEec-CCceEEEEeeeeccCc-----cchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEecc
Q 038351 161 DNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG-----AFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEYM 234 (348)
Q Consensus 161 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 234 (348)
.++||+|+||+||+|+.. +++.||||+++..... ..+.+.+|++++++++|||||++++++..++..++|||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 478999999999999975 6889999998643221 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceeee
Q 038351 235 PRGSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMIQ 302 (348)
Q Consensus 235 ~~gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 302 (348)
+++++....... .+++.||+||| +.+|+||||||+|||++.++.+||+|||+|+....... ..
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~~ 157 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AY 157 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CC
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc--cc
Confidence 988777665432 24888999999 78999999999999999999999999999987654322 22
Q ss_pred cccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 303 TQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 303 ~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
....||+.|+| +|||||||++|||+||++||...
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 34578899987 89999999999999999999653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-38 Score=290.95 Aligned_cols=178 Identities=22% Similarity=0.267 Sum_probs=142.6
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecCC----eEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNED----FKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~ 231 (348)
..|...+.||+|+||.||+|++ +++.||||+++.... .....+.|+..+.+++||||++++++|..++ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4566778999999999999996 577999999864321 1122345666778899999999999998654 689999
Q ss_pred eccCCCCHHHHHhchh-----------HHHHHHHHHHhc-----CCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 232 EYMPRGSLEKCLYSSN-----------YVGFALEYLHFD-----YSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~~-----------~i~~~L~yLH~~-----~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
|||++|+|.++++... +++.||+|+|.. ++++|+||||||+|||+++++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred ecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 9999999999987532 388999999953 357999999999999999999999999999998754
Q ss_pred CCcee--eecccccccCccc------------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 296 EDHFM--IQTQTLATIGYMA------------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 296 ~~~~~--~~~~~~gt~~y~a------------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
..... ......||+.|+| +|||||||++|||+||..||..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 33221 2345678999987 6999999999999999988754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=291.58 Aligned_cols=176 Identities=24% Similarity=0.312 Sum_probs=145.4
Q ss_pred CCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 156 NGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
++|+..+.||+|+||+||+|+. .+++.||||.++.... ...+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999997 4788999999964432 235778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce
Q 038351 233 YMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF 299 (348)
Q Consensus 233 y~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~ 299 (348)
|+.++.+....... .+++.||+||| +.+||||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~- 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence 99765443332221 23889999999 78899999999999999999999999999987653322
Q ss_pred eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
......||+.|+| +||||+||++|||++|+.||+..
T Consensus 158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 2344568888876 99999999999999999999653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-38 Score=288.38 Aligned_cols=180 Identities=23% Similarity=0.375 Sum_probs=144.2
Q ss_pred hhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCc---cchhhHHHhhhcccccccceeeEEEEEecCC----
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSG---AFKSFDFECDVMKSTCYRNLIKIISSRSNED---- 225 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 225 (348)
..++|+..+.||+|+||.||+|+. .+++.||||.++..... ..+.+.+|++++++++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 356799999999999999999996 47889999999754332 2356889999999999999999999987654
Q ss_pred eEEEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
..|+|||||++|+|.+.+.... +++.||+||| +.+|+||||||+|||++.++..+++|||.++..
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence 4799999999999998776432 4888999999 789999999999999999999999999999766
Q ss_pred ccCCc-eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 294 IREDH-FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 294 ~~~~~-~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..... ........||+.|+| +||||+||++|||+||+.||...
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 217 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 217 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc
Confidence 43221 223345679999998 99999999999999999999753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=288.95 Aligned_cols=178 Identities=24% Similarity=0.336 Sum_probs=136.0
Q ss_pred CCCccccccccCCcceEEEeEecC----CceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQD----RMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 230 (348)
++|+..+.||+|+||.||+|+... +..||||.++.... ...+.|.+|++++++++||||+++++++. ++..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 467888999999999999998653 34688888754332 23467899999999999999999999986 4678999
Q ss_pred EeccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCC
Q 038351 231 LEYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRED 297 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~ 297 (348)
||||++|++.+++... .+++.||+||| +.+|+||||||+||+++.++.+||+|||+|+......
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999998876542 23889999999 7899999999999999999999999999998765432
Q ss_pred ceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccccc
Q 038351 298 HFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIFF 338 (348)
Q Consensus 298 ~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~~ 338 (348)
. .......||+.|+| +|||||||++|||+| |++||.....
T Consensus 163 ~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~ 215 (273)
T d1mp8a_ 163 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 215 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred c-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH
Confidence 2 22344567888987 899999999999998 8999976543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-38 Score=285.99 Aligned_cols=174 Identities=24% Similarity=0.285 Sum_probs=147.0
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCc------cchhhHHHhhhccccc--ccceeeEEEEEecCC
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSG------AFKSFDFECDVMKSTC--YRNLIKIISSRSNED 225 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~ 225 (348)
.++|+..+.||+|+||+||+|+.. +++.||||.+...... ....+.+|++++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 467999999999999999999965 7899999998644221 2345788999999987 899999999999999
Q ss_pred eEEEEEeccCC-CCHHHHHhch------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC-CCcEEEeecCCcc
Q 038351 226 FKVLVLEYMPR-GSLEKCLYSS------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD-NIVTHLSDFGIAK 291 (348)
Q Consensus 226 ~~~lV~Ey~~~-gsL~~~l~~~------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DfGla~ 291 (348)
..++||||+.+ +++.+++... .+++.||+||| +.+|+||||||+|||++. ++.+||+|||+|+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccce
Confidence 99999999976 5777776542 24888999999 889999999999999985 5799999999998
Q ss_pred ccccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 292 LLIREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
...... .+...||+.|+| +||||+||++|||+||+.||..
T Consensus 160 ~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 160 LLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp ECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred eccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 764322 245679999987 7999999999999999999965
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-38 Score=293.61 Aligned_cols=172 Identities=22% Similarity=0.360 Sum_probs=144.5
Q ss_pred hhCCCccc-cccccCCcceEEEeEe-cCCceEEEEeeeeccCccchhhHHHhhhcccc-cccceeeEEEEEec----CCe
Q 038351 154 VTNGFSED-NLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKST-CYRNLIKIISSRSN----EDF 226 (348)
Q Consensus 154 ~~~~f~~~-~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~ 226 (348)
..++|... ++||+|+||+||+|+. .+++.||||.++. ...+.+|++++.++ +|||||+++++|.+ +..
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 34678775 4699999999999986 4788999999853 25678899987655 79999999999865 467
Q ss_pred EEEEEeccCCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcC---CCcEEEeecCC
Q 038351 227 KVLVLEYMPRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDD---NIVTHLSDFGI 289 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~DfGl 289 (348)
.|+|||||++|+|.+++.... +++.||+||| +.+|+||||||+|||+++ .+.+||+|||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccce
Confidence 899999999999999986531 3888999999 789999999999999985 56799999999
Q ss_pred ccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 290 AKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 290 a~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
|+....... .....||+.|+| +||||+||++|||+||+.||...
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~ 216 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence 987754332 245679999998 89999999999999999999754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-38 Score=290.78 Aligned_cols=178 Identities=22% Similarity=0.394 Sum_probs=150.6
Q ss_pred CCCccccccccCCcceEEEeEec------CCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCCeEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 228 (348)
++|...+.||+|+||.||+|.+. ++..||||+++.... .....|.+|++++++++||||++++++|..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 56777889999999999999864 357899999864322 23356899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhch----------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEee
Q 038351 229 LVLEYMPRGSLEKCLYSS----------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSD 286 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~----------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~D 286 (348)
+|||||++|+|.+++... .++++||.||| +.+|+||||||+|||+|+++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEee
Confidence 999999999999987642 13888999999 77899999999999999999999999
Q ss_pred cCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCC-CCCccc
Q 038351 287 FGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRK-KPTNKI 336 (348)
Q Consensus 287 fGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~-~P~~~~ 336 (348)
||+|+.+.............||+.|+| +|||||||++|||+||+ +||...
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~ 239 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC
Confidence 999998765544444455568899987 89999999999999985 677543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-38 Score=286.41 Aligned_cols=177 Identities=26% Similarity=0.384 Sum_probs=137.3
Q ss_pred CCCccccccccCCcceEEEeEecC----CceEEEEeeeecc---CccchhhHHHhhhcccccccceeeEEEEEecCCeEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQD----RMEFSVKGFHLQC---SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKV 228 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 228 (348)
++|+..+.||+|+||.||+|+... ...||||.+.... ....+.|.+|++++++++||||++++++|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 468888999999999999998642 2468999986442 2334679999999999999999999999976 4668
Q ss_pred EEEeccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccccc
Q 038351 229 LVLEYMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 229 lV~Ey~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~ 295 (348)
+|||||++|++.+.+.... +++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 9999999999988765432 3889999999 78999999999999999999999999999998755
Q ss_pred CCce-eeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccc
Q 038351 296 EDHF-MIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKI 336 (348)
Q Consensus 296 ~~~~-~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~ 336 (348)
.... .......|+..|+| +|||||||++|||+| |+.||...
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc
Confidence 4332 22234456778887 999999999999998 89999754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-38 Score=282.91 Aligned_cols=172 Identities=28% Similarity=0.409 Sum_probs=137.8
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEec-CCeEEEEEecc
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSN-EDFKVLVLEYM 234 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~Ey~ 234 (348)
++|+..+.||+|+||.||+|+++ +..||||+++.. ...+.|.+|++++++++||||++++++|.. ++..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 35677889999999999999985 668999998643 345779999999999999999999999865 46689999999
Q ss_pred CCCCHHHHHhchh--------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 235 PRGSLEKCLYSSN--------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 235 ~~gsL~~~l~~~~--------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
++|+|.+++.... +++.||.||| +.+|+||||||+||+++.++.+|++|||+++......
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 9999999986532 2889999999 7899999999999999999999999999998764322
Q ss_pred eecccccccCccc------------cccHHHHHHHHHHHc-CCCCCccccc
Q 038351 301 IQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIFF 338 (348)
Q Consensus 301 ~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~~ 338 (348)
....+|+.|+| +|||||||++|||+| |+.||+....
T Consensus 158 --~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~ 206 (262)
T d1byga_ 158 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 206 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred --ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH
Confidence 23456777776 999999999999998 7888876533
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.4e-38 Score=287.30 Aligned_cols=176 Identities=21% Similarity=0.269 Sum_probs=147.0
Q ss_pred CCCccccccccCCcceEEEeEecCCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEec
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLEY 233 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 233 (348)
++|...+.||+|+||+||+|+.++++.||||.+.... ....+.+.+|+.+|++++||||+++++++..++..++|+||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788899999999999999999999999999996543 23357789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCceee
Q 038351 234 MPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 234 ~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~~ 301 (348)
+.++.+..+..... +++.||+||| +.+||||||||+|||++.++.+|++|||.+........ .
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~ 156 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--K 156 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--c
Confidence 98877776655432 4889999999 78899999999999999999999999999987643222 1
Q ss_pred ecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 302 QTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....+++.|+| +||||+||++|||++|+.||+..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 233456666765 89999999999999999999754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-37 Score=287.48 Aligned_cols=175 Identities=27% Similarity=0.448 Sum_probs=142.5
Q ss_pred CCCccccccccCCcceEEEeEecC-Cc--eEEEEeeeec-cCccchhhHHHhhhcccc-cccceeeEEEEEecCCeEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQD-RM--EFSVKGFHLQ-CSGAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 230 (348)
++|+..+.||+|+||.||+|++++ +. .||||++... .....+.|.+|+++++++ +|||||+++++|..++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 577888999999999999998763 33 4778887543 334557799999999998 699999999999999999999
Q ss_pred EeccCCCCHHHHHhch----------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcE
Q 038351 231 LEYMPRGSLEKCLYSS----------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVT 282 (348)
Q Consensus 231 ~Ey~~~gsL~~~l~~~----------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~ 282 (348)
|||+++|+|.++++.. .+++.||.|+| +.+|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 9999999999998643 24889999999 7899999999999999999999
Q ss_pred EEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCC-CCCccc
Q 038351 283 HLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRK-KPTNKI 336 (348)
Q Consensus 283 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~-~P~~~~ 336 (348)
||+|||+|+...... ......||..|+| +|||||||++|||+||. +||...
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~ 230 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 230 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC
Confidence 999999998654322 2234567888887 89999999999999976 567543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-37 Score=287.23 Aligned_cols=173 Identities=27% Similarity=0.443 Sum_probs=142.6
Q ss_pred ccccccCCcceEEEeEecCC----ceEEEEeeeec-cCccchhhHHHhhhcccccccceeeEEEEEec-CCeEEEEEecc
Q 038351 161 DNLISRGGFGSIHKARIQDR----MEFSVKGFHLQ-CSGAFKSFDFECDVMKSTCYRNLIKIISSRSN-EDFKVLVLEYM 234 (348)
Q Consensus 161 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~Ey~ 234 (348)
.++||+|+||+||+|++.+. ..||||+++.. .....++|.+|++++++++||||++++|++.. +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997532 35899998643 33345779999999999999999999999875 56899999999
Q ss_pred CCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCce--
Q 038351 235 PRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHF-- 299 (348)
Q Consensus 235 ~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~-- 299 (348)
++|+|.+++.... +++.||.|+| +.+|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 9999999877432 3888999999 889999999999999999999999999999887543221
Q ss_pred eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 300 MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 300 ~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.......||+.|+| +||||||+++|||+||+.||...
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 12234567888887 89999999999999988887654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-37 Score=287.18 Aligned_cols=177 Identities=24% Similarity=0.382 Sum_probs=151.1
Q ss_pred CCCccccccccCCcceEEEeEe------cCCceEEEEeeeeccC-ccchhhHHHhhhcccc-cccceeeEEEEEecCCeE
Q 038351 156 NGFSEDNLISRGGFGSIHKARI------QDRMEFSVKGFHLQCS-GAFKSFDFECDVMKST-CYRNLIKIISSRSNEDFK 227 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 227 (348)
++|+..+.||+|+||.||+|++ .+++.||||+++.... .....|.+|+.+++++ +|||||+++++|..++..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5677789999999999999985 3567899999975433 2345688999999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHhch------------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEc
Q 038351 228 VLVLEYMPRGSLEKCLYSS------------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFD 277 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~------------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld 277 (348)
++|||||++|+|.++++.. .+++.|++||| +.+|+||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccccc
Confidence 9999999999999988642 23899999999 78899999999999999
Q ss_pred CCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcc
Q 038351 278 DNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNK 335 (348)
Q Consensus 278 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~ 335 (348)
.++.+|++|||+++...............||+.|+| +|||||||++|||+| |++||+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~ 250 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC
Confidence 999999999999998766555555566788999998 899999999999999 5555544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-37 Score=284.75 Aligned_cols=178 Identities=22% Similarity=0.394 Sum_probs=139.5
Q ss_pred CCCccccccccCCcceEEEeEec------CCceEEEEeeeeccC-ccchhhHHHhhhcccc-cccceeeEEEEEecC-Ce
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ------DRMEFSVKGFHLQCS-GAFKSFDFECDVMKST-CYRNLIKIISSRSNE-DF 226 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~ 226 (348)
++|+..+.||+|+||.||+|+.. +++.||||.++.... ...+.+.+|..++.++ +|+||+++++++... +.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 56888899999999999999853 346899999864432 2345678888888777 589999999998764 56
Q ss_pred EEEEEeccCCCCHHHHHhch----------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEcC
Q 038351 227 KVLVLEYMPRGSLEKCLYSS----------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDD 278 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~----------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~ 278 (348)
.++|||||++|+|.++++.. .+++.||+||| +.+|+||||||+|||+++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECC
Confidence 89999999999999998642 13889999999 789999999999999999
Q ss_pred CCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCC-CCCccc
Q 038351 279 NIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRK-KPTNKI 336 (348)
Q Consensus 279 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~-~P~~~~ 336 (348)
++.+||+|||+|+...............||+.|+| +|||||||++|||+||. +||...
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999987765444444456679999998 89999999999999975 577654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-37 Score=284.72 Aligned_cols=179 Identities=26% Similarity=0.413 Sum_probs=146.4
Q ss_pred CCCccccccccCCcceEEEeEecC--------CceEEEEeeeeccC-ccchhhHHHhhhcccc-cccceeeEEEEEecCC
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQD--------RMEFSVKGFHLQCS-GAFKSFDFECDVMKST-CYRNLIKIISSRSNED 225 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 225 (348)
++|...+.||+|+||.||+|+... +..||||+++.... .....+.+|...+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 467778999999999999998532 35799999965433 2346788899999888 7999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhch----------------------------hHHHHHHHHHHhcCCCceEecCCCcCceEEc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS----------------------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFD 277 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~----------------------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld 277 (348)
..++|||||++|+|.++++.. .+++.||+||| +.+||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeec
Confidence 999999999999999998533 13889999999 88999999999999999
Q ss_pred CCCcEEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHc-CCCCCcccc
Q 038351 278 DNIVTHLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFT-RKKPTNKIF 337 (348)
Q Consensus 278 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~ellt-G~~P~~~~~ 337 (348)
.++.+||+|||+++...............+|+.|+| +|||||||++|||+| |++||....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 999999999999998765544444455678889987 899999999999998 688887543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-37 Score=281.71 Aligned_cols=180 Identities=26% Similarity=0.317 Sum_probs=147.1
Q ss_pred HHhhhCCCccccccccCCcceEEEeEec-C-CceEEEEeeeeccC--ccchhhHHHhhhcccc---cccceeeEEEEEec
Q 038351 151 LCRVTNGFSEDNLISRGGFGSIHKARIQ-D-RMEFSVKGFHLQCS--GAFKSFDFECDVMKST---CYRNLIKIISSRSN 223 (348)
Q Consensus 151 ~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~ 223 (348)
+|+..++|+..+.||+|+||+||+|+.. + ++.||||.++.... .....+.+|+++++.+ +||||++++++|..
T Consensus 2 ~c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~ 81 (305)
T d1blxa_ 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 81 (305)
T ss_dssp CCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CCCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence 4667789999999999999999999974 4 56799999965432 2345677888887776 69999999999853
Q ss_pred -----CCeEEEEEeccCCCCHHHHHhc-------------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEe
Q 038351 224 -----EDFKVLVLEYMPRGSLEKCLYS-------------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLS 285 (348)
Q Consensus 224 -----~~~~~lV~Ey~~~gsL~~~l~~-------------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~ 285 (348)
....+++|||++++.+...... ..+++.||+||| +.+|+||||||+|||+++++.+||+
T Consensus 82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 82 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeec
Confidence 3468999999998876544322 124888999999 7889999999999999999999999
Q ss_pred ecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 286 DFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 286 DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
|||+++...... ......||+.|+| +||||+||++|||+||+.||...
T Consensus 159 dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 159 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred chhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 999998764322 2346679999998 99999999999999999999753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-37 Score=283.78 Aligned_cols=178 Identities=24% Similarity=0.312 Sum_probs=149.5
Q ss_pred CCCccccccccCCcceEEEeEec----CCceEEEEeeeecc----CccchhhHHHhhhcccccc-cceeeEEEEEecCCe
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ----DRMEFSVKGFHLQC----SGAFKSFDFECDVMKSTCY-RNLIKIISSRSNEDF 226 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~ 226 (348)
++|+..+.||+|+||+||+|+.. +++.||||.++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56889999999999999999852 57899999985432 2234678899999999987 799999999999999
Q ss_pred EEEEEeccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 227 KVLVLEYMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 227 ~~lV~Ey~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
.++|||||.+|+|.+.+.... +++.||+|+| +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 999999999999998886532 4888999999 7899999999999999999999999999998764
Q ss_pred cCCceeeecccccccCccc--------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 295 REDHFMIQTQTLATIGYMA--------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~a--------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
..... ......|++.|+| +||||+||++|||+||+.||....
T Consensus 181 ~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~ 236 (322)
T d1vzoa_ 181 ADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236 (322)
T ss_dssp GGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred ccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 32221 2234556776665 899999999999999999997654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-36 Score=284.01 Aligned_cols=170 Identities=25% Similarity=0.340 Sum_probs=138.4
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccceeeEEEEEecC------CeEEE
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLIKIISSRSNE------DFKVL 229 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~l 229 (348)
+|+..++||+|+||+||+|+.. +++.||||++.... ..+.+|+++|++++||||++++++|... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5788899999999999999975 68899999986432 3345799999999999999999998543 35789
Q ss_pred EEeccCCCCHHHHHh---c------------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC-cEEEeecCCcccc
Q 038351 230 VLEYMPRGSLEKCLY---S------------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI-VTHLSDFGIAKLL 293 (348)
Q Consensus 230 V~Ey~~~gsL~~~l~---~------------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DfGla~~~ 293 (348)
|||||+++.+..... . ..+++.||+||| +.+|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998764333321 1 124889999999 89999999999999999765 8999999999877
Q ss_pred ccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 294 IREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
..... .....||+.|+| +||||+||++|||++|+.||...
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~ 226 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence 54332 234567777776 89999999999999999999653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-36 Score=276.65 Aligned_cols=179 Identities=21% Similarity=0.268 Sum_probs=143.4
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeecc--CccchhhHHHhhhcccccccceeeEEEEEec-------
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQC--SGAFKSFDFECDVMKSTCYRNLIKIISSRSN------- 223 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------- 223 (348)
..++|+..+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+++|++++||||+++++.+..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 3578999999999999999999974 78999999985442 2345678899999999999999999998865
Q ss_pred -CCeEEEEEeccCCCCHHHHHhc------------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCc
Q 038351 224 -EDFKVLVLEYMPRGSLEKCLYS------------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIA 290 (348)
Q Consensus 224 -~~~~~lV~Ey~~~gsL~~~l~~------------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla 290 (348)
++..++||||++++.+...... ..+++.||+||| +.+|+||||||+|||++.++.+|++|||++
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence 3468999999988766544332 124788999999 889999999999999999999999999999
Q ss_pred cccccCCce--eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 291 KLLIREDHF--MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 291 ~~~~~~~~~--~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
+........ .......||+.|+| +||||+||++|||+||+.||+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 876532211 12234568888887 8999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-35 Score=270.08 Aligned_cols=174 Identities=21% Similarity=0.274 Sum_probs=145.2
Q ss_pred CCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCCeEEEEEe
Q 038351 156 NGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 232 (348)
++|+..+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+.++++++||||+++++++...+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 47889999999999999999974 788899999965432 235678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhchh------------HHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccCCcee
Q 038351 233 YMPRGSLEKCLYSSN------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIREDHFM 300 (348)
Q Consensus 233 y~~~gsL~~~l~~~~------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~~~~~ 300 (348)
++.++++..++.... +++.||+||| +.+|+||||||+|||++.++.+|++|||.|+........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~- 157 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC- 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC-
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCcc-
Confidence 999998887765432 4888999999 789999999999999999999999999999886543221
Q ss_pred eecccccccCccc-------------cccHHHHHHHHHHHcCCCCCc
Q 038351 301 IQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTN 334 (348)
Q Consensus 301 ~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~ 334 (348)
.....++..|+| +||||+||++|||++|+.||.
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred -ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 112223333333 899999999999999999974
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.2e-35 Score=267.93 Aligned_cols=177 Identities=17% Similarity=0.198 Sum_probs=148.1
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccc-cceeeEEEEEecCCeEEEEEe
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCY-RNLIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E 232 (348)
.++|+..+.||+|+||+||+|+.. +++.||||.+.... ..+.+.+|++.++.++| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 367899999999999999999965 68899999875432 34567889999999976 899999999999999999999
Q ss_pred ccCCCCHHHHHhchh-------------HHHHHHHHHHhcCCCceEecCCCcCceEEcC-----CCcEEEeecCCccccc
Q 038351 233 YMPRGSLEKCLYSSN-------------YVGFALEYLHFDYSVLIIHYDLKPSNVLFDD-----NIVTHLSDFGIAKLLI 294 (348)
Q Consensus 233 y~~~gsL~~~l~~~~-------------~i~~~L~yLH~~~~~~iiHrDik~~NILld~-----~~~~kl~DfGla~~~~ 294 (348)
|+ +++|.+++.... +++.||+||| +.+|+||||||+|||++. .+.+||+|||+|+...
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99 689988876432 3778999999 899999999999999974 5789999999999875
Q ss_pred cCCc-----eeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 295 REDH-----FMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 295 ~~~~-----~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
.... ........||+.||| +|||||||++|||+||+.||+...
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence 4321 112345679999998 899999999999999999997543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-36 Score=281.56 Aligned_cols=180 Identities=22% Similarity=0.265 Sum_probs=143.4
Q ss_pred hhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccC-ccchhhHHHhhhcccccccceeeEEEEEecCC----eE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCS-GAFKSFDFECDVMKSTCYRNLIKIISSRSNED----FK 227 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~ 227 (348)
.+.+|+..+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|+++|++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 456799999999999999999986 5889999999964432 23467889999999999999999999987653 23
Q ss_pred EEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 228 VLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
++++||+.+|+|.+++... .+++.||+||| +.+||||||||+|||++.++.+||+|||+|+.....
T Consensus 86 ~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 4455667799999998643 24888999999 789999999999999999999999999999876443
Q ss_pred Cce-eeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 297 DHF-MIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 297 ~~~-~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
... .......||+.|+| +||||+||++|||+||+.||+..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence 221 11234557777876 79999999999999999999754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-35 Score=277.84 Aligned_cols=174 Identities=23% Similarity=0.277 Sum_probs=140.3
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEecCC-----
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSNED----- 225 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 225 (348)
..++|+..+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+++|++++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4578999999999999999999965 688999999964322 23456889999999999999999999998654
Q ss_pred -eEEEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCcccc
Q 038351 226 -FKVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLL 293 (348)
Q Consensus 226 -~~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~ 293 (348)
+.++||||| +.+|....+.. .+++.||+||| +.+|+||||||+|||++.++.+|++|||+|+..
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceecc
Confidence 579999999 55777665432 24889999999 789999999999999999999999999999876
Q ss_pred ccCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 294 IREDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
... .+...||+.|+| +||||+||++|||++|+.||...
T Consensus 172 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 172 DSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp CSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 432 234567788876 99999999999999999999653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.6e-35 Score=270.41 Aligned_cols=172 Identities=22% Similarity=0.284 Sum_probs=143.9
Q ss_pred CCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCccchhhHHHhhhccccc-ccceeeEEEEEec--CCeEEEEE
Q 038351 156 NGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-YRNLIKIISSRSN--EDFKVLVL 231 (348)
Q Consensus 156 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lV~ 231 (348)
++|+..+.||+|+||+||+|+. .+++.||||+++.. ..+.+.+|+++|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5788999999999999999997 47889999998632 3467889999999996 9999999999874 45689999
Q ss_pred eccCCCCHHHHHhc---------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC-cEEEeecCCccccccCCceee
Q 038351 232 EYMPRGSLEKCLYS---------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI-VTHLSDFGIAKLLIREDHFMI 301 (348)
Q Consensus 232 Ey~~~gsL~~~l~~---------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DfGla~~~~~~~~~~~ 301 (348)
|||++++|....+. ..+++.||+||| +.+|+||||||+|||++.++ .+||+|||+|+.......
T Consensus 112 e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~--- 185 (328)
T d3bqca1 112 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--- 185 (328)
T ss_dssp ECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---
T ss_pred eecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCCc---
Confidence 99999998765432 234889999999 88999999999999998654 689999999987654322
Q ss_pred ecccccccCccc-------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 302 QTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 302 ~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
.....+|+.|+| +||||+||+++||++|+.||...
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 244567777776 79999999999999999998653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-34 Score=263.73 Aligned_cols=178 Identities=23% Similarity=0.257 Sum_probs=142.4
Q ss_pred hhCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhcccccccce-eeEEEEEecCCeEEEEE
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNL-IKIISSRSNEDFKVLVL 231 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~ 231 (348)
..++|+..+.||+|+||.||+|+.. +++.||||.+.... ..+.+..|++++++++|+|+ +.+..++...+..++||
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 3467999999999999999999864 68899999876543 34568899999999987765 45556667788999999
Q ss_pred eccCCCCHHHHHhch-------------hHHHHHHHHHHhcCCCceEecCCCcCceEEc---CCCcEEEeecCCcccccc
Q 038351 232 EYMPRGSLEKCLYSS-------------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFD---DNIVTHLSDFGIAKLLIR 295 (348)
Q Consensus 232 Ey~~~gsL~~~l~~~-------------~~i~~~L~yLH~~~~~~iiHrDik~~NILld---~~~~~kl~DfGla~~~~~ 295 (348)
||+ ++++.+.+... .+++.||+||| +.+|+||||||+|||++ .+..+|++|||+|+.+..
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 999 45665554332 24888999999 78999999999999986 356799999999998754
Q ss_pred CCce-----eeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcccc
Q 038351 296 EDHF-----MIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKIF 337 (348)
Q Consensus 296 ~~~~-----~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~~ 337 (348)
.... .......||+.|+| +|||||||++|||+||+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 3321 22345679999998 899999999999999999997643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-34 Score=270.94 Aligned_cols=174 Identities=24% Similarity=0.289 Sum_probs=140.3
Q ss_pred hhCCCccccccccCCcceEEEeEe-cCCceEEEEeeeeccCc--cchhhHHHhhhcccccccceeeEEEEEecC-----C
Q 038351 154 VTNGFSEDNLISRGGFGSIHKARI-QDRMEFSVKGFHLQCSG--AFKSFDFECDVMKSTCYRNLIKIISSRSNE-----D 225 (348)
Q Consensus 154 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~ 225 (348)
..++|+..+.||+|+||+||+|+. .+++.||||++...... ..+.+.+|+++|++++|||+|++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 456899999999999999999996 47999999999754322 345688999999999999999999998643 3
Q ss_pred eEEEEEeccCCCCHHHHHhch-----------hHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 226 FKVLVLEYMPRGSLEKCLYSS-----------NYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~~-----------~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
..++++||+.+|+|.+++... .+++.||+||| +.+|+||||||+|||++.++.+|++|||++....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred ceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcccC
Confidence 346677788899999988643 24888999999 7899999999999999999999999999997654
Q ss_pred cCCceeeecccccccCccc-------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 295 REDHFMIQTQTLATIGYMA-------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~a-------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
.. .....||+.|+| +||||+||++|||++|+.||..
T Consensus 173 ~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~ 221 (348)
T d2gfsa1 173 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221 (348)
T ss_dssp GG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence 32 123445666665 8999999999999999999964
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.6e-33 Score=264.69 Aligned_cols=175 Identities=22% Similarity=0.201 Sum_probs=134.2
Q ss_pred hCCCccccccccCCcceEEEeEec-CCceEEEEeeeeccC--ccchhhHHHhhhcccccccceeeEEEEEec------CC
Q 038351 155 TNGFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCS--GAFKSFDFECDVMKSTCYRNLIKIISSRSN------ED 225 (348)
Q Consensus 155 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~ 225 (348)
.++|+..+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999975 689999999975432 233568899999999999999999999964 36
Q ss_pred eEEEEEeccCCCCHHHHHhc---------hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccccC
Q 038351 226 FKVLVLEYMPRGSLEKCLYS---------SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLIRE 296 (348)
Q Consensus 226 ~~~lV~Ey~~~gsL~~~l~~---------~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~~~ 296 (348)
..|+|||||.++.+...... ..+++.||+||| +.+|+||||||+|||++.++..+++|||+++.....
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhccccc
Confidence 78999999976544433221 234888999999 789999999999999999999999999999876432
Q ss_pred CceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCcc
Q 038351 297 DHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNK 335 (348)
Q Consensus 297 ~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~ 335 (348)
. ..+...+|+.|+| +||||+||+++||++|+.||..
T Consensus 173 ~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~ 220 (355)
T d2b1pa1 173 F---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred c---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence 2 2345567888877 9999999999999999999954
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.95 E-value=1.5e-28 Score=230.46 Aligned_cols=172 Identities=18% Similarity=0.197 Sum_probs=131.4
Q ss_pred CCccccccccCCcceEEEeEec-CCceEEEEeeeeccCccchhhHHHhhhccccc-----------ccceeeEEEEEec-
Q 038351 157 GFSEDNLISRGGFGSIHKARIQ-DRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-----------YRNLIKIISSRSN- 223 (348)
Q Consensus 157 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~- 223 (348)
+|+..+.||+|+||+||+|+.. +++.||||+++... ...+.+.+|++++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 5889999999999999999974 78999999986432 22356788888887775 5789999988764
Q ss_pred -CCeEEEEEeccCCCCHHHHH-h--------------chhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCC------c
Q 038351 224 -EDFKVLVLEYMPRGSLEKCL-Y--------------SSNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNI------V 281 (348)
Q Consensus 224 -~~~~~lV~Ey~~~gsL~~~l-~--------------~~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~------~ 281 (348)
....+++++++..+...... . -..+++.||+|||+ ..+|+||||||+|||++.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 45677777777555432211 1 12248899999994 37899999999999998654 4
Q ss_pred EEEeecCCccccccCCceeeecccccccCccc------------cccHHHHHHHHHHHcCCCCCccc
Q 038351 282 THLSDFGIAKLLIREDHFMIQTQTLATIGYMA------------SYVYSFGIMLLEVFTRKKPTNKI 336 (348)
Q Consensus 282 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a------------sDV~S~Gvvl~elltG~~P~~~~ 336 (348)
++++|||.++..... .....||+.|+| +||||+||+++||++|+.||...
T Consensus 171 ~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred eeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 899999999865432 234568888887 89999999999999999999754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=6.4e-23 Score=175.13 Aligned_cols=128 Identities=16% Similarity=0.114 Sum_probs=99.0
Q ss_pred ccccccccCCcceEEEeEecCCceEEEEeeeeccCc------------------cchhhHHHhhhcccccccceeeEEEE
Q 038351 159 SEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSG------------------AFKSFDFECDVMKSTCYRNLIKIISS 220 (348)
Q Consensus 159 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~H~niv~l~~~ 220 (348)
...+.||+|+||.||+|+..+++.||||.++..... .......|...+.++.|.++++.+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 456899999999999999999999999987532110 01234568888999999999998866
Q ss_pred EecCCeEEEEEeccCCCCHHHHHhc-----hhHHHHHHHHHHhcCCCceEecCCCcCceEEcCCCcEEEeecCCccccc
Q 038351 221 RSNEDFKVLVLEYMPRGSLEKCLYS-----SNYVGFALEYLHFDYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKLLI 294 (348)
Q Consensus 221 ~~~~~~~~lV~Ey~~~gsL~~~l~~-----~~~i~~~L~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~~~ 294 (348)
.. .++||||+++..+.+.-.. ..+++.+++||| +.+|+||||||+|||++++ .++++|||.|+...
T Consensus 83 ~~----~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~ 153 (191)
T d1zara2 83 EG----NAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVG 153 (191)
T ss_dssp ET----TEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCCTTCEETT
T ss_pred cC----CEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEECCCcccCC
Confidence 42 2799999988765432211 235889999999 7899999999999999965 58999999997764
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.75 E-value=5.9e-19 Score=161.19 Aligned_cols=133 Identities=24% Similarity=0.363 Sum_probs=115.5
Q ss_pred CCcccccCcccCCcccCC--CC---------CCcEEEEeccccee---eecCCCCCCCCCCCCCccEEEccc-CcccccC
Q 038351 4 RSHSVLHGWKINHLVRQK--PT---------HKAVTNITFGLLVF---IILCPRYNYPPLRPPQQENLSLAS-NELISVI 68 (348)
Q Consensus 4 ~~~~~~~~w~~~~~~~~~--~~---------~~~v~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~l~L~~-N~l~g~i 68 (348)
|| +++.+|..+. +||. |. ..+||.|+++..+. ..+++.+ ++|++|+.|+|++ |+|+|.|
T Consensus 20 ~~-~~l~sW~~~~-d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l----~~L~~L~~L~Ls~~N~l~g~i 93 (313)
T d1ogqa_ 20 NP-TTLSSWLPTT-DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL----ANLPYLNFLYIGGINNLVGPI 93 (313)
T ss_dssp CC-GGGTTCCTTS-CTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGG----GGCTTCSEEEEEEETTEESCC
T ss_pred CC-CcCCCCCCCC-CCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHH----hcCcccccccccccccccccc
Confidence 55 4799998653 6764 51 22688888865442 2466666 9999999999996 8999999
Q ss_pred cccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceeeeecccccccccc
Q 038351 69 PSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSISY 142 (348)
Q Consensus 69 p~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ls~N~lsG~ip~ 142 (348)
|++|++|++|++|+|++|+++|.+|..+.++..|+.++++.|++.+.+|.++..++.|+.+++++|+++|.+|.
T Consensus 94 P~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~ 167 (313)
T d1ogqa_ 94 PPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167 (313)
T ss_dssp CGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCG
T ss_pred ccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999985
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.50 E-value=5.3e-15 Score=134.50 Aligned_cols=94 Identities=32% Similarity=0.498 Sum_probs=88.6
Q ss_pred CCCCCccEEEcccCcccc--cCcccccCCccCcceeccc-ccccCCCCcCCCCCcccceeecccCcccCccCCccccccc
Q 038351 49 LRPPQQENLSLASNELIS--VIPSTFWNLKDILYLNLSL-NSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNI 125 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g--~ip~~~~~l~~L~~l~l~~-N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~ 125 (348)
+.-.+++.|+|++|+++| +||++|++|++|++|+|++ |+|+|.||.+|++|++|++|+|++|+++|..|..+..+..
T Consensus 47 ~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~ 126 (313)
T d1ogqa_ 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126 (313)
T ss_dssp SSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTT
T ss_pred CCcEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhh
Confidence 334579999999999999 5999999999999999996 9999999999999999999999999999999999999999
Q ss_pred cceeeeecccccccccc
Q 038351 126 LQHLFLGYNRLQGSISY 142 (348)
Q Consensus 126 L~~L~ls~N~lsG~ip~ 142 (348)
|+.+++++|++.+.+|.
T Consensus 127 L~~l~l~~N~~~~~~p~ 143 (313)
T d1ogqa_ 127 LVTLDFSYNALSGTLPP 143 (313)
T ss_dssp CCEEECCSSEEESCCCG
T ss_pred hcccccccccccccCch
Confidence 99999999999999885
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.39 E-value=3e-13 Score=114.20 Aligned_cols=91 Identities=24% Similarity=0.272 Sum_probs=74.9
Q ss_pred CCCccEEEcccCcccccCc-ccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCcccccccccee
Q 038351 51 PPQQENLSLASNELISVIP-STFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHL 129 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~ip-~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L 129 (348)
.++++.|+|++|.|++.++ ..|+++++|+.|+|++|++++.+|..+..+++|+.|+|++|+++...|..+..+++|+.|
T Consensus 28 p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L 107 (192)
T d1w8aa_ 28 PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTL 107 (192)
T ss_dssp CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEE
T ss_pred CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccc
Confidence 4678888888888887664 466888888888888888888888888888888888888888887777788888888888
Q ss_pred eeeccccccccc
Q 038351 130 FLGYNRLQGSIS 141 (348)
Q Consensus 130 ~ls~N~lsG~ip 141 (348)
+|++|++++-.|
T Consensus 108 ~L~~N~l~~i~~ 119 (192)
T d1w8aa_ 108 NLYDNQISCVMP 119 (192)
T ss_dssp ECCSSCCCEECT
T ss_pred ccCCccccccCH
Confidence 888888886433
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.35 E-value=5.5e-13 Score=112.60 Aligned_cols=93 Identities=25% Similarity=0.264 Sum_probs=87.3
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
.++++|+.|+|++|++++.+|..+..+++|++|+|++|++++-.|..|.++++|+.|+|++|+|++..|..+..+++|+.
T Consensus 51 ~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~ 130 (192)
T d1w8aa_ 51 GRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTS 130 (192)
T ss_dssp GGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCE
T ss_pred CCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccc
Confidence 67899999999999999999999999999999999999999777888999999999999999999988899999999999
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
++|++|.+....+
T Consensus 131 l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 131 LNLASNPFNCNCH 143 (192)
T ss_dssp EECTTCCBCCSGG
T ss_pred ccccccccccccc
Confidence 9999999987543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.32 E-value=1.3e-12 Score=102.59 Aligned_cols=88 Identities=22% Similarity=0.178 Sum_probs=76.7
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCcc-CCccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVI-PNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~i-P~~l~~l~~L~ 127 (348)
..+++|+.|+|++|.|+ .||+.++.+++|+.|+|++|+++ .+| .++.+++|+.|++++|+++..- +..+..+++|+
T Consensus 17 ~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~ 93 (124)
T d1dcea3 17 EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLV 93 (124)
T ss_dssp GGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCC
T ss_pred ccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccCCCCCchhhcCCCCCC
Confidence 77899999999999998 48989999999999999999999 566 4899999999999999998532 35788899999
Q ss_pred eeeeeccccccc
Q 038351 128 HLFLGYNRLQGS 139 (348)
Q Consensus 128 ~L~ls~N~lsG~ 139 (348)
.+++++|+++..
T Consensus 94 ~L~l~~N~i~~~ 105 (124)
T d1dcea3 94 LLNLQGNSLCQE 105 (124)
T ss_dssp EEECTTSGGGGS
T ss_pred EEECCCCcCCcC
Confidence 999999998753
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.25 E-value=4e-12 Score=99.67 Aligned_cols=79 Identities=32% Similarity=0.368 Sum_probs=72.4
Q ss_pred cEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceeeeecc
Q 038351 55 ENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLGYN 134 (348)
Q Consensus 55 ~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ls~N 134 (348)
+.|+|++|+++ .+| .+.+++.|++|||++|+++ .||..++.+++|+.|++++|+++. +| .+..+++|+.+++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 57999999999 466 5999999999999999998 799999999999999999999995 55 5899999999999999
Q ss_pred cccc
Q 038351 135 RLQG 138 (348)
Q Consensus 135 ~lsG 138 (348)
+++.
T Consensus 76 ~i~~ 79 (124)
T d1dcea3 76 RLQQ 79 (124)
T ss_dssp CCCS
T ss_pred ccCC
Confidence 9985
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.19 E-value=3.1e-11 Score=98.34 Aligned_cols=88 Identities=17% Similarity=0.112 Sum_probs=76.7
Q ss_pred CCCCCccEEEcccCc-ccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccc
Q 038351 49 LRPPQQENLSLASNE-LISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~-l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
..+++|+.|+|++|+ ++..-+..|.++++|+.|+|++|+++.--|..|..+++|+.|+|++|+|+ .+|..+.....|+
T Consensus 28 ~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~ 106 (156)
T d2ifga3 28 PGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQ 106 (156)
T ss_dssp CSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCC
T ss_pred cCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhcccccc
Confidence 678999999998775 77644567999999999999999999766788999999999999999999 7777666666899
Q ss_pred eeeeeccccc
Q 038351 128 HLFLGYNRLQ 137 (348)
Q Consensus 128 ~L~ls~N~ls 137 (348)
.|+|++|.+.
T Consensus 107 ~L~L~~Np~~ 116 (156)
T d2ifga3 107 ELVLSGNPLH 116 (156)
T ss_dssp EEECCSSCCC
T ss_pred ccccCCCccc
Confidence 9999999886
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.17 E-value=1.6e-11 Score=109.55 Aligned_cols=91 Identities=25% Similarity=0.243 Sum_probs=51.1
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.+++++|+|++..|..|..+++|+.|+|++|++++-.|..+..+++|+.+++++|++++..|..+..+++|+.
T Consensus 126 ~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~ 205 (284)
T d1ozna_ 126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205 (284)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred chhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccc
Confidence 34455555555555555433444555555555555555555544555555555555555555555555555555555555
Q ss_pred eeeeccccccc
Q 038351 129 LFLGYNRLQGS 139 (348)
Q Consensus 129 L~ls~N~lsG~ 139 (348)
|++++|++.+.
T Consensus 206 L~l~~N~i~~~ 216 (284)
T d1ozna_ 206 LYLFANNLSAL 216 (284)
T ss_dssp EECCSSCCSCC
T ss_pred ccccccccccc
Confidence 55555555543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.10 E-value=1.2e-10 Score=102.82 Aligned_cols=86 Identities=23% Similarity=0.213 Sum_probs=41.1
Q ss_pred CCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceee
Q 038351 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLF 130 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ 130 (348)
+++++.|++++|.+++..|..+..+++|+.|++++|++++-.|..+..+++|+.|+|++|+|+ .||..+..+.+|+.|+
T Consensus 123 l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~ 201 (266)
T d1p9ag_ 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201 (266)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEE
T ss_pred ccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEE
Confidence 344444444444444433333444445555555555555444444445555555555555554 4555444455555555
Q ss_pred eeccccc
Q 038351 131 LGYNRLQ 137 (348)
Q Consensus 131 ls~N~ls 137 (348)
|++|.+.
T Consensus 202 L~~Np~~ 208 (266)
T d1p9ag_ 202 LHGNPWL 208 (266)
T ss_dssp CCSCCBC
T ss_pred ecCCCCC
Confidence 5554443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.10 E-value=8.3e-11 Score=104.76 Aligned_cols=93 Identities=24% Similarity=0.253 Sum_probs=70.0
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
.++++|+.|+|++|.+.+..+..+..+++|+.+++++|++++-.|..+..+++|+.|++++|+|++..|..+..+++|+.
T Consensus 102 ~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~ 181 (284)
T d1ozna_ 102 HGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181 (284)
T ss_dssp TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred cccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccch
Confidence 66777788888887777766667777777888888888887555566777777888888888877777777777777888
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
+++++|++++..|
T Consensus 182 l~l~~N~l~~i~~ 194 (284)
T d1ozna_ 182 LLLHQNRVAHVHP 194 (284)
T ss_dssp EECCSSCCCEECT
T ss_pred hhhhhccccccCh
Confidence 8888777776554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.09 E-value=4.6e-11 Score=97.89 Aligned_cols=87 Identities=17% Similarity=0.137 Sum_probs=60.5
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
.++.+++.|+|++|.++. ||..+..++.|++||||+|+++ .|+ .+..+++|+.|++++|+++..-|..+..++.|+.
T Consensus 15 ~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 91 (162)
T ss_dssp ECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred cCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccccc
Confidence 455667777777777764 6666667777777777777777 554 4677777777777777777544444556777777
Q ss_pred eeeecccccc
Q 038351 129 LFLGYNRLQG 138 (348)
Q Consensus 129 L~ls~N~lsG 138 (348)
|++++|+++.
T Consensus 92 L~L~~N~i~~ 101 (162)
T d1a9na_ 92 LILTNNSLVE 101 (162)
T ss_dssp EECCSCCCCC
T ss_pred ceeccccccc
Confidence 7777777653
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.05 E-value=1.2e-10 Score=104.67 Aligned_cols=91 Identities=22% Similarity=0.340 Sum_probs=82.6
Q ss_pred CCCCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCcccccccc
Q 038351 47 PPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNIL 126 (348)
Q Consensus 47 ~~~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L 126 (348)
|...+++|+.|+|++|..++.+|..+.+++.+++|++++|.+++-.|..+..+++|++|+|++|+|+ .||.++..+++|
T Consensus 166 ~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L 244 (305)
T d1xkua_ 166 PQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 244 (305)
T ss_dssp CSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSC
T ss_pred CcccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCC
Confidence 3355789999999999999999999999999999999999999888889999999999999999998 789999999999
Q ss_pred ceeeeecccccc
Q 038351 127 QHLFLGYNRLQG 138 (348)
Q Consensus 127 ~~L~ls~N~lsG 138 (348)
+.|++++|+++.
T Consensus 245 ~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 245 QVVYLHNNNISA 256 (305)
T ss_dssp CEEECCSSCCCC
T ss_pred CEEECCCCccCc
Confidence 999999999883
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.03 E-value=3.8e-10 Score=99.58 Aligned_cols=91 Identities=26% Similarity=0.248 Sum_probs=53.5
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCC------------------------cCCCCCcccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIP------------------------LEIENLKVLVK 104 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP------------------------~~~~~l~~L~~ 104 (348)
+.+++|+.|+|++|.+++ +|..+.++++|+.|+|++|.+.+-.+ ..+..+++|+.
T Consensus 74 ~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~ 152 (266)
T d1p9ag_ 74 GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152 (266)
T ss_dssp SCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred cccccccccccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchh
Confidence 455666666666666664 45555555555555555555554333 33445556666
Q ss_pred eecccCcccCccCCccccccccceeeeeccccccccc
Q 038351 105 IYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSIS 141 (348)
Q Consensus 105 l~ls~N~l~G~iP~~l~~l~~L~~L~ls~N~lsG~ip 141 (348)
|++++|+|++..|..+..+++|+.|+|++|+++ ++|
T Consensus 153 l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp 188 (266)
T d1p9ag_ 153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188 (266)
T ss_dssp EECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCC
T ss_pred cccccccccccCccccccccccceeecccCCCc-ccC
Confidence 666666666655555666666666666666666 455
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.97 E-value=6.4e-10 Score=99.70 Aligned_cols=99 Identities=21% Similarity=0.196 Sum_probs=83.8
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCC-------ccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPN-------AIG 121 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~-------~l~ 121 (348)
..++.++.|++++|.+++..|..+.++++|++|+|++|+|+ .||.++..+++|++|+|++|+++ .|+. ...
T Consensus 192 ~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~ 269 (305)
T d1xkua_ 192 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNT 269 (305)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCT
T ss_pred hccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC-ccChhhccCcchhc
Confidence 67889999999999999988999999999999999999999 89999999999999999999998 4443 345
Q ss_pred cccccceeeeeccccc-cccccccccchhh
Q 038351 122 CLNILQHLFLGYNRLQ-GSISYSKWFSCLE 150 (348)
Q Consensus 122 ~l~~L~~L~ls~N~ls-G~ip~~~~~~~~~ 150 (348)
.+..|+.|++++|.++ ..++ ...|.|.+
T Consensus 270 ~~~~L~~L~L~~N~~~~~~~~-~~~f~~~~ 298 (305)
T d1xkua_ 270 KKASYSGVSLFSNPVQYWEIQ-PSTFRCVY 298 (305)
T ss_dssp TSCCCSEEECCSSSSCGGGSC-GGGGTTCC
T ss_pred ccCCCCEEECCCCcCccCcCC-HhHhcccc
Confidence 5678999999999985 4554 33444433
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.93 E-value=4.4e-10 Score=91.87 Aligned_cols=86 Identities=17% Similarity=0.203 Sum_probs=74.1
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcC-CCCCcccceeecccCcccCccC--Cccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLE-IENLKVLVKIYFSMNNFAGVIP--NAIGCLNI 125 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~-~~~l~~L~~l~ls~N~l~G~iP--~~l~~l~~ 125 (348)
..+++|+.|+|++|.++. |+ .|..+++|++|+|++|+++. +|.. +..+++|+.|++++|+++. ++ ..+..+++
T Consensus 38 ~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~-l~~~~~~~l~~L~~L~L~~N~i~~-~~~l~~l~~l~~ 113 (162)
T d1a9na_ 38 ATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKS 113 (162)
T ss_dssp GGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTT
T ss_pred cccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccC-CCccccccccccccceeccccccc-cccccccccccc
Confidence 567999999999999994 65 58999999999999999995 5544 5689999999999999984 33 46888999
Q ss_pred cceeeeecccccc
Q 038351 126 LQHLFLGYNRLQG 138 (348)
Q Consensus 126 L~~L~ls~N~lsG 138 (348)
|+.+++++|.++.
T Consensus 114 L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 114 LTYLCILRNPVTN 126 (162)
T ss_dssp CCEEECCSSGGGG
T ss_pred cchhhcCCCcccc
Confidence 9999999999864
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.92 E-value=8.8e-10 Score=89.45 Aligned_cols=91 Identities=18% Similarity=0.173 Sum_probs=78.9
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceeccccc-ccCCCCcCCCCCcccceeecccCcccCccCCccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNS-LTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~-l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~ 127 (348)
+.+...+.++++++++.. +|..+..+++|+.|+|++|+ ++.--+..|..+++|+.|++++|+|+..-|..+..+++|+
T Consensus 5 C~c~~~~~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~ 83 (156)
T d2ifga3 5 CCPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83 (156)
T ss_dssp SCCSSSSCEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred CCcCCCCeEEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccc
Confidence 666777789999999874 89999999999999998775 7743346699999999999999999987788999999999
Q ss_pred eeeeeccccccccc
Q 038351 128 HLFLGYNRLQGSIS 141 (348)
Q Consensus 128 ~L~ls~N~lsG~ip 141 (348)
.|+|++|+++ .+|
T Consensus 84 ~L~Ls~N~l~-~l~ 96 (156)
T d2ifga3 84 RLNLSFNALE-SLS 96 (156)
T ss_dssp EEECCSSCCS-CCC
T ss_pred ceeccCCCCc-ccC
Confidence 9999999998 455
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.88 E-value=8.6e-10 Score=101.37 Aligned_cols=87 Identities=25% Similarity=0.411 Sum_probs=55.2
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..++.++.+.++.|.+++ + ..+..+++|+.|+|++|++++- + .+..+++|+.|++++|++++ +| .+..+++|++
T Consensus 282 ~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~ 355 (384)
T d2omza2 282 AGLTALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINW 355 (384)
T ss_dssp TTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCE
T ss_pred cccccccccccccccccc-c-cccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCE
Confidence 455666667777777665 2 3466666677777777777653 2 26666677777777776664 33 4666667777
Q ss_pred eeeeccccccccc
Q 038351 129 LFLGYNRLQGSIS 141 (348)
Q Consensus 129 L~ls~N~lsG~ip 141 (348)
|++++|++++-.|
T Consensus 356 L~l~~N~l~~l~~ 368 (384)
T d2omza2 356 LSAGHNQISDLTP 368 (384)
T ss_dssp EECCSSCCCBCGG
T ss_pred EECCCCcCCCChh
Confidence 7777777665443
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.76 E-value=6.6e-09 Score=87.38 Aligned_cols=102 Identities=19% Similarity=0.220 Sum_probs=78.6
Q ss_pred cEEEEecccceeeecCCCCCCCCCCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCccccee
Q 038351 26 AVTNITFGLLVFIILCPRYNYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKI 105 (348)
Q Consensus 26 ~v~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l 105 (348)
.++.+.+...+...+ ..+ ..+++|+.|+|++|.+++ +|+ |+++++|++|++++|.+. .+| .+.++++|+.|
T Consensus 41 ~l~~L~l~~~~i~~l-~~l----~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L 111 (199)
T d2omxa2 41 QVTTLQADRLGIKSI-DGV----EYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGL 111 (199)
T ss_dssp TCCEEECTTSCCCCC-TTG----GGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEE
T ss_pred CCCEEECCCCCCCCc-ccc----ccCCCcCcCccccccccC-ccc-ccCCcccccccccccccc-ccc-ccccccccccc
Confidence 355566544433222 123 678999999999999997 443 999999999999999987 565 38899999999
Q ss_pred ecccCcccCccCCccccccccceeeeecccccc
Q 038351 106 YFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQG 138 (348)
Q Consensus 106 ~ls~N~l~G~iP~~l~~l~~L~~L~ls~N~lsG 138 (348)
++++|.+.... .+..++.|+.+++++|++..
T Consensus 112 ~l~~~~~~~~~--~~~~l~~L~~L~l~~n~l~~ 142 (199)
T d2omxa2 112 TLFNNQITDID--PLKNLTNLNRLELSSNTISD 142 (199)
T ss_dssp ECCSSCCCCCG--GGTTCTTCSEEECCSSCCCC
T ss_pred ccccccccccc--ccchhhhhHHhhhhhhhhcc
Confidence 99999887643 47788899999999998864
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.74 E-value=4.6e-09 Score=90.03 Aligned_cols=78 Identities=15% Similarity=0.215 Sum_probs=38.7
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|++++|.+++.. .++++++|+.|+|++|++++ ||. +.++++|+.|++++|+++. || .+..++.|+.
T Consensus 148 ~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~~L~~ 221 (227)
T d1h6ua2 148 AGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISD-VS-PLANTSNLFI 221 (227)
T ss_dssp GGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCB-CG-GGTTCTTCCE
T ss_pred ccccccccccccccccccch--hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCC-Cc-ccccCCCCCE
Confidence 33445555555555554321 25555555555555555553 332 4555555555555555553 22 1445555555
Q ss_pred eeee
Q 038351 129 LFLG 132 (348)
Q Consensus 129 L~ls 132 (348)
|+++
T Consensus 222 L~ls 225 (227)
T d1h6ua2 222 VTLT 225 (227)
T ss_dssp EEEE
T ss_pred EEee
Confidence 5554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.71 E-value=3.4e-10 Score=95.65 Aligned_cols=85 Identities=20% Similarity=0.281 Sum_probs=72.2
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|+++ .|| .|.+|++|++|+|++|+++ .||.....+++|+.|++++|+++. ++ .+..+++|+.
T Consensus 45 ~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~ 119 (198)
T d1m9la_ 45 STLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRV 119 (198)
T ss_dssp HHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSE
T ss_pred hcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccccc
Confidence 66889999999999998 476 5899999999999999998 788766677889999999999984 43 4788889999
Q ss_pred eeeecccccc
Q 038351 129 LFLGYNRLQG 138 (348)
Q Consensus 129 L~ls~N~lsG 138 (348)
|++++|+++.
T Consensus 120 L~L~~N~i~~ 129 (198)
T d1m9la_ 120 LYMSNNKITN 129 (198)
T ss_dssp EEESEEECCC
T ss_pred cccccchhcc
Confidence 9999998874
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.62 E-value=2.1e-08 Score=91.79 Aligned_cols=83 Identities=28% Similarity=0.424 Sum_probs=42.7
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|++++|.+++. | .+.+++.++.++++.|++++ + ..+..+++++.|++++|++++..| +..+++|+.
T Consensus 260 ~~~~~L~~L~l~~~~l~~~-~-~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~ 333 (384)
T d2omza2 260 SGLTKLTELKLGANQISNI-S-PLAGLTALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQR 333 (384)
T ss_dssp TTCTTCSEEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCE
T ss_pred cccccCCEeeccCcccCCC-C-cccccccccccccccccccc-c-cccchhcccCeEECCCCCCCCCcc--cccCCCCCE
Confidence 4445555555555555542 2 24455555555555555554 1 234555555555555555554322 455555555
Q ss_pred eeeeccccc
Q 038351 129 LFLGYNRLQ 137 (348)
Q Consensus 129 L~ls~N~ls 137 (348)
|++++|+++
T Consensus 334 L~L~~n~l~ 342 (384)
T d2omza2 334 LFFANNKVS 342 (384)
T ss_dssp EECCSSCCC
T ss_pred EECCCCCCC
Confidence 555555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.61 E-value=2.8e-08 Score=84.11 Aligned_cols=84 Identities=29% Similarity=0.429 Sum_probs=60.0
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
..+++|+.|+|++|.+++ +| .++++++|++|+|++|+++ .|| .+..+++|+.|++++|.++. + ..+..++.++.
T Consensus 65 ~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~ 138 (210)
T d1h6ta2 65 QYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLES 138 (210)
T ss_dssp GGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCE
T ss_pred hhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-cccccccccccccccccccc-c-ccccccccccc
Confidence 557778888888888776 44 3677788888888888877 355 47777788888887777652 2 35666777777
Q ss_pred eeeecccccc
Q 038351 129 LFLGYNRLQG 138 (348)
Q Consensus 129 L~ls~N~lsG 138 (348)
++++.|++++
T Consensus 139 l~~~~n~l~~ 148 (210)
T d1h6ta2 139 LYLGNNKITD 148 (210)
T ss_dssp EECCSSCCCC
T ss_pred cccccccccc
Confidence 7777777664
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.60 E-value=3.1e-10 Score=95.96 Aligned_cols=90 Identities=23% Similarity=0.202 Sum_probs=77.2
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccC-Cccccccccc
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIP-NAIGCLNILQ 127 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP-~~l~~l~~L~ 127 (348)
..+++|+.|+|++|.++ .||..+..+++|+.|+|++|+++ .|+ .+..+++|+.|++++|+++..-. ..+..+++|+
T Consensus 67 ~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~ 143 (198)
T d1m9la_ 67 SGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143 (198)
T ss_dssp HHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCS
T ss_pred cCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccccccccccccchhccccccccccCCCccc
Confidence 77899999999999998 58877777889999999999999 454 48899999999999999985321 5788999999
Q ss_pred eeeeeccccccccc
Q 038351 128 HLFLGYNRLQGSIS 141 (348)
Q Consensus 128 ~L~ls~N~lsG~ip 141 (348)
.|++++|++....+
T Consensus 144 ~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 144 DLLLAGNPLYNDYK 157 (198)
T ss_dssp EEEECSSHHHHHHC
T ss_pred eeecCCCccccCcc
Confidence 99999999876544
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.54 E-value=1.2e-07 Score=80.19 Aligned_cols=84 Identities=21% Similarity=0.301 Sum_probs=52.0
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|+|++|.+++ || .+.++++|+.|++++|.++ .++ .+..+++|+.++++.|.+++. ..+..+++|+.
T Consensus 87 ~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~ 160 (210)
T d1h6ta2 87 ANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDT 160 (210)
T ss_dssp TTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSE
T ss_pred ccCccccccccccccccc-cc-ccccccccccccccccccc-ccc-ccccccccccccccccccccc--ccccccccccc
Confidence 667788888888888775 55 4777777777777777765 333 355555555555555555432 23444555555
Q ss_pred eeeecccccc
Q 038351 129 LFLGYNRLQG 138 (348)
Q Consensus 129 L~ls~N~lsG 138 (348)
+++++|++++
T Consensus 161 l~l~~n~l~~ 170 (210)
T d1h6ta2 161 LSLEDNQISD 170 (210)
T ss_dssp EECCSSCCCC
T ss_pred cccccccccc
Confidence 5555555543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.53 E-value=6.9e-08 Score=80.88 Aligned_cols=84 Identities=24% Similarity=0.296 Sum_probs=42.0
Q ss_pred CCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccce
Q 038351 49 LRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~ 128 (348)
+.+++|+.|++++|.+.. +| .+.+++.|+.|++++|.+... ..+..+++|+.|++++|++.. +| .+..+.+|+.
T Consensus 81 ~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~ 154 (199)
T d2omxa2 81 KNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQ 154 (199)
T ss_dssp TTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSE
T ss_pred cCCccccccccccccccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-cc-cccccccccc
Confidence 555666666666665543 33 255555555555555555432 124455555555555555542 22 3444444555
Q ss_pred eeeecccccc
Q 038351 129 LFLGYNRLQG 138 (348)
Q Consensus 129 L~ls~N~lsG 138 (348)
|++++|++++
T Consensus 155 L~l~~n~l~~ 164 (199)
T d2omxa2 155 LNFSSNQVTD 164 (199)
T ss_dssp EECCSSCCCC
T ss_pred cccccccccC
Confidence 5555544443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.53 E-value=4.3e-07 Score=78.74 Aligned_cols=143 Identities=14% Similarity=0.094 Sum_probs=96.4
Q ss_pred hhHHhhhCCCccccccccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhccccc-ccceeeEEEEEecCCeE
Q 038351 149 LELCRVTNGFSEDNLISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTC-YRNLIKIISSRSNEDFK 227 (348)
Q Consensus 149 ~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 227 (348)
.++.+....|+..+..+-++.+.||+...+ +..+++|+...........+.+|...+..+. +--+.+++.+...++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 456666677776665544555789988654 4467788776554444556788888877664 33467888888888999
Q ss_pred EEEEeccCCCCHHHHHhch-------hHHHHHHHHHH-------------------------------------------
Q 038351 228 VLVLEYMPRGSLEKCLYSS-------NYVGFALEYLH------------------------------------------- 257 (348)
Q Consensus 228 ~lV~Ey~~~gsL~~~l~~~-------~~i~~~L~yLH------------------------------------------- 257 (348)
++||+++++.++.+..... ..++..++-||
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred EEEEEecccccccccccccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence 9999999998775433211 01222222222
Q ss_pred ----------hcC---CCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 258 ----------FDY---SVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 258 ----------~~~---~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
... ...++|+|+.+.||+++++..+-|.||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 111 12379999999999999877777999998864
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.52 E-value=5.5e-08 Score=83.64 Aligned_cols=88 Identities=23% Similarity=0.271 Sum_probs=76.6
Q ss_pred CCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCc-CCCCCcccceeeccc-CcccCccCCccccccccce
Q 038351 51 PPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPL-EIENLKVLVKIYFSM-NNFAGVIPNAIGCLNILQH 128 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~-~~~~l~~L~~l~ls~-N~l~G~iP~~l~~l~~L~~ 128 (348)
.++++.|+|++|.++..-+..|.++++|++|+|++|.+...||. .+..+++++.+++.. |++....|..+..+++|+.
T Consensus 28 ~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~ 107 (242)
T d1xwdc1 28 PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQY 107 (242)
T ss_dssp CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCE
T ss_pred CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccc
Confidence 36899999999999864444789999999999999999988865 578899999999864 7888888888999999999
Q ss_pred eeeecccccc
Q 038351 129 LFLGYNRLQG 138 (348)
Q Consensus 129 L~ls~N~lsG 138 (348)
+++++|++..
T Consensus 108 l~l~~~~l~~ 117 (242)
T d1xwdc1 108 LLISNTGIKH 117 (242)
T ss_dssp EEEESCCCCS
T ss_pred cccchhhhcc
Confidence 9999999874
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.37 E-value=2.4e-07 Score=78.97 Aligned_cols=84 Identities=19% Similarity=0.295 Sum_probs=65.1
Q ss_pred CCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCcccccccccee
Q 038351 50 RPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHL 129 (348)
Q Consensus 50 ~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L 129 (348)
..+.+..+.++++.+.... .+.++++|+.|++++|++++..+ ++++++|+.|++++|++++ +| .+..+++|+.|
T Consensus 127 ~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L 200 (227)
T d1h6ua2 127 GLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD-IS-PLASLPNLIEV 200 (227)
T ss_dssp TCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEE
T ss_pred cccchhhhhchhhhhchhh--hhccccccccccccccccccchh--hcccccceecccCCCccCC-Ch-hhcCCCCCCEE
Confidence 3455555555555555432 36788899999999999985433 8899999999999999986 44 38889999999
Q ss_pred eeeccccccc
Q 038351 130 FLGYNRLQGS 139 (348)
Q Consensus 130 ~ls~N~lsG~ 139 (348)
++++|+++.-
T Consensus 201 ~Ls~N~lt~i 210 (227)
T d1h6ua2 201 HLKNNQISDV 210 (227)
T ss_dssp ECTTSCCCBC
T ss_pred ECcCCcCCCC
Confidence 9999999863
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.35 E-value=4.3e-07 Score=81.42 Aligned_cols=98 Identities=19% Similarity=0.212 Sum_probs=73.1
Q ss_pred EEEEecccceeeecCCCCCCCCCCCCCccEEEcccCcccccCcccccCCccCcceecccccccCCCCcCCCCCcccceee
Q 038351 27 VTNITFGLLVFIILCPRYNYPPLRPPQQENLSLASNELISVIPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIY 106 (348)
Q Consensus 27 v~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~L~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ 106 (348)
.+.++++..+...++ + .+++|+.|+|++|+|+ .||..++ +|+.|++++|+++ .||. + .+.|++|+
T Consensus 40 l~~LdLs~~~L~~lp-~------~~~~L~~L~Ls~N~l~-~lp~~~~---~L~~L~l~~n~l~-~l~~-l--p~~L~~L~ 104 (353)
T d1jl5a_ 40 AHELELNNLGLSSLP-E------LPPHLESLVASCNSLT-ELPELPQ---SLKSLLVDNNNLK-ALSD-L--PPLLEYLG 104 (353)
T ss_dssp CSEEECTTSCCSCCC-S------CCTTCSEEECCSSCCS-SCCCCCT---TCCEEECCSSCCS-CCCS-C--CTTCCEEE
T ss_pred CCEEEeCCCCCCCCC-C------CCCCCCEEECCCCCCc-ccccchh---hhhhhhhhhcccc-hhhh-h--cccccccc
Confidence 456666555443332 2 2578999999999999 7897754 5778889999888 5653 1 24699999
Q ss_pred cccCcccCccCCccccccccceeeeeccccccccc
Q 038351 107 FSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSIS 141 (348)
Q Consensus 107 ls~N~l~G~iP~~l~~l~~L~~L~ls~N~lsG~ip 141 (348)
+++|.++ .+|. ++.++.|+.+++++|.+....+
T Consensus 105 L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~ 137 (353)
T d1jl5a_ 105 VSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPD 137 (353)
T ss_dssp CCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCC
T ss_pred ccccccc-cccc-hhhhccceeecccccccccccc
Confidence 9999998 6775 6789999999999998876433
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.26 E-value=6.4e-08 Score=78.56 Aligned_cols=41 Identities=27% Similarity=0.267 Sum_probs=18.5
Q ss_pred cCCccCcceecccccccC--CCCcCCCCCcccceeecccCccc
Q 038351 73 WNLKDILYLNLSLNSLTG--PIPLEIENLKVLVKIYFSMNNFA 113 (348)
Q Consensus 73 ~~l~~L~~l~l~~N~l~G--~iP~~~~~l~~L~~l~ls~N~l~ 113 (348)
.+++.|++|+||+|+++. .++..+..+++|+.|++|+|.++
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 104 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc
Confidence 344445555555555442 11223344445555555555544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.17 E-value=1.1e-06 Score=78.64 Aligned_cols=59 Identities=27% Similarity=0.340 Sum_probs=41.4
Q ss_pred CCccCcceecccccccCCCCcCCCCCcccceeecccCcccCccCCccccccccceeeeeccccccccc
Q 038351 74 NLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSMNNFAGVIPNAIGCLNILQHLFLGYNRLQGSIS 141 (348)
Q Consensus 74 ~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~N~l~G~iP~~l~~l~~L~~L~ls~N~lsG~ip 141 (348)
.+++|++|+|++|+++ .||.. +++|+.|++++|+|+ .||..+ .+|+.|++++|+++ ++|
T Consensus 282 ~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~~---~~L~~L~L~~N~L~-~lp 340 (353)
T d1jl5a_ 282 LPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPELP---QNLKQLHVEYNPLR-EFP 340 (353)
T ss_dssp CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCCC---TTCCEEECCSSCCS-SCC
T ss_pred cCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-cccccc---CCCCEEECcCCcCC-CCC
Confidence 3567788888888877 67754 456777788888877 677543 45777788888776 455
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.01 E-value=4.1e-06 Score=71.42 Aligned_cols=108 Identities=17% Similarity=0.172 Sum_probs=78.0
Q ss_pred EEEEecccceeeecCCCCCCCCCCCCCccEEEcccCcccccCcc-cccCCccCcceecc-cccccCCCCcCCCCCcccce
Q 038351 27 VTNITFGLLVFIILCPRYNYPPLRPPQQENLSLASNELISVIPS-TFWNLKDILYLNLS-LNSLTGPIPLEIENLKVLVK 104 (348)
Q Consensus 27 v~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~L~~N~l~g~ip~-~~~~l~~L~~l~l~-~N~l~G~iP~~~~~l~~L~~ 104 (348)
++.|.+..-.+..+.+. ...++++|+.|+|++|.+...||. .|.+++.++.|++. .|+++...|..+..+++|+.
T Consensus 31 l~~L~Ls~n~i~~l~~~---~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~ 107 (242)
T d1xwdc1 31 AIELRFVLTKLRVIQKG---AFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQY 107 (242)
T ss_dssp CSEEEEESCCCCEECTT---TTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCE
T ss_pred CCEEECcCCcCCccChh---Hhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccc
Confidence 44555543333334432 127899999999999999988876 67889999999876 57888888888999999999
Q ss_pred eecccCcccCccC-Cccccccccceeeeeccccc
Q 038351 105 IYFSMNNFAGVIP-NAIGCLNILQHLFLGYNRLQ 137 (348)
Q Consensus 105 l~ls~N~l~G~iP-~~l~~l~~L~~L~ls~N~ls 137 (348)
|++++|++...-+ ..+..+..+..+..+++++.
T Consensus 108 l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~ 141 (242)
T d1xwdc1 108 LLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH 141 (242)
T ss_dssp EEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCC
T ss_pred cccchhhhcccccccccccccccccccccccccc
Confidence 9999999974322 34445555665565555544
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.96 E-value=5.7e-07 Score=83.40 Aligned_cols=90 Identities=21% Similarity=0.165 Sum_probs=71.9
Q ss_pred CCCCCccEEEcccCccc----ccCcccccCCccCcceecccccccC----CCCcCCCC-CcccceeecccCcccCc----
Q 038351 49 LRPPQQENLSLASNELI----SVIPSTFWNLKDILYLNLSLNSLTG----PIPLEIEN-LKVLVKIYFSMNNFAGV---- 115 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~----g~ip~~~~~l~~L~~l~l~~N~l~G----~iP~~~~~-l~~L~~l~ls~N~l~G~---- 115 (348)
..++++++|+|++|.++ ..|+..+..+++|+.|||++|+++. .+...+.. ..+|+.|+|++|+++..
T Consensus 24 ~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~ 103 (460)
T d1z7xw1 24 PLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGV 103 (460)
T ss_dssp HHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHH
T ss_pred HhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCcccccccc
Confidence 34589999999999987 3467778899999999999999862 23333432 35799999999999754
Q ss_pred cCCccccccccceeeeecccccc
Q 038351 116 IPNAIGCLNILQHLFLGYNRLQG 138 (348)
Q Consensus 116 iP~~l~~l~~L~~L~ls~N~lsG 138 (348)
++..+..++.|+.|++++|+++.
T Consensus 104 l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 104 LSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp HHHHTTSCTTCCEEECCSSBCHH
T ss_pred ccchhhccccccccccccccchh
Confidence 67778889999999999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.94 E-value=2.8e-05 Score=66.51 Aligned_cols=126 Identities=14% Similarity=0.103 Sum_probs=84.6
Q ss_pred cccCC-cceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhccccccc--ceeeEEEEEecCCeEEEEEeccCCCCHH
Q 038351 164 ISRGG-FGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYR--NLIKIISSRSNEDFKVLVLEYMPRGSLE 240 (348)
Q Consensus 164 lG~G~-fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 240 (348)
+..|. -+.||+...+++..+++|..... ....+..|.+.++.+... .+.+++.+..+++..++||||+++.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 33444 36789999888888888875433 334577888888776533 3567888888888999999999876553
Q ss_pred HH-----------------Hhchh------------H--------------------------HHHHHHHHHhc----CC
Q 038351 241 KC-----------------LYSSN------------Y--------------------------VGFALEYLHFD----YS 261 (348)
Q Consensus 241 ~~-----------------l~~~~------------~--------------------------i~~~L~yLH~~----~~ 261 (348)
+. |+... . ....+..+... ..
T Consensus 95 ~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 174 (255)
T d1nd4a_ 95 SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGED 174 (255)
T ss_dssp TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCC
T ss_pred cccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCC
Confidence 21 11000 0 22233333321 12
Q ss_pred CceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 262 VLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 262 ~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
..++|+|+.|.||+++++..+-|.||+.+..
T Consensus 175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 175 LVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 3389999999999999877778999998764
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.80 E-value=1.1e-06 Score=77.45 Aligned_cols=86 Identities=16% Similarity=0.246 Sum_probs=70.7
Q ss_pred CCCCCccEEEcccCccccc-CcccccCCccCcceecccccccCCCCcCCCCCcccceeeccc-CcccCc-cCCccccccc
Q 038351 49 LRPPQQENLSLASNELISV-IPSTFWNLKDILYLNLSLNSLTGPIPLEIENLKVLVKIYFSM-NNFAGV-IPNAIGCLNI 125 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~-ip~~~~~l~~L~~l~l~~N~l~G~iP~~~~~l~~L~~l~ls~-N~l~G~-iP~~l~~l~~ 125 (348)
....+|+.|+|+++.++.. ++.-+.+|++|++|+|+++++++..+..++++++|+.|++++ +.++.. +..-...+++
T Consensus 43 ~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~ 122 (284)
T d2astb2 43 FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122 (284)
T ss_dssp CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTT
T ss_pred ccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHh
Confidence 4567899999999998765 566788999999999999999999999999999999999998 466532 3333456788
Q ss_pred cceeeeecc
Q 038351 126 LQHLFLGYN 134 (348)
Q Consensus 126 L~~L~ls~N 134 (348)
|+.|+++++
T Consensus 123 L~~L~ls~c 131 (284)
T d2astb2 123 LDELNLSWC 131 (284)
T ss_dssp CCEEECCCC
T ss_pred ccccccccc
Confidence 999999874
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.74 E-value=5.4e-07 Score=72.89 Aligned_cols=81 Identities=20% Similarity=0.172 Sum_probs=63.3
Q ss_pred CCCCCccEEEcccCccccc--CcccccCCccCcceecccccccCCCCc-CCCCCcccceeecccCcccCccCCc------
Q 038351 49 LRPPQQENLSLASNELISV--IPSTFWNLKDILYLNLSLNSLTGPIPL-EIENLKVLVKIYFSMNNFAGVIPNA------ 119 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~--ip~~~~~l~~L~~l~l~~N~l~G~iP~-~~~~l~~L~~l~ls~N~l~G~iP~~------ 119 (348)
..+++|+.|+|++|+++.. ++..+..|++|+.|||++|+++ .++. ......+|+.|++++|.++......
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~ 140 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHH
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHHHH
Confidence 3578999999999999863 4567888999999999999999 5553 3334557899999999998876543
Q ss_pred -cccccccceee
Q 038351 120 -IGCLNILQHLF 130 (348)
Q Consensus 120 -l~~l~~L~~L~ 130 (348)
+..+++|+.||
T Consensus 141 i~~~~P~L~~LD 152 (162)
T d1koha1 141 IRERFPKLLRLD 152 (162)
T ss_dssp HHTTSTTCCEET
T ss_pred HHHHCCCCCEEC
Confidence 55677777776
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.73 E-value=9.9e-07 Score=81.71 Aligned_cols=88 Identities=19% Similarity=0.132 Sum_probs=62.2
Q ss_pred CCCccEEEcccCcccccCccc----ccCCccCcceecccccccCC----CCcCCC-CCcccceeecccCcccC----ccC
Q 038351 51 PPQQENLSLASNELISVIPST----FWNLKDILYLNLSLNSLTGP----IPLEIE-NLKVLVKIYFSMNNFAG----VIP 117 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g~ip~~----~~~l~~L~~l~l~~N~l~G~----iP~~~~-~l~~L~~l~ls~N~l~G----~iP 117 (348)
...|+.+++++|.++..-... +..+++|+.|+|++|+++.. ++..+. ..+.|+.|+|++|+++. .|+
T Consensus 311 ~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~ 390 (460)
T d1z7xw1 311 GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLA 390 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred ccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHH
Confidence 357888888888887653333 34456788888888888653 444444 35678888888888874 356
Q ss_pred Cccccccccceeeeecccccc
Q 038351 118 NAIGCLNILQHLFLGYNRLQG 138 (348)
Q Consensus 118 ~~l~~l~~L~~L~ls~N~lsG 138 (348)
..+...++|++|++++|+++.
T Consensus 391 ~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 391 ATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHHHCCCCCEEECCSSSCCH
T ss_pred HHHhcCCCCCEEECCCCcCCH
Confidence 667777888888888888764
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.69 E-value=1.2e-05 Score=70.62 Aligned_cols=84 Identities=17% Similarity=0.109 Sum_probs=67.0
Q ss_pred CCCccEEEcccC--ccccc-CcccccCCccCcceecccc-cccCCCCcCCCCCcccceeeccc-CcccCccCCccccccc
Q 038351 51 PPQQENLSLASN--ELISV-IPSTFWNLKDILYLNLSLN-SLTGPIPLEIENLKVLVKIYFSM-NNFAGVIPNAIGCLNI 125 (348)
Q Consensus 51 ~~~l~~l~L~~N--~l~g~-ip~~~~~l~~L~~l~l~~N-~l~G~iP~~~~~l~~L~~l~ls~-N~l~G~iP~~l~~l~~ 125 (348)
+++|+.|+|++. +++.. +..-+.++++|++|+|++| .+++..+..++++++|++|++++ ++++......++.+++
T Consensus 147 ~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~ 226 (284)
T d2astb2 147 SETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226 (284)
T ss_dssp CTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTT
T ss_pred ccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCC
Confidence 578999999853 44432 4444567889999999885 58888888899999999999998 6788887788888999
Q ss_pred cceeeeecc
Q 038351 126 LQHLFLGYN 134 (348)
Q Consensus 126 L~~L~ls~N 134 (348)
|+.|+++++
T Consensus 227 L~~L~l~~~ 235 (284)
T d2astb2 227 LKTLQVFGI 235 (284)
T ss_dssp CCEEECTTS
T ss_pred CCEEeeeCC
Confidence 999998766
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.47 E-value=8.8e-06 Score=73.27 Aligned_cols=88 Identities=16% Similarity=0.142 Sum_probs=48.0
Q ss_pred CCCccEEEcccCcccc----cCcccccCCccCcceecccccccCC-----CCcCCCCCcccceeecccCcccCc----cC
Q 038351 51 PPQQENLSLASNELIS----VIPSTFWNLKDILYLNLSLNSLTGP-----IPLEIENLKVLVKIYFSMNNFAGV----IP 117 (348)
Q Consensus 51 ~~~l~~l~L~~N~l~g----~ip~~~~~l~~L~~l~l~~N~l~G~-----iP~~~~~l~~L~~l~ls~N~l~G~----iP 117 (348)
.+.|+.|.+++|.++- .+...+..++.|+.|+|+.|+++.. +...+..+++|+.|++++|.++.. +.
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~ 236 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccc
Confidence 4556666666665542 2333444556666666666665431 223355566666666666665432 34
Q ss_pred Cccccccccceeeeecccccc
Q 038351 118 NAIGCLNILQHLFLGYNRLQG 138 (348)
Q Consensus 118 ~~l~~l~~L~~L~ls~N~lsG 138 (348)
..+...+.|+.|++++|++++
T Consensus 237 ~~l~~~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 237 IALKSWPNLRELGLNDCLLSA 257 (344)
T ss_dssp HHGGGCTTCCEEECTTCCCCH
T ss_pred ccccccccchhhhhhcCccCc
Confidence 445555566666666666543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.30 E-value=1.5e-05 Score=71.68 Aligned_cols=64 Identities=14% Similarity=0.108 Sum_probs=32.7
Q ss_pred CCccCcceecccccccC----CCCcCCCCCcccceeecccCcccCc-----cCCccccccccceeeeeccccc
Q 038351 74 NLKDILYLNLSLNSLTG----PIPLEIENLKVLVKIYFSMNNFAGV-----IPNAIGCLNILQHLFLGYNRLQ 137 (348)
Q Consensus 74 ~l~~L~~l~l~~N~l~G----~iP~~~~~l~~L~~l~ls~N~l~G~-----iP~~l~~l~~L~~L~ls~N~ls 137 (348)
..+.|+.|+++.|+++- .+...+...+.|+.|++++|.++.. +...+...+.|+.|++++|.++
T Consensus 156 ~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~ 228 (344)
T d2ca6a1 156 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 228 (344)
T ss_dssp TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred cCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccc
Confidence 34455666666665542 1222334455566666666655421 2334555555666666666543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.26 E-value=0.00049 Score=62.88 Aligned_cols=75 Identities=12% Similarity=0.088 Sum_probs=47.3
Q ss_pred cccccCCcceEEEeEecC-CceEEEEeeeec--c-----CccchhhHHHhhhccccc---ccceeeEEEEEecCCeEEEE
Q 038351 162 NLISRGGFGSIHKARIQD-RMEFSVKGFHLQ--C-----SGAFKSFDFECDVMKSTC---YRNLIKIISSRSNEDFKVLV 230 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~-----~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV 230 (348)
+.||.|....||+....+ ++.++||.-... . .-.......|.+.|+.+. ...+++++.+. ++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 468999999999998754 567888854321 1 112234556887776553 24566776654 4456899
Q ss_pred EeccCCCC
Q 038351 231 LEYMPRGS 238 (348)
Q Consensus 231 ~Ey~~~gs 238 (348)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.07 E-value=5e-05 Score=61.16 Aligned_cols=88 Identities=10% Similarity=0.049 Sum_probs=61.1
Q ss_pred CCCCccEEEcccC-ccccc----CcccccCCccCcceecccccccCC----CCcCCCCCcccceeecccCcccCc----c
Q 038351 50 RPPQQENLSLASN-ELISV----IPSTFWNLKDILYLNLSLNSLTGP----IPLEIENLKVLVKIYFSMNNFAGV----I 116 (348)
Q Consensus 50 ~~~~l~~l~L~~N-~l~g~----ip~~~~~l~~L~~l~l~~N~l~G~----iP~~~~~l~~L~~l~ls~N~l~G~----i 116 (348)
..+.|+.|+|+++ .++.. +=..+...+.|+.|+|++|.++-. +-..+...+.|+.|++++|.++.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4578899999864 45432 333566778899999999988742 223345567889999999988753 2
Q ss_pred CCccccccccceeeeeccccc
Q 038351 117 PNAIGCLNILQHLFLGYNRLQ 137 (348)
Q Consensus 117 P~~l~~l~~L~~L~ls~N~ls 137 (348)
-..+..-..|+.|++++|+..
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHhCCcCCEEECCCCcCC
Confidence 334555677888999888654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.68 E-value=0.0005 Score=61.06 Aligned_cols=120 Identities=15% Similarity=0.161 Sum_probs=74.3
Q ss_pred ceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhccccccccee--eEE-----EEEecCCeEEEEEeccCCCCHH--
Q 038351 170 GSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLI--KII-----SSRSNEDFKVLVLEYMPRGSLE-- 240 (348)
Q Consensus 170 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv--~l~-----~~~~~~~~~~lV~Ey~~~gsL~-- 240 (348)
-.||++..++|..+++|..+... ...+++..|.+.+..+....+. ..+ ......+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 47999999999999999875432 2346678888888777643332 111 1223456788999998764321
Q ss_pred ---HH---------Hhch---------------------h---------------H----HHHHHHHHHhc----CCCce
Q 038351 241 ---KC---------LYSS---------------------N---------------Y----VGFALEYLHFD----YSVLI 264 (348)
Q Consensus 241 ---~~---------l~~~---------------------~---------------~----i~~~L~yLH~~----~~~~i 264 (348)
.+ ++.. . . +...++.+... ....+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 10 0000 0 0 22233333321 23568
Q ss_pred EecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 265 IHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 265 iHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
||+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.40 E-value=0.00037 Score=55.74 Aligned_cols=89 Identities=15% Similarity=0.069 Sum_probs=67.1
Q ss_pred CCCCCccEEEcccCccccc----CcccccCCccCcceecccccccCC----CCcCCCCCcccceeecccCcccC------
Q 038351 49 LRPPQQENLSLASNELISV----IPSTFWNLKDILYLNLSLNSLTGP----IPLEIENLKVLVKIYFSMNNFAG------ 114 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~----ip~~~~~l~~L~~l~l~~N~l~G~----iP~~~~~l~~L~~l~ls~N~l~G------ 114 (348)
...+.|+.|+|++|.+... +-..+...+.|+.|+|++|.++.. +=..+...++|+.|++++|.+..
T Consensus 41 ~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~ 120 (167)
T d1pgva_ 41 CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVE 120 (167)
T ss_dssp TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHH
T ss_pred hhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHH
Confidence 5568899999999998743 333455678999999999999864 22346778899999999986542
Q ss_pred -ccCCccccccccceeeeeccccc
Q 038351 115 -VIPNAIGCLNILQHLFLGYNRLQ 137 (348)
Q Consensus 115 -~iP~~l~~l~~L~~L~ls~N~ls 137 (348)
.+...+..-+.|+.|+++++...
T Consensus 121 ~~l~~~L~~n~sL~~l~l~~~~~~ 144 (167)
T d1pgva_ 121 MDMMMAIEENESLLRVGISFASME 144 (167)
T ss_dssp HHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHHhCCCccEeeCcCCCch
Confidence 14556666788899998876543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.17 E-value=0.0077 Score=52.49 Aligned_cols=141 Identities=18% Similarity=0.191 Sum_probs=79.1
Q ss_pred hhHHhhhCCCccccc-----cccCCcceEEEeEecCCceEEEEeeeeccCccchhhHHHhhhccccccccee--eEEE--
Q 038351 149 LELCRVTNGFSEDNL-----ISRGGFGSIHKARIQDRMEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRNLI--KIIS-- 219 (348)
Q Consensus 149 ~~~~~~~~~f~~~~~-----lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv--~l~~-- 219 (348)
.++......|...++ |..|---+.|+.+..++ .+++|..... ...+....|++++..+...++. ..+.
T Consensus 6 ~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~ 82 (316)
T d2ppqa1 6 DELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRK 82 (316)
T ss_dssp HHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred HHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccceec
Confidence 455666667766443 34555577899887776 4888877533 2335566777777777644332 1110
Q ss_pred ----EEecCCeEEEEEeccCCCCHHH-----H---------Hhchh----------------------------------
Q 038351 220 ----SRSNEDFKVLVLEYMPRGSLEK-----C---------LYSSN---------------------------------- 247 (348)
Q Consensus 220 ----~~~~~~~~~lV~Ey~~~gsL~~-----~---------l~~~~---------------------------------- 247 (348)
+.........++.++.+..... . ++...
T Consensus 83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (316)
T d2ppqa1 83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 162 (316)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence 1122345566777765532210 0 00000
Q ss_pred --HHHHHHHHHHh----cCCCceEecCCCcCceEEcCCCcEEEeecCCccc
Q 038351 248 --YVGFALEYLHF----DYSVLIIHYDLKPSNVLFDDNIVTHLSDFGIAKL 292 (348)
Q Consensus 248 --~i~~~L~yLH~----~~~~~iiHrDik~~NILld~~~~~kl~DfGla~~ 292 (348)
.+....+.+.. ....++||+|+.+.||+++.+...-|.||+.+..
T Consensus 163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 01112222221 1246699999999999999988778999998854
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.81 E-value=0.0065 Score=55.02 Aligned_cols=72 Identities=15% Similarity=0.113 Sum_probs=47.1
Q ss_pred cccccCCcceEEEeEecCC--------ceEEEEeeeeccCccchhhHHHhhhcccccccc-eeeEEEEEecCCeEEEEEe
Q 038351 162 NLISRGGFGSIHKARIQDR--------MEFSVKGFHLQCSGAFKSFDFECDVMKSTCYRN-LIKIISSRSNEDFKVLVLE 232 (348)
Q Consensus 162 ~~lG~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~E 232 (348)
+.|+.|-.-.+|++...++ ..|.++... .. .......+|..+++.+.-.+ ..++++++.. .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4577788889999986543 345555543 22 22344567888888886334 4577887753 68999
Q ss_pred ccCCCCH
Q 038351 233 YMPRGSL 239 (348)
Q Consensus 233 y~~~gsL 239 (348)
|+++.++
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9986543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.56 E-value=0.002 Score=50.98 Aligned_cols=88 Identities=10% Similarity=0.118 Sum_probs=44.5
Q ss_pred CCCCCccEEEcccCccccc----CcccccCCccCcceecccccccCC----CCcCCCCCcccceeec--ccCcccC----
Q 038351 49 LRPPQQENLSLASNELISV----IPSTFWNLKDILYLNLSLNSLTGP----IPLEIENLKVLVKIYF--SMNNFAG---- 114 (348)
Q Consensus 49 ~~~~~l~~l~L~~N~l~g~----ip~~~~~l~~L~~l~l~~N~l~G~----iP~~~~~l~~L~~l~l--s~N~l~G---- 114 (348)
...++|+.|+|++|.++.. |=..+...++|+.|+++.|.++.. +-..+...++|+.++| +.|.+.-
T Consensus 43 ~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~ 122 (166)
T d1io0a_ 43 KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM 122 (166)
T ss_dssp TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH
T ss_pred hcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHH
Confidence 3445666666666665443 222334455666666666665432 2234455555654333 3455432
Q ss_pred ccCCccccccccceeeeecccc
Q 038351 115 VIPNAIGCLNILQHLFLGYNRL 136 (348)
Q Consensus 115 ~iP~~l~~l~~L~~L~ls~N~l 136 (348)
.|...+.+.+.|+.|+++.++.
T Consensus 123 ~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 123 EIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHhCCCcCEEeCcCCCC
Confidence 2344455555666666655443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.05 E-value=0.0041 Score=49.13 Aligned_cols=88 Identities=13% Similarity=0.110 Sum_probs=60.9
Q ss_pred CCCCCccEEEccc-Cccccc----CcccccCCccCcceecccccccCCCC----cCCCCCcccceeecccCcccCc----
Q 038351 49 LRPPQQENLSLAS-NELISV----IPSTFWNLKDILYLNLSLNSLTGPIP----LEIENLKVLVKIYFSMNNFAGV---- 115 (348)
Q Consensus 49 ~~~~~l~~l~L~~-N~l~g~----ip~~~~~l~~L~~l~l~~N~l~G~iP----~~~~~l~~L~~l~ls~N~l~G~---- 115 (348)
...+.|+.|+|++ |.++.. +=..+...+.|+.|+|++|.++..-- ..+...++|+.+++++|.++..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3458999999997 456433 33345578889999999998875432 2345678899999999988644
Q ss_pred cCCccccccccceeee--ecccc
Q 038351 116 IPNAIGCLNILQHLFL--GYNRL 136 (348)
Q Consensus 116 iP~~l~~l~~L~~L~l--s~N~l 136 (348)
+-..+...+.|+.++| +.|++
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i 116 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPL 116 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCC
T ss_pred HHHHHHhCccccEEeeccCCCcC
Confidence 3356666777776544 45555
|